# EDGAR Filing Document

**Accession Number:** 0001116578
**File Stem:** 0001628280-26-021178
**Filing Date:** 2026-3
**Character Count:** 1400063
**Document Hash:** 5b651ca9c9a1b40b3413b88a669b4956
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-021178.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0001628280-26-021178

**CONFORMED SUBMISSION TYPE**: 20-F

**PUBLIC DOCUMENT COUNT**: 241

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRUDENTIAL PLC
- **CENTRAL INDEX KEY:** 0001116578
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 20-F
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15040
- **FILM NUMBER:** 26794247

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 5TH FLOOR, 10 OLD BAILEY
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** EC4M 7NG
- **BUSINESS PHONE:** 011442075483737

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 5TH FLOOR, 10 OLD BAILEY
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** EC4M 7NG

?xml version='1.0' encoding='ASCII'? puk-20251231

***As filed with the Securities and Exchange Commission on 26 March 2026***

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

***Washington, D.C. 20549***

**FORM 20-F**

---

| | |
|:---|:---|
| ☐ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| OR | OR |
| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the fiscal year ended 31 December 2025 | For the fiscal year ended 31 December 2025 |
| OR | OR |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| OR | OR |
| ☐ | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

---

***Commission File Number: 1-15040***

**PRUDENTIAL PUBLIC LIMITED COMPANY**

(Exact Name of Registrant as Specified in its Charter)

***England and Wales***

(Jurisdiction of Incorporation)

***13th Floor, One International Financial Centre, 1 Harbour View Street, Central, Hong Kong***

(Address of Principal Executive Offices)

***Rebecca Wyatt, Chief of Financial & Capital Reporting***

***+44 20 7220 7588, rebecca.wyatt@prudentialplc.com***

***5th Floor, 10 Old Bailey, London EC4M 7NG, England***

(Name, telephone, e-mail and/or facsimile number and address of company contact person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of Each Class | Trading <br>Symbol(s)<br>| Name of Each Exchange on <br>Which Registered<br>|
| American Depositary Shares, each representing 2 Ordinary Shares, 5 pence par <br>value each<br>| PUK | New York Stock Exchange |
| Ordinary Shares, 5 pence par value each | PUK/D | New York Stock Exchange<sup>\*</sup> |
| 3.125% Senior Notes due 2030 issued by Prudential Funding (Asia) plc | PUK30 | New York Stock Exchange |
| 3.625% Senior Notes due 2032 issued by Prudential Funding (Asia) plc | PUK32 | New York Stock Exchange |

---

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

The number of outstanding shares of each of the issuer's classes of capital or common stock as of 31 December 2025 was

2,548,213,779 Ordinary Shares, 5 pence par value each

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes ☐ No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to

Section 13 or 15(d) of the Securities Exchange Act of 1934.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ Yes ☒ No

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities

Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such

reports), and (2) has been subject to such filing requirements for the past 90 days.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted

pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period

that the registrant was required to submit and post such files).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or an

emerging growth company. See definition of "large accelerated filer," "accelerated filer," and "emerging growth company" in

Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Emerging growth company ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the

registrant has elected to not use the extended transition period for complying with any new or revised financial accounting

standards<sup>†</sup> provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the

effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by

the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the

registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-

based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §

240.10D-1(b). ☐

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this

filing:

U.S. GAAP ☐ International Financial Reporting Standards as issued by the International Accounting Standards Board ☒ Other ☐

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the

registrant has elected to follow:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ Item 17 ☐ Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).☐ Yes ☒ No

\*Not for trading, but only in connection with the registration of American Depositary Shares.

†The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards

Codification after 5 April 2012.

**Table of contents**

---

| | |
|:---|:---|
| **[Forward-looking statement](#if20250981a0d46e4b669404805d1a109_5114)s** | **[8](#if20250981a0d46e4b669404805d1a109_5114)** |
| **[Sources](#if20250981a0d46e4b669404805d1a109_5311)** | **[10](#if20250981a0d46e4b669404805d1a109_5311)** |
| **[Summary of our business](#if20250981a0d46e4b669404805d1a109_11147)** | **[11](#if20250981a0d46e4b669404805d1a109_11147)** |
| [Our business at a glance](#if20250981a0d46e4b669404805d1a109_11147) | **[11](#if20250981a0d46e4b669404805d1a109_11147)** |
| [Our clear and simple strategy](#if20250981a0d46e4b669404805d1a109_11225) | **[14](#if20250981a0d46e4b669404805d1a109_11225)** |
| [Market review](#if20250981a0d46e4b669404805d1a109_10300) | **[16](#if20250981a0d46e4b669404805d1a109_10300)** |
| [Company address and agent](#if20250981a0d46e4b669404805d1a109_5269) | **[18](#if20250981a0d46e4b669404805d1a109_5269)** |
| [Dividend data](#if20250981a0d46e4b669404805d1a109_5287) | **[18](#if20250981a0d46e4b669404805d1a109_5287)** |
| [Competition](#if20250981a0d46e4b669404805d1a109_5303) | **[19](#if20250981a0d46e4b669404805d1a109_5303)** |
| **[Strategic and operating review](#if20250981a0d46e4b669404805d1a109_28)** | **[20](#if20250981a0d46e4b669404805d1a109_28)** |
| **Our b[usiness model](#if20250981a0d46e4b669404805d1a109_10413)** | **[27](#if20250981a0d46e4b669404805d1a109_10413)** |
| **[Financial review](#if20250981a0d46e4b669404805d1a109_79)** | **[29](#if20250981a0d46e4b669404805d1a109_79)** |
| [Overview](#if20250981a0d46e4b669404805d1a109_79) | **[29](#if20250981a0d46e4b669404805d1a109_79)** |
| [Summary consolidated results and basis of preparation of analysis](#if20250981a0d46e4b669404805d1a109_793) | **[31](#if20250981a0d46e4b669404805d1a109_793)** |
| [Explanation of performance and other financial measures](#if20250981a0d46e4b669404805d1a109_9371) | **[32](#if20250981a0d46e4b669404805d1a109_9371)** |
| [Investments](#if20250981a0d46e4b669404805d1a109_5378) | **[37](#if20250981a0d46e4b669404805d1a109_5378)** |
| [Additional information on liquidity and capital resources](#if20250981a0d46e4b669404805d1a109_5386) | **[38](#if20250981a0d46e4b669404805d1a109_5386)** |
| T[EV basis, new business profit, free surplus generation and Group adjusted operating profit](#if20250981a0d46e4b669404805d1a109_5295) | **[39](#if20250981a0d46e4b669404805d1a109_5295)** |
| **[Determining adjusted operating profit of operating segments](#if20250981a0d46e4b669404805d1a109_5723)** | **[40](#if20250981a0d46e4b669404805d1a109_5723)** |
| **[Segment discussion](#if20250981a0d46e4b669404805d1a109_10963)** | **[41](#if20250981a0d46e4b669404805d1a109_10963)** |
| **[Definitions of performance metrics](#if20250981a0d46e4b669404805d1a109_14996)** | **[51](#if20250981a0d46e4b669404805d1a109_14996)** |
| **[Risk review](#if20250981a0d46e4b669404805d1a109_133)** | **[53](#if20250981a0d46e4b669404805d1a109_133)** |
| [Introduction](#if20250981a0d46e4b669404805d1a109_136) | **[53](#if20250981a0d46e4b669404805d1a109_136)** |
| [Risk governance](#if20250981a0d46e4b669404805d1a109_139) | **[53](#if20250981a0d46e4b669404805d1a109_139)** |
| [The Group's principal risks](#if20250981a0d46e4b669404805d1a109_10933) | **[55](#if20250981a0d46e4b669404805d1a109_10933)** |
| **[Risk factors](#if20250981a0d46e4b669404805d1a109_829)** | **[65](#if20250981a0d46e4b669404805d1a109_829)** |
| **[Supervision and regulation of Prudential](#if20250981a0d46e4b669404805d1a109_5403)** | **[77](#if20250981a0d46e4b669404805d1a109_5403)** |
| [Global regulatory and geopolitical developments and trends](#if20250981a0d46e4b669404805d1a109_5411) | **[77](#if20250981a0d46e4b669404805d1a109_5411)** |
| [Prudential in Asia](#if20250981a0d46e4b669404805d1a109_5428) | **[78](#if20250981a0d46e4b669404805d1a109_5428)** |
| [Prudential in Africa](#if20250981a0d46e4b669404805d1a109_5436) | **[82](#if20250981a0d46e4b669404805d1a109_5436)** |
| [Disclosure obligations under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012](#if20250981a0d46e4b669404805d1a109_5420) | **[82](#if20250981a0d46e4b669404805d1a109_5420)** |
| **[Governance](#if20250981a0d46e4b669404805d1a109_11952)** | **[83](#if20250981a0d46e4b669404805d1a109_11952)** |
| [Governance at a glance](#if20250981a0d46e4b669404805d1a109_11952) | **[83](#if20250981a0d46e4b669404805d1a109_11952)** |
| [Our leadership](#if20250981a0d46e4b669404805d1a109_11460) | **[84](#if20250981a0d46e4b669404805d1a109_11460)** |
| [How we operate](#if20250981a0d46e4b669404805d1a109_11873) | **[93](#if20250981a0d46e4b669404805d1a109_11873)** |
| [Committee reports](#if20250981a0d46e4b669404805d1a109_13898) | **[104](#if20250981a0d46e4b669404805d1a109_13898)** |
| [Audit committee financial expert](#if20250981a0d46e4b669404805d1a109_8371) | **[121](#if20250981a0d46e4b669404805d1a109_8371)** |
| [Differences between Prudential's governance practice and the NYSE corporate governance rules](#if20250981a0d46e4b669404805d1a109_8930) | **[121](#if20250981a0d46e4b669404805d1a109_8930)** |
| [Memorandum and Articles of Association](#if20250981a0d46e4b669404805d1a109_8948) | **[123](#if20250981a0d46e4b669404805d1a109_8948)** |
| [Code of ethics](#if20250981a0d46e4b669404805d1a109_8391) | **[126](#if20250981a0d46e4b669404805d1a109_8391)** |
| [Insider trading policies](#if20250981a0d46e4b669404805d1a109_13260) | **[126](#if20250981a0d46e4b669404805d1a109_13260)** |

---

---

| | |
|:---|:---|
| **[Compensation and employees](#if20250981a0d46e4b669404805d1a109_280)** | **[127](#if20250981a0d46e4b669404805d1a109_280)** |
| R[emuneration at a glance](#if20250981a0d46e4b669404805d1a109_11332) | **[127](#if20250981a0d46e4b669404805d1a109_11332)** |
| [Annual report on remuneration](#if20250981a0d46e4b669404805d1a109_11353) | **[130](#if20250981a0d46e4b669404805d1a109_11353)** |
| [Additional remuneration disclosures](#if20250981a0d46e4b669404805d1a109_11372) | **[156](#if20250981a0d46e4b669404805d1a109_11372)** |
| [Share ownership](#if20250981a0d46e4b669404805d1a109_11391) | **[157](#if20250981a0d46e4b669404805d1a109_11391)** |
| [Employees](#if20250981a0d46e4b669404805d1a109_11410) | **[157](#if20250981a0d46e4b669404805d1a109_11410)** |
| **[Additional information](#if20250981a0d46e4b669404805d1a109_8410)** | **[158](#if20250981a0d46e4b669404805d1a109_8410)** |
| [Significant subsidiaries](#if20250981a0d46e4b669404805d1a109_8990) | **[158](#if20250981a0d46e4b669404805d1a109_8990)** |
| [Major shareholders](#if20250981a0d46e4b669404805d1a109_8999) | **[158](#if20250981a0d46e4b669404805d1a109_8999)** |
| [Intellectual property](#if20250981a0d46e4b669404805d1a109_9015) | **[159](#if20250981a0d46e4b669404805d1a109_9015)** |
| [Legal proceedings](#if20250981a0d46e4b669404805d1a109_9023) | **[159](#if20250981a0d46e4b669404805d1a109_9023)** |
| [Material contracts](#if20250981a0d46e4b669404805d1a109_9031) | **[159](#if20250981a0d46e4b669404805d1a109_9031)** |
| [Exchange controls](#if20250981a0d46e4b669404805d1a109_9039) | **[159](#if20250981a0d46e4b669404805d1a109_9039)** |
| [Taxation](#if20250981a0d46e4b669404805d1a109_9047) | **[159](#if20250981a0d46e4b669404805d1a109_9047)** |
| [Documents on display](#if20250981a0d46e4b669404805d1a109_9055) | **[162](#if20250981a0d46e4b669404805d1a109_9055)** |
| [Controls and procedures](#if20250981a0d46e4b669404805d1a109_9063) | **[162](#if20250981a0d46e4b669404805d1a109_9063)** |
| [Listing information](#if20250981a0d46e4b669404805d1a109_9071) | **[163](#if20250981a0d46e4b669404805d1a109_9071)** |
| [Description of securities other than equity securities](#if20250981a0d46e4b669404805d1a109_9079) | **[163](#if20250981a0d46e4b669404805d1a109_9079)** |
| [Purchases of equity securities by Prudential plc and affiliated purchasers](#if20250981a0d46e4b669404805d1a109_9087) | **[164](#if20250981a0d46e4b669404805d1a109_9087)** |
| [Principal accountant fees and services](#if20250981a0d46e4b669404805d1a109_9095) | **[164](#if20250981a0d46e4b669404805d1a109_9095)** |
| [Limitations on enforcement of US Laws against Prudential, its Directors, management and others](#if20250981a0d46e4b669404805d1a109_9111) | **[164](#if20250981a0d46e4b669404805d1a109_9111)** |
| **[Financial Statements](#if20250981a0d46e4b669404805d1a109_304)** | **[165](#if20250981a0d46e4b669404805d1a109_304)** |
| [Consolidated financial statements](#if20250981a0d46e4b669404805d1a109_304) | **[165](#if20250981a0d46e4b669404805d1a109_304)** |
| [Condensed financial information of Registrant](#if20250981a0d46e4b669404805d1a109_9121) | **[253](#if20250981a0d46e4b669404805d1a109_9121)** |
| [Additional unaudited financial information](#if20250981a0d46e4b669404805d1a109_766) | **[260](#if20250981a0d46e4b669404805d1a109_766)** |
| **[Exhibits](#if20250981a0d46e4b669404805d1a109_10088)** | **[268](#if20250981a0d46e4b669404805d1a109_10088)** |

---

**Cross references to form 20-F requirements**

---

| | | | |
|:---|:---|:---|:---|
| **Item** | **20-F Form Requirements** | **Section in this Annual Report on Form 20-F** | **Page** |
| **Item 1** | Identity of Directors, Senior Management <br>and Advisers<br>| n/a |  |
| **Item 2** | Offer Statistics and Expected Timetable | n/a |  |
| **Item 3** | Key Information |  |  |
| **Item 3** | Capitalisation and indebtedness | n/a |  |
| **Item 3** | Reasons for the offer and use of proceeds | n/a |  |
| **Item 3** | Risk factors | Risk factors | **[65](#if20250981a0d46e4b669404805d1a109_829)** |
| **Item 4** | Information on the Company |  |  |
|  | History and development of the company | –Our business at a glance | **[11](#if20250981a0d46e4b669404805d1a109_11147)** |
|  | History and development of the company | –Company address and agent | **[18](#if20250981a0d46e4b669404805d1a109_5269)** |
|  | History and development of the company | –Documents on display | **[162](#if20250981a0d46e4b669404805d1a109_9055)** |
|  | History and development of the company | –Strategic and operating review | **[20](#if20250981a0d46e4b669404805d1a109_28)** |
|  | Business overview | –[Our clear and simple strategy](#if20250981a0d46e4b669404805d1a109_11225) | **[14](#if20250981a0d46e4b669404805d1a109_11225)** |
|  | Business overview | –Our business model | **[27](#if20250981a0d46e4b669404805d1a109_10413)** |
|  | Business overview | –Strategic and operating review | **[20](#if20250981a0d46e4b669404805d1a109_28)** |
|  | Business overview | –Segment discussion | **[41](#if20250981a0d46e4b669404805d1a109_10963)** |
|  | Business overview | –Definitions of performance metrics | **[51](#if20250981a0d46e4b669404805d1a109_14996)** |
|  | Business overview | –Competition | **[19](#if20250981a0d46e4b669404805d1a109_5303)** |
|  | Business overview | –Supervision and regulation of Prudential | **[77](#if20250981a0d46e4b669404805d1a109_5403)** |
|  | Business overview | –Investments | **[37](#if20250981a0d46e4b669404805d1a109_5378)** |
|  | Business overview | –TEV basis, new business profit, free surplus generation <br>and Group adjusted operating profit<br>| **[39](#if20250981a0d46e4b669404805d1a109_5295)** |
|  | Business overview | –Sources | **[10](#if20250981a0d46e4b669404805d1a109_5311)** |
|  | Organisational structure | –Our business model | **[27](#if20250981a0d46e4b669404805d1a109_10413)** |
|  | Organisational structure | –Significant subsidiaries | **[158](#if20250981a0d46e4b669404805d1a109_8990)** |
|  | Property, plants and equipment | Note C10 to the consolidated financial statements | **[239](#if20250981a0d46e4b669404805d1a109_8349)** |
| **Item 4A** | Unresolved Staff Comments | n/a |  |
| **Item 5** | Operating and Financial Review and <br>Prospects<br>|  |  |
| **Item 5** | Operating results | –Strategic and operating review | **[20](#if20250981a0d46e4b669404805d1a109_28)** |
| **Item 5** | Operating results | –Financial review | **[29](#if20250981a0d46e4b669404805d1a109_79)** |
| **Item 5** | Operating results | –Summary consolidated results and basis of preparation <br>analysis<br>| **[31](#if20250981a0d46e4b669404805d1a109_793)** |
| **Item 5** | Operating results | –Determining adjusted operating profit of operating <br>segments<br>| **[40](#if20250981a0d46e4b669404805d1a109_5723)** |
| **Item 5** | Operating results | –Explanation of performance and other financial measures | **[32](#if20250981a0d46e4b669404805d1a109_9371)** |
| **Item 5** | Liquidity and capital resources | –Explanation of performance and other financial measures | **[32](#if20250981a0d46e4b669404805d1a109_9371)** |
| **Item 5** | Liquidity and capital resources | –Additional information on liquidity and capital resources | **[38](#if20250981a0d46e4b669404805d1a109_5386)** |
| **Item 5** | Liquidity and capital resources | –Note D5 to the consolidated financial statements | **[241](#if20250981a0d46e4b669404805d1a109_562)** |
| **Item 5** | Research and development, patents and <br>licenses, etc<br>| n/a |  |
| **Item 5** | Trend information | –Strategic and operating review | **[20](#if20250981a0d46e4b669404805d1a109_28)** |
| **Item 5** | Trend information | –Explanation of performance and other financial measures | **[32](#if20250981a0d46e4b669404805d1a109_9371)** |
| **Item 5** | Critical Accounting Estimates | –Note A3 to the consolidated financial statements | **[176](#if20250981a0d46e4b669404805d1a109_349)** |

---

---

| | | | |
|:---|:---|:---|:---|
| **Item** | **20-F Form Requirements** | **Section in this Annual Report on Form 20-F** | **Page** |
| **Item 6** | Directors, Senior Management and <br>Employees<br>|  |  |
| **Item 6** | Directors and senior management | Board of Directors | **[84](#if20250981a0d46e4b669404805d1a109_11460)** |
| **Item 6** | Compensation | Compensation and employees: | **[127](#if20250981a0d46e4b669404805d1a109_280)** |
| **Item 6** | Compensation | –Remuneration at a glance | **[127](#if20250981a0d46e4b669404805d1a109_11332)** |
| **Item 6** | Compensation | –Annual report on remuneration | **[130](#if20250981a0d46e4b669404805d1a109_11353)** |
| **Item 6** | Compensation | –Summary of current Directors' remuneration policy | **[128](#if20250981a0d46e4b669404805d1a109_15141)** |
| **Item 6** | Compensation | –Additional remuneration disclosure | **[156](#if20250981a0d46e4b669404805d1a109_11372)** |
| **Item 6** | Board practices | –How we operate | **[93](#if20250981a0d46e4b669404805d1a109_11873)** |
| **Item 6** | Board practices | –Committee reports | **[104](#if20250981a0d46e4b669404805d1a109_13898)** |
| **Item 6** | Employees | Employees | **[157](#if20250981a0d46e4b669404805d1a109_11410)** |
| **Item 6** | Share ownership | Share ownership | **[157](#if20250981a0d46e4b669404805d1a109_11391)** |
| **Item 6** | Disclosure of a registrant's action to <br>recover erroneously awarded <br>compensation<br>| n/a |  |
| **Item 7** | Major Shareholders and Related Party <br>Transactions<br>|  |  |
| **Item 7** | Major shareholders | Major shareholders | **[158](#if20250981a0d46e4b669404805d1a109_8999)** |
| **Item 7** | Related party transactions | Note D4 to the consolidated financial statements | **[240](#if20250981a0d46e4b669404805d1a109_559)** |
| **Item 7** | Interests of Experts and Counsel | n/a |  |
| **Item 8** | Financial Information |  |  |
| **Item 8** | Consolidated statements and other <br>financial information | Financial statements | **[165](#if20250981a0d46e4b669404805d1a109_304)** |
| **Item 8** | Consolidated statements and other <br>financial information | Legal proceedings | **[159](#if20250981a0d46e4b669404805d1a109_9023)** |
| **Item 8** | Significant changes | n/a |  |
| **Item 9** | The Offer and Listing |  |  |
| **Item 9** | Offer and listing details | Listing information  | **[163](#if20250981a0d46e4b669404805d1a109_9071)** |
| **Item 9** | Markets | Listing information  | **[163](#if20250981a0d46e4b669404805d1a109_9071)** |
| **Item 10** | Additional Information |  |  |
| **Item 10** | Share capital | n/a |  |
| **Item 10** | Memorandum and Articles of Association | Memorandum and Articles of Association | **[123](#if20250981a0d46e4b669404805d1a109_8948)** |
| **Item 10** | Material contracts | Material contracts | **[159](#if20250981a0d46e4b669404805d1a109_9031)** |
| **Item 10** | Exchange controls | Exchange controls | **[159](#if20250981a0d46e4b669404805d1a109_9039)** |
| **Item 10** | Taxation | Taxation | **[159](#if20250981a0d46e4b669404805d1a109_9047)** |
| **Item 10** | Dividends and paying agents | n/a |  |
| **Item 10** | Statement by experts | n/a |  |
| **Item 10** | Documents on display | Documents on display | **[162](#if20250981a0d46e4b669404805d1a109_9055)** |
| **Item 10** | Subsidiary information | Note D6 to the consolidated financial statements | **[241](#if20250981a0d46e4b669404805d1a109_568)** |
| **Item 10** | Annual report to security holders | Submitted separately |  |

---

---

| | | | |
|:---|:---|:---|:---|
| **Item** | **20-F Form Requirements** | **Section in this Annual Report on Form 20-F** | **Page** |
| **Item 11** | Quantitative and Qualitative Disclosures <br>about Market Risk | –Risk review | **[53](#if20250981a0d46e4b669404805d1a109_133)** |
| **Item 11** | Quantitative and Qualitative Disclosures <br>about Market Risk | –Note C6 to the consolidated financial statements | **[231](#if20250981a0d46e4b669404805d1a109_8133)** |
| **Item 12** | Description of Securities Other than Equity <br>Securities<br>|  |  |
| **Item 12** | American depositary shares | Description of securities other than equity securities | **[163](#if20250981a0d46e4b669404805d1a109_9079)** |
| **Item 13** | Defaults, Dividend Arrearages and <br>Delinquencies<br>| n/a |  |
| **Item 14** | Material Modifications to the Rights of <br>Security Holders and Use of Proceeds<br>| n/a |  |
| **Item 15** | Controls and Procedures | Controls and procedures | **[162](#if20250981a0d46e4b669404805d1a109_9063)** |
| **Item 16A** | Audit Committee Financial Expert | Audit committee financial expert | **[121](#if20250981a0d46e4b669404805d1a109_8371)** |
| **Item 16B** | Code of Ethics | Code of ethics | **[126](#if20250981a0d46e4b669404805d1a109_8391)** |
| **Item 16C** | Principal Accountant Fees and Services | Principal accountant fees and services | **[164](#if20250981a0d46e4b669404805d1a109_9095)** |
| **Item 16D** | Exemptions from the Listing Standards for <br>Audit Committees<br>| n/a |  |
| **Item 16E** | Purchases of Equity Securities by <br>Prudential plc and Affiliated Purchasers<br>| Purchases of equity securities by Prudential plc and <br>affiliated purchasers<br>| **[164](#if20250981a0d46e4b669404805d1a109_9087)** |
| **Item 16F** | Change in Registrant's Certifying Accountant | n/a |  |
| **Item 16G** | Corporate Governance | Differences between Prudential's governance practice <br>and the NYSE corporate governance rules<br>| **[121](#if20250981a0d46e4b669404805d1a109_8930)** |
| **Item 16H** | Mine Safety Disclosure | n/a |  |
| **Item 16I** | Disclosure Regarding Foreign Jurisdictions <br>that Prevent Inspections<br>| n/a |  |
| **Item 16J** | Insider trading policies | Insider trading policies | **[126](#if20250981a0d46e4b669404805d1a109_13260)** |
| **Item 16K** | Cybersecurity | –Risk review | **[53](#if20250981a0d46e4b669404805d1a109_133)** |
| **Item 16K** | Cybersecurity | –Risk factors | **[65](#if20250981a0d46e4b669404805d1a109_829)** |
| **Item 17** | Financial Statements | n/a |  |
| **Item 18** | Financial Statements | Financial statements | **[165](#if20250981a0d46e4b669404805d1a109_304)** |
| **Item 19** | Exhibits | Exhibits | **[268](#if20250981a0d46e4b669404805d1a109_10088)** |

---

As used in this document, unless the context otherwise requires, the terms 'Prudential', 'Prudential Group', the 'Group', 'we', 'us'

and 'our' each refer to Prudential plc together with its subsidiaries, while the terms 'Prudential plc', the 'Company' and the 'parent

company' each refer to 'Prudential plc'. The definitions of the key metrics we use to discuss our performance in this report are set

out in the 'Definitions of performance metrics' section.

This 2025 Annual Report may include references to our website. Information on our website or any other website referenced in

this 2025 Annual Report is not incorporated herein and should not be considered to be part of this 2025 Annual Report. We have

included any website as an inactive textual reference only.

**Forward-looking statements**

This document contains 'forward-looking statements' with respect to certain of Prudential's (and its wholly and jointly owned

businesses') current plans, goals and expectations relating to future financial condition, performance, results, strategy and

objectives. Statements that are not historical facts, including statements about Prudential's (and its wholly and jointly owned

businesses') beliefs and expectations and including, without limitation, commitments, ambitions and targets, including those

related to sustainability (including ESG and climate-related) matters, and statements containing words such as 'may', 'will',

'prospects', 'goal', 'should', 'could', 'continue', 'aims', 'estimates', 'projects', 'believes', 'intends', 'expects', 'plans', 'targets',

'commits', 'seeks' and 'anticipates', and words of similar meaning and the negatives of such words, are forward-looking

statements. These statements are based on plans, assumptions, estimates and projections as at the time they are made, and

therefore undue reliance should not be placed on them. By their nature, all forward-looking statements involve risk and

uncertainty.

A number of important factors could cause actual future financial conditions or performance or other indicated results to differ

materially from those indicated in any forward-looking statement. Such factors include, but are not limited to:

–current and future market conditions, including fluctuations in interest rates and exchange rates, sustained inflationary pressure

(including resulting interest rate increases), volatile or sustained high or low interest rate environments, the performance of

financial and credit markets generally and the impact of economic uncertainty, slowdown or contraction;

–the impact of global political uncertainties, geopolitical instability, armed conflicts and heightened geopolitical tension among

major global powers, including increased friction in cross-border trade and the exercise of laws, regulations and executive

powers to restrict or control trade, financial transactions, capital movements and/or investment, as well as related sanctions,

trade restrictions, and other governmental or regulatory measures, which may also impact policyholder behaviour and reduce

product affordability;

–asset valuation impacts arising from the transition to a lower carbon economy;

–derivative instruments not effectively mitigating any exposures;

–the policies and actions of regulatory authorities, including, in particular, the policies and actions of the Hong Kong Insurance

Authority, as Prudential's Group-wide supervisor, as well as the degree and pace of regulatory changes and new government

initiatives generally;

–the impact on Prudential of systemic risk and other group supervision policy standards adopted by the International Association

of Insurance Supervisors, given Prudential's designation as an Internationally Active Insurance Group;

–the physical, social, morbidity/health and financial impacts of climate change and global health crises (including pandemics), as

well as other catastrophic events, both natural and human-made, which may impact Prudential's business, investments,

operations and its duties owed to customers;

–legal, policy and regulatory developments in response to climate change and broader sustainability-related issues, including the

development and interpretation of regulations, laws and standards relating to sustainability reporting, disclosures and product

labelling (which may be inconsistent across jurisdictions and give rise to conflicts of interpretation between national approaches,

misrepresentation or compliance risks) on the one hand, and those which may seek to limit the influence of sustainability

considerations on the other;

–the collective ability of governments, policymakers, the Group, industry and other stakeholders to implement and adhere to

commitments on mitigation of climate change and broader sustainability-related issues effectively (including not appropriately

considering the interests of all Prudential's stakeholders or failing to maintain high standards of corporate governance and

responsible business practices);

–the impact of competition and rapid technological change, including the pace of innovation, adoption, and changing customer

demands;

–the effect on Prudential's business and results from mortality and morbidity trends, lapse rates and policy renewal rates;

–the timing, impact and realisation of intended benefits, if any, and other uncertainties of future acquisitions or combinations

within relevant industries;

–the impact of internal transformation projects and other strategic actions failing to meet their objectives in a timely manner, or

at all, or adversely impacting the Group's operations or employees;

–the availability and effectiveness of reinsurance for Prudential's businesses;

–the risk that Prudential's operational resilience (or that of its suppliers and partners) may prove to be inadequate, including to

prevent, respond or recover from operational disruption arising from external events;

–disruption to the availability, confidentiality or integrity of Prudential's information technology, digital systems and data,

including hardware and software (or those of its affiliates, suppliers and service providers, and partners) including the risk of

cyberattacks, other data, information or security breaches and challenges in integrating AI tools and their related security and

privacy considerations, which may result in financial loss, business disruption and/or loss of customer services and data and

harm to Prudential's reputation;

–the increased non-financial and financial risks and uncertainties associated with operating joint ventures with independent

partners;

–the impact of changes in capital, solvency standards, accounting standards or relevant regulatory frameworks, and tax and

other legislation and regulations in the jurisdictions in which Prudential and its affiliates operate; and

–the impact of legal and regulatory actions, investigations and disputes.

These factors are not exhaustive. Prudential operates in a continually changing business environment with new risks emerging

from time to time that it may be unable to predict or that it currently does not expect to have a material adverse effect on its

business. In addition, these and other important factors may, for example, result in changes to assumptions used for determining

results of operations or re-estimations of reserves for future policy benefits. Further discussion of these and other important

factors that could cause actual future financial conditions or performance to differ, possibly materially, from those anticipated in

Prudential's forward-looking statements can be found under the 'Risk Factors' heading of this document.

Any forward-looking statements contained in this document speak only as of the date on which they are made or in the case of

any document incorporated by reference, the date of that document. Prudential expressly disclaims any obligation to update any

of the forward-looking statements contained in this document or any other forward-looking statements it may make, whether as a

result of future events, new information or otherwise, except as required pursuant to the UK's Public Offer and Admissions to

Trading Regulations (2024), the UK Prospectus Regulation Rules: Admission to Trading on a Regulated Market, the UK Listing

Rules, the UK Disclosure Guidance and Transparency Rules, the Hong Kong Listing Rules, the SGX-ST Listing Rules or other

applicable laws and regulations. Unless expressly stated otherwise, no statement contained or referred to in this document is

intended to be a profit forecast or profit estimate.

Prudential may also make or disclose written and/or oral forward-looking statements in reports filed with or furnished to the US

Securities and Exchange Commission, the UK Financial Conduct Authority, the Hong Kong Stock Exchange, the Securities and

Futures Commission of Hong Kong and other regulatory authorities, as well as in its annual report and accounts, other periodic

financial reports, proxy statements, offering circulars, registration statements, prospectuses, prospectus supplements, press

releases and other written materials and in oral statements made by directors, officers or employees of Prudential to third parties,

including financial analysts. All such forward-looking statements are qualified in their entirety by reference to the factors discussed

under the 'Risk Factors' heading of this document.

**Cautionary statements**

This document does not constitute or form part of any offer or invitation to purchase, acquire, subscribe for, sell, dispose of or

issue, or any solicitation of any offer to purchase, acquire, subscribe for, sell or dispose of, any securities in any jurisdiction nor

shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.

**Sources** 

Throughout this annual report, Prudential describes the position and ranking of its overall business and individual business units in

various industry and geographic markets. Such data comes from a variety of conventional sources generally accepted as relevant

business indicators by members of the financial services industry and which we believe to be reliable. These sources include formal

(e.g. competitors results release, local regulators and insurance association) and informal (industry exchange) market share

information available from institutions such as Association of Investment Management Companies Thailand, Association of Mutual

Funds in India, Financial Services Authority Indonesia, Hong Kong Insurance Authority, Hong Kong Monetary Authority, Indonesian

Life Insurance Association, Insurance Association of Cambodia, Insurance Commission of Philippines, Insurance Regulatory

Authority (Kenya), Insurance Regulatory Authority (Uganda), Insurance Regulatory and Development Authority of India, Insurance

Services Malaysia Berhad, Investment Trusts Association Japan, Korea Financial Investment Association, Life Insurance

Association of Malaysia, Life Insurance Association of Singapore, Lipper, Ministry of Finance Laos, Morningstar, Myanmar Insurance

Association, National Financial Regulatory Administration (China), National Insurance Commission (Ghana), Nigeria Insurers

Association, Pensions and Insurance Authority (Zambia), Securities Investment Trust and Consulting Association of R.O.C., State

Securities Commission of Vietnam, Taiwan Life Insurance Association, Thai Life Assurance Association, Vietnam Actuarial Network

and Wind Information Co. Ltd (China).

![p6.jpg](puk-20251231_g1.jpg)

**Summary of our business**

Our business at a glance

**A trusted partner for millions**

Our life and health insurance and asset management solutions serve over 17 million customers across

20 markets in Asia and Africa. We are headquartered in Hong Kong and have dual primary listings on

the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU).

---

| | |
|:---|:---|
| ⚫ | Our markets |
| ⚫ | Life insurance – offering a <br>range of products including <br>health and protection<br>|
| ⚫ | Asset management |

---

![7.jpg](puk-20251231_g2.jpg)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Our markets** | **Life business market** <br>**ranking**<sup>1</sup><br>| **APE sales**  | **Top 10 asset** <br>**manager**<sup>2</sup><br>| **Eastspring funds under**<br>**management or advice**<sup>3</sup><br>|
| **Hong Kong and Macau** | **Top 5** | **$2,221m** |  | **$7.7bn** |
| **Indonesia**  | **Top 3** | **$258m** |  | **$4.0bn** |
| **Mainland China** | **Top 5** | **$621m** |  | **$14.0bn** |
| **Malaysia** | **Top 3** | **$436m** |  | **$16.8bn** |
| **Singapore** | **Top 3** | **$938m** |  | **$148.0bn** |
| **Other Markets:** |  |  |  |  |
| **Africa** | **Top 5 in 3** <br>**markets**<br>| **$148m** |  |  |
| **Cambodia** | **Top 3** | **$14m** |  |  |
| **India** | **Top 5** | **$259m** |  | **$43.9bn** |
| **Japan** |  |  |  | **$6.8bn** |
| **Laos** | **Top 3** | **<$1m** |  |  |
| **Myanmar** | **Top 5** | **$12m** |  |  |
| **Philippines** | **Top 3** | **$151m** |  |  |
| **Taiwan** | **Top 3** | **$1,184m** |  | **$11.2bn** |
| **Thailand** | **Top 5** | **$360m** |  | **$14.1bn** |
| **Vietnam** | **Top 10** | **$57m** |  | **$7.0bn** |

---

(1)As reported at full year 2025 unless otherwise specified. Sources include formal (eg competitors' results releases, local regulators and insurance association) and

informal (industry exchange) market share. Ranking based on new business (APE sales, weighted new business premium, retailed weighted received premium, full

year premium or weighted first year premium) or gross written premium depending on availability of data. Hong Kong ranking based on APE sales. Rankings in the

case of Mainland China, Taiwan and Myanmar are among foreign insurers, while for India they are among private companies. Markets based on nine months ended

September 2025: Mainland China, Hong Kong, three months ended March 2025: PPMZ (Africa), full year 2024: Laos, Nigeria (Africa), Uganda (Africa), Zambia (Africa)

and full year 2023: Ghana (Africa) and Kenya (Africa).

(2)As reported at full year 2025. Sources include local regulators, asset management association, investment data providers and research companies (eg

Morningstar, Lipper). Rankings are based on total funds under management (including discretionary funds, where available) of onshore domiciled funds or

public mutual funds of the respective markets.

(3)Full year 2025 Group's share of funds under management or advice based on the market where the funds are contractually managed. Excludes funds managed

in Luxembourg and US.

![9.jpg](puk-20251231_g3.jpg)

Our focus remains firmly on high-quality, sustainable growth, disciplined capital allocation and delivering long-term

shareholder value.

---

| |
|:---|
| **Scale franchise in Asia and Africa:** |
| Well positioned to access growth opportunities in our markets |

---

---

| | | | |
|:---|:---|:---|:---|
| **1.** | **2.** | **3.** | **4.** |
| **Leading positions** <br>**across high** <br>**growth markets in** <br>**Asia and Africa**<br>| **Trusted** <br>**household brand** <br>**with nearly 180-**<br>**year heritage**<br>| **Balanced and** <br>**scaled distribution** <br>**channels**<br>| **Integration of** <br>**life insurance and** <br>**asset** <br>**management** <br>**capabilities**<br>|
| **Top three** positions <br>in nine life markets<br>| ![Pru-Logo.gif](puk-20251231_g4.gif) | **Second largest** <br>number of MDRT <br>agents globally<br>The **#1** independent <br>life insurer in Asia <br>bancassurance<br>| Total **$277.7bn** funds <br>under management <br>by Eastspring<br>|

---

**Driving Value creation through focus on execution:**<br>

---

| | | | |
|:---|:---|:---|:---|
| **Agency** | **Bancassurance** | **Health** | **Customer** |

---

Focus on

activation and

productivity

Deepening

penetration and

increasing mix of

health and

protection

Focus on quality

health and

protection

business

Focus on driving

acquisition and

loyalty

**Improving technology capabilities and operational effectiveness**<br>

---

| | |
|:---|:---|
| **Delivering high quality, consistent growth and driving shareholder returns:** | **Delivering high quality, consistent growth and driving shareholder returns:** |
|  | **Confidence** |
| Delivered **>10%** growth <br>across our key metrics<sup>1</sup><br>Implementing additional <br>**$1.2bn** buyback in <br>2026. Expected **$1.3bn** <br>capital return in 2027<sup>2</sup>. <br>**>$7bn** Capital returns <br>to shareholders in 2024–<br>27<sup>3</sup><br>2026 guidance of <br>double-digit growth <br>across our key metrics<sup>1</sup><br>| On track to deliver 2027 <br>objectives <br>|

---

1. Our key metrics are: new business profit, basic earnings per share based on adjusted operating profit and operating free surplus generated from in-force

insurance and asset management business.

2. Subject to Hong Kong Insurance Authority approval

3. Capital returns will be set taking into account the Group's financial condition and prospects, applicable capital and solvency requirements, investment

opportunities, market conditions and the general economic environment.

Our clear and simple strategy

Our mission is to be the most trusted partner and protector for this generation

and generations to come by providing simple and accessible financial and health

solutions.

"For Every Life" speaks to our ambition to meet the huge underserved needs of potentially four billion people across our markets

in Asia and Africa. With the collective wisdom of our talented people, we will partner with customers to improve their health and

financial understanding so that they can build the life they want.

"For Every Future" speaks to our ambition to add value to the wider community, for a more sustainable and inclusive future. We

are here to protect this generation, just as we have previous generations, and those we are yet to meet.

![12.jpg](puk-20251231_g5.jpg)

**Organisational model replicating successes at pace and scale**<br>

---

| |
|:---|
| **Multi-market growth engines** |
| *Read more about our markets in the 'Market Review' and 'Segment discussion' sections* |

---

---

| | | | |
|:---|:---|:---|:---|
| **Greater China** | **ASEAN** | **India** | **Africa** |

---

---

| | | |
|:---|:---|:---|
| Technology-<br>powered <br>distribution<br>| Transforming <br>health <br>business model<br>| Enhancing <br>customer <br>experiences<br>|

---

**Group-wide enablers**<br>

---

| | | |
|:---|:---|:---|
| **Open-architecture** <br>**technology platform**<br>| **Engaged people &** <br>**high-performance** <br>**culture**<br>| **Wealth and investment** <br>**capabilities**<br>|

---

**Value creation for all stakeholders**<br>

---

| | | | |
|:---|:---|:---|:---|
| **Customers** | **Employees** | **Shareholders** | **Communities** |

---

---

| |
|:---|
| **Managing our risks** |
| Thoughtful risk management through advocating the interests of our people, customers, regulators and shareholders |
| **Underpinned by the three pillars of our sustainability strategy** |
| Simple and accessible health and financial protection • Responsible investment • Sustainable business |

---

![p14.jpg](puk-20251231_g6.jpg)

**Market review**

**Multi-market growth engines**

We have extensive access to some of the world's fastest growing markets. Our

strategic plan leverages this advantage to deliver growth across our target

markets.

**Socioeconomic trends**

---

| |
|:---|
| **Low life insurance** <br>**penetration**<br>|
| **Penetration of GDP**<sup>1</sup> **(%)**<br> **Asia Health Protection Gap**<sup>2</sup><br> **Prudential's life markets** <br>**forecast**<sup>3</sup><br>|

---

![35184372089041](puk-20251231_g7.gif)

![](puk-20251231_g8.gif)

![](puk-20251231_g8.gif)

![](puk-20251231_g8.gif)

![35184372089056](puk-20251231_g9.gif)

![](puk-20251231_g10.gif)

![](puk-20251231_g10.gif)

3.8x

2.2x

2.1x

1.4x

---

| | |
|:---|:---|
| ■ | Asia |
| ■ | World |

---

Gross written premium

rebased 2015 to 100

---

| |
|:---|
| **How Prudential is responding:**  |
| Focused on being a trusted partner to our customers.<br>Targeted investment in structural growth markets in Asia and Africa. <br>Operational execution across our strategic pillars.<br>Financial delivery for shareholders through our revised capital allocation framework. |

---

(1)Swiss Re Institute; sigma No. 2/2025 - Insurance penetration (premiums as a percentage of GDP).

(2)Swiss Re Institute: Asia Life & Health consumer survey 2025. $300 billion protection gap covers Prudential markets only in premium equivalent terms.

Combines mortality protection gap (dependent support shortfall after primary income earner death) and health protection gap, defined as uncovered out-of-

pocket health care costs that cause financial strain to households.

(3)Source: Swiss Re sigma - Gross Written Premium growth 2015 to 2035. Asia excluding Australia, Japan, and Korea

![map-20-F.jpg](puk-20251231_g11.jpg)

Greater China

**Demand drivers**

**–Hong Kong and Macau** Demand from Mainland Chinese

visitors continues to be a structural growth engine, while the

domestic market is bolstered by the net migration of skilled

professionals.

**–Mainland China** Supportive regulatory environment, rising

household wealth and a health protection gap exceeding

$140bn<sup>1</sup>.

**–Taiwan** Solid GDP growth and sustained long term

savings demand across a c.24m population.

**Our platform to execute**

**–Hong Kong and Macau** Scaled, tech enabled agency model.

Long standing exclusive bancassurance partnerships.

**–Mainland China** Expanding bancassurance presence and

ongoing agency transformation. Nationwide coverage: 23

branches across 102 cities - which represent 80 per cent of

GDP.

**–Taiwan** Competitive participating savings propositions

delivered through a multi-channel distribution platform.

ASEAN

**Demand drivers**

Access to a geographically diverse population exceeding 700

million<sup>2</sup>, low insurance penetration, and presence across nine

markets, anchored by Indonesia, Malaysia and Singapore.

**Our platform to execute**

–Region's leading multi-channel distribution franchise.

–Market leader in bancassurance – partnerships with

established bank partners.

–Indonesia: Balanced growth across agency and

bancassurance, with consistent leadership in the Syariah

market.

–Malaysia: Multi-channel model underpins resilient

performance during agency transformation, with leadership

in the Takaful market.

–Singapore: High quality franchise, with a focus on strong

adviser productivity and product innovation to drive

increased penetration in the high-net-worth segment.

Africa

**Demand drivers**

–Five market footprint; access to over 400 million people

and an aggregate GDP base of over $600 billion<sup>5</sup>.

–Low insurance penetration.

–High out of pocket healthcare spending.

**Our platform to execute**

–Continued investment in agency capability.

–Expansion of bancassurance distribution (over 950 bank

branches from more than 25 partnerships).

–Market leading positions in Uganda and Zambia.

India

**Demand drivers**

–Life insurance penetration roughly 3 per cent<sup>6</sup>.

**Our platform to execute**

–Long-standing partnership with ICICI bank across life

insurance and asset management.

–Well diversified distribution mix supporting scale and

resilience.

–Top five market position in life insurance.

–Progressing on regulatory approvals and operational

readiness for the future launch of our standalone health

insurance business.

Eastspring

**Demand drivers**

–New wealth creation of roughly $10 trillion annually<sup>3</sup>.

–Ongoing global capital reallocation towards Asia – 38 per

cent of expected global net new investment flows by 2027<sup>4</sup>.

**Our platform to execute**

–Broad Asian footprint with around 400 investment

professionals across 10 key markets.

–Partnership with Prudential's life businesses.

–Strong investment capability; local insight and regional

scale.

(1)Source: Swiss Re Institute. Asia Life & Health consumer survey 2025. Health

protection gap in premium equivalent terms

(2)Source: UN Department of Economic and Social Affairs World Population

Prospects.

(3)Source: BCG Global Wealth Report 2025.

(4)Source: Broadridge APAC Quarterly Trends Report Q2 2025.

(5)Source: United Nations Population Prospects and IMF World Economic

Outlook. Africa markets include Ghana, Kenya, Nigeria, Uganda and Zambia

(6)Source: Swiss Re Institute; sigma No. 2/2025 - Insurance penetration

(premiums as a percentage of GDP)

Company address and agent

Prudential plc is a public limited company incorporated on 1 November 1978, registered in England and Wales and operating under

the Companies Act 2006. Refer to the 'Memorandum and Articles of Association' sub-section of the 'Governance' section of this

report for further information on the constitution of the Company.

Prudential's registered office is 5th Floor, 10 Old Bailey, London, EC4M 7NG, England (telephone: +44 (0)20 7220 7588).

Prudential's principal executive offices are located at 13th Floor, One International Financial Centre, 1 Harbour View Street,

Central, Hong Kong. The Group maintains a corporation website containing a wide range of information relevant for private and

institutional investors: www.prudentialplc.com. Information on our website is not incorporated herein and should not be

considered to be part of this 2025 Annual Report.

Dividend data

Under UK company law, Prudential plc may pay dividends only if sufficient distributable reserves of the Company are available for

that purpose and if the amount of its net assets is greater than the aggregate of its called-up share capital and non-distributable

reserves (such as the share premium account) and the payment of the dividend does not reduce the amount of its net assets to

less than that aggregate. 'Distributable reserves' are accumulated, realised profits not previously distributed or capitalised less

accumulated, realised losses not previously written off, on the applicable GAAP basis. For further information about the Company,

please refer to the section headed Condensed Financial Information of Registrant (Schedule II).

The retained profit of the Company is principally generated from dividend and interest income received from subsidiaries. Many of

its insurance subsidiaries are subject to regulations that restrict the amount of dividends that they can pay to the Company. These

restrictions are discussed in more detail in notes C9.3 and D6.2 to Prudential's consolidated financial statements.

Subject to the restrictions referred to above, Prudential plc's directors have the discretion to determine whether to pay an interim

dividend and the amount of any such interim dividend but must take into account the Company's financial position. The directors

also have the discretion to recommend payment of a final dividend, such recommendation to be approved by ordinary resolution

of the shareholders. The approved amount may not exceed the amount recommended by the directors.

The following table shows certain information regarding the dividends per share of Prudential plc relating to the years indicated.

First and second interim dividends are recorded in the period in which they are paid. The first 2025 interim dividend was paid on

16 October 2025 and the second interim dividend will be paid on 13 May 2026. Further information on the Group's 2025 dividends

is provided in note B5 to Prudential's consolidated financial statements.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **US cents per share** | **2025** | 2024 | 2023 | 2022 | 2021 |
| First Interim Ordinary Dividend | **7.71** | 6.84 | 6.26 | 5.74 | 5.37 |
| Second Interim Ordinary Dividend | **18.89** | 16.29 | 14.21 | 13.04 | 11.86 |

---

Reflecting the Group's capital allocation priorities, a portion of capital generation will be retained for reinvestment in organic

growth opportunities and for investment in capabilities, and dividends will be determined primarily based on the Group's operating

capital generation after allowing for the capital strain of writing new business and recurring central costs. Dividends are expected

to grow broadly in line with the growth in the Group's operating free surplus generation, and will be set taking into account

financial prospects, investment opportunities and market conditions.

In line with the guidance for 2025 and our dividend policy, the Board has approved a 2025 second interim cash dividend of 18.89

cents per share (2024: 16.29 cents per share). Combined with the first interim cash dividend of 7.71 cents per share (2024: 6.84

cents per share), the Group's total 2025 cash dividend is 26.60 cents per share (2024: 23.13 cents per share), an increase of 15

per cent.

A dividend reinvestment plan (DRIP) will continue to be offered to shareholders on the UK register. A scrip dividend alternative,

with the issuance of new ordinary shares on the Hong Kong line only and the dilutive effect neutralised by a share repurchase on

the London line, will be offered in respect of the 2025 second interim dividend.

Guidance on the application of the dividend policy and changes to our capital allocation framework are set out in the Financial

review section.

Competition

There are other significant participants in each of the financial services markets in which Prudential operates. Our competitors

include both mutual and stock financial companies. In addition, regulatory and other developments in many of Prudential's

markets have blurred traditional financial service industry lines and opened the market to new competitors and increased

competition. In some of Prudential's markets, other companies may have greater financial resources, allowing them to benefit

from economies of scale, and may have stronger brands than Prudential does in that market.

The principal competitive factors affecting the sale of Prudential's products in its chosen markets are:

–Price and yields offered;

–Financial strength and ratings;

–Commission levels, charges and other expenses;

–Range of product lines and product quality;

–Brand strength, including reputation, quality of service and use of technological advances;

–Distribution channels;

–Investment management performance; and

–Historical bonus/contract enhancement and bonus interest levels.

Prudential offers different products in its different markets in Asia and Africa and, accordingly, faces different competitors and

different types of competition in each market. In all of the markets in which Prudential operates, its products are not unique and,

accordingly, it faces competition from market participants who offer a varied range of similar and identical products.

The competitive landscape across Asia and Africa differs widely by geographical market, reflecting differing levels of market

maturity and regulation. Prudential's competitors include both the subsidiaries of global life insurers and local domestic (including

state-owned) entities. The majority of local domestic life insurers in Asia and Africa remain focused on their core home markets.

The developed and liberalised markets of Hong Kong and Singapore are dominated by subsidiaries and branches of global life

insurance groups. The developing markets in South-east Asia such as Indonesia, Vietnam and the Philippines also see a high level

of participation by global life insurance groups. The large and relatively mature markets, such as Taiwan, are dominated by local

domestic insurers. In certain countries, the life insurance markets are dominated by local domestic insurers or by joint venture

entities between global insurance groups and local companies.

**Strategic and operating review**

The following discussion and analysis should be read in conjunction with Prudential's consolidated financial statements and the

related notes for the year ended 31 December 2025 included in this document.

The results discussed below are not necessarily indicative of the results to be expected in any future periods. This discussion

contains forward-looking statements based on current expectations, which involve risks and uncertainties. Actual results and the

timing of certain events may differ significantly from those projected in these forward-looking statements due to a number of

factors, including those set forth in the 'Forward-looking statements' and 'Risk factors' sections and elsewhere in this document.

**Operating segments and performance measures**

The Group's operating and reported segments for financial reporting purposes are defined and presented in accordance with IFRS

8 'Operating Segments'. Under the Group's management and reporting structure, its chief operating decision maker is the Group

Executive Committee (GEC), chaired by the Chief Executive Officer. There have been no changes to the Group's operating

segments from those reported in the Group's consolidated financial statements for the year ended 31 December 2024. Operations

and transactions that do not form part of any business unit are reported as 'Unallocated to a segment' and generally comprise

head office functions.

The performance measure of operating segments utilised by the Group is IFRS operating profit based on longer-term investment

returns (adjusted operating profit) as described below. This measurement basis distinguishes adjusted operating profit from other

constituents of total profit or loss for the year, including short-term interest rate and other market fluctuations and gain or loss on

corporate transactions. Further explanation on the determination of adjusted operating profit is provided in the 'Determining

adjusted operating profit of operating segments' section.

**New business sales**

The Group reports Annual Premium Equivalent (APE) new business sales as a measure of new policies sold in the year, which is a

key metric for the Group's management of the development of the business. This metric provides an indicative volume measure of

transactions undertaken in the reporting period that have the potential to generate profits for shareholders. APE new business

sales are calculated as the aggregate of annualised regular premiums and one-tenth of single premiums on new business written

during the year for all insurance products, including premiums for contracts designated as investment contracts and excluded from

the scope of IFRS 17. The use of the one-tenth of single premiums is intended to normalise policy premiums into the equivalent of

regular annual payments. This measure is commonly used in the insurance industry to allow comparisons of the amount of new

business written in a period by life insurance companies, particularly when the sales contain both single premium and regular

premium business. APE new business sales is not directly reconcilable to the primary financial statements, since there is no

equivalent measure under IFRS 17.

**Joint ventures (JVs) and associates**

Under IFRS, the Group accounts for its investments in JVs and associates by using the equity method of accounting. The Group's

share of profit or loss of its JVs and associates is presented in a single line in the income statement on a net of related tax basis.

For the purpose of segmental reporting on the Group's other performance metrics such as APE new business sales and adjusted

operating profit, the Group's proportionate share of the results of the JVs and associates are included within total Group results

and on a pre-tax basis for the segmental analysis of adjusted operating profit, with related tax charges included separately within

the 'Growth markets and other' segment.

**Currency volatility**

Our approach to evaluating the financial performance of the Group is to present percentage growth rates before the impact of

fluctuations in the value of the USD against local currencies in our operating markets - that is, on a constant exchange rate (CER)

basis. In a period of currency volatility, this measure allows an assessment of underlying results and business trends. This is

because our businesses receive premiums and pay claims in local currencies and are therefore not exposed to any cross-currency

trading effects. To maintain comparability in the discussion below the same basis has been applied. Growth rates based on actual

exchange rates (AER) are also shown in the financial tables presented for IFRS measures in this report. Consistent with previous

reporting periods, the assets and liabilities of our businesses are translated at year-end exchange rates so the effect of currency

movements has been fully incorporated within reported shareholders' equity.

In the remainder of this section, when we comment on the performance of our businesses, we focus on their performance

measured in local currency, ie presented here by reference to percentage growth expressed on a CER basis, unless otherwise

stated. In each such case, the performance of our businesses on an AER basis is explained by the same factors discussed in the

comments below, together with the impact of currency movements.

Discussion of the financial performance of the Group and its segments is contained separately in the Financial review and Segment

discussion sections that follow. Unless otherwise stated, the discussion in the following commentary is provided on a CER basis.

For the 2025 comparatives to 2024, the CER results were calculated using the 2025 average exchange rates.

Overview

In 2023, we launched our new strategy and with it we defined our purpose – For Every Life, For Every Future. The strategy sets

out our priorities in transforming the business to one that would deliver high quality consistent growth and drive compelling

shareholder returns.

We are now over halfway through this transformation journey and remain confident in meeting our two 2027 financial objectives

related to the compound annual growth rate in new business profit and operating free surplus generation from in-force insurance

and asset management business<sup>1</sup>.

We are well positioned to deliver on our strategy and objectives. Prudential is a trusted household brand across Asia, with a nearly

180-year heritage. We operate a multi-market and multi-channel model entirely focused on the growing markets across Greater

China, the countries within ASEAN, India and Africa. We are the only Asian regional company offering both life insurance and

stand-alone asset management services. Our insurance businesses have top three positions in seven Asian and two African

markets<sup>2</sup> and offer life and health insurance together with savings and investment products across balanced and scaled

distribution channels. Eastspring, our Asia-based asset management business serves both in-house and third-party clients, has

over US$277 billion in funds under management and is ranked in the top 10 in six of its markets.<sup>3</sup>

We delivered on our guidance for 2025 with each of new business profit, basic earnings per share based on adjusted operating

profit and operating free surplus generated from in-force insurance and asset management business growing by more than 10 per

cent in 2025. The 2025 dividend per share increased by 15 per cent compared with 2024. We continue to build our business by

taking action across our strategic pillars:

**–**In **agency**, we continue to professionalise our agency force, through a focus on quality recruitment, improving agent

productivity and operational efficiency through digital solutions;

–In **bancassurance**, where growth remains high, we have focused on quality, leading to improved product profitability. We

continue to deepen our strategic relationships, for example with Standard Chartered Bank and CITIC, and selectively broadening

our partnerships, with successful activation of our new strategic partnership with Bank Syariah Indonesia (BSI) in Indonesia;

–In **health** we are building the customer propositions to improve experience and ensuring the internal discipline to profitably

capture the growing need for health and other protection cover in our markets; and

–In **customer** we are continuing the roll out of our digital tools to enhance customer servicing and engagement and focussing on

creating differentiated propositions that cater to different life stages.

All of our strategic pillars are supported by our technology and operations function. We are modernising, simplifying and

modularising our technology platform, so that it is scalable, more resilient and operationally efficient. We are also using data and

AI to drive innovation and enhance growth and efficiency.

Alongside these operational deliveries we also completed a number of strategic portfolio management actions. The initial public

offering (together with an earlier private placement, the IPO) of ICICI Prudential Asset Management Company (IPAMC) in India

successfully completed in December. This generated proceeds (after tax and costs) of $1.4 billion from the disposal of a proportion

of our interest. We also resolved the outstanding litigation in relation to our Malaysia conventional life business, and in January

2026 we increased our holding in this business to 70 per cent. In addition, we have completed the divestment of our three

Francophone Africa businesses and Eastspring Korea.

We also completed the $2 billion share buyback programme that was announced in 2024 and refined our capital allocation

framework with a desire to drive further shareholder returns. We now expect to return more than $7 billion to shareholders over

the period 2024-2027. Further details are set out in the Capital management section below.

**Outlook**

The Group has a strong balance sheet and capital position. The current global uncertainties, challenges and conflicts could have

implications for the wider economic and market environment in which we will operate. However, we continue to see significant

growth opportunities in the markets in which we operate, with Asia life insurance premiums growing twice as fast as other regions<sup>4</sup>

alongside low insurance penetration and a large health protection gap. Our performance in 2025 demonstrates we are well

positioned to capture this opportunity, given our leading positions across these high growth markets, our balanced and scaled

distribution channels, and our life insurance and asset management capabilities.

In 2026 we expect Prudential to continue to deliver double-digit growth across our three key metrics - new business profit, basic

earnings per share based on adjusted operating profit and operating free surplus generated from in-force insurance and asset

management business.

Looking ahead, our focus remains firmly on high-quality, sustainable growth, disciplined capital allocation and delivering long-term

shareholder value. We carry the momentum of 2025 into 2026 and are firmly on track to achieve our 2027 financial objectives.

**Key 2025 performance highlights**<sup>5</sup>

*All growth rates in the Strategic and Operating Review are reported on a constant exchange rate (CER) basis unless otherwise* 

*stated.*

Prudential delivered on its guidance for growth in new business profit of greater than 10 per cent in 2025. Growth was broad

based across our life insurance markets. It also delivered on its guidance for 2025 on its operating free surplus generation from in-

force insurance and asset management business growing by more than 10 per cent in 2025, reflecting the quality of new business

written in recent years, together with our ongoing actions to improve cash generation and reduce operating variances.

The strength of our business is underpinned by the quality of our multi-channel agency and bancassurance distribution platform.

We have the second largest number of Million Dollar Round Table (MDRT) qualifying agents globally, and we remain the number

one independent insurer in Asia bancassurance<sup>6</sup> with over 180 bank partners across our markets, including 11 strategic partners.

Over the year we delivered an increase in agent productivity, the effect of which was muted by a fall in average monthly active

agents, especially in our emerging ASEAN markets. We remain focused on delivering our transformation of the agency channel.

Our priorities for building a professionalised agency force are:

–quality recruitment supported by the roll-out of our PRUVenture programme to further markets;

–increasing productivity through driving upward mobility to MDRT qualification; and

–supporting the agency channel through new and enhanced digital tools.

These digital tools include rolling out our digital agency platform PRUForce, which empowers agents with lead management

capabilities through PRULeads.

The bancassurance channel saw a growth in new business profitability underpinned by new product introductions, repricing actions

and favourable mix effects. APE sales growth in bancassurance was led by our strategic partnerships with Standard Chartered

Bank (SCB) and CITIC bank, while our new partnership with BSI has delivered over 7,500 new customers and is making a growing

contribution to Indonesia's bancassurance business.

Hong Kong new business profit growth was driven by sales growth and margin enhancement across both domestic customers and

Mainland China visitors and both the agency and bancassurance channels. We are confident in the continuation of the underlying

drivers of demand from both the domestic and Mainland China visitors segments and for sustained quality growth for the Hong

Kong segment.

Indonesia delivered new business profit growth, driven by improvements in margin, supported by a shift towards higher margin

products.

Our Mainland China joint venture has continued its transformation journey with a double-digit increase in new agency recruits and

a deepening relationship with our strategic partner, CITIC, where we accelerated sales momentum by focusing on their top 50

outlets, driving stronger execution and productivity. The business remains focused on delivering sustainable high-quality growth,

supported by disciplined risk management.

In the second half of the year, Malaysia's agency channel recovered strongly from market-wide disruption experienced in the first

half of the year. Our bancassurance channel continued to show strong new business growth in 2025.

Singapore saw APE sales growing strongly in the second half of 2025, following the fall in volumes seen in the first half of the

year. We have seen a shift in demand towards savings and wealth products. Our Singapore business operates multi-channel

distribution through agency, financial advisers and bancassurance, with strategic partnerships with UOB and Standard Chartered

providing broad access to target customer segments. The business now has a comprehensive suite of products to serve the high-

net-worth segment and is focused on building momentum for the future.

Our growth markets and other segment collectively saw growth in new business driven by Taiwan and Thailand, partially offset by

continuing headwinds in Vietnam.

Eastspring's funds under management and advice, which includes contributions from its wholly-owned, joint venture and associate

businesses increased by 8 per cent (on an actual exchange rate basis) from $258.0 billion at 31 December 2024 to $277.7 billion

at 31 December 2025. The growth reflected large positive inflows from external retail clients and our life businesses as well as

positive market movements. These increases were partly offset by reductions from the partial disposal of our investment in

IPAMC, following its IPO, and the sale of Eastspring Investments Korea.

Profit after tax for 2025 was $4,119 million (2024: $2,439 million on a constant exchange rate basis, $2,415 million on an actual

exchange rate basis), reflecting the growth in profit from our insurance and asset management businesses and the gain on partial

divestment of our shares in IPAMC, together with improved short-term market fluctuations in 2025 as compared with the prior

year.

**Capital management**

The Group's regulatory capital position remains strong, with an estimated shareholder surplus above the Group's Prescribed

Capital Requirement (GPCR) of $17.1 billion at 31 December 2025 (31 December 2024: $15.9 billion on an actual exchange rate

basis) and a cover ratio of 262 per cent (31 December 2024: 280 per cent).

A total dividend of 26.60 cents per share was approved for 2025, up 15 per cent, with a 2025 second interim dividend of 18.89

cents per share.

In August 2025, the Group provided a capital management update. In this update we explained that, given the Group's capital

strength and the inflection point reached in our operating free surplus generation, we have shifted our capital allocation framework

towards a total return orientation. Our dividend policy, which remains unchanged, is to grow dividends broadly in line with the

Group's net operating free surplus generation after allowing for new business investment, central costs and investment in

capabilities. In addition to the ordinary dividend, the Board will now consider making additional recurring returns of capital out of

the annual flow of capital generation. Capital returns will be set taking into account the Group's financial condition and prospects,

applicable capital and solvency requirements, investment opportunities, market conditions and the general economic environment.

In the near term, this results in the following expectations:

–An increase of more than 10 per cent in the total ordinary dividend per share for each of 2026 and 2027; and

–Additional returns of capital to shareholders: $500 million of share buybacks in 2026 and $600 million in 2027<sup>8</sup>.

In addition, we will make additional returns of $700 million in 2026 and plan $700 million in 2027<sup>8</sup> from the net proceeds from the

recently completed IPO of IPAMC.

Overall we expect that more than $7 billion will have been returned to shareholders over the period 2024–2027.

Further details on the Group's revised capital allocation framework and dividend policy are included in the Financial review.

Progress within our three strategic pillars

**Technology-powered distribution**

*Prudential's diversified distribution platform is focused on growth and innovation. It is centred around* 

*agency and bancassurance; in agency we are focused on improving productivity and quality* 

*recruitment; in bancassurance we are supported by partnerships with quality banks in Asia and Africa.*

**Agency**

Our agency channel remains central to the Group's growth strategy and is a significant competitive advantage. Strengthened

agent quality and enhanced productivity were features of the channel's transformation in 2025.

We remain focused on the key drivers of growth: driving upward mobility of agents to the Million Dollar Round Table (MDRT) level,

recruiting high quality agents and using technology, including AI, to support increased productivity and agent activation. To

support this, we are carrying out a substantial investment programme which made good progress in 2025. This included

enhancing our recruitment proposition and selection processes, with an increasing focus on quality. During 2025 we increased the

contribution to APE sales from our MDRT qualifiers, supported by AI-enabled bespoke digital learning & development programmes,

and solidified our position as the second-largest MDRT agency force globally.

Agency's APE sales increased by 1 per cent to $2,778 million, and we saw an uplift in agent productivity and quality across

multiple markets.

Growth in agency new business profit was driven by our developed markets of Hong Kong and Singapore, supported by our

emphasis on quality recruitment, targeted upskilling programmes and expansion of our health and protection proposition. Hong

Kong continued the successful execution of quality recruitment initiatives such as PRUVenture, coupled with continued upskilling

and a focus on upward mobility. 2025 also saw the launch of a first-in-market whole life limited pay hospital cash protection plan

in Hong Kong. In Singapore agency momentum built in the second half of the year, reflecting improvement in agent productivity.

In our emerging ASEAN markets, our focus is on quality agent recruitment and while overall active agent numbers declined in the

year, new business profit per active agent rose. Following the success of PRUVenture in Hong Kong, we are expanding this

recruitment initiative to these markets. In 2025 we launched PRUVenture in Malaysia and saw promising growth in active agents in

the second half of 2025 compared with the first half. This helped deliver double-digit growth in agency new business profit in the

second half compared with the same period in the prior year.

Market innovation continued with the launch of a generative AI-led performance management platform (PruAction) in Singapore,

providing real-time insights to support agent productivity improvements and goal achievement. Rollout to additional markets is

planned for 2026.

**Driving agent productivity**

Improvements in agent productivity measured using new business profit were led by strong upward mobility in the affluent plus

segment and high-value MDRT cohorts across Singapore, Malaysia, Indonesia and Africa.

Our long-term global partnership with MDRT.org continued to support uplift in agent capabilities through bespoke learning and

development. Our MDRT agents grew their APE sales by 4 per cent in the year.

While productivity improved, overall monthly average active agents numbered 57,000, lower year-on-year, with declines in

emerging ASEAN markets, particularly the Philippines and Vietnam. This, in part, reflects management actions to accelerate

quality-driven transformation in these historically mass-recruitment markets. In contrast, Hong Kong, Singapore and Malaysia

recorded strong momentum in the second half of the year with monthly average active agent numbers higher than in the first half,

supported by quality recruitment and enhanced upskilling initiatives.

**Quality Recruitment**

Our focus is on attracting and enabling agents who can deliver sustained performance and, in particular, drive increased health

and protection as a proportion of our sales mix.

Our PRUVenture quality-focused recruitment programme continued to scale across markets, driving higher activation and

sustained productivity, led by Malaysia where PRUVenture recruits in 2025 delivered six times higher APE sales per agent

compared with non-PRUVenture recruits. Following strong results in Hong Kong and Malaysia we will continue to roll out best

practices to other ASEAN emerging markets.

These outcomes demonstrate the success of our strategy toward building high-quality, professional agency teams with strong

long-term potential.

**Upskilling our agency force**

In 2025 we moved into the next phase of our company-wide transformation programme to build a full-time, professional and

advisory-led agency channel. Key initiatives included:

–Enhancing recruitment propositions, selection processes and leader capability development;

–Scaling learning and development curricula, including AI-enabled and digital learning;

–Deploying real-time performance insights through GenAI tools such as PruAction; and

–Strengthening our propositions for relevant segments of customers across Hong Kong, Singapore, Malaysia and Indonesia to

improve client service and deepen long-term relationships.

These investments are creating a future-fit, tech-enabled agency force equipped to meet evolving customer needs.

**Bancassurance**

Prudential's bancassurance business continues to strengthen as a core component of our technology-enabled distribution strategy.

By combining deep partnerships with leading banks and increasingly sophisticated digital capabilities, we are improving the reach,

quality and consistency of customer engagement across our Asian and African markets. Our long-term focus remains on scaling

high-quality growth, broadening customer access and enhancing partner productivity in a disciplined and sustainable way.

In 2025, our bancassurance channel delivered another year of strong progress towards our 2027 ambition to increase new

business profit. We saw sustained execution across markets and the continued effectiveness of our product and distribution

strategies.

APE sales increased 11 per cent to $2,873 million.

**Deepening regional and local partnerships**

Our bancassurance success continues to be driven by longstanding regional partnerships—for example with Standard Chartered

Bank (SCB) and CITIC—and complemented by strong contributions from local partner networks. Through co-developed distribution

models and targeted capability building, we generated over 200,000 new-to-bancassurance customers from strategic partners in

2025. We continue to broaden our reach with new partners such as BSI in Indonesia and CIMB in Singapore. The activation of our

strategic partnership with BSI in Indonesia has expanded our access to the high-potential Syariah segment. A broad suite of

protection and savings products has been introduced, enabling BSI to contribute meaningfully to Indonesia's bancassurance

business with over 7,500 new customers since inception.

Beyond exclusive partnerships, non-exclusive relationships delivered 7 per cent APE sales growth, reinforcing the resilience and

diversity of our bancassurance distribution platform.

**Expanding Solutions for all customer segments**

We continue to enhance our product suite, ensuring that customers benefit from solutions that reflect their evolving financial,

health and protection needs. Key developments during the year include:

–Launch of a first-in-market whole life limited pay hospital cash protection plan in Hong Kong;

–Introduction of a combined critical illness and savings solution for SCB Malaysia customers;

–A new high-end medical plan for bank partners in Taiwan;

–Wealth and legacy planning solutions for high-net-worth customers, including a new legacy protection plan in Hong Kong and

Whole Life Legacy offerings in Malaysia, Taiwan, Indonesia and Thailand; and

–Mass-market propositions through the BSI partnership, including PruSafar, designed for customers undertaking the Hajj.

These developments further strengthen the breadth and relevance of our customer propositions.

**Partner Capability and Digital Enablement**

Digital and analytics-driven enhancements remain central to improving customer journeys and advisor productivity. We continue

to embed data-led tools that support more personalised engagement and improve sales effectiveness across partner networks.

Supporting bank partner capability remains a priority. In 2025, in partnership with SCB, we delivered holistic training to over 150

SCB employees across key roles in the bancassurance partnership. In 2026, we will extend this effort, scaling reach to sales

leaders and integrating AI-enabled coaching to further enhance partner effectiveness.

**Transforming the health business model**

*We continue to make strong progress in transforming our health business, an important component of* 

*our wider health and protection offerings. Our dedicated health operating model has now been in place* 

*for two years, and we are building momentum across product innovation, advanced claims and* 

*provider management and empowering more sales teams to become champions of health.* 

In 2025, our health and protection business delivered disciplined product repricing, improved new business margin and maintained

a continued focus on portfolio sustainability.

We took decisive actions to keep healthcare affordable for customers. Against a backdrop of double-digit medical inflation across

many of our markets, we contained our medical cost growth to single digit by renegotiating provider contracts, strengthening

claims management, increasing our focus on Group fraud, waste and abuse management, which lead to savings of over $100

million in 2025, and embedding more sustainable product design.

Following our announcement to establish a standalone health insurance business in India, we are progressing on regulatory

approvals and operational readiness, positioning us for a launch in the near future.

This year, we refreshed our health value proposition, anchored by a long-term vision: *To give peace of mind to every patient in* 

*Asia and Africa*, and a customer promise: *Help when you need it most*. A Prudential health policy provides customers with peace of

mind, ensuring that when care is needed, they are protected. Throughout the journey, we help customers understand what is

happening, and what to expect next.

We introduced the Peace of Mind Plan as a clearer articulation of our health strategy, focused on five actions: tailored

propositions; operational excellence; end worry and hassle; guide patients at every step; and make sales teams champions of

health.

**Tailored propositions**

We continue to develop innovative, segment-specific, integrated propositions that address diverse customers' needs across our

markets. In Hong Kong, we launched Encash, combining health, protection and savings to meet evolving customer needs for

financial security and peace of mind. This innovation reflects our strategy to differentiate through customer-centric design and

long-term value creation.

In 2025, we provided cover to over 540,000 new health insurance customers<sup>9</sup> across Asia, reflecting strong demand for our

differentiated health proposition and the effectiveness of our segmented product strategy.

**Operational excellence**

We continue to strengthen our claims, underwriting and fraud, waste and abuse management, to better manage medical costs and

keep healthcare affordable. In 2025, we deployed a GenAI solution in close partnership with Google to support medical claim

adjudication in Malaysia. We also introduced Data Insights from Claims Experience ('DICE') in Indonesia and Malaysia, alongside

our Group fraud, waste and abuse framework with market-specific operating models.

We also continue to enhance our health underwriting capabilities through data-driven, inclusive guidelines and AI-powered

solutions designed to increase underwriting automation and efficiency. In Hong Kong, we launched MedScreen+, an innovative AI

underwriting tool to provide a faster, simpler and more transparent underwriting process for underwriters, while supporting our

financial consultants with instant and indicative underwriting results for customers.

**End worry and hassle**

We continue to enhance our health customer journey by expanding self-service capabilities in PRUServices. In 2025, we launched

core health functionalities that allowed customers to track the status of their claims and submit claims efficiently in Singapore,

Malaysia and Indonesia, enhancing the overall claims experience and reducing the servicing burden on our agents.

**Guide patients at every step**

We continue to build Guided Care - our signature experience designed to support our customers end-to-end, from symptom triage

and appointment booking to post-care follow-up, supported by our PRUHealth team nurses. In 2025, we launched pilots in Hong

Kong and Indonesia to facilitate breast cancer screening appointments and validated that patients value additional support when

they need it most.

We also accelerated the development of a tiered regional provider network to enhance control over medical claims costs and

improve health outcomes, delivering the annualised claims savings as previously outlined.

**Make sales teams champions of health**

We are empowering our sales teams to sell health products more effectively through targeted training and enhanced performance

management. Technology also played a role: in Singapore, we introduced a Health AI chatbot to help agents access information

more quickly, alongside recognition programmes that incentivise health sales. Together, these actions supported over 48,000

active health agents across our health priority markets in selling health policies during the year.

**Enhancing customer experiences**

*At Prudential, we are relentlessly focused on serving customers well. We believe that satisfied, loyal* 

*customers help us drive higher customer lifetime value. We have been making good progress to* 

*achieve our vision of enhancing customer experience.*

We remain firmly committed to delivering best-in-class experiences that earn the long-term trust of our customers. Our ambition is

to achieve top-quartile performance in the relationship net promoter score (rNPS), a measure of how likely customers are to

recommend Prudential, and to reach customer retention rates of 90–95 per cent by 2027. As at full year 2025, six of our business

units<sup>7</sup> were performing in the top quartile based on rNPS, reflecting continued year-on-year improvement in advocacy and

satisfaction. Eight out of ten business units improved their rNPS in 2025 compared with 2024. Customer retention increased by 1

percentage point to 88 percent, illustrating further progress toward our 2027 target.

These outcomes demonstrate the strength of our customer-centric approach and the impact of our strategic focus on delivering

consistently positive experiences.

**Compelling and differentiated propositions for every stage of life**

We continue to design and deliver customer-led propositions tailored to the evolving needs of individuals and families across our

markets. Our product suite remains comprehensive and aligned to diverse life stages, addressing health, protection and wealth

needs across income segments. Highlights in 2025 include:

–Health and Protection:

–In Malaysia, PRUWith You Plus offers a flexible plan with an increasing sum assured, enabling customers to adapt their

coverage over time. It also strengthens family protection by providing additional children's coverage at no extra cost, without

required underwriting.

–In Hong Kong, we introduced Prime Vantage Prestige Protector, a single-premium life protection product launched in

December 2025. It enhances legacy planning flexibility, provides updated guaranteed death benefits, and extends coverage to

the juvenile segment, with streamlined onboarding for high-net-worth clients.

–In Taiwan, we expanded our participating product suite by integrating health and protection benefits, offering solutions

tailored to needs such as critical illness, severe cancer, and all-cancer protection.

–Savings and Investment – We continue to strengthen our wealth offerings in key markets:

–In Hong Kong, the Entrust Multi-Currency Plan launched in February meets increasing demand for currency flexibility,

supporting advanced legacy planning and multi-currency wealth solutions.

–In Singapore, we expanded our high-net-worth proposition with a multi-pay Indexed Universal Plan, building on the success of

the earlier single-premium version. This offering enables high-net-worth clients to grow, protect and transfer wealth

across generations.

**Delivering a seamless, technology-enabled customer journey**

Delivering consistently excellent customer experiences requires integrated digital capabilities embedded across the customer

lifecycle. In 2025, we accelerated this transformation through upgrades to our digital servicing platforms and continued

investment in data and automation.

A key milestone this year was the enhancement of PRUServices, our digital self-service platform, which now incorporates real-time

feedback to further elevate customer journeys. PRUServices is live in nine business units<sup>7</sup> as of March 2026. Increased adoption of

the platform demonstrates meaningful channel shift towards digital self-service. The proportion of new business-processing

through auto-underwriting was 70 per cent in December 2025.

We are also leveraging artificial intelligence across several customer touchpoints. AI-enabled claims adjudication is improving

speed, accuracy and efficiency in claims processing, enhancing overall satisfaction while supporting operational scalability.

**Building advocacy for lifetime value**

We continue to strengthen how we engage customers through personalised, timely, and data-led interactions. Our Customer

Engagement Platform (CEP)—a key enabler of long-term advocacy—is now active across ten business units<sup>7</sup>. CEP enables us to

tailor communications by using AI to trigger engagement based on real-time events, using timing and content that is likely to be

the most valued by the customer.

In 2025, over $300 million of APE sales were generated from customers who interacted with Prudential via the platform,

demonstrating the material commercial impact of enhanced engagement. We will continue to expand the depth and intelligence of

CEP through AI-powered personalisation and data-driven insights to further improve lead quality and nurture long-term customer

relationships.

**Notes**

(1)The objectives assume exchange rates at December 2022 and are based on regulatory and solvency regimes applicable across the Group at the time the

objectives were set. The objectives assume that the same TEV and free surplus methodology will be applicable over the period and no material change to the

economic assumptions will occur.

(2)As reported at full year 2025 unless otherwise specified. Sources include formal (eg competitors' results releases, local regulators and insurance association)

and informal (industry exchange) market share. Ranking based on new business (APE sales, weighted new business premium, retailed weighted received

premium, full year premium or weighted first year premium) or gross written premium depending on availability of data. Hong Kong ranking based on APE

sales. Rankings in the case of Mainland China, Taiwan and Myanmar are among foreign insurers, while for India they are among private companies. Markets

based on nine months ended September 2025: Mainland China, Hong Kong, three months ended March 2025: PPMZ (Africa), full year 2024: Laos, Nigeria (Africa),

Uganda (Africa), Zambia (Africa) and full year 2023: Ghana (Africa) and Kenya (Africa).

(3)As reported at full year 2025. Sources include local regulators, asset management association, investment data providers and research companies (eg

Morningstar, Lipper). Rankings are based on total funds under management (including discretionary funds, where available) of onshore domiciled funds or

public mutual funds of the respective markets.

(4)Source: Swiss Re Institute - gross written premium growth 2015 to 2035 in Asia excluding Australia, Japan, and Korea.

(5)As in previous years, we discuss our performance in this report on a constant currency basis, unless stated otherwise. We discuss our financial position on an

actual exchange rates basis, unless otherwise noted. See note A1 to the consolidated financial statements for more detail on our exchange rate presentation.

The definitions of the key metrics we use to discuss our performance are set out in the "Definitions of performance metrics" section later in this document.

(6)Based on full year 2024 data from local regulators, industry associations and Prudential internal data. Estimates are based on market intelligence, if data is not

publicly available.

(7)Business units equate to legal entities in this instance.

(8)Subject to Hong Kong Insurance Authority approval.

(9)All individuals covered by new health policies.

![p32.jpg](puk-20251231_g12.jpg)

**Our business model**

**We are Prudential.**

For every life, we are partners.

For every future, we are protectors.

Key resources,

relationships

and differentiators

**Customers and Brand**

Prudential focuses on delivering high-quality

customer experiences that build long-term trust and

value. We are a trusted household brand with a

nearly 180–year legacy.

We are investing in digital capabilities to strengthen

service efficiency and personalise engagement.

**Markets** 

Few businesses have the breadth of our access to

the world's fastest-growing insurance markets

across Asia and Africa, which have low insurance

penetration and a large health protection gap. We

hold top-three positions in seven out of the 14 Asian

life markets and two out of the five African life

markets in which we have a presence<sup>1</sup>.

Eastspring, our in-house asset manager, spans 10

markets, manages $277.7 billion of assets and

occupies top-10 positions in 6 of its markets<sup>2</sup>.

**Products** 

The Group offers customer-led health, protection,

savings and investment solutions tailored to

changing needs across life stages, including

high-net-worth and multi-currency propositions.

We seek to develop new and enhanced propositions

in each of our markets to ensure we continue to

meet the evolving needs of our customers.

**Distribution** 

Prudential has a multi-channel distribution platform

of scale. We have one of the largest agency forces

in Asia, and we are the number one independent

insurer in Asia bancassurance.

We have scale in both agency and bancassurance

channels with around 57,000 average monthly

active agents across 2025 and more than 180 bank

partners, 11 of which are strategic.

---

| | |
|:---|:---|
| ![Icon-Plus.gif](puk-20251231_g13.gif) | *See more on our strategic pillars of* <br>*technology powered distribution,* <br>*transforming the health business model* <br>*and enhancing customer experiences in* <br>*the Strategic and operating review* <br>*section*<br>|

---

How we create value

---

| |
|:---|
| We exist to help people achieve financial security and <br>peace of mind by providing life insurance, health <br>protection, and asset management solutions across Asia <br>and Africa. Our goal is to deliver sustainable long-term <br>value for customers, shareholders, and communities.<br>|
| **Underpinned by our commitment to** <br>**sustainability**<br>**Focusing on our rigorous risk** <br>**management**<br>|

---

(1)See note (2) to the strategic and operating review for

basis.

(2)See note (3) to the strategic and operating review for

basis.

![BM-2.jpg](puk-20251231_g14.jpg)

**Writing new business**<br>

We sell products designed to meet the

needs of customers and support our

agents in the sales process. We aim to

write new business that provides

attractive returns to our shareholders.

**Managing the monies and** <br>**policies of our existing** <br>**customers**<br>

By putting the customer at the heart of

what we do, we seek to retain them

alongside managing the investments

that back their policies and the costs of

running our business.

**Allocating capital**<br>

We reinvest the cash flow

generated by existing policies into

new business and extending our

customer, digitally-enabled

distribution and health

capabilities, compounding the

growth of the business. These

cash flows are also used to meet

our central costs and pay

recurring returns to shareholders.

---

| |
|:---|
| Value we create for stakeholders |
| **Customers** |
| We aim to deliver superior customer <br>experiences. Our mission is 'to be <br>the most trusted partner and <br>protector for this generation and <br>generations to come, by providing <br>simple and accessible financial and <br>health solutions'. How we are <br>delivering for our customers will be <br>assessed against our ambition to <br>achieve top quartile relationship NPS <br>by 2027 and our customer retention <br>rate. |
| **Employees** |
| We provide an inclusive working <br>environment where we develop <br>talent, reward performance, protect <br>our people and value our <br>differences. We measure success for <br>our employees through engagement <br>scores from annual surveys. |
| **Shareholders** |
| We can accelerate value creation for <br>our shareholders and other <br>stakeholders by exercising <br>operational and financial discipline <br>as we execute our strategy.  |
| **Communities** |
| Our purpose reflects our <br>commitment to the wider <br>communities in which we operate, <br>through meeting the underserved <br>needs of our markets and supporting <br>a more sustainable future. Our <br>commitment to sustainability is <br>underpinned by our ambition to <br>achieve net zero by 2050 and a 55% <br>reduction in weighted average <br>carbon intensity (WACI) by 2030 <br>against our 2019 baseline. |

---

**6 business** 

**units**

with top quartile rNPS in 2025

Retention rate of **88%** in 2025

Our ambition is

**top quartile** 

employee engagement when

compared to our peers.

**$1.8bn** capital returns to

shareholders in 2025 (2024:

$1.4bn)

**53%** 

2025 reduction in WACI from

2019 baseline

**Financial review**

Overview

Our financial performance in 2025 demonstrated the strength of our business model and our balance sheet as we both delivered

high quality growth and enhanced capital returns to our shareholders.

In line with our guidance, we delivered double-digit growth across all of our key financial performance metrics<sup>1</sup>. This performance

reinforces our confidence both in delivering double-digit growth in 2026 and in achieving our 2027 financial objectives<sup>2</sup>(related to

the compound annual growth rate in new business profit and operating free surplus generation from in-force insurance and the

asset management business).

As we progressed along the path we set for ourselves to deliver our 2027 objectives, we reached an inflection point in our organic

capital generation. This, alongside the Group's capital strength, underpinned the update of our capital allocation framework in

August 2025, where we shifted towards a total return orientation.

In addition, we also completed a number of important actions demonstrating our disciplined approach to capital allocation. These

included the initial public offering (together with an earlier private placement, the IPO) of IPAMC in India, where we disposed of a

portion of our interest, reducing our holding from 49 per cent to 35 per cent, resulting in proceeds after deducting costs and tax of

$1.4 billion. Other actions completed include the $2 billion share buyback launched in 2024, and the sales of Eastspring Korea and

our three Francophone Africa businesses. We also issued our inaugural Singapore dollar-denominated bond on attractive terms.

Following the conclusion of the litigation regarding the ownership of our Malaysia conventional life business in 2025, we increased

our holding in this business to 70 per cent at an attractive price in January 2026.

2025 saw generally lower government bond yields, both in the US and across many of our Asia markets. The US 10-year yield

reduced to 4.3 per cent from 4.7 per cent at the end of 2024, with larger reductions notable in Singapore and Indonesia.

Equity market performance was relatively volatile, but with many indices recording double-digit growth over the year. The S&P

500 Index increased by 16 per cent, the MSCI Asia ex Japan Index increased by 27 per cent and the Hang Seng Index increased

by 28 per cent.

The period was also characterised by considerable foreign exchange volatility, with the US dollar weakening compared with most

global currencies.

As in previous periods, we comment on our performance below in local currency terms (expressed on a constant exchange rate

basis) to show the underlying business trends in periods of currency movement. We discuss our financial position on an actual

exchange rate basis, unless otherwise noted. All metrics used by management to assess performance (along with profit after tax)

are before deducting the amount attributable to non-controlling interests, unless otherwise stated in the definition. Balance sheet

metrics are presented net of non-controlling interests. The definitions of the key metrics we use to discuss our performance in this

report are set out in the 'Definitions of performance metrics' section later in this document.

We continued to build our record of high quality new business growth. This reflects the benefit of our diversified platform across

Asia and Africa, and across distribution channels. We continue to prioritise profitable new business with attractive capital

generation profiles. A significant proportion of our new business is from health and protection, participating and linked savings

products, limiting our market risk exposure. We continue to take strategic actions to improve our in-force performance. These

actions particularly in health claims management and in containing costs, have resulted in a material reduction in the level of

adverse operating variances. Cost in the year included $(230) million of investment in enhancing our customer, distribution, health

and technology capabilities, in line with our strategy.

Our CSM rose 14 per cent (on an actual exchange rate basis) to $25.0 billion in the year, primarily reflecting strong new business

CSM growth of 9 per cent and favourable economic and foreign exchange impacts.

After the net positive impact of short-term market fluctuations (including interest rates) and the overall benefit of corporate

transactions, driven by the gain on disposal of a portion of our interest in IPAMC, profit after tax was $4,119 million (2024: $2,415

million on an actual exchange rate basis, $2,439 million on a constant exchange rate basis). This profit, along with $443 million of

positive foreign exchange rate movements but partially offset by $(1,828) million of returns to shareholders, led to an increase in

shareholders' funds, which were up 15 per cent to $20,117 million at 31 December 2025 (31 December 2024: $17,492 million).

Our net asset value per share rose to $7.90 (31 December 2024: $6.58).

Our capital allocation framework continues to target holding a resilient regulatory capital position. Our period-end GWS

shareholder cover ratio was 262 per cent.

As part of our regular financing plans, we issued SGD 600 million (USD 462 million, net of costs) of subordinated debt at an

attractive coupon of 3.8 per cent – an inaugural raising of debt in an Asian currency further demonstrating our credit standing and

access to capital. At 31 December 2025, our Group leverage ratio (Moody's basis) was 13 per cent, unchanged from the end of

2024. During the year, S&P Global Ratings upgraded the Financial Strength rating of Prudential's core entities to 'AA' from 'AA-',

consistent with our ambition to remain an 'AA' company and reflecting our balance sheet strength.

This balance sheet strength, together with the progress of the business and the trajectory of our operating free surplus

generation, enabled us to shift our capital allocation framework towards a total return orientation.

Our priorities in allocating capital under our capital management framework and our dividend policy, which is unchanged, is set

out later in this section. We announced in August 2025 a revision to this framework which set out our expectations for the

following in the near term:

–An increase of more than 10 per cent in the total ordinary dividend per share for each of 2026 and 2027; and

–Additional returns of capital to shareholders: $500 million of share buybacks in 2026 and $600 million in 2027<sup>5</sup>in addition to the

return of the net proceeds from the IPO of IPAMC.

We will continue to assess the deployment of free surplus in the context of the Group's growth aspirations, leverage capacity and

liquidity and capital needs, based on the free surplus ratio. We seek to operate with a free surplus ratio of between 175 per cent

and 200 per cent. If the free surplus ratio is above the operating range over the medium term, and taking into account

opportunities to reinvest at appropriate returns and allowing for market conditions, capital will be returned to shareholders.

In line with the dividend policy, the Board has approved a second interim dividend of 18.89 cents per share (2024 16.29 cents per

share). When combined with the first interim dividend, the Group's total 2025 dividend is 26.60 cents per share, an increase of 15

per cent over 2024. We launched a $1.2 billion buyback in January 2026 comprising $500 million of recurring capital returns and

$700 million of net proceeds from the IPAMC IPO. The balance of the net proceeds from the IPAMC IPO will be returned to

shareholders during 2027<sup>5</sup>.

We provide a discussion of our operating results and financial review in this section, which is organised as follows:

–Summary consolidated results and basis of preparation of analysis

–Explanation of performance and other financial measures

–Movement in contractual service margin

–Other income and expenditure

–IFRS effective tax rates

–Total tax contributions

–Tax strategy

–Shareholders' equity

–Capital management

–Dividend

–Group capital position

–Financing and liquidity

–Cash remittances

–Investments

–Additional information on liquidity and capital resources

–TEV basis, new business profit, free surplus generation and Group adjusted operating profit

**2024 compared with 2023 results commentary**

The Group has taken advantage of the allowance under the SEC's FAST Act rules to omit the third year discussion on the Group's

financial performance, in particular the 2024 compared with 2023 results commentary, in this annual report on Form 20-F on the

basis that discussion of the trends in the Group's results by segment is included in the Group's prior year 2024 Annual Report on

Form 20-F, which is available on our website and at www.sec.gov.

Summary consolidated results and basis of preparation analysis

The following table sets forth Prudential's selected consolidated financial data in accordance with IFRS standards for the years

indicated, which is derived from Prudential's audited consolidated financial statements.

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Insurance revenue | **11080** | 10358 | 9371 |
| Insurance service expense: |  |  |  |
| Claims incurred | **(3331)** | (3147) | (2913) |
| Directly attributable expenses incurred | **(1455)** | (1328) | (1258) |
| Amortisation of insurance acquisition cash flows | **(3435)** | (3157) | (2745) |
| Other insurance service expenses | **(23)** | (131) | (197) |
|  | **(8244)** | (7763) | (7113) |
| Net expense from reinsurance contracts held | **(212)** | (302) | (171) |
| **Insurance service result** | **2624** | 2293 | 2087 |
| Investment return: |  |  |  |
| Interest revenue calculated using the effective interest method | **413** | 477 | 340 |
| Other investment return on financial investments | **15851** | 5442 | 9423 |
|  | **16264** | 5919 | 9763 |
| Fair value movements on investment contract liabilities | **(72)** | (95) | (24) |
| Net insurance and reinsurance finance income (expense): |  |  |  |
| Net finance expense from insurance contracts | **(14612)** | (4154) | (8839) |
| Net finance (expense) income from reinsurance contracts held | **(159)** | (338) | 191 |
|  | **(14771)** | (4492) | (8648) |
| **Net investment result** | **1421** | 1332 | 1091 |
| Other revenue | **411** | 382 | 369 |
| Non-insurance expenditure | **(1031)** | (1003) | (990) |
| Finance costs: interest on core structural borrowings of shareholder-financed businesses | **(183)** | (171) | (172) |
| Gain (loss) attaching to corporate transactions | **1515** | (71) | (22) |
| Share of profit (loss) from joint ventures and associates, net of related tax | **364** | 477 | (91) |
| Profit before tax *(being tax attributable to shareholders' and policyholders' returns)* <sup>note</sup> | **5121** | 3239 | 2272 |
| Tax charge attributable to policyholders' returns | **(180)** | (286) | (175) |
| Profit before tax attributable to shareholders' returns | **4941** | 2953 | 2097 |
| Total tax charge attributable to shareholders' and policyholders' returns | **(1002)** | (824) | (560) |
| Remove tax charge attributable to policyholders' returns | **180** | 286 | 175 |
| Tax charge attributable to shareholders' returns | **(822)** | (538) | (385) |
| **Profit for the year** | **4119** | 2415 | 1712 |
| **Attributable to:** |  |  |  |
| Equity holders of the Company | **3978** | 2285 | 1701 |
| Non-controlling interests | **141** | 130 | 11 |
| **Profit for the year** | **4119** | 2415 | 1712 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Earnings per share (in cents)** | **2025** | 2024 | 2023 |
| Based on profit attributable to equity holders of the Company: |  |  |  |
| Basic | **154.2¢** | 84.1¢ | 62.1¢ |
| Diluted | **153.5¢** | 84.0¢ | 61.9¢ |

---

**Note**

This measure is the formal profit before tax measure under IFRS. It is not the result attributable to shareholders principally because total corporate tax of the

Group includes those taxes on the income of consolidated with-profits and unit-linked funds that, through adjustments to benefits, are borne by policyholders.

These amounts are required to be included in the tax charge under IAS 12. Consequently, the profit before tax measure is not representative of pre-tax profit

attributable to shareholders.

Explanation of performance and other financial measures

Total profit after tax for 2025 was $4,119 million, $1,704 million higher than the $2,415 million earned in 2024. This primarily

reflected a $1,988 million increase in profit before shareholder tax to $4,941 million, which includes a $1,515 million net gain from

corporate transactions in the year (2024: a loss of $(71) million). The gain was primarily realised following the partial divestment

of the Group's holding in IPAMC upon its IPO.

The effective tax rate for 2025 was broadly in line with the prior year at 17 per cent (2024: 18 per cent) and given the higher level

of profit, resulted in a $(284) million increase in shareholder tax charge from $(538) million to $(822) million.

Further analysis of the results by each segment is provided in the Segment discussion section that follows.

**Movement in contractual service margin**

The CSM balance represents a discounted stock of unearned profit, which will be released over time as services are provided. This

balance increases due to additions from profitable new business contracts sold in the period and the unwind of the discounting

applied to the in-force book. It is also updated for any changes in expected future profitability, where applicable, including the

effect of short-term market fluctuations for business measured using the variable fee approach. The release of the CSM, which is

the main driver of adjusted operating profit, is then calculated after allowing for these movements.

In a normalised market environment, if the contribution from new business and the unwind of the CSM balance is greater than the

rate at which services are provided, then the CSM balance will increase. The new business added to the CSM will, therefore, be an

important factor in building the CSM, and we expect the compounding effect from the new business added to the CSM over time to

support growth in profit in the future.

The table below sets out the movement of CSM including the Group's share of the CSM of the JVs and associates over the year. As

the Group's share of the results of the JVs and associates are included in the Group's profit, including their related movement in

CSM is a key driver to understanding changes in profitability. The movement of CSM excluding the JVs and associates is provided

in note C3.2 to the consolidated financial statements.

**Contractual service margin net of reinsurance**

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| **Net opening balance at 1 January** | **21960** | 21012 |
| ***Changes that relate to future service*** |  |  |
| Changes in estimates that adjust the CSM | **1811** | 724 |
| New contracts in the year | **2835** | 2596 |
|  | **4646** | 3320 |
| ***Changes that relate to current service*** |  |  |
| Release of CSM to profit or loss | **(2554)** | (2352) |
| ***Net finance expense (income) from insurance contracts*** |  |  |
| Accretion of interest on GMM contracts | **348** | 321 |
| Other net finance expense (income) | **(43)** | 15 |
|  | **305** | 336 |
| Effect of movements in exchange rates | **648** | (356) |
| **Net closing balance at 31 December** | **25005** | 21960 |

---

Profitable new business in 2025 grew the CSM by $2,835 million. This increase exceeded the release of the CSM to the income

statement in the period of $(2,554) million, demonstrating the strength of our franchise and its ability to deliver future growth in

CSM and ultimately profit.

Changes in estimates that adjust the CSM reflect economic and other variances to update the CSM for changes in expected future

profitability including the impact of short-term market effects of business accounted for under the variable fee approach.

Movements in exchange rates had a positive impact of $648 million on the closing CSM. Overall the CSM grew by 14 per cent.

**Other income and expenditure**

---

| | | | |
|:---|:---|:---|:---|
|  | Actual exchange rate | Actual exchange rate | Actual exchange rate |
| | **2025 $m** | 2024 $m | 2023 $m |
| Net investment return and other items | **(41)** | 21 | (21) |
| Interest payable on core structural borrowings | **(184)** | (171) | (172) |
| Corporate expenditure | **(237)** | (237) | (230) |
|  | **(462)** | (387) | (423) |
| Restructuring and IFRS 17 implementation costs\* | **(171)** | (207) | (201) |
| **Central costs unallocated to a segment** | **(633)** | (594) | (624) |

---

\*Restructuring and IFRS 17 implementation costs largely comprise the costs of Group-wide projects including the implementation of IFRS 17 (including one-off

costs associated with embedding IFRS 17), reorganisation programmes and initial costs of establishing new business initiatives and operations. The costs

include those incurred in insurance and asset management operations of $(49) million (2024: $(59) million; 2023: $(81) million.

Corporate expenditure of $(237) million is unchanged from the prior year, reflecting continued control of head office costs.

Interest payable on core structural borrowings of $(184) million (2024: $(171) million) reflects the additional interest on the

additional SGD 600 million debt instrument issued in May 2025. Net investment return and other items totalled $(41) million

(2024: $21 million) reflecting lower interest rates and lower average central cash balances. As anticipated, restructuring costs

were lower at $(171) million (2024: $(207) million).

**IFRS effective tax rates**

The effective tax rate on total IFRS profit in 2025 was 17 per cent, broadly in line with the effective tax rate in 2024 of 18 per

cent.

In 2025 the new OECD global minimum tax rules were implemented in Hong Kong, effective from 1 January 2025. This brings the

whole Prudential group into scope of the new tax rules. The IFRS tax charge for 2025 includes $(23) million (2024: $nil) in respect

of global minimum tax.

**Total tax contributions** 

The Group continues to make significant tax contributions in the jurisdictions in which it operates, with $(1,353) million remitted

to tax authorities in 2025. This was higher than the equivalent amount of $(1,086) million remitted in 2024 (on an actual

exchange rate basis), principally due to taxes paid on corporate transactions, mainly the partial disposal of our investment in

IPAMC.

**Tax strategy**

The Group publishes its tax strategy annually which, in addition to complying with the mandatory UK (Finance Act 2016)

requirements, also includes a number of additional disclosures that provide insight into the Group's tax contributions. An updated

version of the tax strategy, including 2025 data, is expected to be available on the Group's website before 29 May 2026.

**Shareholders' equity**

---

| | | |
|:---|:---|:---|
| **Group IFRS shareholders' equity** |  |  |
|  | **2025 $m** | 2024 $m |
| Profit for the year | **4119** | 2415 |
| Less non-controlling interest | **(141)** | (130) |
| **Profit after tax for the year attributable to shareholders** | **3978** | 2285 |
| Exchange movements, net of related tax | **443** | (309) |
| External cash dividends | **(594)** | (552) |
| Share repurchases/buybacks | **(1234)** | (878) |
| Adjustment to non-controlling interest | **–** | (857) |
| Other movements | **32** | (20) |
| **Net increase (decrease) in shareholders' equity** | **2625** | (331) |
| IFRS shareholders' equity at beginning of the year | **17492** | 17823 |
| **IFRS shareholders' equity at end of the year** | **20117** | 17492 |
| **IFRS shareholders' equity per share**<sup>3</sup> | **790¢** | 658¢ |

---

Group IFRS shareholders' equity increased from $17.5 billion at the start of 2025 to $20.1 billion at 31 December 2025. This

increase reflects $4.0 billion of profit earned in the period, including the profit from the disposal of the Group's partial interest in

IPAMC that we plan to return to shareholders, and positive exchange movements of $0.4 billion, partly offset by dividend

payments and share buybacks of $(1.8) billion.

**Capital management**

In the first half of 2025, we refined our capital allocation framework with a desire to drive better shareholder returns. This led to a

shift in focus towards a total return orientation out of the annual flow of capital generation. Following this refinement our capital

allocation priorities are as follows:

We continue to target resilient capital buffers such that the Group shareholder coverage ratio is above 150 per cent of the

shareholder Group Prescribed Capital Requirement to ensure the Group can withstand volatility in markets and operational

experience. We seek to operate with a free surplus ratio of between 175 per cent and 200 per cent;

–Following sufficient capital being held, our priority for allocating capital will be re-investing in writing high-quality new business;

–Our next priority is investing in enhancing our core capabilities, primarily in the areas of customer, distribution and health as

well as technology and operations (including data);

–Our dividend policy remains to grow broadly in line with net operating free surplus generation, which is calculated after

investment in new business, central costs and capability investment. Given the strength of our capital generation, we expect to

grow the ordinary dividend by more than 10 per cent in both 2026 and 2027. In addition to the ordinary dividend, the Board will

consider making additional recurring returns of capital out of the annual flow of capital generation. Capital returns will be set

taking into account the Group's financial condition and prospects, applicable capital and solvency requirements, investment

opportunities, market conditions and the general economic environment. This change reflects our long-term confidence in our

business model and, as previously highlighted, means we are planning additional capital returns, with $500 million of share

buybacks in 2026 already announced and a further $600 million expected in 2027<sup>5</sup>;

–We will invest in value accretive inorganic opportunities where there is good strategic fit, with investment decisions, as always,

being carefully judged against the alternative of returning surplus capital to shareholders; and

–We assess the deployment of free surplus in the context of the Group's growth aspirations, leverage capacity and liquidity and

capital needs, based on the free surplus ratio. We seek to operate with a free surplus ratio of between 175 per cent and 200 per

cent. If the free surplus ratio is above the operating range over the medium term, and taking into account opportunities to

reinvest at appropriate returns and allowing for market conditions, capital will be returned to shareholders.

To generate capital to allocate to these priorities, we will also prioritise managing our in-force embedded value to ensure

maximum conversion into free surplus over time. We will drive improved emergence of free surplus by managing claims, expenses

and persistency in each market. This additional free surplus will enable our continued investment in profitable new business at

attractive returns, as well as in our strategic capabilities, and support payments of returns to shareholders, including dividends.

**Dividend**

Reflecting the Group's capital allocation priorities, a portion of capital generation will be retained for reinvestment in organic

growth opportunities and for investment in capabilities, and dividends will be determined primarily based on the Group's operating

capital generation after allowing for the capital strain of writing new business and recurring central costs. Dividends are expected

to grow broadly in line with the growth in the Group's operating free surplus generation, and will be set taking into account

financial prospects, investment opportunities and market conditions.

In line with the guidance for 2025 and our dividend policy, the Board has approved a 2025 second interim cash dividend of 18.89

cents per share (2024: 16.29 cents per share). Combined with the first interim cash dividend of 7.71 cents per share (2024: 6.84

cents per share), the Group's total 2025 cash dividend is 26.60 cents per share (2024: 23.13 cents per share), an increase of 15

per cent.

A dividend reinvestment plan (DRIP) will continue to be offered to shareholders on the UK register. A scrip dividend alternative,

with the issuance of new ordinary shares on the Hong Kong line only and the dilutive effect neutralised by a share repurchase on

the London line, will be offered in respect of the 2025 second interim dividend.

Guidance on the application of the dividend policy alongside changes to our capital allocation framework are set out at the start of

the Financial review.

**Group capital position**

The Prudential Group applies the Insurance (Group Capital) Rules set out in the GWS Framework issued by the Hong Kong

Insurance Authority (HKIA) to determine Group regulatory capital requirements (both minimum and prescribed levels). Prudential

Corporation Asia Limited (PCAL) is classified as a Domestic Systemically Important Insurer (D-SII) by the HKIA. PCAL is a direct

subsidiary of Prudential plc and is incorporated in Hong Kong. The GWS Group capital adequacy requirements require that total

eligible Group capital resources are not less than the GPCR and that GWS Tier 1 group capital resources are not less than the

GMCR. More information is set out in note I(i) of the Additional unaudited financial information.

The Group holds material participating business in Hong Kong, Singapore and Malaysia. Alongside the regulatory GWS capital

basis, a shareholder GWS capital basis is also presented which excludes the contribution to the Group GWS eligible Group capital

resources, the GMCR and the GPCR from these participating funds.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | 31 Dec 2024 | 31 Dec 2024 | 31 Dec 2024 |
| | **Shareholder** | **Policyholder\*** | **Total†** | Shareholder | Policyholder\* | Total† |
| Group capital resources ($bn) | **27.6** | **19.3** | **46.9** | 24.8 | 16.3 | 41.1 |
| of which: Tier 1 capital resources ($bn) | **19.9** | **1.5** | **21.4** | 17.6 | 1.3 | 18.9 |
| Group Minimum Capital Requirement ($bn) | **6.0** | **0.8** | **6.8** | 5.1 | 0.7 | 5.8 |
| Group Prescribed Capital Requirement ($bn) | **10.5** | **13.3** | **23.8** | 8.9 | 11.3 | 20.2 |
| **GWS capital surplus over GPCR ($bn)** | **17.1** | **6.0** | **23.1** | 15.9 | 5.0 | 20.9 |
| **GWS coverage ratio over GPCR (%)** | **262%** |  | **197%** | 280% |  | 203% |
| **GWS Tier 1 surplus over GMCR ($bn)** |  |  | **14.6** |  |  | 13.1 |
| **GWS Tier 1 coverage ratio over GMCR (%)** |  |  | **316%** |  |  | 325% |

---

\*This allows for any associated diversification impacts between the shareholder and policyholder positions reflected in total company results where relevant.

†The total company GWS coverage ratio over GPCR presented above represents the eligible group capital resources coverage ratio as set out in the GWS

framework, while the total company GWS Tier 1 coverage ratio over GMCR represents the Tier 1 capital coverage ratio.

As at 31 December 2025, the estimated shareholder GWS capital surplus over the GPCR is $17.1 billion (31 December 2024:

$15.9 billion), representing a coverage ratio of 262 per cent (31 December 2024: 280 per cent), comfortably above the Group's

risk appetite of 150 per cent as discussed in the capital management section above. The estimated total GWS capital surplus over

the GPCR is $23.1 billion (31 December 2024: $20.9 billion) representing a coverage ratio of 197 per cent (31 December 2024:

203 per cent).

Operating capital generation in 2025 was $1.7 billion after allowing for central costs and the investment in new business. Other

movements covering non-operating, foreign exchange and other items were $0.8 billion and included the beneficial impact of the

partial sale of our interest in IPAMC. The shareholder GWS surplus also reflects the issuance of $0.5 billion in subordinated debt in

the year, which contributed positively to the Group's available capital. These increases were offset by the payment of external

dividends and share buybacks which together totalled $(1.8) billion. Overall, the increase in shareholder GWS capital surplus in

2025 was $1.2 billion.

The Group's GWS position is resilient to external macroeconomic movements as demonstrated by the sensitivity disclosure

contained in note I(i) of the Additional financial information, alongside further information about the GWS measure.

The GWS capital surplus set out in the table above includes amounts held within operating entities as well as at the centre. The

businesses may remit this surplus as dividends provided the local regulatory requirements are met and there are sufficient

unrestricted accounting profits.

**Financing and liquidity**

Prudential seeks to maintain its financial strength rating with applicable credit rating agencies, which derives, in part, from its high

level of financial flexibility to issue debt and equity instruments, which is intended to be maintained in the future. Prudential has

substantial headroom to issue debt while remaining within the guidelines set by the credit rating agencies for its current financial

strength rating of AA from S&P (upgraded from AA-), Aa3 from Moody's and AA- from Fitch.

**Net core structural borrowings of shareholder-financed businesses**

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Core borrowings of shareholder-financed businesses  | **4459** | 3925 |
| Less: holding company cash and short-term investments | **(4282)** | (2916) |
| Net core structural borrowings of shareholder-financed businesses | **177** | 1009 |
| Group leverage ratio (Moody's total leverage basis) | **13%** | 13% |

---

The total core borrowings of the shareholder-financed businesses were $4.5 billion at 31 December 2025 (31 December 2024:

$3.9 billion). In May 2025, the Group issued SGD 600 million 3.80 per cent subordinated debt maturing on 22 May 2035, with

proceeds, net of costs, of $462 million. The Group had central cash resources of $4.3 billion at 31 December 2025 (31 December

2024: $2.9 billion), resulting in net core structural borrowings of the shareholder-financed businesses of $0.2 billion at end of

31 December 2025 (31 December 2024: $1.0 billion) on an IFRS basis. We have not breached any of the requirements of our core

structural borrowings nor modified any of their terms during 2025.

With the exception of a $750 million perpetual note that the Group retains the right to call at par on a quarterly basis, the Group's

debt securities have contractual maturities that fall between 2029 and 2035. Further analysis of the maturity profile of the

borrowings is presented in note C5.1 to the IFRS financial results.

In addition to its net core structural borrowings of shareholder-financed businesses set out above, the Group has structures in

place to enable access to funding via the medium-term note programme, the US shelf programme (the platform for issuance of

SEC-registered bonds in the US market), a commercial paper programme and committed revolving credit facilities. All of these are

available for general corporate purposes. Proceeds from the Group's commercial paper programme are not included in the holding

company cash and short-term investment balance.

Prudential plc has maintained a consistent presence as an issuer in the commercial paper market for the past decade and had

$520 million in issue at 31 December 2025 (31 December 2024: $527 million).

As at 31 December 2025, the Group had a total of $1.5 billion of undrawn committed facilities which expire in 2031 and a further

$100 million that expire in 2029. Apart from small drawdowns to test the process, these facilities have never been drawn, and

there were no amounts outstanding at 31 December 2025.

**Cash remittances**

**Holding company cash flow**<sup>4</sup>

---

| | | | |
|:---|:---|:---|:---|
|  | Actual exchange rate | Actual exchange rate | Actual exchange rate |
| | **2025 $m** | 2024 $m | Change % |
| **Net cash remitted by business units** | **2137** | 1383 | 55 |
| Net interest (paid) received | **(55)** | 17 | n/a |
| Corporate expenditure | **(308)** | (253) | (22) |
| Centrally funded recurring bancassurance fees | **(223)** | (198) | (13) |
| **Total central outflows** | **(586)** | (434) | (35) |
| **Holding company cash flow before dividends and other movements** | **1551** | 949 | 63 |
| Dividends paid, net of scrip dividends | **(594)** | (552) | (8) |
| **Operating holding company cash flow after dividends but before other** <br>**movements**<br>| **957** | 397 | 141 |
| **Other movements** |  |  |  |
| Issuance of debt, net of costs | **462** | – | n/a |
| Share repurchases/buybacks (including costs) | **(1252)** | (860) | n/a |
| Other corporate activities | **1117** | (109) | n/a |
| Total other movements | **327** | (969) | n/a |
| **Net movement in holding company cash** | **1284** | (572) | n/a |
| Cash and short-term investments at the beginning of the year | **2916** | 3516 |  |
| Foreign exchange movements | **82** | (28) |  |
| **Cash and short-term investments at the end of the year** | **4282** | 2916 |  |

---

Remittances from our businesses were $2,137 million (2024: $1,383 million), reflecting both our growing operating free surplus

generation and timing of when dividends are paid up to the centre. The remittances in 2024 are also net of cash advanced to CPL,

our joint venture business in Mainland China, of $(174) million in anticipation of the capital injection in early 2025, with no such

payments occurring in 2025. Remittances were used to meet central outflows of $(586) million (2024: $(434) million) and to pay

cash dividends of $(594) million (2024: $(552) million).

Central outflows include net interest paid of $(55) million (2024: net interest received of $17 million), which reflects lower interest

receipts on central cash balances, given current interest rates and lower average cash balances following the share buyback

programme. Interest payments made on core structural borrowing, which are largely fixed, marginally increased following the debt

raised in May 2025.

Cash outflows for corporate expenditure of $(308) million (2024: $(253) million) include cash outflows for restructuring costs. The

increase represents timing differences on recharges to operating subsidiaries and differences between expense accrual and cash

payment.

We had a $462 million increase in cash resources from new debt issued in May 2025 and used $(1,252) million of cash to settle

repurchases of shares in 2025, largely to complete our $2 billion share buyback programme.

Other corporate activities of $1,117 million in 2025 largely comprises the $1.4 billion net proceeds received upon the IPO of IPAMC

in December, offset by the settlement on the case with Detik Ria in Malaysia in July 2025 and other miscellaneous Group

investment.

The Group will continue to seek to manage its financial condition such that it has sufficient resources available to provide a buffer

to support the retained businesses in stress scenarios and to provide liquidity to service central outflows.

**Notes**

(1)Our key metrics are: new business profit, basic earnings per share based on adjusted operating profit and operating free surplus generated from in-force

insurance and asset management business.

(2)These objectives assume exchange rates at December 2022 and are based on regulatory and solvency regimes applicable across the Group at the time the

objectives were set. The objectives assume that the same TEV and free surplus methodology will be applicable over the period and no material change to the

economic assumptions.

(3)See note II of the Additional financial information for definition and reconciliation to IFRS balances.

(4)Holding company cash and short term investments in Group head office companies.

(5)Subject to Hong Kong Insurance Authority approval.

Investments

The overall financial strength of Prudential and the results, both current and future, of the insurance business are in part

dependent upon the quality and performance of the various investment portfolios.

**Prudential's total investments** 

Prudential's total investments, net of derivative liabilities, at 31 December 2025 were $195,154 million (31 December 2024:

$165,342 million), of which $32,178 million (31 December 2024: $28,712 million) were held to cover linked liabilities related to

unit-linked products and assets to cover external unit holders in relation to the consolidated investment funds. Prudential's

insurance business's investments, excluding assets to cover linked liabilities and those attributable to external unit holders of

consolidated investment funds, are largely held by Prudential's Singapore and Hong Kong operations.

Further analysis on financial investments and fair value measurement is included in notes C1 and C2 to Prudential's consolidated

financial statements, in accordance with IFRS 7 'Financial Instruments: Disclosures'.

**Prudential's insurance investment strategy and objectives**

Prudential's insurance investments support our life insurance businesses across Asia and Africa, leveraging local teams on the

ground. The Group Chief Investment Office provides strategic direction on all investment related activities, and supports and

empowers local teams to seize global opportunities and make well-informed decisions.

Our investment strategy is designed to achieve optimal risk-adjusted returns over the long term by building a globally diversified,

high quality, multi-asset portfolio, taking into account of risks, returns, policyholder expectations, and bonus sustainability. Each

of the operations formulates a strategy based on the nature of its underlying liabilities, its level of capital and its local regulatory

requirements.

Our exposure to interest rate risk is discussed in the Risk Review section, which includes the risk arising from the guarantees of

some non-unit-linked investment savings products. This exposure exists due to the potential for an asset and liability mismatch

where long-dated liabilities and guarantees are backed by relatively shorter-dated assets. While this risk cannot be eliminated, it is

monitored and managed through local risk and asset liability management committees against risk appetite aligned with the

Group's limit framework.

**Internal funds under management or advice**

Prudential manages a significant portion of its Group funds through its fund management business, Eastspring Investments.

The responsibility for asset allocations, mandates and selection of investment managers for Prudential insurance policies lies with

the life companies, overseen by the Group Chief Investment Office.

In each operation, local management analyses the liabilities and determines asset allocation, benchmarks and permitted

deviations appropriate for its operation. These benchmarks and deviations are agreed upon with fund managers, who implement

the specific investment strategy through their local fund management operations.

In addition to Eastspring Investments, which has over 400+ investment professionals across 10 Asian markets, Prudential also

partners with best-in-class third-party global asset managers to access global investment opportunities to deliver strong,

sustainable performance.

Additional information on liquidity and capital resources

The nature of insurance means that the life businesses, in a normal economic cycle, have access to sufficient liquidity to meet

their obligations when due. Prudential plc therefore focuses the Group's liquidity considerations on the liquidity of its central

companies and its ability to fund growth, meet the capital needs of the operating business and its own financing and expense

costs. This liquidity comprises the cash and short-term investments held by the specified companies as well as bank facilities

available to it which are not recorded on the balance sheet. Further information on the parent's financing and liquidity is outlined

in 'Financing and liquidity' section above.

After making sufficient enquiries the directors of Prudential have a reasonable expectation that the Company and the Group have

adequate resources to continue their operations for a period of at least 12 months from the date that the financial statements are

approved. Further information is provided in note A1 to the consolidated financial statements.

The liquidity requirements of Prudential's life insurance businesses are regularly monitored to match anticipated cash inflows with

cash requirements. Cash needs are forecast and projected sources and uses of funds, as well as the asset, liability, investment

and cash flow assumptions underlying these projections are reviewed periodically. Adjustments are made periodically to the

investment policies with respect to, among other things, the maturity and risk characteristics of the investment assets to reflect

changes in the business cash needs and the changing competitive and economic environment.

The liquidity sources for Prudential's life insurance businesses comprise premiums, deposits and charges on policies, proceeds

from the sale and maturity of investments, borrowings and capital contributions from the parent company. The liquidity

requirements comprise benefits and claims, operating expenses, interest on debt and purchases of investments.

The parent company, including the central finance subsidiaries, held cash and short-term investments $4,282 million as at 31

December 2025.

The sources of cash included dividends, loans and cash remittances received by Prudential from its principal operating subsidiaries,

JVs and associates as well as debt and equity issuances. Amounts are distributed to the parent company after considering capital

requirements. Further information on local statutory capital requirements, capital requirements and sources are located in note C9

to the consolidated financial statements.

The amount of remittances paid to the parent by Prudential's main operations is determined after considering the development,

growth and investment requirements of the operating businesses and subject to the applicable legal and regulatory restrictions.

Further information on cash remittances to the Group and other sources of funding accessible to the Group is detailed in the 'Cash

remittances' section above.

The contractual maturities of the financial liabilities of the Group recognised on the consolidated balance sheet as at 31 December

2025, including lease liabilities, are provided in note C2.3 to the consolidated financial statements.

Information on the Group's purchase obligations, which comprise the unfunded commitments relating to investment funds and not

recognised on the consolidated balance sheet, is provided in note D5 to the consolidated financial statements.

TEV basis, new business profit, free surplus generation and

Group adjusted operating profit

In addition to IFRS basis results, Prudential's filings with the Financial Conduct Authority (FCA), the Stock Exchange of Hong Kong

and the Singapore Stock Exchange include reporting by Key Performance Indicators (KPIs). These include results prepared on a

Traditional Embedded Value (TEV) basis, as well as new business profit and operating free surplus generation measures, which are

alternative performance measures.

TEV results are prepared on a supplementary basis to the Group's IFRS results. TEV is a way of measuring the current value to

shareholders of the future profits from the life businesses (considering only policies that are in-force at the balance sheet date)

using a set of actuarial assumptions and after making an allowance for the aggregate risks of that business, plus total net worth.

It also includes a provision for future unallocated central corporate expenditure. The value of future new business is excluded from

the embedded value. Prudential publishes its TEV results semi-annually.

Prudential converted to TEV from 2025, replacing the European Embedded Value (EEV) basis. This transition increases the

comparability of the Group's external reporting to its key peers and reduces the economic volatility seen in the Group's embedded

value reporting, with a view to improving the transparency of underlying growth in new business profit. In implementing TEV, the

Group has retained its operating assumptions and much of the EEV methodology. The changes made were in respect of the

discount rates and the treatment of central head office expenditure.

New business sales are provided as an indicative volume measure of transactions undertaken in the reporting period that have the

potential to generate profits for shareholders. New business profitability is a key metric for the Group's management in respect of

the development of the business. New business profit reflects the value of future profit streams which are not fully captured in the

year of sale under IFRS reporting. New business margin is shown by reference to annual premium equivalent (APE), which is

calculated as the aggregate of regular new business amounts and one-tenth of single new business amounts. TEV basis new

business profit and margins are also published quarterly.

Operating free surplus generation is the financial metric we use to measure the internal cash generation of our business operations

and for our life operations is generally based (with adjustments) on the capital regimes that apply locally in the various

jurisdictions in which the Group operates. It represents amounts emerging from the in-force business during the period, net of

amounts reinvested in writing new business. For asset management and other non-insurance operations (including the Group's

central operations), free surplus is taken to be IFRS basis shareholders' equity, net of goodwill attributable to shareholders, with

central Group debt recorded as free surplus to the extent that it is classified as capital resources under the Group's capital regime.

Prudential's filings with the Financial Conduct Authority, the Stock Exchange of Hong Kong and the Singapore Stock Exchange also

include discussion of the Group adjusted IFRS operating profit based on longer-term investment returns (adjusted operating

profit), which is the aggregation of the segment adjusted operating profit and the central expenditure (including restructuring

costs) discussed in this document.

**Determining adjusted operating profit of operating segments**

**Operating segments**

The Group's operating and reported segments for financial reporting purposes are defined and presented in accordance with IFRS

8 'Operating Segments'. Under the Group's management and reporting structure, its chief operating decision maker is the Group

Executive Committee (GEC), chaired by the Chief Executive Officer. There have been no changes to the Group's operating

segments from those reported in the Group's consolidated financial statements for the year ended 31 December 2024. Operations

and transactions that do not form part of any business unit are reported as 'Unallocated to a segment' and generally comprise

head office functions.

**Performance measure**

The performance measure of operating segments utilised by the Group is IFRS operating profit based on longer-term investment

returns (adjusted operating profit) as described below. This measurement basis distinguishes adjusted operating profit from other

constituents of total profit or loss for the year, including short-term interest rate and other market fluctuations and gain or loss on

corporate transactions. Note B1.1 shows the reconciliation from adjusted operating profit to total profit for the year.

**Determination of adjusted operating profit**

**(a)Approach adopted for insurance businesses** 

The measurement of adjusted operating profit reflects that, for the insurance business, assets and liabilities are held for the longer

term. The Group believes trends in underlying performance are better understood if the effects of short-term fluctuations in

market conditions, such as changes in interest rates or equity markets, are excluded.

–Returns on investments that meet the definition of an 'underlying item', namely those investments that determine some of the

amounts payable to a policyholder such as assets within unit-linked funds or with-profits funds, are recorded in adjusted

operating profit on an actual return basis. The exception is for investments backing the shareholders' 10 per cent share of the

estate within the Hong Kong with-profits fund. Changes in the value of these investments, including those driven by market

movements, pass through the income statement with no liability offset. Consequently, adjusted operating profit recognises

investment return on a longer-term basis for these assets.

–For insurance contracts measured under the general measurement model (GMM), the impact of market movements on both the

non-underlying insurance contract balances and the investments they relate to are considered together. Adjusted operating

profit allows for the long-term credit spread (net of the expected defaults) or long-term equity risk premium on the debt and

equity-type instruments, respectively. Deducted from this amount is the unwind of the illiquidity premium included in the

current discount rate for the liabilities and any non-attributable investment management expenses.

–Some GMM best estimate liabilities (BEL) components are calculated by reference to the investment return of assets, even if the

BEL component itself is not considered an underlying item, for example, the BEL component related to future fee income or a

guarantee. In these cases for the purposes of determining operating profit, the BEL component is calculated assuming a longer-

term investment return and any difference between the actual return arising in the period and the longer-term investment

return is taken to non-operating profit. There is no impact on the balance sheet of this allocation.

–A longer-term rate of return is applied to all other investments held by the Group's insurance business for the purposes of

calculating adjusted operating profit. More details on how longer-term rates are determined are set out below.

The difference between the net investment result recorded in the income statement and the longer-term returns determined using

the above principles is recorded as 'short-term interest rate and other market fluctuations' as a component of non-operating profit.

The 'insurance service result' is largely recognised in adjusted operating profit in full with the main exception being the gains or

losses that arise from market and other related movements on onerous contracts measured under the variable fee approach

(VFA). If these gains and losses are capable of being offset across more than one annual cohort of the same product or fund as

applicable, then the adjusted operating profit is determined by amortising the net of the future profits and losses on all contracts

where profits or losses can be shared. Any difference between this and the amount included in the income statement for onerous

contracts is classified as part of 'short-term interest rate and other market fluctuations', a component of non-operating profit.

**(b)Determination of longer-term returns**

The longer-term rates of return are estimates of the long-term trend investment returns having regard to past performance,

current trends and future expectations. These rates are broadly stable from year to year but may be different between regions,

reflecting, for example, differing expectations of inflation in each business unit. The assumptions are for the returns expected to

apply in equilibrium conditions. The assumed rates of return do not reflect any cyclical variability in economic performance and are

not set by reference to prevailing asset valuations.

For collective investment schemes that include different types of assets (eg equities and debt securities), weighted assumptions

are used reflecting the asset mix underlying the relevant fund mandates.

***Debt securities and loans***

For debt securities and loans, the longer-term rates of return are estimates of the long-term government bond yield, plus the

estimated long-term credit spread over the government bond yield, less an allowance for expected credit losses. The credit spread

and credit loss assumptions reflect the mix of assets by credit rating. Longer-term rates of return range from 2.8 per cent to 8.7

per cent for 2025 (2024: 2.8 per cent for 8.8 per cent; 2023: 2.8 per cent to 8.4 per cent).

***Equity-type securities***

For equity-type securities, the longer-term rates of return are estimates of the long-term trend of investment returns for income

and capital. Longer-term rates of return range from 8.6 per cent to 15.7 per cent for all years shown.

***Derivative value movements*** 

In the case where derivatives change the nature of other invested assets (eg by lengthening the duration of assets, hedging

overseas bonds to the currency of the local liabilities, or by providing synthetic exposure to equities), the longer-term return on

those invested assets reflects the impacts of the derivatives.

**(c)Non-insurance businesses**

For these businesses, the determination of adjusted operating profit reflects the underlying economic substance of the

arrangements and excludes market-related items only where it is expected these will unwind over time.

**Segment discussion**

The following commentary provides an overview of each of the Group's segments, together with a discussion of their 2025

financial performance. Prudential has chosen to explain its consolidated results principally by reference to profits for the year,

reflecting profit after tax. In explaining movements in profit for the year, reference is made to trends in profit before shareholder

tax and the shareholder tax charge.

Unless otherwise stated, we discuss our performance on a constant currency basis. The definitions of the key metrics we use to

discuss our performance in this report are set out in the 'Definitions of performance metrics' section later in this document,

including, where relevant, references to where these metrics are reconciled to the most directly comparable IFRS measure.

The Group's operating segments for financial reporting purposes are defined and presented in accordance with IFRS 8, 'Operating

segments' on the basis of the management reporting structure and its financial management information. Further details on the

Group's determination of operating segments are provided in the 'Determining adjusted operating profit of operating segments'

section.

For the Group's insurance segments, the commentary on financial performance below is also by reference to adjusted operating

profit.

Adjusted operating profit, the Group's segmental performance measure used by management, reflects that the assets and

liabilities of our insurance businesses are held for the longer term and the Group's belief that the trends in underlying performance

are better understood if the effects of short-term fluctuations in market conditions, such as changes in interest rates or equity

markets, are excluded. The adjusted operating profit by segment discussed below also excludes restructuring costs and revenue

recognised to cover the tax charge attributable to policyholders.

The Group also describes its segmental performance by reference to the level of new business in the year which is measured using

APE new business sales as defined in note II(v) of the 'Additional unaudited financial information'.

Hong Kong

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>**2025 $m** | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales | **2221** | 2063 | 8% | 2065 | 8% | 1966 |
| Profit before shareholder tax | **1414** | 949 | 49% | 949 | 49% | 1047 |
| Profit after tax | **1333** | 851 | 57% | 851 | 57% | 976 |
| Adjusted operating profit | **1219** | 1069 | 14% | 1070 | 14% | 1013 |

---

In Hong Kong, Prudential is supported by a strong brand, a well-established agency force and a product suite designed to meet

customers' evolving health, protection and long-term financial needs across life stages. Hong Kong is a high-income market and

exhibits sustained demand for comprehensive solutions spanning medical protection, wealth accumulation, retirement and legacy

planning.

Our multi-channel distribution model is anchored by a high-performing agency force and a longstanding bancassurance partnership

with Standard Chartered Bank, complemented by a selective presence in the broker channel. This positions us well to capture

growth across the domestic and Mainland China visitor segments, including an expanding local customer base driven by net

migration of skilled professionals. We remain focused on high-quality, capital-efficient new business, underpinned by disciplined

sales practices and an emphasis on health and protection-led propositions.

Hong Kong plays a pivotal role in serving Mainland China visitors seeking currency and asset diversification, professional financial

advice and access to high-quality healthcare and complex protection products. Demand for Hong Kong-based long-term savings

and protection solutions remains resilient. Supported by our presence across all cities in the Greater Bay Area, including Macau,

we are well placed to serve customers across one of the region's most significant economic hubs.

We continued to innovate during 2025, with several market-first solutions. Key launches included Entrust, a pioneering trust-like

multi-currency savings proposition, and Encash, a first-in-market whole-life hospital cash and long-term savings solution. We also

launched Prime Vantage Prestige Protector, a tailored protection solution for high-net-worth customers, strengthening our

presence in a strategically important segment.

Our commitment to building an inclusive, high-performance culture was validated through Prudential Hong Kong being recognised

as one of the 'Best Companies to Work for in Asia' for the fourth consecutive year.

**Financial performance** 

Hong Kong delivered another year of strong and broad-based growth in 2025, supported by 8 per cent growth in APE sales.

The agency channel's quality recruitment of new agents helped lift average monthly active agents by 12 per cent. We also saw

growth in the productivity of MDRT-qualified agents, underscoring the strength and quality of our agency force.

The bancassurance channel delivered a strong performance supported by record sales through Standard Chartered Bank (SCB)

underscoring the strength of our long-standing partnerships.

Prudential is a market leader in health and protection. Our innovative health solutions launched in 2024 and 2025 fuelled a 44 per cent

increase in health APE sales, demonstrating our strong capability to meet rising customer demand for comprehensive protection and

wellness offerings.

The profit after tax for our Hong Kong business was $1,333 million, up 57 per cent compared with 2024 on both the AER and CER basis.

In Hong Kong, adjusted operating profit was $1,219 million, up 14 per cent on an AER and CER basis, as we continued to benefit from the

ongoing growth in new business. This growth, together with favourable economics, led to a higher release from the CSM compared with

2024. The net investment result, a large component of which is net investment earnings on shareholder assets, was marginally lower,

reflecting (as was the case at half year) significant remittances to the centre from strong levels of local capital surplus.

Profit before shareholder tax increased by $465 million on an AER and CER basis. As well as the double-digit growth in adjusted

operating profit described above, Hong Kong benefitted from bond gains on shareholder assets exceeding long-term expectations as

interest rates fell. This compared with interest rises in 2024 that led to asset returns being below long-term expectations.

The effective shareholder tax rate on profit before tax was 6 per cent in 2025 compared with 10 per cent in 2024. In Hong Kong

taxable profit is computed as 5 per cent of net insurance premiums. The lower effective tax rate in 2025 is primarily due to

withholding tax refunds on US investments.

Indonesia

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>**2025 $m** | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales | **258** | 262 | (2)% | 252 | 2% | 277 |
| Profit before shareholder tax | **271** | 221 | 23% | 213 | 27% | 199 |
| Profit after tax | **224** | 181 | 24% | 174 | 29% | 156 |
| Adjusted operating profit | **250** | 268 | (7)% | 258 | (3)% | 221 |

---

In Indonesia, we are among the top three life insurers<sup>1</sup> across the combined conventional and Syariah markets.

2025 saw a challenging period for the Indonesian life insurance industry, including civil unrest in the third quarter. Despite these

headwinds, Prudential recorded 2 per cent growth in APE sales, demonstrating our strong operational resilience and ability to

successfully navigate a challenging environment.

We continue to diversify our distribution, with our agency channel maintaining its market-leading position, and our bancassurance

channel achieving record APE sales.

We remain proactive in managing the significant challenges in the health market due to rising medical inflation. We continue to

strengthen the resilience of our health portfolio through disciplined repricing and through the expansion of our Priority Hospital

Network to improve cost efficiency and elevate care standards. We are also improving our agency capability to deliver

higher-quality health solutions.

The focus on customers alongside enhanced purchasing and service experiences, including new digital servicing features, helped

improve customer satisfaction in the year with an improved rNPS.

Our dedicated Syariah entity, Prudential Syariah Indonesia, delivered a strong performance in 2025 and is now the number one

Syariah life insurer in Indonesia by volume of APE sales. Our partnership with BSI, the largest Syariah bank in the country with 20

million customers, delivered a strong performance in its first year of operations. We continue to successfully develop the BSI

partnership, with activation of the in-branch referral model across all of BSI's priority branches and top-tier retail branches. We

anticipate that our partnership with BSI will be a meaningful driver of future growth, with sales activity expected to build

progressively through 2026.

**Financial performance**

Indonesia's growth in new business profitability in 2025 was driven by management actions including prudent medical repricing

and a shift towards higher margin traditional products, as we continue to diversify our product mix.

Our agency business successfully navigated the challenging environment in the third quarter and ended the year on a positive

note. There has been continued focus on optimising the number of active agents and enhancing recruitment quality.

Strong sales via the bancassurance channel were driven by strong momentum in investment-linked products through both SCB

and UOB, as well as a promising contribution from our new partnership with BSI.

The adjusted operating profit for Indonesia for 2025 was $250 million (2024: $258 million on a constant exchange rate basis).

This was marginally lower than the prior year, reflecting the investment in capabilities within our Syariah business, as we

operationalise our new bancassurance partnership with BSI and the shift in product mix towards longer-duration products. The

profit from these products is higher overall but spread over a longer period, dampening the release from the IFRS CSM in the

short term.

The profit after tax in 2025 was up 24 per cent (on an actual exchange rate basis) to $224 million, with the small decline in

adjusted operating profit more than offset by the benefit of falling interest rates on shareholder assets increasing net investment

return in the year. This is compared to a loss in the prior year when interest rates rose.

The effective shareholder tax rate on profit before tax was 17 per cent in 2025, similar to the effective tax rate of 18 per cent in

2024. 44

Mainland China – CITIC Prudential Life (CPL)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>2025 $m | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales  | **621** | 464 | 34% | 464 | 34% | 534 |
| (Loss) profit  | **(24)** | 159 | n/a | 159 | n/a | (577) |
| Adjusted operating profit | **411** | 363 | 13% | 363 | 13% | 368 |

---

Amounts included in the table above represent the Group's 50 per cent share.

As described below, the tax related to life joint ventures and associate including that of CPL is allocated to the 'Growth markets and other' segment

Prudential's life business in Mainland China, CITIC Prudential Life (CPL), is a 50/50 joint venture with CITIC, a leading Chinese

state-owned conglomerate. CPL operates with an extensive footprint across 23 branches, covering 102 cities in Mainland China. In

2025, CPL celebrated its 25<sup>th</sup> year of operation.

CPL benefits from the strong brands of both shareholders with a multi-distribution platform that offers a diverse set of products to

meet customers' needs. The business focuses on the affluent segments of the market where individuals typically have more

resilient personal income levels, and are still significantly underpenetrated.

CPL has a high-quality agency force as well as an extensive network of 59 bancassurance partners with 850 active physical bank

branches across Mainland China. The broad reach of CPL's banking partners and the strong capabilities of CPL's agency business in

the affluent segments enable CPL to access customer groups with high potential to generate sustainable, high-quality new

business growth. CPL continued to prioritise quality agent recruitment and deepen penetration within its bank partners' customer

bases.

We expect this growth to be driven primarily by health and protection, long-term policyholder participating savings products and

pensions. The business remains focused on delivering sustainable, high-quality growth, supported by disciplined risk management

in a prolonged low interest rate environment in Mainland China.

In 2025, our business in Mainland China has continued to evolve in response to supportive regulatory developments and interest

rate volatility. CPL maintained its disciplined focus on delivering high-quality new business as we actively rebalance our product

mix from non-participating to participating solutions. At the end of 2025, CPL's local comprehensive solvency ratio stood at 209

per cent, well in excess of regulatory requirements. In January 2026 CPL issued RMB5 billion of perpetual debt.

Exposure arising from the Group's net investment position is actively managed, including the use of derivative instruments to

reduce sensitivity to further downward movements in interest rates. With initiatives underway to enhance the quality and

resilience of the franchise, the Group is well positioned to capture opportunities from the supportive demographics with rising

wealth and an ageing population expected to increase demand for savings and protection over time.

**Financial performance**

APE sales grew by 34 per cent, with very strong momentum in the second half and including sales to around 87,000 new-to-

Prudential customers. We saw an increasing proportion of participating business in our sales mix.

CPL's agency channel delivered a reduction in new business for 2025 overall. However, CPL continued its transformation journey

with quality recruitment and development generating momentum in the second half of 2025. CPL continues to develop its high-

quality agency force, with a 14 per cent increase in new agency recruits and a 7 per cent increase in the number of active agents

compared with the prior year.

In the bancassurance channel, an increase in new business profit was supported by a strong focus on productivity. Our partnership

with CITIC Bank continued to strengthen, and we accelerated sales momentum by focusing on their top 50 outlets, driving

stronger execution and productivity. Our deeper collaboration with the private banking segments of our bank partners supported

greater engagement with high-net-worth customers and we achieved a 7 per cent increase in active branches. Overall, all our top

ten partners delivered double to triple-digit APE sales growth in the period.

The loss for the year for CPL was $(24) million compared with a gain of $159 million in 2024 on an AER and CER basis. The

adjusted operating profit before tax for CPL was $411 million, 13 per cent higher than the prior year on an AER and CER basis. Our

focus on quality new business helped reduce the level of losses on contracts that IFRS defines as onerous as compared with 2024.

Higher asset levels as the business grew helped increase net investment returns, albeit this was partially offset by actions to

derisk the investment portfolio. A higher adjusted operating profit was more than offset by an increase in losses arising from

short-term market movements. While interest rates marginally increased in 2025, the small benefit arising from a higher discount

rate was more than offset by the impact on the discount rate of credit spreads narrowing. After allowing for these market-related

losses, CPL generated a small IFRS loss for the year of $(24) million. This amount is recorded before any related tax, which under

the Group's segment definition is recorded under the 'Growth markets and other' segment.

Malaysia

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>**2025 $m** | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales | **436** | 406 | 7% | 434 | –% | 384 |
| Profit before shareholder tax | **416** | 380 | 9% | 405 | 3% | 320 |
| Profit after tax | **325** | 296 | 10% | 316 | 3% | 257 |
| Adjusted operating profit | **410** | 338 | 21% | 361 | 14% | 305 |

---

Prudential is a leading life insurer in the Malaysia conventional market and the largest Takaful operator<sup>1</sup>, making Prudential the

largest life insurance provider in the country<sup>1</sup>. It has built its success on a multi-channel distribution platform.

Our bancassurance business maintained its number one position in the market with a 21 per cent share. Meanwhile, our agency

business demonstrated strong growth in recruits and active agents in the latter part of the year, with the number of agents

qualifying for MDRT status increasing by 7 per cent from the prior year.

Recognising society's evolving needs, we introduced innovative legacy planning and investment products in 2025, which have

experienced rapid growth and adoption within our target customer segment.

The health insurance market in Malaysia continues to experience persistent increases in medical inflation, driven by rising

treatment costs and higher rates of hospital admission. Against this backdrop, we have taken a leading role in addressing these

pressures to ensure the long-term sustainability of our health portfolio. We continue to take action to ease the impact on

customers by both operating a structured and consistently applied approach to repricing and tackling the underlying drivers of cost

escalation. As part of these efforts, we have advanced our use of technology to strengthen claims management and operational

effectiveness.

Our strategic focus on disciplined health management has also enabled us to respond quickly to the industry guidance issued by

Bank Negara Malaysia, which places caps on premium increases. The capabilities we have built—particularly in cost analytics,

portfolio quality, and digital enablement—position us well to navigate these regulatory changes while preserving our

competitiveness. This is reflected in the continued strengthening of our health margins, underpinned by an improving profile mix

despite the challenging operating conditions.

As at 31 December 2025, Prudential owned 51 per cent of the ordinary shares of the holding company of PAMB (with 100 per cent

share included in the operating statistics shown above consistent with the Group's policy for subsidiaries) and a 49 per cent share

in the Takaful joint venture. In January 2026 Prudential increased its holding in the shares of the holding company of PAMB to 70

per cent.

**Financial performance**

In 2025, in the agency channel, overall, there was a fall in volume due to lower number of active agents, especially in the first half

of the year. Agency distribution faced material disruption throughout the first half of the year due to overall market sentiment

arising from medical repricing. By adopting a rigorous, recurring repricing regime, we have been able to limit pricing increases.

Our agency channel rebounded strongly in the second half of 2025. The growth was driven by targeted product launches, strong

recruitment growth and robust on-the-ground activation of agents. The business is positioned well to carry this strong momentum

of increased recruitment, activation and growing MDRT qualification in 2026.

The good performance in the bancassurance channel was driven by effective collaboration with our bank partners including SCB

UOB and Bank Simpanan Nasional (BSN). The SCB partnership delivered record growth, driven by a successful revamp of our

insurance specialist model to accelerate protection sales. The launch of two new innovative individual life plans, focused on legacy

and savings, helped the UOB partnership record strong growth. BSN also delivered growth in new business profit for our Takaful

joint venture, driven primarily by the sale of attractively priced life products.

The profit after tax for our business in Malaysia increased from $296 million to $325 million (on an actual exchange rate basis),

driven by the increase in adjusted operating profit described below. Overall short-term market movements were a small positive,

albeit smaller than the prior year.

The adjusted operating profit for our business in Malaysia increased by 14 per cent to $410 million (21 per cent on an AER basis),

as the business grew and our actions to improve our claims management and operational effectiveness led to reduced operating

variances.

The effective shareholder tax rate on profit before tax was 22 per cent in both 2025 and 2024.

Singapore

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>**2025 $m** | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales | **938** | 870 | 8% | 890 | 5% | 787 |
| Profit before shareholder tax | **1137** | 659 | 73% | 674 | 69% | 607 |
| Profit after tax | **966** | 566 | 71% | 579 | 67% | 512 |
| Adjusted operating profit | **706** | 693 | 2% | 709 | –% | 584 |

---

We remain among Singapore's leading providers of health and protection, savings and investment-linked solutions<sup>1</sup>. We have a top

three market share and more than 90 years of local presence. Our business operates multi-channel distribution across agency,

financial advisers and bancassurance. Strategic partnerships with UOB and Standard Chartered Bank broaden our access to retail

and commercial banking customers and high-net-worth individuals.

We continue to meet evolving customer needs across life stages: expanding comprehensive health and retirement offerings for

affluent customers; maintaining a strong position in the integrated Shield market alongside partnerships with healthcare and

technology providers; and enhancing investment-linked propositions, including a greater choice of ESG-themed funds for younger

customers.

Our agency force retained its leading position in the market while Prudential Financial Adviser (PFA), established in 2023, grew its

advisory force by over 18 per cent in 2025. PFA offers holistic wealth and general insurance alongside our core solutions.

Our Singapore business again earned external recognition, ranking No.1 Insurer in The Straits Times Singapore's Best Customer

Service survey for the third consecutive year.

**Financial performance**

The second half of 2025 saw strong APE sales momentum, with APE sales up 19 per cent, reversing the 7 per cent reduction seen

in the first half. Overall APE sales were up 5 per cent year-on-year as we continue to innovate to meet customer needs across

channels. In particular, we expanded our wealth offerings in Singapore to cater for different needs. Our drive for innovation was

demonstrated by the launch of a first-in-market index-linked whole life and endowment participating plan, which provides

potential upside from index growth while safeguarding customers' savings from market downturns. This sales mix shifted towards

the savings and wealth segment.

The second half momentum was driven by agency, with APE sales growing 27 per cent compared with the same period in the prior

year. Agency productivity, as measured by new business profit per active agent increased in the year, and average case sizes

increased by 17 per cent. Within our agency business, we continue to grow and develop PFA in order to expand our wealth

offerings. We are also continuing to build on our high-performing agency channel with a focus on driving active agent numbers

and productivity. The strength of our advisors was demonstrated by the over 1,350 agents that qualified for MDRT status in the

year.

Our bancassurance business experienced some volume challenges but positive product mix effects improved new business

profitability. A multi-pay Indexed Universal Life Plan was launched, building on the success of the single-premium version

introduced in 2024. This product continues our focus on serving the high-net-worth segment by helping clients accumulate and

protect their wealth while creating a lasting legacy for future generations. We also embarked on a new strategic partnership with

CIMB bank in the fourth quarter to further expand our customer base.

Looking ahead, we remain very well positioned in Singapore with a market-leading, multi-channel franchise. We continue to lead

the market in terms of health new business, and we now have a comprehensive range of products for the high-net-worth segment

across our channels.

The profit after tax for our Singapore business was $966 million, 71 per cent higher than 2024 on an actual exchange rate basis.

Adjusted operating profit for our business in Singapore was broadly flat when compared to 2024. Increased operating earnings

from growth in the underlying business was offset by headwinds from economic movements impacting the level of losses that IFRS

defines as onerous.

Profit before shareholder tax increased by $478 million on an AER basis. As well as the benefit from a strengthening of the local

currency compared to the US dollar, falling interest rates have led to gains on bonds backing shareholders' equity and increases to

the future profit expected from our health and protection contracts, which are classified as general measurement model contracts

under IFRS. 2024 saw unfavourable short-term market movements following increases in interest rates.

The effective shareholder tax rate on profit before tax was 15 per cent in 2025, similar to the effective tax rate of 14 per cent in

2024. 47

Growth markets and other

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | <br>**2025 $m** | 2024 $m | Change | 2024 $m | Change | Actual <br>exchange rate<br>2023 $m |
| APE sales | **2187** | 2137 | 2% | 2184 | —% | 1928 |
| Profit before shareholder tax | **640** | 655 | (2)% | 660 | (3)% | 875 |
| Profit after tax | **535** | 503 | 6% | 504 | 6% | 775 |
| Adjusted operating profit | **614** | 688 | (11)% | 689 | (11)% | 746 |

---

Our growth markets and other segment incorporates our life businesses in Taiwan, a number of markets in the ASEAN region:

Thailand, Vietnam, the Philippines, Cambodia, Laos and Myanmar, as well as those in India and Africa.

The profit after tax (and the adjusted operating profit measure) for the 'Growth markets and other' segment includes the tax

charge on the profits/losses for the three life joint ventures and associates in Mainland China, India and Malaysia (Takaful

business), respectively. The level of tax charge from joint ventures and associates included in adjusted operating profit is $(9)

million higher than that incurred in 2024.

The adjusted operating profit for the segment was $614 million compared with $689 million in 2024 on a constant exchange rate

basis. While we saw growth in many of our markets this was offset by a decline in adjusted operating profit in Vietnam. In addition

we incurred start-up costs in our new India health entity and saw reduced interest income being earned by the insurance holding

companies in this segment.

Overall short-term market movements generated a small benefit in 2025, as compared with a small negative in 2024, and after

allowing for this total profit after tax increased 6 per cent on an actual exchange rate basis to $535 million.

A detailed discussion of new business performance by key businesses is presented below.

**Africa**

Prudential Africa operates in 5 key markets with access to a population of around 400 million. We exited the businesses in

Cameroon, Cote d'Ivoire and Togo during the year. APE sales for the 5 remaining markets grew by 24 per cent in 2025, with all

five of our markets growing as did both our agency and bancassurance channels. Our agency business saw an increase in both

monthly average active agents and in agents qualifying for MDRT status. Our bancassurance channel benefits from over 25 bank

partnerships with access to over 950 branches. The franchise ranks in the top 5 in 3 of its markets with number-one rankings in

Uganda and Zambia. Nigeria and Kenya, though we are currently not in the top 5, offer tremendous growth opportunities. Strong

growth in agency in both of these markets and operationalisation of the SCB distribution deal in Kenya in 2025, position these

markets well for future growth. In addition we successfully completed the integration of the Zenith life business in Nigeria.

**India**

ICICI Prudential Life, in which we maintain a 22 per cent shareholding, remains one of India's leading private-sector life insurers,

with a top 5 position amongst private life insurers. It is listed on both the National Stock Exchange and the Bombay Stock

Exchange and as at 31 December 2025 had a market capitalisation of $10.5 billion. Its broad and well-established distribution

capabilities provide access to a wide customer base across key segments, supporting the business's long-term growth trajectory.

APE sales in India declined (2) per cent for the full year, following strong growth in 2024. The year ended well with year-on-year

APE sales growth in the last quarter of 2025, including strong growth of protection products. The increase in protection sales,

particularly in the retail channel, combined with other beneficial product mix effects, helped margins improve compared to the

prior year. The bancassurance channel grew in the period, reflecting an increase in both the number of partners and productivity.

**The Philippines**

Our business in the Philippines continues to lead the industry by market share. Challenges in recruitment and activation of new

and mid-tier agents led to a lower number of overall active agents in 2025. As a consequence, APE sales were lower than the prior

year.

We have seen positive traction with product offerings for affluent customers with new product launches proving popular with

customers in this segment and the agents who serve them. Favourable product mix effects supported margins and agent

productivity. We continue our efforts to focus on quality agency recruitment and developing our existing agency force and saw an

increase in the number of our agents qualifying for MDRT status.

**Taiwan**

Taiwan is an attractive insurance market, supported by high GDP growth and a population of circa 23 million. Prudential grew APE

sales by 5 per cent in the year, building on the strong prior-year performance and helping us to retain our position as the number

one foreign insurer in the market.

Our participating savings product suite remains a core competitive advantage in meeting customers' long-term savings needs. We

continue to build on our record of product innovation by tailoring our participating product to the savings and protection needs of

different customer segments and distribution partners. In 2025 we introduced a new medical solution that combines health and

mortality protection.

Our multi-channel strategy remains central to our distribution strength. Both the bancassurance and brokerage channels delivered

APE sales growth during the year. We successfully onboarded new partners and deepened collaboration with existing partners

through customised campaigns and targeted offerings. This was supported by the awarding of a twAAA rating in the year by

Taiwan Ratings.

**Thailand**

In Thailand, we continue to focus on our bancassurance channel, complemented by other distribution channels including digital,

agency, direct marketing and brokerage. Overall APE sales increased by 9 per cent. During 2025 we introduced several new

products including a market-leading whole-of-life participating product that supports high-net-worth and affluent clients with their

wealth succession and wealth transfer goals. The increase in APE sales, together with positive channel mix effects, led to increased

new business profit in the period.

Our bancassurance channel grew APE sales compared with the prior year, and we retained our top three position<sup>1</sup> in

bancassurance sales in the market. We responded to lower interest rates by increasing our focus on participating and health and

protection products, as part of a strategic initiative to broaden our customer propositions and protect the portfolio from interest

rate risks.

**Vietnam**

APE sales in Vietnam materially declined in 2025, in both the agency and bancassurance channels. The local industry continues to

face disruption, including recent and ongoing regulatory change. In our agency business, we have acted early to ensure

compliance with regulatory changes ahead of the deadline, and we continue to invest in our agency force to support our long-term

quality growth ambitions. In the bancassurance channel, we continue to work closely with our partners to drive quality sales,

rather than market share. For example, through our partnership with Vietnam International Bank, we have implemented key

initiatives that not only align with, but in some areas go beyond, the requirements of Vietnam's new insurance law.

We believe that the market will regain growth momentum as customer confidence is restored. We continue to believe that, in the

medium and longer term, there is significant opportunity to meet the structural demand for savings and protection solutions due

to the low market penetration rate and a significant protection gap.

Eastspring

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
| | **2025** | 2024 | Change | 2024 | Change | Average <br>exchange rate<br>2023 |
| Total funds under management ($bn) | **277.7** | 258.0 | 8% | 266.4 | 4% | 237.1 |
| Fee margin based on operating income (bps) | **30** | 30 | –bps | 30 | –bps | 31 |
| Cost/income ratio (%) | **52** | 52 | –ppts | 52 | –ppts | 53 |
| Profit before shareholder tax ($m) | **1889** | 293 | 545% | 290 | 551% | 280 |
| Profit after tax ($m) | **1633** | 264 | 519% | 260 | 528% | 254 |
| Profit after tax excluding corporate <br>transactions ($m)<br>| **305** | 275 | 11% | 272 | 12% | (26) |
| Adjusted operating profit ($m) | **329** | 304 | 8% | 301 | 9% | 280 |

---

Eastspring is the Group's asset management business. It is well positioned with one of the widest footprints in Asia through our

operations in 10 key markets, of which we have top 10 positions in six. With around 400 investment professionals, Eastspring

provides tailored advice and bespoke solutions to its client base which comprises third-party clients, both retail and institutional

accounts, and the Group's insurance entities.

Eastspring currently manages and advises on funds of $277.7 billion (referred to as funds under management or FUM), including

$174.5 billion of funds on behalf of Prudential plc. Adjusted operating profit before tax grew by 9 per cent, while our cost/income

ratio stayed flat against prior year. Total net inflows (including money market funds) were $16.0 billion (2024: $12.8 billion).

**Strengthening our momentum**

2025 was characterized by continued volatility in global markets and equity markets were generally higher at the end of the year

than at the beginning. During a period which saw global trade tariff policy changes, persistent inflation and geopolitical tensions,

Eastspring proactively advised its clients, increased engagement, and guided investors through fast-moving market and policy

shifts.

The ability to navigate uncertainty is underpinned by deep investment expertise, synergies with Prudential Life companies, and

continued investment in capabilities. Together, these strengths enable us to deliver excellence for clients across market cycles.

*Investments:* At year end, 74 per cent of FUM outperformed their benchmark over one year (31 December 2024: 60 per cent) and

65 per cent of FUM outperformed their benchmark over three years (31 December 2024: 61 per cent). While performance in the

first half was marginally impacted by market reactions to 'Liberation Day', our disciplined risk management and agility in capturing

positive market momentum have positioned us ahead of benchmarks across key strategies:

–Fixed Income strategies continue to outperform, supported by an enhanced focus on risk management and portfolio

construction. This consistency underscores our ability to navigate volatility while delivering value for clients.

–Equities delivered solid performance. In recent years, we have broadened our Asian strategies to include Value, Growth, Income

and Quant approaches. This diversification helps reduce cyclical volatility in performance.

–Multi-asset strategies continue to make gains. We've developed diversified income-focused solutions that offer clients a

balanced approach to investment markets. We have also enhanced risk mitigation overlays to guard against sudden market

downturns and focused on strengthening governance and performance oversight frameworks.

Our expertise was further recognised with 54 industry accolades during the year, including Best Asia Pacific (ex-Japan) Local

Currency Fixed Income Manager at the Citywire Asia Asset Management Awards 2025, and Best Fund Provider for Asia Pacific

Equity at the Asian Private Banker Asset Management Awards.

*Distribution:* A cornerstone of maintaining long-term relationships with our clients is understanding clearly what they value from

an institutional investment firm and investment advisor. This includes co-creating solutions and specialist products that meet their

specific needs and taking into account market conditions. In 2025, this led to us revising our suite of high conviction strategies.

We also made significant progress in expanding our book of clients across both institutional and retail sectors:

–Institutional: Demand from global institutions continued to grow in 2025, particularly for our Japan and Global Emerging Market

(GEM) strategies. We also achieved a significant milestone in Singapore with our selection for the MAS' Equity Market

Development Programme (EQDP) mandate.

–Retail: We deepened partnerships with leading regional and local banks across Singapore, Indonesia, Thailand, and Taiwan,

broadening access to our investment capabilities.

Complementing these efforts, our 2025 flagship 'Think Asia. Think Active.' campaign further elevated Eastspring's visibility and

positioned us strongly as the partner of choice for active investing in Asia.

*Joint ventures:* As at 31 December 2025, Eastspring FUM includes $43.9 billion from our remaining 35 per cent share in IPAMC

and $13.8 billion from our 49 per cent share in funds managed by CITIC–Prudential Fund Management Company Limited (CPFMC)

in China.

In China, CPFMC's fixed income and active equity strategies outperformed, with the CITIC Prudential Wenyue Bond fund ranking in

the top 1 per cent of the industry and the CITIC Prudential Xinxuan fund ranking in the top 4 per cent of the industry. Distribution

momentum continued, generating over $1.2 billion in flows during the year.

**Focused execution** 

In 2025, we focused on three strategic priorities:

–Scaling third-party business to serve a broader base of institutional and retail clients;

–Strengthening the partnership with Prudential Life companies to serve evolving insurance needs underpinned by competitive and

consistent investment performance; and

–Transforming our operating model to develop an efficient and integrated enterprise model that increases operating leverage and

supports the long-term growth of the company.

As part of our focus on markets where we can deliver the greatest value, we completed the sale of Eastspring Investments Korea

in the first half of 2025. This allows us to concentrate on the 10 markets where our pan-Asian investment capabilities and

distribution network are strongest.

In December 2025 we also completed the IPO of IPAMC, crystallising value for the Group's shareholders, and reduced our stake

from 49 per cent to 35 per cent, which will be reflected in a reduced share of profits from 2026.

**Investing in capabilities** 

Asia remains one of the most compelling long-term opportunities globally, supported by a large, growing and increasingly affluent

population. Investors are rotating capital to Asia, seeking diversification amid macroeconomic divergence and policy uncertainty in

other parts of the world. Asia-Pacific (APAC) alone is expected to drive up to 38 per cent of global net new flows by 2027<sup>2</sup>,

underscoring the scale of the opportunity ahead.

Eastspring is well positioned to capture this opportunity. With a wide Asian footprint, deep local insights, and one of the largest

Asia-based investment teams, we combine scale with expertise.

As we step into 2026, Eastspring is focused on areas where we have proven strengths and growth opportunities. We are

enhancing our investment capabilities and innovating solutions to meet evolving client needs. By investing in our people and

expertise, expanding client access, and strengthening our operating platform, we will create long-term value for clients and

stakeholders.

**Financial performance**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Actual exchange rate | Actual exchange rate | Actual exchange rate | Constant exchange rate | Constant exchange rate | |
|  | **2025** | 2024 | Change | 2024 | Change | |
| | **$m\*** | $m\* | % | $m\* | % | Actual <br>exchange rate<br>2023<br>$m\* |
| **External funds under management ($bn)** | **103.2** | 109.4 | (6) | 109.4 | (6) | 96.1 |
| Internal funds under management ($bn) | **127.5** | 115.4 | 10 | 123.8 | 3 | 110.0 |
| Internal funds under advice ($bn) | **47.0** | 33.2 | 42 | 33.2 | 42 | 31.0 |
| **Total internal funds under management or** <br>**advice ($bn)**<br>| **174.5** | 148.6 | 17 | 157.0 | 11 | 141.0 |
| **Total funds under management or advice ($bn)** | **277.7** | 258.0 | 8 | 266.4 | 4 | 237.1 |
| **Total external net flows** | **5573** | 5824 | (4) | 5637 | (1) | 4054 |
| **Analysis of adjusted operating profit** |  |  |  |  |  |  |
| Retail operating income | **470** | 414 | 14 | 412 | 14 | 353 |
| Institutional operating income | **339** | 333 | 2 | 335 | 1 | 347 |
| Operating income before performance-related fees | **809** | 747 | 8 | 747 | 8 | 700 |
| Performance-related fees | **5** | – | n/a | – | n/a | (2) |
| **Operating income (net of commission)** | **814** | 747 | 9 | 747 | 9 | 698 |
| Operating expense | **(418)** | (385) | (9) | (390) | (7) | (372) |
| Group's share of tax on joint ventures' adjusted <br>operating profit<br>| **(67)** | (58) | (16) | (56) | (20) | (46) |
| **Adjusted operating profit** | **329** | 304 | 8 | 301 | 9 | 280 |
| Adjusted operating profit after tax | **305** | 275 | 11 | 272 | 12 | 254 |
| **Average funds managed by Eastspring ($bn)** | **271.7** | 249.3 | 9 | 251.6 | 8 | 225.9 |
| Fee margin based on operating income | **30bps** | 30bps | –bps | 30bps | –bps | 31bps |
| Cost/income ratio  | **52%** | 52% | –ppts | 52% | –ppts | 53% |

---

\*Unless otherwise stated.

Eastspring's total FUM grew to $277.7 billion at 31 December 2025 (31 December 2024: $258.0 billion on an actual exchange rate

basis), with average FUM across the year increasing 8 per cent compared with the prior year. This largely reflected net inflows from

third parties and the Group's life business and positive market movements (including foreign exchange), partly offset by Eastspring

FUM reductions from the listing of IPAMC's equity shares and the sale of Eastspring Investments Korea. Overall, managed assets

remain well diversified across both clients and asset classes, with asset mix shifting marginally during 2025 from equity and fixed

income to multi-asset.

Eastspring's adjusted operating profit grew 9 per cent in the year to $329 million, which includes a $27 million (2024: $22 million)

net investment gain, reported within operating income before performance-related fees, on shareholders' investments including

seed capital. Excluding the gains on shareholders' investments from both periods, adjusted operating profit was 8 per cent higher,

in line with average FUM growth. Both cost/income ratio and fee margin stayed broadly constant with those recorded in 2024.

The effective shareholder tax rate on profits was 14 per cent in 2025, compared with 10 per cent in 2024. The higher rate in 2025

is primarily due to capital gains tax on the partial disposal of our investment in IPAMC.

**Notes**

(1)As reported at full year 2025 unless otherwise specified. Sources include formal (eg competitors' results releases, local regulators and insurance association)

and informal (industry exchange) market share. Ranking based on new business (APE sales, weighted new business premium, retailed weighted received

premium, full year premium or weighted first year premium) or gross written premium depending on availability of data. Hong Kong ranking based on APE

sales. Rankings in the case of Mainland China, Taiwan and Myanmar are among foreign insurers, while for India they are among private companies. Markets

based on nine months ended September 2025: Mainland China, Hong Kong, three months ended March 2025: PPMZ (Africa), full year 2024: Laos, Nigeria (Africa),

Uganda (Africa), Zambia (Africa) and full year 2023: Ghana (Africa) and Kenya (Africa).

(2)Source: Broadridge APAC Quarterly Trends Report Q2 2025.

**Definitions of performance metrics**

**Adjusted operating profit**

Adjusted IFRS operating profit based on longer-term investment returns.

This alternative performance measure is reconciled to IFRS profit for the year in note B1.1 of the IFRS financial results and a fuller

definition given in note B1.2.

**Annual premium equivalent (APE) sales**

A measure of new business activity that comprises the aggregate of annualised regular premiums and one-tenth of single

premiums on new business written during the year for all insurance products.

See note II(v) of the Additional unaudited financial information for further explanation.

**Average monthly active agents**

An active agent is defined as an agent who sells at least one case with a Prudential life insurance entity in the month. Average

monthly active agents is expressed for each reporting period as the sum of active agents in each month divided by the number of

months in the period.

**Basic earnings per share (EPS) based on adjusted operating profit**

Calculated as adjusted operating profit after tax, less non-controlling interests, divided by the weighted average number of

ordinary shares outstanding during the year, excluding those held in employee share trusts, which are treated as cancelled.

See note B4 to the consolidated financial statements for more detail and calculation, including the diluted version of this metric

and reconciliation to basic earnings per share based on profit after tax.

**Customer numbers**

A customer is defined as a unique individual or entity who holds one or more policies, that has had premiums paid, with a

Prudential life insurance entity, including 100 per cent of customers of the Group's joint ventures and associates. Group business

is a single customer for the purpose of this definition.

**Customer relationship net promoter score (rNPS)**

Net promoter score on overall strength of customer relationship, based on customers' survey responses to how likely they would

be to recommend Prudential. It measures the response on a scale of 0–10 where 9 or 10 are Promoters, 7 or 8 are Passives and

0–6 are Detractors. The score equates to the percentage of promoters less the percentage of detractors. Our customer rNPS

target relates to each market's NPS performance versus their respective peers.

**Customer retention rate**

Calculated as the number of customers at the beginning of the period minus exits during the year (net of reinstatement) over the

number of customers at the beginning of the period.

**Eastspring cost/income ratio**

The cost/income ratio is calculated as operating expenses, adjusted for commissions and share of contribution from joint ventures

and associates, divided by operating income, adjusted for commission, share of contribution from joint ventures and associates

and performance-related fees.

See note II(iv) of the Additional unaudited financial information for calculation.

**Eastspring investment performance – percentage of funds under management outperforming** 

**benchmarks**

This measure represents the percentage of active funds under management at the balance sheet date that outperformed their

performance benchmark over the time period stated (one or three years). Funds with no performance objective, which includes

passive funds and non-discretionary portfolio, are excluded from this measure.

**Eastspring total funds under management or advice**

Total funds under management or advice including external funds under management, money market funds, funds managed on

behalf of M&G plc and internal funds under management or advice.

**Group funds under management**

Represents all assets managed or administered by or on behalf of the Group, including those assets managed by third parties.

Assets under management include managed assets that are included within the Group's statement of financial position and those

assets belonging to external clients outside the Prudential Group, which are therefore not included in the Group's statement of

financial position. A reconciliation to this measure from investments shown in the Group balance sheet is given in note I(iii) of the

Additional unaudited financial information.

**Group leverage ratio (Moody's basis)**

Leverage measure calculated as the Group gross debt, including commercial paper, as a proportion of the sum of IFRS

shareholders' equity, 50 per cent of the surplus in the Group's with-profit funds, 50 per cent of the CSM and the Group's gross

debt including commercial paper.

**GWS capital surplus over GPCR**

Estimated GWS capital resources in excess of the GPCR before allowing for the 2025 second interim dividend. GWS capital surplus

is determined on a shareholder basis and a total Group basis as described in note I(i) of the additional information.

**Health products**

Health products comprise health and personal accident insurance products, which provide morbidity or sickness benefits and

include health, disability, critical illness and accident coverage. These typically are annually renewable and would involve diagnosis

and treatment from licensed physicians/medical facilities. Critical illness products paying lump sum benefits are not in scope.

**IFRS shareholders' equity per share**

IFRS shareholders' equity per share is calculated as closing IFRS shareholders' equity divided by the number of issued shares at

the end of the period.

See note II(iii) of the Additional unaudited financial information for calculation.

**Net cash remitted by business units**

Net cash amounts remitted by businesses are included in the holding company cash flow. This comprises dividends and other

transfers from businesses, net of capital injections, that are reflective of earnings and capital generation.

**Net zero**

A state in which greenhouse gas emissions from activities in the value chain of an organisation are reduced as close to zero as

possible, with any residual emissions balanced by removals from the atmosphere, in a time frame consistent with the Paris

Agreement. Our ambition is that the assets we hold on behalf of our insurance companies will be net zero by 2050.

**New to bancassurance customers from strategic partners**

The number of customers who hold at least one insurance policy of any type (including either Individual or Group policies as Life

Assured) sold by our strategic bank partners (excluding partners of joint ventures and associates and our strategic partner in

Cambodia and Laos) at the end of the measurement period, but do not hold any insurance policies sold by our relevant strategic

bank partners at the beginning of the measurement period. The measurement period is the current period of the report.

**Operating return on IFRS shareholders' equity**

Calculated as adjusted operating profit, net of tax and non-controlling interests, divided by the average IFRS shareholders' equity.

See note II(ii) of the Additional unaudited financial information for the calculation.

**Proportion of new business-processing through auto-underwriting**

The number of new business application submissions subject to automatic and real-time assessment of underwriting decisions

based upon set rules, providing policy underwriting decision without manual intervention, divided by the total number of new

business application submissions for the reporting period.

**Shareholder GWS coverage ratio over GPCR (%)**

Estimated ratio of capital resources (as measured under the GWS framework) over GPCR attributable to the shareholder business,

before allowing for the 2025 second interim dividend.

**Tier 1 capital resources**

Tier 1 capital in accordance with the classification of tiering capital under the GWS Framework, which reflects the different local

regulatory regimes along with guidance issued by the Hong Kong IA. This is considered to be the highest quality capital.

**Tier 2 Capital resources**

Tier 2 capital in accordance with the classification of tiering capital under the GWS Framework, which reflects the different local

regulatory regimes along with guidance issued by the Hong Kong IA. This tends to be additional capital, such as subordinated

debt, that can absorb losses but is less secure than Tier 1.

**Total GWS coverage ratio over GPCR (%)**

Estimated ratio of capital resources (as measured under the GWS framework) over GPCR attributable to both the shareholder and

policyholder business, before allowing for the 2024 second interim dividend.

**Weighted average carbon intensity (WACI)**

Reflects a portfolio's exposure to carbon-intensive companies, expressed in tCO2e/$m revenue. The WACI is currently the market

standard for measuring the carbon footprint of an investment portfolio, as described by global disclosure frameworks.

**Risk review**

1Introduction

Prudential's Group Risk Framework, risk appetite and robust governance have enabled the business to manage and control its risk

exposure throughout market volatility and uncertainty in 2025 to support the Group's strategy of delivering sustainable value for

all our stakeholders. As Prudential focuses on executing its strategy across Asia and Africa, the Group-wide Risk and Compliance

function has continued to provide advice, recommendations and assurance on risk and compliance matters. It also engages with

Prudential's Group-wide supervisor, the Hong Kong Insurance Authority (Hong Kong IA), on critical activities, while overseeing the

risks and implications to the ongoing business with the goal of ensuring that the Group remains within its approved risk appetite.

Our risk strategy outlines four essential strategic pillars covering stewardship, agile and robust risk management, effective

systems of governance and compliance, and a value-add mindset. This is also supported by three enablers, including

standardisation and simplification of controls and processes, timely access to data and increased use of technology and analytics,

and building capabilities at scale. The Group effectively leverages its risk management and compliance experience in more mature

markets, applying it appropriately to its growth markets. The manner and extent of their application in specific businesses takes

into account the specific risks and the extent of challenges under complex operating environments, and is reflective of

opportunities, customer issues and needs, and local customs. Prudential will continue to take a holistic, coordinated and disciplined

approach in managing the increasingly dynamic, multifaceted and often interconnected risks facing its businesses.

Below we explain how we manage risk, including through our risk governance framework and processes. We then describe the

principal risks the Group faces, including how each principal risk is managed, followed by a detailed description of the specific risk

factors that may affect our business, the Group and our stakeholders.

2 Risk governance

**aSystem of governance** 

Prudential has in place a system of governance that seeks to embed clear ownership of risk, together with risk policies and

standards to enable risks to be identified, measured and assessed, managed and controlled, and monitored and reported. The

Group Risk Framework, owned by the Board, details Prudential's risk governance, risk management processes and risk appetite.

The Group's risk governance arrangements are based on the 'three lines' model. The 'first line' is responsible for taking and

managing risk within the risk appetite, while the 'second line' provides additional challenge, expertise and oversight to support risk

and compliance management, and the 'third line' provides independent assurance on the design, effectiveness and implementation

of the overall system of internal control. The Risk and Compliance function reviews, assesses, oversees and reports on the Group's

aggregate risk exposure and solvency position from an economic, regulatory compliance and credit ratings perspective.

The Group Governance Framework is reviewed regularly with the goal of ensuring that the framework remains fit for purpose and

continues to support sound and prudent management and oversight of the Group's business. The Group also regularly reviews the

Group Risk Framework and supporting policies, including sustainability policies, to ensure that sustainability considerations, which

are integral to the wider Group governance, are appropriately reflected in processes and embedded within all business functions.

**bGroup Risk Framework**

The Group Risk Framework sets out the approach to managing risk within the Group and its subsidiaries and supports the

implementation of the Group's Risk Strategy.

**i.Risk governance and culture**

Prudential's risk governance comprises the Board, organisational structures, reporting relationships, delegations of authority, roles

and responsibilities, and risk and compliance policies that have been established to enable sound business decision-making in

relation to control activities and risk-related matters. The Risk Committee leads the risk governance structure, supported by

independent Non-executive Directors on the risk committees of the Group's material subsidiaries. The Risk Committee is

responsible for approving changes to the Group Risk Framework and the core risk and compliance policies that support it, and has

direct lines of communication to, and reporting and oversight of, the risk committees of the Group's material subsidiaries, as well

as maintaining regular dialogue with the Chairs of major next-tier operating subsidiary risk committees. The chief risk officers of

the Group's material subsidiaries and major next-tier operating subsidiaries also attend the Risk Committee meetings on a

rotational basis.

The Group Risk Framework and underlying policies support sound risk management practices by requiring a focus on customers,

longer-term goals and sustainability, the avoidance of excessive risk taking, and highlighting and addressing acceptable and

unacceptable behaviours. This is supported by the inclusion of risk and sustainability considerations in performance management and

remuneration for key executives; the building of appropriate skills and capabilities in risk management; and ensuring that employees

understand and care about their role in managing risks through open discussions, collaboration and engagement. The Risk Committee

has a key role in providing advice to the Remuneration Committee on risk management considerations to be applied in respect of

executive remuneration.

Fostering and overseeing the embedding of culture, including risk culture, is a responsibility of the Board, which recognises its

importance in the way the Group conducts business. The Group has a set of fundamental values, referred to as 'The PruWay', that

serve as the Group's guiding principles to ethical and authentic conduct, and apply equally to all members of Prudential.

Prudential's Code of Conduct and Group Governance Manual, supported by the Group's risk-related policies, are reviewed

regularly. The Code of Conduct lays down the principles and guidelines that outline the ethical standards and responsibilities of the

organisation and our people. Supporting policies include those related to regulatory compliance, anti-money laundering, sanctions,

anti-bribery and corruption, counter fraud, conduct, conflicts of interest, confidential and proprietary information and securities

dealing. The Group's Third-Party Supply and Outsourcing Policy requires that human rights and modern slavery considerations be

taken into account for material supplier arrangements. Procedures to allow individuals to speak out safely and anonymously against

unethical behaviours and conduct violations are also in place. These together with our values encourage a culture of risk vigilance.

Sustainability is integral to the Group's risk culture. The Risk Committee supports the sustainability strategy by ensuring

sustainability-related risks, including climate-related risks and opportunities, people, and culture are effectively managed.

**ii.The risk management cycle**

The Group's risk management cycle refers to the ongoing process of identifying, measuring and assessing, managing and

controlling, monitoring and reporting the risks to which the business is exposed. It includes an assessment of capital adequacy to

ensure that the Group's solvency needs are met at all times, as well as stress and scenario testing that also includes climate

scenario analysis.

**Risk identification**

The Group performs a robust assessment and analysis of principal and emerging risk themes through the risk identification

process, the Group Own Risk and Solvency Assessment report, and the risk assessments undertaken as part of the business

planning review, including how they are managed and mitigated, which in turn supports decision-making. Top-down and bottom-

up processes are in place to support Group-wide identification of principal risks. The Group's principal risks, which are reported

and managed by the Group with enhanced focus, are reviewed and updated on a regular basis.

An emerging risk identification framework also exists to support the Group's preparations in managing financial and non-financial risks

expected to materialise beyond the business-planning horizon. The Group's emerging risk identification process recognises the

dynamic materiality of emerging risk themes, whereby the topics and the associated risks that are important to the Group and its

respective key stakeholders can change over time, often very quickly. This is often seen in connection with sustainability-related

and technology-related risks, which can potentially impact the Group both financially and reputationally given evolving stakeholder

expectations.

**Risk measurement and assessment**

All identified risks are assessed based on an appropriate methodology for that risk. Quantifiable risks which are material and

mitigated by holding capital are modelled in the Group's internal model, which is used to determine the Group Internal Economic

Capital Assessment (GIECA) with robust processes and controls on model changes. The GIECA model and results are subject to

independent validation.

**Risk management and control**

The Group's control procedures and systems focus on aligning the levels of risk taking with the Group's strategy and can only provide

reasonable, not absolute, assurance against material misstatement or loss. The Group's risk policies define the Group's appetite for

material risks and set out the risk management and control requirements to limit exposure. These policies also set out the processes to

enable the measurement and management of these risks in a consistent and coherent way, including the flows of management

information required. Stress and scenario testing is also in place to assess the robustness of capital adequacy and liquidity, as well as

to support recovery planning. This includes reverse stress testing, which requires the Group to ascertain the point of business model

failure and is another tool that helps to identify the key risks and scenarios that may have a material impact on the Group. The

methods and risk management tools employed to mitigate each of the Group's principal risks are detailed in section 3 below.

**Risk monitoring and reporting**

The Group's principal risks are highlighted in the management information received by the Risk Committee and the Board, which

also includes key exposures against risk appetite and developments in the Group's principal and emerging risks.

**iii. Risk appetite, limits and triggers**

The Group aims to balance the interests of the broad spectrum of its stakeholders (including customers, investors, employees,

regulators, communities and key business partners) and understands that a well-managed acceptance of risk lies at the heart of

its business. The Group generates stakeholder value by selectively taking exposure to risks, mitigated to the extent it is cost effective to

do so, and where these are an outcome of its chosen business activities and strategy. Those risks for which the Group has no

tolerance are actively avoided. The Group's systems, procedures and controls are designed to manage risk appropriately, and its

approach to resilience and recovery aims to maintain the Group's ability and flexibility to respond in times of stress.

Qualitative and quantitative expressions of risk appetite are defined and operationalised through risk limits, triggers and

indicators. The Risk and Compliance function reviews the appropriateness of these measures at least annually. The Board

approves changes to the Group's aggregate risk appetite and the Risk Committee has delegated authority to approve changes to

the system of limits, triggers and indicators.

Group risk appetite is defined and monitored in aggregate by the setting of objectives for its capital requirements, liquidity and

non-financial risk exposure, covering risks to stakeholders, including those from participating and third-party businesses:

**1. Capital requirements:** Limits on capital requirements aim to ensure that, in both business-as-usual and stressed conditions,

the Group maintains adequate capital in excess of internal economic capital requirements and regulatory capital requirements,

achieves its desired target credit rating to meet its business objectives, and avoids the need for supervisory intervention. The two

measures in use at the Group level are the GWS and GIECA capital requirements.

**2. Liquidity:** The objective of the Group's liquidity risk appetite is to help ensure that appropriate cash resources are available to

meet financial obligations as they fall due in both business-as-usual and stressed scenarios. This is measured using a liquidity

coverage ratio, which considers the sources of liquidity against liquidity requirements under stress scenarios.

**3. Non-financial risks:** The Non-Financial Risk Appetite Framework is in place to identify, measure and assess, manage and

control, monitor and report effectively on material non-financial risks across the business. The non-financial risk appetite is framed

around the perspectives of its varied stakeholders, accounts for current and expected changes in the external environment, and

provides limit and trigger appetite thresholds for non-financial risk categories across the Group's locations. The Group accepts a

degree of non-financial risk exposure as an outcome of its chosen business activities and strategy, and aims to manage these risks

effectively to maintain its operational resilience, and commitments to customers and all other stakeholders, and to avoid material

adverse financial loss or impact to its reputation.

Group limits operate within these expressions of risk appetite to constrain material risks, while triggers and indicators provide

additional defined points for escalation. The Risk Committee, supported by the Risk and Compliance function, is responsible for

reviewing the risks inherent in the Group's business plan and for providing the Board with a view on the risk/reward trade-offs and

the resulting impact to the Group's aggregated position relative to Group risk appetite and limits, including non-financial risk

considerations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

3 The Group's principal risks

The delivery of the Group's strategy in building long-term value for all our stakeholders inevitably requires the acceptance of

certain risks. The materialisation of any of these risks within the Group or in its joint ventures, associates or key third-party

partners may have a financial impact and may affect the performance of products or services or the fulfilment of commitments to

customers and other stakeholders, or could otherwise have an adverse impact on Prudential's brand and reputation.

This section provides a high-level overview of the principal risks faced by the Group, including the key tools used to manage each

risk. A detailed description of these and other risks is presented under the heading 'Risk factors' below.

**Risks to the Group's financial position** 

**The global economic and geopolitical environment may impact the Group directly by affecting trends in financial** 

**markets and asset values, as well as driving short-term volatility. Risks in this category include the market risks to** 

**our investments and the credit quality of our investment portfolio, as well as liquidity risk.**

**Global economic and geopolitical conditions**

In 2025, Prudential continued to navigate a highly complex and rapidly evolving macroeconomic and geopolitical landscape marked

by persistent uncertainties and potential challenges. Expectations entering the year for easing inflation and a potential rate-cutting

cycle by the US Federal Reserve were disrupted by the escalation of protectionist trade policies, including in the US as well as by

major trading partners. These, among other measures, have heightened macroeconomic uncertainty, geopolitical tension, and

market volatility, while driving up import costs and fuelling inflationary pressures across markets, particularly in the US, where

Treasury yields rose in Q2 2025 amid growing concerns over inflation and policy direction, before easing later in the year as the US

Federal Reserve resumed monetary easing. Although US employment, household consumption and income growth were resilient,

supported at least in part by an AI infrastructure-related investment cycle, trade policy uncertainty and higher trade barriers weighed

on business sentiment and parts of the manufacturing and investment cycle. The broader implications for global growth remain

uncertain, especially for countries materially impacted by these trade measures. The trajectory of interest rates remains volatile,

shaped by the evolving stance of US economic policy and decisions from the US Federal Reserve, which reduced its policy rate by 75

basis points in total during 2025. This, coupled with evolving US protectionist policies, may exert pressure on borrower

creditworthiness and business growth prospects. Moody's downgrade of the US sovereign rating in May 2025, resulting in the US

losing its AAA credit rating from all three major credit rating agencies for the first time in a century, further underscores the fragility

of the fiscal and policy landscape.

Mainland China continued to face its own set of economic headwinds in 2025, including slower economic growth, ongoing concerns

in its property sector, subdued domestic private sector activity, and weakening customer demand, which continue to place

downward pressure on its interest rates. These challenges, compounded by US protectionist measures and broader trade and

technology frictions, increased uncertainty for Mainland China and other significant economic blocs. Although a temporary US-

China tariff truce was agreed in May and high-level engagement resumed in October, elevated tariff levels and export controls

continued to weigh on supply chains and regional trade, potentially constraining the growth outlook for both the broader Asian

region and the global economy. These dynamics could further depress China government bond yields and increase the challenges

of investment management in Mainland China.

Geopolitical tensions, notably US-China relations, and various conflicts, while varying in intensity and impact, may lead to further

realignment and fragmentation risks within and between blocs and regions. Wars in Ukraine and the Middle East, alongside

broader concerns about shipping security and sanctions risk, contributed to episodic disruptions to trade, supply chains, and

commodities markets; any escalation or sustained tensions in these regions may lead to heightened market volatility, and

materially higher energy costs and inflation, particularly for net oil-importing economies. In parallel, the US also pursued

negotiations and preliminary framework agreements with a range of trading partners, including consultations with ASEAN

economies on tariff and non-tariff measures, adding to fragmentation risk and broader geopolitical uncertainty.

Elevated market volatility and uneven global growth continue to pose risks to investment performance, especially if recessionary

pressures materialise in key markets where Prudential operates. These macroeconomic and geopolitical developments are considered

material to the Group and may increase operational and business disruption, regulatory (including sanctions) risks and financial

market risks, thereby potentially impacting Prudential's sales and distribution networks. The potential impacts to the Group are

included in sections 1.1 and 1.2 of the Risk factors.

**Market risks to our investments**

(Audited)

The value of Prudential's direct investments may be impacted by fluctuations in interest rates, equity and property prices, credit

spreads, and foreign exchange rates. These risks are highly correlated to macroeconomic and geopolitical movements, together

with government and central bank actions. Certain exposures, including alternative investments, may also be subject to higher

valuation uncertainty and lower liquidity compared with public market assets. There is also potentially indirect impact through the

value of the net equity of its joint ventures and associates. The Group's direct exposure to inflation remains modest. Exposure

mainly arises through an increase in medical claims obligations, driven by rising medical prices as well as potential impact on

customers from an affordability perspective. Medical inflation risk as well as challenges for insurers linked to affordability and

existing challenges in persistency are detailed in the Insurance risks section below.

The Group has appetite for market risk where it arises from profit-generating insurance activities to the extent that the risk

remains part of a balanced portfolio of sources of income for shareholders and is compatible with a robust solvency position. The

Group's market risks are managed and mitigated by the following:

–The Group Financial Risk Policy;

–The Group Capital and ALM Committee and Group ALM Policy;

–Changes in asset allocation, bonus revisions, repricing and the use of reinsurance where appropriate;

–The Group Investment Committee and Group Investment Policy;

–The Group Chief Investment Office, which is responsible for the formulation and execution of the company's investment

strategies;

–Hedging using derivatives, including currency forwards and swaps, bond forwards/futures, interest rate futures and swaps, and

equity futures;

–The monitoring and oversight of market risks through the regular reporting of management information;

–Regular deep-dive assessments; and

–The Group Crisis Management Procedure, which defines specific governance to be invoked in the event of a crisis such as a

significant market, liquidity or credit-related event, cyber incident or staff safety issue.

**Interest rate risk, including ALM**

Interest rate risk is driven by the impact of the valuation of Prudential's assets (particularly government and corporate bonds) and

liabilities, which are dependent on market interest rates.

The Group's risk exposure to rising interest rates arises from the potential impact to the present value of future fees for unit-

linked businesses, such as in Singapore, Indonesia and Malaysia, as well as the impact to the present value of the future profits

for accident and health products, such as in Hong Kong and Singapore. Exposure to higher interest rates also arises from the

potential impact to the value of fixed income assets not attributed to policyholder liabilities, such as the assets in the shareholder

funds.

The Group's risk exposure to lower/decreased interest rates arises from the guarantees of some non-unit-linked products with a

savings component, including the Hong Kong, Singapore, Taiwan and Mainland China's participating and non-participating

businesses. This exposure results from the potential for an asset and liability mismatch, where long-dated liabilities and

guarantees are backed by short-dated assets.

The Group Capital and ALM Committee is a management committee supporting the identification, assessment and management of

key financial risks to the achievement of the Group's business objectives. It oversees ALM, solvency and liquidity risks of the local

businesses as well as the declaration and management of non-guaranteed benefits for participating and universal life businesses.

Local business units are responsible for the management of their own asset and liability positions, with appropriate governance in

place. The objective of the local business unit ALM process is to meet policyholder liabilities with the returns generated from the

investment assets held, while maintaining the financial strength of capital and solvency positions. The ALM strategy adopted by

the local business units considers the liability profile and related assumptions of in-force business and new products to

appropriately manage investment risk within ALM risk appetite, under different scenarios in accordance with policyholders'

reasonable expectations, and economic and local regulatory requirements. Assessments are carried out on an economic basis

which is consistent with the Group's internal economic capital methodology. Factors such as local regulations, the availability of

assets, currency, duration, and diversifications are considered as appropriate.

The Group's appetite for interest rate risk requires that assets and liabilities should be tightly matched for exposures where assets

or derivatives exist that can cover these exposures. Interest rate risk is accepted where this cannot be hedged, provided that this

arises from profitable products and to the extent that such interest rate risk exposure remains part of a balanced exposure to risks

and is compatible with a robust solvency position. When asset and liability duration mismatch cannot be eliminated, it is monitored

and managed through local risk and asset liability management committees and Group risk limits consistent with the Group's

appetite for interest rate risk.

**Equity and property investment risk**

The shareholder exposure to equity price movements arises from various sources, including from unit-linked products where fee

income is linked to the market value of funds under management. Exposure also arises from participating businesses through

potential fluctuations in the value of future shareholders' profits and where bonuses declared are based broadly on historical and

current rates of return from the businesses' investment portfolios, which include equities.

The material exposures to equity risk in the Group's businesses include Mainland China's exposure to equity risk through

investments in equity assets for most of its products, including participating and non-participating savings products and protection

and unit-linked products. The Hong Kong and Singapore businesses, and to a lesser extent, the Taiwan and Malaysia businesses,

contribute to the Group's equity risk exposure due to the equity assets backing participating products. The Singapore, Indonesia

and Malaysia businesses are also exposed to equity risk through their unit-linked products.

The Group has limited acceptance for exposures to equity risk from non-participating products if it is not rewarded for taking the

equity risk. The Group accepts equity exposure that arises from future fees (including shareholder transfers from the participating

businesses) but limits its exposure to policyholder guarantees by hedging against equity movements and guarantees where it is

considered economically optimal to do so.

Where equity risk is accepted, it is explicitly defined by the strategic asset allocation, as well as monitored and managed through

local risk and ALM committees. Overall exposure to equity risk from the participating businesses is also managed through Group

risk limits consistent with the Group's appetite for equity risk.

**Currency risk** 

The geographical diversity of Prudential's businesses means that it is exposed to the risk of foreign exchange rate fluctuations.

Prudential's operations generally write policies and invest in assets denominated in local currencies, but some entities within the

Group write policies, invest in assets or enter into other transactions in the US dollar or other non-local currencies. This can lead

to fluctuations in the Group's consolidated financial statements upon the translation of local operating results into the Group's

presentation currency in the US dollar. Additionally, the Group is affected by exchange rate movements through changes in the

value of remittances received from the local business units. This risk is further detailed in section 1.6 of the Risk factors.

The Group accepts the currency risk that emerges from profits retained locally to support the growth of the Group's business and

the translation risks from capital being held in the local currency of the business to meet local regulatory and market

requirements. However, in cases where a surplus arising in an overseas operation supports Group capital or shareholders' interest

(i.e. remittances), this exposure is hedged if it is economically optimal to do so. The Group does not accept significant shareholder

exposures to foreign exchange risks in currencies outside the local territory.

Currency risk is managed by the Group Capital and ALM Committee through the implementation of asset allocation on funds which

captures the exposure to non-locally-denominated assets.

**Liquidity risk**

(Audited)

Prudential's liquidity risk arises from the need to have sufficient liquid assets to meet policyholder and third-party payments as

they fall due, considered under both business-as-usual and stressed conditions. It includes the risk arising from funds composed of

illiquid assets and results from a mismatch between the liquidity profile of assets and liabilities. Liquidity risk may impact market

conditions and valuation of assets in a more uncertain way than other risks like interest rate or credit risk. It may arise, for

example, where external capital is unavailable at sustainable cost, where derivatives transactions require a sudden significant

need of liquid assets or cash to post as collateral to meet derivatives margin requirements, or where redemption requests are

made against funds managed for external clients (both retail and institutional). Liquidity risk is considered material at the level of

the Group.

The Group has no appetite for any business to have insufficient resources to cover its outgoing cash flows, or for the Group as a

whole to not meet cash flow requirements from its debt obligations under any plausible scenario. The Group has significant

internal sources of liquidity sufficient to meet its expected cash requirements for at least 12 months from the date the financial

statements are approved, without having to resort to external sources of funding. As at 31 December 2025, the Group had a total

of $1.5 billion of undrawn committed facilities which expire in 2031 and a further $100 million that expire in 2029. Access to

further liquidity is available through the debt capital markets and the Group's extensive commercial paper programme. Prudential

has maintained a consistent presence as an issuer in the market for the past decade.

A number of risk management tools are used to manage and mitigate liquidity risk, including the following:

–The Group's Financial Risk Policy;

–Regular assessment and reporting by the Group and business units of liquidity coverage ratios, which are calculated under both

base case and stressed scenarios;

–The Group's Liquidity Risk Management Plan;

–The Group's Collateral Management Standard;

–The Group's contingency plans and identified sources of liquidity;

–The Group's ability to access the money and debt capital markets;

–The Group's access to external committed credit facilities; and

–The Group Crisis Management Procedure.

**Credit risk** 

(Audited)

Invested credit risk is the potential for loss resulting from a borrower's failure to meet its contractual debt obligation(s) and arises

from investments in debt instruments. Volatility in credit spreads can signal deteriorations in credit quality even though credit

selection remains conservative and selective with the intention to hold to maturity. Counterparty risk, a type of credit risk, is the

potential loss resulting from a counterparty that defaults on its contractual obligation(s) through financial transactions such as

reinsurance arrangements, derivative contracts with third parties, and its cash deposits with banks. Invested credit and

counterparty risks are considered material risks for the Group's business units.

The total debt securities at 31 December 2025 held by the Group's operations were $92 billion (31 December 2024: $73.8 billion).

The majority (85 per cent, 31 December 2024: 84 per cent) of the portfolio are investments either held in unit-linked funds or that

support insurance products where policyholders participate in the returns of a specified pool of investments<sup>1</sup>. The gains or losses

on these investments will largely be offset by movements in policyholder liabilities<sup>2</sup>. The remaining 15 per cent (31 December

2024: 16 per cent) of the debt portfolio (the 'shareholder debt portfolio') are investments where gains and losses broadly impact

the income statement, albeit short-term market fluctuations are recorded outside of adjusted operating profit.

–**Group sovereign debt:** Prudential invests in bonds issued by national governments. This sovereign debt holding within the

shareholder debt portfolio represented 59 per cent or $8.2 billion<sup>3</sup> of the total shareholder debt portfolio as at 31 December

2025 (31 December 2024: 54 per cent or $6.3 billion). The particular risks associated with holding sovereign debt are detailed

further in the disclosures in the Risk factors. The total exposures held by the Group in sovereign debt securities at 31 December

2025 are given in note C1 of the consolidated financial statements.

–**Corporate debt portfolio**<sup>6</sup>**:** In the shareholder debt portfolio, corporate debt exposures totalled $4.9 billion of which $4.6 billion or

95 per cent were investment grade rated (31 December 2024: $4.9 billion of which $4.5 billion or 93 per cent were investment

grade rated).

–**Financial sector debt exposure and counterparty credit risk:** The financial sector, especially banks, represents a material concentration in

the Group's corporate debt portfolio which largely reflects the composition of the fixed income markets across the regions in

which Prudential is invested. As such, exposure to the financial sector, particularly banks, is a key part of its core investments,

considered to be a material risk for the Group, as well as being important for the hedging and other activities undertaken to

manage its various financial risks.

At 31 December 2025:

–94 per cent of the Group's shareholder portfolio (excluding all government and government-related debt) is investment grade

rated<sup>4</sup>. In particular, 63 per cent of the portfolio is rated<sup>4</sup> A- and above (or equivalent); and

–The Group's shareholder portfolio is well diversified: no individual sector<sup>5</sup> makes up more than 15 per cent of the total portfolio

(excluding the financial and sovereign sectors).

The Group's holdings across its life portfolios are high-quality investments in the domestic markets in which we operate or USD-

denominated investments. These portfolios therefore include a mix of sovereign debt investments and a diverse set of high-quality

names, including those with either government or considerable parent company balance sheet support. Any impacts to global

rates are therefore key areas of monitoring focus for the Group. The impacts of macroeconomic risks surrounding the tariffs

imposed by the US are being closely monitored, including the potential for deterioration in the credit quality of the Group's

invested credit exposures, particularly due to rising funding costs and overall credit risks, and the extent of downward pressure on

the fair value of the Group's portfolios during adverse market conditions. The Group's portfolio is generally well diversified in

relation to individual issuers and companies particularly in local markets where depth (and therefore the liquidity of such

investments) may be low. Acknowledging that downgrade or default risks can never be eliminated, the Group has appetite to

accept credit risk to the extent that it remains part of a balanced portfolio of sources of income for shareholders and is compatible

with a robust solvency position. This risk is further detailed in sections 1.4 and 1.5 of the Risk factors.

The Group actively reviews its investment portfolio to maintain the robustness and resilience of the solvency position. A number of

risk management tools are used to manage and mitigate credit and counterparty credit risk, including the following:

–The Group's Financial Risk Policy;

–The Global Counterparty Limit Framework, concentration limits on large names and limits on portfolio-level credit quality;

–Collateral arrangements for derivative, secured lending reverse repurchase and reinsurance transactions which aim to provide a

high level of credit protection; and

–The Risk Committee and Group Investment Committee's oversight of credit and counterparty credit risk and sector and/or

name-specific reviews.

Counterparty risk exposures, arising from cash, derivatives and reinsurance activities, are managed using an array of risk

management tools, including a comprehensive system of rating-based limits, a focus on prioritising investment grade banks and

implementing collateral arrangements as much as possible. Regarding reinsurance, the Group uses reinsurers, rated A- or above

where feasible, with collateral taken to support the reinsurance exposure where appropriate. Where necessary, Prudential

mitigates the level of its counterparty credit risk by reducing its exposure, or seeking alternative instruments.

**Risks from the nature of our business and our industry**

**These include the Group's non-financial risks such as operational processes, change delivery, third-party and** 

**outsourcing, customer conduct, regulatory compliance and legal, model, financial crime, and business continuity** 

**risks. With our increasing reliance on technology, data and cyber security risks remain areas of focus. Insurance** 

**risks and business concentration risks are also assumed by the Group in providing its products. Furthermore, there** 

**are risks associated with the oversight of the Group's joint ventures and associates stemming from our operation in** 

**certain markets.** 

**Non-financial risks**

The complexity of Prudential, its activities and the extent of its transformation efforts from time to time creates a challenging

operating environment and exposure to a variety of non-financial risks which are considered to be material at a Group level. The

Group does not actively seek to take non-financial risks. Instead, it operates a control environment and framework for good

governance intended to prevent material losses or other negative impacts. The Group's non-financial risks, which are not

exhaustive and discussed further in section 2 of the Risk factors, are outlined below.

Alongside the Non-Financial Risk Appetite Framework, associated risk policies and standards are in place that individually engage

with specific non-financial risks which include subject matter expert-led processes that are designed to help identify, assess,

manage and control these risks, including:

–Reviews of key non-financial risks and challenges within Group and business units' business plans during the annual planning

cycle, to support business decisions;

–Corporate insurance programmes to limit the financial impact of operational risks;

–Risk management across the change delivery lifecycle of major initiatives, such as prioritisation, execution planning, and the

management of risks, issues, and interdependencies during the delivery of the Group's change portfolio and activities;

–Screening and transaction monitoring systems for financial crime and a programme of compliance control monitoring reviews

and regular risk assessments;

–Internal and external reviews of cyber security capability and defences;

–Regular updating and risk-based testing of crisis management, business continuity and disaster recovery plans;

–Established processes to deliver the highest quality of service to fulfil customers' needs and expectations; and

–Active engagement in managing compliance obligations and monitoring regulatory developments and supervisory focus areas.

**Operational processes risk**

Operational processes risk is the risk of failure to adequately or accurately process different types of operational transactions,

including customer/policy servicing , asset and investment management operations, finance operations and the operational provision

of compensation to our distribution channels. Due to human error, among other reasons, operational incidents do occur from time to

time and no system or process can entirely prevent their occurrence. Apart from the financial impacts of inaccurate processing, other

impacts may include regulatory penalties, reputational damage and resources spent to amend the errors.

The Group Operational Resilience Policy outlines the Group's requirements for managing operational resilience including business

continuity, disaster recovery, and crisis management risks that the Group is exposed to. See details in the 'Business Continuity

Risk' section below. The Group aims to manage the risk effectively by maintaining operational resilience and honouring

commitments to customers and other stakeholders.

The aim of the Group Approval Committee Request Policy is to establish a robust governance process and a delegated authority

framework for the approval of all significant expenditures, projects and initiatives undertaken within the Group that are funded by

shareholders' resources.

Further detail on the risks to the Group arising from system issues or control gaps is included in sections 2.1 and 2.3 in the Risk

factors.

**Change delivery risk**

Change delivery risk is driven by the concurrent implementation of multiple complex initiatives across the organisation. Failure to

deliver these initiatives and benefits within defined timelines, scope, and cost, with an engaged and appropriately skilled

workforce, may negatively impact the Group, ranging from its operational capability, control environment, reputation, delivery of

business strategies, shareholder value, and market competitiveness. The transformation and change programmes may also

introduce new or increase existing business risks and dependencies, which add management complexity. Further detail on the

risks to the Group associated with large-scale transformation and complex strategic initiatives is included in section 2.1 of the Risk

factors.

The Group aims to ensure that strong programme governance is in place with embedded risk practices to achieve ongoing and nimble

risk oversight, with regular risk monitoring and reporting to risk committees. The Group's Transformation Standards are in place to

ensure appropriate governance and controls to mitigate risks. Governance forums are established to oversee the implementation and

risk management of the key change delivery/transformation initiatives from various dimensions such as customer-centricity, strategic,

financial, operational (including digital platforms) and risk management. In addition, Prudential is continuously enhancing strategic

capabilities through internal talent development and talent acquisition. Developing a workforce that remains engaged through change

and provides adequate resources for our people to manage change, connect, grow and succeed is one of the priorities for the company.

**Third-party management risk**

Third party management risk refers to the risk that third-party supply and outsourcing arrangements, including intra-group

arrangements, fail, or provide inadequate service or act in a manner that is not aligned with Prudential's values, policies,

standards or in the interests of existing and potential customers, which could result in significant business interruptions, liability

for losses and costs, reputational damage and regulatory breaches for Prudential.

The Group is increasingly leveraging third parties to access core markets, achieve growth and drive process efficiency. The Group

has a number of important third-party relationships, with market counterparties and outsourcing partners, including distribution,

technology and ecosystem providers. In addition to intra-group arrangements, the Group also maintains material strategic

partnerships and bancassurance arrangements, which create reliance on the operational resilience and performance of outsourcing

and business partners. This risk is explored in more depth in section 2.3 of the Risk factors.

The Group Third-Party Supply and Outsourcing Policy outlines the Group's requirements for managing third-party risk, which

includes material outsourcing arrangements, that is aligned to the Hong Kong IA's GWS Framework. In addition, the Group Third-

Party Risk Oversight Policy is embedded within business units who are responsible for overseeing its implementation, with

compliance achieved through a comprehensive programme that includes risk assessment, risk-based assurance, internal audit and

monitoring activities. These measures collectively ensure that appropriate contract performance and risk management measures

are in place to manage the risk of third-party failures that breach risk appetite and satisfy regulatory expectations.

**Technology, data and cyber security risks**

Risks related to malicious attacks on Prudential systems or third-parties, service disruption, distributed denial of services (DDoS)

attacks, exfiltration of data, loss of data integrity and the impact on the privacy of our data remain prevalent, owing to the

accessibility of malicious tools available to potential adversaries, and increasing advancement of technology such as generative AI

and other artificial intelligence methods. Regulatory expectations of cyber security and data protection controls are becoming

increasingly complex as the Group continues to develop and expand digital services and products. Reliance on third-party service

providers and business partners is also increasing. Further details on the risks to the Group associated with operating in high-risk

markets is included in sections 2.4 and 2.5 of the Risk factors.

Consistent with the system of governance set out in section 2 above, Prudential follows a 'three lines' model for managing

technology-related risks, with a resiliency enhancement programme in progress to further strengthen our capabilities in managing

disruptions or failures on system platforms serving our customers. Group Technology, the first line, is primarily responsible for risk

identification, assessment, mitigation, monitoring and reporting. Group Technology Risk Management, the second line, provides

advisory, assurance and oversight of the risk domains. A number of risk management tools are in place including: key risk

indicators covering key technology risk areas; annual risk assessment to identify specific risks, priorities and focus areas; and

deep-dive reviews on different technology domains to provide assurance of controls. In addition, the Group Technology Risk

Committee, as a first-line committee, is responsible for overseeing the effectiveness of technology risk management across the

Group, including information security and privacy. Any material risks identified are reported to the Risk Committee. The Group's

internal audit, the third line, provides independent assessment of control effectiveness and management awareness for both the

first and second lines, with a comprehensive audit plan across all risk domains, including cyber security. Cyber and privacy risks

are reported regularly to the Risk Committee by the Chief Technology Risk Officer. In addition, the Risk Committee and Audit

Committee receive regular updates on technology and cyber security from senior leaders across the first and second lines,

including the Head of Infrastructure and Security, the Head of Technology Risk Management, and the Chief Technology Risk

Officer. Collectively, these leaders bring extensive experience in overseeing technology risk, resilience, and security across the

Group. Further, the Group Executive Committee (GEC) participates in annual cyber tabletop exercises and risk workshops to

ensure members are well equipped to respond to a cyber or information security incident and fully understand the latest threats

and regulatory expectations.

In addition, a strong cybersecurity culture is also promoted across the Group through mandatory annual information security and

privacy training for all employees, complemented by regular phishing simulation exercises and periodic cyber incident response

drills to reinforce cyber risk awareness. The Group's Global Integrated Command Centre has also been set up to provide Group-

wide monitoring, detection and incident management capabilities.

The Group has developed data minimisation and 'privacy-by-design' principles, where data should only be collected and used for

its intended purpose and is not retained longer than necessary. The handling of sensitive data is governed by policies such as the

Group Information Security Policy, the Group Privacy Policy, and the Group Data Governance Policy, each aligned to applicable

laws and regulations. These policies, together with our third-party risk management practices, aim to ensure privacy and system

availability are maintained for Prudential and its third-party service providers.

AI advancements are shaping the present and future of the insurance industry. Our goal is to remain at the forefront by providing

services that are technologically advanced, secure, ethically sound, and socially responsible. With our customers at the core of our

operations, we apply our AI Ethics Principles in everything we do. These principles apply to both our own and third-party solutions,

ensuring that every AI system and innovation is thoroughly evaluated via appropriate governance channels for ethical

considerations and that associated risks are well managed. An oversight forum for the use of AI is also in place to ensure

compliance with the AI Ethics Principles adopted by the Group with the aim to ensure the safe use of AI. Employees are also

regularly reminded of the paramount importance of these AI ethics across all markets, while we engage in ongoing dialogues and

cooperative initiatives with our regulators. Prudential's AI governance and ethics principles are available at **https://**

**www.prudentialplc.com/en/site-services/ai-statement**

We continue to observe a rise in malware and ransomware threats and the Group continues to maintain and, where appropriate,

enhance defences to protect its systems from cyber security attacks. Prudential has adopted a holistic risk management approach,

designed to prevent and disrupt attacks against the Group and to aid recovery, should an attack occur. Other defences include but

are not limited to: distributed denial of services (DDoS) protection for Group websites, AI-based endpoint security software,

continuous security monitoring, network-based intrusion detection, and employee training and awareness campaigns.

In addition, the Group recognises the evolving threat of AI-generated deepfakes and other sophisticated social engineering tactics

targeting corporate activities. As part of our broader cyber resilience strategy, we continue to enhance awareness efforts,

strengthen detective controls, and bolster incident response capabilities. While deepfake detection technologies are still maturing,

the Group actively monitors advancements and collaborate with industry partners to assess and integrate emerging solutions as

they become enterprise-ready.

The Group tests the effectiveness of cyber security and privacy controls via a dedicated 'red team' to identify potential

vulnerabilities, and engages and rotates external expert vendors to perform adversarial testing on our systems. In addition, we

engage external consultants to assess and benchmark the maturity of Prudential's cyber, information security and privacy

controls.

A private 'Bug Bounty' programme invites external security practitioners to identify and report security issues and vulnerabilities,

supported by a Vulnerability Disclosure Programme that allows independent security researchers to report security issues and

vulnerabilities via the Prudential websites.

The Group has subscribed to services from independent security consultants to monitor our external security posture on an

ongoing basis. Whilst the cyber threat landscape has continued to elevate due to ransomware and supply chain compromise

events, the Group did not experience any cyber security and data breaches with a material impact on its business strategy,

operations or financial condition in 2025.

**Customer conduct risk**

Prudential's conduct of business, especially in the design and distribution of its products and the servicing of customers, is crucial

in ensuring that the Group's commitment to meeting its customers' needs and expectations is fulfilled. The Group's Customer

Conduct Risk Framework reflects management's focus on customer outcomes.

Factors that may increase conduct risk can be found throughout the product life cycle, from the complexity of the Group's products

and services to its diverse distribution channels, which include its agency workforce, partnership distribution, virtual face-to-face

sales, and sales via online digital platforms.

The Group has developed a Group Customer Conduct Risk Policy, which sets out five customer conduct standards that the

business is expected to meet:

–Treat customers fairly, honestly and with integrity;

–Provide and promote products and services that meet customer needs, are clearly explained, and that deliver real value;

–Manage customer information appropriately, and maintain the confidentiality of customer information;

–Provide and promote high standards of customer service; and

–Act fairly and promptly to address customer complaints and any errors found.

Conduct risk is managed via a range of controls that are assessed through the Group-wide risk and control assessment

programme and overseen within reporting to its boards and committees.

Management of the Group's conduct risk is key to the Group's strategy. Prudential's conduct risks are managed and mitigated

using the following tools, among others:

–The Group's Code of Conduct and conduct standards, product risk and other related risk policies, and supporting controls

including the Group's financial crime risk control programme;

–A culture that supports the fair treatment of the customer, incentivises the right behaviour through proper remuneration

structures, and provides a safe environment to report conduct risk-related issues via the Group's internal processes and the Speak

Out programme;

–Product controls, such as a product conduct risk assessment, which is a component of the product development process and

helps identify and manage product-related conduct risks;

–Distribution controls, including monitoring programmes relevant to the type of business (insurance or asset management),

distribution channel (agency, bancassurance or digital) and ecosystem, to help ensure sales are conducted in a manner that

considers the fair treatment of customers;

–Quality of sales processes, services and training, and use of other initiatives such as special requirements for vulnerable

customers, to improve customer outcomes;

–Appropriate claims management and complaint-handling practices;

–The monitoring and oversight of key conduct risk areas through the regular reporting of management information; and

–Regular assurance review and periodic conduct risk assessments.

**Regulatory compliance and legal risk**

Prudential operates in highly regulated markets and under the ever-evolving requirements and expectations of diverse and dynamic

regulatory, legal and tax regimes which may impact its business or the way the business is conducted. The complexity of legal and

regulatory compliance continues to evolve and increase, representing a challenge for international businesses. Compliance with the

Group's legal or regulatory obligations (including in respect of international sanctions) in one jurisdiction may conflict with the law or

policy objectives of another jurisdiction or may be seen as supporting the law or policy objectives of one jurisdiction over another,

creating additional legal, regulatory compliance and reputational risks. These risks may be increased where the scope of regulatory

requirements and obligations is uncertain, including where the interpretation and application of laws and regulations within the

jurisdictions in which Prudential operates may be subject to change, and where specific cases applicable to the Group are complex.

In certain jurisdictions in which Prudential operates, there are several ongoing policy initiatives and regulatory developments which

will impact the way Prudential is supervised. Further information on specific areas of regulatory and supervisory focus and changes are

included in section 4 of the Risk factors.

The Group monitors regulatory and legal developments at a market and global level and these considerations form part of the

Group's ongoing engagement with regulators or supervisors, government policy teams, and industry groups.

Risk management and mitigation of regulatory and legal risk at Prudential includes a comprehensive set of compliance operating

arrangements, such as policies, procedures, reporting protocols, risk management measures, disclosures, and training, to ensure

ongoing compliance with regulatory and legal obligations. Appropriate controls or tools have been systematically integrated

into the daily operations of Prudential:

–Close monitoring and assessment of our business controls and regulatory landscape, with explicit compliance consideration of

risk themes in strategic decisions, risk governance, customer protection, conduct and culture, technology, data, operations,

financial crime, and cross-border activities;

–Ongoing engagement with relevant regulators, government policy teams and international standard setters; and

–Compliance oversight to ensure adherence to new regulatory developments, including those associated with emerging risk

topics.

**Model risk**

Model risk is the risk of adverse financial, regulatory, operational, or reputational impact, or misinformed business and strategic

decision-making, arising from reliance on a model or user-developed application (UDA) that is inaccurate, incorrect or misused.

The Group utilises various tools that form an integral part of operational activities, including the calculation of regulatory or

internal capital requirements, the valuation of assets and liabilities, the determination of hedging requirements, and the

assessment projects and strategic transactions.

Technological developments, in particular in the field of AI and the increased use of generative AI, pose new considerations for

model risk oversight provided under the Group Risk Framework.

The Group has no appetite for model or UDA-related incidents leading to regulatory breaches. There is limited appetite for failures

to develop, implement and monitor appropriate risk mitigation measures to manage model and UDA risk. The Group's model and

UDA risk is managed and mitigated via the Model and UDA Risk Framework, which applies a risk-based approach to tools

(including those under development) with the aim to ensure a proportionate level of risk management. The framework

requirements include:

–A set of risk oversight, management and governance requirements;

–Regular risk assessment requirements of all tools taking into account potential impact on various stakeholders, including

policyholders; and

–Regular independent validation (including limitations, known errors and approximations) of all Group critical tools.

**Financial crime risk**

As with all financial services firms, Prudential is exposed to risks relating to: money laundering (the risk that the products or

services of the Group are used by customers or other third parties to transfer or conceal the proceeds of crime); sanctions

compliance breaches (the risk that the Group undertakes business with individuals and entities on the lists of the main sanctions

regimes); bribery and corruption (the risk that employees or associated persons seek to influence the behaviour of others to

obtain an unfair advantage or receive improper benefits); and fraud (including the risk of fraudulent insurance claims or billing).

The consequences of the Group's criminal liability for failure to prevent financial crime and bribery include reputational damage

(including market and financing issues, loss of confidence by business partners, and increased vulnerability to bribe solicitation

and demands), financial costs and fines. Further detail on the risks to the Group associated with operating in high-risk markets is

included in section 2.6 of the Risk factors.

The Group's response to financial crime is aligned with applicable laws and regulations in the jurisdictions in which it operates.

Group-wide policies covering anti-money laundering, sanctions, anti-bribery and corruption, and counter fraud are in place which

reflect these requirements and are applicable to all staff. Local business units are responsible for overseeing implementation of

policies and procedures and organising risk-based training and communications. Compliance is achieved through a programme of

risk assessment, risk-based assurance, internal audit activity and monitoring.

The Group continues to enhance its financial crime risk management capability through investment in advanced analytics and AI

tools. These actions aim to strengthen prevention, increase detection and deliver enhanced oversight of financial crime risk.

The Group has a formal and mature confidential reporting system in place for reporting and escalation of elevated risk, through

which employees and other stakeholders can report concerns relating to potential misconduct. The process and results of this

system are overseen by the Audit Committee.

**Business continuity risk**

Prudential is exposed to business continuity risk including potential environmental, technological, geopolitical and third-party-

related threats or disruptions that could disrupt the company's critical business services and operations.

The Group continually seeks to increase business resilience and anticipate emerging disruptive threats through forecasting,

adaptation, planning, preparation and testing of contingency plans and the Group's ability to respond effectively to and operate

through disruptive events. Operational resilience is at the core of the Group's embedded Business Continuity Management (BCM)

programme and framework that help to protect the Group's systems, service delivery to customers, and its key stakeholders.

Taking a proactive approach to anticipating disruption risk, the BCM programme covers risk assessments, business impact

analyses, maintenance and testing of business continuity, crisis management and disaster recovery plans. The Group Crisis

Management Procedure serves as a cross-functional response tool to limit the impact of any disruptive event and is regularly

reviewed and tested. The consideration of impacts on customers is at the core of our resilience efforts, focusing on the delivery of

critical business services.

**Insurance risks**

(Audited)

Insurance risks make up a significant proportion of Prudential's overall risk exposure. The profitability of the Group's businesses

depends on a mix of factors including levels of, and trends in, mortality (policyholders dying), morbidity (policyholders becoming ill

or suffering an accident) and policyholder behaviour (variability in how customers interact with their policies, including utilisation

of withdrawals, take-up of options and guarantees and persistency, ie lapsing/surrendering of policies), increases in the costs of

claims over time (claim inflation), and changes in the regulatory environment. The risks associated with adverse experience

relative to assumptions associated with product performance and customer behaviour are detailed in section 2.7 of the Risk

factors. The Group has appetite for retaining insurance risks in the areas where it believes it has expertise and operational controls

to manage the risk and where it judges it to be more value-creating to do so than to transfer the risk, but only to the extent that

these risks remain part of a balanced portfolio of sources of income for shareholders and are compatible with a robust solvency

position.

Inflationary and other economic pressures also impact morbidity experience in several markets (see below). Elevated interest

rates may lead customers to lapse in preference for alternate saving options that offer higher levels of guarantees. A high-inflation

environment, and the broader uncertainty, may also increase lapses, surrenders and fraud, as well as heighten premium

affordability challenges.

The principal drivers of the Group's insurance risk vary across its business units. In Hong Kong, Singapore, Indonesia and

Malaysia, a significant volume of health and protection business is written, and the most significant insurance risks are medical

claims inflation risk, morbidity risk and persistency risk.

The Group manages and mitigates insurance risks using the following, among other methods:

–The Group's Insurance Risk Policy, which sets out the required governance, standards, processes and controls for effective

insurance risk management, notably through underwriting and claims practices;

–The Group's Product Risk Policy, which sets out the required governance, standards, processes and controls for effective product

risk management and approvals for new, or changes to existing, products (including the role of the Group). The policy also

describes how the Group's Customer Conduct Risk Policy is met in relation to new product approvals and current and legacy

products;

–The Group's Financial Crime Policy (see the 'Financial crime risk' section above);

–Using persistency, mortality, morbidity and longevity assumptions that reflect recent experience and expectation of future

trends, and the use of industry data and expert judgement where appropriate;

–Using reinsurance to mitigate, manage and diversify mortality and morbidity risks, and as inputs into assumption setting;

–Ensuring appropriate underwriting to determine which policies are issued, and appropriate claims management practices

(including the Fraud, Waste and Abuse Framework) to adjudicate claims fairly and accurately whilst mitigating mortality and

morbidity risks;

–Using product repricing and other claims management initiatives in order to mitigate morbidity and medical claims inflation risk;

–Maintaining the quality of sales processes and training, and using initiatives to increase customer retention in order to mitigate

persistency risk; and

–Monitoring, oversight and escalation of experience as it emerges.

**Medical claims inflation risk**

A key assumption when setting and reviewing health insurance premiums is the rate of medical claims inflation, which is often in

excess of general price inflation. The cost of medical treatment could increase more than expected, resulting in higher than

anticipated medical claims cost passed on to Prudential. There may also be constraints on our ability to pass the medical claims

inflation impact onto customers via increased health insurance premiums due to market, regulatory, societal or other constraints.

The Group's primary management of this risk is by retaining the right to reprice products and appropriate overall claims limits

within policies, either per type of medical treatment or in total across a policy, annually and/or over the policy lifetime. Regular

repricing is one of the measures we adopt to maintain clear customer expectations of the nature of these products and the

associated medical claims inflation. This risk is further managed through a range of activities and mitigants, including end-to-end

analytics identifying fraud, waste or abuse, tariff and discount negotiations with hospital and other medical providers, robust claim

adjudication rules and processes, product innovation, and proactive collaboration with regulators to balance health insurance profit

sustainability and premium affordability considerations.

**Morbidity risk**

Morbidity risk is the risk of deviations in the future frequency and magnitude of non-fatal accident and sickness claims relative to

initial assumptions that are adverse to shareholder value. It can be influenced by a range of factors including: inflationary, economic

and other pressures on the cost of medical treatment; medical advances which can reduce the incidence and improve recovery

rates of serious health conditions but can also increase diagnosis rates and/or increase or prolong treatment costs of certain

conditions; government and regulatory policies; opportunistic activities (including fraud); and natural events (including

pandemics). Morbidity risk can also result from: product design features that incentivise adverse policyholder behaviour;

inappropriate or insufficiently informed initial assumptions; claims volatility due to random fluctuation or a large-scale systemic event;

insufficient recognition of an individual's medical, financial and/or and other relevant circumstances during the policy application

assessment process; and/or ineffective claims assessments leading to payment of claims that are inconsistent with the insurance

product's contract and/or best practice.

The Group manages morbidity risk through prudent product design, use of reinsurance, underwriting and claims management,

oversight and escalation of experience as it emerges and, for certain products, the right to reprice where appropriate. Prudential's

morbidity assumptions reflect its recent experience, inputs from reinsurers who have industry-level experience, and expectation of

future trends for each relevant line of business.

**Persistency risk**

Persistency risk results from adverse changes in policy surrenders, paid-ups and non-forfeiture, and other policy discontinuances and

policy alterations (including a medical reimbursement downgrade where the policyholder reduces the level of the coverage/protection in

order to reduce premium payments). In general, adverse persistency experience results in deterioration of profits and shareholder value

and can be an indicator of inadequate sales quality controls, and can elevate conduct, reputational and regulatory risks. Persistency risk

generally stems from misalignment between customer needs and purchased product as a result of product collaterals and/or sales

process gaps, operational barriers to premium renewal payment, insufficient post-sale communication and engagement with the

customer leading to a deterioration of appreciation of the value of their policy, and/or changes in policyholder circumstances resulting

from external drivers.

The Group manages persistency risk by appropriate controls across the product life cycle. These include: review of and revisions to

product design and incentive structures where required; ensuring appropriate salesforce training and sales processes, including those

ensuring active customer engagement and high service quality; appropriate customer disclosures and product collaterals; use of

customer retention initiatives; and post-sale management through regular experience monitoring. Strong risk management and

mitigation of conduct risk and the identification of common characteristics of business with high lapse rates is also crucial. Where

appropriate, allowance is made for the relationship (either assumed or observed historically) between persistency and investment

returns. Modelling this dynamic policyholder behaviour is particularly important when assessing the likely take-up rate of options

embedded within certain products. Lapse experience following any repricing, including a medical reimbursement downgrade, is

also monitored.

**Business concentration risk**

Prudential operates in markets in both Asia and Africa via various channels and product mix; although largely diversified at the

Group level, several of these markets are exposed to certain levels of concentration risk. From a channel concentration

perspective, some of the Group's key markets rely more on agency and some markets rely more on bancassurance. From a

product concentration perspective, some of the Group's markets focus heavily on specific product types, depending on the target

customer segments. Geographically, the Greater China (Hong Kong, Mainland China and Taiwan) region contributes materially to

the Group's top and bottom lines. Uncertainties in macroeconomic and geopolitical conditions as well as regulatory changes may

impact the levels of business concentration, including any changes in business from Mainland China visitors to Hong Kong as well

as the domestic business in Mainland China, and adversely impact the Group's business performance and financial condition.

To improve business resilience, the Group continues to look for opportunities to enhance business diversification in products,

distribution channels and geographical markets, by building multi-market growth engines as part of its strategy.

**Risks associated with the oversight of the Group's joint ventures and associates**

Prudential operates, and in certain markets is required by local regulation to operate, through joint ventures and other joint ownership or

associates. For such operations, the level of control exercisable by the Group depends on the terms of the contractual agreements

between participants. Whilst the joint ventures and associates are run as separate entities, the Group's interests are best safeguarded by

our ability to effectively oversee and influence these joint ventures and associates in a way that is proportionate to our ownership level

and control. Further information on the risks to the Group associated with its joint ventures and other shareholders and third parties are

included in section 2.6 of the Risk factors.

The Group exercises primary oversight and control over joint ventures and associates through our nominated directors and other

representatives on the Board and Board Committees, whose appointments are subject to regular review. The Group has effective

access to management information on these businesses via the Board and Board Committees, the businesses' public disclosures,

and established regular touchpoints with key business functions of these organisations (eg audit). Key updates on joint ventures

and associates are provided to the Group's governance such as the Risk Committee and the Audit Committee. The Group has a

Joint Venture Oversight Framework in place outlining the Group's oversight of the joint ventures over which it does not exercise

management control. The Group also regularly reviews its governance frameworks and policies to ensure optimal oversight over

joint ventures and associates.

**The Group's sustainability-related (including ESG and climate-related) risks**

**Sustainability-related risks refer to (a) environmental, social or governance issues, trends or events that could have** 

**a financial or non-financial impact on the Group, and/or (b) the Group's sustainability-focused activities, strategy** 

**and commitments that could have an external impact on the environment and wider society in which the Group** 

**operates.**

**Sustainability-related (including ESG and climate-related) risks**

Sustainability-related risk refers to material and emerging risks associated with key sustainability themes that may undermine the

long-term success of the Group business by adversely impacting: (i) its financial performance, operational resilience and

sustainability credentials; (ii) its reputation and brand; and (iii) its ability to attract and retain customers, investors, employees

and distribution and other business partners. These may therefore impact the results of its operations and delivery of its business

strategy and long-term financial success.

Sustainability-related risks arise from the activities that support implementation of the Group's sustainability strategy, which is

centred on three key pillars (providing simple and accessible health and financial protection, responsible investment and creating a

sustainable business) and may increase the expectations of the Group's stakeholders with regard to the Group's potential external

environmental and social impact within the markets in which the Group operates.

Whilst some material sustainability themes are reflected in the risk taxonomy as standalone risks, the risks associated with most

sustainability topics are generally treated as thematic cross-cutting risks (eg climate-related physical and transition risks,

greenwashing risk). These are risk themes that can have significant interdependencies with and influence on, and can potentially

amplify, the established risks.

As custodians of stakeholder value for the long term, the Group seeks to manage sustainability-related risks and their potential

impact on its business and stakeholders through transparent and consistent implementation of its strategy in its markets and

across operational, underwriting and investment activities. It is enabled by strong internal governance, sound business practices

and a responsible investment approach, with sustainability-related considerations integrated into investment processes and

decisions, and the performance of fiduciary and stewardship duties, including via voting and active engagement decisions with

respect to investee companies, as both an asset owner and an asset manager. Priorities for the Group in 2025 remained the same,

including the enhancement of governance and controls around sustainability-related topics and external disclosures, incorporating

sustainability goals for all people managers, internal knowledge sharing and capacity-building, the implementation of frameworks

and governance for transition finance investments, the preparation for adoption of the Hong Kong Stock Exchange and Singapore

Exchange's climate disclosure requirements, and continued progress towards the Group's external climate-related commitments.

The Group participates in networks, industry forums and working groups, such as the Principles for Responsible Investment (PRI),

to further develop, understanding and support action in relation to managing sustainability risks and promoting a just and

inclusive transition, which the Group considers are consistent with its fiduciary responsibilities. The Group also actively engages

with, responds and contributes to, discussions, consultations and information-gathering exercises with local regulators,

international supervisory bodies and global industry standard setters. Collectively, these activities enable the Group to better

identify material sustainability-related risks, and potential opportunities toward addressing them.

Potential regulatory compliance and litigation risks remained significant globally and across Asia in 2025, as sustainability-related

topics remained high on the agenda of both local regulators, major exchanges and international supervisory bodies. These include

the Hong Kong Stock Exchange and Singapore Exchange, both of which began implementing mandatory climate disclosure

requirements in 2025; the UK Financial Conduct Authority, which is consulting on the implementation of similar disclosure

requirements; the International Association of Insurance Supervisors (IAIS); as well as the European Commission, the European

Securities and Market Authority, the Monetary Authority of Singapore which have strengthened rules on the use of sustainability

and ESG nomenclature in the labelling of investment products.

Delivery of the Group's Sustainability Strategy, including the decarbonisation commitments and the development of sustainable

and inclusive offerings, heightens the risk of accusations of misleading or unsubstantiated representations to the extent of the

environmental or societal impact of the Group's activities and the sustainability features of new products (eg greenwashing), which

subsequently increases the risk of potential litigation, regulatory action or reputational damage. Evolving and diverging

approaches to sustainability efforts in various jurisdictions also create challenges in addressing conflicting requirements and

expectations.

Further details of the Group's sustainability-related risks and legal and regulatory compliance risks are included in sections 3.1 and

4.1 of the Risk factors.

The Group Risk Framework continues to be critically evaluated and updated where required to ensure both sustainability-related

considerations and risks to the Group, including those arising from stakeholder expectations of the external impact of the Group's

activities, are appropriately identified, assessed, monitored and managed. Consideration is given to a number of risk

characteristics which sustainability-related risks may exhibit, but which are not generally recognised in more traditional risk

management practices. These characteristics are reflected in the materiality assessment of sustainability-related risk themes, the

decision on how to treat the risks associated with the themes, and the assessment and enhancement of existing controls or

development of new controls where necessary.

Risk management and mitigation of sustainability risks continues to be embedded across the Group and risk processes, including:

–Recognition within the emerging risk identification and evaluation processes that emerging sustainability themes and the

associated risks can potentially quickly change from immaterial to material (dynamic materiality);

–Advancement in assessment of both physical and transition risks across the Group's operations and investments, including

evaluation of a new tool to assess climate risks on investments, conducting updated assessments of climate-related impacts on

operations, and completing an internal assessment of climate-related impacts on insurance risks;

–Workshops and ongoing function-wide training on specific risk themes, including sustainability risk principles, greenwashing risk

and the risks associated with delivery of the Group's external responsible investment commitments;

–The definition of appropriate (and longer) time horizons, including with respect to climate risk management, and adding the

requirement to consider appropriate time horizons in risk-based decision-making;

–Proactive identification, monitoring and assessment of emerging sustainability regulations and policy developments at both

global and local levels through horizon scanning;

–Continued enhancement of existing frameworks, policies, processes and standards as necessary to mitigate amplified risks and

meet regulatory requirements, particularly those associated with product labelling and disclosures; and

–Deep dives into emerging and increasingly material sustainability themes, including climate-related risks, and development of

Board-level and broader Group-wide training.

The Group publishes a Sustainability Report that sets out in more detail the Group's sustainability activities during the year. The

Sustainability Report is available on the Group's website.

**Notes**

(1)Reflecting products that are classified as variable fee approach only.

(2)With the exception of investments backing the shareholders' 10 per cent share of the estate within the Hong Kong participating fund.

(3)Excluding assets held to cover linked liabilities.

(4)Based on middle ranking from Standard & Poor's, Moody's and Fitch ratings, where available. Where ratings are not available from these rating agencies, local

external ratings agencies' ratings and, lastly, internal ratings have been used.

(5)Source of segmentation: Bloomberg Sector, Bloomberg Group and Merrill, a Bank of America company. Anything that cannot be identified from the three

sources noted is classified as other.

(6)Corporate debt comprises corporate bonds and asset-backed securities.

**Risk factors**

A number of risk factors may affect the financial condition, results of operations and/or prospects of Prudential and its wholly- and

jointly-owned businesses, as a whole, and, accordingly, the trading price of Prudential's shares. The risk factors mentioned below

should not be regarded as a complete, exhaustive and comprehensive statement of all potential risks and uncertainties. The

information given is as of the date of this document, and any forward-looking statements are made subject to the factors specified

under 'Forward-looking statements'.

**1Risks relating to Prudential's financial condition**

**1.1 Prudential's businesses are inherently subject to market fluctuations and general economic** 

**conditions, each of which may adversely affect the Group's business, financial condition,** 

**results of operations and prospects.**

Uncertainty, fluctuations or negative trends in global and national macroeconomic conditions and investment climates could have a

material adverse effect on the Group's business, financial condition, results of operations and prospects, including as a result of

increased strategic, business, insurance, product and customer conduct risks, as well as heightened volatility in financial markets,

asset prices and funding conditions.

actual or expected changes in both monetary and regulatory policies in Mainland China, the US and other jurisdictions together

with their impact on base interest rates and the valuation of asset classes and inflation expectations; slowdowns or reversals in

world or regional economic growth arising from geopolitical conflicts and/or global issues such as pandemics, natural catastrophes,

and sector-specific (eg in banking, insurance, or real estate) slowdowns or deteriorations which have the potential to result in

widespread contagion impacts. Other factors include fluctuations in global commodity and energy prices, unemployment rates,

aging demographics, social unrest, concerns over the serviceability of sovereign debt in certain economies, increased levels of

geopolitical and political risk and policy-related uncertainty, protectionism, trade policies, and sociopolitical and climate-driven

events.

The adverse effects of such factors could be felt principally through the following items:

–Changes to interest rates could reduce Prudential's capital strength and impair its ability to write significant volumes of new

business. Increases in interest rates could adversely impact the financial condition of the Group through changes in the present

value of future fees for unit-linked businesses and/or the present value of future profits for accident and health products; and/or

reduce the value of the Group's assets and/or have a negative impact on its assets under management and profit. Decreases in

interest rates could: increase the potential adverse impact of product guarantees included in non-unit-linked products with a

savings component; reduce investment returns on the Group's portfolios; impact the valuation of debt securities; and/or

increase reinvestment risk for some of the Group's investments from accelerated prepayments and increased redemptions.

Rapid or volatile changes in interest rates, rather than sustained directional movements alone, could further increase hedging

costs, basis risk and model risk.

–A reduction in the financial strength and flexibility of corporate entities may result in a deterioration of the credit rating profile

and valuation of the Group's invested credit portfolio (which may lead to an increase in regulatory capital requirements for the

Group or its businesses), increased credit defaults and debt restructurings and wider credit and liquidity spreads, leading to

realised and unrealised credit losses by the Group. Similarly, securitised assets in the Group's investment portfolio are subject to

default risk and may be adversely impacted by delays or failures of the underlying borrowers to make payments of principal and

interest when due.

–Failure of Prudential's counterparties (such as banks, reinsurers and counterparties to cash management and risk transfer or

hedging transactions) to meet commitments, or legal, regulatory or reputational restrictions on the Group's ability to deal with

these counterparties, could give rise to a negative impact on Prudential's financial position and on the accessibility or

recoverability of amounts due or the adequacy of collateral. Geographic or sector concentrations of counterparty credit risk

could exacerbate the impact of these events where they materialise.

–Estimates of the value of financial instruments may become more difficult in certain illiquid, volatile or closed markets, and

determining the value at which financial instruments can be realised is highly subjective. Processes to ascertain such values

require substantial elements of judgement, assumptions and estimates (which may change over time). Where the Group is

required to sell its investments within a defined time frame, such market conditions may result in the sale of these investments

at below expected or recorded prices.

–The Group holds certain investments that may, by their nature, lack liquidity or have the potential to lose liquidity rapidly, such

as investment funds (including money market funds), privately placed fixed maturity securities, mortgage loans, complex

structured securities and alternative investments. If these investments were required to be liquidated at short notice, the Group

could experience difficulty in doing so and could be forced to sell them at a lower price than it otherwise would have been able

to realise.

–Increased illiquidity driven by the uncertainty over the accessibility of financial resources could adversely affect the Group's

ability to meet policyholder benefit and expense obligations. This could occur if capital resources are reduced as valuations

decline under extreme market conditions, external capital is unavailable at sustainable cost, increased liquid assets are required

to be held as collateral under derivative transactions, or redemption restrictions are placed on Prudential's investments in illiquid

funds. In addition, significant redemption requests could also be made on Prudential's issued funds, and while this may not have

a direct impact on the Group's liquidity, it could result in reputational damage to Prudential. The potential impact of increased

illiquidity is more uncertain than for other risks such as interest rate or credit risk and may be exacerbated during periods of

market stress.

–A reduction in revenue from the Group's products could occur where fee income is linked to account values or the market value

of the funds under management. Sustained inflationary pressures which may drive higher interest rates may also impact the

valuation of fixed income investments and reduce fee income.

–The transition, including where disorderly or fragmented, to a lower carbon economy, the timing and speed of which is uncertain

and will vary by country, may also result in greater uncertainty, fluctuations or negative trends in asset valuations and reduced

liquidity, particularly for carbon-intensive sectors, and may have a bearing on inflation levels. The extent of the financial market

and economic impact of these factors may be highly uncertain and unpredictable and influenced by the actions, including the

duration and effectiveness of mitigating measures, taken by governments, policymakers, institutions and the public. See risk

factors 3.1 below.

For some non-unit-linked products with a savings component, it may not be possible to hold assets which will provide cash flows

to match those relating to policyholder liabilities. This may particularly be the case in jurisdictions where bond markets are less

developed or where the duration of policyholder liabilities is longer than the duration of bonds issued and available, and in certain

markets where regulated premium and claim values are set with reference to the interest rate environment prevailing at the time

of policy issue. This results in a mismatch due to the duration and uncertainty of the liability cash flows and the lack of sufficient

assets of a suitable duration. While this residual asset/liability mismatch risk can be managed, it cannot be eliminated. If interest

rates in these markets are lower than those used to calculate premium and claim values over a sustained period, this could have a

material adverse effect on Prudential's reported profit and the solvency of its business units. In addition, part of the profit from the

Group's operations is related to bonuses for policyholders declared on participating products, which are impacted by the difference

between actual investment returns of the participating fund (which are broadly based on historical and current rates of return on

equity, real estate and fixed income securities) and minimum guarantee rates offered to policyholders. This profit could be lower,

particularly in a sustained low interest rate environment. Bonuses are shaped not only by the aforementioned conditions, but also

by local regulations in certain markets, which require the management of participating funds to ensure a fair and equitable

allocation of distributable surplus or profits and alignment with policyholders' reasonable expectations. This interplay adds further

complexity to the effective management of these products and could have a material adverse effect on Prudential's results of

operations and prospects.

In general, upheavals in the financial markets may affect general levels of economic activity, employment and customer

behaviour. As a result, insurers may experience an elevated incidence of claims, fraud, lapses, partial withdrawals or surrenders of

policies, and some policyholders may choose to defer or stop paying insurance premiums or reduce deposits into retirement plans.

Uncertainty over livelihoods, elevated cost of living and challenges in affordability may adversely impact the demand for insurance

products and increase regulatory risk in meeting regulatory requirements and expectations with respect to vulnerable customers

(see risk factor 2.7). In addition, there may be a higher incidence of counterparty failures. If sustained, this environment is likely

to have a negative impact on the insurance sector over time and may consequently have a negative impact on Prudential's

business, balance sheet and profitability. For example, this could occur if the recoverable value of intangible assets for

bancassurance agreements is reduced. New challenges related to market fluctuations and general economic conditions may

continue to emerge. For example, sustained inflationary pressures driving interest rates to higher levels may lead to increased

lapses for some guaranteed savings products where higher levels of guarantees are offered by products of the Group's

competitors, reflecting consumer demand for returns at the level of, or exceeding, inflation. High inflation, combined with an

economic downturn or recession, may also result in affordability challenges, adversely impacting the ability of consumers to

purchase insurance products. Rising inflation, via medical claims inflation (with rising medical import prices a factor under current

market conditions), may adversely impact the profitability of the Group's businesses.

Any of the foregoing factors and events, individually or together, could have a material adverse effect on Prudential's business,

financial condition, results of operations and prospects.

**1.2 Geopolitical and political risks and uncertainty may adversely impact economic conditions,** 

**increase market volatility and regulatory risks, cause operational disruption to the Group** 

**and its businesses and impact the implementation of its strategic plans, which could have** 

**adverse effects on Prudential's business, financial condition, results of operations, and** 

**prospects.**

The Group is exposed to geopolitical and political risks and uncertainty in the diverse markets in which it operates. Such risks may

include:

–The application of government regulations, executive powers, sanctions, protectionist or restrictive economic and/or trade

policies (including tariffs and embargoes) and related measures such as export controls, investment restrictions/screening and

restrictions on the provision of services, restrictions on product design and repricing, or other measures adopted by

governments, businesses or industries which increase trade barriers or restrict trade, sales, financial transactions, or the

transfer of capital, investment, data (including data localisation requirements) or other intellectual property, with respect to

specific territories, markets, companies or individuals;

–An increase in the volume and pace of domestic regulatory changes, including those applying to specific sectors or business

activities;

–The increased adoption or implementation of laws and regulations which may purport to have extra-territorial application

(including the extraterritorial or secondary effects of sanction regimes or other trade restrictions);

–An increase in military tensions, regional hostilities or new conflicts which may disrupt business operations, investments, market

confidence and expectations and growth;

–Withdrawals or expulsions from existing trading blocs or agreements or financial transaction systems, or fragmentation of

systems, including those which facilitate cross-border payments;

–The implementation of measures favouring local enterprises including changes to the maximum level of non-domestic ownership

by foreign companies, differing treatment of foreign-owned businesses under regulations and tax rules, or international trade

disputes affecting foreign companies;

–Increased costs due to government mandates or regulations imposing a financial contribution to the government as a condition

for doing business;

–Uncertainty in the enforceability of legal obligations where their interpretation may change or be subject to inconsistent or

conflicting interpretation and application across jurisdictions or over time; and

–Measures which require businesses of overseas companies to operate through locally incorporated entities or with local partners,

or with requirements for minimum local representation on executive or management committees.

The above risks may have an adverse impact on Prudential through their effects on the macroeconomic outlook and the

environment for global, regional and national financial markets. Prudential may also face risks arising from economic sanctions

imposed as a result of geopolitical conflicts and national security and economic decisions. The above risks may adversely impact

the economic, business, legal and regulatory environment in specific markets or territories in which the Group, its joint ventures or

jointly owned businesses, sales and distribution networks, or third-party service providers have operations. For internationally

active groups such as Prudential, operating across multiple jurisdictions, such measures may add to the complexity of legal and

regulatory compliance and increase the risk of conflicts between the requirements of one jurisdiction and another and the potential

for increased compliance costs or restrictions on business activities. See risk factors 4.1 and 4.3 below.

Geopolitical and political risks and uncertainty may adversely impact the Group's operations and its operational resilience.

Increasing geopolitical and political tensions may lead to conflict, civil unrest and/or civil disobedience as well as increases in

domestic and cross-border cyber intrusion activity or other forms of hostile or malicious activity. Such events could impact

operational resilience by disrupting Prudential's IT systems, both software and hardware (including any network, storage,

applications, models and platform technologies), operations, new business sales and renewals, distribution channels and services

to customers, which may result in a reduction in contributions from business units to the central cash balances and profit of the

Group, decreased profitability, financial loss, adverse customer impacts and reputational damage and could require the diversion

of management attention and resources.

Legislative or regulatory changes and geopolitical or political risks which adversely impact the international trading and economic

relationships of Hong Kong, which is both a key market and the location of Group head office functions, may result in adverse

sales, operational and product distribution impacts to the Group and could impair the Group's ability to coordinate regional or

global operations efficiently.

**1.3 As a holding company, Prudential is dependent upon its subsidiaries to cover operating** 

**expenses, dividend payments and share buybacks. Any changes in the financial condition of** 

**Prudential's subsidiaries could have an adverse effect on the Group's business, financial** 

**condition, results of operations and prospects.**

The Group's insurance and asset management operations are generally conducted through direct and indirect subsidiaries, which

are subject to the risks discussed elsewhere in this 'Risk factors' section.

As a holding company, Prudential's principal sources of funds are remittances from subsidiaries, shareholder-backed funds, the

shareholder transfer from long-term funds and any amounts that may be raised through the issuance of equity, debt and

commercial paper.

Prudential's subsidiaries are generally subject to insurance, asset management, foreign exchange and tax laws, rules and

regulations (including in relation to distributable profits that can limit their ability to make remittances). In some circumstances,

including where there are changes to general market conditions, this could limit Prudential's ability to pay dividends to

shareholders, to make available funds held in certain subsidiaries to cover the operating expenses of other members of the Group,

or to execute business strategies such as share buybacks.

A material change in the financial condition of any of Prudential's subsidiaries may have a material effect on the Group's business,

financial condition, results of operations and prospects.

**1.4 Prudential's investment portfolio is subject to the risk of potential sovereign debt credit** 

**deterioration, which could have a material adverse effect on Prudential's business, financial** 

**condition, results of operations and prospects.**

Investing in sovereign debt creates exposure to the direct or indirect consequences of geopolitical, political, social or economic

changes (including changes in governments, heads of state or monarchs), military conflicts, regime change, pandemics and

associated disruption, and other events affecting the markets in which the issuers of such debt are located and the

creditworthiness of the sovereign. Investment in sovereign debt obligations involves risks that are different from investment in the

debt obligations of corporate issuers. In addition, the issuer of the debt or the governmental authorities that control the

repayment of the debt may be unable or unwilling to repay principal or pay interest when due (or in the agreed currency) in

accordance with the terms of such debt, and Prudential may have limited recourse to compel payment in the event of a default or

restructuring. A sovereign debtor's willingness or ability to repay principal and to pay interest in a timely manner may be affected

by, among other factors, its financial position, the extent and availability of its foreign currency reserves, the availability of

sufficient foreign exchange on the date a payment is due, the relative size of the debt service burden to the economy as a whole,

the sovereign debtor's policy toward local and international lenders, geopolitical tensions and conflicts and the political constraints

to which the sovereign debtor may be subject. Fiscal risks faced by sovereigns could increase due to elevated levels of

indebtedness and increasing demands on government budgets stemming from rising social welfare costs, defence expenditures

and climate transition efforts.

Moreover, governments may use a variety of techniques, such as intervention by their central banks or imposition of regulatory

controls or taxes, to devalue their currencies' exchange rates, or may adopt monetary, fiscal and other policies (including to

manage their debt burdens) that have a similar effect, all of which could adversely impact the value of an investment in sovereign

debt even in the absence of a technical default. Periods of economic uncertainty may affect the volatility of market prices of

sovereign debt to a greater extent than the volatility inherent in debt obligations of other types of issuers and may reduce market

liquidity of these debts.

In addition, if a sovereign default or other such events described above were to occur, as has happened on certain occasions in the

past, other financial institutions may also suffer losses or experience solvency or other concerns, which may result in Prudential

facing additional risks relating to investments in such financial institutions that are held in the Group's investment portfolio. There

is also risk that public perceptions about the stability and creditworthiness of financial institutions and the financial sector

generally might be adversely affected, as might counterparty relationships between financial institutions.

If a sovereign were to default on or restructure its obligations, or adopt policies that devalued or otherwise altered the currencies

in which its obligations were denominated, this could have a material adverse effect on Prudential's business, financial condition,

results of operations and prospects.

**1.5 Downgrades in Prudential's financial strength and credit ratings could significantly impact** 

**its competitive position and damage its relationships with creditors or trading** 

**counterparties.**

Prudential's financial strength and credit ratings, which are used by the market to measure its ability to meet policyholder

obligations, are important factors affecting public confidence in Prudential's products, and, as a result, its competitiveness.

Downgrades in Prudential's ratings as a result of, for example, decreased profitability, a deteriorating solvency position, increased

costs, increased indebtedness or other concerns could have an adverse effect on its ability to market products, retain current

policyholders and attract new policyholders, as well as the Group's ability to compete for acquisition and strategic opportunities.

Downgrades could have an adverse effect on the Group's financial flexibility, including its ability to issue commercial paper in a

timely manner at acceptable levels and pricing, if at all, the potential imposition of higher funding costs, requirements to post

collateral under or in connection with transactions, and constraints on its ability to manage market risk exposures. The interest

rates at which Prudential is able to borrow funds are affected by its credit ratings, which are in place to measure the Group's

ability to meet its contractual obligations.

In addition, changes in methodologies and criteria used by rating agencies could result in downgrades that do not reflect changes in the

general economic conditions or Prudential's financial condition or operating performance.

Any such downgrades could have a material adverse effect on Prudential's business, financial condition, results of operations and

prospects. Prudential cannot predict what actions rating agencies may take, or what actions Prudential may take in response to any

such actions, which could also adversely affect its business and prospects.

**1.6 Prudential is subject to the risk of exchange rate fluctuations owing to the geographical** 

**diversity of its businesses.**

Prudential's operations generally write policies and invest in assets denominated in local currencies, but in some markets

Prudential also writes policies and invests in assets denominated in non-local currencies, primarily in the US dollar. Although this

practice limits the effect of exchange rate fluctuations on local operating results, it can lead to fluctuations in Prudential's

consolidated financial statements upon the translation of results into the Group's presentation currency. This exposure is not

separately managed at the Group level. The Group presents its consolidated financial statements in the US dollar. The results of

some entities within the Group are not denominated in or linked to the US dollar and some enter into transactions which are

conducted in non-US-dollar currencies. Prudential is subject to the risk of exchange rate fluctuations from the translation of the

results of these entities and non-US-dollar transactions, including the risks from the maintenance of the HK dollar peg to the US

dollar. In cases where a non-US-dollar-denominated surplus arises in an operation which is to be used to support Group capital or

shareholders' interest (ie remittances), this currency exposure may be hedged where considered economically favourable.

Prudential is also subject to residual risks arising from currency swaps and other derivatives that are used to manage such

currency exposure. In addition, there may be second-order effects arising from changes in policyholder behavior if policies

denominated in a foreign currency (eg US dollar) are deemed unattractive, which could lead to higher surrender outgo and

unfavourable shifts in new business sales.

**2Risks relating to Prudential's business activities and industry**

**2.1 The implementation of large-scale transformation, including complex strategic initiatives,** 

**gives rise to significant design and execution risks and may affect Prudential's operational** 

**capability and capacity. Failure of these initiatives to meet their objectives may adversely** 

**impact the Group and the delivery of its strategy.**

Prudential undertakes operating model changes, corporate restructurings, transformation programmes and acquisitions or

disposals to support its business strategy, enhance customer experience, strengthen operational resilience, meet regulatory and

industry requirements, and maintain competitiveness. These initiatives are often large-scale, complex and interconnected, aiming

to drive efficiency, enhance digital capabilities, and expand strategic partnerships across multiple business functions and markets.

While there can be no assurance of the successful completion or realisation of the intended benefits, if at all, of these initiatives,

unplanned costs, implementation delays or failure to deliver intended outcomes could adversely affect Prudential's business,

employees, customers, financial condition, results of operations or prospects and could result in the diversion of management

attention and resources. Leadership changes and shifts in business or operating models may also create uncertainty for employees

and place additional strain on operational capacity and change-management practices and could adversely affect employee

engagement, retention and productivity. Initiatives undertaken to execute the Group's strategy, enhance the control environment,

adopt significant accounting standard changes and/or respond to regulatory developments may further amplify these risks. Risks

relating to these regulatory changes are described in risk factor 4.1 below.

The rapid pace of technological advancement presents both opportunities and risks for the Group's transformation journey.

Prudential's exploration and implementation of innovative technologies, particularly artificial intelligence (AI), to enhance

operational efficiency, decision-making, and strategic agility, exposes Prudential to challenges or failures in adopting innovative

technologies, such as failure to systematically, prudently and/or effectively implement AI, and may put Prudential at risk of losing

competitive advantage, as well as exposure to additional regulatory, information security, privacy, operational, ethical and conduct

risks. High-quality training data is essential for building accurate and robust AI models. Without sufficient, well-structured and

relevant data, AI systems may produce unreliable or biased results or outputs that are not explainable or auditable. Real-world

data collected during deployment and ongoing monitoring and updates may improve the reliability, efficiency and performance of

AI models, but may also introduce new risks if such data is incomplete, inaccurate, improperly governed or biased. Prudential

seeks to consider potential risks and negative outcomes, and proactively build risk mitigation governance practices, when

implementing AI technologies to mitigate these unintended effects,

**2.2 Prudential's businesses are conducted in highly competitive environments with rapidly** 

**developing demographic trends. The profitability of the Group's businesses depends on** 

**management's ability to respond to these pressures and trends.**

The markets for financial services are highly competitive, with a number of factors affecting Prudential's ability to sell its products

and its profitability, including price and yields offered, financial strength and ratings, range of product lines and product quality,

range of distribution channels (including the emergence of new distribution models) and distribution quality, illustrative point-of-

sale customer investment returns, ability to implement and comply with regulatory changes, the imposition of regulatory

sanctions, brand strength and name recognition, investment management performance and fund management trends, historical

bonus levels, delivery of non-guaranteed benefits (notably non-guaranteed investment returns) according to reasonable customer

expectations set at and after the point-of-sale, the ability to respond to developing demographic trends, societal expectations,

political influences, customer appetite for different types of insurance products, technological advances, and the interplay of these

factors. In some of its markets, Prudential faces competitors that are larger, have greater financial resources or a greater market

share, have different financial and/or risk appetites, offer a broader range of products or have higher bonus rates. Further,

heightened competition for talented and skilled employees, agents and independent financial advisers may limit Prudential's

potential to grow its business as quickly as planned or otherwise implement its strategy. Technological advances, including those

enabling increased capability for gathering large volumes of customer health data and developments in capabilities and tools for

analysing and interpreting such data (such as AI, machine learning and predictive models as well as other digital technologies),

may result in increased competition to the Group, and may reshape customer expectations and potentially give rise to new

distribution models that may impact traditional distribution channels. This may also increase the competition risks resulting from a

failure by the Group to retain existing talent, as well as hiring for newly emerging roles. Additionally, evolving regulatory

requirements and the development of new technologies, including AI, may vary across the markets the Group operates in. This

could limit the Group's ability to implement these technologies uniformly, resulting in disparities in innovation and cost efficiency,

and adversely impacting the Group's competitive position.

The Group's principal competitors include global life insurers, regional insurers and multinational asset managers. In most

markets, there are also local companies that have a material market presence.

Prudential believes that competition will intensify across all regions in response to consumer demand, digital and other technological

advances (including the use of AI to improve operational efficiency and enhance customer experiences), new entrants with business

models that have the potential to disrupt the existing value chain, the need for economies of scale and the consequential impact of

consolidation, regulatory actions and other factors. Prudential's ability to generate an appropriate return depends significantly upon

its capacity to anticipate and respond appropriately to these competitive pressures.

Failure to do so may adversely impact Prudential's ability to attract and retain customers and, importantly, may limit Prudential's ability

to take advantage of new business opportunities in the markets in which it operates, which may have an adverse impact on the Group's

business, financial condition, results of operations, growth and prospects.

**2.3 Adverse experience in the operational risks inherent in Prudential's business, and those of** 

**its material outsourcing partners, could disrupt its business functions and have a negative** 

**impact on its business, financial condition, results of operations and prospects.**

Operational risks are present in all of Prudential's businesses, including the risk of loss arising from inadequate or failed internal

processes, systems or human error, misconduct, fraud, the effects of natural or man-made catastrophic events (such as natural

disasters, pandemics, cyber attacks, acts of terrorism, military conflict, civil unrest and other catastrophes) or other external events.

These risks may also adversely impact Prudential through its partners. Prudential relies on the performance and operations of a

number of agency, bancassurance, outsourcing (including but not limited to external technology, data hosting and payments) and

service partners. These include back-office support functions, such as those relating to technology infrastructure, development and

support, and customer-facing operations and services, such as product distribution and services (including through digital channels),

and investment operations. This creates reliance upon the operational resilience of these partners and exposes Prudential to the risk that

the operations and services provided by these partners are disrupted, or fail to meet required service levels. Further, Prudential operates

in extensive and evolving legal and regulatory environments which adds to the complexity of the governance and operation of its

business processes and controls.

Exposure to such risks could impact Prudential's operational resilience and ability to perform necessary business functions if there

are disruptions to its systems, operations, new business sales and renewals, distribution channels and services to customers, or

could result in the loss of confidential or proprietary data. Such risks, as well as any weaknesses in administration systems (such

as those relating to policyholder records) or actuarial reserving processes, may also result in increased expenses, as well as legal

and regulatory penalties or sanctions, decreased profitability, financial loss and customer conduct risk impacts. This could damage

Prudential's reputation and relationships with its customers and business partners. A failure to adequately oversee service partners

(or their technology and operational systems and processes including their security) could result in significant service degradation

or disruption to Prudential's business operations and services to its customers, which may have reputational or conduct risk

implications and could have a material adverse effect on the Group's business, financial condition, results of operations and

prospects.

Prudential's business requires the processing of a large number of transactions for a diverse range of products. It also employs

complex and interconnected technology and finance systems, models and user-centric applications in its processes to perform a

range of operational functions. These functions include the calculation of regulatory or internal capital requirements, the valuation

of assets and liabilities, and the acquisition of new business using AI and digital applications. Many of these tools form an integral

part of Prudential's information and decision-making frameworks, and errors, limitations or misinterpretation of such tools may

give rise to adverse consequences in core business activities, decision-making and reporting. Errors or limitations in these tools, or

their inappropriate usage, may lead to regulatory breaches, inappropriate decision-making, financial loss, customer detriment,

inaccurate external reporting or reputational damage. The long-term nature of much of the Group's business also means that

accurate records must be maintained securely for significant time periods.

The performance of the Group's core business activities and the uninterrupted availability of services to customers rely

significantly on and require significant investment in resilient IT applications, data hosting, infrastructure and security architectural

design, data governance and management and other operational systems, personnel, controls and mature processes. During

large-scale disruptive events or times of significant change, or due to other factors impacting operational performance including

adequacy of skilled/experienced personnel, the operational effectiveness of these systems and processes at Prudential and/or its

third-party service providers may be adversely impacted. In particular, Prudential and its business partners are making increasing

use of emerging technological tools and digital services, or forming strategic partnerships with third parties to provide these

capabilities. Automated distribution channels and services to customers increase the criticality of providing uninterrupted services.

A failure to implement appropriate governance and management of the incremental operational risks from emerging technologies

may adversely impact Prudential's reputation and brand, the results of its operations, its ability to attract and retain customers

and its ability to deliver on its long-term strategy and therefore its competitiveness and long-term financial success.

Although Prudential's technology, compliance and other operational systems, models and processes incorporate strong governance

and controls designed to manage and mitigate the operational and model risks associated with its activities, there can be no

complete assurance as to the resilience of these systems and processes or that governance and controls will always be effective, if

at all. Due to human error, among other reasons, operational and model risk incidents may occur from time to time, and no

system or process can entirely prevent them. Prudential's legacy and other technology systems, data and processes, as with

operational systems and processes generally, may also be susceptible to failure or security/data breaches.

**2.4 Cyber security risks, including attempts to access or disrupt Prudential's technology** 

**systems, and loss or misuse of personal data, could have potential adverse financial impacts** 

**on the Group and could result in loss of trust from Prudential's customers and employees** 

**and reputational damage, which in turn could have material adverse effects on the Group's** 

**business, financial condition, results of operations and prospects.**

Prudential and its business partners operate in an escalating cyber security risk landscape. Individuals (including employees, contractors

and agents), groups or AI-enabled cyber tools may pose intentional or unintentional threats to the availability, confidentiality, and

integrity of Prudential's technology systems. These risks extend to the security of both corporate and customer data. The evolution of

ransomware (a form of malicious software (malware) designed to restrict data access until a ransom is paid) could pose a threat to

Prudential by impeding operations or resulting in the public exposures of sensitive information if the ransom is not promptly paid. Where

these risks materialise, they could result in disruption to key operations, make it difficult to recover critical data or services, or result in

damage to assets, any of which could result in loss of trust from Prudential's customers and employees, reputational damage and direct

or indirect financial loss.

The vast amount of personal and financial data held by financial services companies makes them attractive targets for cyber crime

groups. Recent trends indicate that ransomware attacks are on the rise due to the proliferation of ransomware exploit toolkits and

Ransomware-as-a-Service (RaaS) offerings, which provide threat actors with easy access to powerful attack tools. Simultaneously,

global cyber security threats are becoming more sophisticated and impactful. As financial institutions increasingly rely on third-

party vendors and interconnected systems, vulnerabilities in these supply chains can also be exploited by cyber criminals. A

compromised vendor or service provider could inadvertently introduce malicious code or backdoors into the financial institution's

infrastructure, leading to potential data breaches or ransomware incidents or operational disruption.

Prudential's increasing profile in its current markets and those in which it is entering, growing customer interest in interacting with

their insurance providers and asset managers through the internet and social media, improved brand awareness, and increasing

adoption of the Group's digital platforms could also increase the likelihood of Prudential being considered a target by cyber

criminals.

There is an increasing requirement and expectation on Prudential and its business partners not only to hold the data of customers,

shareholders and employees securely, but also to ensure its ongoing accuracy and that it is being used in a transparent,

appropriate and ethical way, including in decision-making where automated processes or AI are employed. As Prudential and its

business partners increasingly adopt digital technology (including AI) in business operations, the data the Group generates creates an

opportunity to enhance customer engagement while maintaining a responsibility to keep customers' personal data safe. Various

policies and frameworks are in place to govern the handling of customers' data. Failure to adhere to these policies may result in

regulatory scrutiny and sanctions and detriment to customers and third-party partners, and may adversely impact the reputation

and brand of the Group, its ability to attract and retain customers, and deliver on its long-term strategy.

The risk to the Group of not meeting these requirements and expectations may be increased by the expansion of cloud-based

infrastructure and the usage of digital distribution and service channels, which can collect a broader range of personal and health-

related data from individuals at increased scale and speed, as well as the use of complex tools, machine learning and AI

technologies to process, analyse and interpret this data.

New and currently unforeseeable regulatory, reputational and operational issues may also arise from the increased use of

emerging technology such as generative AI which requires careful consideration and guardrails established to enable its safe use.

Regulatory developments in cyber security and data protection continue to progress worldwide. The focus on data privacy has

continued to increase, with regulators in Asia and globally introducing new data privacy laws or enhancing existing ones. Such

developments may increase the complexity of requirements and obligations in this area, in particular where they involve AI or

data localisation restrictions, or where they require system-level modifications to digital applications or platforms or impose

differing and/or conflicting requirements compared with those of other jurisdictions.

Prudential faces increased financial and reputational risks due to both dynamic changes in the regulatory landscape and the risk of

a significant breach of IT systems or data. These risks extend to joint ventures and third-party suppliers in light of a dynamic

cyber threat landscape including supply chain compromise, computer viruses, unauthorised access and cyber security attacks such

as 'denial of service' attacks, phishing and disruptive software campaigns. Despite multi-layered security defences, there is no

guarantee that such events will not occur, and they could have significant adverse effects on Prudential's business, financial

condition, results of operations and prospects.

**2.5 Prudential's digital platforms may heighten existing business risks to the Group or introduce** 

**new risks as the markets in which it operates, and its partnerships and product offerings** 

**evolve.**

Prudential's digital platforms are subject to a number of risks, including those related to legal and regulatory compliance and the

conduct of business; the execution of complex change initiatives; information security and data privacy; the use of models and the

handling of personal data (including those using or used by AI); the resilience and integrity of IT infrastructure and operations;

and the management of third parties. These existing risks for the Group may be increased due to several factors:

–The number of current and planned markets in which Prudential's digital platforms operate, each with their own laws and

regulations, regulatory and supervisory authorities, the scope of application of which may be uncertain, conflicting or change at

pace, may increase regulatory compliance risks;

–The implementation of planned digital platforms and services, which may require the delivery of complex, interconnected

change initiatives across current and planned markets. This may give rise to design and execution risks, which could be

amplified where these change initiatives are delivered concurrently;

–The increased volume, breadth and sensitivity of data on which the digital platforms are dependent and to which the Group has

access, holds, analyses and processes through its models, increases information security, data privacy and usage risks.

Furthermore, the use of complex models, including where AI is used for critical decision-making, in an application's features and

offerings may give rise to ethical, operational, security, conduct, litigation and reputational risks if they do not function as

intended, if at all;

–Reliance on and/or collaboration with a number of third-party partners and providers, which may vary according to the market.

This may increase operational disruption risks to the uninterrupted provision of services to customers, regulatory compliance

and conduct risks, and the potential for reputational risks; and

–Support for, and development of, the platforms being provided outside some of the individual markets in which the platforms

operate, which may increase the complexity of local legal and regulatory compliance.

New product offerings and functionality (including those supported by AI) may be developed and provided through digital

platforms, which may introduce new regulatory, operational, conduct and strategic risks for the Group. Regulations may be

introduced, which limit the permitted scope of online or digitally distributed insurance and asset management services, or

deployment of new technological services, and may restrict current or planned offerings provided by the platform.

A failure to implement appropriate governance and management of the incremental and new risks detailed above may adversely

impact Prudential's reputation and brand, its ability to attract and retain customers, its competitiveness, its ability to deliver on its

long-term strategy and the financial position of the Group.

**2.6 Prudential operates in certain markets with joint venture partners and other shareholders** 

**and third parties. These businesses face the same risks as the rest of the Group and also** 

**give rise to certain risks to Prudential that the Group does not face with respect to its** 

**wholly-owned subsidiaries, which could adversely affect Prudential's reputation and its** 

**business, financial condition, results of operations and prospects.** 

Prudential operates, and in certain markets is required by local regulation to operate, through joint ventures and other joint

ownership or third-party arrangements (including associates). The financial condition, operations and reputation of the Group may

be adversely impacted, or the Group may face regulatory censure, in the event that any of its partners fails or is unable to meet

its obligations under the arrangements, encounters financial difficulty, or fails to comply with local or international regulation and

standards such as those pertaining to the prevention of financial crime and sustainability (including climate-related) risks (see risk

factor 3.1 below), or fails to resolve disputes that may arise from existing agreements or during the course of implementing

business strategy. Reputational risks to the Group are amplified where any joint ventures or jointly owned businesses carry the

Prudential name.

A portion of the Group's business comes from its joint venture and associate businesses in Mainland China and India, respectively.

For such operations, the level of control exercisable by the Group depends on the terms of the contractual agreements as well as

local regulatory constraints applicable to the joint venture and associate businesses, such as listing requirements; and, in

particular, those terms providing for the allocation of control among, and continued cooperation between, the participants. As a

result, the level of oversight, control and access to management information the Group is able to exercise at these operations may

be lower compared to the Group's wholly-owned businesses. This may increase the uncertainty for the Group over the financial

condition of these operations, including the valuation of their investment portfolios and the extent of their invested credit and

counterparty credit risk exposure, resulting in heightened risks to the Group as a whole. This may particularly be the case where

the geographies in which these operations are located experience market or sector-specific slowdowns, disruption, volatility or

deterioration. In addition, the level of control exercisable by the Group could be affected by changes in the maximum level of

foreign ownership imposed on foreign companies in certain jurisdictions. The exposure of the Group to the risks detailed in risk

factor 2.1 above may also evolve in line with the Group's strategic initiatives, such as the expansion of the Group's operations

through joint ventures or jointly-owned businesses.

In addition, a significant proportion of the Group's product distribution is carried out through agency arrangements and contractual

arrangements with third-party service providers not controlled by Prudential, such as bancassurance arrangements, and the Group

is therefore dependent upon the continuation of these relationships. The effectiveness of these arrangements, or temporary or

permanent disruption to them, such as through significant deterioration in the reputation, financial position or other circumstances

of the third-party service providers, material failure in controls (such as those pertaining to third-party service providers' systems

failure or the prevention of financial crime), regulatory changes affecting their governance or operation, or their failure to meet

any regulatory requirements could adversely affect Prudential's reputation and its business, financial condition, results of

operations and prospects.

**2.7 Adverse experience relative to the assumptions used in pricing products and reporting** 

**business results could have a material adverse effect on Prudential's business, financial** 

**condition, results of operations and prospects.**

In common with other life insurers, the profitability of the Group's businesses depends on a mix of factors including mortality and

morbidity levels and trends, policy surrenders and other policy discontinuances or alterations, customer take-up rates on product

options, economic conditions, investment performance and impairments, unit costs of administration and new business acquisition

expenses.

The potential adverse impacts to the profitability of the Group's businesses from the upheavals in financial markets and levels of

economic activity on customer behaviours are described in risk factor 1.1 above.

Prudential, like other insurers, needs to make assumptions about a number of factors in determining the pricing of its products, for

setting reserves, and for reporting its capital levels and the results of its long-term business operations. A further factor is the

assumptions that Prudential makes about future expected levels of the rates of early termination of products by its customers

(known as persistency). This is relevant to a number of lines of business in the Group. Prudential's persistency assumptions reflect

a combination of recent past experience for each relevant line of business and expert judgement, especially where a lack of

relevant and credible experience data exists. Any expected change in future persistency is also reflected in the assumptions. If

actual levels of persistency are significantly different than assumed, the Group's results of operations could be adversely affected.

The Group's businesses are subject to inflation risk. In particular, the Group's medical insurance businesses are also exposed to

medical inflation risk, which is often in excess of general price inflation. While the Group has the ability to reprice some of its

products, such repricing is dependent on the availability of operational and resource capacity to do so, as well as the Group's

ability to implement such repricing in light of the increased regulatory restrictions, political influences, and customer and societal

expectations reflecting the affordability of insurance products and the protection of vulnerable customers, as well as the

commercial considerations of the markets the Group operates in. Increasing regulatory requirements relating to the design and

repricing of medical reimbursement products may also impact the profitability of these products. Further, the profitability of the

Group's businesses may be adversely impacted by downgrade and/or policy termination experience following any repricing of

medical reimbursement products.

In addition, Prudential's business may be adversely affected by epidemics, pandemics and other effects that give rise to a large

number of deaths or additional sickness claims, as well as increases in the cost of medical claims. Pandemics, significant influenza

and other epidemics have occurred a number of times historically, but the likelihood, timing or severity of future events cannot be

predicted. The effectiveness of external parties, including governmental and non-governmental organisations, in combatting the

spread and severity of any epidemics, as well as pharmaceutical treatments and vaccines (and their rollouts) and non-

pharmaceutical interventions, could have a material impact on the Group's claims experience.

Prudential uses reinsurance to selectively transfer mortality, morbidity and other risks. This exposes the Group to: the

counterparty risk of a reinsurer being unable to pay reinsurance claims or otherwise meet their commitments; the risk that a

reinsurer changes reinsurance terms and conditions of coverage, or increases the price of reinsurance which Prudential is unable

to pass on to its customers; the risk of ambiguity in the reinsurance terms and conditions leading to uncertainty whether an event

is covered under a reinsurance contract; and the risk of being unable to replace an existing reinsurer, or find a new reinsurer, for

the risk transfer being sought.

Any of the foregoing, individually or together, could have a material adverse effect on Prudential's business, financial condition,

results of operations and prospects.

**3 Risks relating to sustainability (including environmental, social and governance (ESG) and** 

**climate-related) matters**

**3.1 The failure to understand and respond effectively to the risks associated with sustainability** 

**factors could adversely affect Prudential's achievement of its long-term strategy.**

Sustainability-related risks refer to (i) environmental, social or governance issues, trends or events that could have a financial or

non-financial impact on the Group, and/or (ii) the Group's sustainability-focused activities, strategy and commitments that could

have an external impact on the environment and wider society. A failure to manage the risks associated with key sustainability

themes may undermine Prudential's financial performance, operational resilience and sustainability credentials, adversely impact

its reputation and brand, and its ability to attract and retain customers, investors, employees and distribution and other business

partners, and therefore the results of its operations and the delivery of its business strategy and long-term financial success. As

investors are increasingly being seen as partly responsible for the actions of the companies they invest in, Prudential, as an asset

owner and asset manager, may also incur sustainability-related risks from investee companies.

**aEnvironmental risks**

Environmental concerns, notably those associated with climate change, biodiversity loss and nature degradation, present potential

long-term risks to the sustainability ambitions of Prudential and may impact its customers and other stakeholders. Prudential is

therefore exposed to the long-term impact of climate change and nature degradation risks, which include the financial and non-

financial impacts of transition, physical, reputational and shareholder, regulatory, customer or third-party litigation risks.

Recognising the long-term nature of the Group's investment time horizon, the global transition, including where disorderly or

fragmented, to a lower carbon economy and nature preservation may have an adverse impact on investment valuations and

liquidity as the financial assets of carbon-intensive companies in some asset sectors re-price as a result of increased operating

costs and a reduction in demand for their products and services. The speed of this transition, and the extent to which it is orderly

and managed versus disorderly and reactive, will be influenced by factors such as changes in geopolitics, public policy, technology

and customer or investor sentiment. Prudential's stakeholders increasingly expect and/or rely on the Group to support an orderly,

inclusive and sustainable transition based on an understanding of the relevant market and investee-company-level transition plans

with consideration given to the impact on the economies, businesses, communities and customers in these markets. The potential

economic impacts of transition risks may also have a broader economic impact that may adversely affect customers and their

demand for the Group's products.

The Group's ability to sufficiently understand, measure and appropriately respond to transition risk may be limited by insufficient

or unreliable data on the carbon exposure, nature impacts and dependencies, and transition plans of investee companies. This

may impact the Group's ability to deliver on its external decarbonisation commitments and the implementation of sustainability

considerations in existing or new sustainability-orientated investment strategies and products. Additionally, current limitations in

financial climate and nature modelling tools make it challenging to assess the financial impact of climate-related risks on the

Group and its investment portfolio, particularly for longer-term time horizons.

The direct physical impacts of climate change and nature degradation, including shorter-term event-driven (acute) physical risks

such as increasingly frequent and severe typhoons, floods, heatwaves, and wildfires, and those associated with longer-term shifts

in climate patterns such as elevated temperatures, extremely high rainfall, and prolonged drought (chronic physical risks), may

become increasingly significant factors in the mortality and morbidity risk assessments for the Group's insurance product

underwriting and offerings and their associated claims profiles. These physical climate risks have the potential to

disproportionately impact economies in the Asia and Africa markets in which Prudential operates and invests. Similarly, nature-

related physical risks can impact life and health liabilities where, for example, pollution, poor water quality, waste contamination

and overexploitation of the natural environment can all contribute to biodiversity degradation, which in turn can potentially pose

threats to human health.

A failure to understand, manage and provide greater transparency of its exposure to these environment-related risks may have

increasingly adverse implications for Prudential and its stakeholders. At the same time, evolving and diverging approaches to

sustainability in different jurisdictions, in some cases with extraterritorial reach, create challenges for global businesses such as

Prudential in meeting differing requirements and expectations.

**bSocial risks**

Social risks that could impact Prudential may arise from a failure to consider diversity, wellbeing, changing needs, human rights

and interests of its customers and employees and the communities in which the Group or its third parties operate. Perceived or

actual inequity and income disparities have the potential to further erode social cohesion across the markets in which the Group

operates, which may increase operational and disruption risks for Prudential and impact the delivery of the Group's strategy across

these markets. Direct physical impacts of climate change and deterioration of the natural environment, together with the societal

impact from actions that support the global transition to a lower carbon economy, may disproportionately impact the stability of

livelihoods and health of lower socioeconomic groups within the markets in which the Group operates. These risks are heightened

as Prudential operates in multiple jurisdictions that are particularly vulnerable to climate change and biodiversity degradation, with

distinct local cultures and considerations.

Evolving social norms and emerging population risks associated with public health trends (such as an increase in obesity,

metabolic syndrome and mental health deterioration) and demographic changes (such as population urbanisation and ageing), as

well as potential migration or displacement due to factors including climate- and nature-related developments, may affect

customer lifestyles and therefore may impact the level of claims and persistency under the Group's insurance product offerings.

As a provider of insurance and investment services, the Group is increasingly focused on making its products more accessible

through the use of digital services, technologies and distribution methods to customers. As a result, Prudential has access to

extensive amounts of customer personal data, including data related to personal health, and an increasing ability to analyse and

interpret this data through the use of complex tools, machine learning and AI technologies. The Group is therefore exposed to an

increase in technology risk, including potential unintended consequences from algorithmic biases, as well as regulatory, ethical and

reputational risks associated with customer data misuse or security breaches. These risks are explained in risk factors 2.4 and 2.5

above. The increasing digitalisation of products, services and processes may also result in new and unforeseen regulatory

requirements and stakeholder expectations, including those relating to how the Group supports its customers through this

transformation.

Failure to foster an inclusive, diverse and open environment for the Group's employees in accordance with the Group Code of

Conduct could impact the ability to attract and/or retain employees and increase potential reputational risk. The business practices

within the Group's third-party supply chain and investee companies with regards to topics including labour standards, respect for

human rights and modern slavery also expose the Group to potential reputational risk.

Insurers use the claims and risk profiles of different homogeneous customer cohorts such as age, gender and health status to

determine the insurance premiums and/or charges. In some societal settings, insurers' ability to set differential premiums and/or

charges may be viewed as an equitable and risk-based practice. In other societal settings, this may be viewed as discriminatory.

Failure to understand and manage these divergent views across the markets in which Prudential operates may adversely impact

the financial condition and reputation of the Group.

**cGovernance** 

A failure to maintain high standards of corporate governance may adversely impact the Group, its customers and its employees,

increasing the risk of poor decision-making and inadequate oversight and management of key risks. Poor governance may arise

where key governance committees lack independence, diversity, skills or experience among their members, or where oversight

responsibilities and mandates are unclear or insufficient. Inadequate oversight over remuneration also increases the risk of poor

senior management behaviour.

Prudential operates across multiple jurisdictions and has a group and subsidiary governance structure which may add further

complexity to these considerations. Participation in joint ventures or partnerships where Prudential does not have direct overall

control, along with the use of third-party service providers, increases the potential for reputational risks arising from inadequate

governance.

The pace and volume of global standards and sustainability, environmental and climate-related regulations emerging across the

markets in which the Group operates, the Group's goals of delivering on existing and new exclusions or restrictions on investments

in certain sectors, engagements and reporting commitments, such as the International Sustainability Standards Board (ISSB)

standards for climate-related disclosures, and the demand for externally assured reporting may give rise to regulatory compliance,

operational, disclosure and litigation risks, which may be increased by the multi-jurisdictional coordination required in adopting a

consistent risk management approach. The launch of sustainability-focused funds or products, or the (method of) incorporation of

sustainability considerations within the investment process for existing products, may increase the risks related to the perceived

fulfilment of fiduciary duties to customers and investors by the Group's appointed asset managers, and may subsequently increase

regulatory compliance, customer conduct, product disclosure, litigation and reputational risks. Prudential's voluntary memberships

of, or participation within, industry organisations and groups or their initiatives may also increase stakeholder expectations of the

Group's acquiescence or compliance with their publicised positions or aims.

The reputational and litigation risks of the Group may subsequently increase where the stated positions or aims of such industry

organisations or their initiatives continue to evolve, or where jurisdictions interpret their objectives as adversely impacting on

markets or consumers, including, for example, perceived conflicts with anti-trust laws. See risk factor 4.1 for details of

sustainability including ESG and climate-related regulatory and supervisory developments with potential impacts for the Group.

Sustainability risks may directly or indirectly impact Prudential's business and the achievement of its strategic focus on providing

greater and more accessible health and financial protection, and responsible stewardship and investment within the markets in

which the Group operates to support a just and inclusive transition and nature restoration. Such risks may also adversely impact

Prudential from meeting its objective of building a sustainable business that delivers a positive impact on its broad range of

stakeholders, ranging from customers, institutional investors, employees and suppliers to policymakers, regulators, industry

organisations and local communities. A failure to transparently implement the Group's Sustainability Strategy across its local

businesses and its operational, underwriting and investment activities, as well as a failure to implement and uphold responsible

business conduct, may adversely impact the financial condition and reputation of the Group. This may also negatively impact the

Group's stakeholders, who all have expectations, concerns and aims related to sustainability matters, which may differ, both

within and across stakeholder groups and the markets in which the Group operates. In its investment activities, Prudential's

stakeholders increasingly have expectations of, and place reliance on, an approach to responsible investment that demonstrates

how sustainability considerations are effectively integrated into investment decisions and the performance of fiduciary and

stewardship duties. These duties include effective implementation of exclusions, voting and active engagement decisions with

respect to investee companies, as both an asset owner and an asset manager, in line with internally defined procedures and

external commitments. The increased demands and expectations of stakeholders for transparency and disclosure of the activities

that support these duties further heighten disclosure risks for the Group, including those associated with potentially overstating or

misstating the positive environmental or societal impacts of the Group's activities, products and services (eg greenwashing).

**4 Risks relating to legal and regulatory requirements**

**4.1 Prudential conducts its businesses subject to regulation and associated regulatory risks,** 

**including changes to the basis of regulatory supervision or intervention of the Group, the** 

**level of regulatory scrutiny arising from the Group's reported events, the effects and pace of** 

**changes in the laws, regulations, policies, their interpretations and application, and any** 

**industry/ or accounting standards in the markets in which it operates.**

Any non-compliance with laws, regulations, government policies, or common industry practices and standards or rules in the

financial services and insurance sector (including those applicable to relevant companies, individuals or distributors) can adversely

affect Prudential's operations, licences or business continuity. In the markets in which Prudential operates, it is subject to

regulatory requirements for ongoing business operations as well as obligations with respect to financial crime, including anti-

money laundering (AML), sanctions compliance, and anti-corruption and fraud, which may either impose obligations on the Group

to act in a certain manner or restrict the way that the Group can act in respect of specified individuals, organisations, businesses,

territories and/or governments. A failure to comply with such requirements may adversely impact the reputation of Prudential

and/or result in the imposition of legal or regulatory penalties, heightened regulatory scrutiny or enforcement actions, or

restrictions on the Group, including limitations on its ability to conduct business.

The impact from regulatory developments may also be material to Prudential; for instance, changes may be required to its product

range, distribution channels, sales and servicing practices, data handling, operational processes, competitiveness, profitability,

capital requirements, risk appetite and risk management approaches, corporate or governance structure, financial and non-

financial disclosures and reported results, and financing requirements. Regulatory changes and political influences may also impact

the Group's ability to reprice its products, particularly medical reimbursement products as observed in some markets that the

Group operates in. Changes in capital-related regulations may affect the sensitivity of capital to market factors and the allocation

of capital and liquidity within the Group. Regulators may also change solvency requirements or methodologies for determining

components of the regulatory or statutory balance sheet, including the reserves and the level of capital required to be held by

individual businesses (with implications for the Group capital position). Other government interventions due to financial and global

economic conditions may also lead to a tightened business operating environment and heightened regulatory scrutiny.

For internationally active groups such as Prudential, operating across multiple jurisdictions (including cross-border activities) may

increase the complexity and volume of legal and regulatory compliance challenges. The multitude of laws and regulations in the

jurisdictions in which Prudential operates is dynamic and may be subject to ongoing changes. Legal and regulatory obligations may

also be unclear in their application to particular circumstances, which may affect Prudential's ability to enforce the Group's rights in

the manner intended and reduce predictability for Prudential's business operations. Compliance with Prudential's legal or

regulatory obligations, including those in respect of international sanctions, sustainability efforts and human resources practices, in

one jurisdiction may conflict with the law or policy objectives of another jurisdiction, or may be seen as supporting the law or

policy objectives of that jurisdiction over another, creating additional legal, regulatory compliance and reputational risks for the

Group. Geopolitical and global tensions may also lead to realignment among blocs, or challenging supply chains, which may lead

to an increase in the volume and complexity of international sanctions or controls. These risks may be increased where uncertainty

exists as to the scope of regulatory requirements and obligations, and where the complexity of specific cases applicable to the

Group is high.

Further information on specific areas of regulatory and supervisory requirements or changes is included below.

**aGroup-wide Supervision (GWS) regulatory framework**

The Hong Kong Insurance Authority (Hong Kong IA) is the Group-wide supervisor for Prudential. The Group is subject to the Hong

Kong IA's GWS Framework, which is principles-based and outcome-focused, allowing the Hong Kong IA to exercise direct

regulatory powers over the designated holding companies of multinational insurance groups. Prudential has in place various

monitoring mechanisms and controls to ensure ongoing compliance and to promote constructive engagement with the Hong Kong

IA as its Group-wide supervisor.

**bThe Group's regulatory landscape**

In 2025, the Hong Kong IA and regulators in the markets in which Prudential operates continued to focus on customer protection

and the resilience of the insurance industry. New mandates and guidelines were issued in several markets whereby industry

participants are required to assess, monitor and manage non-financial, financial and sustainability risks. Business conduct and

consumer protection remain the priority for regulators, with emphases on products, sales, servicing and data protection

expectations, as well as operational resilience, investment management, third-party management and technology risk

management.

Major regulatory changes and reforms are in progress in some of the Group's key markets, with some uncertainty regarding the

full impact on Prudential:

–In Hong Kong, the Hong Kong IA continued to strengthen customer protection in the management of participating businesses

throughout 2025, including the implementation of an illustration rate cap for participating policies, updated remuneration

structures for intermediaries, and supervision of product fulfilment ratios. Mitigating unlicensed activities and sales conduct

remain key priorities.

–In Mainland China, the National Financial Regulatory Administration continues to enhance its supervision of the market through

comprehensive inspections and enforcement actions. In 2025, regulatory developments in the financial sector continued to

evolve, including updated regulations or initiatives related to market conduct, product governance, compliance management,

and enforcement methodologies, potentially increasing the risk exposure of industry players.

–In Singapore, the Monetary Authority of Singapore (MAS) introduced new requirements for financial institutions aimed at

strengthening the management of third parties, technology, and cybersecurity. These enhanced regulations require robust risk

management, strengthened controls, and effective recovery procedures, supported by the implementation of appropriate

mechanisms. The regulators also introduced mandatory product design changes to Shield medical insurance riders with the

publicly stated expectation that premiums will be reduced by approximately 30% as a result.

–In Malaysia, Bank Negara Malaysia (BNM) initiated revised capital adequacy requirements aimed at improving risk-based capital

measurements and reporting, scheduled to take effect in 2027. In addition, BNM introduced new regulatory changes for health

products, including those relating to customer journey and affordability. Heightened BNM supervision is expected to continue in

the medical insurance sector.

–In Indonesia, regulatory oversight of the insurance industry remains a key priority, guided by the Otoritas Jasa Keuangan (OJK)

five-year regulatory roadmap in place since 2023, aimed at enhancing customer protection and covering other aspects such as

agent licensing, data, capital, products, actuarial matters, reporting, risk management and operational controls.

–In Vietnam, following significant insurance regulatory changes and industry reform since 2023, the insurance sector has been

stabilising, with enhanced expectations regarding customer protection, intermediary management, and data privacy controls.

–In Thailand, the regulatory environment continues to evolve with proposed legislative reforms to strengthen corporate

governance, risk-based capital requirements, and financial stability in the insurance sector.

–In Taiwan, the regulator has introduced a new Insurance Capital Standard, effective from 1 January 2026, with more

risk-sensitive and internationally aligned solvency requirements.

–In the Philippines, regulatory developments under Philippine Financial Reporting Standard 17, introduced in 2024 to enhance

transparency and comparability in financial reporting, are set for full implementation in January 2027. These changes will

include a new Quantitative Impact Assessment (QIA) and quarterly status updates in local regulatory filing from 2025 onwards,

as well as implications for capital management.

–In India, the Insurance Regulatory and Development Authority of India (IRDAI) continues to promote the governance and use of

technology to transform the insurance landscape in the country. In addition, the IRDAI is planning to introduce risk-based

capital requirements.

Furthermore, the growing adoption of technology, digital services and AI across the industry has introduced new and unforeseen

regulatory requirements and issues, including heightened expectations regarding the use of AI, as well as other resilience-related

concerns such as data security, privacy and cyber resilience. These regulatory developments are being actively monitored and

addressed as necessary.

The pace and volume of sustainability-related regulatory changes, including ESG and climate-related changes, are also increasing.

Regulators in Hong Kong, Singapore, Malaysia, Taiwan, Indonesia, Philippines, Thailand, Mainland China and the UK are either in

the process of initiating or have developed supervisory and disclosure requirements or guidelines related to environmental and

climate change risk management. With international standard setters, such as the ISSB, progressing with global sustainability and

climate-related disclosure requirements, local jurisdictions are considering adopting and, in some cases, mandating

implementation. In 2025, the Stock Exchange of Hong Kong, the Singapore Exchange, the Securities Commission of Malaysia and

Taiwan's Financial Supervisory Commission incorporated IFRS climate-related disclosure standards into their reporting rules, while

others announced roadmaps or began consultations to adopt these standards in the coming years. As local regulatory expectations

continue to increase, we expect many frameworks to include relief mechanisms that allow local entities to rely on the parent

company's ISSB-aligned group disclosures, rather than preparing separate local disclosures, which should ease the regulatory

burden on our operating companies. However, this interoperability may not always be seamless owing to regional variations in

how the standards have been adapted, so the potential for overlapping reporting burdens across jurisdiction remains. Across Asia,

sustainable finance taxonomies have been introduced in Hong Kong, Singapore, Malaysia, Indonesia, and Taiwan with efforts to

support green investment. Recent high-profile examples of government and regulatory enforcement and civil actions against

companies for misleading investors on sustainability and ESG-related information demonstrate that disclosure, reputational and

litigation risks remain high and may increase, particularly as companies increase their disclosures or product offerings in this area.

Regulators and industry bodies, such as the UK Financial Conduct Authority, the European Commission (working with the

European Securities and Markets Authority, and the MAS have further established more prescriptive requirements and guidelines

regarding the use of sustainability and ESG nomenclature in the labelling of investment products. These changes and

developments may give rise to regulatory compliance, customer conduct, operational, reputational, and disclosure risks, requiring

Prudential to coordinate across multiple jurisdictions to apply a consistent risk management approach, which may prove difficult

against the backdrop of contrary trends in the US.

A rapid pace and high volume of regulatory changes and interventions, and the swiftness of their application, including those

driven by the financial services industry, have been observed in recent years across many of the markets in which the Group

operates. The transformation and regulatory changes have the potential to introduce new, or increase existing, regulatory risks

and supervisory interest, while increasing the complexity of ensuring concurrent regulatory compliance across markets driven by

the potential for increased intra-group connectivity and dependencies. In jurisdictions with ongoing policy initiatives and regulatory

developments that will impact the way Prudential is supervised, these developments are monitored at both market and Group

level and inform the Group's risk framework and engagement with regulators or supervisors, policymakers and industry groups.

**cInternational insurance standards developments** 

The International Association of Insurance Supervisors (IAIS) sets global standards for the insurance sector, through the

Insurance Core Principles and the Common Framework (ComFrame). The Insurance Core Principles provide a broad framework for

insurance supervision globally, while ComFrame offers additional, enhanced standards for the supervision of Internationally Active

Insurance Groups (IAIGs). These standards significantly influence group-wide regulatory frameworks such as the Hong Kong IA's

GWS requirements, consequently impacting Prudential, which has been designated as an IAIG by the Hong Kong IA according to

the criteria set out in IAIS's ComFrame. The IAIS's standards and guidelines also play a crucial role in shaping regional regulations

in many jurisdictions in which Prudential operates.

There are a number of ongoing global industry developments by the IAIS that could lead to new macroprudential, operational and

conduct standards, resulting in additional burdens or adverse impacts on the Group and its business units. These developments

cover the monitoring of key insurance risks and trends (including protection gaps), standards setting, and the assessment of

standards implementation in the areas of systemic risk, the Insurance Capital Standard (ICS), insights for sustainability risk

(including climate risk), customer treatment and AI-related aspects specifically for the global insurance sector.

In November 2025, the Financial Stability Board (FSB), a global body that ensures international financial stability, reaffirmed its

decision to use the IAIS's Holistic Framework for the assessment and mitigation of systemic risk in the insurance sector. The FSB

continues to publish an annual list of insurers that will be subject to resolution requirements, in order to provide transparency to

market participants that the reported insurers and their regulators and supervisors are working to be better equipped to address

stress or failure, and shows that the relevant authorities are working together across borders. The Holistic Framework also

includes the Global Monitoring Exercise, which is a process for the identification of any build-up of systemic risk and the IAIS

conducted a consultation with a revised document published on the Global Monitoring Exercise in 2025. Prudential continues to

participate in the exercise. The IAIS also initiated a public consultation on draft revised application papers on recovery and

resolution in November 2025. The MAS introduced a Domestic Systemically Important Insurers (D-SII) framework in Singapore

effective from 1 January 2024 and has designated Prudential Assurance Company Singapore as a D-SII. In 2025, the Hong Kong

IA introduced a new framework for the classification of D-SIIs (entities whose failure will cause significant disruption to the local

financial system in Hong Kong) and classified Prudential Corporation Asia Limited, which is the senior regulated entity within the

Group, as a D-SII. The MAS and the Hong Kong IA are expected to continue to align with the latest FSB and IAIS standards and

guidelines relating to systemic risk.

The ICS was adopted by the IAIS in December 2024, and is a global, risk-based measure of capital adequacy for IAIGs as the

quantitative element of IAIS's ComFrame. The ICS will serve as a group-wide prescribed capital requirement, which is a solvency

control level below which supervisors will intervene on group capital adequacy grounds. Prudential, as an IAIG, continues to work

with the Hong Kong IA on the implementation of the ICS.

As a result, there remains a degree of uncertainty over the potential impact of ongoing global industry and regulatory

developments across the Group.

**dChanges in accounting standards and other principles to determine financial metrics** 

The Group's financial statements are prepared in accordance with IFRS. In addition, the Group provides supplementary financial

metrics prepared on alternative bases to discuss the performance and position of its business. Any changes or modification to IFRS

accounting policies or the principles applied to determine the supplementary metrics may require a change in the way in which

future results will be determined and/or a retrospective adjustment of reported results to ensure consistency. Furthermore,

investors, rating agencies and other stakeholders may take time to gain familiarity with the revised results and to interpret the

Group's business performance and dynamics. Such changes may also require systems, processes and controls to be updated and

developed that, if not managed effectively, may increase the operational risk of the Group in the short term.

**ePolicyholder protection schemes**

Various jurisdictions in which Prudential operates have created policyholder protection schemes that require mandatory

contributions from market participants in some instances in the event of a failure of a market participant. As a major participant in

the majority of its chosen markets, circumstances could arise in which Prudential, along with other companies, may be required to

make such contributions.

**4.2 The Group and its intermediaries may conduct business in a way that adversely impacts the** 

**fair treatment of customers, which could negatively affect Prudential's business, financial** 

**condition, result of operations and prospects, as well as its relations with current and** 

**potential customers and its reputation.**

At any stage of the customer and product life cycle, the Group or its intermediaries may conduct business in a way that adversely

impacts customer outcomes and the fair treatment of customers ('conduct risk'). This may arise through a failure to design,

provide and promote suitable products and services to customers that meet their needs, are clearly explained or deliver real value,

provide and promote a high standard of customer service, appropriately and responsibly manage customer information, or

appropriately handle and assess complaints. A failure to identify or implement appropriate governance and management of

conduct risk may result in harm to customers and regulatory sanctions and restrictions, and may adversely impact Prudential's

reputation and brand, its ability to attract and retain customers, its competitiveness, and its ability to deliver on its long-term

strategy. There is an increased focus by regulators and supervisors on customer protection, suitability and inclusion across the

markets in which the Group operates, thereby increasing regulatory compliance and reputational risks to the Group in the event

the Group is unable to effectively implement the regulatory changes and reforms.

Prudential is, and in the future may continue to be, subject to legal and regulatory actions in the ordinary course of its business on

matters relevant to product sales (including sales distribution practices and product suitability) and the delivery of customer

outcomes. Such actions relate, and could in the future relate, to the application of current regulations or the failure to implement

new regulations, regulatory reviews of broader industry practices and products sold in the past under acceptable industry or

market practices at the time (including in relation to lines of business that are no longer active) and changes to the tax regime

affecting products. Regulators may also focus on the approach that product providers use to select third-party distributors and to

monitor the appropriateness of sales made by them and the responsibility of product providers for the deficiencies of third-party

distributors.

**4.3 Litigation, disputes and regulatory investigations may adversely affect Prudential's business,** 

**financial condition, cash flows, results of operations and prospects**

Prudential is, and may in the future be, subject to legal actions, disputes and regulatory investigations in various contexts,

including in the ordinary course of its insurance, asset management and other business operations. These legal actions, disputes

and investigations may relate to aspects of Prudential's businesses and operations that are specific to Prudential, or that are

common to companies that operate in Prudential's markets. Legal actions and disputes may arise under contracts, regulations or

from a course of conduct taken by Prudential, including individual claims, class action litigation, arbitration, enforcement

proceedings and other regulatory or governmental actions including government investigations. Although Prudential believes that

it has adequately provided in all material respects for the costs of known litigation and regulatory matters, no assurance can be

provided that such provisions will be sufficient or that material new matters will not arise. Given the large or indeterminate

amounts of damages sometimes sought, the possibility of fines, penalties, remediation costs or other sanctions and the inherent

unpredictability of litigation and disputes, it is possible that an adverse outcome could have a negative effect on Prudential's

business, financial condition, cash flows, results of operations and prospects.

In addition, Prudential operates in some jurisdictions in which the legal framework for the enforcement of contracts can be

unpredictable. As a consequence, the enforceability of legal obligations and their interpretation may change or be subject to

inconsistent application, which could adversely affect Prudential's legal rights.

**4.4 Changes in tax legislation may result in adverse tax consequences for the Group's business,** 

**financial condition, results of operations and prospects.**

Tax rules, including those relating to the insurance industry, and their interpretation may change, possibly with retrospective

effect, in any of the jurisdictions in which Prudential operates. Significant tax disputes with tax authorities, and any change in the

tax status of any member of the Group or in taxation legislation or its scope or interpretation could affect Prudential's business,

financial condition, results of operations, and prospects.

The Organisation for Economic Co-operation and Development (OECD) is currently undertaking a project intended to modernise the

global international tax system, commonly referred to as Base Erosion and Profit-Shifting 2.0. The project has two pillars. The first pillar

is focused on the allocation of taxing rights between jurisdictions for in-scope multinational enterprises that sell cross-border goods and

services into countries with little or no local physical presence. The second pillar is focused on developing a global minimum tax rate of

15 per cent applicable to in-scope multinational enterprises.

Based on the OECD statement issued on 8 October 2021, Prudential does not expect to be affected by proposals under the first

pillar given they include an exemption for regulated financial services companies.

Under the second pillar, the OECD published detailed model rules in December 2021 for developing a global minimum tax rate of

15 per cent applicable to in-scope multinational enterprises, followed by detailed guidance in March 2022 and further sets of

guidance each year, most recently in January 2026. Further guidance is expected. Several jurisdictions in which the Group has

operations have implemented either a global minimum tax or a domestic minimum tax at a rate of 15 per cent, in line with the

OECD proposals, effective for either 2024 onwards or 2025 onwards. In June 2025, Hong Kong, where the Group's ultimate parent

entity is a tax resident, implemented both the global minimum tax and domestic minimum tax, effective from 1 January 2025.

This brings the Group into scope of the rules from 2025 onwards.

In compliance with the relevant IFRS accounting standard, the Group will separately disclose any amount of global minimum tax

included in the Group's IFRS tax charge for the relevant accounting period. The rules are complex and require calculations to be

undertaken at jurisdiction level aggregating all in-scope entities in that jurisdiction into a single calculation. The design of the rules

when applied to Prudential means that a global minimum tax is most likely to arise, and could have an adverse impact on the

Group's business, financial condition, results of operations and prospects, in periods where there is positive investment

performance in jurisdictions whose domestic corporate income tax regimes have features favouring certain types of investment.

**Supervision and regulation of Prudential**

Prudential has insurance and investment operations in Asia and Africa, and is subject to applicable material insurance and other

financial services regulations discussed below.

The Hong Kong Insurance Authority (Hong Kong IA) is the Group-wide supervisor for Prudential. The Hong Kong IA's GWS

Framework applies a principles-based and outcome-focused approach and allows the Hong Kong IA to exercise direct regulatory

powers over the designated holding companies of international insurance groups as authorised by the Insurance Ordinance

(Cap.41) of the Hong Kong Special Administrative Region of the People's Republic of China with details specified under 'GL32:

Guideline on Group Supervision' issued by the Hong Kong IA. Prudential also applies the Insurance (Group Capital) Rules issued by

the Hong Kong IA to determine group regulatory capital requirements (both minimum and prescribed levels). Further information

is provided in the 'Explanation of Performance and Other Financial Measures' section and in note I(i) of Additional Unaudited

Financial Information. Prudential's individual insurance and asset management businesses are supervised at a local entity level

and local statutory capital requirements apply. For more detailed information on the framework of local capital requirements, see

note C9 of the Consolidated Financial Statements.

Global regulatory and geopolitical developments and trends

Prudential operates in highly regulated markets, and as the nature and focus of regulations and laws evolve, the complexity of

regulatory compliance continues to increase and represents a challenge for international businesses.

Regulatory focus on the financial services industry remains broad and often concurrent across jurisdictions. In 2025, the Hong

Kong IA and regulators in the markets in which Prudential operates continued to focus on customer protection and the resilience of

the insurance industry, including the management of business practices and operational soundness with appropriate governance

and controls. New or expanded mandates and guidelines were issued in several markets whereby industry participants are

required to assess, monitor and manage non-financial, financial and sustainability risks.

Business conduct and consumer protection remain the priority for regulators, with emphasis on products, sales, servicing and data

protection expectations, as well as various operational processes including resilience, investment management, third-party

management and technology risk management. Additionally, the increasing use of technology, digital and artificial intelligence (AI)

across the industry has led to new regulatory requirements and issues, including expectations regarding the governance and

ethical use of AI as well as other resilience-related aspects such as data security, privacy and cyber resilience. Prudential falls

within the scope of these conduct and resilience-related regulations, requiring that regulatory developments are appropriately

addressed.

Further, the International Association of Insurance Supervisors (IAIS) sets international standards for the global insurance sector,

through the Insurance Core Principles (ICPs) and the Common Framework (ComFrame). The ICPs provide a broad framework for

insurance supervision globally, while ComFrame offers additional, specific standards for the supervision of Internationally Active

Insurance Groups (IAIGs). These standards significantly influence group-wide regulatory frameworks such as the Hong Kong IA's

GWS requirements, consequently impacting Prudential, which has been designated as an IAIG by the Hong Kong IA according to

the criteria set out in IAIS's ComFrame. The IAIS's standards and guidelines also play a crucial role in shaping regional regulations

in many jurisdictions in which Prudential operates. There are a number of ongoing standards initiated by the IAIS that could lead

to additional macroprudential and conduct requirements that could result in additional burdens or adverse impacts on the Group

and its business units. These developments cover monitoring key insurance risks and trends, including protection gaps, setting

standards and providing guidance, assessing the implementation of standards in the areas of systemic risk, the Insurance Capital

Standard (ICS), sustainability risk (including climate risk), and cyber and AI-related risks in the global insurance sector.

The pace and high volume of regulatory changes and interventions, and the swiftness of their application, including those driven

by the financial services industry, have been observed in recent years across many of the markets in which the Group operates.

The transformation and regulatory changes have the potential to introduce new, or increase existing, regulatory risks and

supervisory interest, while increasing the complexity of ensuring concurrent regulatory compliance across markets driven by the

potential for increased intra-group connectivity and dependencies. In jurisdictions with ongoing policy initiatives and regulatory

developments that will impact the way Prudential is supervised, these developments are monitored at both market and Group

level and inform the Group's risk framework. Recurring engagement with principal regulators, policymakers, standard setters and

industry groups are in place to proactively navigate the regulatory landscape and continuously detect emerging risks.

Other ongoing risk management and mitigation of regulatory risk at Prudential includes a comprehensive set of compliance and

financial crime controls, including policies, procedures, risk management measures, monitoring and reporting protocols,

disclosures and training, to ensure ongoing adherence to active and newly issued regulatory obligations.

In 2025, Prudential operated against a highly uncertain macroeconomic and geopolitical backdrop. The US combined a broader

protectionist trade stance with elevated market volatility; Moody's downgraded the US to Aa1 and Treasury yields fluctuated

higher through part of the year even as the Federal Reserve delivered three rate cuts and signalled a cautious outlook. Mainland

China faced slowing growth, a prolonged property downturn, and benchmark yields near historical lows, while US–ASEAN tariff

negotiations underscored fragmentation risks for global supply chains. These conditions remain material to the Group, potentially

increasing operational disruption, regulatory (including sanctions) exposure, and financial-market risks, with implications for sales,

distribution, and reputation.

**Climate Change and Sustainability**

Global and regional regulators are accelerating sustainability and climate disclosure requirements, with Hong Kong, Singapore,

Malaysia and Taiwan adopting IFRS Sustainability Standards and tightening rules on product labelling to curb greenwashing.

International bodies (ISSB, TNFD) are driving convergence, while enforcement actions highlight rising compliance, reputational

and litigation risks. Prudential continues to apply a consistent cross-jurisdictional approach to manage these developments.

The Group continues to actively engage with, and respond to, discussions, consultations and supervisory information-

gathering exercises. Details of the Group's sustainability-related risks are included in the disclosure on Risk Factors. The

Group continues to leverage and share its Group-wide experience and knowledge with its local businesses on their

sustainability policies and approaches, both to provide support as well as to help drive consistency across Prudential's

businesses. The Group Risk Framework continues to be critically evaluated to ensure that sustainability-related risks to

the Group, and the external impact from the Group's activities, are appropriately captured.

**Financial crime**

In each of the markets in which it operates, Prudential is subject to regulatory requirements and obligations with respect to

financial crime including anti-money laundering (AML), anti-bribery and corruption, and sanctions compliance, which may either

impose obligations on the Group to act in a certain manner or restrict the way that it can act in respect of specified individuals,

organisations, businesses, jurisdictions and/or governments. The Group has appropriate systems and controls to mitigate financial

crime risks, including sanctions and anti-bribery and corruption, and it examines these on an ongoing basis as part of its proactive

supervision agenda.

Prudential in Asia

**Regulators, laws and major regulations of insurance business** 

Prudential in Asia operates in highly regulated markets and under the ever-evolving requirements and expectations of diverse and

dynamic regulatory, legal and tax regimes which may impact its business or the way the business is conducted. The businesses

are subject to all relevant local regulatory and supervisory schemes. These laws and regulations vary from jurisdiction to

jurisdiction, but it is the local regulators that typically grant (or revoke) licences and therefore control the ability to operate a

business.

The Hong Kong IA developed its GWS Framework for multinational insurance groups under its supervision based on a principle-

based and outcome-focused approach, which enables the Hong Kong IA to exercise regulatory powers over the designated holding

companies of multinational insurance groups. The GWS Framework became effective for Prudential upon designation by the Hong

Kong IA in May 2021. Prudential has put in place ongoing controls and monitoring mechanisms to ensure ongoing compliance with

requirements of the Group-wide supervisor. In 2025, the Hong Kong IA introduced a new Domestic Systemically Important Insurer

(D-SII) framework to enhance the stability of Hong Kong's financial system, with Prudential also classified as one of the first two

D-SIIs. The Group is monitoring the actual obligations that are currently being developed by the Hong Kong IA.

The complexity of legal and regulatory (including sanctions) compliance continues to evolve and increase in Asia, where economies

in the region are in various phases of maturity, which also represents a challenge for international businesses. In general

(although there are exceptions), regulators in developing economies continue to build the regulatory framework relevant to their

level of economic development. Increasing regulatory developments in the region will continue to affect Prudential's Asia

businesses. At the same time, the global geopolitical tensions described under the "Global regulatory and geopolitical

developments and trends" section have also posed uncertainties and complexity in regulatory compliance for Prudential's

businesses in some of the jurisdictions. The Group has in place appropriate frameworks designed to continuously monitor and deal

with the various regulatory concerns.

Consistent with the global trend, the central issues for the Group's regulators in various Asia markets throughout 2025 continued

to be efforts to ensure the financial resilience of the insurance industry (including to address solvency and capital demands), the

protection of customers that are relevant to product and service performance, and operational soundness with appropriate

governance, controls and resilience. Efforts were made and new regulations and guidelines were continuously issued in a number

of markets to assist and require the industry to assess, monitor and manage non-financial and financial risks, including insurance

risk, capital and solvency. Business conduct and consumer protection continue to be a key priority for regulators in Asia. The

regulatory developments in the region are consistent with those described under the 'Global regulatory and geopolitical

developments and trends' section.

Significant additional details of the regulatory regimes, to which Prudential's Asia insurance operations are subject, are discussed

below:

**Hong Kong** 

Prudential currently operates two subsidiaries in Hong Kong for life (Prudential Hong Kong Limited) and general (Prudential

General Insurance Hong Kong Limited) insurance businesses, with both entities now fully under the regulatory regime of the Hong

Kong IA. The sale of mandatory pensions by agents is regulated by the Mandatory Provident Fund (MPF) Schemes Authority which

supervises the MPF intermediaries. Investment-linked insurance and voluntary health insurance schemes manufactured by local

insurers are also required to obtain approvals respectively from the Securities and Futures Commission and the Health Bureau,

before launching of such businesses or new products.

The Hong Kong IA has in place comprehensive regulations covering all aspects of the insurance customer lifecycle. The regulator

continued to strengthen customer protection in the management of participating businesses throughout 2025, including the

implementation of an illustration rate cap for participating policies, an updated remuneration structure for intermediaries, and

supervision of product fulfilment ratios. Mitigation of unlicenced activities and sales conduct remained their 2025 priorities.

**Singapore** 

Prudential Assurance Company Singapore (Pte.) Limited is registered with the Monetary Authority of Singapore (MAS) to design

and sell life, accident and health insurance products pursuant to the Insurance Act and Financial Advisers Act.

Under the Insurance Act, MAS is responsible for insurance regulation and supervision of insurance companies. MAS has detailed

regulatory frameworks to govern insurance companies and the distribution of insurance products in Singapore. MAS regulations

cover, inter alia, product development, pricing and management of insurance products, market conduct standards, investments

undertaken, public disclosure requirements, reinsurance management, maximum representatives tier structure, loans and

advances and product disclosure. MAS also issues directions and regulations for the prevention of money laundering and to

counter financing terrorism. This is in addition to the general AML law under which suspicious transactions must also be notified to

the Commercial Affairs Department, an enforcement agency of the Singapore Police Force.

The Financial Adviser Act gives MAS the authority to regulate and supervise all financial advisory activities conducted by insurance

companies. The MAS regulation covers, among other things, the appointment, training and remunerations of representatives,

disciplinary action, mandatory disclosure to clients, sales and recommendations process on investment products, replacement

(switching) of investment products and fair dealings with customers. Mandatory disclosure to clients covers both product

information and basic data about the representatives and the firm.

In 2025, MAS introduced new requirements for financial institutions aimed at strengthening the management of third parties,

technology, and cybersecurity. These enhanced regulations require robust risk management, improved controls, and effective

recovery procedures, along with the implementation of appropriate mechanisms. A consultation related to Artificial Intelligence

Risk Management is also underway.

**Indonesia** 

PT. Prudential Life Assurance and its subsidiary PT Prudential Sharia Life Assurance are authorised to carry out long-term

insurance business in Indonesia. Prudential's operations in Indonesia are authorised to distribute life insurance products based on

either conventional or Syariah principles, through agency, bancassurance (including direct marketing) and other alternate

distribution channels.

The financial regulatory regime in Indonesia operates on a 'twin peaks' model with the Financial Services Authority of Indonesia,

the Otoritas Jasa Keuangan (OJK) responsible for microprudential supervision and Bank Indonesia retaining its macroprudential

responsibilities. The implementation of AML controls in the insurance industry is monitored by the Indonesian Financial Transaction

Reports and Analysis Center.

General supervisory focus on insurer governance has increased, in particular on the autonomy of decision-making of local insurers.

In 2023, the OJK issued its five-year industry roadmap with plans to establish an insurance industry that is healthy, efficient, high

integrity, strengthens consumer and community protection, and supports national growth. The roadmap has covered areas

comprehensively to enhance policyholder protection as well as other aspects on licensing, data, capital, products, actuarial, risk,

reporting and operational controls. The implementation of this roadmap is ongoing till 2027, with continual emphasis in 2025 on

customer protection, financial soundness, IFRS 17 implementation and health insurance, etc.

**Malaysia**

Prudential Assurance Malaysia Berhad (PAMB) carries out life insurance business in Malaysia.

The Bank Negara Malaysia (BNM) is the central bank of Malaysia and is the regulatory body responsible for supervising and

regulating the financial services sector, including the conduct of insurance and Takaful business (insurance that is compliant with

Islamic principles). BNM places considerable emphasis on fair market conduct by the insurance industry and protection of

consumers' interests and is also responsible for administering legislation in relation to AML matters. BNM has the power to enforce

sanctions on financial institutions.

In addition, PAMB is a member of the Life Insurance Association of Malaysia (LIAM), a self-regulatory body. Resolutions and

circulars issued by the LIAM are binding on the member insurance companies.

Prudential BSN Takaful Berhad (Prudential Takaful, a Prudential joint venture with Bank Simpanan Nasional) is a Takaful insurer in

Malaysia.

The Takaful business in Malaysia is regulated by BNM. In addition, Prudential Takaful is also a member of the Malaysian Takaful

Association, an association for Takaful operators that seeks to improve industry self-regulation through uniformity in market

practice and to promote a higher level of co-operation within the industry.

The BNM introduced new regulatory changes in 2025 with varying degrees of implications on health products, including customer

journey and affordability. Increasing BNM supervision is expected to continue in the medical insurance areas. The regulator has

also initiated an Open Finance initiative (under consultation) that is proposing a consent-based framework that gives customers

explicit control over how their financial data is shared across the financial sector. The rollout is expected to begin with banks, with

insurers joining in later phases likely from 2028, subject to final confirmation after consultation.

**Mainland China**

CITIC-Prudential Life Insurance Company Limited, Prudential's joint venture with CITIC in which Prudential has a 50 per cent

share, is authorised to conduct life insurance business in China.

The body responsible for regulation of the insurance sector is the National Financial Regulatory Administration (NFRA), which is the

official body authorised in Mainland China to conduct the administration, supervision and regulation of the Chinese insurance

market since May 2023 and to ensure that insurers operate in a stable manner in compliance with the law.

In 2025, the regulator continues to enhance its supervision of the market through comprehensive inspections and enforcement

actions. Regulatory developments in the financial sector continue to evolve, including updated regulations or initiatives in 2025

related to market conduct, product governance, compliance management, rating and enforcement methodologies, with

implications for industry players.

**Thailand**

Prudential Life Assurance (Thailand) Public Company Limited carries out life insurance business in Thailand. The Office of

Insurance Commission, under the supervision of the Ministry of Finance, regulates insurers, brokers and agents. The sale of unit

linked products are regulated by the Thailand Securities and Exchange Commission. The main regulation regarding AML in

Thailand is the Anti-Money Laundering Act of 1999 (AMLA). The Anti-Money Laundering Office was also established upon the

enactment of the AMLA as a state agency responsible for enforcing the AMLA and anti-terrorism funding regulations, as well as

reviewing related regulatory standards.

The regulatory environment continues to evolve with proposed legislative reforms to strengthen corporate governance, risk-based

capital requirements, sustainability and financial stability in the insurance sector.

**Vietnam**

Prudential Vietnam Assurance Private Limited is licensed and regulated by the Ministry of Finance (MoF) as a life insurance

company. An insurance company is not permitted to operate both life and non-life insurance at the same time, except in the case

of a life insurance company that offers personal health and protection care insurance as a supplement to life insurance.

The Insurance Supervision Authority of the MoF Vietnam specifically undertakes the supervision of insurance companies. The

fundamental principles of the operation of insurance companies are set out in the Insurance Business Law. While the amended

Law took effect on 1 January 2023, it also contains provisions on risk-based capital (RBC), with a five-year grace period. Further,

following the significant insurance regulatory changes introduced within the past 24 months, the insurance sector has been

stabilising and transitioning to a heightened regulatory landscape, including adapting to enhanced customer protection,

intermediary management, and data privacy controls across the market in the period of 2025.

AML controls in the insurance industry are monitored by the Anti-Money Laundering Department under the Banking Inspectorate

and Supervision Department of the State Bank of Vietnam.

**Other markets**

---

| | | | |
|:---|:---|:---|:---|
| **Market** | **Operation** | **Key regulator** | **AML Reporting Agency** |
| **Cambodia** | Prudential (Cambodia) <br>Life Assurance PLC <br>| Insurance Regulator of Cambodia (under <br>the Non-Banking Financial Service <br>Authority)<br>| Cambodian Financial Intelligence Unit |
| **India** | ICICI Prudential Life <br>Insurance Company <br>Limited<br>| Insurance Regulatory and Development <br>Authority of India (IRDAI)<br>| Financial Intelligence Unit - India (under <br>the Ministry of Finance)<br>|
| **Laos** | Prudential Life <br>Assurance (Lao) <br>Company Limited<br>| Ministry of Finance and its regulatory unit, <br>Department of Government Investment <br>Enterprise and Insurance Management <br>Authority (DSI)<br>| Anti-Money Laundering Intelligence Office <br>(AMLIO)<br>|
| **Myanmar** | Prudential Myanmar <br>Life Insurance <br>Company Limited<br>| Financial Regulatory Department (under the <br>Ministry of Planning and Finance (MoPF))<br>| Myanmar Financial Intelligence Unit |
| **The** <br>**Philippines**<br>| Pru Life Insurance <br>Corporation of UK<br>| Insurance Commission (IC) | Anti-Money Laundering Council (AMLC) |
| **Taiwan** | PCA Life Assurance <br>Company Limited<br>| Financial Supervisory Commission (FSC) | Financial Intelligence Unit, Taiwan |

---

In India, the IRDAI continues to promote the use of technology to transform the insurance landscape in the country. Also, the

IRDAI is planning to introduce risk-based capital requirements. These changes will unfold over time and will be influenced by

various factors including the overall economic environment, consumer behaviour, and technological advancements.

In addition, the Taiwan regulator has introduced new Insurance Capital Standard with effect from 1 January 2026 with more

risk-sensitive and internationally aligned solvency requirements.

**Regulation of investment and fund management businesses and other regulated operations** 

Prudential conducts investment and fund management businesses through subsidiaries or joint ventures (JVs) in Asia in Hong

Kong, Japan, Taiwan, Mainland China, India, Singapore, Malaysia, Vietnam, Thailand and Indonesia. Eastspring Investments also

has a presence in Luxembourg and the US. All operations are authorised and licensed by the relevant authorities in the respective

markets. Depending on the licensing regime in the respective jurisdiction, Eastspring entities are generally authorised to conduct

fund/investment management and investment advisory activities for both retail and institutional funds. In addition, two of the JV

companies are licensed to provide trust services to funds. Further, Prudential Investment Management Pte Ltd also commenced

operations in March 2024 to provide investment advice solely to Prudential's intra-Group insurance entities on strategic asset

allocation and conducting due diligence on fund managers and fund products.

Significant additional details of the regulatory regimes, to which Prudential's Asia asset management operations are subject, are

included below.

**Singapore** 

Eastspring Singapore is regulated by the Monetary Authority of Singapore (MAS). The Company holds a Capital Markets Services

Licence under the Securities and Futures Act, Cap 286 to conduct the following regulated activities: (a) fund management and

(b) dealing in Capital Market Products.

Eastspring Singapore is also an exempt financial adviser under the Financial Advisers Act 2001.

In addition, Eastspring Singapore holds other registrations outside of Singapore, including the Registered Investment Adviser with

the United States Securities and Exchange Commission (US SEC), Foreign Portfolio Investor (FPI) registration under the Securities

and Exchange Board of India and the Renminbi Qualified Foreign Institutional Investors with the China Securities Regulatory

Commission (CSRC). As such, the US SEC and CSRC regulations relevant to these registrations apply to Eastspring Singapore.

Furthermore, Eastspring Singapore is the appointed fund manager and global distributor of the Eastspring Investments

Luxembourg Société d'Investissement à Capital Variable (SICAV) funds. Accordingly, the UCITS regulations issued by the

Commission de Surveillance du Secteur Financier (CSSF) and certain requirements by the European Union (EU) and European

Securities and Markets Authority (ESMA) are relevant to Eastspring Singapore in relation to its SICAV appointed fund manager and

global distributor roles.

Key regulatory developments effected in 2025 included the revised MAS reporting requirements for the supervisory survey

(Quarterly Data Collection) that will take effect for the Dec 2025 data collection; newly issued MAS Circular on Governance and

Management of Variable Capital Companies; and newly introduced MAS Guidelines on Standards of Conduct for Digital Advertising

Activities. The aim behind the digital advertising guidelines is to strengthen governance and accountability of financial institutions

in managing their digital advertising activities, especially on social media platforms.

Prudential Investment Management Pte Ltd is similarly regulated by the Monetary Authority of Singapore. The Company holds a

Capital Markets Services Licence under the Securities and Futures Act 2001 to conduct the regulated activities of fund

management. The Company does not manage portfolios on a discretionary basis or offer any fund products.

**India** 

ICICI Prudential Asset Management Company and ICICI Prudential Trust are Prudential's two asset management related JVs with

ICICI Bank Limited. These two entities are registered with the Securities and Exchange Board of India (SEBI) to perform asset

management activities and to act as trustees to funds registered with SEBI respectively. On 19 December 2025, ICICI Prudential

Asset Management Company Ltd has successfully been listed on the Bombay Stock Exchange and National Stock Exchange of

India.

SEBI is primarily set up to protect the interests of investors in the securities market. It promotes the development of the securities

market and regulates the business. It regulates the operations of depositories, participants, custodians of securities, foreign

portfolio investors, and credit rating agencies and acts to prohibit fraudulent and unfair trade practices related to the securities

market. It ensures that investors are educated on the securities markets and undertakes research and development to ensure the

securities market is efficient at all times.

**Malaysia** 

Eastspring Investments Berhad (EIMY) and Eastspring Al-Wara' Investments Berhad are primarily regulated by the Securities

Commission Malaysia. EIMY is also a reporting institution under the Anti-Money Laundering, Anti-Terrorism Financing and Proceeds

of Unlawful Activities Act 2001 and is bound by BNM requirements. In addition, EIMY is a member of the Federation of Investment

Managers Malaysia (FIMM), a self-regulatory organisation for the unit trust industry. FIMM regulates its members while ensuring

that investors are protected and public interests are upheld.

**Thailand** 

Eastspring Asset Management (Thailand) Co. Ltd., Prudential's majority owned subsidiary, is an investment management company

regulated by the Securities and Exchange Commission of Thailand (TSEC). It is licensed to conduct fund management and

investment advisory services.

The core obligation of the TSEC as prescribed by the Securities and Exchange Act is to carry out supervision. The TSEC has the

responsibility to issue rules and regulations, ensure compliance and pursue enforcement in case of violations. In order to create an

effective supervisory mechanism and sustainable capital market, the TSEC has moved towards more principles-based regulations

and self-discipline among practitioners by issuing preventive regulations, conducting monitoring activities, imposing enforcement

actions and providing supportive measures to improve regulatory standards and practices within the financial industry.

**Mainland China** 

Eastspring Overseas Investment Fund Management (Shanghai) Company Limited and Eastspring Investment Fund Management

(Shanghai) Company Limited, both Eastspring subsidiaries, as well as CITIC-Prudential Fund Management, Prudential's asset

management joint venture with CITIC Trust, and its subsidiary, Shanghai CPE Asset Management Company, are governed by the

CSRC. The duties of CSRC include the formulation and development of policies, rules and regulations for the securities and futures

markets as well as to perform regulatory supervision over the management and the managerial officials of the relevant

companies.

In addition, these entities need to abide by the self-regulatory rules established by the Asset Management Association of China,

covering private investment fund management institutions, fund products, qualified investors, fund custody, fund sales, fund

investment, information disclosure, accounting, fund valuation and outsourcing of services.

**Other key regulators**

Other key regulators for investment and fund management businesses are as follows:

---

| | | |
|:---|:---|:---|
| **Market** | **Operation** | **Key regulator** |
| Hong Kong | Eastspring Investments (Hong Kong) <br>Limited<br>| Securities and Futures Commission (SFC) |
| Indonesia | PT Eastspring Investments Indonesia | Otoritas Jasa Keuangan (OJK) |
| Japan | Eastspring Investments Limited | Japan Financial Services Agency (JFSA) |
| Luxembourg | Eastspring Investments (Luxembourg) S.A. | Commission de Surveillance du Secteur Financier (CSSF) |
| Taiwan | Eastspring Securities Investment Trust Co. <br>Ltd.<br>| Financial Supervisory Commission Republic of China (Taiwan) <br>(FSC)<br>Securities Investment Trust & Consulting Association (SITCA)<br>|
| United States | Eastspring Investments Inc. | Securities Exchange Commission (US SEC)<br>Financial Industry Regulatory Authority (FINRA)<br>|
| Vietnam | Eastspring Investments Fund Management <br>Company<br>| State Securities Commission of Vietnam (SSC) |

---

Prudential in Africa

Prudential has operations in Ghana, Kenya, Uganda, Zambia and Nigeria. The regulatory landscape in these jurisdictions continues

to evolve and regulators are introducing new laws and regulations to continuously strengthen the licensing, market conduct and

financial-related regulatory requirements, and to develop a safe and stable insurance industry and deepen insurance penetration.

Disclosure obligations under Section 219 of the Iran Threat

Reduction and Syria Human Rights Act of 2012

Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Securities

Exchange Act of 1934, Prudential is required to disclose certain activities and those of its affiliates related to Iran and to persons

sanctioned by the US under programs relating to terrorism, proliferation of weapons of mass destruction and trading with North

Korea that have occurred in the twelve-month period covered by this report.

During the twelve-month period ended 31 December 2025, Prudential's non-US affiliates had contractual relationships with

twenty-five persons sanctioned by the Office of Foreign Assets Control (OFAC) of the US Department of Treasury in relation to

Iran, terrorism, proliferation of weapons of mass destruction and trading with North Korea. These persons took out insurance

policies with premiums totalling $211,277 with Prudential's affiliates located in Asia before the relevant sanctions designations

became effective. The contracts were entered into in compliance with laws and regulations applicable to the relevant affiliates at

the time they were entered into. None of the Prudential non-US affiliates is a US person. Fourteen of these twenty-five

relationships were terminated, while the remaining eleven remain in force and are in compliance with local laws and regulations.

Premiums received on these insurance policies were negligible relative to the total premium generated in 2025. As the

provisioning of insurance liabilities is undertaken on a portfolio basis, it is not practical to estimate the net profits attributable to

these contracts. Prudential does not intend to engage in any new business dealings with these sanctioned individuals.

![154.jpg](puk-20251231_g15.jpg)

**Governance**

**Governance at a glance**

**Governance highlights**

Capital management

–Reviewed and refined capital allocation framework

including commitment to recurring capital returns of

$1.1 billion over 2026-2027; and

–Considered and approved the IPO of ICICI Prudential

Asset Management Company including the

distribution of proceeds to shareholders.

Succession planning

–Process to identify potential Chair successors, led

by the Senior Independent Director (SID) and

supported by the Nomination & Governance

Committee, leading to announcement of

appointment of Chair-Designate in January 2026.

Board and Committee

composition changes

Strategy

–Oversight of the delivery of the Group's strategy announced in August 2023

and progress against the Group's 2027 objectives; and

–Considering the framework for the development of the Group's long-term

strategy beyond 2027.

**March 2026:** 

–Sir Douglas Flint appointed

as Non-executive Director

and Chair-Designate. He

also joined the Nomination &

Governance Committee and

the Remuneration

Committee.

Business operations

–Overseeing ongoing delivery of double-digit growth; and

–Spent time with local leadership and top talent from the Indonesia teams as

part of the Board's ongoing commitment to understanding the local business

environment and operational context.

**October 2025**

–Amy Yip retired from the

Board.

**July 2025**

–Guido Fürer appointed as

Non-executive Director and

member of the Audit and

Risk Committees.

Stakeholders

Extensive shareholder

engagement by:

– the Chair and the SID in

connection with Chair

succession; and

–the Remuneration Committee

Chair ahead of presenting

the proposed Directors'

Remuneration Policy to

shareholders at the 2026 AGM.

Board performance

review

–Internal review confirmed

effective performance of the

Board and principal committees

and identified areas of focus for

2026. 84

Our leadership

**Board of Directors**

The Board establishes the purpose, values and strategy of the Group and

promotes its long-term success for the benefit of our shareholders and other

stakeholders. Our Board members bring a diverse range of skills and experience

to support our strategy in our chosen markets.

**Committee membership**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ![BOD_Icons_A.gif](puk-20251231_g16.gif) | Audit | ![BOD_Icons_N.gif](puk-20251231_g17.gif) | Nomination & Governance | ![BOD_Icons_Re.gif](puk-20251231_g18.gif) | Remuneration | ![BOD_Icons_Ri.gif](puk-20251231_g19.gif) | Risk | ![BOD_Icons_S.gif](puk-20251231_g20.gif) | Sustainability | ![BOD_Icons_Chair.gif](puk-20251231_g21.gif) | Committee Chair |

---

**Shriti Vadera (Age: 63)**

Chair of the Board

![BOD_Icons_N-Chair.gif](puk-20251231_g22.gif)

![BOD_Icons_Re.gif](puk-20251231_g18.gif)

Appointed to the Board:

May 2020

(Chair since January 2021)

Shriti was Chair of Santander UK Group Holdings, Senior Independent Director at BHP and a Non- executive Director of Astra

Zeneca. Between 2009 and 2014, she undertook a wide range of assignments, such as advising the South Korean Chair of the

G20, two European countries on the Eurozone and banking crisis, the African Development Bank on infrastructure financing and a

number of global investors and sovereign wealth funds on strategy and economic and market developments.

From 2007 to 2009, Shriti was a minister in the UK Government, serving in the Cabinet Office, Business Department and

International Development Department. She led on the UK Government's response to the global financial crisis and its Presidency

of the G20. From 1999 to 2007 she was a member of HM Treasury's Council of Economic Advisers. Shriti's career began with 15

years in investment banking with SG Warburg/UBS, where she had a strong focus on emerging markets.

Shriti holds a Bachelor's degree in Philosophy, Politics and Economics from Oxford University.

**Relevant skills and experience for Prudential**

–Senior boardroom experience and leadership skills at complex organisations, including extensive experience in the financial services

sector, with international operations and at the highest levels of international negotiations between governments and in multinational

organisations.

–Wide-ranging and global experience in economics, public policy and strategy, as well as deep understanding and insight into global and

emerging markets and the macro-political and economic environment.

**Key appointments**

–The Royal Shakespeare Company (Chair)

–Institute of International Finance (Board Member).

–World Bank Private Sector Investment Lab (Chair).

**Sir Douglas Flint (Age: 70)** 

Chair Designate

![BOD_Icons_N.gif](puk-20251231_g17.gif)

![BOD_Icons_Re.gif](puk-20251231_g18.gif)

Appointed to the Board: March 2026

Sir Douglas retired as Group Chair of HSBC Holdings plc in September 2017, having been appointed to that role in 2010. For 15

years prior to that, he was HSBC's Group Finance Director, having joined from KPMG where he was a partner.

Sir Douglas has been Chair of Aberdeen Group Plc since January 2019 and will be stepping down on 28 April 2026, and Chair of IP

Group plc since November 2018 and will be stepping down from this role in June 2026.

He was also previously a non-executive director at BP plc from 2005-2011, Chairman of the Institute of International Finance from

June 2012 to December 2016, and a member of both the Mayor of Beijing's and the Mayor of Shanghai's International Business

Leaders' Advisory Boards.

Sir Douglas received his CBE in 2006 and knighthood in 2018 recognising his services to the finance industry.

Sir Douglas is a member of the Institute of Chartered Accountants of Scotland.

**Relevant skills and experience for Prudential**

–Senior boardroom experience including extensive experience leading global financial institutions.

–Deep knowledge of Asia, including Prudential's key markets, and understanding of global finance.

**Listed company directorships**

–Aberdeen Group plc (Chair).

–IP Group plc (Chair).

**Other key appointments**

–The Royal Marsden NHS Foundation Trust and Charity (Chair).

–Monetary Authority of Singapore, Advisory Council (Member).

–Institute of International Finance (Board Member).

**Anil Wadhwani (Age: 57)** 

Chief Executive Officer

Appointed to the Board:

February 2023

Prior to joining Prudential, Anil served as President and CEO of Manulife Asia where he successfully grew and transformed its

diversified and multi-channel business with significant market share gains in many key markets and made it the company's largest

source of core earnings. Prior to this, he spent 25 years with Citi in Asia Pacific, EMEA and the US, in a number of consumer

financial services roles. Anil holds a Master's degree in Management Studies from the Somaiya Institute of Management Studies

and a Bachelor's degree in Commerce from the Narsee Monjee College of Commerce and Economics.

**Relevant skills and experience for Prudential**

–With more than 30 years of experience in markets around the world, Anil is a global financial leader with significant expertise,

particularly in Asia.

–Anil has a proven track record of successful digital transformation, having led the modernisation of technology platforms across

13 markets in Asia in his role at Manulife.

**Key appointments**

–Monetary Authority of Singapore, Advisory Council (Member).

**Jeremy Anderson (Age: 67)** 

Senior Independent Director

![BOD_Icons_Ri-Chair.gif](puk-20251231_g23.gif)

![BOD_Icons_A.gif](puk-20251231_g16.gif)

![BOD_Icons_N.gif](puk-20251231_g17.gif)

Appointed to the Board:

January 2020

(Senior Independent Director since May 2023)

Jeremy was formerly the Chair of Global Financial Services at KPMG International, having previously been in charge of its UK

financial services practice and held roles including Head of Financial Services at KPMG Europe, Head of Clients and Markets KPMG

Europe and CEO of KPMG's UK consulting business. Jeremy served as a member of the Group Management Board of Atos Origin

and as Head of its UK operations. Jeremy also served on the board of the UK Commission for Employment and Skills.

Jeremy was awarded a CBE in 2005 for his services to employment. He holds a Bachelor's degree in Science (Economics) from

University College London.

**Relevant skills and experience for Prudential**

–Substantial leadership experience in financial services in the UK, Asia and the US.

–More than 30 years of experience advising international companies on audit and risk management.

**Listed company directorships**

–UBS Group AG, including its subsidiary, UBS AG (Senior Independent Director and audit committee Chair).

**Other key appointments**

–Credit Suisse International (Non-executive Director).

–The Kingham Hill Trust (Trustee).

–The Productivity Group (Non-executive Director).

**Arijit Basu (Age: 65)** 

Independent Non-executive Director

![BOD_Icons_A.gif](puk-20251231_g16.gif)

![BOD_Icons_S.gif](puk-20251231_g20.gif)

Appointed to the Board:

September 2022

Arijit retired as the Managing Director of State Bank of India (SBI) in September 2020 concluding a 40-year career, having joined

in 1983. During his career, he held a number of senior positions at the bank across retail, corporate and international banking,

business process re-engineering, IT and risk management. He was Managing Director and Chief Executive Officer of SBI Life

Insurance Company (a subsidiary of SBI), one of India's leading life insurers, from 2014 until 2018, and took it public in 2017.

Since his retirement from SBI, Arijit has worked as a consultant, including advising the Life Insurance Corporation of India on its

2022 IPO.

Arijit is a certified associate of the Indian Institute of Bankers. He holds a Master's degree in History and a Bachelor's degree in

Economics from the University of Delhi.

**Relevant skills and experience for Prudential**

–Extensive experience in India's banking and insurance industries spanning nearly 40 years.

–Held high-profile leadership roles and gained broad operational experience from various senior positions within SBI.

**Listed company directorships**

–IndusInd Bank Limited (Non-executive Director and Chair).

**Other key appointments**

–Academic Council of the College of Supervisors, RBI (Chair).

–Peerless Hospitex Hospital and Research Center Ltd (Non-executive Director).

**Chua Sock Koong (Age: 68)**

Independent Non-executive Director

![BOD_Icons_Re-Chair.gif](puk-20251231_g24.gif)

![BOD_Icons_N.gif](puk-20251231_g17.gif)

Appointed to the Board: May 2021

From 2007 to 2020, Sock Koong was Chief Executive Officer of Singapore Telecommunications Limited (Singtel), Asia's leading

communications technology group, having previously held a number of senior roles at the firm, including Treasurer, Chief

Executive Officer International and Group Chief Financial Officer. From April 2018 until March 2024, Sock Koong was a Non-

executive Director of Cap Vista Pte Ltd and, from March 2018 until March 2024, she was a Non-executive Director of the Defence

Science and Technology Agency.

Sock Koong is a Fellow Member of the Institute of Singapore Chartered Accountants and a Chartered Financial Analyst. She holds

a Bachelor's degree in Accountancy from the University of Singapore.

**Relevant skills and experience for Prudential**

–More than 30 years' experience working in business leadership and operations with significant experience in the Asia market.

–Significant boardroom experience, having served in several C-suite roles throughout her career.

**Listed company directorships**

–Bharti Airtel Limited (Non-executive Director).

–Royal Philips NV (Non-executive Director).

–Ayala Corporation (Non-executive Director).

**Other key appointments**

–Dubai Financial Services Authority (Director).

–Singapore Securities Industry Council (Member).

–The Singapore Public Service Commission (Deputy Chair).

–The Singapore Council of Presidential Advisers (Member).

**Guido Fürer (Age: 62)** 

Independent Non-executive Director

![BOD_Icons_A.gif](puk-20251231_g16.gif)

![BOD_Icons_Ri.gif](puk-20251231_g19.gif)

Appointed to the Board: July 2025

From 2012 to 2023 Guido was Group Chief Investment Officer and a member of the Group Executive Committee of Swiss Re

Group, heading up the Global Asset Management division.

During his 25-year career with the firm he also served as Country President, Swiss Re Switzerland from 2019 to 2023, chaired

Swiss Re's Global Strategic Council, and its Zurich Pension Fund, and served as a Trustee of the Swiss Re Foundation. Prior to

joining Swiss Re, Dr Fürer held leading positions at Swiss Bank Corp/O'Connor and Associates in options trading and capital

markets.

Between 2018 and 2022, Guido was a non-executive director, and chaired the Group Risk Committee, of pan-Asian insurer FWD

Group, gaining insight into various key markets.

Guido has been a non-executive director of Swiss-headquartered insurance and banking group Baloise Holding Ltd since April 2024

and chair of its Risk & Investment Committee since April 2025. Since the merger of Baloise and Helvetia in December 2025, Guido

has been a non-executive director of Helvetia Baloise Holding Ltd and chair of its Investment & Risk Committee.

Guido has a master's degree in Economics and a doctorate in Financial Risk Management from the University of Zurich, where he

is now Chair of the Advisory Board of the Department of Finance.

**Relevant skills and experience for Prudential**

–Over three decades of international experience across financial services, including key Asia markets.

–Extensive knowledge and expertise in asset management, insurance and asset-liability management.

**Listed company directorships**

–Helvetia Baloise Holding Ltd (Non-executive Director and Investment and Risk Committee chair).

**Other key appointments**

–Department of Finance, University of Zurich (Chair of the Advisory Board).

**Ming Lu (Age: 67)** 

Independent Non-executive Director

![BOD_Icons_N.gif](puk-20251231_g17.gif)

![BOD_Icons_Re.gif](puk-20251231_g18.gif)

Appointed to the Board:

May 2021

Ming is a Senior Advisory Partner at KKR, having previously been Executive Chairman, Asia Pacific at KKR Asia Limited and a

partner of Kohlberg Kravis Roberts & Co. L.P. He also serves as a member of the KKR Asian Private Equity Investment Committee

and the KKR Asian Portfolio Management Committee. Ming has played a significant role in private equity investments across Asia

Pacific and, since 2018, has played a leadership role in KKR's Asia growth and expansion, including serving as a member of the

Asia Infrastructure Investment Committee and Asia Real Estate Investment Committee.

Ming previously worked for CITIC, China's largest direct investment firm, before moving to Kraft Foods International Inc. He was

President of Asia Pacific at Lucas Varity, and a partner at CCMP Capital Asia (formerly J.P. Morgan Partners Asia), where he was

responsible for investment in the automotive, consumer and industrial sectors across several countries throughout Asia. Ming has

also held directorships at Ma San Consumer Corporation, Unisteel Technology International Limited, Weststar Aviation Service Sdn

Bhd and MMI Technologies Pte Ltd. He was a Non-executive Director of Jones Lang LaSalle Inc from 2009 to 2021.

Ming holds a Master's degree in Business Administration from the University of Leuven and a Bachelor's degree in Arts

(Economics) from the Wuhan University of Hydroelectrical Engineering.

**Relevant skills and experience for Prudential**

–More than 30 years of experience investing in and developing businesses throughout the Asia Pacific region.

–Brings deep knowledge and up-to-date insights on China and other key markets.

**Listed company directorships**

–Jardine Matheson Holdings Limited (Non-executive Director).

**Other key appointments**

–KKR Asia Ltd (Senior Advisory Partner).

**George Sartorel (Age: 68)** 

Independent Non-executive Director

![BOD_Icons_S-Chair.gif](puk-20251231_g25.gif)

![BOD_Icons_N.gif](puk-20251231_g17.gif)

![BOD_Icons_Re.gif](puk-20251231_g18.gif)

![BOD_Icons_Ri.gif](puk-20251231_g19.gif)

Appointed to the Board:

January 2022

From 2014 to 2019 George was the regional Chief Executive Officer of Allianz's Asia Pacific business, having previously held a

range of senior roles within the company, including Chief Executive of both Allianz Italy and Allianz Turkey, Global Head of Change

Programmes for Allianz Group, and General Manager of Allianz Malaysia and Allianz Australia and New Zealand. George also sat on

the Financial Advisory Panel of the Monetary Authority of Singapore from 2015 to 2019. George's career began at Manufacturers

Mutual Insurance in Australia in 1973, before its acquisition by Allianz in 1998.

George holds a Master's degree in International Business Studies from Heriot-Watt University.

**Relevant skills and experience for Prudential**

–Considerable operational expertise in the insurance industry gained over a 40-year career, including experience of digital

transformation.

–A range of senior leadership roles, including as regional Chief Executive Officer of Allianz AG's Asia Pacific business and several

country-head positions prior to that.

**Listed company directorships**

–Insurance Australia Group Limited (Non-executive Director).

**Mark Saunders (Age: 62)** 

Independent Non-executive Director

![BOD_Icons_A.gif](puk-20251231_g16.gif)

![BOD_Icons_Ri.gif](puk-20251231_g19.gif)

Appointed to the Board: April 2024

Prior to retirement, Mark was the Group Chief Strategy and Corporate Development Officer and a member of the executive committee of

AIA Group Ltd. Following retirement he was honoured with the Lifetime Achievement Award in 2022 at the 26th Asia Insurance Industry

Awards. Mark started his actuarial career in 1988 at UK-headquartered insurance business Clerical Medical Investment Group, relocating

to Hong Kong in 1994, becoming CEO/Controller of the business and living there since. He joined Tillinghast (now Willis Towers Watson)

in 1997 and during his 16-year tenure he led the Asia Pacific insurance practice, establishing a leadership position in insurance consulting

with particular expertise in actuarial appraisal value assessments and enhancements of insurers across 20 markets in Asia Pacific,

providing expert opinions, and leading Towers Watson's Hong Kong business as Managing Principal.

Mark is a Fellow of the Institute of Actuaries of the UK, a Chartered Actuary, and a Fellow and the President of the Actuarial

Society of Hong Kong. He holds an honours degree in Mathematics from the University of Manchester.

**Relevant skills and experience for Prudential**

–Extensive knowledge of, and leadership positions within, the insurance industry and Asia markets, having been employed in the

industry for 35 years.

–Extensive commercial insight gained as a senior executive of AIA and significant actuarial and industry experience.

**Key appointments**

–Blackstone Inc (Senior Adviser).

–Actuarial Society of Hong Kong (President).

**Claudia Suessmuth Dyckerhoff (Age: 59)**

Independent Non-executive Director

![BOD_Icons_Ri.gif](puk-20251231_g19.gif)

![BOD_Icons_S.gif](puk-20251231_g20.gif)

Appointed to the Board:

January 2023

Claudia joined the global consultancy firm McKinsey & Partners in 1995 and worked in several senior roles. She was responsible

for helping to build the firm's healthcare services and systems sector in Asia Pacific, including working with the Chinese Ministry of

Health to help develop their views on China's national healthcare systems. From March 2021 until October 2023, Claudia was also

a Non-executive Director of Huma Therapeutics Ltd, a global health technology company.

Claudia holds a PhD in Business Administration from the University of St. Gallen in Switzerland and a Master's degree in Business

Administration from CEMS/ESADE in Barcelona.

**Relevant skills and experience for Prudential**

–Considerable experience in the healthcare services and technology sectors across China and the broader Asia-Pacific region. Her

board experience has helped her develop valuable insights around the implementation of transformation through technology,

digital and data.

–Knowledge of Asian markets, particularly China, having been based in Shanghai for nearly 15 years and Hong Kong for a further

two years.

**Listed company directorships**

–Ramsay Health Care Ltd (Non-executive Director).

–Clariant AG (Non-executive Director).

–Lonza Group (Independent Non-executive Director) (from May 2026).

**Other key appointments**

–QuEST Global Services Private Ltd (Non-executive Director).

–Evidentli (Chair).

**Jeanette Wong (Age: 66)**

Independent Non-executive Director

![BOD_Icons_A-Chair.gif](puk-20251231_g26.gif)

![BOD_Icons_Ri.gif](puk-20251231_g19.gif)

![BOD_Icons_S.gif](puk-20251231_g20.gif)

Appointed to the Board: May 2021

From 2008 to 2019, Jeanette led DBS Group's institutional banking business, where she was responsible for corporate banking,

global transaction services, strategic advisory, and mergers and acquisitions. Prior to this, she was the DBS Group's Chief Financial

Officer from 2003 to 2008, having previously been Chief Administrative Officer. As part of her role at DBS Group, Jeanette held

Non-executive Director positions with ASEAN Finance Corporation, TMB Bank and the Bank of the Philippine Islands. Jeanette

began her career in Singapore at Banque Paribas before moving to Citibank and then J.P. Morgan in Singapore, where she held

senior pan-Asian roles. She has previously served as a Non-executive Director of EssilorLuxottica, Fullerton Fund Management Ltd

and Neptune Orient Lines Limited.

Jeanette is a member of the UBS Board, where she has served as a member of the audit committee since 2019. Jeanette also

serves as a member of the audit committee on the Singapore Airlines board, and chair of the audit committee at PSA

International.

Jeanette holds a Master's degree in Business Administration from the University of Chicago and a Bachelor's degree in Business

Administration from the National University of Singapore.

**Relevant skills and experience for Prudential**

–Over 35 years of operational experience in financial services.

–Extensive knowledge and experience of ASEAN markets as well as significant boardroom experience gained from a number of

non-executive roles.

**Listed company directorships**

–UBS Group AG, including its subsidiary, UBS AG (Non-executive Director and audit committee member).

–Singapore Airlines Limited (Non-executive Director).

**Other key appointments**

–Council of CareShield Life (Chair).

–GIC Pte Ltd (Non-executive Director).

–PSA International Pte Ltd (Non-executive Director).

–National University of Singapore (Board of Trustees).

**Tom Clarkson (Age: 50)** 

Company Secretary

Appointed as Company Secretary: August 2019

Relevant skills and experience As the Company Secretary, Tom is a trusted adviser to the Board and plays an important role in the

governance and administration of Prudential. Before his appointment as Company Secretary, Tom held a number of senior roles at

Prudential, including Head of Compliance, Business Partners and prior to that, Group Litigation & Regulatory Counsel.

Tom is a qualified solicitor and is admitted to practise in England and Wales. Before joining Prudential, he practised law at Herbert

Smith LLP, between 2002 and 2012, which included secondments to Lloyds Banking Group and Royal Bank of Scotland.

**Group Executive Committee**

The Group Executive Committee (GEC) supports the CEO in the day-to-day management of the

business and implementation of strategy. It is constituted and chaired by the CEO. For the purposes of

the Hong Kong Listing Rules, senior management is defined as the members of the GEC.

**Anette Bronder (Age: 58)**

Chief Technology and Operations Officer

**Relevant skills and experience**

In her role as the Chief Technology and Operations Officer, Anette plays a pivotal role in steering Prudential's technology initiatives

and maintaining operational discipline. On the technology front, she is responsible for aligning technology strategies with overall

business objectives, ensuring Prudential remains at the forefront of technological advancements. For operations, she evaluates all

operational aspects across the organisation to shape and define Prudential's target operating model, ensuring to maximise

economies of skill and scale, ultimately enhancing the customer experience.

Before taking on this role, Anette was a Partner at KPMG in Switzerland, where she contributed to digital transformation

programmes within the insurance sector. Prior to that, Anette served as Group Chief Operating Officer at Swiss Re and held senior

positions across the technology and telecommunications sectors.

Anette holds a Master of Economics and Social Sciences from the University of Stuttgart, Germany.

**Ben Bulmer (Age: 51)**

Chief Financial Officer

**Relevant skills and experience**

Ben was appointed Chief Financial Officer of Prudential in May 2023. As CFO, he is responsible for managing the Finance function,

including all aspects of financial reporting and planning such as performance management including planning and forecasting,

financial reporting, capital management and investment management as well as the Group Actuarial function, strategy, investor

relations and sustainability.

Ben joined Prudential in 1997 and has held various leadership roles including CFO, Insurance and Asset Management, regional CFO

of Prudential Asia, CFO of Eastspring Investments, the Group's asset management business, CFO of Prudential Hong Kong's Life

and General Insurance businesses and Chief Accountant of Prudential Asia.

Ben is a Chartered Accountant (The Chartered Institute of Management Accountants) and holds a Bachelor's degree from The

London School of Economics.

**Catherine Chia (Age: 58)**

Chief Human Resources Officer

**Relevant skills and experience**

In her role as Chief Human Resources Officer, Catherine leads Prudential's Group-wide people and culture agenda, working to build

a high performance organisation where great talent is engaged, inspired and developed.

Catherine joined from StarHub, Singapore, where she had been Chief HR Officer since 2018, driving workforce optimisation,

culture transformation, talent development and employee engagement. She also chaired the company's Covid-19 task force.

Before leading the HR function at StarHub, Catherine held global and regional senior HR leadership roles in LEGO, United Overseas

Bank, and Dell Inc. in Singapore and Shanghai.

Catherine holds a Bachelor's Degree with Honours in Social Sciences from the National University of Singapore. She served as a

Nominations Committee member of Daughters of Tomorrow (Singapore) and was a board member of the Singapore Breast Cancer

Foundation.

**Avnish Kalra (Age: 58)**

Chief Risk and Compliance Officer

**Relevant skills and experience**

In his role as Chief Risk and Compliance Officer, Avnish is responsible for managing Risk, Compliance, Legal, Audit, Company

Secretariat and Government Relations functions across all of the Group's insurance and asset management businesses. He joined

Prudential in 2014.

Avnish is a Chartered Accountant with over 30 years of experience in Financial Services in Asia. Prior to joining Prudential, he was

the Asia Chief Risk Officer for Aviva for six years and also worked at Bank of America for 14 years in various capital markets,

trading and risk roles. In previous roles, he also worked for EY in Dubai and for PwC in India.

**Rajeev Mittal (Age: 55)**

Chief Executive Officer, Eastspring Investments

**Relevant skills and experience**

As CEO of Eastspring, Rajeev chairs the Eastspring Executive Management Committee and is responsible for the management and

strategic development of the firm.

Rajeev has over 30 years' asset management experience in Asia and Europe. Most recently, he served as Managing Director and

Head of Asia at Fidelity International, spearheading growth in the Asia Pacific (excluding Japan) and Middle East markets. Prior to

this, he spent 26 years at AIG and PineBridge Investments, initially as an investor, before being appointed CEO of PineBridge

Europe in 2009, then CEO of PineBridge Asia Pacific from 2011 to 2018.

Rajeev holds a Bachelor of Science degree in Mathematics and Statistics from the University of Bradford.

**Angel Ng (Age: 58)**

Regional CEO, Greater China; Group Customer, Wealth and Product

**Relevant skills and experience**

In her role as Regional CEO, Greater China; Group Customer, Wealth and Product, Angel plays an integral role in driving

Prudential's business in Hong Kong, the Chinese Mainland, and Taiwan, in addition to leading the development of the Group-wide

Customer pillar, Wealth proposition and Products, across our markets in Asia and Africa.

With 25 years of expertise in financial services, Angel has extensive experience in the Asia Pacific region and beyond. Before

joining Prudential, she was the Head of Asia North & Australia, Cluster and Banking at Citi, overseeing geographical management,

client coverage, product delivery, and banking segments across six major markets.

Her tenure at Citi included senior roles such as Head of Asia for Citi Global Wealth, where she managed the Asia Private Bank and

Consumer Bank, and CEO for Citi Hong Kong and Macau. Prior to her time at Citi, Angel held senior positions at Procter & Gamble,

and China Light and Power Hong Kong.

Angel is actively involved in the Hong Kong community, serving on various boards and committees. Her roles include membership

on the New Business Committee of the Financial Services Development Council, the Room to Read Asia Pacific Board, and the

Board of Trustees of Chung Chi College at The Chinese University of Hong Kong, among others.

Angel holds a Bachelor of Business Administration degree from the Chinese University of Hong Kong.

**Kenneth Rappold (Age: 55)**

Chief Strategy and Transformation Officer

**Relevant skills and experience**

Prior to joining Prudential, Kenneth was Manulife Asia's Chief Financial Officer for five years, responsible for Finance, Strategy and

Business Development across 10 Asian markets. Prior to this, he was Aviva Asia's Regional Chief Financial Officer based in

Singapore and held senior finance roles for seven years with AIA in Hong Kong, Thailand and Korea.

Kenneth holds a Master's Degree in Accounting from the University of Texas at Austin and a Master's Degree in Applied Economics

from Johns Hopkins University. Kenneth is a Chartered Financial Analyst (CFA®) charterholder, a licensed US Certified Professional

Accountant (CPA), a certified Financial Risk Manager (FRM) and is a Fellow, Life Management Institute (FLMI). Additionally, Ken is

a certified professional coach with the International Coaching Federation.

**Naveen Tahilyani (Age: 52)**

Regional CEO, Indonesia, Malaysia, the Philippines, India, Africa; Group Agency and Health

**Relevant skills and experience**

In his role as Regional CEO, Naveen is responsible for our businesses in Indonesia, Malaysia, the Philippines, India and Africa, and

leads the Group's Agency and Health businesses across all markets.

Most recently Managing Director and Chief Executive of Tata Digital and a non-executive director of TATA AIA Life Insurance,

Naveen's insurance career has included more than seven years across two terms as Managing Director and CEO of Tata AIA,

between which he led AIA's Group Partnership Distribution business across Asia.

Prior to his career in insurance as an executive, Naveen spent more than seventeen years at McKinsey, advising banks and

insurance companies across Asia.

Naveen holds a Postgraduate Diploma in Business Management from the Indian Institute of Management, Ahmedabad and a B

Tech in Electronics and Communication from the Indian Institute of Technology, Madras.

**Dennis Tan (Age: 57)**

Regional CEO, Singapore, Thailand, Vietnam, Cambodia, Laos, Myanmar; Group Partnership Distribution

**Relevant skills and experience**

Prior to his appointment to the Group Chief Executive Committee, Dennis was CEO of Prudential Assurance Company Singapore for

two years.

Dennis holds the positions of Non-Executive Director and Chairman of the Board of Directors of Prudential Financial Advisers

Singapore Pte. Ltd., Prudential Life Assurance (Thailand) Public Company Limited, Director of Prudential Singapore Holdings Pte.

Limited, and Chairperson and Member of the Members' Council at Prudential Vietnam Assurance Private Limited.

Outside of Prudential, he serves as Council Member at The Institute of Banking and Finance Singapore.

Before joining Prudential, he spent 10 years at OCBC Bank, where he led a 3,100-strong consumer banking division as Head of

Consumer Financial Services for seven years.

Dennis is Singaporean and holds a Bachelor of Science degree in Business (Honours with Distinction) from Indiana University and

has completed the Stanford Executive Programme at Stanford University's Graduate School of Business. He is also a Certified

Financial Planner.

![p156.jpg](puk-20251231_g27.jpg)

How we operate

**Board governance structure**

---

| |
|:---|
| **Shareholders** |
| **Board of Directors**  |
| The Board establishes the purpose, values and strategy of the Group and promotes its long-term success for the benefit of our <br>shareholders and other stakeholders. The Board delegates to the following principal committees: |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Audit** <br>**Committee** <br>| **Risk Committee**  | **Remuneration** <br>**Committee**<br>| **Nomination &** <br>**Governance** <br>**Committee** <br>| **Sustainability** <br>**Committee**<br>|
| Responsible for <br>oversight and review <br>of financial reporting. <br>It oversees the <br>effectiveness of the <br>internal control and <br>risk management <br>framework, including <br>the effectiveness of <br>financial and non-<br>financial reporting <br>controls, and for <br>making the relevant <br>disclosures in the <br>Annual Report. It also <br>considers the <br>effectiveness and <br>objectivity of the <br>internal and external <br>auditors. <br>| Responsible for <br>oversight and review <br>of the Group's risk <br>appetite, tolerance <br>and strategy. It <br>monitors current and <br>potential future risk <br>exposures, the <br>effectiveness of the <br>Group's risk <br>management <br>framework and <br>adherence to <br>applicable risk policies <br>and regulatory <br>obligations. <br>| Responsible for <br>recommending <br>remuneration policy <br>and overseeing the <br>implementation and <br>operation of that <br>policy, including <br>approving <br>remuneration for the <br>Chair, the CEO and <br>other members of the <br>Group Executive <br>Committee.<br>| Responsible for <br>oversight of Board and <br>executive succession <br>plans (unless <br>considered by the <br>Board), nominating <br>candidates for <br>appointment to the <br>Board, oversight of <br>Board performance <br>and corporate <br>governance matters. <br>| Responsible for <br>providing leadership, <br>direction and <br>oversight of the <br>Group's sustainability <br>strategy, including <br>environmental <br>matters, responsible <br>investment, social <br>sustainability, and <br>people. The <br>Committee leads on <br>workforce <br>engagement. <br>|
| **Chief Executive Officer (CEO)** | **Chief Executive Officer (CEO)** | **Chief Executive Officer (CEO)** | **Chief Executive Officer (CEO)** | **Chief Executive Officer (CEO)** |
| Responsible for the day-to-day management of the business. | Responsible for the day-to-day management of the business. | Responsible for the day-to-day management of the business. | Responsible for the day-to-day management of the business. | Responsible for the day-to-day management of the business. |
| **Group Executive Committee** | **Group Executive Committee** | **Group Executive Committee** | **Group Executive Committee** | **Group Executive Committee** |
| The Group Executive Committee (GEC) is responsible for executing the strategy approved by the Board and supporting <br>the CEO. | The Group Executive Committee (GEC) is responsible for executing the strategy approved by the Board and supporting <br>the CEO. | The Group Executive Committee (GEC) is responsible for executing the strategy approved by the Board and supporting <br>the CEO. | The Group Executive Committee (GEC) is responsible for executing the strategy approved by the Board and supporting <br>the CEO. | The Group Executive Committee (GEC) is responsible for executing the strategy approved by the Board and supporting <br>the CEO. |

---

---

| | | |
|:---|:---|:---|
| **Chief Financial Officer** <br>The Chief Financial Officer (CFO) is <br>responsible for managing the <br>Finance function, including all <br>aspects of financial reporting and <br>planning, and investor <br>engagement.<br>| **Chief Risk and** <br>**Compliance Officer**<br>The Chief Risk and Compliance <br>Officer (CRCO) is responsible for <br>leadership of risk management <br>and compliance activities of the <br>Group, including setting the Group <br>Risk Framework and related <br>policies, supporting strategic <br>planning to ensure risks are <br>managed within appetite, and <br>leading engagement with <br>regulators and policymakers <br>across markets. <br>| **Company Secretary**<br>The Company Secretary advises <br>the Board and management on <br>governance-related matters and <br>supports the Chair in ensuring the <br>effective functioning of the Board <br>and its committees. The Company <br>Secretary is available to all <br>Directors to provide advice and <br>support and facilitates Directors' <br>induction and ongoing professional <br>development.<br>|
| The CFO and the CRCO are standing attendees at, and receive all papers for, <br>meetings of the Board (except private meetings of Non-executive Directors). <br>They also attend meetings of the Audit and Risk committees and the CFO <br>attends meetings of the Sustainability Committee. | The CFO and the CRCO are standing attendees at, and receive all papers for, <br>meetings of the Board (except private meetings of Non-executive Directors). <br>They also attend meetings of the Audit and Risk committees and the CFO <br>attends meetings of the Sustainability Committee. |  |
| The CFO and CRCO are members of the GEC, but the Board approves their <br>appointment and removal. Their performance reviews consider feedback from <br>the Chairs of the Audit and Risk committees respectively, and their <br>remuneration is determined by the Remuneration Committee. | The CFO and CRCO are members of the GEC, but the Board approves their <br>appointment and removal. Their performance reviews consider feedback from <br>the Chairs of the Audit and Risk committees respectively, and their <br>remuneration is determined by the Remuneration Committee. |  |

---

![157.jpg](puk-20251231_g28.jpg)

**Board, Director and committee responsibilities**

Led by the Chair, the Board is responsible for the overall leadership of the Group, which includes:

Delivering long-term sustainable

success for shareholders and

contributing to wider society

Ensuring effective engagement with

stakeholders

Monitoring performance and

implementation of strategy and

strategic objectives, capital allocation,

and business plans

Fostering and overseeing the

embedding of culture

Establishing the Group's purpose,

values and strategy and ensuring that

these and the Group's culture are

aligned

Ensuring that an effective system of

internal control and risk management

is in place and approving the Group's

overall risk appetite and tolerance

Approving the appointment of

Directors, including the CEO and, on

recommendation of the CEO, the

appointment of the CFO and the

CRCO, ensuring an effective system

of talent development and succession

planning for senior leadership roles

Approving the Group's long-term

strategic objectives, business plan

and budgets

Approving Prudential's periodic

financial reporting disclosures

In order to carry out its functions effectively, the Board delegates some of its responsibilities to its principal committees, which

consist of Non-executive Directors only.

The Board receives regular updates on the activities of its committees.

The Board's responsibilities are outlined in the schedule of matters reserved to the Board, which is available on our website at

www.prudentialplc.com/en/investors/governance-and-policies/board-and-committees-governance.

The Board's responsibilities are also subject to relevant laws and regulations, and to Prudential's Articles of Association, which can

be found at www.prudentialplc.com/en/investors/governance-and-policies/memorandum-and-articles-of-association.

The roles of Chair and CEO are separate, with a clear division of responsibilities between the Chair's leadership of the Board and

the CEO's responsibilities for the day-to-day management of the Group. All other Board members are independent Non-executive

Directors who offer strategic guidance and constructive challenge to management. At the date of this report, the Board consists of

11 Non-executive Directors and one Executive Director, who is the CEO.

The Board's size allows for effective decision-making and reflects a broad range of views and perspectives. More information on the

skills and experience of individual Directors can be found in their biographies above. More information on their independence can

be found below.

The Chair, CEO and SID all have written terms of reference, which are approved by the Board and kept under regular review.

**Board meetings** 

Typically, five meetings each year are held in person, and two shorter meetings are held virtually. In addition, the Board (or a

committee established by the Board for that purpose) meets virtually to discuss the full-year and half-year results. Scheduled

meetings typically take place at our head office in Hong Kong or at one of our businesses, providing opportunities for Board

members to engage directly with management and the wider workforce. Additional meetings are arranged as required and are

often held virtually, particularly if called at short notice.

Board and committee papers are typically provided one week ahead of a meeting and when a Director is unable to attend, their

views are canvassed in advance by the Chair.

**Roles, responsibilities and meeting attendance**

---

| | | | |
|:---|:---|:---|:---|
| Role and responsibilities | Board member | Board <br>meetings<sup>1</sup><br>| AGM <br>attendance <br>2025<br>|
| **Chair**<br>The Chair is responsible for the leadership of the Board in its role to promote <br>the long-term sustainable success of the Company and in holding <br>management to account. She shapes the culture in the boardroom, is <br>responsible for ensuring the Board's effectiveness and leads on Director-<br>level succession. Working with the CEO, the Chair sets the Board's agenda, <br>with a focus on strategy, performance and value creation, and ensures <br>effective communication with shareholders and other stakeholders. Together <br>with the CEO, she also represents the Group externally.<br>| Shriti Vadera | 7/7 | Y |
| **CEO**<br>The CEO is accountable to, and reports to, the Board. He is responsible for <br>the day-to-day management of the Group, including developing and <br>recommending the Group's long-term strategic objectives and business <br>plans to the Board. He is also responsible for executing the approved <br>strategy and business plans, and embedding the Group's values and culture. <br>The CEO plays a key role in communicating with shareholders and other <br>stakeholders, and in establishing the Group's internal control framework.<br>| Anil Wadhwani | 7/7 | Y |
| **Senior Independent Director**<br>The SID acts as a sounding board for the Chair and supports her in the <br>delivery of her objectives. The SID is also an intermediary for other <br>Directors and shareholders as needed and leads the annual performance <br>evaluation of the Chair.<br>| Jeremy Anderson | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. |  |  |  |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Arijit Basu | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Chua Sock Koong  | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Guido Fürer (from <br>July 2025)<br>| 3/3 | n/a |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Ming Lu | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | George Sartorel | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Mark Saunders  | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Claudia <br>Suessmuth <br>Dyckerhoff<br>| 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Jeanette Wong | 7/7 | Y |
| **Non-executive Directors**<br>Non-executive Directors offer constructive challenge to management and <br>hold them to account against agreed performance objectives. They also <br>provide strategic guidance, offer specialist advice and serve on at least one <br>of the Board's principal committees. | Amy Yip (until 31 <br>October 2025)<br>| 5/6 | Y |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. |  |  |  |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. | Jeanette Wong (Audit Committee) | Jeanette Wong (Audit Committee) | Jeanette Wong (Audit Committee) |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. | Jeremy Anderson (Risk Committee) | Jeremy Anderson (Risk Committee) | Jeremy Anderson (Risk Committee) |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. | Chua Sock Koong (Remuneration <br>Committee) | Chua Sock Koong (Remuneration <br>Committee) | Chua Sock Koong (Remuneration <br>Committee) |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. | Shriti Vadera (Nomination & Governance <br>Committee) | Shriti Vadera (Nomination & Governance <br>Committee) | Shriti Vadera (Nomination & Governance <br>Committee) |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. | George Sartorel (Sustainability <br>Committee) | George Sartorel (Sustainability <br>Committee) | George Sartorel (Sustainability <br>Committee) |
| **Committee chairs**<br>Committee chairs are responsible for the leadership and governance of <br>their respective Committees. They set the agenda for committee meetings <br>and report to the Board on committee activities. |  |  |  |

---

(1)The Board held six scheduled meetings, plus one additional short meeting to consider full-year results.

(2) Amy Yip was unable to attend one Board meeting due to conflicting commitments.

**Standing Committee**

In addition to the principal committees, the Board operates a Standing Committee that meets to discuss any ad hoc urgent issues

that cannot be delayed until the next scheduled Board meeting. All Directors are members of the Standing Committee. Before

making decisions, the Standing Committee must agree that the topics for discussion do not require consideration by the whole

Board.

The Standing Committee allows for agile decision-making when required, while ensuring that all Board members receive notice of

items that need to be addressed urgently and have an opportunity to contribute. In 2025, the Standing Committee met once.

**Delegation to management** 

While responsibility for the day-to-day management of the business and implementation of strategy has been delegated to the

CEO, the CEO delegates certain responsibilities to senior executives (principally to other members of the GEC). In addition, the

Board has delegated certain approvals to the GEC, within financial limits set by the Board.

The members of the GEC, and short biographies of each individual, can be found above.

The GEC typically meets weekly and supports the CEO in the day-to-day management of the business and the implementation of

strategy.

The GEC has delegated approval authority up to certain financial limits to individual Committee members and sub-committees,

each of which is responsible for supporting, advising and making management decisions on significant activities across the Group.

The sub-committees are respectively responsible for:

–Customer, Wealth & Operations

–Agency Distribution

–Technology

–Partnership Distribution

–Health

The management of the Group is organised into Strategic Business Groups which bring together the mature and growth

businesses within different markets to drive performance, operational excellence and the sharing of best practice. Each Strategic

Business Group is headed up by a Regional CEO who is responsible for driving performance, operational excellence and sharing of

best practice for the mature and growth businesses within their business group. The Regional CEOs of these groups are

responsible for the operational results of the businesses within their group and for the Group-wide delivery of enabling functions.

The Eastspring CEO is responsible for the growth of Eastspring's business and the delivery of its investment performance.

The CEO conducts quarterly reviews with each Regional CEO and the Eastspring CEO, focusing on performance across each CEO's

respective markets, Group-wide strategic pillars and enablers over the previous quarter, and the outlook and plans for the

upcoming quarter. The meeting agenda changes throughout the year, emphasising results preparation in the first quarter and

business planning in the fourth quarter. Additionally, every six months, the CEO reviews business performance with the four

Material Subsidiaries (Hong Kong, Singapore, Indonesia and Malaysia). These meetings are typically attended by members of the

GEC and other members of management such as Pillar and Enabler leads and stakeholders from Head Office and the respective

Strategic Business Group.

**Subsidiary governance** 

Prudential is committed to high standards of governance across the whole Group. The Group Governance Manual (GGM), which

includes the Group Code of Conduct (Code), outlines the Group-wide approach to governance, risk management and internal

control, and helps embed it into the day-to-day operations of the business.

The GGM also outlines the Group's governance framework, Group-wide policies and standards, including the Group Risk

Framework, delegated authorities and lines of responsibility, and is supported by a programme of regular training across the

Group.

The Nomination & Governance Committee monitors significant aspects of the Group's governance framework and governance

policies, including those of the Group's Material Subsidiaries (as described below), and makes recommendations to the Board

when needed. The Risk Committee approves the GGM's Group Risk Framework, an integral part of the GGM, while the Audit

Committee monitors Group-wide compliance with the GGM throughout the year. Businesses manage and report compliance with

the Group-wide mandatory requirements set out in the GGM through an ongoing GGM policy exemption and breach reporting

process. This includes compliance with the Group Risk Framework, which is summarised in this report.

Reflecting the developing nature of the Group and the markets in which we operate, the GGM is reviewed regularly with any

significant changes to key policies reported to the relevant Board Committee. The GGM helps the Board embed the Group's system

of risk management and internal control into the day-to-day operations of the business.

**Regulators** 

Prudential Corporation Asia Limited is a designated insurance holding company under the Hong Kong Insurance Ordinance and falls

within the scope of the Hong Kong IA's Group-wide Supervision (GWS) Framework. The GWS Framework includes requirements for

Hong Kong insurance groups to have appropriate corporate governance arrangements in place and to maintain appropriate internal

controls for the oversight of their business. The Group was recently classified as a Domestic Systemically Important Insurer by the

Hong Kong IA. The composition of the Prudential Corporation Asia Limited board of directors mirrors the Prudential plc Board.

Individual regulated entities within the Group are also subject to entity-level regulations in the jurisdictions in which they carry out

business.

**Employee voice** 

Prudential's programme for workforce engagement is led by the Sustainability Committee and all Board members take part in

engagement activities.

**Shareholder Communications Policy and engagement** 

We have dual primary listings on the Hong Kong Stock Exchange and the London Stock Exchange, as well as a secondary listing

on the Singapore Stock Exchange and a listing of American Depositary Shares on the New York Stock Exchange. These listings are

each subject to laws or rules that inform our Shareholder Communications Policy.

The policy ensures that shareholders and the broader investment community receive timely, balanced and understandable

information about the Company and its financial performance, strategic goals, plans and material developments. This enables

existing and prospective shareholders to exercise their rights and make decisions on an informed basis.

Information released by the Company to the various stock exchanges is also posted on the Company's website

(www.prudentialplc.com). Prudential's corporate communications are available in English and Chinese.

The Group maintains an active and wide-ranging investor engagement programme led by the Chief of Investor Relations, with

participation from the CEO, CFO and other members of the GEC where appropriate. Throughout 2025, Management engaged with

institutional investors across Asia, North America, Europe, the UK and the Middle East through a combination of one-to-one and

group meetings, investor conferences and organised roadshows, in some cases organised by brokers. Insights gathered from

these interactions are regularly reported to the Board and are considered as part of its strategic decision-making.

The Chair holds an annual engagement programme with major shareholders. The Remuneration Committee Chair also engages

with major shareholders each year to gather feedback on the implementation of the Directors' Remuneration Policy, and in 2025

sought views on the proposed new policy which is subject to shareholder approval at the AGM in 2026. Other Non-executive

Directors, in particular the SID and committee chairs, are available to meet with shareholders on request.

Shareholders are able to share their views on matters affecting the Company through a range of engagement channels available

throughout the year, including investor events. The Group offers hybrid AGMs to enable participation from shareholders wherever

they are based. Retail shareholders in the UK are also able to meet periodically with the Chair and management in person.

Throughout the year, retail shareholders are able to access dedicated services through the Company's registrar, Computershare.

More information is available on the Company's website, including contact details for the Group's Secretariat.

The Group undertakes a broad programme of investor engagement, hosting presentations and maintaining active dialogue with

shareholders and the research community through both live and online channels. The Group benefits from active research

coverage in Hong Kong, Singapore and the UK and provides research analysts with appropriate access to the management team.

The Board conducts an annual review of its Shareholder Communications Policy. For the year ended 31 December 2025, the Board

concluded that the Shareholder Communications Policy continues to be effective.

**Living our values – embedding and monitoring our culture**

The Board established the Group's purpose, values and strategy and satisfies itself that these and our culture are aligned, which is

critical to our long-term value creation and sustainability. We aim to operate a high-performance culture where employees are

motivated, engaged, and collectively committed to achieving exceptional results that support our business strategy. We work

towards achieving this through both actions and behaviours, guided by our values, known as The PruWay. Our Code of Conduct

provides a valuable tool to help all employees to uphold The PruWay, act with integrity and operate ethically. The Board

recognises that Prudential's culture starts at the top and is a key enabler to delivering our strategic objectives and purpose.

Throughout the year, the Board monitored the extent the Group's culture was embedded throughout the organisation in a number

of ways:

**Board engagement**

Board and Committee meetings and workshops are attended by senior representatives from Head Office and various business

units, providing a valuable engagement opportunity for Board members. In addition, the Board usually holds at least one meeting

a year at one of our local businesses and spends time interacting directly with local management and employees. New Directors

spend time with management both at Head Office level and in business units as part of their induction process. This is

supplemented by targeted engagement sessions including regular town hall meetings led by members of the GEC, both at Group

and local business level, with observations reported to the Board.

The Sustainability Committee leads on employee engagement on behalf of the Board and monitors the annual programme of

activities, which range from Director participation in internal engagement events to participation in town hall events and smaller

sessions with local leadership teams and talent. The Sustainability Committee also considered insights gained from the employee

survey conducted in 2025.

The Board gains additional insight into the culture across the organisation through the activities of the Audit and Risk Committees.

The Audit Committee receives feedback from the internal auditors on their observations on culture and its alignment to purpose

and values as observed from their review activities and engagement with management, including on certain key indicators such as

management's risk awareness and responsiveness to addressing audit findings. Where there have been significant audit findings,

the Audit Committee asks the accountable executives to attend to report to the Committee on the root causes of the issues and

how they are addressing them. The Audit Committee also oversees the Group's Speak Out procedures and seeks assurance that

management are taking appropriate steps to address any issues identified. The Audit Committee meets regularly in private with

the Chief of Internal Audit, the Group General Counsel (who has overall responsibility for the Speak Out programme), and the

external auditor, providing additional opportunities for any potential culture issues that they have observed to be raised. The Risk

Committee monitors risk culture and reports to the Board on how well this is embedded across the Group. During the course of

2025, it discussed initiatives to enhance the monitoring of, and reporting on, risk culture including a set of key culture metrics.

This work will be continued in 2026.

The Chairs of the Audit and Risk Committees regularly engage with the local business unit Non-executive Directors, providing an

additional lens for monitoring local culture across the Group.

The combination of interactions in formal and informal settings provides the Board with a range of touchpoints for effective

monitoring of culture.

**Development and Succession planning** 

The Board conducted an annual review of development and succession planning for the GEC, including the CEO. The CEO led the

discussion on his direct reports, enabling a robust conversation and opportunity for all Non-executive Directors to ask constructive

and appropriately challenging questions on the strength of the succession pipeline and how senior leaders are being developed in

line with the desired culture. This provided the Board with further insight into how well senior management set the tone from the

top. The Sustainability Committee looks at the development of talent and succession pipelines across the organisation (below GEC

level).

Strengthening and elevating our leadership capability is one of our key priorities for 2026. Our aim is to further strengthen our

teams' alignment on outcomes that matter most, and focus efforts on where it creates the greatest impact. Complementing 'what',

we continue to emphasise the 'how' of performance – how leaders show up, lead, communicate and live our values (The PruWay).

This includes reinforcing inclusive leadership behaviours and practices and creating an environment where diversity of thought is

encouraged and valued.

More information on Board succession planning is available in the Nomination & Governance Committee report.

**Remuneration** 

To embed the organisation's values and reflect our performance culture, we have enhanced our performance and reward

management approach to drive equal emphasis on WHAT (business KPIs) and HOW (value and behaviours), including our PruWay

360 Feedback process on the HOW factors. The Sustainability Committee is updated on performance management below GEC level

and the Remuneration Committee is updated on the remuneration architecture for staff within its purview, which includes

alignment of pay to our performance culture. The Risk Committee advises the Remuneration Committee on risk management and

conduct considerations to ensure that risk management, culture and conduct are appropriately reflected in the design and

operation of executive remuneration. The Remuneration Committee also considers workforce remuneration, including alignment of

the Group's incentive arrangements with culture. Our target is that all people managers have at least one sustainability-linked goal

by 2026, which fosters a culture where every employee understands their role in creating a more inclusive, resilient and

sustainable future.

More information on Board remuneration is available in the Directors' Compensation and Employees report.

**Code of Conduct**

Our Code of Conduct is reviewed annually by the Sustainability Committee and any changes recommended are approved by the

Board. The Code sets out the principles that guide our values and the personal conduct expected of our workforce and provides a

clear foundation for our corporate culture. All employees provide confirmation annually that they have adhered to the Code.

**Whistle blowing**

Prudential operates a robust whistleblowing programme ('Speak Out'), which is overseen by the Audit Committee. The

arrangements promote a culture of openness, honesty and accountability and are assessed annually by an independent

whistleblowing charity in the UK.

**Employee surveys**

A high performance culture is key for our success, embedding The PruWay which defines our ways of working with one another

and how we deliver value for all our stakeholders. We conduct all-employee surveys at least annually and the outcomes are

reviewed in detail by the Sustainability Committee and reported to the Board. This provides valuable insights into how our desired

culture is embedded across the breadth of the organisation and allows the Board to address any areas requiring more focus.

**Outcomes of culture monitoring**

Through the activities set out above and the regular updates from the CEO, the Chair of the Sustainability Committee and the

Chief of Human Resources, the Board received assurance that Prudential's culture is aligned to its purpose and values, while

recognising further areas of embedding and alignment required. Meetings with accountable executives in response to operational

incidents or internal audit findings help the Board in understanding the root causes of incidents and whether they are reflective of

wider cultural issues: where there is any sense of cultural issues, the Board will follow up with ongoing scrutiny. Overall, the Board

gained broad understanding of practices and behaviours across the Group and how these align with the purpose, values and

strategy of the Group, including an understanding of the approach to the culture of risk ownership in the business and was able to

assess how effectively the tone from the top is reflected throughout the organisation. This assessment informs the Board and its

committees in their approach to challenging management and informs decision-making in relation to Executive remuneration. The

assessment also contributes to the programme of focused work by the Risk Committee on first line risk ownership and

accountability.

**Board activities**

![](puk-20251231_g29.gif)

**Key areas of focus – how the Board spent its time in 2025**

---

| | |
|:---|:---|
| Q1 | Q2 |
| **February**  | **May** |
| –Discussed macro-economic context and key areas of <br>focus for the year. These included the three key <br>strategic priorities of agency, health and operations, and <br>particular markets;<br>–Considered potential IPO of ICICI Prudential Asset <br>Management Company;<br>–Discussed action plan to address key findings from the <br>investor perception survey carried out in 2024; and<br>–Received feedback from the Group-wide Supervisor on <br>key observations and actions expected of the Group <br>following the Regulatory College in November 2024 and <br>approved the Group's response.<br>| –Considered updates to the Group's capital allocation <br>framework;<br>–Approved in principle the IPO of ICICI Prudential Asset <br>Management Company;<br>–Discussed aspects of Group strategy, in particular <br>regarding agency, the Hong Kong business, and the <br>framework for developing the Group's longer-term <br>strategy; <br>–Approved the establishment of an entity in Bermuda as <br>part of an initiative to enhance capital optimisation and <br>internal reinsurance capabilities; <br>–Approved updates to the Group risk appetite and the <br>2025 Group Own Risk and Solvency Assessment Report <br>for submission to the Hong Kong Insurance Authority; <br>and <br>–Attended the AGM.<br>|
| **March**  | **June** |
| –Discussed macroeconomic and geopolitical trends <br>affecting the Group's key markets, supported by the <br>Group Chief Economist; <br>–Considered the Group's capital allocation framework; <br>–Approved the 2024 second interim dividend;<br>–Reviewed the Group's Operations strategy, a key <br>component for enabling delivery of strategic goals and <br>enhancing customer experience; <br>–Reviewed options for enhancing the Group's asset <br>management capabilities in particular asset classes; <br>–Discussed priority areas of focus in the agency channel;<br>–Approved the final 2025-2027 Group Business Plan (on <br>TEV basis and with re-based economics);<br>–Discussed the investor communications strategy to <br>address key findings from the 2024 independent <br>investor survey, building on the action plan discussed in <br>February; <br>–Reviewed and approved documents and statements <br>related to year-end reporting, following review and <br>recommendation by the Audit Committee; <br>–Reviewed and confirmed effectiveness of risk <br>management and internal control system; <br>–Discussed findings of the 2024 internal Board <br>performance review and agreed action plan; <br>–Received feedback from the Chair and Remuneration <br>Committee Chair on their annual shareholder <br>engagement programmes; and <br>–Approved key items for the AGM.<br>| –On the recommendation of the Nomination & <br>Governance Committee, approved the appointment of <br>Guido Fürer to the Board.<br>|

---

![Board_activities_Scheduled_meetings_virtual.jpg](puk-20251231_g30.jpg)

![Board_activities_Scheduled_meetings_in_person.jpg](puk-20251231_g31.jpg)

![Board_activities_AGM.jpg](puk-20251231_g32.jpg)

![Board_activities_Strategy_workshop.jpg](puk-20251231_g33.jpg)

![Board_activities_Scheduled_meetings_in_person.jpg](puk-20251231_g31.jpg)

![Board_activities_Virtual_meetings_financials.jpg](puk-20251231_g34.jpg)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ![Board_activities_Scheduled_meetings_virtual.gif](puk-20251231_g35.gif) | ![Board_activities_Scheduled_meetings_in_person.gif](puk-20251231_g36.gif) | Scheduled meeting: In-<br>person<br>| ![Board_activities_Virtual_meetings_financials.gif](puk-20251231_g37.gif) | Virtual meeting to consider financial reporting | Virtual meeting to consider financial reporting | Virtual meeting to consider financial reporting |
| ![Board_activities_AGM.gif](puk-20251231_g38.gif)<br> AGM  | ![Board_activities_Site_visvit.gif](puk-20251231_g39.gif) | Site Visit | ![Board_activities_Strategy_workshop.gif](puk-20251231_g40.gif) | Strategy <br>Workshop<br>| ![Board_activities-1.gif](puk-20251231_g41.gif) | Board committee meeting - virtual |

---

---

| | |
|:---|:---|
| Q3 | Q4 |
| **July** | **October**  |
| –Reviewed progress of delivery of strategic objectives, <br>focusing particularly on agency, health, technology and <br>operations;<br>–Considered the framework for the development of the <br>Group's long-term strategy beyond 2027; <br>–Progress review of the execution of the Group's Health <br>strategy; <br>–Further discussion of the Group's capital allocation <br>framework and approval of updates announced as part <br>of the Half Year Results; <br>–Considered initiatives to enhance the Group's asset <br>management capabilities in particular asset classes; <br>–As part of the Board visit to Indonesia, received update <br>on the Indonesia business (see below for further <br>details); <br>–Approved funding for the newly established Bermuda <br>entity; and <br>–Approved the settlement of litigation in Malaysia <br>(announced on 31 July 2025). <br>| –Annual offsite strategy sessions, which included deep <br>dives into key pillars of the Group's strategy, including <br>AI, Wealth and the Group's strategic approach in China, <br>as well as scenario analysis to underpin the Group's <br>long-term strategic planning; <br>–Discussed the approach to the Group's 2026-2028 <br>business plan; <br>–CITIC Pru Life Business and Strategy update, joined by <br>Chair of CITIC Pru Life; <br>–Update on initiative to enhance the Group's asset <br>management capabilities in certain asset classes; <br>–Discussed development and succession planning for the <br>CEO and other GEC roles; and<br>–Received an update on the IPO of ICICI Prudential Asset <br>Management Company and approved pre-IPO <br>placements. <br>|
| **August**  | **December** |
| –Reviewed and approved documents and statements <br>related to half-year reporting, following review and <br>recommendation by the Audit Committee; and <br>–Approved the first interim dividend for 2025. <br>| –Approved the 2026-2028 business and capital plan and <br>2026 strategic priorities; <br>–Considered the framework for the development of the <br>Group's long-term strategy beyond 2027;<br>–Discussed the performance, challenges and strategic <br>transformation of the agency channel; <br>–Deep dive into the Eastspring asset management <br>business; <br>–Considered the Group's strategic approach in India; <br>–Final approval for IPO of ICICI Prudential Asset <br>Management Company;<br>–Received an update on Government Relations strategy; <br>–Received updates on progress made in the Group's <br>people and culture initiatives and focus areas for 2026; <br>–Approved the establishment of a Bermuda business unit <br>to support Wealth strategy; and <br>–Reflected on lessons learnt and insights gained over the <br>year. |
|  | –Approved the 2026-2028 business and capital plan and <br>2026 strategic priorities; <br>–Considered the framework for the development of the <br>Group's long-term strategy beyond 2027;<br>–Discussed the performance, challenges and strategic <br>transformation of the agency channel; <br>–Deep dive into the Eastspring asset management <br>business; <br>–Considered the Group's strategic approach in India; <br>–Final approval for IPO of ICICI Prudential Asset <br>Management Company;<br>–Received an update on Government Relations strategy; <br>–Received updates on progress made in the Group's <br>people and culture initiatives and focus areas for 2026; <br>–Approved the establishment of a Bermuda business unit <br>to support Wealth strategy; and <br>–Reflected on lessons learnt and insights gained over the <br>year. |
|  | –Approved the 2026-2028 business and capital plan and <br>2026 strategic priorities; <br>–Considered the framework for the development of the <br>Group's long-term strategy beyond 2027;<br>–Discussed the performance, challenges and strategic <br>transformation of the agency channel; <br>–Deep dive into the Eastspring asset management <br>business; <br>–Considered the Group's strategic approach in India; <br>–Final approval for IPO of ICICI Prudential Asset <br>Management Company;<br>–Received an update on Government Relations strategy; <br>–Received updates on progress made in the Group's <br>people and culture initiatives and focus areas for 2026; <br>–Approved the establishment of a Bermuda business unit <br>to support Wealth strategy; and <br>–Reflected on lessons learnt and insights gained over the <br>year. |

---

![Board_activities_Scheduled_meetings_in_person.jpg](puk-20251231_g31.jpg)

![Board_activities_Scheduled_meetings_in_person.jpg](puk-20251231_g31.jpg)

![Board_activities_Site_visvit.gif](puk-20251231_g39.gif)

![Board_activities_Strategy_workshop.jpg](puk-20251231_g33.jpg)

![Board_activities_Scheduled_meetings_in_person.jpg](puk-20251231_g31.jpg)

![Board_activities-1.gif](puk-20251231_g41.gif)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ![Board_activities_Scheduled_meetings_virtual.gif](puk-20251231_g35.gif) | ![Board_activities_Scheduled_meetings_in_person.gif](puk-20251231_g36.gif) | Scheduled meeting: In-<br>person<br>| ![Board_activities_Virtual_meetings_financials.gif](puk-20251231_g37.gif) | Virtual meeting to consider financial reporting | Virtual meeting to consider financial reporting | Virtual meeting to consider financial reporting |
| ![Board_activities_AGM.gif](puk-20251231_g38.gif)<br> AGM  | ![Board_activities_Site_visvit.gif](puk-20251231_g39.gif) | Site Visit | ![Board_activities_Strategy_workshop.gif](puk-20251231_g40.gif) | Strategy <br>Workshop<br>| ![Board_activities-1.gif](puk-20251231_g41.gif) | Board committee meeting - virtual |

---

In addition, the Board received regular performance updates from the CEO, CFO, the Chief of Investor Relations and regional

business heads, alongside reviews of operational performance in key markets and across distributions channels, ensuring

comprehensive oversight of financial and operational matters and progress in executing the Group's strategic priorities. The Board

also considered reporting on the Group's other principal stakeholder groups including employees, regulators and policy-makers,

and, at an aggregated level, customers, to ensure that stakeholder considerations continued to inform decision-making.

The Board considered the evolving landscape of macro-economic and geopolitical trends, supported by regular analysis and

briefings from the Group Chief Economist and the Chief Government Relations and Policy Officer, as well as regulatory and political

developments in the markets in which the Group operates. Additional insights were provided through regular reports from the CEO

and CRCO on the Group's engagement with its key regulators.

Governance and risk management considerations remained integral to the Board's decision-making, supported by regular reports

from the CRCO and the Board's approval of all strategic and material operational matters in line with the Group's internal risk

management and governance policies.

The Board's approach was further informed by updates from the Chairs of the Audit, Risk, Remuneration, Nomination &

Governance, and Sustainability Committees, each of which provided advice and assurance over their respective areas of

responsibility.

**Director development programme**

Throughout the year, the Board and its committees received regular business updates and participated in deep-dive sessions that

helped to develop their knowledge of individual businesses, current and emerging issues relevant to the Group and particular

products and business opportunities. The development programme for the Board included the following in 2025:

---

| | |
|:---|:---|
| **January** | Global sustainability trends impacting the insurance industry (externally-facilitated) (Sustainability Committee) |
| **February** | Impact of global sustainability trends on Prudential (Sustainability Committee) |
| **March** | Geopolitical and macro-economic update<br>Deep dive into key drivers of Group valuation<br>Deep dive into management of participating products (Risk Committee)<br>|
| **April** | Update on US tariffs<br>Deep dive into Hong Kong products and associated investment risk<br>UK Corporate Governance Code – Provision 29 (Audit Committee)<br>|
| **May** | Deep dive into product portfolio (Risk Committee)<br>Overview of global remuneration trends and practices (Remuneration Committee)<br>Hong Kong business update and market overview<br>Board workshop on asset and liability management, led by the Group Chief Investment Officer<br>Update on US tariffs<br>Externally-led Board workshop on AI adoption in practice<br>|
| **July** | Indonesia business update and market overview<br>Externally-led session on Indonesia's macro-economic and political landscape<br>Deep dive into foreign ownership rules across markets (Risk Committee)<br>Update on GIECA internal model review (Risk Committee)<br>|
| **October** | Global macro-economic and geopolitical trends, led by the Group Chief Economist<br>External view of Prudential from a top 20 investor<br>CITIC Pru Life business update and market overview<br>Update on evolving regulatory capital standards (Risk Committee)<br>Deep dive into investment strategy and governance, led by the Group Chief Investment Officer<br>Asset management business update and market overview<br>|
| **December** | Deep dive into alternatives investment process (Risk Committee) |

---

The Risk Committee received regular updates on geopolitical, macroeconomic and regulatory developments, updates on regulatory

developments and external trends in respect of financial crime, cyber security, data privacy, and AI, and on a rotating basis was

briefed by the CROs of the Material Subsidiaries on the regulatory developments, industry trends and key risks in their markets.

The Sustainability Committee received regular updates on the ESG geopolitical landscape.

Board visit to Indonesia

In July, the Board visited Indonesia and spent time with our Conventional Life, Syariah and Eastspring businesses. This was an

opportunity for the Board to speak with colleagues and agents to deepen its understanding of the Indonesian market, the

opportunities for growth and the strategies being pursued by the businesses.

As well as presentations on the businesses, the visit involved interactions with employees, agents and strategic partners including:

–Spending time with the local management teams as well as hosting a meet and greet event with top talent in order for the

Board to hear directly from potential future leaders.

–Seeing examples of the innovative ways in which Prudential and its strategic partners are developing and using technology to

better serve customers and support agents.

–Meeting with agency leaders to celebrate successes and share views on market opportunities and how Prudential enables them to

succeed.

–Hearing about sustainability initiatives and the work of the Prudence Foundation in Indonesia.

The Board hosted a dinner with local stakeholders and strategic partners, as well as a dinner with agency leaders. During the

visit, the Chair and CEO met with the President of Indonesia, Prabowo Subianto and Minister for Health, Budi Gunadi Sadikin. They

witnessed the official signing of a Memorandum of Understanding between the Indonesian Ministry of Health and Prudential which

established a strategic framework for capacity-building, digital-health innovation, and other support to advance Indonesia's

national Health Transformation agenda. This collaboration further strengthens Prudential's commitment to Indonesia, one of our

key markets.

**Board performance** 

The Board carries out formal and rigorous reviews of its own

![Internal board performance.jpg](puk-20251231_g42.jpg)

performance, as well as that of its committees and each

individual Director, on an annual basis. These reviews are

overseen by the Nomination & Governance Committee. In line

with governance guidelines, the review is carried out by an

external reviewer every three years.

In addition to the annual review, the Chair meets regularly

with the Non-executive Directors to exchange feedback on the

Board's performance.

---

| | |
|:---|:---|
| Year 1 |  |
| **External Review** |  |
| **External Review** | interview-based review, <br>facilitated externally <br>|
| Year 2 |  |
| **Internal Review** |  |
| **Internal Review** | interview and/or <br>questionnaire-based <br>review, led by the Chair <br>and the Company <br>Secretary |
| Year 3 | interview and/or <br>questionnaire-based <br>review, led by the Chair <br>and the Company <br>Secretary |
| **Internal Review** |  |
| **Internal Review** | interview and/or <br>questionnaire-based <br>review, led by the Chair <br>and the Company <br>Secretary<br>|

---

![Board perdormance.jpg](puk-20251231_g43.jpg)

---

| |
|:---|
| **Internal board performance** <br>**review process for 2025**<br>|
| **Scoping** |
| –Company Secretary discussed proposed <br>approach with Chair.<br>–Chair and Company Secretary updated <br>Nomination & Governance Committee.<br>|
| **Questionnaire** |
| –Company Secretary facilitated the <br>performance review of the Board through a <br>questionnaire for the Board and each principal <br>Committee which covered: Board composition <br>and dynamics; meeting management and <br>support; the Board's oversight of different <br>areas; risk management and internal control; <br>succession planning; the work of the <br>Committees; and priorities for change.<br>|
| **Feedback** |
| –Company Secretary analysed responses to <br>the questionnaire and discussed themes with <br>Chair.<br>–Chair assessed individual performance of each <br>Director and fed back observations.<br>–SID consulted with Board members on <br>performance of Chair and fed back <br>observations.<br>|
| **Outcomes** |
| –Outcomes of individual Director reviews were <br>discussed by the Nomination & Governance <br>Committee.<br>–Outcomes of Board performance review were <br>discussed by the Nomination & Governance <br>Committee/Board to exchange ideas, agree <br>priorities and actions.<br>–Each principal Committee discussed the <br>relevant Committee themes.<br>|

---

The review concluded that substantial progress had been made

in addressing the recommendations from the 2024 review. It

further confirmed that the Board and its principal Committees

continued to operate effectively throughout the year. While no

significant improvements were deemed necessary, a number

of potential enhancement opportunities were identified and

discussed.

Through the review and subsequent discussion, the Board identified areas of particular focus and related actions:

---

| | |
|:---|:---|
| **Theme** | **Outcome of 2025 review** |
| Board training  | –Board and Committee training programme to focus on fast-evolving <br>areas such as technology and AI, alongside refresher sessions on key <br>products.<br>|
| Operation of the Board | –Noting progress in 2025 in increasing time focused on strategic topics, <br>continue to streamline Board agendas to ensure maximum time is <br>allocated to the development of the Group's future strategy. <br>–Continue to streamline papers to help support the Board's focus on key <br>strategic matters.<br>–Deepening Board oversight of senior management development and <br>succession planning.<br>|
| Operation of the Committees | –Deepening oversight of talent development and succession planning <br>across the Group (including to ensure a diverse talent pipeline) <br>(Sustainability and Nomination & Governance Committees).<br>–Continue to focus on AI, technology, data and cyber risks and controls <br>(Audit and Risk Committees).<br>–Further refining agendas in order to allocate more time to the most <br>significant topics (Audit, Risk and Sustainability Committees).<br>|

---

**Actions during 2025 arising from the 2024 review**

---

| | | |
|:---|:---|:---|
| **Theme** | **Outcomes of 2024 review** | **Progress in 2025** |
| Operation of the <br>Board<br>| –Review Board forward agenda to increase <br>time on strategic matters during meetings <br>in person relative to operating and financial <br>performance.<br>–Noting progress in 2024, continue to <br>streamline Board papers and hone key <br>messages.<br>–Refine the suite of metrics to support the <br>Board's monitoring of performance and <br>progress against execution of strategic and <br>financial objectives.<br>| –Good progress was made in this regard, with significant <br>time spent on strategic matters during 2025.<br>–Board papers continued to evolve, with further focus in <br>this area in 2026 to ensure continuous improvement.<br>–Metrics were updated to keep pace with the development <br>of strategic and financial objectives. Further <br>enhancements are expected in 2026 to capture any new <br>reporting metrics.<br>|
| Induction and <br>education<br>| –Identify opportunities for Board education <br>sessions in anticipation of key topics coming <br>to the Board or Committees for discussion.<br>–Bring more external perspectives into the <br>Boardroom.<br>| –Board and Committee education sessions were held on <br>various topics. Further sessions are being arranged in <br>2026.<br>–External perspectives on a range of topics were shared <br>with the Board, which included speakers on AI, macro-<br>economic and geopolitical trends, and other key external <br>trends impacting the industry, as well as from a long-<br>standing investor.<br>|

---

**Director evaluation** 

Individual performance evaluation of Non-executive Directors was undertaken by the Chair who gathered feedback from each

Board member and from relevant GEC members on each Director's performance. The Nomination & Governance Committee

discussed the performance of Directors at its meeting in March 2026 as part of the overall Board review. The Chair relayed

feedback on individual Directors' performance in one-to-one conversations.

Feedback on the performance of the Chair was gathered at a meeting of the independent directors chaired by the SID, without the

Chair present. The SID then discussed the feedback with the Chair.

The outcome of these evaluations informed the Nomination & Governance Committee's recommendation for Directors to be put

forward for re-election by shareholders.

The performance of the CEO, in his executive capacity, is subject to regular review. As part of the annual performance evaluation

of all employees, the Chair assessed the performance of the CEO in consultation with the non-executive Board, while the CEO

appraised the performance of all other GEC members. The Chair of the Risk Committee provided feedback to the CEO on the

performance of the CRCO, and the Chair of the Audit Committee provided feedback to the CEO on the performance of the CFO.

GEC members' performance, including that of the CEO, is also reviewed by the Remuneration Committee as part of its decision-

making.

**Audit Committee report**

**Committee's purpose**

The Committee is responsible for oversight and review of financial reporting. The Committee also oversees the effectiveness of the

internal control and risk management framework, including the effectiveness of financial and non-financial reporting controls, and

is responsible for making the relevant disclosures in the Annual Report. In addition, it considers the effectiveness and objectivity of

the internal and external auditors.

*More information about the Audit Committee can be found in its terms of reference, which are available at www.prudentialplc.com/*

*en/investors/governance-and-policies/board-and-committees-governance*

**Committee performance** 

The operation of the Committee was reviewed as part of the annual Board performance review. No material issues were identified.

The Committee discussed the output of the evaluation and agreed areas of focus. These are included in the consolidated outcomes

of the 2025 Board performance review above

**Membership and 2025 meeting attendance**

---

| | | |
|:---|:---|:---|
| **Committee members** | **Member since** | **2025 meetings**<sup>1</sup> |
| Jeanette Wong, Chair | May 2021 (Chair since March 2024) | 15/15 |
| Jeremy Anderson | January 2020 | 15/15 |
| Arijit Basu | September 2022 | 15/15 |
| Guido Fürer | July 2025 | 8/8 |
| Mark Saunders | April 2024 | 15/15 |
| Amy Yip<sup>2</sup> | March 2021 | 11/13 |

---

(1)The Committee held five scheduled meetings, plus six additional shorter meetings to consider periodic financial reporting. In addition, the Committee held two

joint meetings with the Risk Committee and two joint meetings with the Sustainability Committee.

(2)Amy Yip was unable to attend one scheduled meeting and one of the joint meetings due to conflicting commitments. She retired from the Board with effect

from 31 October 2025.

**Regular attendees**

---

| | |
|:---|:---|
| –Chair of the Board<br>–Chief Executive Officer<br>–Chief Financial Officer <br>–Chief Risk and Compliance Officer<br>| –Company Secretary<br>–Chief of Financial & Capital Reporting<br>–Chief Internal Auditor<br>–External Audit Partners<br>|

---

The Committee's 2025 agenda focused on financial reporting and controls. A key focus of the Committee has been overseeing the

transition to TEV, including reviewing the assumptions underpinning the framework, such as the calibration of risk discount rates.

We hope that shareholders find the increased comparability of our reporting to key peers useful.

A further priority was overseeing the multi-year programme to transform the Group's Finance function. The project is assessing

the capabilities and tools required across financial, actuarial and management reporting to ensure that the Finance function

continues to operate in an effective and efficient way as the business grows and develops in line with our Group strategy. The

Committee has remained focused on the safe delivery of the programme and supporting the realisation of its intended benefits,

receiving detailed updates from the project team in May and October.

Ahead of changes to the declarations required under the UK Corporate Governance Code regarding the effectiveness of material

controls, which came into effect for financial years beginning on or after 1 January 2026, the Committee spent time understanding

the new requirements and evolving best practice for such declarations and oversaw the preparations for the new requirements.

We continued to work closely with other Board committees. We held two joint meetings with the Risk Committee in May and

October, which focused in particular on technology risks. Holding these meetings jointly enabled us to combine our expertise and

discuss the topics and challenges in more depth.

The Committees together received a status update on our two-year programme to enhance the Group's control environment as a

key enabler for achieving our growth strategy, in which controls are efficiently managed to accelerate value through operational

and financial discipline. The programme has progressed well in delivering the expected enhancements and our focus will now move

on to monitoring the successful embedding across the organisation.

We also met jointly with the Sustainability Committee in March and December to discuss non-financial reporting controls and

receive an update on Sustainability reporting requirements across our markets.

Jeremy Anderson (Chair of the Risk Committee) and Jeanette Wong continued to work closely with our counterparts in our

subsidiaries. Jeanette Wong maintained her regular engagement with the Chairs of our Material Subsidiaries and extended this to

include the Chairs of the largest next-tier operating subsidiaries. We held two governance forums for the members of audit and

risk committees in those subsidiaries to discuss common issues and share best practice, in particular focusing on the role of audit

committees in overseeing the Group's risk management and internal control framework.

More detail on our activities is provided in the report below.

---

| |
|:---|
| Key committee activities in <br>2025 |
| **March**<br>–Full-year reporting;<br>–Annual review of risk management and internal <br>controls;<br>–Internal audit effectiveness;<br>–Consideration of auditor re-appointment; and<br>–Oversight of non-financial reporting (jointly with <br>the Sustainability Committee).<br>**April**<br>–Q1 Business performance update; and<br>–Externally-facilitated education session: Provision <br>29 of the UK Corporate Governance Code. <br>**May**<br>–Projects: transformation of the Finance function <br>and preparation for Provision 29; <br>–Bi-annual actuarial update;<br>–External auditor: effectiveness review and audit <br>engagement terms;<br>–Annual report on Speak-Out programme; and<br>–Technology risk management (jointly with the <br>Risk Committee).<br>**July**<br>–Half-year reporting; and<br>–Preparation for material controls reporting under <br>Provision 29.<br>**August**<br>–Half-year reporting.<br>**October**<br>–Transformation of the Finance function;<br>–Auditor independence policy annual review;<br>–Technology risk management (jointly with the <br>Risk Committee); and <br>–Control environment enhancement project <br>(jointly with the Risk Committee). <br>**November**<br>–Q3 Business performance update.<br>**December**<br>–Full-year reporting;<br>–Bi-annual actuarial update;<br>–2026 Internal audit plan;<br>–Review of risk management and internal <br>controls; and<br>–Non-financial reporting controls for full-year 2025 <br>reporting (jointly with the Sustainability <br>Committee).<br>|

---

**2026 priorities**

–Oversight of AI, data and cyber controls (in collaboration with the Risk Committee);

–Oversight of risk management and internal control framework effectiveness and monitoring under new requirements (Provision

29, UK Code); and

–Monitoring the ongoing transformation of the Finance function.

More detail on our activities is provided in the report

**Accounting judgements and estimates supporting the Group's results**

One of the Committee's key responsibilities is to monitor the integrity of periodic financial reports. This includes the Half Year

Financial Report, the Annual Report and Accounts (including compliance with the GWS public reporting requirements), associated

results announcements and Form 20-F disclosures. The Committee also reviews the quarterly business performance updates

provided for the first and third quarters.

In reviewing these and other items, the Committee receives reports from management and, as appropriate, reports from internal

and external assurance providers. When considering financial reporting matters, the Committee assesses compliance with relevant

accounting standards, regulations and governance codes focusing on key areas of judgement and complexity.

No material changes were made to the Group's IFRS accounting policies during 2025, as set out in note A3.

**Assumptions setting** 

The Committee reviewed the key assumptions and judgements supporting the Group's IFRS results, including those made in

valuing the Group's insurance contract balances, investments and intangible assets. The Committee also reviewed the

assumptions underpinning the Group's TEV results.

**Insurance contract balances**

The measurement of insurance contract balances is based on the best estimate of future cash flows, including those to and from

policyholders, over a long period of time. These estimates can, depending on the type of business, be highly judgemental. Critical IFRS

accounting policies, estimates and judgements on the measurement of contract liabilities are set out in note A3, with further details on

products and the measurement of contractual service margin (CSM) provided in note C3. The sensitivity of the Group's metrics to key

economic and non-economic assumption changes is set out in note C6 to the consolidated financial statements. The Committee

considered proposed changes to assumptions and other estimates in advance of 2025 reporting. Key assumptions considered were:

–The persistency, mortality, morbidity (including expectations of future medical costs inflation and related premium rises) and

expense assumptions (including consideration of future expense levels anticipated in the business plan) within insurance

businesses. When assessing these assumptions, the Committee considered recent experiences and whether adverse variances

were expected to be short term in nature; and

–Economic assumptions, including investment returns, associated risk discount rates for TEV and related illiquidity premiums for

IFRS. Note A3 sets out the Group's approach to setting risk discount rates, incorporating illiquidity premiums, for IFRS.

The Committee was satisfied that the assumptions adopted by management were appropriate.

**Valuation of investments** 

The Committee received information on the carrying value of investments in the Group's balance sheet which acknowledged that

most of the Group's investments continued to be based on quoted prices in an active market (circa 82 per cent being included in

level 1 as at 31 December 2025). Further information on the valuation of assets is contained in note C2 of the consolidated

financial statements. On level 3 investments, the Committee noted that management had focused in the year on enhancing

control around valuation, particularly how reviews of supporting information were performed and documented. Climate change

does not directly impact fair values, particularly where these are built on observable inputs (i.e. level 1 and level 2); however, the

impact of environmental risks on the Group's assets and liabilities is discussed in more detail in note C6 of the consolidated

financial statements and the Risk review. The Committee agreed that, overall, investments were valued appropriately.

**Intangible assets** 

The Committee received information to enable it to review the carrying value of certain intangible asset balances, principally the

Group's distribution rights asset and goodwill. After reviewing the information provided and considering the results of the work

performed by management, the Committee was satisfied that the carrying value of the intangibles reviewed was appropriate. More

information on the Group's intangibles is contained in note C4 of the consolidated financial statements.

**2025 corporate transactions**

The Committee received information from management on accounting for specific corporate transactions that took place in 2025.

This included the settlement of a dividend claim made by Detik Ria, the 49 per cent shareholder in Sri Han Suria Sdn Bhd, the

holding company of Prudential Assurance Malaysia Berhad, which resulted in a small increment to the Group's IFRS shareholders'

equity, and the gain through the sale of shares arising upon the initial public offering of ICICI Prudential Asset Management

Company Limited.

**Other financial reporting matters**

**Going concern and viability statements** 

The Committee considered various analyses from management on the capital and liquidity positions at both Group and parent

company level, taking into account the Group's principal risks. This included an assessment of the impact that different stress

scenarios may have on the Group's business plan and its resilience to those threats. Following this review, the Committee

recommended to the Board that it remains appropriate to adopt the going concern basis of accounting in preparing the financial

statements and that the disclosures in the 2025 Annual Report and Accounts on the Group's longer-term viability are both

reasonable and appropriate.

**Fair, balanced and understandable** 

The Committee carried out a formal review of whether the 2025 Annual Report and Accounts are 'fair, balanced and

understandable' as required by the UK Corporate Governance Code. In particular, it considered whether the report gives a full

picture of the Group's business model, strategy, financial position and performance in the year, with important messages

appropriately highlighted. The consideration included key developments arising in the year, how progress against the Group's key

strategic objectives is presented in the Annual Report, and the balance of discussion of performance across the Group's operations

and segments. Other aspects considered included the level of consistency between financial statements and management

narrative sections and the prominence of alternative performance measures, and risk disclosures.

After completion of its detailed review, the Committee agreed that, taken as a whole, the Group's 2025 Annual Report and

Accounts are fair, balanced and understandable.

**Taxation** 

The Committee regularly received updates on the Group's tax matters and provisions for certain open tax items, including tax

matters in litigation. The Committee agreed that the level of provisioning adopted by management is appropriate. In 2025, the

Committee reviewed the effects on the Group's reported results of the introduction of a global minimum tax rate of 15 per cent,

which became fully effective for the Group in 2025. It also reviewed the associated disclosures of the change – see notes B3 and

C7 of the consolidated financial statements for further information. The Committee reviewed and approved the annual update of

the Group's Tax Strategy information ahead of publication on the website.

**Parent company financial statements** 

The Committee reviewed the parent company profit and loss account and balance sheet, which includes the recoverability of the

parent company's investment in subsidiaries by assessing and confirming that the net assets of the relevant subsidiaries

(approximating their minimum recoverable amount) were in excess of their carrying value at the balance sheet date.

**External audit**

**External audit effectiveness** 

The Group's external auditor is Ernst & Young LLP (EY) and oversight of this relationship is one of the Committee's key

responsibilities. Matters considered by the Committee in the year included:

–EY's detailed audit strategy for the year, approach to risk assessment and coverage of the audit response to highlighted

significant risks;

–EY's approach to Group materiality setting and their proposal on how that is applied to individual business units;

–EY's knowledge around the key assumptions, and their insight and constructive challenge to management by highlighting where

those assumptions are positioned on a range;

–EY's insight around the key accounting judgements and estimates and demonstration of professional scepticism in dealing with

management;

–The outcome of management's internal evaluation of the auditor and audit quality, as discussed below; and

–Other external evaluations of EY, with a focus on the FRC's Annual Quality Review.

The Committee maintains an open dialogue on emerging risks and issues with the EY Group Lead Partners via a regular schedule

of meetings aligned to key reporting milestones. In 2025, the Committee met with EY's Group Lead Partners without management

present on two separate occasions.

**Management's internal evaluation of EY**

This was conducted in May 2025 using a questionnaire seeking input from Committee members, members of Material Subsidiary

audit committees, the CFO and the Group's senior financial leadership. The survey asked questions covering EY's knowledge and

expertise (including industry insight), professional scepticism and challenge, audit process, and quality of both written and oral

communications. Comments as well as a numerical score were collected and analysed. The feedback supported the conclusion that

the audit performed by EY was carried out to a high standard and demonstrates an appropriate degree of challenge to

management. While some areas of improvement were identified, no material concerns were raised. EY was given the opportunity

to respond to the findings and EY discussed proposed improvements to address specific points raised in the evaluation.

**FRC audit quality inspection of EY** 

When assessing the audit quality of EY, the Committee reviewed the inspection results published by relevant regulators in respect

of the firm. In July 2025, the FRC published its 2024-2025 Audit Quality Inspection findings in respect of EY and other large UK

audit firms, carried out by its Audit Quality Review (AQR) team. In July 2025, the Hong Kong AFRC also published its 2024-2025

Annual Inspection Report for Hong Kong audit firms. Both reports showed improvements in overall grades for EY from the prior

year. Overall, the Committee was satisfied that no specific actions were needed for the Prudential plc 2025 audit as a result of the

FRC AQR inspection findings.

**Auditor independence and objectivity** 

The Committee monitors auditor independence and objectivity, which is supported by the Group's Auditor Independence Policy

(the Policy). The Committee reviews and approves any changes to the Policy annually. The Policy sets out the circumstances in

which the external auditor may undertake non-audit services and is based on four key principles, which specify that the auditor

should not:

–have a mutual or conflicting interest with the Group;

–audit its own firm's work;

–act as management or employees of the Group; or

–be placed in a position of advocacy for the Group.

The Policy has two permissible service types: those that require specific approval by the Committee on an engagement basis, and

those that are pre-approved by the Committee with an annual monetary limit capped at no more than five per cent of the Group

audit fee in the proposed year and capped at $65,000 individually. Non-audit services undertaken by EY were agreed prior to the

commencement of work and were confirmed as permissible for the external auditor to undertake in accordance with the Policy,

which complies with the rules and regulations of the FRC's Revised Ethical Standard (2024), the US Securities and Exchange

Commission (SEC) and the standards of the Public Company Accounting Oversight Board (PCAOB).

The Committee monitored the nature and extent of non-audit services on a regular basis to ensure the provision of such services

complied with the Policy and did not impair the auditor's objectivity or independence. The Committee noted that EY typically only

performed non-audit services where they complemented its role as external auditor, for example, the review of half-year and TEV basis

results or additional assurance to support capital market announcements.

In keeping with professional ethical standards, EY provided regular updates and confirmed on a bi-annual basis its independence

to the Committee, setting out the supporting evidence such as details of non-audit services and the potential threats and related

safeguards in providing those services. The confirmation was included in a report that was considered by the Committee prior to

publication of the financial results.

The Committee will continue to monitor developments to ensure the Group's policies and processes around audit effectiveness and

independence evolve in line with market practice.

**Fees paid to the external auditor** 

The fees paid to EY for the year ended 31 December 2025 amounted to $16.3 million, of which $4.2 million were total amounts

payable in respect of non-audit services, except those required by law and regulation as defined by the FRC's Revised Ethical

Standard (2024). A breakdown of the fees payable to EY can be found in note B2.4 of the consolidated financial statements. The

FRC cap on the ratio of non-audit fees over average audit fees for the past three years is only applicable for the year ending 31

December 2026, being the fourth year of EY being the Group's external auditor.

The $4.2 million of non-audit services referenced above included the review of the Group's half-year financial statements, TEV

disclosures and other limited assurance work. In all cases, EY was considered the most appropriate firm to carry out the work,

given their knowledge of the Group and the accumulated expertise gained from running these engagements alongside the main

audit. All non-audit services were pre-approved by the Committee and were in line with the Policy discussed above.

**Reappointment of the external auditor** 

EY completed its third audit of the Group since appointment at the Company's AGM in May 2023 following the competitive tender

process in 2020. Based on the outcome of the effectiveness evaluation, discussed above, and all other considerations, the

Committee concluded that there was nothing in the performance of the auditor that would require a change at the next AGM. The

Committee, therefore, recommends that EY be reappointed as the auditor, with John Headley remaining as the Group Lead

Partner. A resolution to this effect will be proposed to shareholders at the 2026 AGM. Under the relevant audit tender rules, the

Company is required to conduct its next audit tender before the audit of the financial year 2033.

Throughout the 2025 financial year, the Company complied with the provisions of the Statutory Audit Services for Large

Companies Market Investigation (Mandatory Use of Competitive Tender Processes and Audit Committee Responsibilities) Order

2014 issued by the UK Competition and Markets Authority.

**Whistleblowing**

**Speak Out**

The Group continues to operate a Group-wide whistleblowing programme ('Speak Out'), hosted by an independent third party

(Navex). The Speak Out programme received ad hoc reports through a wide variety of channels, including a web portal, QR code,

free-to-call hotlines, emails and letters. Reports are captured, confidentially recorded by Navex and triaged by Group

Investigations before being investigated by the appropriate in-house teams.

The Committee is responsible for overseeing the effectiveness of the Group's whistleblowing arrangements. The Committee

received regular reports of the most serious cases and other significant matters raised through the programme, together with the

actions taken to address them. The Committee was also briefed on emerging Speak Out trends and themes, causal factors and

post-investigation remediation. The Committee may request, and has requested, further reviews of particular areas of interest

where it considered additional scrutiny appropriate.

Through an annual Speak Out report and quarterly updates, the Committee reviews the Group's Speak Out programme, satisfying

itself that it continues to comply with legal, regulatory and governance requirements. The Committee also considered the

consistency of approach adopted across subsidiary audit committees, where locally recorded Speak Out events, themes and trends

are reported and considered. Where relevant, the Committee requested information on the sharing of lessons learned.

The Committee regularly spent time privately with the Group General Counsel (who has ultimate responsibility for the operation of

the Speak Out programme) to understand outcomes of investigations, ensure that investigations were adequately resourced and

appropriately managed, that there had been no retaliation against anyone making a report and that investigations were not

improperly influenced.

An annual assessment of Speak Out arrangements is undertaken by an independent UK-based whistleblowing charity, 'Protect' and

benchmarked against peers. The assessment confirmed that the Group's programme continued to perform well and in accordance

with best practice.

**Internal audit** 

**Regular reporting** 

The Committee received regular updates from Group-wide Internal Audit (GwIA) on audits conducted and management's progress

in addressing audit findings within agreed timelines. Any delays in implementing remediation actions were escalated to the

Committee and subject to enhanced scrutiny.

The independent assurance provided by GwIA formed a key part of the Committee's deliberations on the Group's overall control

environment. During 2025, the areas reviewed included: strategic change initiatives, customer outcomes, technology security,

financial risk and financial controls, operations, outsourcing; and regulatory compliance.

The Chief Internal Auditor reports functionally to the Committee Chair and has direct access to the Chair of the Board and to the

CEO. For administrative purposes (excluding strictly all audit-related matters), the Chief Internal Auditor has a reporting line to

the CRCO. In addition to formal Committee meetings, the Committee meets with the Chief Internal Auditor in private to discuss

matters relating to, for example, the effectiveness of the internal audit function, significant audit findings and the risk and control

culture of the organisation. Where internal audit has identified high priority audit findings, the Committee typically asks the

accountable executive to attend the following Committee meeting in order to provide an update on the remedial actions being

taken.

The Committee Chair also meets with the independent quality assurance provider engaged by GwIA to discuss the outcome of the

quality reviews of GwIA's work and actions arising.

**Annual internal audit plan and focus for 2026** 

GwIA operates a 12-month audit planning approach, which provides the Committee with a view of the planned audit coverage and

resources needed for the next 12 months, with a formal reassessment being conducted at the half-year point to reflect topical

control issues, changes in risk profile and/or regulatory focus and business initiatives. In December 2025, the annual internal audit

plan and audit resources for 2026 were approved.

The 2026 internal audit plan was based on a bottom-up risk assessment of audit needs. These were mapped against various

metrics and based on a top-down approach to compliance. The plan was then assessed against a series of risk and control

parameters, including the top risks identified by the Risk Committee, to verify that it was appropriately balanced between financial

matters, business change, and regulatory and operational risk drivers, and provides appropriate coverage of key risk areas and

audit themes. Key areas of focus for this plan are: transformation and change management; customer outcomes; technology;

financial risk and financial controls; operations; investment management; outsourcing; and risk management and regulatory

compliance.

**Effectiveness of internal audit**

The Committee is responsible for the approval of the GwIA charter, audit plan and resources, and monitors the effectiveness of the

function.

The Committee assesses the effectiveness of GwIA through a combination of External Quality Assessment (EQA) reviews, required

every five years, and an annual quality assurance (QA) internal effectiveness review.

The last EQA review was conducted in Q4 2021, with GwIA being assessed as a mature function and receiving the highest rating

(Generally Conforms) under the Institute of Internal Audit's framework. Based on the 2025 internal effectiveness review, a self-

assessment performed by the internal audit function (supported by the third-party quality assurance team engaged by GwIA), the

Committee concluded that GwIA had continued to operate independently of management and in compliance with the requirements

of the Global Internal Audit standards in all material aspects and had remained aligned to mandated objectives during 2025.

**Internal control and risk management**

**Internal control and risk management framework** 

The Committee is responsible for reporting and making recommendations to the Board on the effectiveness of the Group's system

of risk management and internal control.

The Committee received particular information on the operation and effectiveness of the financial reporting controls throughout

the year. Together with the Sustainability Committee, it also received an overview of the non-financial metrics reported in the

Annual Report and the controls that support this non-financial reporting. These controls focus on the metric being clearly defined

and on ownership and review of the data reported within the Group. The Committee also discussed the scope of external

assurance obtained on certain climate-related reporting metrics.

The Committee considers the outcome of the annual review of the system of risk management and internal control, noting areas

for improvement and the actions that have been implemented or are in progress.

**Changes to internal control and risk management requirements**

The Committee undertakes an annual effectiveness review of the internal control and risk management framework on behalf of the

Board, with regular focus on specific emerging risk themes, which supports the external reporting process. In preparation for

changes to the requirements under the UK Code, which we will report against starting from the 2026 Annual Report, the

Committee held an externally-facilitated workshop to better understand the new requirements of Provision 29 and the amendment

to Principle O and evolving best practice in implementing them. The Committee considered guidance on defining and identifying

material controls, Board responsibilities, the scope of risk and control coverage, and features of effective risk management and

internal control frameworks.

In subsequent meetings, the Committee considered the definition of material control in the Group's context, the approach to

identifying material controls, and the proposed assurance approach that will support the Committee and Board when making

future declarations on the effectiveness of material controls.

**Group Governance Manual** 

The Group Governance Manual (GGM), which includes the Group Code of Conduct, Group Governance Framework and the Joint

Venture Oversight Framework, sets out the general principles by which Prudential conducts its business and the standards

expected, and defines the Group-wide approach to governance, risk management and internal control.

Exemptions and breaches of mandatory requirements outlined in the Group-wide policies, standards, and delegated authorities are

monitored, with remedial actions taken as necessary. All staff and applicable contingent workers are expected to submit an annual

declaration confirming compliance with the Group Code of Conduct.

**Risk Committee report**

**Committee's purpose**

The Committee is responsible for oversight and review of the Group's risk appetite, tolerance and strategy. It monitors current and

potential future risk exposures, the effectiveness of the Group's risk management framework and adherence to the various risk

policies and regulatory obligations.

*More information on the Risk Committee can be found in its terms of reference, which are available at www.prudentialplc.com/en/*

*investors/governance-and-policies/board-and-committees-governance.*

**Committee performance** 

The operation of the Committee was reviewed as part of the annual Board performance review. No material issues were identified.

The Committee discussed the output of the evaluation and agreed areas of focus. These are included in the consolidated outcomes

of the 2025 Board performance review above.

**Membership and 2025 meeting attendance**

---

| | | |
|:---|:---|:---|
| **Committee members** | **Member since** | **2025 meetings**<sup>1</sup> |
| Jeremy Anderson, Chair | January 2020 (Chair since May 2020) | 8/8 |
| Guido Fürer | July 2025 | 5/5 |
| George Sartorel | May 2022 | 8/8 |
| Mark Saunders | April 2024 | 8/8 |
| Claudia Suessmuth <br>Dyckerhoff<sup>2</sup><br>| January 2023 | 6/8 |
| Jeanette Wong | May 2021 | 8/8 |

---

(1)The Committee held five scheduled meetings, plus two joint meetings with the Audit Committee. One short meeting was held to discuss the risk aspects of the

Group Business Plan.

(2)Claudia Suessmuth Dyckerhoff was unable to attend one scheduled meeting and one joint meeting with the Audit Committee due to conflicting commitments.

**Regular attendees**

---

| | |
|:---|:---|
| –Chair of the Board <br>–Chief Executive Officer <br>–Chief Risk and Compliance Officer <br>–Chief Financial Officer <br>–Company Secretary <br>–Chief Internal Auditor<br>| Members of the Risk, <br>Compliance and Security <br>leadership team are invited to <br>attend each meeting as <br>appropriate.<br>|

---

The committee continued to focus on the volatile geopolitical and macroeconomic landscape throughout the year, assessing and

responding to the risks to our operations and capital requirements. Of note were our discussions on managing the impact of the

US tariff announcements in April on the Group's operations, and the management of market and liquidity risks against that

backdrop, which was closely monitored by the Committee.

We continued to monitor significant regulatory changes impacting the Group and evolving expectations of governments and

regulators in our markets, especially as many of our markets continue to experience high levels of medical cost inflation.

In our annual assessment of top risks, we tightened our focus on the most significant risks to the Group. Key risk themes

monitored by the Committee included risks to the delivery of our strategic objectives, and risks arising from strategic initiatives

including transformation and distribution models, as well as risks associated with technology. In addition, we discussed the

management of risks arising from persistency, morbidity, investment performance, third parties and outsourcing, and material

joint ventures affecting the Group's risk profile.

We regularly invite Chief Risk Officers from our local business units to attend our meetings and brief the Committee on the specific

risks and challenges they face in their markets. This provides useful additional context to help the Committee identify and monitor

top risks and other material risks. In 2025, we heard from the CROs from Hong Kong, Eastspring, Indonesia and Vietnam.

There are also regular discussions with the Risk Committee Chairs in our Material Subsidiaries, which were expanded during the

course of the year to also include the Risk Committee Chairs of the next tier of operating subsidiaries.

We continued to collaborate with other Board committees, holding two joint meetings with the Audit Committee. These focused on

technology risk and our two-year programme to enhance the Group's control environment, as a key enabler for achieving the

Group's growth strategy. Following the successful delivery of the desired enhancements, the focus will now be on monitoring

effective embedding within the frontline. The Committee will continue to receive updates in 2026.

Following an assessment of the risk culture in the organisation, we reviewed the outcomes and identified targeted actions to

further strengthen risk culture and improve consistency across the Group.

As for all financial services groups, cyber security is a key area of focus. As well as looking at the Group's arrangements for

defending against, identifying and responding to attacks, we also considered the arrangements of our key third-party suppliers,

seeking to learn lessons from high profile cyber attacks on other companies. We have strengthened our technology governance,

with particular focus on foundational technology controls, data and AI.

Key activities and other regular activities are described below.

---

| |
|:---|
| Key committee activities in <br>2025 |
| **March**<br>–Approval of top risks;<br>–Business focus – Hong Kong, China and <br>Eastspring;<br>–Emerging risks – medical claims cost, investment <br>risk/ALM, competitive market dynamics;<br>–Management of participating products; and<br>–Annual update on Anti-Bribery & Corruption and <br>on Anti-Money Laundering, Counter Terrorist <br>Financing & Sanctions.<br>**May**<br>–Annual approval of documents for submission to <br>the Hong Kong IA;<br>–Business focus – Hong Kong and Vietnam;<br>–Annual product portfolio review;<br>–Material Group outsourcing arrangements; and<br>–Technology risk management (jointly with the <br>Audit Committee).<br>**July**<br>–GIECA methodology – risk implications connected <br>with the transition from EEV to TEV;<br>–Business focus – Indonesia;<br>–Foreign ownership rules; and<br>–Risk considerations regarding the incentive <br>design for the CEO and other members of the <br>GEC.<br>**October**<br>–Business focus – Hong Kong and Vietnam;<br>–Annual Group risk framework review;<br>–Model risk management;<br>–Evolving regulatory capital standards;<br>–Technology risk management, including cyber <br>security (jointly with the Audit Committee); and<br>–Control environment (jointly with the Audit <br>Committee).<br>**December**<br>–Business focus – Hong Kong;<br>–Risk modelling assumptions – annual review;<br>–Risk appetite and limits – annual review;<br>–Annual review of the Risk and Compliance <br>function effectiveness and approval of the 2026 <br>Risk and Compliance plan;<br>–Joint venture oversight; and<br>–Alternative assets investment process.<br>|

---

**2026 priorities** 

–Further refine agendas in order to allocate more Committee time to the most significant topics;

–Increase our focus on technology, cyber and AI risks;

–Deep dive into the new methodology for our Group Internal Economic Capital Assessment model; and

–Deep dive into Reinsurance following the establishment of our Bermuda-based reinsurance entity.

**Other activities during 2025**

In addition to the key activities highlighted above, the Committee considered the following matters within its remit during the

year:

**Risk Management**

The Committee stayed abreast of evolving internal and external incidents and risk events throughout the year. It evaluated the

Group's top risks and considered recommendations for the inclusion of additional risks in this category and changes to the scope of

existing top risks. These top risks shape the Committee's oversight and the reporting to the Committee, and drive the focus of

activities by the Risk and Internal Audit functions.

A significant part of each meeting is dedicated to reporting by the Group CRCO and his team. The regular CRCO report typically

highlights the Group's exposure to and management of its principal risks, emerging risk themes, material joint ventures impacting

the Group's risk profile, external developments (including regulatory changes) and material transformation initiatives. The

Committee Chair provided regular updates on Material Subsidiary risk committees and their focus on key risks, operating

landscape and business challenges, supplemented by updates from the CRCO on management actions.

The Risk Committee agreed the planned second line risk reviews, deep dives, assurance reviews and read-across reviews. These

were reported to the Committee over the course of the year, in particular focusing on participating fund management, technology

risk, model risk, third-party and outsourcing management, financial crime, sustainability risk and product-related key risks. The

Committee also commissioned other reviews and read-across exercises as incidents and/or issues arose throughout the year.

The strength of the Group's capital and liquidity positions was closely monitored by the Committee to ensure the Group remained

resilient, to safeguard the interests of stakeholders. The Committee reviewed the results of stress and scenario testing, a key tool

for identifying and measuring risks, to ensure the Group remained in a robust financial and operational condition when under

severe stress, and that established governance frameworks and procedures were in place for senior management to respond to

actual and potential severe stress scenarios. Testing concluded that extreme stresses would be required to breach the Group's

recovery activation measures.

**Risk and Compliance Framework, including appetite and tolerance, and Risk Governance** 

The Committee approved updates to the Group Risk Framework and its associated policies and recommended them to the Board

for approval where necessary, as part of the annual review, to ensure they remain fit for purpose and align with the Group

Governance Manual. The Committee also reviewed the Group Risk Appetite and recommended risk appetite and tolerance changes

to the Board for approval. Regular reports of any breaches of the Group's risk appetite and mitigating actions were provided to the

Committee throughout the year.

Subsidiary and joint-venture risk governance reviews, and progress updates on the enhancement of joint-venture oversight, were

presented to the Committee to ensure appropriate governance arrangements are adopted.

Jointly with the Audit Committee, the Risk Committee is overseeing a Group-wide control enhancement programme aimed at

strengthening the Group control environment and uplifting resilience through a number of targeted workstreams, with key areas of

focus including: business controls, assurance, risk and control framework, governance and reporting, and risk culture. Updates

were provided to a joint meeting of the Risk and Audit Committees.

The Committee remained agile and considered risk and compliance-related findings, as well as other cultural indicators related to

risk management and tolerance identified by Internal Audit or other functions.

**Strategies and Business Plans** 

As part of its role in overseeing and advising the Board on future risk exposures and strategic risks, the Committee reviewed the

risk assessment of the 2025-2028 Group Business Plan, which highlighted key financial and non-financial risks in respect of the

plan and the achievement of the Group's strategic objectives.

**External and Regulatory Reporting**

Key reports reviewed and, where necessary, recommended to the Board for approval by the Committee before submission to the

Hong Kong Insurance Authority (IA) included:

–The Group's Own Risk and Solvency Assessment;

–The Group's Recovery Plan, supported by the Group Crisis Procedure and Liquidity Risk Management Plan;

–The Group Internal Economic Capital Assessment (GIECA) assumptions and methodology changes following transition from EEV

to TEV, and bi-annual GIECA results; and

–The FY24 Insurance Capital Standard (ICS) results and updates on the future of ICS implementation, including potential impact

on the Group.

The Committee also received regular reports on key regulatory compliance risks and mitigation activities across the Group's

businesses. Updates covered material regulatory compliance risk issues or concerns, significant regulatory developments and

landscape changes, major review findings and interventions, and key Compliance functional activities. These matters encompassed

day-to-day business practices, conduct and customer outcomes, anti-fraud, anti-bribery and corruption, anti-money laundering,

counter-terrorist financing, and sanctions risks. The Committee was also updated on the key matters arising from the annual

Supervisory College and other notable regulatory interactions with the Hong Kong IA and other relevant regulators of the Group,

and tracked the Group's progress in delivering agreed actions.

The Committee reviewed the Group's financial viability and operational resilience under a range of stress scenarios.

**Risk and Compliance function**

The Committee evaluated the effectiveness of the Risk and Compliance function, including its oversight of the Group's principal

risks.

**Remuneration**

Throughout the year, the Committee advised the Remuneration Committee on risk management considerations associated with

executive remuneration arrangements, including the assessment of proposed executive remuneration structures and outcomes,

and the draft Directors' Remuneration Policy, which will be put to shareholders for approval at the 2026 AGM.

**Nomination & Governance** 

**Committee report**

**Committee's purpose**<br>The Committee is responsible for the oversight of Board and executive succession (unless considered by the Board), nominating <br>candidates for appointment to the Board, oversight of Board performance and corporate governance matters. It assists the <br>Board in retaining an appropriate balance of skills to support the strategic objectives of the Group, ensuring a formal, rigorous <br>and transparent approach to the appointment of Directors, and maintaining an effective framework for succession planning. It <br>also supports and advises the Board on governance arrangements. <br>

More information on the role and responsibilities of the Nomination & Governance Committee can be found in its terms of

reference, which are available at www.prudentialplc.com/en/about-us/corporate-governance-and-corporate-actions/governance-

structure/

**Committee performance** 

The operation of the Committee was reviewed as part of the annual Board performance review. No material issues were identified.

The Committee discussed the output of the evaluation and agreed areas of focus. These are included in the consolidated outcomes

of the 2025 Board performance review above.

---

| | | |
|:---|:---|:---|
| **Committee members** | **Member since** | **2025 meetings** |
| Shriti Vadera | May 2020 (Chair since January 2021) | 3/3 |
| Jeremy Anderson | November 2022 | 3/3 |
| Chua Sock Koong | May 2022 | 3/3 |
| Sir Douglas Flint | March 2026 | n/a |
| Ming Lu | May 2021 | 3/3 |
| George Sartorel | May 2022 | 3/3 |

---

**Regular attendees**

–Chief Executive Officer <br>–Chief Human Resources Officer<br>–Company Secretary <br>

The Committee's primary focus during the year has been the search for the new Board Chair and Chair of the Nomination &

Governance Committee. This process was led by Jeremy Anderson, our Senior Independent Director, and involved all Board

members. The Board has decided to appoint Sir Douglas Flint. He joined the Board on 4 March, and subject to his election by

shareholders, he will take over the role of Board Chair and Chair of the Nomination & Governance Committee at the end of the

Annual General Meeting and Shriti Vadera will step down at that point. They are already working together closely on Sir Douglas

Flint's induction and transition to the role to ensure a smooth succession. More details on the appointment process are set out

below.

As highlighted last year, a particular area of focus for the Committee was enhancing the Board's asset management experience.

We welcomed Guido Fürer to the Board in July, and he also joined our Audit and Risk Committees. Guido brings a wealth of

knowledge and expertise in respect of asset-liability management, insurance and asset management. He has completed his

comprehensive induction programme.

In October, Amy Yip retired from the Board at the end of her six-year term.

During Shriti Vadera's time as Chair, the Board has changed significantly in order to reflect the transformation of Prudential from a

global financial holding company to an operating company focused on the long-term opportunities of Asia and Africa. Our Board

succession plan has focused on the skills and experience required to reflect that transition and the continued delivery of our

strategy. The mix of skills and experience now represented on our Board includes the deep operating experience in our key

markets in Asia, and the balance of sectoral experience across insurance, asset management, and health. The Committee, under

Sir Douglas's leadership, will continue to focus on ensuring that the Board has the skills and experience appropriate for the

Group's long-term strategic goals. While all Directors have a strong digital understanding, the Committee will look to deepen the

Board's expertise in respect of technology and AI.

The Committee also performed its usual role in overseeing the Board performance review, assessing Board members for election

by shareholders and overseeing governance arrangements of the Group. The performance review concluded that good progress

had been made addressing last year's recommendations and that the Board and its committees continued to operate effectively,

whilst identifying areas for further enhancement

---

| |
|:---|
| Key Committee activities in <br>2025 |
| **March** |
| –Non-executive Director succession planning and <br>Committee membership review;<br>–Year-end consideration of matters relating to <br>Board composition and directors' performance, <br>underpinning the Committee's recommendation <br>for the re-election of Directors at the 2025 AGM;<br>–Governance Report for the 2024 Annual Report; <br>–Board and Committee performance review – <br>discussion of output; and <br>–Corporate Governance developments.<br>|
| **November** |
| –Chair succession planning. |
| **December** |
| –Chair succession planning;<br>–Board evaluation – approach; <br>–Director induction; and<br>–Corporate Governance developments.<br>|

---

**2026 priorities**

–Continue Board succession planning, with particular focus on expertise in technology and AI;

–Continued focus on increasing diversity in Board composition; and

–Supporting a smooth transition of the Chair.

**Appointment of Chair Designate of Prudential Plc**

–Following a previous search for a Deputy Chair based in Hong Kong (which did not lead to an appointment), the search for

potential candidates for the Chair role commenced after the 2025 AGM.

–Spencer Stuart were engaged to support the search in Asia and the UK.

–Following evaluation of a long-list of candidates, the SID and Chair held initial discussions with a number of potential candidates.

–A selection of candidates was interviewed, first by members of the Nomination & Governance Committee, the CEO and the Chair

of the Audit Committee, and then by the remaining members of the Board.

–In addition to initial conversations conducted virtually, the CEO met with the short-listed candidates in person.

–The Nomination & Governance Committee and the CEO discussed feedback from the interviews and agreed a final short-list.

–The short-listed candidates met with the Board and presented their thoughts on the Group and its strategic opportunities and

challenges, and answered questions.

–A thorough reference process was conducted to support the process.

–The Group's regulator was engaged before a final decision was reached by the Board.

**Ensuring an effective succession process**

–The appointment process was led by the SID.

–The SID chaired discussions in meetings of the Nomination & Governance Committee and the Board, and the Chair recused

herself including from any decision-making.

–Between formal meetings, the SID kept Directors informed of progress with regular updates and discussions at each stage of the

search process.

–He engaged the Group's regulator during the latter stages, and after the announcement offered to meet with top investors to

answer questions they had on the process.

**Sir Douglas is ideally positioned to lead the next stage of Prudential's development**

–Sir Douglas has extensive experience leading global financial institutions and brings deep experience across the geographic

regions in which we operate, together with his decades of leadership experience in banking, insurance and asset management.

–He has a wealth of established relationships in Asia and the UK and his deep knowledge of Asia and understanding of global

finance is particularly important for Prudential and represented the best match to the role specification.

–He also has extensive experience in international trade and investments and in innovation and development in capital markets,

which are important areas for Prudential as we enter the next phase of our growth.

–Sir Douglas is an experienced Chair with a long track record of leading boards, shaping strategy and forging effective

relationships with CEOs.

**Supporting a smooth transition**

–Sir Douglas will receive a tailored induction programme in line with our usual approach to Non-executive Director induction,

incorporating visits to key markets.

–As part of his induction, as well as meeting with Management at Group and Local Business Unit level, Sir Douglas will meet with

various of the Group's advisers to get their external perspectives on the Group and will hold introductory meetings with the

Company's top investors.

–As Chair-Designate, Sir Douglas will attend Board and Committee meetings in March and May and join the Board's visit to

Beijing in April. The Chair will work closely with him during this period in order to hand over the role and key stakeholder

relationships.

**Board composition, skills and succession** 

The Committee continually reviews the leadership needs of the Group, including both Executive and Non-executive Directors.

Board succession plans are supported and informed by the results of the annual Board performance review, individual Director

evaluations and any skills gaps identified. Ongoing succession planning helps the Board maintain a balance in the mix of skills and

experience of its members.

The Committee reviews the size, structure and composition of the Board and its principal committees and considers the balance of

Non-executive to Executive Directors on the Board, the overall number of Directors and their respective skills and experience. The

Chair also considers the needs of the Board and its committees as part of the annual Board performance review and the

Committee discusses desired skills as part of succession planning throughout the year.

Non-executive Directors bring a range of industry experience, sector expertise and personal strengths to the Board. To support its

assessment of skills and succession planning, the Committee maintains a skills matrix that helps map the Board's existing skills

and identify any gaps relevant to the Group's strategic goals. The regular and ongoing review of potential new directors by the

Committee allows for a controlled approach to the succession of new Non-executive Directors, and for a transition period in

respect of Directors reaching the end of their tenure.

While the Committee does not consider there to be any immediate skills gaps on the Board to address, a key area of focus for the

Committee is ensuring that the Board has the skills and experience to continue to oversee the Group's technology and AI strategy

over the longer-term.

During 2025, the Committee also reviewed the membership of the Board's principal Committees and concluded that membership

was appropriate.

**Executive roles** 

Given the importance of executive succession planning to the successful delivery of the Group's strategy, the full Board discussed

succession planning for the CEO and the other GEC roles. The approach to and methodology for CEO and GEC development and

succession planning was refreshed by the CEO and CHRO in 2024 and is discussed with the Board on an annual basis. In 2025, the

Board discussed the development and succession plans for individual GEC members, including the CEO, and succession and the

actions being taken to renew and strengthen the succession pipeline.

**Process for appointing new Directors** 

The Committee assists the Board to put in place a formal, rigorous and transparent approach to the appointment of new Directors.

The process begins with the identification of a vacancy or desired skills. A candidate profile is prepared, reflecting the desired skills

and experience, as well as the Board's diversity objectives, and specialist search consultants are engaged on behalf of the

Committee. The Committee selects candidates for the shortlist and interviews the chosen candidates, assessing them against the

required skills and fit with the Company's culture. Other Board members also participate in the interview process depending on the

particular appointment. The SID leads the Committee in the process of appointing a new Chair and the Chair leads the process for

the appointment of a new CEO, involving all Non-executive Directors in the process.

Due diligence checks run alongside, which commence at an early stage to ensure there are no undue delays to the search and

appointment process, and Prudential liaises with the relevant regulatory authorities. The Committee is kept up to date as needed.

During the year, the Committee engaged Spencer Stuart and Egon Zehnder to support searches for Non-executive Directors. Both

firms are also engaged by the Group for management recruitment. There are no other connections to Prudential or to any of the

Directors.

**Directors' induction, training and development** 

Working with the Chair, the Committee oversees the process by which each new non-executive appointee is provided with a

tailored induction programme. The induction programme for new Non-executive Directors covers a series of core topics, including

an overview of the Group, its key businesses and the control environment, as well as content tailored to reflect the new Board

member's role, their prior industry experience and any particular needs identified during the recruitment process. For those who

have not previously held a non-executive role, the programme also includes sessions to help the new Director transition

successfully from an executive career to a non-executive role. New Board members are also typically assigned a longer-tenured

Non-executive Director to support them in their new role and provide advice and feedback. New Directors usually join the Audit or

Risk Committee to develop their knowledge of the business. During 2025, the Committee oversaw the induction for Guido Fürer.

All Directors have the opportunity to discuss their individual development needs as part of their Director evaluations and are

encouraged to ask for specific updates during the year. At the end of the year, suggested topics are shared with the Board for

feedback. Directors are asked to provide information on any external training or development on a yearly basis. All Directors have

the right to obtain professional advice at Prudential's expense.

**Board, Committee and Director performance reviews** 

The Committee oversees the performance review of the Board, its committees and individual Directors, and considered the

approach to the internal reviews carried out in respect of performance during 2025. No material issues were identified in respect

of the operation of the Board or the principal Committees, which were included in the Board evaluation. The findings were

presented to the Board and the Committee in March 2025 and are described above.

Following evaluation, the Committee decided that each of the Directors continued to perform effectively and was able to devote

appropriate time to their responsibilities, and that the Board and its Committees had an appropriate combination of skills, experience

and knowledge.

In support of this decision, the Committee found that the Non-executive Directors continued to demonstrate the desired attributes and

contribute effectively to decision-making, and that they exercised sound judgement in holding Management to account. As a result, the

Committee recommended these Directors for re-election at the 2026 AGM (excluding the Chair, who will not stand for re-election).

**Induction of Guido Fürer**

Guido joined the Board on 1 July as an independent Non-executive Director and member of the Audit and Risk Committees. He

received an extensive induction programme, overseen by the Company Secretary and the Chair, which was tailored to his role and

background, and provided him with an understanding of the Group's business, strategy, performance, operations and culture, as

well as the interests of the Group's key stakeholders.

Guido participated in Board deep-dive sessions and had one-to-one meetings with GEC members in order to gain a deeper

understanding of the Group's business, the growth opportunities in key markets, the particular challenges faced, and the

strategies being pursued. He visited the Indonesia businesses as part of the Board's meetings in Indonesia in July, and Singapore

(together with Jeremy Anderson) for meetings with local management teams and top talent. He also participated in the Board

meeting in May 2025 as an observer.

Guido met with the CFO in order to better understand the drivers of the Group's key financial metrics as well as the Group's capital

management framework. He also met with the Group's brokers for an external perspective on the shareholder base and key issues

for investors.

Given his background in investment and asset-liability management, Guido spent time with the Eastspring management team as well as

with the Group Chief Investment Officer.

As a member of the Risk Committee, Guido met with the CRCO who provided an overview of the Group's risk profile, risk

management and internal control framework and key risks. He had more detailed sessions with senior members of the Risk team

covering areas such as risk appetite limits and triggers, capital regimes, conduct, and prevention of financial crime.

As a member of the Audit Committee, Guido met with the Chief of Financial & Capital Reporting to learn about the Group's

financial reporting, including key assumptions and areas of judgment, and also with the Group's external auditor. In addition, he

met with the Chief of Internal Audit to get further insights on the Group's system of internal controls, and with the Group Director,

Global Investigations who provided a briefing on the Group's speak out programme.

Guido received briefings on his duties as a Director under relevant UK and Hong Kong corporate governance frameworks and the

Group's regulatory environment. As part of this, Guido received training on 26 June 2025 on his obligations as a director of a Hong

Kong listed company as required by Rule 3.09D of the Hong Kong Listing Rules and confirmed his understanding of those

obligations.

The majority of the induction programme was undertaken prior to Guido joining the Board, and he participated in the Board

meeting in May as an observer. The rest of the induction was completed within three months of his appointment. Following the

conclusion of his formal induction programme, Guido provided the Company Secretary with feedback and the progress of the

induction was reported to the Committee.

**Board Diversity Policy** 

To ensure the Board benefits from a broad mix of skills and expertise, the Committee looks for candidates whose backgrounds,

experience and skills enhance the Board's overall effectiveness, especially in the markets where we operate. When initiating a

search, the Committee briefs search consultants on the Board's requirements, and candidates are assessed against a range of

criteria including sector expertise, operational and commercial experience, knowledge of our key markets, diversity (including

diversity of thought), inclusion and equal opportunities.

The UK Listing Rules require boards to meet and report on diversity and gender targets. The Board's target for female

representation on the Board is 40 per cent. Whilst we exceeded this target with 45 per cent at the end of 2024, following the

appointment of Guido Fürer in July 2025 and the retirement of Amy Yip in October 2025, the overall representation of women on

our Board fell to 36 per cent as at 31 December 2025. The Board continues to prioritise diversity and inclusion in Board succession

planning and is committed to restoring compliance with the target of 40 per cent set out in the UK Listing Rules. However, given

the specific markets in which the Group operates, the pool of female candidates with the requisite experience and expertise is

more limited and the Board expects that it will take some time to be able to restore gender diversity to the target level.

The Board also has a target (as required by the UK Listing Rules) that at least one of its senior board positions of Chair, CEO or

Senior Independent Director should be held by a woman. As of 31 December 2025, the role of Chair was held by a woman and, in

addition, three of our five principal committees were chaired by a woman.

The UK Listing Rules require that we appoint at least one Director from what is regarded in the UK as an ethnic minority

background. Whilst we comply with this target, we do not consider this to be the most pertinent measure for an Asia-based group.

We aim to reflect the diversity of our markets in our Board composition and we have comfortably exceeded this recommendation,

with 6 of our 11 Directors meeting the ethnicity criteria as at 31 December 2025 (55 per cent).

The Group's Diversity and Inclusion Policy applies at all levels of the business and the Committee is responsible for overseeing a

diverse pipeline of talent for the Board and other senior roles, driving a Group-wide culture where our people feel valued, are

treated fairly and are respected. In recent years, the Board as a whole has reviewed executive succession planning.

The Board considers that the pipeline for diverse talent to serve on the GEC is reasonable, but with continued effort needed. We

met our target of employing 35 per cent women in Group Leadership Team roles by the end of 2023. As at 31 December 2025, the

representation of women was 38 per cent, compared to 37 per cent in 2024. Our target is to increase the representation of women

on our Group Leadership Team to 42 per cent by the end of 2027. Our Group Leadership Team comprises the direct reports of all

GEC members, all CEOs of our life businesses and their direct reports, all CEOs of our Eastspring businesses, and select roles that

are essential in delivering our strategy.

During 2025, we continued to shape an inclusive workplace where every individual can thrive and reach their full potential. The

Sustainability Committee discussed key focus areas, which are to increase the representation and visibility of women within

leadership pipelines; to create equal opportunities for growth and advancement for all employees; to foster everyday experiences

of inclusion, belonging and wellbeing; and to empower employee networks (PruCommunities) to amplify diverse voices and

perspectives across Prudential. A number of potential initiatives to address these priorities and metrics were discussed for

implementation in 2026, among them strengthening gender diversity in leadership positions.

**Terms of appointment** 

Non-executive Directors are appointed for an initial term of three years and, subject to review by the Committee and re-election

by shareholders, it is expected that Non-executive Directors serve a second term of three years. After six years, Non-executive

Directors may be appointed for a further year, up to a maximum of three additional years, or more in certain limited

circumstances. Reappointment is subject to rigorous review as well as re-election by shareholders.

In line with the UK Code, the notice of the AGM includes details on the skills and experience of each Director seeking re-election

and specific reasons why their contribution is, and continues to be, important to the Company's long-term sustainable success.

The Directors' remuneration report sets out the terms of Non-executive Directors' letters of appointment and the terms applicable

to the Executive Director's contract.

**Independence** 

All Directors have a statutory duty to exercise independent judgement. For Non-executive Directors, the application of

independent judgement is critical to their role in providing constructive challenge and holding management to account, while

providing strategic guidance and offering specialist advice. The independence of Non-executive Directors is assessed as part of the

appointment process and is reviewed annually. To support the assessment, each Non-executive Director (except the Chair)

provides an annual independence confirmation. Members of the Audit Committee are also assessed against the independence

criteria outlined in the Sarbanes-Oxley Act.

When considering the independence of the Non-executive Directors, the Committee and the Board took into account that both

Jeremy Anderson and Jeanette Wong serve as non-executive directors of UBS Group AG. The Committee and the Board have

determined that this relationship does not affect the independence of those Non-executive Directors. Based on their contributions

to Board discussions to date, the Board is confident that they can be expected to continue to demonstrate objectivity and

independence of judgement.

The Committee also took into account that Sir Douglas and Anil Wadhwani are both members of the Monetary Authority of

Singapore Advisory Council and that Sir Douglas and Shriti Vadera both serve as directors on the Institute of International

Finance. The Committee and the Board have determined that these relationships do not affect the independence of Sir Douglas

which was assessed on his appointment as Chair Designate.

There are no other cross-directorships of material companies which would affect independence.

**Time commitment** 

Non-executive Directors are expected to devote sufficient time to carry out their duties. The expected time commitment for Non-

executive Directors is agreed and set out in writing in their letters of appointment. The appointment process also evaluates the

individual's external time commitments and their impact on each Director's suitability for the role. The assessment takes into

account the time required to prepare for and attend Board and committee meetings, the AGM, general projects, Board training,

dinners and other activities. Any future external appointments that could impact a Director's ability to meet their expected time

commitment must first be discussed with the Chair, or, in the case of the Chair, with the SID.

Should the Executive Director wish to take on any external appointments, this would also be subject to Board consent. In line with

UK Code recommendations, the Executive Director is not permitted to hold more than one non-executive directorship with a FTSE

100 company or other significant appointment.

The time commitment required of the Non-executive Directors is kept under periodic review by the Committee to align with any

changes to the meeting cycle of the Board and the principal committees.

The Committee was satisfied that all Non-executive Directors had committed sufficient time to meet their responsibilities and

contribute effectively.

The current time expectations for Board and Committee members are given below. The time expectations for Directors performing

Chair roles are considerably more.

**Number of regular scheduled meetings** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Approximate time commitment** | **Approximate time commitment** | **Approximate time commitment** | **Approximate time commitment** | **Approximate time commitment** |
| Board | Board | Board | Board |  |
| 7 meetings  | 7 meetings  | 7 meetings  | 7 meetings  | **30 days** |
| Audit Committee | Audit Committee | Audit Committee | Audit Committee |  |
| 5 meetings | 5 meetings |  | **15 days** | **15 days** |
| Risk Committee  | Risk Committee  | Risk Committee  | Risk Committee  |  |
| 5 meetings | 5 meetings |  | **8.5 days** | **8.5 days** |
| Remuneration Committee | Remuneration Committee | Remuneration Committee | Remuneration Committee | Remuneration Committee |
| 4 meetings |  | **6 days** | **6 days** | **6 days** |
| Sustainability Committee | Sustainability Committee | Sustainability Committee | Sustainability Committee | Sustainability Committee |
| 3 meetings | **5.5 days** | **5.5 days** | **5.5 days** | **5.5 days** |
| Nomination & Governance Committee | Nomination & Governance Committee | Nomination & Governance Committee | Nomination & Governance Committee | Nomination & Governance Committee |
| 3 meetings | **5 days** | **5 days** | **5 days** | **5 days** |

---

The Board typically holds five meetings in person and two shorter meetings virtually, plus two additional short virtual meetings to

consider full-year/half-year results.

In addition to five full-length meetings, the Audit Committee holds a number of shorter virtual meetings to discuss corporate

reporting and meets jointly with the Risk Committee, usually twice annually, and with the Sustainability Committee, at least once

annually.

In addition to five full-length meetings, the Risk Committee meets jointly with the Audit Committee, usually twice annually.

In addition to four full-length meetings, the Remuneration Committee holds an additional virtual meeting to consider year-end

matters.

The Sustainability Committee typically holds three full-length meetings and two shorter virtual meetings, jointly with the Audit

Committee, to consider the Sustainability Report and reporting processes.

The Nomination & Governance Committee typically holds three meetings but will meet as required in order to consider ongoing

appointment processes.

**Conflicts of interest** 

Directors have a statutory duty to avoid conflicts of interest, and Prudential has procedures in place to identify and mitigate

conflicts of interest. These processes help to ensure decisions are made in the best interests of the Company. The Board has

delegated authority to the Committee to identify and authorise any actual or potential conflicts of interest, referring any especially

material conflicts to the Board.

When recommending a candidate for appointment or re-election, the Committee considers the external appointments of the

individual and, where appropriate, recommends authorisation of any conflicts to the Board, attaching conditions to the

authorisation where necessary. Should a Director wish to take on a new external position during the year, the Chair (or the SID in

the case of the Chair) will evaluate the proposed appointment and will refer it to the Committee (or the Board) for authorisation if

a conflict or potential conflict is identified.

The Board considers that the procedures for dealing with conflicts of interest operate effectively.

**Governance** 

The Committee is updated on corporate governance developments, which in 2025 included updates on corporate reporting and

changes to the Hong Kong Corporate Governance Code and Listing Rules. The Committee also keeps under review significant

aspects of the Group's governance framework and governance policies, including those of the Group's Material Subsidiaries, and

makes recommendations to the Board when needed.

The Audit and Risk committees oversee the effectiveness of subsidiary audit and risk governance arrangements and regularly

consider the effectiveness of the audit and risk committees of the Material Subsidiaries, including the composition of those bodies

and the effectiveness of individual members.

**Sustainability Committee report**

**Committee's purpose**

The Committee is responsible for providing leadership, direction and oversight of the Group's sustainability strategy including

environmental matters, responsible investment, social sustainability and people. The Committee also leads on workforce

engagement.

*More information on the role and responsibilities of the Sustainability Committee can be found in its terms of reference, which are* 

*available at www.prudentialplc.com/en/investors/governance-and-policies/board-and-committees-governance*

**Committee performance** 

The operation of the Committee was reviewed as part of the annual Board performance review. No material issues were identified.

The Committee discussed the output of the evaluation and agreed areas of focus. These are included in the consolidated outcomes

of the 2025 Board performance review above.

**Membership and 2025 meeting attendance**

---

| | | |
|:---|:---|:---|
| **Committee members** | **Member since** | **2025 meetings**<sup>1</sup> |
| George Sartorel, Chair  | September 2024  | 6/6 |
| Arijit Basu  | September 2024  | 6/6 |
| Claudia Suessmuth <br>Dyckerhoff <br>| September 2024  | 6/6 |
| Jeanette Wong  | September 2024  | 6/6 |

---

(1)The Committee held three scheduled meetings. In addition, the Committee held two joint meetings with the Audit Committee and one joint meeting with the

Remuneration Committee.

**Regular attendees**

---

| | |
|:---|:---|
| –Chair of the Board<br>–Chief Executive Officer <br>–Chief Financial Officer <br>–Chief Human Resources Officer <br>| –Chief Sustainability Officer<br>–Company Secretary <br>|

---

Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing

simple and accessible financial and health solutions. Our strategy is to deliver high-quality growth and strong shareholder value.

Sustainability is a key component of this strategy: it enhances our ability to foster long-term business resilience, better support

and empower our diverse customers and employees, address emerging risks, and capitalise on new growth opportunities in a

constantly changing environment.

Our sustainability strategy is focused on three key pillars of: developing simple and accessible health and financial protection;

financing a just and inclusive transition; and running a sustainable and responsible business. Through our strategy, we are

fostering financial literacy and inclusion in our markets and a culture of innovation and high performance.

The Committee provides leadership and direction on the Group's sustainability strategy and its implementation, monitoring

progress against the Group's sustainability-related goals, reviewing sustainability reporting, and overseeing the organisational

culture, employee wellbeing and engagement, as well as the Group's community investment programmes.

External complexity and uncertainties in the environmental, social and governance landscape continued in 2025, characterised by

global headwinds, conflicting regional dynamics and geopolitical instability. To help us stay abreast of significant trends and

developments, we held two workshops at the beginning of the year. In the first, we heard external views on the global trends

shaping sustainability. In the second, we considered how those trends and emerging risks impact on Prudential's sustainability

strategy and reporting and we agreed the Committee's areas of focus for the year.

In addition to monitoring the embedding of our sustainability strategy across the Group, the key themes of our work in 2025 were

the implementation and expansion of our Financing the Transition (FTT) framework, inclusive insurance, and our people and

culture.

Following the introduction of our FTT framework in 2024, the Committee continued to assess progress against the Group's target

to commit $6bn of FTT portfolio investments by 2030, as well as progress in decarbonising the portfolio. We discussed and

approved the expansion of our FTT framework to make climate adaptation and nature-related opportunities investible alongside

climate mitigation. We also considered, with the Remuneration Committee, how best to embed the FTT target, and other

sustainability metrics, into our Executive remuneration architecture.

2025 was also the year when we discussed and shaped our updated Climate Transition Plan to keep pace with evolving market

practices and emerging regulatory expectations. Our Plan now includes our FTT framework, enhanced stewardship priorities, and

nature-related considerations. We have also introduced a comprehensive Environmental Framework, setting out our

decarbonisation targets to 2030 alongside a holistic climate strategy, including the development of inclusive insurance products.

Following on from the publication of our Inclusive Insurance Framework in 2024, the Committee monitored progress on the

development of innovative prospective products and services that could enable us to distribute more affordable and accessible

insurance products for underserved customers, potentially unlocking new business opportunities. This included considering the

lessons learnt from case studies being run in a couple of our markets to test the viability of propositions.

Another important part of our work focused on our people: we reviewed employee engagement activities along with workforce

policies and practices, and monitored the embedding of our organisational values. We considered the output of our annual

employee survey which monitors our culture and values, tracking changes over time and enabling the Group to focus on areas

requiring attention.

We worked closely with other committees, holding two joint meetings with the Audit Committee on non-financial reporting controls

and working with the Remuneration Committee on the inclusion of Sustainability measures in long-term performance-related

awards.

Additional details on our activities are provided below.

---

| | |
|:---|:---|
| Key committee activities in 2025 | Key committee activities in 2025 |
| **January**<br>–Externally-facilitated workshop covering the global <br>sustainability and climate change landscape, key <br>trends and challenges, examining headwinds, risks <br>and opportunities, investor perspectives, regulatory <br>outlook and reporting trends.<br>**February**<br>–Internal workshop considering potential impact of <br>the above on the key pillars of Prudential's <br>sustainability strategy. The Committee also <br>considered regulatory developments, including <br>evolving sustainability reporting requirements, and <br>agreed its 2025 priorities; <br>–Review of FY24 Sustainability Report;<br>–Annual review of Group Code of Conduct, <br>recommended to the Board for approval;<br>–Update on sustainability-related geopolitical <br>landscape;<br>–Update on FTT investments;<br>–Review of people-related matters, including diversity <br>and employee survey results, considering themes <br>from the employee survey and management's <br>response to them, including deep dives into <br>'hotspots'; and<br>–Update on on regulatory developments, including the <br>adoption of ISSB standards across the Group's <br>markets. <br>**March** <br>Jointly with the Audit Committee<br>–Oversight of non-financial reporting and approval of <br>FY24 Sustainability Report.<br>**April**<br>–Review and approval of 2025 Modern Slavery <br>Statement.<br>| **June**<br>–Update on sustainability-related geopolitical <br>landscape;<br>–Considered approach to Climate Transition Plan; <br>–Considered potential changes to sustainability <br>measures included in long-term incentive plans;<br>–Considered the transition to ISSB-aligned reporting <br>in the FY25 Sustainability Report;<br>–Review of workforce policies and practices, including <br>to ensure alignment with the Group's purpose, <br>values and strategy; and<br>–Update on Prudence Foundation.<br>**October**<br>–Approach to FY25 Sustainability Report, including <br>alignment between TCFD and ISSB standards to <br>meet reporting requirements for both Hong Kong <br>and the UK;<br>–Considered position paper on nature and climate <br>adaptation, to supplement our FTT framework;<br>–Inclusive insurance update; and<br>–Diversity, inclusion, equity and belonging strategy.<br>Jointly with the Remuneration Committee<br>–Agreed changes to sustainability measures for long-<br>term incentive plans (ahead of shareholder <br>consultation).<br>**December**<br>–Publication of FTT addendum white paper to <br>define nature and climate adaptation investment <br>opportunities.<br>Jointly with the Audit Committee<br>–Non-financial reporting controls for FY 2025 <br>disclosures; and<br>–Update on sustainability reporting standards across <br>our markets, including compliance with ISSB.<br>|

---

**Regular reporting**

In addition, the Committee receives regular updates from the Chief Sustainability Officer on progress against the implementation

of the sustainability strategy and KPIs. It receives regular updates from the Chief HR Officer on people-related initiatives and on a

dashboard of people-related metrics, covering trends in wellbeing, gender diversity and attrition. Committee (and Board) members

participate in employee engagement activities and the Committee regularly reflects on the feedback obtained from such

engagements.

**2026 priorities** 

–Oversee progress towards our inclusive insurance ambitions;

–Deepen our oversight of talent development and succession planning across the Group (including to ensure a diverse talent

pipeline); and

–Continue to support the Board on monitoring culture across the organisation.

**Remuneration Committee**

The report on the Remuneration Committee's activities can be found in the 'Compensation and employees' section below.

Audit committee financial expert

The Board has determined that Jeanette Wong, Chair of the Audit Committee, qualifies as an audit committee financial expert

within the meaning of Item 16A of Form 20-F, and that Jeanette Wong is independent within the meaning of Rule 10A-3 under the

Exchange Act.

Governance - Differences between Prudential's governance

practice and the NYSE corporate governance rules

The New York Stock Exchange ('NYSE') corporate governance rules for foreign companies recognise foreign companies must

comply with domestic governance requirements. As a foreign private issuer, Prudential must comply with the following NYSE rules:

1. The Company must satisfy the audit committee requirements of the SEC;

2. The Chief Executive Officer must promptly notify the NYSE in writing after any executive officer of the Company becomes

aware of any non-compliance with any applicable provisions of Section 303(A) of the NYSE's Listed Company Manual;

3. The Company must submit an executed written affirmation annually to the NYSE affirming the Company's compliance with

applicable NYSE Corporate Governance Standards and submit an interim written affirmation notifying it of specified changes to

its audit committee or a change to the Company's status as a foreign private issuer; and

4. The Company must provide a brief description of any significant difference between its corporate governance practices and

those followed by US companies under the NYSE listing standards.

As a company listed on the London Stock Exchange, Prudential is required to comply with the UK Listing Rules, the Disclosure

Guidance and Transparency Rules and the Admission to Trading on a Regulated Market regime issued by the FCA. Prudential is

also required, pursuant to the UK Listing Rules, to report on its compliance with the UK Corporate Governance Code (the 'UK

Code') which is issued by the Financial Reporting Council. Throughout 2025, the UK Code applicable to Prudential consisted of a

number of principles, and a series of more detailed provisions. The UK Listing Rules stipulate that Prudential must set out to

shareholders how it has applied the principles of the UK Code and a statement as to whether it has complied with all relevant

provisions. Where it has not complied with all relevant provisions, it must set out reasons for such deviation (the 'comply or

explain' regime).

As a result of its listing on the Hong Kong Stock Exchange, Prudential is also required to comply with the continuing obligations set

out in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the 'HK Listing Rules') and is

expected to comply with or explain any deviation from the provisions of the Corporate Governance Code contained in Appendix C1

to the HK Listing Rules (the 'HK Code').

The material differences between Prudential's corporate governance practices and the NYSE rules on corporate governance ('NYSE

Rules') are set out below. Unless specifically indicated otherwise, references to compliance with the UK Code below also include

compliance with the HK Code.

**Independence of directors**

The NYSE Rules require that the majority of the board be independent and sets out specific tests for determining director

independence. The UK Code requires that at least half of the board, excluding the chair, should be non-executive directors whom

the board considers to be independent. Where there are circumstances which are likely to impair, or could appear to impair, a

non-executive director's independence, and the board nonetheless considers that the non-executive director is independent, a

clear explanation is provided in the annual report. The UK Code also requires that the board should include an appropriate

combination of executive and non-executive (and, in particular, independent non-executive) directors, such that no individual or

small group of individuals can dominate the board's decision making.

Every non-executive director must satisfy the Hong Kong Stock Exchange that they have the character, integrity, independence

and experience to effectively fulfil their role. The HK Listing Rules set out a number of factors which may impact independence.

Each independent Non-executive Director is asked, on an annual basis, to confirm whether any of the factors are relevant to their

personal circumstances (without treating any such factor as necessarily conclusive).

The independence of Directors is outlined in the 'Board of Directors' section above.

**Separation of duties**

The NYSE Rules do not specify a requirement for the roles of Chief Executive Officer and Chair to be separate.

The UK Code requires that these roles be fulfilled by different individuals. As at 25 March 2026, the roles of the Chief Executive

Officer and Chair of the Board are fulfilled by Anil Wadhwani and Shriti Vadera, respectively.

**Committees of the board**

The Prudential Board has established a number of Board Committees which are similar in both composition and purpose to those

required under the NYSE Rules. The membership of these committees is entirely made up of non-executive directors whom the

Board has deemed to be independent, with the exception of the Chair who was independent on appointment. The Chair is no

longer assessed as independent in accordance with the UK Code. The Chair of the Nomination & Governance Committee is the

Chair of the Board, as permissible under the UK and HK Codes. The Chair is a member of the Remuneration Committee but not a

member of the Risk or Audit Committees.

In accordance with Rule 10A-3 of the Exchange Act, Prudential is required to have an Audit Committee which complies with the

requirements of that rule. The Audit Committee of Prudential complies with these requirements except that it is responsible for

considering the appointment, re-appointment or removal of the auditor and to make recommendations to the Board, and for

shareholders to vote on at the annual general meeting. Shareholders are asked at the annual general meeting to authorise the

Audit Committee to set the remuneration of the auditor. Prudential's Audit Committee reviews the Company's internal financial

controls and, unless expressly addressed by the Board itself, reviews the Company's internal control and risk management

systems in relation to financial reporting. The Risk Committee has responsibility for the oversight of risk management across the

Group.

The role of the compensation committee under NYSE rules is fulfilled at Prudential by the Remuneration Committee, which consists

of independent Non-executive Directors and the Chair of the Board. As permitted by the UK Code, the Chair of the Board can be a

member of the Remuneration Committee if they were independent on appointment, but cannot chair the Committee.

Prudential has established a Nomination & Governance Committee whose membership consists of independent Non-executive

Directors and the Chair of the Board. The Committee is not responsible for developing and recommending a set of corporate

governance guidelines to apply to the Company as would be applicable for a US domestic company.

**Non-executive Director meetings**

To empower non-management directors to serve as a more effective check on management, the NYSE Rules require that the non-

management directors of each listed company must meet at regularly scheduled executive sessions without management.

Prudential complies with the equivalent provisions set out in the UK Code.

**Code of ethics**

Under the NYSE Rules, NYSE listed companies must adopt and disclose a code of business conduct and ethics for directors, officers

and employees, and promptly disclose any waiver of the code for directors or executive officers.

Prudential's Code of Conduct is available on Prudential's website. As required by the NYSE Rules, Prudential has extended the

applicability of its Code of Conduct to all employees and agents.

**Approval of equity compensation plans**

The NYSE Rules for US companies require that shareholders must be given the opportunity to vote on all equity-compensation

plans and material revisions thereto, except for employment inducement awards, certain grants, plans and amendments in the

context of mergers and acquisitions, and certain specific types of plans. Prudential complies with corresponding domestic

requirements in the UK Listing Rules issued by the FCA where appropriate, which mandate that the Company must seek

shareholder approval for certain employee share plans, however, the Board does not explicitly take account of the NYSE definition

of 'material revisions'. The HK Listing Rules also provide that shareholder approval is required when making certain amendments

to equity compensation plans.

Memorandum and Articles of Association

Prudential plc is incorporated and registered in England and Wales, under registered number 1397169. Its objects are unrestricted,

in line with the default position under the Companies Act 2006.

The following is a summary of the rights of Prudential shareholders including certain provisions of Prudential's Articles of

Association (the Articles). The rights of Prudential shareholders are set out in the Articles or are provided for by English Law. This

document is a summary and, therefore, does not contain full details of the Articles. A complete copy of the Articles was filed as an

exhibit to Form 20-F on 26 March 2024. In addition, the Articles may be viewed on Prudential's website.

**Rights and obligations** 

The issued share capital of Prudential is not currently divided into different classes of shares.

The rights and obligations attaching to the Company's shares are set out in full in the Articles. There are currently no voting

restrictions on Ordinary Shares, all of which are fully paid, and each share carries one vote on a poll. If votes are cast on a show

of hands, each shareholder present in person or by proxy, or in the case of a corporation, by its duly authorised corporate

representatives, has one vote. The same individual may be appointed as proxy or as a corporate representative by more than one

member.

Holders of Ordinary Shares have the right to participate in distributions of profits, by way of dividend and have the right to

participate in the surplus assets of the Company available for distribution in the event of a winding up or liquidation, voluntary or

otherwise in proportion to the amounts paid up or credited as paid up on such Ordinary Shares.

Where, under an employee share scheme, participants are the beneficial owners of the shares but not the registered owners, the

voting rights are normally exercisable by the trustee on behalf of the beneficial owner in accordance with the relevant plan rules.

The trustees would not usually vote any unallocated shares held in trust but they may do so at their discretion provided it would

be considered to be in the best interests of the beneficiaries of the trust and permitted under the relevant trust deed.

As at 23 March 2026, Trustees held 0.62 per cent of the issued share capital under the various plans in operation.

Rights to dividends under the various plans are set out in the 'Compensation and Employees' section of this report.

**Transfer of shares**

In accordance with English company law, shares may be transferred by an instrument of transfer or through an electronic system

(currently CREST) and no transfer is restricted except that the Directors may, in certain circumstances, refuse to register transfers

of shares. If the Directors make use of that power, they must send the transferee notice of the refusal within two months.

Certain restrictions may be imposed from time to time by applicable laws and regulations (for example, insider trading laws) and

pursuant to the listing rules of both the FCA and the Hong Kong Stock Exchange, as well as under the rules of some of the Group's

employee share plans.

**Changes in share capital and authority to issue shares**

Under English law, directors require authority from shareholders, other than under certain types of employee share schemes,

whenever shares are issued. Newly issued shares must first be offered to existing shareholders pro rata to their holdings (pre-

emption rights) subject to certain exemptions, for example, where shares are issued for non-cash consideration or in respect of

certain types of employee share schemes.

Prudential seeks authority from its shareholders on an annual basis to issue shares up to a maximum amount of which a defined

number may be issued without pre-emption rights being applied. Dis-application of statutory pre-emption procedures is also

available for rights issues. The existing authorities to issue shares and dis-apply pre-emption rights, granted at the 2025 annual

general meeting, are due to expire at the end of the 2026 annual general meeting of the Company when shareholder approval will

be sought to renew those authorities.

Shares may not be consolidated or sub-divided without approval by an ordinary resolution of the shareholders.

Reductions in Prudential's issued share capital and share premium account must be approved by a special resolution of the

shareholders and must be confirmed by an order of the court.

Subject to the Articles, if the share capital is divided into different classes of shares, the rights of any class of shares may be

changed or deemed varied, only if such measure is approved by a special resolution passed at a separate meeting of the members

of that class, or with the written consent of members holding at least three quarters of the shares of that class. At least two

persons holding or representing by proxy at least one-third in nominal amount of the issued shares of the class must be present at

such a meeting in person or by proxy to constitute a quorum.

The Board may not authorise, create or increase the amount of, any shares of any class or any security convertible into shares of

any class or any security which is convertible into shares of any class ranking, as regards rights to participate in the profits or

assets in the Company, in priority to a series or class of preference shares without the consent in writing of at least three-quarters

in nominal value of, or the sanction of a special resolution of, the holders of such series or class of preference shares.

**Shares authorised but not issued** 

**Preference shares** 

The Directors have authority to allot Sterling preference shares up to a maximum nominal amount of £20 million, Dollar preference

shares up to a maximum nominal amount of $20 million, and Euro preference shares up to a maximum nominal value of

€20 million, the terms of which will be determined by the Board on allotment. This authority, originally granted in 2004 for five

years, was renewed most recently by shareholders at the 2024 annual general meeting and is due to expire at the conclusion of

the 2029 annual general meeting, unless renewed by shareholders. It is anticipated that shareholder approval will be sought to

renew the authority at the 2029 annual general meeting of the Company.

Prior to the date of allotment, the Board shall determine whether the preference shares are to be redeemable and the terms of

any redemption, their dividend rights, their rights to a return of capital or to share in the assets of the Company on a winding up

or liquidation and their rights to attend and vote at general meetings of the Company prior to the date on which the preference

shares are allotted.

The Board may only capitalise any amounts available for distribution in respect of any series or class of preference shares if to do

so would mean that the aggregate of the amounts so capitalised would be less than the multiple, if any, determined by the Board

of the aggregate amount of the dividends payable in the 12-month period following the capitalisation on the series or class of

preference shares and on any other preference shares in issue which rank pari passu in relation to participation in profits. This

restriction may be overturned with either: (i) the written consent of the holders of at least three-quarters in nominal value; or (ii) a

special resolution passed at a general meeting of the holders of the class or series of preference shares.

**Dividends** 

Under English law, Prudential may pay dividends only if distributable profits are available for that purpose. Distributable profits are

accumulated, realised profits not previously distributed or capitalised, less accumulated, realised losses not previously written off

in a reduction or reorganisation of capital. Even if distributable profits are available, Prudential may only pay dividends if the

amount of its net assets is not less than the aggregate of its called-up share capital and undistributable reserves (including, for

example, the share premium account) and the payment of the dividend does not reduce the amount of the net assets to less than

that aggregate. Subject to these restrictions, Prudential's Directors may recommend to ordinary shareholders that a final dividend

be declared and recommend the amount of any such dividend or determine whether to pay a distribution by way of an interim

dividend, and the amount of any such interim dividend, but must take into account Prudential's financial position. Final dividends

become a legal liability of a company upon the later of the date they are declared and the date the shareholder approval expresses

them to be payable. Interim dividends only become a legal liability of a company at the point they are paid.

The Company or its Directors determine the date on which Prudential pays dividends. Prudential pays dividends to the

shareholders on its share registers on the record date in proportion to the number of Ordinary Shares held by each shareholder.

There are no fixed dates on which entitlements to dividends arise. Interest is not payable on dividends or on other amounts

payable in respect of Ordinary Shares.

If a shareholder does not claim a dividend within six years of such dividend becoming due for payment, such shareholder forfeits

their right to receive it. Such unclaimed amounts may be invested or otherwise used for Prudential's benefit.

The Company periodically undertakes share forfeiture programmes. If a shareholder is recorded as untraced for more than six

years, the shares are deemed as forfeited and sold by the Company. The proceeds from the sale of the forfeited shares are held

for a period of two years by the Company, as required under the Articles.

A number of dividend waivers are in place and these relate to Ordinary Shares issued but not allocated under the Group's

employee share plans. These shares are primarily held by the Trustees and will, in due course, be used to satisfy requirements

under the Group's employee share plans.

**Shareholder meetings**

English law provides for shareholders to exercise their power to decide on corporate matters at general meetings. In accordance

with English law, the Company is required to call and hold annual general meetings. General meetings to consider specific matters

may be held at the discretion of Prudential's Directors or must be convened, in accordance with English law, following the written

request of shareholders representing at least five per cent of the voting rights of the issued and paid-up share capital. The quorum

required under the Articles for a general meeting is two shareholders present in person or by proxy and entitled to vote on the

business to be transacted.

Under English law, notice periods for all general meetings must be at least 21 clear days unless certain requirements are met.

Prudential seeks an authority annually at its annual general meeting to hold general meetings (other than annual general

meetings) on 14 clear days' notice.

Save for where a holder has failed to pay any monies payable in respect of their Ordinary Shares following a call by the Company,

holders of partly paid Ordinary Shares may attend, be counted in the quorum at meetings and vote. If more than one joint

shareholder votes, only the vote of the shareholder whose name appears first in the register is counted. A shareholder whose

shareholding is registered in the name of a nominee may only attend and vote at a general meeting if appointed by their nominee

as a proxy or a corporate representative. Any shareholder who is entitled to attend and vote at a general meeting may appoint

one or more proxies to attend and vote at the meeting on their behalf.

**Shareholders resident abroad**

There are no limitations on non-resident or foreign shareholders' rights to own Prudential securities or exercise voting rights where

such rights are given under English company law.

**Board of Directors**

Subject to the Articles and to any directions given by special resolution by shareholders, the business of the Company is managed

by the Board, which may exercise all the powers of the Company. However, the Company's shareholders must approve certain

matters, such as changes to the share capital and the election and re-election of Directors. Directors are appointed subject to the

Articles. The Board may appoint Directors to fill vacancies and appoint additional Directors who hold office until the next annual

general meeting. The Articles require that each Director must have beneficial ownership of a given number of Ordinary Shares.

The number of Ordinary Shares is determined by ordinary resolution at a general meeting and is currently 2,500.

Shareholders may appoint and remove Directors by ordinary resolution at a general meeting of the Company. The UK Corporate

Governance Code contains a provision that all directors should stand for annual re-election. In line with these provisions, all

Directors, except those who are retiring or being elected for the first time, are expected to stand for re-election at the 2026 annual

general meeting.

There is no age restriction applicable to Directors in the Articles.

**Borrowing powers**

The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge any of its assets provided

that the total aggregate amount borrowed (excluding, amongst other things, intra-group borrowings and amounts secured by

policies, guarantees, bonds or contracts issued or given by the Company or its subsidiaries in the course of its business) by the

Company and its subsidiaries does not, exceed the aggregate of the share capital and consolidated reserves and of one-tenth of

the insurance funds of Prudential and each of its subsidiaries as shown in the most recent audited consolidated balance sheet of

the Group prepared in accordance with English law.

**Disclosure of interests**

There are no provisions in the Articles that require persons acquiring, holding or disposing of a certain percentage of Ordinary

Shares to make disclosure of their ownership percentage. Shareholders are required to disclose certain interests in accordance

with Rule 5 of the UK's Disclosure Guidance and Transparency Rules by notifying Prudential of the percentage of the voting rights

they directly or indirectly hold or control if the percentage of the voting rights:

–reaches, exceeds or falls below 3 per cent and/or any subsequent whole percentage figure above 3 per cent as a result of an

acquisition or disposal of Ordinary Shares or financial instruments; or

–reaches, exceeds or falls below any such threshold as a result of any change in the number of voting rights attached to the

Ordinary Shares.

The UK Disclosure Guidance and Transparency Rules set out in detail the circumstances in which an obligation to disclose will

arise, as well as certain exemptions from those obligations.

The City Code on Takeovers and Mergers also imposes strict disclosure requirements with regard to dealings in the securities of an

offeror or offeree company on all parties to a takeover and also on their respective associates during the course of an offer period.

**Directors' interests in contracts**

A Director may hold positions with, or be interested in, other companies (subject to Board authorisation where such position or

interest can reasonably be regarded as giving rise to a conflict of interest) and, subject to applicable legislation, contract with the

Company or any other company in which Prudential has an interest, provided they have declared their interest to the Board.

In accordance with English company law, the Articles allow the Board to authorise any matter which would otherwise involve a

Director breaching their duty under the Companies Act 2006 to avoid conflicts of interest or potential conflicts of interest and the

relevant Director is obliged to conduct themselves in accordance with any terms imposed by the Board in relation to such

authorisation.

A Director may not vote or be counted in the quorum in relation to any resolution of the Board in respect of any contract in which

they have an interest. This prohibition does not, however, apply to any resolution where that interest cannot reasonably be

regarded as likely to give rise to a conflict of interest or where that interest arises only from certain matters specified in the

Articles, including the following:

–certain matters that benefit the Group (such as a guarantee, indemnity or security in respect of money lent or obligations

undertaken by the Director at the request of or for the benefit of the Company or one of its subsidiaries);

–certain matters that are available to all other Directors and/or employees (such as the provision to the Director of an indemnity

where all other Directors are being offered indemnities on substantially the same terms or in respect of any contract for the

benefit of Group employees under which the Director benefits in a similar manner to the employees); and

–certain matters that arise solely from the Director's interest in shares or debentures of the Company (such as where Prudential

or one of its subsidiaries is offering securities in an offer in which the Director is entitled to participate as a holder of securities

or in respect of any contract in which a Director is interested by virtue of their interest in securities in the Company).

The Company may by ordinary resolution suspend or relax these provisions to any extent or ratify any contract not properly

authorised by reason of a contravention of these provisions contained in its Articles.

**Directors' power to vote on own terms of appointment**

A Director shall not vote on or be counted in the quorum in relation to any resolution of the Board concerning their own

appointment, or the settlement or variation of the terms or the termination of their own appointment, as the holder of any office

or place of profit with the Company or any other company in which the Company is interested.

**Directors' remuneration**

The remuneration of the Executive Director and the Chair is determined by the Remuneration Committee, which consists solely of

Non-executive Directors. The Chair, who is a member of the Remuneration Committee, does not participate in discussions or

decisions of the committee about their own remuneration. The remuneration of the Non-executive Directors is determined by the

Board. For further information, including information on payments to Directors for loss of office, see 'Compensation and

Employees'.

**Change of control** 

There is no specific provision in the Articles that would have an effect of delaying, deferring or preventing a change in control of

Prudential and that would operate only with respect to a merger, acquisition or corporate restructuring involving Prudential, or any

of its subsidiaries.

**Exclusive jurisdiction**

Under the Articles, any proceeding, suit or action between a shareholder and Prudential and/or its Directors arising out of or in

connection with the Articles or otherwise, between Prudential and any of its Directors (to the fullest extent permitted by law),

between a shareholder and Prudential's professional service providers and/or between Prudential and Prudential's professional

service providers (to the extent such proceeding, suit or action arises in connection with a proceeding, suit or action between a

shareholder, Prudential and/or its Directors and/or such professional service provider) may only be brought in the courts of

England and Wales.

Code of ethics

Prudential has a code of ethics, as defined in Item 16B of Form 20-F under the Exchange Act, which Prudential calls its Group Code

of Conduct (the Code) which applies to all employees, contingent workers and the Board of Directors.

Prudential's Group Code of Conduct and Group Governance Manual, supported by the Group's risk-related policies, are reviewed

each year to ensure it remains fit for purpose, taking into consideration both internal and external factors. The Code sets out the

principles and guidelines that outline the ethical standards and responsibilities of the Group and its people. Supporting Group

policy requirements include those related to compliance and financial crime, covering anti-money laundering, sanctions, anti-

bribery and corruption, conduct, conflicts of interest, confidential and proprietary information and securities dealing. The Group's

Third-Party Supply and Outsourcing Policy requires that human rights and modern slavery considerations are embedded in

material supplier arrangements. Procedures to allow individuals to speak out safely and anonymously against unethical behaviours

and conduct violations are also in place.

Prudential's Code is available on its website at www.prudentialplc.com.

Insider trading policies

Prudential has adopted an Insider Trading Policy that governs the purchase, sale, and other dispositions of its securities by the

Board of Directors, senior management and employees of the Group. This policy is designed to promote compliance with

applicable insider trading laws, rules and regulations. A copy of Prudential's Insider Trading Policy was previously filed with the

Securities and Exchange Commission on 26 March 2025 as an exhibit to Prudential's Form 20-F.

![p202.jpg](puk-20251231_g44.jpg)

**Compensation and Employees**

**Remuneration at a glance**

**Elements of Executive Director remuneration**

The charts below show the breakdown of the Chief Executive Officer's remuneration<sup>1</sup> under the current Policy (a maximum AIP of

200 per cent of salary and full vesting of a PLTIP award of 425 per cent of salary) and the proposed 2026 Policy (a maximum AIP

of 250 per cent and full vesting of PLTIP at 375 per cent. A significant portion of remuneration remains performance-based, long-

term and at risk. Performance-related remuneration is subject to malus (forfeiture or reduction before delivery) and clawback

(recovery provisions for a period after delivery). The malus and clawback provisions are detailed in the Directors' remuneration

policy.

(1)Excluding the value of any benefits provided during the year

---

| | |
|:---|:---|
| **Current structure** | **Proposed structure**  |

---

**Principles underlying the Policy**

---

| | |
|:---|:---|
| **Proportionality**<br>–No incentives are paid for performance below threshold. <br>Financial targets are set against the Board-approved plan.<br>–Under the PLTIP, 20 per cent of each portion of the award <br>will vest for achieving threshold performance.<br>–The Committee approves termination arrangements of <br>Executive Directors to ensure that there is no reward for <br>failure.<br>**Simplicity**<br>–The structure comprises fixed remuneration, annual and <br>long-term incentives only.<br>–There is a demonstrable link between performance and <br>reward outcomes.<br>**Alignment to culture**<br>–Chief Executive Officer's pension benefit of 13 per cent of <br>salary is aligned with that of the wider workforce.<br>–Advice from the Risk Committee is taken to ensure that <br>risk management, culture and conduct are appropriately <br>reflected in the operation of Executive Directors' <br>remuneration.<br>–The vesting period attached to the PLTIP reflects the time <br>horizon of the business plan. <br>–The additional post-vesting holding period and share <br>ownership guidelines align Executive Director interests <br>with those of other stakeholders.<br>| **Predictability**<br>–This report details the connection between the <br>performance of the business and the remuneration <br>outcomes for the Chief Executive Officer under the <br>applicable incentive schemes. <br>**Clarity**<br>–The Committee consults regularly with the Company's <br>largest shareholders on executive pay proposals before they <br>are implemented.<br>–Details of Executive Director pay proposals are clearly set <br>out in the Annual report on remuneration.<br>**Risk**<br>–The Risk Committee advises the Committee on risk <br>management considerations to inform remuneration <br>decisions.<br>–The Committee has flexibility to adjust incentive outcomes <br>and to apply malus and clawback to awards and incentive <br>payments.<br>–The holding period on PLTIP awards extends the award <br>time horizon to five years.<br>–In-employment share ownership guidelines provide a <br>strong connection to the sustained success of the <br>Company. Post-employment requirements continue the <br>alignment with Company success and stakeholder <br>interests. <br>|

---

![p203.jpg](puk-20251231_g45.jpg)

**How the current Directors' remuneration Policy operates** 

The remuneration policy was approved by shareholders at our AGM on 25 May 2023. The policy is summarised below for

convenience. The full and definitive policy can be found on our website at

https://www.prudentialplc.com/content/dam/prudential-plc/investor/governance-and-policies/policies-and-statements/directors-

remuneration-policy-2022.pdf.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Key elements of remuneration** | **Key elements of remuneration** | **2026** | **2027** | **2028** | **2029** | **2030** | **Key features of operation of the policy** |
| **Fixed pay** | **Salary and** <br>**benefits**<br>|  |  |  |  |  | –Salaries reviewed annually with increases generally no greater than <br>those of the workforce unless there is a change in role or <br>responsibility. Benefits reflect individual circumstances and are <br>competitive in the local market.<br>–Pension contributions and/or a cash supplement up to 13% of salary.<br>–Executive Directors based in Hong Kong receive this in addition to <br>contributions into the Hong Kong Mandatory Provident Fund. |
|  | **Pension** |  |  |  |  |  | –Salaries reviewed annually with increases generally no greater than <br>those of the workforce unless there is a change in role or <br>responsibility. Benefits reflect individual circumstances and are <br>competitive in the local market.<br>–Pension contributions and/or a cash supplement up to 13% of salary.<br>–Executive Directors based in Hong Kong receive this in addition to <br>contributions into the Hong Kong Mandatory Provident Fund. |
| **Short-**<br>**term** <br>**variable** <br>**pay** | **Cash** <br>**bonus** <br>|  |  |  |  |  | –The maximum opportunity is up to 200 per cent of salary.<br>–40 per cent of bonus is deferred for three years. Deferral will be in <br>cash where share ownership guidelines have been met, or otherwise <br>in shares.<br>–Awards are subject to the achievement of financial and personal <br>objectives, with a Pillar I capital underpin aligned with the Hong Kong <br>Insurance Authority capital framework.<br>–Award is subject to malus and clawback provisions. |
| **Short-**<br>**term** <br>**variable** <br>**pay** | **Deferred** <br>**bonus**<br>|  |  |  |  |  | –The maximum opportunity is up to 200 per cent of salary.<br>–40 per cent of bonus is deferred for three years. Deferral will be in <br>cash where share ownership guidelines have been met, or otherwise <br>in shares.<br>–Awards are subject to the achievement of financial and personal <br>objectives, with a Pillar I capital underpin aligned with the Hong Kong <br>Insurance Authority capital framework.<br>–Award is subject to malus and clawback provisions. |
| **Long-term** <br>**variable** <br>**pay**<br>Three-year <br>performance <br>assessment<br>| **Prudential** <br>**Long Term** <br>**Incentive** <br>**Plan** <br>**(PLTIP)**<br>|  | Performance period |  | Holding period |  | –Maximum award under the PLTIP is 550 per cent of salary although <br>regular awards are below this level.<br>–Awards are subject to a three-year vesting period from date of grant <br>and a further two-year holding period from the end of the vesting <br>period.<br>–Awards are subject to relative TSR and financial performance <br>measures, as well as a business integrity scorecard.<br>–Awards are subject to malus and clawback provisions.<br>|
| **Share** <br>**ownership** <br>**guidelines**<br>|  |  |  |  |  |  | –Chief Executive Officer guidelines are 400 per cent of salary.<br>–Executives generally have five years to build this level of ownership.<br>–Executives leaving the Board are required to hold the lower of their <br>actual shareholding at the date they leave the Board or their in-<br>employment share ownership guideline for a period of two years.<br>|

---

**Summary of proposed major Policy changes for Executive Directors**<sup>1</sup>

---

| | | |
|:---|:---|:---|
| **Remuneration** <br>**element** | **Proposed changes** | **Rationale** |
| **Fixed pay** | –Scope to increase the annual salary for Executive <br>Directors above the increases for other employees <br>if the Committee believes it appropriate, based on <br>factors considered during the salary review.<br>| –This allows the Committee to apply its judgement <br>to ensure the overall package remains <br>competitive. Should the Committee consider using <br>this power, this would usually be discussed with <br>major investors before a decision was made.<br>|
| **Short-term** <br>**variable pay**<br>| –The maximum opportunity is 250 per cent of <br>salary for Executive Directors. Annual awards are <br>disclosed in the relevant Annual report on <br>remuneration.<br>| –This change is part of rebalancing the usual total <br>maximum incentive opportunity between long-<br>term incentive and annual bonus.<br>|
|  | –AIP awards are to be paid in cash if an Executive <br>Director meets their share ownership guideline at <br>the end of the financial year for which the bonus <br>is paid. If not, they will normally be required to <br>defer in shares the lower of 40 per cent of their <br>bonus, or the portion of bonus sufficient to meet <br>the share ownership guideline.<br>| –This change, together with the other <br>recommended changes, is designed to ensure the <br>overall remuneration package is competitive. Our <br>peers generally deliver a greater proportion of <br>total remuneration in cash and over a much <br>shorter timeframe.<br>|
| **Long-term** <br>**variable pay**<br>| –The statement that 'Annual awards are usually <br>significantly below the maximum 550 per cent of <br>salary' has been removed from the proposed <br>Policy. The Committee would seek to consult with <br>major shareholders before making any increase to <br>current award levels.<br>| –The PLTIP maximum is unchanged, with the <br>proposed 2026 award reduced by 50 per cent of <br>salary to 375 per cent.<br>–The annual PLTIP award level will continue to be <br>disclosed in the Annual report on remuneration.<br>|

---

**Notes**

(1)Further details on all proposed Policy changes are provided in the 'New Directors' remuneration policy' section.

**What performance means for Executive Director remuneration in 2025**

At Prudential, remuneration packages are designed to ensure strong alignment between pay and performance. In 2025, the

Group's performance was appropriately reflected in the incentive outcomes as set out below, and as described in greater detail in

the Annual report on remuneration.

**Mr Wadhwani's 2025 AIP outcome**

---

| | | | |
|:---|:---|:---|:---|
| **Measure** | **Weighting** | **Outturn** | **% achieved** |

---

![35184372088895](puk-20251231_g46.gif)

---

| | | |
|:---|:---|:---|
| Group new business profit | 36% | 21.3% |
| Group adjusted operating profit | 16% | 16.0% |
| Group net operating free surplus generated | 16% | 16.0% |
| Group cash flow | 12% | 9.6% |
| **Total Group financial measures** | **80%** | **62.9%** |
| Personal objectives | 20% | 19.0% |
| **Total bonus** | **100%** | **81.9%** |

---

**2023 PLTIP outcome**

---

| | | | |
|:---|:---|:---|:---|
| **Measure** | **Weighting** | **Outturn** | **% achieved** |

---

---

| | | |
|:---|:---|:---|
| Three-year relative TSR | 35% | –% |
| Return on embedded value | 40% | 33.0% |
| Business integrity scorecard | 25% | 22.1% |
| **Total PLTIP** | **100%** | **55.1%** |

---

![35184372088906](puk-20251231_g47.gif)

Annual report on remuneration

**Role and responsibilities of the Remuneration Committee**

The role and responsibilities of the Committee are set out in its terms of reference, which are reviewed by the Committee and

approved by the Board on a periodic basis, and can be found on the Company's website at https://www.prudentialplc.com/

content/dam/prudential-plc/investor/governance-and-policies/board-and-committees-governance/egroup-remuneration-

committee-tors-2-jan-2025.pdf.coredownload.inline.pdf. The Committee's role is to assist the Board in meeting its responsibilities

regarding the determination, implementation and operation of the overall remuneration policy for the Group, including the

remuneration of the Chair of the Board, Chief Executive Officer, Group Executive Committee members, the Company Secretary

and the Chief Internal Auditor, as well as overseeing the remuneration arrangements of other staff within its purview. In 2025, the

Committee met seven times and also dealt with a number of matters by email circulation.

The principal responsibilities of the Committee set out in its terms of reference and discharged during 2025 were:

–Approving the operation of performance-related pay schemes operated for the Chief Executive Officer, other members of the

Group Executive Committee, the Company Secretary and Chief Internal Auditor, and determining the targets and individual

payouts under such schemes;

–Consulting with shareholders and the principal advisory bodies on the proposed Directors' Remuneration Policy and decisions

taken in respect of the Chief Executive Officer's remuneration arrangements for 2026;

–Reviewing the operation and awards made under all share plans requiring approval by the Board and/or the Company's

shareholders;

–Monitoring the compliance of the Chair, Chief Executive Officer, other members of the Group Executive Committee, and non-

executive Directors with share ownership guidelines;

–Reviewing and approving individual packages for the Chief Executive Officer and other members of the Group Executive

Committee including for any new hires and departures and the fees of the Chair. Reviewing workforce remuneration practices

and related policies across the Group when setting the remuneration policy for the Executive Director, as well as the alignment

of incentives and awards with culture;

–Monitoring the remuneration and risk management implications of remuneration of senior executives across the Group and other

selected roles; and

–Overseeing the implementation of the Group remuneration policy for those roles within scope of the specific arrangements

referred to in the Hong Kong Insurance Authority's (HKIA) Group-Wide Supervision (GWS) Framework.

The Chief Executive Officer attends meetings by invitation. The Committee also had the benefit of advice from the:

–Chief Risk and Compliance Officer;

–Chief Financial Officer;

–Chief Human Resources Officer; and

–Director, Group Reward and CHRO, UK.

Individuals are not present when their own remuneration is discussed and the Committee is always careful to manage potential

conflicts of interest when receiving views from the Chief Executive Officer or senior management about executive remuneration

proposals.

During 2025 WTW was the independent remuneration adviser to the Committee, having been appointed by the Committee

following a competitive tender process in 2024. WTW is a member of the Remuneration Consultants' Group and voluntarily

operates under its code of conduct when providing advice on executive remuneration in the UK. In addition to the guidance

provided at the formal meetings of the Committee, the engagement partners regularly advise the Chair of the Committee directly

between meetings. The Committee is comfortable that the WTW engagement partners and team providing remuneration advice to

the Committee do not have connections with Prudential that may impair their independence and objectivity.

The total fees paid to WTW for the provision of independent advice to the Committee in 2025 were £186,010, charged on a fixed

fee as well as a time and materials basis. WTW provided Prudential management with remuneration market data in respect of the

wider workforce as well as actuarial consulting and technology services, which were rendered by entirely separate teams within

WTW.

Management also received external advice and data from a number of other providers, including legal counsel. This advice, and

these services, are not considered to be material.

The operation of the Committee was reviewed as part of the annual Board performance review. No material issues were identified.

The Committee discussed the output of the evaluation and agreed areas of focus. These are included in the consolidated outcomes

of the 2025 Board performance review.

---

| | | |
|:---|:---|:---|
| **Membership and 2025 meeting attendance** | **Membership and 2025 meeting attendance** | **Membership and 2025 meeting attendance** |
| **Committee members** | **Member since** | **2025 meetings**<sup>1</sup> |
| Chua Sock Koong <br>(Chair)<br>| May 2021 <br>(Chair since May 2022)<br>| 7/7 |
| Ming Lu | May 2022 | 7/7 |
| George Sartorel | May 2023 | 7/7 |
| Shriti Vadera<sup>2</sup> | May 2024 | 6/7 |
| **Regular attendees**<br>–Chief Executive Officer<br>–Company Secretary<br>–Chief Human Resources Officer (CHRO)<br>–Director, Group Reward and CHRO, UK<br>–Remuneration Committee Adviser  | **Regular attendees**<br>–Chief Executive Officer<br>–Company Secretary<br>–Chief Human Resources Officer (CHRO)<br>–Director, Group Reward and CHRO, UK<br>–Remuneration Committee Adviser  | **Regular attendees**<br>–Chief Executive Officer<br>–Company Secretary<br>–Chief Human Resources Officer (CHRO)<br>–Director, Group Reward and CHRO, UK<br>–Remuneration Committee Adviser  |
| (1)The Committee held four scheduled meetings. In addition, the Committee held one additional short meeting to consider year-end matters and two short <br>meetings to consider ad hoc business. The Committee also held a working session in May to discuss an early outline of potential changes to the Directors' <br>Remuneration Policy.<br>(2)Shriti Vadera was unable to attend one additional meeting due to travel commitments. | (1)The Committee held four scheduled meetings. In addition, the Committee held one additional short meeting to consider year-end matters and two short <br>meetings to consider ad hoc business. The Committee also held a working session in May to discuss an early outline of potential changes to the Directors' <br>Remuneration Policy.<br>(2)Shriti Vadera was unable to attend one additional meeting due to travel commitments. | (1)The Committee held four scheduled meetings. In addition, the Committee held one additional short meeting to consider year-end matters and two short <br>meetings to consider ad hoc business. The Committee also held a working session in May to discuss an early outline of potential changes to the Directors' <br>Remuneration Policy.<br>(2)Shriti Vadera was unable to attend one additional meeting due to travel commitments. |

---

**Table of Executive Director total remuneration (the 'single figure') – *audited information***

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **$000s** | salary | taxable<br>benefits\*<br>| total<br>bonus†<br>| PLTIP<br>releases‡<br>| pension<br>benefits§<br>| other <br>remuneration<sup>1</sup><br>| Total fixed<br>remuneration<sup>~</sup><br>| Total variable<br>remuneration<sup>~</sup><br>| Total <br>remuneration<br>the 'single <br>figure'^<br>|
| **Anil Wadhwani (2025)** | **1575** | **635** | **2580** | **3581** | **207** | **–** | **2417** | **6161** | **8578** |
| Anil Wadhwani (2024) | 1574 | 503 | 2801 | – | 207 | 1439 | 2284 | 4240 | 6524 |

---

\*Benefits include the cost of providing the use of a car and driver, medical insurance, and expatriate benefits. Benefits of significant value include housing costs

($405,000), which is in line with Asia practice.

†The total value of the bonus, comprising both the 60 per cent delivered in cash and 40 per cent bonus deferred for three years. Given that Mr Wadhwani has

met his share ownership guideline, the 2025 bonus will be deferred in cash. The deferred part of the bonus is subject to malus and clawback provisions in

accordance with the malus and clawback policies, but no further performance conditions.

‡ The estimated value of the 2025 PLTIP awards vesting for Mr Wadhwani has been calculated based on the average share price over the last three months of

2025 (HKD110.34) and includes the accumulated dividends delivered in the form of shares. The Committee's approach to determining the level of vesting for

this award is set out in the 'Remuneration in respect of performance periods ending in 2025' section. The actual value of vesting PLTIP awards, based on the

share price on the date awards vest, will be shown in the 2026 report. The estimated value per share of the 2023 LTIP awards is 1.6 per cent lower than the

value per share at grant. No adjustment to vesting levels has been proposed as a result of the share price depreciation.

§Pension benefits include contributions into defined contribution schemes as outlined in the Pension benefit entitlement section.

~Total fixed remuneration includes salary, taxable benefits and pension benefits. Total variable remuneration includes total bonus, PLTIP releases (where

applicable), and variable remuneration elements of Mr Wadhwani's buyout.

^Each remuneration element is rounded to the nearest $1,000 and totals are the sum of these rounded figures. Total 2025 remuneration has been converted to

US dollars using the exchange rate of 7.7960 for HKD and 0.7581 for GBP. Exchange rate fluctuations will, therefore, impact the reported value. Exchange

rates used for 2024 reporting were 7.8030 for HKD and 0.7824 for GBP. The 31 per cent year-on-year increase in Mr Wadhwani's remuneration reflects the

vesting in 2025 of his first PLTIP award and that an element of his replacement award that vested in 2024 was included in the 2023 single figure in line with the

regulations. Had that element been included in the restated 2024 single figure the increase would have been 19 per cent.

**Note**

(1)'Other remuneration' for 2024 consists of the value of a replacement award made in relation to remuneration forfeited by Mr Wadhwani as a consequence of

leaving his former employer, Manulife, and joining Prudential. In line with the regulations, this has been recalculated using the actual share price at vesting

(HKD84.00) and actual performance outcomes (141%) and includes the accumulated dividends. Further details can be found in the Recruitment arrangements

section later in this report.

**Remuneration in respect of performance in 2025 - *audited information***

**Base salary**

After due deliberation and following consultation with shareholders, the Committee considered that there should be no increase to

the Chief Executive Officer's salary for 2025. Mr Wadhwani's salary, therefore, remains as it was at his appointment. The average

increase for the wider workforce was 5.2 per cent.

---

| | | |
|:---|:---|:---|
| Executive Director | 2025 salary<br>(local currency)<br>from<br>1 January 2025 <br>| 2025 salary<br>(USD) <br>from<br>1 January 2025<sup>1</sup><br>|
| Anil Wadhwani | HKD 12,281,000 | $1575000 |

---

**Note**

(1)2025 salary converted to US dollars using an exchange rate of 7.7960 for HKD and rounded to the nearest $1,000.

**Pension benefit entitlements**

Pension benefit arrangements for 2025 are set out in the table below. The employer pension contribution available to the wider

workforce is 13 per cent of salary.

---

| | | |
|:---|:---|:---|
| Executive Director | 2025 pension benefit | Life assurance provision |
| Anil Wadhwani | Pension supplement in lieu of pension of 13 per cent of <br>salary and a HKD18,000 employer payment to the Hong <br>Kong Mandatory Provident Fund.<br>| Eight times salary. |

---

**Annual bonus outcomes for 2025**

**Target setting**

For 2025, financial AIP metrics comprised 80 per cent of the bonus opportunity for the Chief Executive Officer. The financial

element of the Chief Executive Officer's 2025 bonus was determined by the achievement of four Group measures, namely TEV new

business profit, adjusted operating profit, net operating free surplus generation, and cash flow, which are aligned to the Group's

growth and cash generation focus. The performance ranges were based on the annual business plans approved by the Board and

set in line with the trajectory for the Group's 2027 strategic goals, in the context of anticipated market conditions.

Personal objectives comprised 20 per cent of the bonus opportunity for the Chief Executive Officer. These objectives were

established at the start of the year and reflect the Group's strategic priorities as set by the Board for 2025.

AIP payments are subject to meeting minimum capital thresholds which are aligned to the Group Risk Framework and appetite (as

adjusted for any Risk Committee approved counter-cyclical buffers) ensuring that incentive outcomes reflect both financial

performance and appropriate risk management, as described in the Chief Risk and Compliance Officer's report.

The Committee seeks advice from the Risk Committee on risk management considerations to inform decisions about remuneration

architecture and performance measures to ensure that risk management, culture and conduct are appropriately reflected in the

design and operation of the Executive Director's remuneration.

**Performance assessment**

The Committee determines the bonus outcome based on pre-determined measures and considers whether the formulaic outcome

reflects overall Company and individual performance.

The Committee considered a report from the Chief Risk and Compliance Officer, which was approved by the Risk Committee. This

report confirmed that the 2025 results were achieved within the Group's and businesses' risk framework and appetite. The Chief

Risk and Compliance Officer also considered the effectiveness of risk management and internal controls, and specific actions taken

to mitigate risks, particularly where these may be at the expense of profits or sales. The report also confirmed that the Group met

minimum capital thresholds, which were aligned to the Group Risk Framework and appetites. The Committee took into account

this advice when determining the AIP outcome for the Chief Executive Officer.

The table below illustrates the weighting of performance measures for 2025 and the level of achievement under the AIP:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Executive Director | Weighting of measures<br>(% of total bonus <br>opportunity) | Weighting of measures<br>(% of total bonus <br>opportunity) | Performance against <br>measures<br>(% of max for each <br>component) | Performance against <br>measures<br>(% of max for each <br>component) | 2025 AIP <br>outcome <br>(% of max <br>opportunity) |  |  |  |  |
| Executive Director | Group<br>financial<br>measures<br>| Personal<br>objectives<br>| Group<br>financial<br>measures<br>| Personal<br>objectives<br>| 2025 AIP <br>outcome <br>(% of max <br>opportunity) | Maximum <br>2025 AIP <br>(% of salary)<br>| Actual 2025 <br>AIP <br>(% of salary)<br>| 2025 salary | 2025 AIP award<sup>2</sup> |
| Anil Wadhwani<sup>1</sup> | 80% | 20% | 78.6% | 95% | 81.88% | 200% | 163.77% | 1575295 | 2579793 |

---

**Notes**

(1)Values converted to US dollars using an exchange rate of 7.7960 for HKD.

(2)Bonus awards are subject to 40 per cent deferral for three years. As the share ownership guideline has been met, the deferral will be made in cash.

The Committee determined the 2025 AIP award on the basis of the performance of the Group and of the Chief Executive Officer.

In making these decisions, it reflected on factors including:

–The overall contribution of the executive;

–Behavioural, conduct and risk management considerations; and

–Wider experience of stakeholders and overall corporate performance.

The AIP outcome was considered appropriate in the context of the above, and as such, no discretion was exercised.

**Financial performance**

The level of performance required for threshold, target and maximum payment against the Group's 2025 AIP financial measures

and the results achieved are set out below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| 2025 AIP measure | Weighting | Threshold<br>($m)<br>| Target<br>($m)<br>| Stretch target<br>($m)<br>| Achievement<br>($m)<br>|
| Group TEV new business profit | 45% | 2571 | 2856 | 2999 | 2782 |
| Group adjusted operating profit | 20% | 2836 | 3151 | 3309 | 3306 |
| Group net operating free surplus generated | 20% | 1358 | 1509 | 1585 | 1675 |
| Group cash flow | 15% | 1600 | 1829 | 2058 | 1829 |

---

Following the adoption of TEV reporting with effect from 1 January 2025, the Committee reviewed its long-established practice of

adjusting financial targets to reflect prevailing interest rate and foreign exchange rate assumptions applicable for the full year

reporting. Under TEV reporting, interest rate volatility in both NBP and OFSG is reduced as a result of the use of long-term

economic assumptions. As such, after careful consideration, the Committee felt it was appropriate to: discontinue adjustments for

interest rate volatility on performance measures directly affected by the adoption of TEV reporting, specifically, the NBP and OFSG

metrics; continue adjusting the IFRS metric for economic movements (recognising that underlying market volatility will persist and

cannot practically be removed); and continue adjusting for exchange rate movements across all metrics, as it was broadly in line

with market practice. Adjustments to targets in any given year may be upwards or downwards and are designed to ensure that

outcomes reflect management's performance in the year by neutralising the effect of interest rates and foreign exchange

movements during that year.

**Personal performance**

20 per cent of the Chief Executive Officer's annual bonus is based on the achievement of personal objectives, which may include:

–meeting individual conduct and customer measures;

–contribution to Group strategy as a member of the Board; and

–specific goals for which he is responsible and progress on major projects.

The below summarises the Chief Executive Officer's performance against his 2025 personal objectives and strategic priorities. The

assessment was undertaken by the Chair of the Board.

---

| | | | |
|:---|:---|:---|:---|
| 2025 personal objectives | Key achievements | Weighting | Performance <br>outcome<br>|
| **People and Culture** | –Strengthened the Group Executive Committee through senior <br>appointments, effective onboarding and clear portfolio <br>accountability.<br>–Advanced succession planning and leadership pipeline <br>development for key Group Leadership Team roles.<br>–Further embedded a performance led, values driven culture, <br>strengthening alignment between delivery, behaviours and <br>reward outcomes.<br>| 20% | 19% |
| **Transformation** | –Delivered the Group's financial and operational commitments <br>under the current strategy with double digit growth in our <br>key metrics<sup>1</sup>, including consistent double digit growth across <br>all quarters in new business profit, reflecting disciplined <br>execution and sustained operational focus<br>–Continued execution of the Transformation Agenda across <br>Agency, Health and Operations, supported by sustained <br>investment in capabilities, systems and technology.<br>–Improved operational efficiency and performance, including <br>reductions in operating variances and enhancement of <br>PruServices (our digital servicing portal now live for <br>customers in nine business units).<br>–Worked with joint venture partners, for example CITIC in <br>China saw new business profit growth of 27 per cent.<br>| 35% | 32% |
| **Strategy** | –Maintained a clear focus on capital allocation and capital <br>management, demonstrating the Group's ability to fund <br>growth and deliver shareholder returns.<br>–Reached an inflection point in the Group's operating free <br>surplus generation. Completed the $2bn share buyback and <br>launched a further $1.2bn buyback programme in early <br>2026. <br>–Delivered key strategic initiatives and transactions (eg the <br>IPO of IPAMC in India), generating cash returns and <br>supporting the Group's capital position.<br>| 25% | 24% |
| **Stakeholder relations** | –Strengthened shareholder engagement through clear, <br>consistent communication.<br>–Improved rNPs in eight out of ten business units, contributing <br>to an increase in customer retention to 88 per cent. <br>–Engaged with regulators across key markets, securing <br>regulatory approvals and expanding market access.<br>| 20% | 20% |
| Recognising Mr Wadhwani's performance against his personal objectives, the Committee judged that an assessment of **95%** of <br>the portion of the bonus attributable to personal objectives (20% weighting) was appropriate. | Recognising Mr Wadhwani's performance against his personal objectives, the Committee judged that an assessment of **95%** of <br>the portion of the bonus attributable to personal objectives (20% weighting) was appropriate. | Recognising Mr Wadhwani's performance against his personal objectives, the Committee judged that an assessment of **95%** of <br>the portion of the bonus attributable to personal objectives (20% weighting) was appropriate. | Recognising Mr Wadhwani's performance against his personal objectives, the Committee judged that an assessment of **95%** of <br>the portion of the bonus attributable to personal objectives (20% weighting) was appropriate. |

---

**Note**

(1)Our key metrics are: new business profit, basic earnings per share based on adjusted operating profit and operating free surplus generated from in-force

insurance and asset management business.

Further details of Key Management Remuneration may also be found in note B2.3 of the consolidated financial statements.

**Long-term incentives vesting in respect of performance to 31 December 2025 – *audited***

***information***

**Prudential Long Term Incentive Plan (PLTIP)**

**Target setting**

Our long-term incentive plans have stretching performance conditions that are aligned to the strategic priorities of the Group. In

determining the financial targets attached to the awards made in 2023, the Committee had regard to the stretching nature of the

three-year business plan for return on embedded value and capital positions as set by the Board. Furthermore, in setting the

conduct and diversity targets under the business integrity scorecard, the Committee considered input presented by the Chief Risk

and Compliance Officer, on behalf of the Risk Committee, in assessing conduct risk and had regard to the Company's commitment

under the Women in Finance Charter for the diversity measure.

Further details may also be found in note B2.2 of the consolidated financial statements.

**Performance assessment**

In deciding the proportion of the awards to be released, the Committee considered actual results against performance targets. The

Committee also reviewed information about underlying Company performance to ensure vesting levels were appropriate, including

an assessment of whether results were achieved within the Group's risk framework and appetite. Finally, overall vesting levels

were reviewed to ensure that levels of reward provided remain reflective of the Company's performance.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Weighting | Threshold (20 per cent of <br>award vests)<br>| Stretch (100 per cent of <br>award vests)<br>| Performance achieved | Vesting <br>outcome<br>|
| Relative TSR<sup>1</sup> | 35% | Median | Upper quartile | Below median | – |
| Return on embedded <br>value (RoEV)<sup>2</sup><br>| 40% | 9.35% | 12.65% | 11.3% | 82.5% |
| Reduction in WACI<sup>3</sup> | 5% | 25.0% | 35.0% | 53.0% | 100.0% |
| GWS operating capital <br>generation<sup>4</sup><br>| 5% | $3,698 million | $5,004 million | Above target but below the <br>cumulative stretch target<br>| 81.2% |
| GIECA<sup>5</sup> | 5% | $7,853 million | $10,625 million | Above target but below the <br>cumulative stretch target<br>| 82.6% |
| Diversity<sup>6</sup> | 5% | 35.0% | 40.0% | 38% | 78% |
| Conduct<sup>7</sup> | 5% | Partial achievement | Stretch achievement | No conduct, culture or <br>governance issues that resulted <br>in significant capital add-ons or <br>material fines<br>| 100.0% |
| **Total** | 100% |  |  |  | 55.09% |

---

**Notes**

(1)Relative TSR is measured on a ranked basis over three years relative to peers. The peer group for the 2023 awards consists of AIA, China Life, China Pacific

Insurance, China Taiping Insurance, DBS Group, Great Eastern, Hang Seng Bank, Manulife Financial, MetLife, New China Life, Ping An Insurance and Standard

Chartered. As Great Eastern shares recommenced trading on 21 August 2025, the Committee decided that Great Eastern's actual TSR performance over the full

performance period would be used.

(2)The average three-year Group RoEV relative to the 2023–2025 Board-approved business plan; these targets were adjusted for the change in reporting on a

TEV basis.

(3)Reduction in weighted average carbon intensity (WACI) as at 31 December 2025 compared with the baseline as at 31 December 2019. The baseline and

targets have been externally validated. Please see our Sustainability report for details of our ambitions and progress to date.

(4)Cumulative three-year GWS operating capital generation.

(5)Cumulative three-year GIECA operating capital generation.

(6)Diversity is measured as the percentage of Group Leadership Team (GLT) that is female at the end of 2025. For these purposes, GLT members who are

employed by our operating joint venture Prudential BSN Takaful Berhad are included.

(7)Conduct is assessed through appropriate management action, ensuring there are no significant conduct/culture/governance issues that could result in

significant capital add-ons or material fines.

As disclosed in last year's report, the Group started reporting on a TEV basis in January 2025. As RoEV was set on a European

Embedded Value basis the targets required adjustment. In revising the targets, the Committee adopted the following principles:

–Participants should not be advantaged or disadvantaged by the transition to the TEV reporting methodology;

–The value of outstanding awards and their key terms (vesting dates, holding periods, malus and clawback provisions) are

unaffected;

–If performance conditions are revised, the revised conditions should be no more or less stretching than those originally attached

to the awards; and

–Details of the revised targets will be disclosed.

These principles, similar to those adopted in respect of the demergers of the Jackson and M&G businesses, were discussed with

and supported by our largest shareholders in late 2024 and early 2025 and before the revisions were made.

Details of cumulative achievement under the capital measures have not been disclosed, as the Committee considers that these are

commercially sensitive and disclosure would put the Company at a disadvantage compared to its competitors. The Committee will

keep this disclosure policy under review based on whether, in its view, disclosure would compromise the Company's competitive

position.

**PLTIP vesting**

The Committee considered a report from the Chief Risk and Compliance Officer, which was approved by the Risk Committee. This

report confirmed that the financial results were achieved within the Group's risk framework and appetite. On the basis of this

report and the performance of the Group described above, the Committee decided that it was not appropriate to apply any

adjustment to the formulaic vesting outcome of the 2023 PLTIP awards.

**Long-term incentives awarded in 2025**

**2025 share-based long-term incentive awards**

The table below shows the conditional award of shares made to the Chief Executive Officer under the PLTIP in 2025 and the

performance conditions attached to this award.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Executive Director | Role | Number of <br>shares subject <br>to award | Face value of award | Face value of award | Percentage of awards <br>released for achieving <br>threshold targets | End of performance period |
| Executive Director | Role | Number of <br>shares subject <br>to award | % of salary | (USD)\* | Percentage of awards <br>released for achieving <br>threshold targets | End of performance period |
| Anil Wadhwani | Chief Executive Officer | 635353 | 425% | 6695004 | 20% | 31 December 2027 |

---

\*Award calculated based on the average share price over the three dealing days prior to the grant date in March, being HKD 82.15. The value has been

converted to US dollars at the exchange rate of 7.7960.

The measures, weightings and targets for the 2025 PLTIP award for the Chief Executive Officer are summarised below:

---

| | | | |
|:---|:---|:---|:---|
|  |  | Threshold<sup>1</sup> | Maximum |
| Measure | Weighting | 20% vesting | 100% vesting |
| Relative TSR<sup>2</sup> | 45% | Median | Upper quartile |
| NBP<sup>3,5</sup> | 15% | $8,575m | $11,601m |
| Gross OFSG<sup>4,5</sup> | 15% | $9,288m | $12,567m |
| Business integrity scorecard | 25% | see below | see below |

---

**Notes**

(1)Performance below threshold results in 0% vesting.

(2)Relative TSR is measured on a local currency basis since this has the benefit of simplicity and directness of comparison. The TSR peer group comprises: AIA

Group, China Life Insurance, China Pacific Insurance Company, China Taiping Insurance, DBS Group, Hang Seng Bank, Manulife Financial, MetLife, New China

Life, Oversea-Chinese Banking Corporation Limited, Ping An Insurance, and Standard Chartered.

(3)NBP measures the value creation of writing new business and is a key metric to indicate growth.

(4)Gross OFSG will be calculated as the operating free surplus generated within local businesses before investment in new business and any central costs.

(5)The threshold and maximum values for NBP and gross OFSG shown above were set on a TEV basis following the change in reporting, effective 1 January 2025.

Under the business integrity scorecard, performance will be assessed for each of the five measures at the end of the three-year

performance period:

---

| | | | |
|:---|:---|:---|:---|
| Measure | Weighting | Threshold performance<sup>1</sup><br>(20% vesting)<br>| Stretch performance<sup>1</sup><br>(100% vesting)<br>|
| Reduction in WACI<sup>2</sup> | 5% | 50% reduction | 55% reduction |
| GWS capital measure<sup>3,5</sup> | 5% | Threshold | Stretch |
| GIECA measure<sup>4,5</sup> | 5% | Threshold | Stretch |
| Diversity<sup>6</sup> | 5% | 38% female | 42% female |
| Conduct<sup>7</sup> | 5% | Partial achievement of Group <br>expectations<br>| Achieving Group expectations |

---

**Notes**

(1)Performance below threshold results in nil vesting.

(2)Reduction as at 31 December 2027 compared with the baseline as at 31 December 2019. The baseline and targets have been externally validated. This element

is subject to a transition finance underpin which must be met before any part of the WACI element vests.

(3)Cumulative three-year GWS operating capital generation.

(4)Group Internal Economic Capital Assessment (GIECA) surplus generation is a Pillar 2 economic capital metric.

(5)The targets for the GWS capital measure and the GIECA measure are deemed to be commercially sensitive and, if disclosed, would put the Company at a

disadvantage compared to its competitors. They will be published in the Annual Report for the final year of the performance period.

(6)Diversity is measured as the percentage of GLT that is female. For these purposes, GLT members who are employed by our joint venture Prudential BSN

Takaful Berhad are included.

(7)Through strong risk management action, ensure there are no significant conduct/culture/governance issues that result in significant capital add-ons or material

fines.

The Committee will review awards on vesting to assess whether outcomes appropriately reflect underlying Company performance

and to ensure that participants do not benefit from windfall gains. In making this determination, the Committee will consider

Prudential's stretching performance targets, the share performance of Prudential and its peers, the performance of the indices on

which Prudential is listed, and any other factors it deems relevant.

**Recruitment arrangements – *audited information***

As detailed in the 2023 Directors' remuneration report, in order to facilitate Mr Wadhwani's appointment, the Company agreed to

replace remuneration forfeited by him and reimburse costs he incurred as a consequence of him leaving his former employer,

Manulife, and joining Prudential. Full details of these arrangements were provided in the 2023 Directors' remuneration report.

**Replacement award** 

As part of these recruitment arrangements, a replacement award was made under a one-off award agreement entered into on 8

March 2023 in accordance with Rule 9.4.2 of the UK Listing Rules. The replacement award was made on a like-for-like basis with

the award subject to release in accordance with the original vesting time frames and, where applicable, satisfaction of the Manulife

performance conditions attached to the original awards.

Three types of forfeited awards were replaced:

–performance shares were replaced with Prudential plc shares with the performance conditions tied to the original award (to be

determined by the Committee based on performance outcomes published in the relevant Manulife Management Information

Circulars);

–restricted shares were replaced at face value; and

–market-value stock options were only replaced to the extent that they were 'in the money'.

The award comprised (i) a cash-settled nominal-cost option over Prudential plc shares, and (ii) replacement cash payments (which

were paid in 2023 and reported in the 2023 single figure table). The nominal-cost option was granted to Mr Wadhwani on 21

March 2023 to replace the other forfeited Manulife awards in tranches. Part of the award vested in 2024 and was reported in the

2024 single figure table; further details of the vesting and exercise of the balance of the replacement award are provided below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Replacement award<sup>1</sup> | No. of notional <br>shares under <br>option <br>outstanding at <br>1 January <br>2025<br>| Exercise price<br>(HKD)<br>| No. of notional <br>shares <br>exercised in <br>2025<br>| No. of <br>notional <br>shares <br>lapsed in <br>2025<br>| No. of notional <br>shares under <br>option <br>outstanding at <br>31 December <br>2025<br>| End of <br>performance <br>period<br> (if applicable)<br>| Exercise period | Market price <br>at date of <br>vesting (HKD)<br>|
| **Performance shares** | **Performance shares** | **Performance shares** | **Performance shares** |  |  |  |  |  |
| 2022<sup>2, 3</sup> | 163004 | 0.48 | 127686 | 35318 | – | 31 Dec <br>2024<br>| 1 May–8 May <br>2025<br>| 84.00 |
| **Restricted shares** | **Restricted shares** | **Restricted shares** |  |  |  |  |  |  |
| 2022 | 60738 | 0.48 | 60738 | – | – | n/a | 1–30 March <br>2025<br>| 79.40 |
| **Stock options** | **Stock options** |  |  |  |  |  |  |  |
| 2020 | 11552 | 0.48 | 11552 | – | – | n/a | 5 March–3 <br>April 2025<br>| 79.40 |
|  | **235294** |  | **199976** | **35318** | **–** |  |  |  |

---

**Notes**

(1)All awards were made in the form of options over notional shares.

(2)Elements of the replacement award that are reportable within the restated 'Table of 2024 Executive Director total remuneration'. These values have been

restated to reflect the share price at the time of vesting and actual performance outcomes where applicable.

(3)Performance shares were replaced at their maximum value (180% of target) and remained subject to the satisfaction of the original Manulife performance

conditions. The number of notional shares that vested was determined by dividing the total number of notional shares under option by 180% and multiplying

this by the vesting outcome of 141% of target as published in the 2024 Manulife Management Information Circular.

**Malus and Clawback** 

The Committee may apply clawback and/or a malus adjustment to variable pay (annual bonus, long-term incentives and

replacement awards). The circumstances and the period during which malus and clawback provisions may be applied, are set out

in the Malus and clawback Policy section of the New Directors' remuneration policy. The clawback period is considered appropriate

by the Committee as, given the nature of the company's business, it allows sufficient time for any relevant circumstances to come

to light. Malus and clawback were not exercised during the year under review.

**Pay comparisons**

**Performance graph and table**

The chart below illustrates the TSR performance of Prudential, the FTSE 100 (as the Company has a listing on the London Stock

Exchange and is a constituent of the FTSE 100 index), and the peer group of international insurers, which comprise the Company's

TSR peer group for the 2025 PLTIP awards. The chart illustrates the performance of a hypothetical investment of $100 in ordinary

shares of Prudential plc over the 10-year period from 1 January 2016 to 31 December 2025 compared to a similar investment in

the FTSE 100 or an index of the Company's peers. Total shareholder return is based on returns index data calculated on a daily

share price growth plus reinvested dividends (as measured at the ex-dividend dates).

**Prudential TSR vs FTSE 100 and TSR peer group average – total shareholder return over 10-year period** 

**to December 2025**

![12644383819883](puk-20251231_g48.gif)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ■ | Prudential | ■ | FTSE 100 | ■ | Peer group |

---

The information in the table below shows the total remuneration for the Chief Executive Officer over the same period:

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| $000<sup>1</sup> | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
| Chief Executive Officer<sup>2,3</sup> | MW | MW | MW | MW | MW | MW | MW | MFP | MFP | AW | AW | AW |
| Salary, pension and benefits | 3029 | 2415 | 2423 | 2122 | 2126 | 2249 | 663 | 1476 | 447 | 1986 | 2284 | 2417 |
| Annual bonus payment | 2904 | 2673 | 2848 | 2804 | 1355 | 3057 | 693 | 2161 | 441 | 2638 | 2801 | 2580 |
| (As % of maximum) | (99.5)% | (94.0)% | (95.0)% | (96.0)% | (46.0)% | (96.7)% | (96.0)% | (98.0)% | (97.4)% | (99.0)% | (89.0)% | (81.9)% |
| LTIP vesting | 4016 | 5955 | 4837 | 2746 | 4286 | 1052 | 2108 | 1255 | 307 | – | – | 3581 |
| (As % of maximum) | (70.8)% | (95.8)% | (62.5)% | (62.5)% | (68.8)% | (17.8)% | (45.5)% | (45.5)% | (27.6)% | – | – | (55.1)% |
| Other payment<sup>4</sup> | – | – | – | – | – | – | – | – | – | 7081 | 1439 | – |
| Chief Executive Officer 'single <br>figure' of total remuneration<sup>5</sup><br>| 9950 | 11042 | 10109 | 7671 | 7768 | 6358 | 3464 | 4892 | 1195 | 11705 | 6524 | 8578 |

---

**Notes**

(1)All remuneration has been converted to USD using the average exchange rate for each respective financial year.

(2)In years where there has been a change in Chief Executive Officer, the figures shown for each individual's remuneration in that year relate only to their service

as Chief Executive Officer.

(3)The Chief Executive Officers are: MW: Mike Wells MFP: Mark FitzPatrick AW: Anil Wadhwani

(4)Other payment refers to the value of remuneration forfeited by Mr Wadhwani as a consequence of his leaving his former employer and replaced by the

Company.

(5)Further details on the 'single figure' are provided in the 'single figure' table for the relevant year. The figures provided reflect the value of vesting LTIP awards

on the date of their release. For Mark FitzPatrick, the LTIP vesting for 2022 and 2023 also include performance periods in which he served in the role of Group

Chief Financial Officer and Chief Operating Officer.

**Relative importance of spend on pay**

The table below sets out the amounts payable in respect of 2024 and 2025 on all employee pay, dividends and the share buyback

programme:

---

| | | | |
|:---|:---|:---|:---|
| | 2024 | 2025 | Percentage<br>change<br>|
| All employee pay ($m)<sup>1</sup> | 1210 | **1323** | 9% |
| Dividends and share buyback programme ($m)<sup>2</sup> | 1360 | **1834** | 35% |

---

**Notes**

(1)All employee pay as taken from note B2.1 of the consolidated financial statements.

(2)Dividends paid in the year as taken from note B5 and the share buyback programme value from note C8 of the consolidated financial statements.

**Percentage change in remuneration**

The table below illustrates the year-on-year change in remuneration for each Director compared to a wider employee comparator

group:

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Salary (% change) | Salary (% change) | Salary (% change) | Salary (% change) | Salary (% change) | Benefits<sup>10</sup> (% change) | Benefits<sup>10</sup> (% change) | Benefits<sup>10</sup> (% change) | Benefits<sup>10</sup> (% change) | Benefits<sup>10</sup> (% change) | Bonus<sup>9</sup> (% change) | Bonus<sup>9</sup> (% change) | Bonus<sup>9</sup> (% change) | Bonus<sup>9</sup> (% change) | Bonus<sup>9</sup> (% change) |
| | **2024-**<br>**25**<br>| 2023-<br>24<br>| 2022-<br>23<br>| 2021-<br>22<br>| 2020-<br>21<br>| **2024-**<br>**25**<br>| 2023-24 | 2022-<br>23<br>| 2021-<br>22<br>| 2020-<br>21<br>| **2024-**<br>**25**<br>| 2023-2<br>4<br>| 2022-<br>23<br>| 2021-<br>22<br>| 2020-<br>21<br>|
| **Executive Director** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Anil Wadhwani<sup>1</sup> | **–** | 19% | – | – | – | **26%** | 3% | – | – | – | **(8)%** | 6% | – | – | – |
| **Chair and Non-**<br>**executive Directors**<sup>3</sup><br>|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Shriti Vadera<sup>2</sup> | **2%** | (1)% | 1% | 2% | 907% | **10%** | (18)% | 10% | 35% | – | **–** | – | – | – | – |
| Jeremy Anderson | **1%** | 5% | 12% | 3% | 13% | **25%** | 300% | – | – | – | **–** | – | – | – | – |
| Arijit Basu<sup>4</sup> | **2%** | 1% | 198% | – | – | **33%** | 200% | – | – | – | **–** | – | – | – | – |
| Guido Fürer<sup>5</sup> | **–** | – | – | – | – | **–** | – | – | – | – | **–** | – | – | – | – |
| Ming Lu<sup>6</sup> | **2%** | 0% | 0% | 58% | – | **–** | – | – | – | – | **–** | – | – | – | – |
| George Sartorel<sup>4</sup> | **3%** | 7% | 34% | – | – | **(40)%** | 400% | – | – | – | **–** | – | – | – | – |
| Mark Saunders<sup>7</sup> | **36%** | – | – | – | – | **–** | – | – | – | – | **–** | – | – | – | – |
| Claudia Suessmuth <br>Dyckerhoff<sup>8</sup><br>| **2%** | 1% | – | – | – | **50%** | 100% | – | – | – | **–** | – | – | – | – |
| Chua Sock Koong<sup>6</sup> | **1%** | (1)% | 5% | 70% | – | **0%** | 100% | – | – | – | **–** | – | – | – | – |
| Jeanette Wong<sup>6</sup> | **6%** | 19% | 0% | 74% | – | **(33)%** | – | – | – | – | **–** | – | – | – | – |
| Amy Yip<sup>8</sup> | **(15)%** | 0% | 0% | 1% | 0% | **–** | – | – | – | – | **–** | – | – | – | – |
| UK-based employees | **4.0%** | 4.6% | 6.0% | 6.7% | 3.1% | **46.1%** | (14.5)% | 45.1% | (7.3)% | 0.7% | **(9.9)%** | (13.6)% | 143% | 7.9% | 5.8% |

---

**Notes**

(1)Anil Wadhwani was appointed as Chief Executive Officer on 25 February 2023. The change in salary and benefits in 2023–24 reflects his pro-rated pay for

2023. In addition, his 2023 bonus was determined using his pro-rated salary. The percentage change in remuneration is calculated in USD.

(2)Shriti Vadera joined the Board and the Nomination & Governance Committee on 1 May 2020 and became Chair on 1 January 2021. The change in pay in 2020–

21 reflects her pro-rated pay for 2020 as well as her change in role. Fluctuations in benefits are also in part due to exchange rate movements where not dollar-

denominated.

(3)Fluctuations in Non-executive Directors' pay are due to changes in Committee memberships and changes in the basic fee or additional fees for being a

Committee Chair or member. Fluctuations in benefits are also in part due to exchange rate movements where not dollar-denominated.

(4)Arijit Basu and George Sartorel joined the Board in 2022. The changes in pay in 2022–23 reflect their pro-rated pay for 2022.

(5)Guido Fürer joined the Board on 1 July 2025.

(6)Ming Lu, Chua Sock Koong and Jeanette Wong joined the Board in 2021. The changes in pay in 2021–22 reflect their pro-rated pay for 2021.

(7)Mark Saunders joined the Board on 1 April 2024. The change in pay in 2024–25 reflects his pro-rated pay for 2024.

(8)Amy Yip retired from the Board on 31 October 2025.

(9)The year-on-year change in bonus for UK-based employees between 2022 and 2023 reflects changes in the structure of their bonus plan and business

performance. The increase in the level of taxable benefits from 2022 to 2023 for employees reflects the extension of private medical cover offered to

employees and the introduction of critical illness cover.

(10)The year-on-year change in benefits from 2024 to 2025 for Mr Wadhwani reflects the increased cost in the provision of a car and driver, medical insurance and

expatriate benefits and for UK-based employees the change reflects a new health cash plan introduced to align with Group-wide minimum standards and a

higher private medical insurance cost in 2025 compared to 2024.

The regulations prescribe that this comparison should include all employees of the parent company. The number of individuals

employed by the parent company is insufficient to be the basis of a representative comparison. Therefore, the Committee has

decided to use all UK-based employees as the basis for this calculation. The average pay for all employees has been calculated on

a full-time equivalent basis by reference to the total pay awarded to UK employees in each year from 2025 back to 2019. The

salary increase includes uplifts made through the annual salary review, as well as any additional changes in the year; for example,

to reflect promotions or role changes.

**Chief Executive Officer pay compared with employee pay and gender pay gap**

As reported in prior years, the UK headcount of Prudential Services Limited is below the 250-person threshold, which triggers

mandatory publication of the gender pay gap and the CEO pay ratio. After due consideration, we have decided that the UK gender

pay gap and CEO pay ratio are not meaningful, given our relatively small employee headcount in the UK.

**Consideration of workforce pay and approach to engagement**

The Committee believes that its approach to executive remuneration is consistent with the pay, reward and progression policies

for other employees within the Group. The base salary and total remuneration levels for the Chief Executive Officer and other

employees are competitively positioned within the relevant markets and reflect the operation of our remuneration structures,

which are effective in appropriately incentivising staff, having regard to our risk framework and risk appetites, and to rewarding

the 'how' as well as the 'what' of performance. During 2025, the Committee considered workforce remuneration and related

policies in the businesses across the Group. Information presented to the Committee, by way of a dashboard, included how the

Company's incentive arrangements are aligned with the culture and informed the Committee's decision-making on executive pay

and policy. By way of example, employee salary increase budgets are considered as part of the review of the Chief Executive

Officer's compensation and salary increases.

The Committee considered the Chief Executive's remuneration in the context of workforce pay and is satisfied that it remains

appropriate. In 2025, salary increases for other employees across the Group's businesses were 5.2 per cent while the Chief

Executive Officer received no salary increase in January 2025. Employee engagement is led by the Sustainability Committee. The

Strategic report describes how it discharged this responsibility during 2025.

The Group operates PRUshareplus, an all-employee share purchase plan available to employees in 25 countries – 15 in Asia, eight

in Africa and two in Europe – allowing our people to invest in the Company's shares. Similar Syariah-compliant plans are available

in our Syariah business. The Group also operates a UK Save As You Earn (SAYE) scheme and Share Incentive Plan (SIP). UK-

based employees are eligible to participate in both plans. Further details are provided in note B2.2 of the consolidated financial

statements.

As part of our continuing efforts to safeguard our employees' wellbeing, we held our fifth Prudential Recharge Day on 19

September 2025. All employees Group-wide were encouraged to take the day as an extra day off to rest and recharge, and to

spend time with family and friends.

**Chair and Non-executive Director remuneration in 2025 – *audited information***

**Chair fee**

Shriti Vadera's fee was reviewed by the Committee during 2025. Having considered the fee against external benchmarks and that

it was last increased in July 2022, the Committee felt that it was appropriate to increase her fee to $1,005,000, effective from 1

July 2025.

**Non-executive Directors' fees**

The Non-executive Directors' fees are denominated in US dollars. The fees were reviewed by the Board during 2025 with a 3.2%

increase made to the basic fee, which had been last increased in July 2022; this fee change was effective from 1 July 2025.

---

| | | |
|:---|:---|:---|
| Annual fees<sup>2</sup> | From<br>1 July 2024<br> ($)<br>| From<br>1 July 2025<br> ($)<br>|
| Basic fee | 125000 | 129000 |
| Additional fees: |  |  |
| Audit Committee Chair | 92000 | 92000 |
| Audit Committee member | 39000 | 39000 |
| Remuneration Committee Chair | 80000 | 80000 |
| Remuneration Committee member | 39000 | 39000 |
| Risk Committee Chair | 92000 | 92000 |
| Risk Committee member | 39000 | 39000 |
| Nomination & Governance Committee Chair<sup>1</sup> | – | – |
| Nomination & Governance Committee member | 19000 | 19000 |
| Sustainability Committee Chair | 60000 | 60000 |
| Sustainability Committee member | 30000 | 30000 |
| Senior Independent Director | 61000 | 61000 |

---

**Notes**

(1)There is no fee paid for the role of Nomination & Governance Committee Chair.

(2)As detailed in the Directors' remuneration policy, should a new committee or working group be formed, the remit of an existing committee be materially

expanded, or a new Non-executive Director role established, new or additional fees may be paid. Any fees will be commensurate with the new or additional

responsibilities and time commitment involved.

If, in a particular year, the number of meetings and/or time commitment is materially greater than usual, the Company may

determine that the provision of additional fees is fair and reasonable. No additional fees were paid in 2025.

The resulting fees paid to the Chair and Non-executive Directors are:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025 fees**<br>**($000)** <br>| 2024 fees<br>($000) <br>| **2025**<br>**taxable**<br>**benefits\***<br>**($000)** <br>| 2024<br>taxable<br>benefits\*<br>($000) <br>| **Total 2025**<br>**remuneration:**<br>**the 'single**<br>**figure'**<br> **($000)†‡**<br>| Total 2024<br>remuneration:<br>the 'single<br>figure'<br> ($000)†‡<br>|
| **Chair** |  |  |  |  |  |  |
| Shriti Vadera | **986** | 966 | **123** | 112 | **1109** | 1078 |
| **Non-executive Directors** |  |  |  |  |  |  |
| Jeremy Anderson | **338** | 335 | **5** | 4 | **343** | 339 |
| Arijit Basu | **196** | 192 | **4** | 3 | **200** | 195 |
| Guido Fürer<sup>1</sup> | **104** | – | **–** | – | **104** | – |
| Ming Lu<sup>2</sup> | **185** | 182 | **–** | – | **185** | 182 |
| George Sartorel | **284** | 277 | **3** | 5 | **287** | 282 |
| Mark Saunders | **205** | 151 | **–** | – | **205** | 151 |
| Claudia Suessmuth Dyckerhoff | **196** | 192 | **3** | 2 | **199** | 194 |
| Chua Sock Koong | **226** | 223 | **2** | 2 | **228** | 225 |
| Jeanette Wong | **288** | 271 | **2** | 3 | **290** | 274 |
| Amy Yip<sup>3</sup> | **138** | 163 | **–** | – | **138** | 163 |
| **Total** | **3146** | 2952 | **142** | 131 | **3288** | 3083 |

---

\*Benefits include the cost of providing the use of a car and driver and medical insurance where applicable.

†Each remuneration element is rounded to the nearest $1,000 and totals are the sum of these rounded figures. The Chair and Non-executive Directors are not

entitled to participate in annual bonus plans or long-term incentive plans.

‡Remuneration components denominated in GBP have been converted to US dollars using an exchange rate of 0.7824 for the 2024 single figure calculation and

0.7581 for the 2025 single figure calculations. As Non-executive Directors and the Chair do not receive variable remuneration components, the table above

does not include a sum of total fixed and total variable remuneration.

**Notes**

(1)Guido Fürer joined the Board on 1 July 2025.

(2)During 2024, Ming Lu donated his fee to InspringHK Sports, an independent non-profit organisation based in Hong Kong.

(3)Amy Yip retired from the Board on 31 October 2025.

**Statement of Directors' shareholdings – audited information**

The interests of Directors in ordinary shares of the Company are set out below. 'Beneficial interest' includes shares owned outright

and deferred annual incentive awards, detailed in the Additional remuneration disclosures section. It is only these shares that

count towards the share ownership guidelines.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | | | 31 December 2025<br>(or on date of stepping down) | 31 December 2025<br>(or on date of stepping down) | 31 December 2025<br>(or on date of stepping down) | Share ownership <br>guidelines | Share ownership <br>guidelines |
| | 1 January <br>2025 (or on <br>date of <br>appointment)<br>Total<br>beneficial<br>interest<br> (number of<br> shares)<br>| Number<br>of shares<br>acquired <br>during the <br>year<br>| Number<br>of shares<br>disposed of <br>during the <br>year<br>| Total<br>beneficial<br>interest\*<br> (number of<br> shares)<br>| Number<br>of shares<br>subject to<br>performance<br>conditions†<br>| Total interest<br>in shares<br>| Share<br>ownership<br>guidelines<sup>‡</sup><br> (% of <br>salary/fee)<br>| Beneficial<br>interest as a<br>percentage <br>of basic <br>salary/<br>basic fees<sup>§</sup><br>|
| **Chair** |  |  |  |  |  |  |  |  |
| Shriti Vadera | 117500 | – | – | 117500 | – | 117500 | 100% | 159% |
| **Executive Director** |  |  |  |  |  |  |  |  |
| Anil Wadhwani<sup>1</sup> | 329573 | 137035 | – | 466608 | 1770768 | 2237376 | 400% | 403% |
| **Non-executive Directors** |  |  |  |  |  |  |  |  |
| Jeremy Anderson | 19157 | – | – | 19157 | – | 19157 | 100% | 202% |
| Arijit Basu | 9691 | 4000 | – | 13691 | – | 13691 | 100% | 144% |
| Guido Fürer | – | 13000 | – | 13000 | – | 13000 | 100% | 137% |
| Ming Lu | 12600 | 5000 | – | 17600 | – | 17600 | 100% | 186% |
| George Sartorel | 13000 | 1000 | – | 14000 | – | 14000 | 100% | 148% |
| Mark Saunders | 13750 | – | – | 13750 | – | 13750 | 100% | 145% |
| Claudia Suessmuth Dyckerhoff | 4800 | – | – | 4800 | – | 4800 | 100% | 51% |
| Chua Sock Koong | 15000 | – | – | 15000 | – | 15000 | 100% | 158% |
| Jeanette Wong | 14600 | – | – | 14600 | – | 14600 | 100% | 154% |
| Amy Yip | 14013 | – | – | 14013 | – | 14013 | 100% | 148% |

---

\*Beneficial interests include shares held directly or indirectly by connected persons. The only changes in the Directors' interests in ordinary shares between 31

December 2025 and 17 March 2026 were the acquisition of 109 shares through the Prudential All Employee Share Purchase Plan by Anil Wadhwani.

†Further information on share awards subject to performance conditions are detailed in the 'share-based long-term incentive awards' part of the Additional

remuneration disclosures section.

‡The holding requirement under the Articles of Association (2,500 ordinary shares) must be obtained within one year of appointment to the Board. Executive

Directors and the Chair have five years to reach their guideline. Non-executive Directors have three years from their date of joining to reach the guideline.

§Based on the average closing price for the six months to 31 December 2025 (HKD106.05) and the exchange rate of 7.7960 for HKD.

The Company and its Directors, Chief Executives and shareholders have been granted a partial exemption from the disclosure requirements under Part XV of the

Securities and Futures Ordinance (SFO). As a result of this exemption, Directors, Chief Executives and shareholders do not have an obligation under the SFO to

notify the Company of shareholding interests, and the Company is not required to maintain a register of Directors' and Chief Executives' interests under section

352 of the SFO, nor a register of interests of substantial shareholders under section 336 of the SFO. The Company is, however, required to file with the Stock

Exchange of Hong Kong Limited any disclosure of interests notified to it in the United Kingdom.

**Note**

(1)Anil Wadhwani was appointed on 25 February 2023 and had met his share ownership guidelines by the end of 2025. Total beneficial interest includes deferred

bonus awards without performance conditions.

**Directors' terms of employment**

Details of the service contract of the Chief Executive Officer are outlined in the table below. The Directors' remuneration policy

contains further details of the terms included in Executive Director service contracts. As required by the Hong Kong Listing Rules,

all Executive Director service contracts can be terminated by the Company by giving no more than 12 months' notice (or payment

in lieu of such notice) and without compensation payments other than any termination payments required by law.

---

| | | | |
|:---|:---|:---|:---|
| | Date of contract | Notice period<br>to the<br>Company<br>| Notice period<br>from the<br>Company<br>|
| **Executive Director** |  |  |  |
| Anil Wadhwani | 25 February 2023 | 12 months | 12 months |

---

**Letters of appointment of the Chair and Non-executive Directors**

Details of Non-executive Directors' individual appointments are outlined below. The Directors' remuneration policy contains further

details on their letters of appointment. The Chair and Non-executive Directors are not entitled to receive any payments for loss of

office. As required by the Hong Kong Listing Rules, the appointment of the Chair and the Non-Executive Directors can be

terminated by the Company by giving no more than six months' notice (12 months' notice for the Chair), or payment in lieu of

such notice and without compensation payments other than any termination payments required by law.

---

| | | | |
|:---|:---|:---|:---|
| Chair/Non-executive Director | Appointment by the Board | Notice period | Time on the Board at 2026 AGM |
| **Chair** |  |  |  |
| Shriti Vadera (Chair from 1 January <br>2021)<br>| 1 May 2020 | 12 months | 6 years |
| **Non-executive Directors** |  |  |  |
| Amy Yip<sup>1</sup> | 2 September 2019 | 6 months | n/a |
| Jeremy Anderson | 1 January 2020 | 6 months | 6 years 4 months |
| Ming Lu | 12 May 2021 | 6 months | 5 years |
| Chua Sock Koong | 12 May 2021 | 6 months | 5 years |
| Jeanette Wong | 12 May 2021 | 6 months | 5 years |
| George Sartorel | 14 January 2022 | 6 months | 4 years 4 months |
| Arijit Basu | 1 September 2022 | 6 months | 3 years 8 months |
| Claudia Suessmuth Dyckerhoff | 1 January 2023 | 6 months | 3 years 4 months |
| Mark Saunders | 1 April 2024 | 6 months | 2 years 1 month |
| Guido Fürer | 1 July 2025 | 6 months | 10 months |

---

**Note**

(1)Amy Yip retired from the Board on 31 October 2025.

**Payments to past Directors and payments for loss of office – *audited information***

Payments to past Directors, as they relate to their Directorships, are described below. A *de minimis* threshold of £10,000 has been

set by the Committee; any payments or benefits provided to a past Director above this amount will be reported. There were no

payments to past Directors in 2025, nor any additional payments to Directors for loss of office in the year.

**Statement of voting at general meeting**

The Directors' remuneration policy was approved by shareholders at the 2023 Annual General Meeting. At the 2025 Annual

General Meeting, shareholders were asked to vote on the 2024 Directors' remuneration report. Each of these resolutions received

a significant vote in favour and the Committee is grateful for this support and endorsement by our shareholders. The votes

received were:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Resolution** | Votes for | % of<br>votes cast<br>| Votes against | % of<br>votes cast<br>| Total votes cast | Votes withheld |
| To approve the Directors' <br>remuneration policy (2023 AGM)<br>| 2176820906 | 95.71 | 97529901 | 4.29 | 2274350807 | 12342304 |
| To approve the Directors' <br>remuneration report (2025 AGM)<br>| 1967863835 | 92.40 | 161804212 | 7.60 | 2129668047 | 1720482 |

---

**Statement of implementation of remuneration policy in 2026** 

The proposed implementation of remuneration policy set out below is subject to shareholder approval of the Directors'

remuneration policy at the AGM to be held on 28 May 2026. Information about the 2026 Directors' remuneration policy is set out

in the New Directors' remuneration policy.

**Base salary**

The Chief Executive Officer's remuneration package was reviewed in 2025, with the Committee considering the expected salary

increases budgeted for other employees in 2026, alongside external benchmarks. These benchmarks, based on the 2025 TSR peer

group, Asia-focused insurers and financial services firms, were selected to reflect that we compete for talent globally, particularly

within financial services organisations with significant operations in Asia.

After due deliberation and consultation with the Company's shareholders, the Committee considered that Mr Wadhwani's salary for

2026 should be increased by 3 per cent. This recognises the time elapsed since his current base salary was last set in 2022 and

his strong leadership and performance since joining the Company. Since the wider Prudential workforce received an average 5.1

per cent salary increase, 2026 will be the 14th consecutive year in which the increases generally offered to executives have been

below or close to the bottom of the range of salary increases budgeted for the broader workforce.

Mr Wadhwani's annual salary, effective 1 January 2026, will be HKD12,650,000.

**2026 pension entitlements**

Mr Wadhwani's pension benefits will remain aligned to the workforce rate, currently considered to be 13 per cent of salary. In

addition, statutory contributions will continue to be made into mandatory pension arrangements in Hong Kong, in line with local

requirements.

**Annual bonus**

Mr Wadhwani will be eligible for a maximum bonus opportunity of 250 per cent of salary, subject to deferral in line with the 2026

Directors' remuneration policy.

For 2026, the AIP for the Chief Executive Officer's bonus will continue to be based on financial measures (80 per cent) and on

personal and strategic objectives (20 per cent). Given the strong connection between remuneration and our longer-term strategic

objectives, and that we are mid-way through our strategic cycle, we intend to keep the measures and weightings for the 2026 AIP

unchanged from 2025, as set out below:

–Group new business profit – 45 per cent;

–Group adjusted operating profit – 20 per cent;

–Group net operating free surplus generation – 20 per cent; and

–Group holding Company cash flow – 15 per cent.

In 2025, we transitioned our external reporting from IFRS operating profit pre-tax to IFRS operating profit post-tax, to better align

with investor expectations and peer disclosures. Accordingly, the IFRS measure for AIP from 2026 will be based on a post-tax

basis.

The Committee considers the forward-looking targets to be commercially sensitive. The performance targets and outcomes will be

set out in next year's Directors' remuneration report.

**2026 share-based long-term incentive awards**

Award levels

Mr Wadhwani will be eligible to receive a 2026 PLTIP award of 375 per cent of salary.

The Committee will review awards on vesting to ensure that participants do not benefit from windfall gains. The Committee will

consider Prudential's stretching performance targets, the share performance of Prudential and its peers, the performance of the

indices on which Prudential is listed, and any other factors it deems relevant when determining vesting.

Performance conditions

The measures, weightings and targets for the 2026 PLTIP award for the Chief Executive Officer are summarised below:

---

| | | | |
|:---|:---|:---|:---|
| **Measure** | Weighting | Threshold <br>performance<sup>1</sup><br>(20% vesting)<br>| Stretch performance<br>(100% vesting)<br>|
| Relative TSR<sup>2</sup> | 40% | Median | Upper quartile |
| NBP<sup>3</sup> | 15% | $9,630m | $13,029m |
| Gross OFSG<sup>4</sup> | 15% | $10,841m | $14,668m |
| RoEV<sup>5</sup> | 15% | 14.3% | 19.3% |
| Business integrity scorecard | 15% | see below | see below |

---

**Notes**

(1)Performance below threshold results in 0% vesting.

(2)Relative TSR is measured on a local currency basis since this has the benefit of simplicity and directness of comparison. For 2026 awards, the 2026 TSR peer

group comprises: AIA Group, China Life Insurance, China Pacific Insurance Company, China Taiping Insurance, DBS Group, Manulife Financial, MetLife,

Oversea-Chinese Banking Corporation Limited, New China Life, Ping An Insurance, and Standard Chartered.

(3)NBP measures the value creation of writing new business and is a key metric to indicate growth.

(4)Gross OFSG will be calculated as the operating free surplus generated within local businesses before investment in new business and any central costs.

(5)RoEV is a comprehensive performance measure for the Group, capturing both new business growth and the efficient management of in-force business.

Under the business integrity scorecard, performance will be assessed for each of the three measures at the end of the three-year

performance period:

---

| | | | |
|:---|:---|:---|:---|
| **Measure** | Weighting<br>(% of total <br>LTIP)<br>| Threshold performance<br>(20% vesting)<br>| Stretch performance<br>(100% vesting)<br>|
| Financing the Transition<sup>1</sup> | 5% | $3.783bn | $4.017bn |
| GWS capital measure<sup>2, 4</sup> | 5% | Threshold | Stretch |
| GIECA measure<sup>3, 4</sup> | 5% | Threshold | Stretch |

---

**Notes**

(1)Cumulative committed/invested capital over the three-year performance period. The targets have been externally validated. This element is subject to a WACI

reduction underpin which must be met before any part of the FTT element vests.

(2)Cumulative three-year GWS operating capital generation relative to threshold.

(3)GIECA surplus generation is a Pillar 2 economic capital metric.

(4)The targets for these metrics are deemed to be commercially sensitive and, if disclosed, would put the Company at a disadvantage compared to its

competitors. They will be published in the Annual Report for the final year of the performance period.

**Chair and Non-executive Directors**

Fees for the Chair and Non-executive Directors were reviewed in 2025 with changes effective from 1 July 2025, as set out in the

Chair and Non-executive Director remuneration in 2025 section. The next regular fee level review will be conducted in 2026.

**New Directors' remuneration policy**

This section sets out the revised Directors' remuneration policy ('Policy') which will be put forward to shareholders for a binding

vote at the 2026 AGM on 28 May 2026. If approved, this Policy will apply immediately for three years following the AGM, unless

prior shareholder approval is obtained for an amendment. This Policy has evolved from the current Policy which was approved at

the AGM held on 25 May 2023 and has applied from that date. The Committee considers that the Policy maintains strong

alignment between executive remuneration and Company performance.

The current Policy has operated as intended. Full details of the existing Policy can be found on our website at https://

www.prudentialplc.com/content/dam/prudential-plc/investor/governance-and-policies/policies-and-statements/directors-

remuneration-policy-2022.pdf.

During 2025, the Committee reviewed the Policy. In order to allow the Company to attract and retain best-in-class Executive

Directors from within or outside the Group in Asia, the Committee determined that it was essential to take steps to better align the

Policy with the remuneration practices of peers while also taking account of the need to reinforce the community of interest

between Executive Directors and other stakeholders, the views of our shareholders, the remuneration of the workforce, the UK

Corporate Governance Code, and the Company's broader regulatory and competitive environment. The Committee has determined

that there would be no increase to the total usual annual maximum incentive opportunity available to Executive Directors.

In considering the remuneration arrangements, the Committee was aware that there is no one remuneration design which is

typical among our peers in Asia. Companies operate a wide variety of incentive models.

Notwithstanding these differences in design, our peers generally deliver a greater proportion of remuneration in cash and pay over

a much shorter timeframe than the Company's existing reward models. In formalising the revised Policy, input was sought from

the management team, while ensuring that conflicts of interest were suitably mitigated. Advice also was sought from the Risk

Committee to ensure the Policy appropriately reflects risk management considerations and supports risk-aligned remuneration

outcomes. To ensure objectivity when formulating and operating the Policy, the Committee is entirely made up of independent

Non-executive Directors and no-one is present when their own remuneration is being discussed by the Committee.

**Changes from 2023 Policy**

The Committee evaluated a number of alternative remuneration structures. Following careful consideration and discussion with our

major investors, the Committee has decided to retain key features of the current incentive structure and of the Policy approved by

shareholders in May 2023, while introducing some changes to equip the Group to recruit and retain critical executive talent in the

Asia market. The Policy and the sections on the Annual Incentive Plan (AIP) and Prudential Long Term Incentive Plan (PLTIP) in

particular have been simplified to offer greater flexibility and clarity. The principal differences between the 2026 and 2023 Policies

are set out below.

---

| | | | |
|:---|:---|:---|:---|
| Policy element(s) | 2023 Policy | Recommended 2026 Policy | Commentary |
| **Base salary –** <br>**value**<br>| –Annual salary increases for <br>Executive Directors will normally <br>be in line with the increases for <br>other employees unless there is a <br>change in role or responsibility.<br>| –Annual salary increases for <br>Executive Directors will normally <br>be in line with the increases for <br>other employees. The Committee <br>can determine to increase the <br>annual salary for Executive <br>Directors above the increases for <br>other employees if it believes that <br>this is appropriate based on <br>factors considered during the <br>salary review.<br>| –Our long-standing practice has <br>been for annual salary increases <br>for Executive Directors to be <br>below the increases for other <br>employees. Notwithstanding that <br>it is anticipated that this will <br>continue to be the case, this <br>change allows the Committee to <br>apply their judgement to ensure <br>the overall remuneration package <br>remains competitive.<br>–Should the Committee consider <br>using this power, this would <br>usually be discussed with major <br>investors before a decision was <br>made and its reasons for making <br>the decision would be disclosed in <br>the relevant Annual report on <br>remuneration.<br>|

---

---

| | | | |
|:---|:---|:---|:---|
| Policy element(s) | 2023 Policy | Recommended 2026 Policy | Commentary |
| **Benefits** | –Executive Directors and Non-<br>executive Directors (NEDs) can <br>receive reimbursement for <br>business expenses (including any <br>tax liability) incurred when <br>travelling overseas in performance <br>of duties.<br>–If as a consequence of the <br>Company's corporate structure, <br>Non-executive Directors are <br>required to prepare personal tax <br>returns in Hong Kong and/or the <br>UK, in addition to preparing their <br>personal tax return for the <br>jurisdiction which is their place of <br>residence, the Company will <br>reimburse the costs of personal <br>tax return preparation for <br>whichever locations are not their <br>place of residence (including <br>payment of any tax cost <br>associated with the provision of <br>the benefit).<br>| –Business expense reimbursement <br>is also applicable to Executive <br>Directors. The description of <br>reimbursed business expenses <br>has been expanded to include <br>banking fees and any other <br>reasonable fees for professional <br>services incurred when travelling <br>overseas in performance of duties <br>or due to the Company's <br>corporate structure.<br>–Modest gifts or awards to <br>Executive Directors on customary <br>occasions of the same value as <br>offered to the wider workforce in <br>the same location, for example <br>long service awards.<br>| –Reflects the administrative <br>obligations created for the <br>Executive Directors and NEDs in <br>discharging their services.<br>–Supports alignment with the wider <br>workforce.<br>|
| **Bonus –** <br>**opportunity**<br>| –The maximum AIP opportunity is <br>up to 200 per cent of salary for <br>Executive Directors. Annual <br>awards are disclosed in the <br>relevant Annual report on <br>remuneration.<br>| –The maximum AIP opportunity is <br>up to 250 per cent of salary for <br>Executive Directors. Annual <br>awards are disclosed in the <br>relevant Annual report on <br>remuneration.<br>| –This change is part of rebalancing <br>the usual total maximum incentive <br>opportunity between long-term <br>incentive and bonus, i.e. reducing <br>the 2026 PLTIP award by 50 per <br>cent of salary and increasing the <br>2026 AIP award by 50 per cent of <br>salary.<br>|
| **Bonus – form** <br>**and timing of** <br>**payment**<br>| –40 per cent of an Executive <br>Director's bonus will be deferred <br>in cash for three years provided <br>that their share ownership <br>guideline is met. Deferred awards <br>will be made in shares if the <br>Executive Director's share <br>ownership guideline has not yet <br>been achieved. The Committee <br>retains discretion to vary the <br>proportion of the bonus to be <br>deferred and the length of the <br>deferral period.<br>–The release of deferred bonus <br>awards is not subject to any <br>further performance conditions. <br>Deferred bonus awards in shares <br>carry the right to accumulate an <br>amount to reflect the dividends <br>payable in respect of the shares <br>that vest during the deferral <br>period. These dividend <br>equivalents will normally be <br>settled in shares, but there is the <br>flexibility to deliver them in cash. <br>The amount of the dividend <br>equivalent payment may assume <br>the re-investment of the relevant <br>dividends in shares.<br>| –Up to 40% of an Executive <br>Director's bonus will be deferred <br>into shares, for three years, while <br>they are building their share <br>ownership and until their share <br>ownership guideline has been <br>met, otherwise a bonus is paid <br>immediately in cash. Achievement <br>of the share ownership guideline <br>will be assessed as at the end of <br>the financial year for which the <br>bonus is paid. <br>–For the avoidance of doubt, an <br>Executive Director will need to <br>continue to meet the share <br>ownership guideline (even during <br>the share ownership guideline <br>build up period) for AIP awards to <br>be paid in cash. If the share <br>ownership guideline is not met at <br>the end of a financial year, the <br>necessary portion of the AIP paid <br>in respect of that year will be <br>delivered in shares.<br>| –This change, together with the <br>other recommended changes, is <br>designed to ensure the overall <br>remuneration package is <br>competitive. Our peers generally <br>deliver a greater proportion of <br>total remuneration in cash and <br>over a much shorter timeframe.<br>|
| **Fees for the** <br>**Chair and** <br>**Non-executive** <br>**directors**<br>| –The Chair receives an annual fee <br>for the performance of their role.<br>–All Non-executive Directors <br>receive a basic fee for their duties <br>as a Board member. Additional <br>fees are paid for added <br>responsibilities. <br>| –The Chair receives an annual fee <br>for the performance of their role. <br>–All Non-executive Directors <br>receive a basic fee for their duties <br>as a Board member. Additional <br>fees are paid for added <br>responsibilities.<br>–A portion of fees may be delivered <br>in the form of shares without <br>performance conditions, based on <br>the market value of the shares, if <br>the Board/ Committee deems that <br>this is appropriate.<br>| –We intend to continue to pay fees <br>in cash in 2026. A provision <br>allowing a portion of fees to be <br>delivered in shares provides the <br>Board/ Committee flexibility in <br>light of relevant circumstances, <br>including changes in market <br>practice, during the life of the <br>Policy.<br>|

---

**Fixed pay Policy for Executive Directors**

---

| | | |
|:---|:---|:---|
| Component and purpose | Operation | Opportunity |
| Base salary<br>Paying salaries at a competitive <br>level enables the Company to <br>recruit and retain key Executive <br>Directors.<br>| Offer Executive Directors market competitive base <br>salaries.<br>The Committee usually reviews salaries annually <br>with changes normally effective from 1 January. In <br>determining base salary for each Executive <br>Director, the Committee considers factors such as:<br>–Salary increases for other employees across the <br>Group;<br>–The performance and experience of each <br>Executive Director;<br>–The size and scope of the role;<br>–Group financial performance;<br>–Internal relativities; and<br>–External factors such as economic conditions <br>and market data, taking into account the <br>geographies and markets in which the Company <br>operates and competes for talent.<br>| Annual salary increases for Executive <br>Directors will normally be in line with the <br>increases for other employees unless the <br>Committee determines otherwise based on <br>the factors considered during the salary <br>review.<br>|
| Benefits<br>Provided to Executive Directors to <br>support their health and <br>wellbeing, and to assist them in <br>carrying out their duties <br>effectively.<br>Relocation and location-specific <br>benefits allow Prudential to <br>attract high calibre Executive <br>Directors in the international <br>talent market and to deploy them <br>appropriately.<br>| The Committee has the discretion to offer <br>Executive Directors benefits which reflect their <br>individual circumstances and are competitive <br>within their local market, including but not limited <br>to:<br>–Health and wellness benefits;<br>–Protection and security benefits;<br>–Transport benefits;<br>–Family and education benefits;<br>–All employee share plans and savings plans;<br>–Relocation and location-specific benefits;<br>–Reimbursed business expenses (including any <br>relevant tax liability, banking fees and any other <br>reasonable fees for professional services such as <br>legal, tax, property and financial advice) <br>incurred when travelling overseas in <br>performance of duties or due to the Company's <br>corporate structure; and<br>–Modest gifts or awards on customary occasions <br>of the same value as offered to the wider <br>workforce in the same location, such as long <br>service awards.<br>| The maximum paid will be the cost to the <br>Company of providing these benefits. The <br>cost of these benefits may vary from year <br>to year but the Committee is mindful of <br>achieving the best value from providers.<br>|
| Provision for an income in <br>retirement<br>Pension benefits provide <br>Executive Directors with <br>opportunities to save for an <br>income in retirement.<br>| Executive Directors are offered pension benefits <br>that are competitive and appropriate in the <br>context of pension benefits for the wider <br>workforce.<br>Executive Directors have the option to:<br>–Receive payments into a defined contribution <br>scheme or similar arrangement; and/or<br>–Take a cash supplement in lieu of contributions.<br>In addition, Executive Directors may receive <br>statutory contributions to mandatory pension <br>arrangements in the country in which they are <br>based, in line with local requirements.<br>| Executive Directors will be entitled to <br>receive pension contributions or a cash <br>supplement (or a combination of the two) <br>in line with the workforce rate. In 2026, <br>this is considered to be 13 per cent of base <br>salary.<br>In addition, statutory contributions will be <br>made to mandatory pension arrangements <br>in the country in which the Executive <br>Directors are based, in line with local <br>requirements.<br>|

---

---

| | |
|:---|:---|
| **Annual bonus Policy for Executive Directors** | **Annual bonus Policy for Executive Directors** |
| **Purpose** | The purpose of the Annual Incentive Plan (AIP) is to provide a competitive package in the markets in <br>which we compete for talent. Payments under the AIP reward the delivery of stretching financial, functional <br>and/or personal objectives which are drawn from the annual business plan measured over a period not <br>exceeding one financial year.<br>|
| **Opportunity** | The maximum annual AIP opportunity is up to 250 per cent of salary for Executive Directors.<br>Annual awards are disclosed in the relevant Annual report on remuneration.<br>|
| **Operation** | Currently Executive Directors participate in the AIP with payments based on the achievement of financial, <br>functional and/or personal objectives generally assessed over one financial year.<br>Payments under the AIP will normally be made in cash following the end of the performance year unless <br>an Executive Director is yet to meet their share ownership guideline as assessed at the end of the financial <br>year, in which case they will normally be required to defer 40 per cent of their bonus in the form of shares <br>for three years. If a deferral in shares of less than 40 per cent would mean that the Executive Director has <br>met their share ownership guideline, this lower portion would be deferred in shares and the balance would <br>be paid immediately in cash. The Committee retains discretion to vary the proportion of the bonus to be <br>deferred and/or the length of the deferral period.<br>The release of deferred bonus awards is not subject to any further performance conditions. Deferred bonus <br>awards in shares carry the right to accumulate a 'dividend equivalent' amount to reflect the dividends <br>payable on those shares. The amount of the dividend equivalent may assume the re-investment of the <br>relevant dividends in shares.<br>|
| **Determining annual** <br>**bonus awards**<br>| The Committee determines the AIP award for each Executive Director with reference to the performance <br>achieved against approved performance ranges.<br>In making this assessment, the Committee will take into account the personal performance of the <br>Executive Director and the Group's risk management framework and appetite, as well as other relevant <br>factors. To assist them in their assessment, the Committee considers advice from the Risk Committee on <br>whether results were achieved within the Group's and businesses' risk management framework and <br>appetite and to relevant conduct standards.<br>The Committee may adjust the formulaic outcome based on the performance targets to reflect the <br>underlying performance of the Company by applying discretion within the limits of the Policy. The <br>Committee will disclose in the relevant Annual report on remuneration where discretion is used.<br>|
| **Performance** <br>**measures**<br>| The Committee determines the performance conditions and sets annual targets with reference to the <br>business plans approved by the Board.<br>No bonus is payable under the AIP for performance at or below the threshold level, increasing to 100 per <br>cent for achieving or exceeding the maximum level.<br>The weightings of the performance measures for 2026 for the Chief Executive Officer are 80 per cent <br>Group financial measures and 20 per cent personal measures.<br>The Committee retains the discretion to adjust performance conditions and/or targets if events occur (such <br>as a material acquisition and/or divestment of a Group business or the requirements of the Company's <br>regulators, or a change in prevailing market conditions) which cause the Committee to determine that the <br>measures and/or targets are no longer appropriate and that amendment is required so that they achieve <br>their original purpose.<br>|

---

---

| | |
|:---|:---|
| **Long-term incentive Policy for Executive Directors** | **Long-term incentive Policy for Executive Directors** |
| **Purpose** | The purpose of the Prudential Long Term Incentive Plan (PLTIP) is to provide a competitive package in the <br>markets in which we compete for talent and to reinforce the community of interest between the Executive <br>Directors and other stakeholders. Specifically, the PLTIP is designed to incentivise the delivery of longer-<br>term business plans; the creation of sustainable long-term returns for shareholders; and the achievement <br>of Group strategic priorities, such as disciplined risk and capital management.<br>|
| **Opportunity** | The value of shares awarded under the PLTIP (in respect of any given financial year) may not exceed 550 <br>per cent of the Executive Director's annual basic salary. On recruitment, any buy out awards will not count <br>towards this limit provided that they replace foregone awards on a like for like basis.<br>Annual awards are disclosed in the relevant Annual report on remuneration. The Committee would seek to <br>consult with major shareholders before making any increase to current award levels.<br>|

---

---

| | |
|:---|:---|
| **Long-term incentive Policy for Executive Directors** | **Long-term incentive Policy for Executive Directors** |
| **Operation** | Currently, Executive Directors receive PLTIP awards with full vesting only achieved if the Company meets <br>stretching performance targets normally measured over three years. Subject to the Committee's discretion <br>mentioned below, the extent that performance conditions are not achieved at the end of the three-year <br>performance period, the unvested portion of any award lapses and performance cannot be retested. <br>Wherever possible, the targets attached to PLTIP awards will be disclosed prospectively at the time of the <br>award. Where PLTIP targets are commercially sensitive, they will be published in the Annual Report of the <br>final year of the performance period.<br>The Committee retains the discretion to adjust (including by reducing to nil) the formulaic outcome under <br>the PLTIP if it considers that:<br>(1)the extent to which any performance condition has been met does not reflect the underlying financial <br>or non-financial performance of the participant or any member of the Group over the performance <br>period; or<br>(2)there exists any other reason why an adjustment is appropriate, taking into account such factors as <br>the Committee considers relevant, including the context of circumstances that were unexpected or <br>unforeseen at the date of grant.<br>The Committee will disclose in the relevant Annual report on remuneration where discretion is used. <br>Vested awards are normally also subject to a holding period which usually ends on the fifth anniversary of <br>the award (unless the Committee determines otherwise, in exceptional circumstances, such as an <br>Executive Director passing away).<br>If the Committee so determines, the Company may sell such number of shares under a PLTIP award as is <br>required to satisfy any income tax liability that in respect of a PLTIP award and the 'net of tax' balance of <br>shares will be subject to the holding period.<br>PLTIP awards carry the right to accumulate a 'dividend equivalent' amount to reflect the dividends payable <br>on those shares. The amount of the dividend equivalent may assume the re-investment of the relevant <br>dividends in shares. <br>|
| **Performance** <br>**measures**<br>| The performance conditions applicable to PLTIP awards may be set by reference to financial, non-financial <br>and strategic objectives, and the majority of a PLTIP award will be subject to quantitative targets. The <br>Committee sets targets with reference to the business plans approved by the Board. The achievement of <br>performance at the threshold level results in vesting of 20 per cent of the award, increasing to 100 per <br>cent for achieving the maximum level.<br>The Committee may decide to attach different performance conditions and/or change the conditions' <br>weighting for future PLTIP awards. Where relevant, the performance conditions attached to each award will <br>be based on the business plans and priorities of the Group and disclosed in the relevant Annual report on <br>remuneration.<br>The Committee considers advice from the Risk Committee on whether results were achieved within the <br>Group's and businesses' risk management framework and appetite and to relevant conduct standards.<br>The Committee retains the discretion to adjust performance conditions and/or targets if events occur (such <br>as a material acquisition and/or or the requirements of the Company's regulators or a change in prevailing <br>market conditions) which cause the Committee to determine that the measures and/or targets are no <br>longer appropriate and that amendment is required so that they achieve their original purpose.<br>|

---

**Share ownership guidelines for Executive Directors**

It is imperative that the Company's remuneration arrangements align the interests of Executive Directors and other stakeholders.

Share ownership guidelines reinforce this alignment.

---

| | |
|:---|:---|
| **In-employment** <br>**guidelines**<br>| Under the Articles of Association, Executive Directors are required to hold at least 2,500 shares and have <br>one year from their date of appointment to the Board to acquire these.<br>The share ownership guideline for the Chief Executive Officer during their employment is 400 per cent of <br>salary.<br>Executive Directors normally have five years from the later of the date of their appointment or promotion, <br>or the date of an increase in these guidelines, to build this level of ownership. Shares earned and deferred <br>under the AIP are included in calculating the Executive Director's shareholding for these purposes, as are <br>shares held by members of an Executive Director's household. Unvested share awards under long-term <br>incentive plans are not included but vested share awards under long-term incentive plans which are <br>subject to a post- vesting holding period are included.<br>Should an Executive Director not meet the share ownership guidelines, the Committee retains the <br>discretion to determine how this should be addressed, taking account of all the prevailing circumstances.<br>|
| **Post-Directorship** <br>**guidelines**<br>| When an Executive Director leaves the Board, they will be required to hold the lower of their actual <br>shareholding on the date of them stepping down from the Board and their in-employment share ownership <br>guideline for a period of two years.<br>The Committee has the discretion to disapply or reduce this requirement in extenuating circumstances, for <br>example if the Executive Director takes up a role with a regulator or for compassionate reasons.<br>This obligation will be implemented by requiring Executive Directors leaving the Board to obtain clearance <br>to deal in the Company's shares during the two years during which this post-Directorship share ownership <br>guideline applies, in the same way as they must during the time on the Board.<br>|

---

**Malus and clawback Policy**

The Committee may apply clawback and/or a malus adjustment to variable pay in certain circumstances as set out below and can

also delay the release of awards pending the completion of an investigation which could lead to the application of malus or

clawback. Additional malus and/or clawback provisions may be introduced by the Committee where required to do so by

regulatory requirements.

---

| | |
|:---|:---|
| | Circumstances where the Committee may exercise its discretion to apply malus or clawback to an award |
| Malus<br>Allows deferred cash <br>awards and unvested <br>shares awarded under <br>deferred bonus and <br>LTIP plans to be <br>forfeited or reduced in <br>certain circumstances.<br>| Malus may be applied where there are exceptional circumstances, such as:<br>–a material misstatement in the published results of any member of the Group, for any period during or <br>after the performance period (or if no performance periods are applicable, the vesting period);<br>–an error in the assessment of any applicable performance conditions, the determination of the relevant <br>bonus or the number of shares subject to an award (or where such assessment was based on inaccurate <br>or misleading information);<br>–gross misconduct;<br>–a breach by the Executive Director of any restrictive covenants or other similar undertakings;<br>–where the Executive Director has caused a material financial loss for the Group as a result of (i) <br>reckless, negligent or wilful actions or omissions; or (ii) inappropriate values or behaviour;<br>–where a member of the Group is censured by a regulatory body or suffers significant reputational <br>damage; and<br>–insolvency or corporate failure.<br>|
| Clawback<br>Allows cash and share <br>awards, including <br>shares subject to the <br>holding period, to be <br>recovered before or <br>after release in certain <br>circumstances.<br>| Clawback may be applied where there are exceptional circumstances, such as the circumstances listed <br>above:<br>–For the PLTIP, at any time before the fifth anniversary of the award date; and<br>–For the AIP, at any time before the fifth anniversary of the end of the bonus performance period.<br>|

---

**Notes to the Policy table for Executive Directors** 

**Committee's judgement**

The Committee is required to make judgements when assessing Company and individual performance under the Policy. In

addition, the Committee has discretions under the Company's share plans, for example, to determine if a leaver should retain their

unvested awards (and if so, the basis on which they are retained) and whether to apply malus or clawback to an award. The

exercise of any such discretions during the year will be reported and explained in the next Annual report on remuneration.

The Committee may approve payments or awards in excess of, in a different form to, or calculated or delivered other than as

described above, where the Committee considers such changes necessary or appropriate in light of regulatory requirements. If

these changes are considered by the Committee to be material, the Company will seek to consult with its major shareholders.

The Committee may make amendments to the rules of the AIP and PLTIP in accordance with the relevant plan rules. The

Committee retains the ability to amend incentive performance conditions or targets if anything happens which causes the

Committee to consider it appropriate that the amended condition will not be materially more or less challenging to satisfy the

original conditions.

**Key differences between Directors' remuneration and the remuneration of the wider workforce**

Across the Group, remuneration is reviewed regularly with the intention that all employees are paid appropriately in the context of

their relevant market and given their individual skills, experience and performance. The Committee regularly receives information

on workforce remuneration and related policies and takes this into account when determining Executive Director remuneration (for

example: it considers salary increase budgets for the workforce when determining the salaries of Executive Directors).

**Legacy payments** 

The Committee reserves the right to make any remuneration payments and/or payments for loss of office (including exercising

any discretion available to it in connection with such payments) notwithstanding that they are not in line with the Policy set out

above where the terms of the payment were agreed (i) before 15 May 2014 (the date the Company's first shareholder-approved

Policy came into effect); (ii) before this Policy came into effect, provided that the terms of the payment were consistent with the

shareholder-approved Policy in force at the time they were agreed; or (iii) at a time when the relevant individual was not a

Director of the Company and, in the opinion of the Committee, the payment was not in consideration for the individual becoming

or having been a Director of the Company. For these purposes 'payments' includes the Committee satisfying awards of variable

remuneration and, in relation to an award over shares, the terms of the payment are 'agreed' at the time the award is granted.

**Currency and references to 'shares'** 

In this Policy, references to shares may include share awards settled in shares listed on any of the stock exchanges where the

Company has a listing. Remuneration may be denominated and paid in any currency the Committee determines.

**Scenarios of total remuneration**

The chart below provides an illustration of the future total remuneration for the Executive Director in respect of his remuneration

opportunity for 2026. Four scenarios of potential outcome are provided based on the assumptions shown in the notes to the chart.

The Committee is satisfied that the maximum potential remuneration of the Executive Director is appropriate. Prudential's Policy is

to offer Executive Directors remuneration which reflects the performance and experience of the Executive Director, internal

relativities and Group financial and non-financial performance. In order for the maximum total remuneration to be payable:

> Financial performance must exceed the Group's stretching business plan;

> Relative TSR must be at or above the upper quartile relative to the peer group;

> The business integrity scorecard, aligned to the Group's strategic priorities, must be fully satisfied;

> Functional and personal performance objectives must be fully met; and

> Performance must be achieved within the Group's risk framework and appetite.

The fourth scenario below illustrates the maximum potential remuneration (shown in the third scenario) on the assumption that

the Company's share price grows by 50 per cent over three years.

**Scenario Chart - Anil Wadhwani**

![12644383719961](puk-20251231_g49.gif)

![](puk-20251231_g50.gif)

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | $15.65m |
|  |  | $12.60m | **58%** |
|  | $8.14m | **48%** |  |
|  | **45%** |  |  |
|  |  | **32%** | **26%** |
| $2.46m | **25%** |  |  |
| **100%** | **30%** | **20%** | **16%** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ■ | Fixed Pay | ■ | Short-term incentives | ■ | Long-term incentives |

---

**Notes**

The scenarios in the chart above have been calculated on the following assumptions:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Minimum | In line with expectations | Maximum | Share price growth |
| **Fixed pay** | –Base salary at 1 January 2026.<br>–Pension allowance for the year has been calculated at 13% of salary in line with this Policy.<br>–Estimated value of other benefits based on amounts paid in 2025. | –Base salary at 1 January 2026.<br>–Pension allowance for the year has been calculated at 13% of salary in line with this Policy.<br>–Estimated value of other benefits based on amounts paid in 2025. | –Base salary at 1 January 2026.<br>–Pension allowance for the year has been calculated at 13% of salary in line with this Policy.<br>–Estimated value of other benefits based on amounts paid in 2025. | –Base salary at 1 January 2026.<br>–Pension allowance for the year has been calculated at 13% of salary in line with this Policy.<br>–Estimated value of other benefits based on amounts paid in 2025. |
| **Annual bonus** | No bonus paid | 50% of maximum AIP | 100% of maximum AIP | 100% of maximum AIP |
| **Long-term incentives** <br>**(excludes dividends)**<br>| No PLTIP vesting | Vesting of 60% of PLTIP <br>award (midway between <br>threshold and <br>maximum)<br>| Vesting of 100% of <br>PLTIP award<br>| Vesting of 100% of <br>PLTIP award; plus, share <br>price growth of 50 per <br>cent over three years.<br>|

---

**Approach to recruitment remuneration**

The table below outlines the approach that Prudential will take when recruiting a new Executive Director. This approach would also

apply to internal promotions.

The approach to recruiting a Non-executive Director or a Chair is outlined in the 'Recruitment of a new Chair or Non-executive

Director' section.

---

| | | |
|:---|:---|:---|
| Element | Principles | Potential variations |
| **Base pay** | The salary for a new Executive Director will be set using <br>the approach set out in the Fixed pay Policy table.<br>|  |
| **Benefits and** <br>**pension**<br>| The benefits for a new Executive Director will be <br>consistent with those outlined in the Fixed pay Policy <br>table.<br>|  |
| **Variable** <br>**remuneration** <br>**opportunity**<br>| The variable remuneration opportunities for a new <br>Executive Director would be consistent with the limits <br>and structures outlined in the Annual bonus and Long-<br>term incentive plan award Policy tables.<br>|  |
| **Awards and** <br>**contractual** <br>**rights forfeited** <br>**when leaving** <br>**previous** <br>**employer**<br>| On joining the Board from within the Group, the <br>Committee may allow an Executive Director to retain <br>any outstanding deferred bonus and/or long-term <br>incentive awards and/or other contractual <br>arrangements that they held on their appointment. <br>These awards (which may have been made under plans <br>not listed in this Policy) would usually remain subject to <br>the original rules, performance conditions and vesting <br>schedule applied to them when they were awarded.<br>If an externally appointed Executive Director forfeits <br>one or more bonuses (including outstanding deferred <br>bonuses) on leaving a previous employer, these <br>payments or awards may be replaced in either cash, or <br>awards of Prudential shares of an equivalent value. <br>Replacement awards will normally be released on the <br>same schedule as the foregone bonuses.<br>If an externally appointed Executive Director forfeits <br>one or more long-term incentive awards on leaving a <br>previous employer, these may be replaced with <br>Prudential awards with an equivalent value.<br>Replacement awards will generally be made under the <br>terms of a long-term incentive plan approved by <br>shareholders, and vest on the same schedule as the <br>foregone awards. Where forgone awards were subject <br>to performance conditions, performance conditions will <br>normally be applied to awards replacing foregone long-<br>term incentive awards; these will usually be the same <br>as those applied to the long-term incentive awards <br>made to Prudential Executive Directors in the year in <br>which the forfeited award was made, the original <br>conditions applied by the previous employer or other <br>performance conditions which the Committee believes <br>are appropriate in the circumstances. Where foregone <br>awards were not subject to performance conditions, <br>performance conditions will not normally be applied to <br>awards replacing them. Replacement awards will <br>normally be subject to malus and clawback.<br>If an externally appointed Executive Director incurs <br>costs or other losses in connection with joining <br>Prudential (such as buying out their notice period with a <br>previous employer at the Company's request), the <br>Executive Director may be reimbursed, including any <br>tax payable in respect of the costs or losses.<br>| The Committee may consider compensating a <br>newly-appointed Executive Director for other <br>relevant contractual rights forfeited when leaving <br>their previous employer and/or for remuneration <br>foregone as a result of leaving their previous <br>employer.<br>The use of Listing Rule 9.3.2 may be used to <br>facilitate the recruitment of an Executive Director. <br>The Committee does not anticipate using this rule <br>on a routine basis but reserves the right to do so in <br>an exceptional circumstance. For example, this rule <br>may be required if, for any reason, like-for-like <br>replacement awards on recruitment could not be <br>made under existing plans.<br>This provision would only be used to compensate for <br>remuneration forfeited or foregone on leaving a <br>previous employer.<br>|

---

**Policy on payment on loss of office**

---

| | | |
|:---|:---|:---|
| Element | Principles | Potential variations |
| **Notice** <br>**periods**<br>| The Company's policy is that Executive Directors' <br>service contracts will not require the Company to give <br>an Executive Director more than 12 months' notice <br>without prior shareholder approval. A shorter notice <br>period may be offered where this is in line with market <br>practice in an Executive Director's location.<br>The Company is required to give to, and to receive <br>from, the current Executive Director 12 months' notice <br>of termination. An Executive Director whose contract is <br>terminated would be entitled to salary and benefits in <br>respect of their notice period. The payment of the <br>salary and benefits would either be phased over the <br>notice period or, alternatively, a payment in lieu of <br>notice may be made.<br>In agreeing the terms of departure for any Executive <br>Director, other than on death or disablement, the <br>Company will have regard to the need to mitigate the <br>costs for the Company, which would normally be <br>reduced or cease if the departing Executive Director <br>secures alternative paid employment during the notice <br>period.<br>| If an Executive Director is dismissed for cause, their <br>contract would be terminated with immediate effect and <br>they would not receive any payments in relation to <br>their notice period.<br>Should an Executive Director die, their estate would not <br>be entitled to receive payments and benefits in respect <br>of their notice period – provisions are made under the <br>Company's life assurance scheme to provide for this <br>circumstance.<br>Should an Executive Director step down from the Board <br>but remain employed by the Group, they would not <br>receive any payment in lieu of notice in respect of their <br>service as a Director.<br>|
| **Outstanding** <br>**deferred** <br>**bonus** <br>**awards**<br>| The treatment of outstanding deferred bonuses will be <br>decided by the Committee, taking into account the <br>circumstances of the departure including the <br>performance of the Executive Director.<br>Deferred bonus awards are normally retained by <br>participants leaving the Company. Awards will usually <br>vest on the original timetable and will not normally be <br>released early on termination.<br>Prior to release, awards remain subject to the malus <br>terms originally applied to them. The clawback <br>provisions will continue to apply.<br>| Any Executive Director dismissed for cause would <br>forfeit all outstanding deferred bonus awards.<br>Should an Executive Director die, outstanding deferred <br>bonus awards will be released as soon as possible after <br>the date of death. In the case of ill health and in other <br>exceptional circumstances, the Committee has the <br>discretion to accelerate the vesting of any outstanding <br>deferred bonus awards.<br>Should an Executive Director step down from the Board <br>but remain employed by the Group, they would retain <br>any outstanding deferred bonus awards. These awards <br>would remain subject to the original rules and vesting <br>schedule applied to them when they were awarded.<br>|
| **Unvested** <br>**long-term** <br>**incentive** <br>**awards**<br>| The treatment of unvested long-term incentive awards <br>will be decided by the Committee, taking into account <br>the circumstances of the departure including the <br>performance of the Executive Director.<br>Where an Executive Director is determined to be a good <br>leaver, unvested long-term incentive awards will <br>normally subsist. These awards will ordinarily be pro-<br>rated, unless the Committee determines otherwise, to <br>reflect the proportion of the performance period that <br>has elapsed, and will vest on the original timescale. <br>Awards will remain subject to the original performance <br>conditions assessed over the entire performance period, <br>unless the Committee decides to assess the <br>performance conditions over a shorter period.<br>Good leavers are defined as those who leave as a result <br>of injury or disability, retirement with the approval of <br>the employing company, their employing company or <br>business ceasing to be part of the Group, or in any <br>other circumstances at the discretion of the Committee. <br>Individuals who die in service will also be treated as <br>good leavers.<br>Where an Executive Director is not determined to be a <br>good leaver, unvested long-term incentive awards will <br>lapse on cessation of employment.<br>Awards remain subject to the malus and clawback <br>terms and holding periods originally applied to them.<br>| Any Executive Director dismissed for cause would <br>forfeit all unvested long-term incentive awards.<br>If the Committee has judged that the departing <br>Executive Director should retain their unvested long-<br>term incentive awards with the expectation that:<br>–the Executive Director is retiring from their <br>professional executive career; and/or<br>–the Executive Director will not be seeking to secure <br>alternative employment with another organisation of <br>comparable size as the Company or that is within the <br>financial services sector,<br>the Committee retains the power to lapse all unvested <br>long-term incentive awards should the Committee <br>deem that the Executive Director has subsequently <br>secured similar paid executive employment elsewhere.<br>On death, disablement and in other exceptional <br>circumstances, the Committee has discretion to release <br>unvested long-term incentive awards earlier than the <br>end of the vesting period. The malus and clawback <br>provisions would continue to apply.<br>Should an Executive Director step down from the Board <br>but remain employed by the Group, they would retain <br>any outstanding long-term incentive awards which they <br>held on their change of role. These awards would <br>remain subject to the original rules, performance <br>conditions and vesting schedule.<br>|

---

**Policy on payment on loss of office** continued

---

| | | |
|:---|:---|:---|
| Element | Principles | Potential variations |
| **Vested long-**<br>**term** <br>**incentive** <br>**awards,** <br>**subject to** <br>**the holding** <br>**period**<br>| The treatment of vested long-term incentive awards <br>within their holding period will be decided by the <br>Committee, taking into account the circumstances of <br>the departure.<br>Executive Directors will normally retain their vested <br>long-term incentive awards that remain subject to the <br>holding period. Normally these awards will remain <br>subject to the holding period and be released in <br>accordance with the original timescale.<br>Awards remain subject to the malus and clawback <br>terms originally applied to them.<br>| Any Executive Director dismissed for cause would <br>normally forfeit vested long-term incentive awards.<br>On death, disablement and in other exceptional <br>circumstances, the Committee has discretion to release <br>vested long-term incentive awards earlier than the end <br>of the holding period. The malus and clawback <br>provisions would continue to apply.<br>Should an Executive Director step down from the Board <br>but remain employed by the Group, they would retain <br>any vested long-term incentive awards that remain <br>subject to the holding period. These awards would <br>remain subject to the original rules and release <br>schedule applied to them when they were awarded (ie <br>the holding period will continue to apply).<br>|
| **Bonus for** <br>**final year of** <br>**service**<br>| The payment of any bonus for the final year of service <br>will be decided by the Committee, giving full <br>consideration to the circumstances of the departure <br>including the performance of the Executive Director.<br>The Committee may award a departing Executive <br>Director a bonus which will usually be pro-rated to <br>reflect the portion of the final financial year in which <br>they served which had elapsed on the last day that <br>they worked. Any such bonus would normally be <br>calculated with reference to financial, functional and/or <br>personal performance measures in the usual way. If <br>appropriate, the Committee may, at its discretion waive <br>any requirement for a portion of the final bonus to be <br>deferred.<br>| Any Executive Director dismissed for cause would not <br>be eligible for any bonus that has not been paid.<br>Should an Executive Director die, or in any other <br>exceptional circumstances (such as an Executive <br>Director's terminal illness), whilst serving as an <br>employee, a time pro-rated bonus may be awarded. In <br>such circumstances, deferral will not be applied and the <br>payment will be made wholly in cash.<br>The Committee may decide to award an Executive <br>Director stepping down from the Board but remaining <br>with the Group a bonus pro-rated to reflect the portion <br>of the financial year which had elapsed on the date of <br>their change of role. This would be calculated with <br>reference to financial, functional and/or personal <br>performance measures in the usual way. The <br>Committee may determine that a portion of such a <br>bonus must be deferred.<br>|
| **Other** <br>**payments**<br>| Consistent with other employees, Executive Directors <br>may receive payments to compensate them for the loss <br>of employment rights on termination. Payments may <br>include:<br>–A nominal amount for agreeing to non-solicitation <br>and confidentiality clauses;<br>–Directors and Officers insurance cover for a specified <br>period following the Executive Director's termination <br>date;<br>–Payment for outplacement services;<br>–Statutory redundancy payments or gratuities (where <br>applicable);<br>–Reimbursement of legal fees;<br>–Support with preparation of tax returns; and<br>–Repatriation assistance.<br>The Committee reserves the right to make additional <br>exit payments where such payments are made in good <br>faith:<br>–In discharge of an existing legal obligation (or by way <br>of damages for breach of such an obligation); or<br>–By way of settlement or compromise of any claim <br>arising in connection with the termination of a <br>Director's office or employment.<br>|  |
| **Post-**<br>**Directorship** <br>**guidelines**<br>| –When an Executive Director leaves the Board, they <br>will be subject to post-cessation share ownership <br>guidelines.<br>–Further details are included in the section on 'Share <br>ownership guidelines for Executive Directors'.<br>|  |

---

**Policy on corporate transactions**

---

| | |
|:---|:---|
| | Treatment |
| **Deferred AIP Awards** | In the event of a corporate transaction (eg takeover, material merger, or demerger, winding up etc.), <br>the Committee will determine whether awards will:<br>|
|  | –Vest; and/or<br>–Continue in accordance with the rules of the plan; and/or<br>–Lapse and, in exchange, the participant will be granted an award under any other share or cash <br>incentive plan which the Committee considers to be broadly equivalent to the award.<br>|
| **Long-term incentive** <br>**awards**<br>| In the case of a corporate transaction (e.g. takeover, material merger, or demerger, winding up etc.), <br>the Committee will determine whether awards will:<br>|
|  | –Be exchanged for replacement awards (either in cash or shares) of equal value unless the <br>Committee and successor company agree that the original award will continue; or<br>–Vest (to the extent determined by the Committee).<br>|
|  | Where awards vest, the Committee will have regard to (i) the performance of the Company, (ii) unless <br>the Committee determines otherwise, the proportion of the performance period that has elapsed and <br>(iii) any other matter that the Committee considers relevant or appropriate.<br>Vested awards will normally be released from any relevant holding period.<br>|

---

**Service contracts**

Executive Directors' service contracts provide details of the broad types of remuneration to which they are entitled, and about the

kinds of plans in which they may be invited to participate. The service contracts offer no certainty as to the value of performance-

related reward and confirm that any variable payment will be at the discretion of the Company.

A copy of the service contract between the Prudential Group and the Executive Director is available for inspection at Prudential's

registered office during normal hours of business and will also be available at any General Meeting of the Company. Details of the

duration of Executive Directors' service contracts are set out in the 'Directors' terms of employment and external appointments'

section of the Annual report on remuneration.

**Statement of consideration of conditions elsewhere in the Company**

Across the Group, remuneration is reviewed regularly with the intention that all employees are paid appropriately in the context of

their local market and given their individual skills, experience and performance. Each business' salary increase budget is set with

reference to local market conditions. The Committee considers salary increase budgets across the workforce when determining the

salaries of Executive Directors.

Prudential does not specifically consult with employees when setting the Policy: Prudential is a global organisation with employees

and agents in multiple businesses and geographies. The Board has mechanisms for engagement by Non-executive Directors to

gather employees' views on a range of topics and for these views to be represented to the Board. As many employees are also

shareholders, they are able to participate in binding votes on the Policy and annual advisory votes on the Annual report on

remuneration. The remuneration principles that apply to Executive Directors are cascaded to employees as appropriate. We are

committed to being fully transparent about our executive remuneration arrangements and have an internal microsite dedicated to

executive pay.

**Statement of consideration of shareholder views**

The Committee and the Company undertake regular consultation with key institutional investors on the Policy and its

implementation. This engagement is led by the Committee Chair and is an integral part of the Company's investor relations

programme. The Committee is grateful to shareholders for the feedback that is provided and takes this into account when

determining executive remuneration.

**Remuneration Policy for Non-executive Directors and the Chair**

---

| | | | |
|:---|:---|:---|:---|
| | Fees | Benefits | Share Ownership Guidelines |
| *Non-executive* <br>*Directors*<br>| All Non-executive Directors receive a basic <br>fee for their duties as a Board member. <br>Additional fees are paid for added <br>responsibilities such as Chairship and <br>membership of committees, acting as the <br>Senior Independent Director or carrying <br>out any other role determined by the <br>Board from time to time. Fees may be <br>denominated and paid in any currency the <br>Board Committee determines and are paid <br>to Non-executive Directors subject to any <br>appropriate deductions. A portion of the <br>fees may be delivered in shares without <br>performance conditions, based on the <br>market value of the shares, if the Board <br>deems that this is appropriate.<br>The basic and additional fees are usually <br>reviewed annually by the Board with any <br>changes normally effective from 1 July. In <br>determining the level of fees, the Board <br>considers factors including:<br>| Non-executive Directors do not currently <br>receive benefits or a pension allowance or <br>participate in the Group's employee <br>pension schemes.<br>Non-executive Directors receive <br>reimbursed business expenses (including <br>any relevant tax liability, banking fees and <br>any other reasonable fees for professional <br>services such as legal, tax, property and <br>financial advice) incurred when travelling <br>overseas in performance of duties or due <br>to the Company's corporate structure.<br>If as a consequence of the Company's <br>corporate structure, Non-executive <br>Directors are required to prepare personal <br>tax returns in Hong Kong and/or the UK, <br>in addition to preparing their personal tax <br>return for the jurisdiction which is their <br>place of residence, the Company will <br>reimburse the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit). | Under the Articles of <br>Association, Non-<br>executive Directors are <br>required to hold at least <br>2,500 shares and have <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>It is further expected <br>that Non-executive <br>Directors will hold <br>shares with a value <br>equivalent to one times <br>the annual basic fee <br>(excluding additional <br>fees for Chairship and <br>membership of any <br>committees).<br>Non-executive Directors <br>will normally be <br>expected to attain this <br>level of share ownership <br>within three years of <br>their date of <br>appointment. |
|  | –The time commitment and other <br>requirements of the role;<br>–Group financial performance;<br>–Salary increases for all employees; and<br>–Market data.<br>| Non-executive Directors do not currently <br>receive benefits or a pension allowance or <br>participate in the Group's employee <br>pension schemes.<br>Non-executive Directors receive <br>reimbursed business expenses (including <br>any relevant tax liability, banking fees and <br>any other reasonable fees for professional <br>services such as legal, tax, property and <br>financial advice) incurred when travelling <br>overseas in performance of duties or due <br>to the Company's corporate structure.<br>If as a consequence of the Company's <br>corporate structure, Non-executive <br>Directors are required to prepare personal <br>tax returns in Hong Kong and/or the UK, <br>in addition to preparing their personal tax <br>return for the jurisdiction which is their <br>place of residence, the Company will <br>reimburse the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit). | Under the Articles of <br>Association, Non-<br>executive Directors are <br>required to hold at least <br>2,500 shares and have <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>It is further expected <br>that Non-executive <br>Directors will hold <br>shares with a value <br>equivalent to one times <br>the annual basic fee <br>(excluding additional <br>fees for Chairship and <br>membership of any <br>committees).<br>Non-executive Directors <br>will normally be <br>expected to attain this <br>level of share ownership <br>within three years of <br>their date of <br>appointment. |
|  | If, in a particular year, the number of <br>meetings and/or time commitment is <br>materially greater than usual, the <br>Company may determine that the <br>provision of additional fees in respect of <br>that year is fair and reasonable.<br>Should a new committee or working group <br>be formed, or the remit of an existing <br>committee (for which duties were <br>previously paid or unpaid) be materially <br>expanded, or a new Non-executive <br>Director role established, the new or <br>additional fees paid for acting as the chair <br>or a member of the committee will be <br>commensurate with the new or additional <br>responsibilities and time commitment <br>involved.<br>The fees paid to Non-executive Directors <br>in aggregate will not exceed the limit <br>specified by the Articles of Association. <br>Non-executive Directors are not eligible to <br>participate in annual bonus plans or long-<br>term incentive plans.<br>| Non-executive Directors do not currently <br>receive benefits or a pension allowance or <br>participate in the Group's employee <br>pension schemes.<br>Non-executive Directors receive <br>reimbursed business expenses (including <br>any relevant tax liability, banking fees and <br>any other reasonable fees for professional <br>services such as legal, tax, property and <br>financial advice) incurred when travelling <br>overseas in performance of duties or due <br>to the Company's corporate structure.<br>If as a consequence of the Company's <br>corporate structure, Non-executive <br>Directors are required to prepare personal <br>tax returns in Hong Kong and/or the UK, <br>in addition to preparing their personal tax <br>return for the jurisdiction which is their <br>place of residence, the Company will <br>reimburse the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit). | Under the Articles of <br>Association, Non-<br>executive Directors are <br>required to hold at least <br>2,500 shares and have <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>It is further expected <br>that Non-executive <br>Directors will hold <br>shares with a value <br>equivalent to one times <br>the annual basic fee <br>(excluding additional <br>fees for Chairship and <br>membership of any <br>committees).<br>Non-executive Directors <br>will normally be <br>expected to attain this <br>level of share ownership <br>within three years of <br>their date of <br>appointment. |

---

**Remuneration Policy for Non-executive Directors and the Chair** continued

---

| | | | |
|:---|:---|:---|:---|
| | Fees | Benefits | Share Ownership Guidelines |
| **Chair** | The Chair receives an annual fee for the <br>performance of their role. This fee is <br>agreed by the Committee. The fee may be <br>denominated and paid in any currency the <br>Committee determines and is paid to the <br>Chair subject to any appropriate <br>deductions. A portion of the fee may be <br>delivered to the Chair in shares without <br>performance conditions, based on the <br>market value of the shares, if the <br>Committee deems this to be appropriate. <br>On appointment, the fee may be fixed for <br>a specified period of time. Following the <br>fixed period (if applicable) this fee will <br>normally be reviewed annually. Any <br>changes in the fee are usually effective <br>from 1 July. <br>In determining the level of the fee for the <br>Chair, the Committee considers factors <br>including: | The Chair may be offered benefits <br>including:<br>| Under the Articles of <br>Association, the Chair is <br>required to hold at least <br>2,500 shares and has <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>The Chair has a share <br>ownership guideline. <br>This is currently one <br>times the annual fee and <br>it is normally expected <br>that this level of share <br>ownership would be <br>attained within five <br>years of the date of <br>appointment. |
|  | The Chair receives an annual fee for the <br>performance of their role. This fee is <br>agreed by the Committee. The fee may be <br>denominated and paid in any currency the <br>Committee determines and is paid to the <br>Chair subject to any appropriate <br>deductions. A portion of the fee may be <br>delivered to the Chair in shares without <br>performance conditions, based on the <br>market value of the shares, if the <br>Committee deems this to be appropriate. <br>On appointment, the fee may be fixed for <br>a specified period of time. Following the <br>fixed period (if applicable) this fee will <br>normally be reviewed annually. Any <br>changes in the fee are usually effective <br>from 1 July. <br>In determining the level of the fee for the <br>Chair, the Committee considers factors <br>including: | –Health and wellness benefits;<br>–Protection and security benefits;<br>–Transport benefits;<br>–Reimbursement of business expenses <br>(including any relevant tax liability, <br>banking fees and any other reasonable <br>fees for professional services such as <br>legal, tax, property and financial advice) <br>incurred when travelling overseas in <br>performance of duties or due to the <br>Company's corporate structure; and<br>–Relocation and location-specific benefits <br>(where appropriate).<br>| Under the Articles of <br>Association, the Chair is <br>required to hold at least <br>2,500 shares and has <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>The Chair has a share <br>ownership guideline. <br>This is currently one <br>times the annual fee and <br>it is normally expected <br>that this level of share <br>ownership would be <br>attained within five <br>years of the date of <br>appointment. |
|  | The Chair receives an annual fee for the <br>performance of their role. This fee is <br>agreed by the Committee. The fee may be <br>denominated and paid in any currency the <br>Committee determines and is paid to the <br>Chair subject to any appropriate <br>deductions. A portion of the fee may be <br>delivered to the Chair in shares without <br>performance conditions, based on the <br>market value of the shares, if the <br>Committee deems this to be appropriate. <br>On appointment, the fee may be fixed for <br>a specified period of time. Following the <br>fixed period (if applicable) this fee will <br>normally be reviewed annually. Any <br>changes in the fee are usually effective <br>from 1 July. <br>In determining the level of the fee for the <br>Chair, the Committee considers factors <br>including: | If as a consequence of the Company's <br>corporate structure, the Chair is required <br>to prepare personal tax returns in Hong <br>Kong and/or the UK, in addition to <br>preparing their personal tax return for the <br>jurisdiction which is their place of <br>residence, the Company may reimburse <br>the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit).<br>The maximum paid will be the cost to the <br>Company of providing these benefits.<br>The Chair is not eligible to receive a <br>pension allowance or to participate in the <br>Group's employee pension schemes. | Under the Articles of <br>Association, the Chair is <br>required to hold at least <br>2,500 shares and has <br>one year, from their <br>date of appointment to <br>the Board, to acquire <br>these.<br>The Chair has a share <br>ownership guideline. <br>This is currently one <br>times the annual fee and <br>it is normally expected <br>that this level of share <br>ownership would be <br>attained within five <br>years of the date of <br>appointment. |
|  | –The time commitment and other <br>requirements of the role;<br>–The performance and experience of the <br>Chair;<br>–Internal relativities;<br>–Company financial performance; and<br>–Market data.<br>| If as a consequence of the Company's <br>corporate structure, the Chair is required <br>to prepare personal tax returns in Hong <br>Kong and/or the UK, in addition to <br>preparing their personal tax return for the <br>jurisdiction which is their place of <br>residence, the Company may reimburse <br>the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit).<br>The maximum paid will be the cost to the <br>Company of providing these benefits.<br>The Chair is not eligible to receive a <br>pension allowance or to participate in the <br>Group's employee pension schemes. |  |
|  | The Chair is not eligible to participate in <br>annual bonus plans or long-term incentive <br>plans.<br>| If as a consequence of the Company's <br>corporate structure, the Chair is required <br>to prepare personal tax returns in Hong <br>Kong and/or the UK, in addition to <br>preparing their personal tax return for the <br>jurisdiction which is their place of <br>residence, the Company may reimburse <br>the costs of personal tax return <br>preparation for whichever locations are not <br>their place of residence (including <br>payment of any tax cost associated with <br>the provision of the benefit).<br>The maximum paid will be the cost to the <br>Company of providing these benefits.<br>The Chair is not eligible to receive a <br>pension allowance or to participate in the <br>Group's employee pension schemes. |  |

---

**Recruitment of a new Non-executive Director or Chair**

The fees for a new Non-executive Director will be consistent with the current basic fee paid to other Non-executive Directors (as

set out in the Annual report on remuneration for that year) and will be reflective of their additional responsibilities as chair and/or

members of Board committees and any additional roles that they perform.

The fee for a new Chair will be set with reference to the time commitment and other requirements of the role and the experience

of the candidate, as well as internal relativities among the other Executive and Non-executive Directors. To provide context for this

decision, data would be sought for suitable market reference point(s).

**Notice periods – Non-executive Directors and Chair**

Non-executive Directors are appointed pursuant to letters of appointment with notice periods of six months without liability for

compensation. A contractual notice period of 12 months by either party applies for the current Non-executive Chair. The notice

period for a new Chair may be set at six months. The Chair and Non-executive Directors would not be entitled to any payments for

loss of office. Details of the individual appointments of the Chair and Non-executive Directors are set out in the 'Letters of

appointment of the Chair and Non-executive Directors' section of the Annual report on remuneration.

For information on the terms of appointment for the Chair and Non-executive Directors, please see the Nomination & Governance

Committee report.

Additional remuneration disclosures

**Directors' outstanding long-term incentive awards and other share awards**

The table below sets out the Chief Executive Officer's PLTIP awards.

**Share-based long-term incentive awards**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Plan name | Year of<br>award<br>| Conditional <br>share awards <br>outstanding <br>at 1 Jan 2025<br>(Number of <br>shares)<br>| Conditional <br>awards in <br>2025<br>(Number of <br>shares)<br>| Market price <br>at date of <br>award<br>(HK dollars)<br>| Dividend <br>equivalents <br>on vested <br>shares<br>(Number of <br>shares <br>released)<br>| Rights <br>exercised in <br>2025<br>| Rights lapsed <br>in 2025<br>| Conditional <br>share awards <br>outstanding at <br>31 December <br>2025<br>(Number of <br>shares)<br>| Date of<br>end of<br>performance<br>period<br>|
| **Anil** <br>**Wadhwani**<br>|  |  |  |  |  |  |  |  |  |  |
|  | PLTIP | 2023 | 438098 | – | 107.4 | – | – | – | 438098 | 31 Dec 25 |
|  | PLTIP | 2024 | 697317 |  | 75.1 | – | – | – | 697317 | 31 Dec 26 |
|  | PLTIP | 2025 | – | 635353 | 82.75 | – | – | – | 635353 | 31 Dec 27 |
|  |  |  | 1135415 | 635353 |  | – | – | – | 1770768 |  |

---

**Other share awards**

The table below sets out the Chief Executive Officer's deferred bonus share awards.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Year of <br>grant<br>| Conditional<br>share <br>awards <br>outstanding<br>at 1 Jan <br>2025<br>(Number of <br>shares)<br>| Conditionally<br>awarded in <br>2025<br>(Number of <br>shares)<br>| Dividends<br>accumulated<br>in 2025<sup>1</sup><br>(Number of <br>shares)<br>| Shares<br>released<br>in 2025<br>(Number <br>of shares)<br>| Conditional<br>share <br>awards <br>outstanding<br>at 31 <br>December <br>2025<br>(Number of <br>shares)<br>| Date of end of <br>restricted<br>period<br>| Date of<br>release<br>| Market<br>price at<br>date of<br>award<br>(HK <br>dollars)<br>| Market<br>price at<br>date of<br>vesting <br>or<br>release<br>(HK <br>dollars)<br>|
| **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** | **Anil Wadhwani** |
| Deferred 2023 annual incentive <br>award<br>| 2023 | 34232 | – | 675 | – | 34907 | 31 Dec 25 |  | 114.3 |  |
| Deferred 2024 annual incentive <br>award<br>| 2024 | 132790 | – | 2623 | – | 135413 | 31 Dec 26 |  | 75.1 |  |
| Deferred 2025 annual incentive <br>award<br>| 2025 | – | 106435 | 2102 |  | 108537 | 31 Dec 27 |  | 82.8 |  |
|  |  | 167022 | 106435 | 5400 | – | 278857 |  |  |  |  |

---

**Note**

(1)A dividend equivalent was accumulated on these awards.

**Dilution**

Releases from the Prudential Long Term Incentive Plan and the Prudential Agency Long Term Incentive Plan are satisfied using

newly issued shares rather than by purchasing shares in the open market. Shares relating to options granted under all-employee

share plans are also satisfied by newly issued shares. The combined dilution from all outstanding shares and options at 31

December 2025 was 0.13 per cent of the total share capital at the time. Deferred bonus awards will continue to be satisfied by the

purchase of shares in the open market.

Share ownership

**Directors shareholdings**

The current shareholding policy and the interests of directors in ordinary shares of Prudential are shown under the sections 'How

the current Directors' remuneration policy operates' and 'Statement of Directors' Shareholdings' above.

Prudential is not owned or controlled directly or indirectly by another corporation or by any government or by any other natural or

legal person severally or jointly and Prudential is not currently aware of any arrangements that might result in a change in

Prudential's control.

As of 17 March 2026, Prudential's executive director did not have any options or rights to purchase securities from Prudential's

options and other share awards.

There were no share options held by the directors and other executive officers as at 31 December 2025.

**Options to purchase and discretionary awards of securities from Prudential**

As of 17 March 2026, 79,824 options were outstanding, which Prudential issued under the SAYE schemes. Each option represents

the right of the bearer to subscribe for one share at a particular pre-determined exercise price at a pre-set exercise date.

As of 17 March 2026, 17,491,971 shares were outstanding under other awards. Of those 537,576 shares outstanding under the

Annual Incentive Plan, 1,257,475 shares were outstanding under the Restricted Share Plan, 1,770,768 shares were outstanding

under the PLTIP, 13,926,152 shares were outstanding under the PGLTIP. Such outstanding awards held by directors or other

executive officers at 31 December 2025 are included under 'Directors' outstanding long-term incentive awards and other share

awards' above.

The aggregate proceeds that would arise if all outstanding options under the SAYE schemes were exercised is £0.512 million. The

latest expiration dates for exercise or release of the securities underlying the options or awards and the number of options or

shares are set out in the table below.

---

| | | | |
|:---|:---|:---|:---|
| Year of Expiration | Options Outstanding Under Savings <br>Related Share Option Schemes (in <br>millions)<br>| Shares Outstanding Under Other <br>Awards (in millions)<br>| Total (in millions) |
| 2026 | 0.010 | 7.361 | 7.371 |
| 2027 | 0.006 | 6.564 | 6.570 |
| 2028 | 0.020 | 3.471 | 3.491 |
| 2029 | 0.019 | 0.004 | 0.023 |
| 2030 | 0.024 | – | 0.024 |
| 2031 | – | – | – |
| Total | 0.079 | 17.400 | 17.479 |

---

Information concerning the Group's share award and share option plans for its employees is provided above as well as in note

B2.2 to the consolidated financial statements.

Employees

The average number of staff employed by the Group during the years is shown below:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Asia and Africa operations <sup>note</sup> | **14770** | 14851 | 14479 |
| Head office function | **568** | 561 | 551 |
| **Total Group** | **15338** | 15412 | 15030 |

---

**Note**

The Asia and Africa operations staff numbers above exclude 634 (2024: 702; 2023: 621) commission-based sales staff who have an employment contract with the

Group.

As of 31 December 2023, two employees were paying union subscriptions through the UK payroll. By 31 December 2024, this

number had decreased to nil, and there were no new subscriptions as of 31 December 2025.

**Additional Information**

Significant subsidiaries

The table below sets forth Prudential's significant operating subsidiaries.

---

| | | |
|:---|:---|:---|
| | Main activity | Country of incorporation |
| Prudential Assurance Company Singapore (Pte) Limited | Insurance | Singapore |
| PT Prudential Life Assurance | Insurance | Indonesia |
| Prudential Hong Kong Limited | Insurance | Hong Kong, China |
| Prudential Assurance Malaysia Berhad | Insurance | Malaysia |

---

**Note** 

Each significant subsidiary operates mainly in its country of incorporation. The Company has 100 per cent of the voting rights of the subsidiaries in Singapore and

Hong Kong and 94.6 per cent of the voting rights in the Indonesia subsidiary attaching to the aggregate of the shares across the types of capital in issue. The

percentage of share ownership for these subsidiaries is the same as the percentage of the voting power held. The Company has 51 per cent of the voting rights in

Prudential Assurance Malaysia Berhad and the results of this business are consolidated in the Group's consolidated financial statements reflecting the controlling

interest of the Group. In January 2026, the Group acquired an additional 19 per cent share ownership in Sri Han Suria Sdn. Bhd., the holding company that owns

Prudential Assurance Malaysia Berhad, increasing the Group's aggregate voting rights to 70 per cent.

Major shareholders

The table below shows the holdings of major shareholders in the Company's issued share capital as notified to the Company in

accordance with the Disclosure Guidance and Transparency Rules. At 23 March 2026, Prudential had received the following

notifications:

**Significant Changes in Ownership** 

Major shareholders of Prudential have the same voting rights per share as other shareholders. See Governance – Memorandum

and Articles of Association - Voting Rights. Information provided to Prudential by major shareholders pursuant to the FCA's

Disclosure Guidance and Transparency Rules (DTR) is published on the London Stock Exchange and the Securities and Exchange

Commission via Form 6-K. The information is also available on Prudential's website. The percentage of voting rights detailed below

was calculated at the time of the relevant disclosure made in accordance with Rule 5 of the DTR.

Notifications received within the last three years, up until 23 March 2026:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Year | Name of Company | Date Prudential <br>was notified<br>| Number of <br>Prudential shares <br>held<br>| Total number of <br>voting rights held<br>| % of total voting <br>rights attaching <br>to issued share <br>capital<br>| Change in interest |
| 2023 | Norges Bank<sup>1</sup> | January | 81606950 | 82856666 | 3.01 | Decrease in interest |
| 2023 | Norges Bank<sup>2</sup> | March | 84451785 | 85503331 | 3.10 | Increase in interest |
| 2024 | UBS Group AG - <br>Investment Bank & <br>Global Wealth <br>Management<sup>3</sup><br>| September | 142921434 | 147711614 | 5.41 | Increase in interest |
| 2024 | UBS Group AG - <br>Investment Bank & <br>Global Wealth <br>Management<sup>4</sup><br>| September | – | Below 5% | – | Decrease in interest |
| 2024 | Norges Bank<sup>5</sup> | September | 113736635 | 113899085 | 4.21 | Increase in interest |
| 2025 | Norges Bank | January | 133901071 | 133901071 | 5.05 | Increase in interest |
| 2025 | BlackRock, Inc.<sup>6</sup> | March | 86062389 | 169811259 | 6.45 | Increase in interest |
| 2025 | BlackRock, Inc.<sup>7</sup> | April | 160579923 | 166829075 | 6.35 | Decrease in interest |
| 2025 | Norges Bank | July | 129001525 | 129001525 | 4.99 | Decrease in interest |
| 2025 | BlackRock, Inc.<sup>8</sup> | September | 121431446 | 176302530 | 6.84 | Increase in interest |
| 2025 | BlackRock, Inc.<sup>9</sup> | September  | 169673441 | 176689294 | 6.86 | Increase in interest  |
| 2025 | Norges Bank | November  | 101764021 | 101764021 | 3.97 | Decrease in interest  |
| 2026 | Norges Bank | March | 101906209 | 101906209 | 4.02 | Increase in interest |
| 2026 | Norges Bank<sup>10</sup> | March | 100596209 | 101812778 | 4.02 | Decrease in interest |
| 2026 | Norges Bank<sup>11</sup> | March | 101510455 | 102214467 | 4.04 | Increase in interest |

---

**Notes**

(1)Total voting rights include 1,249,716 shares on loan (right to recall).

(2)Total voting rights include 1,051,546 shares on loan (right to recall).

(3)Total voting rights include 3,680 American Depository Receipts (ADRs), 76,313 right to recall of lent shares, 3,898 right to recall of ADRs, and 2,927,304 long

call options. Total voting rights also include 64,852 equity swaps, 14,133 long call options and 1,700,000 short put options.

(4)Voting rights below 5% are exempt from reporting under DTR.

(5)Total voting rights include 162,450 shares on loan (right to recall).

(6)Total voting rights include 1,685,854 ADRs, 81,135,169 Securities Lending and 927,847 contracts for difference (CFDs).

(7)Total voting rights include 1,687,415 ADRs, 4,532,433 Securities Lending and 29,304 CFDs.

(8)Total voting rights include 2,179,039 ADRs, 52,691,550 Securities Lending and 495 CFDs.

(9)Total voting rights include 2,185,088 ADRs, 4,830,270 Securities Lending and 495 CFDs.

(10) Total voting rights include 1,216,569 shares lent or otherwise transferred (right to recall).

(11) Total voting rights include 704,012 shares lent or otherwise transferred (right to recall).

**Current major shareholders:** 

---

| | | | |
|:---|:---|:---|:---|
| Shareholder | **Date advised** | **Percentage of** <br>**voting rights**<br>| **Voting rights** |
| BlackRock, Inc.<sup>9</sup> | September 2025 | 6.86 | 176689294 |
| Norges Bank<sup>11</sup> | March 2026 | 4.04 | 102214467 |

---

As at 23 March 2026, there were 107 shareholders with a US address on Prudential's register of shareholders. These shares

represented approximately 0.01 per cent of Prudential's issued ordinary share capital. As at 23 March 2026, there were 102

registered Prudential ADR holders. The shares represented by these ADRs amounted to approximately 2.51 per cent of Prudential's

issued ordinary share capital.

Prudential is not currently aware of any arrangements which may at a subsequent date result in a change of control of Prudential.

Intellectual property

Prudential conducts business under the 'Prudential' and 'Eastspring Investments' brand names and logos. It is also the registered

owner of numerous domain names, including 'www.prudentialplc.com' and 'www.eastspring.com'.

There are arrangements between Prudential plc, Prudential Financial Inc. and M&G plc relating to their respective uses of the

Prudential name. Under these arrangements Prudential Financial Inc. has the right to use the Prudential name in the Americas,

certain parts of the Caribbean, Japan, Korea and Taiwan. Following the demerger of M&G from the Group in October 2019, M&G

has the right to use the Prudential brand in the United Kingdom and Europe. Prudential has the right to use the name everywhere

else in the world although third parties have rights to the name in certain countries.

Legal proceedings

The Group is involved in various litigation and regulatory proceedings from time to time. While the outcome of such litigation and

regulatory issues cannot be predicted with certainty, the Group believes that the ultimate outcome of any current or pending

matters will not have a material adverse effect on the Group's financial condition, results of operations, or cash flows.

Material contracts

Not applicable.

Exchange controls

Other than the requirement to report certain events and transactions to HM Revenue & Customs, there are currently no UK laws,

decrees or regulations that restrict the export or import of capital, including, but not limited to, foreign exchange controls, or that

affect the remittance of dividends or other payments to non-UK residents or to US holders of Prudential's securities, except as

otherwise set forth under 'Taxation' in this section.

Taxation

The following is a summary, under current law and practice, of the principal UK tax, US federal income tax, Hong Kong and

Singapore tax considerations relating to an investment by a US taxpayer in Prudential ordinary shares or ADSs. The discussion is

based on laws, treaties, judicial decisions, and regulatory interpretations in effect on the date hereof, all of which are subject to

change possibly retrospectively. Prudential plc is incorporated in the UK and tax resident in Hong Kong, and the following

summary reflects these facts. This summary applies to you only if:

–You are an individual US citizen or resident, a US corporation, or otherwise subject to US federal income tax on a net income

basis in respect of your holding of Prudential ordinary shares or ADSs;

–You hold Prudential ordinary shares or ADSs or shares held or traded in Singapore through the Central Depository (CDP) as a

capital asset for tax purposes;

–If you are an individual, you are not resident in the United Kingdom for UK tax purposes, and do not hold Prudential ordinary

shares or ADSs for the purposes of a trade, profession, or vocation that you carry on in the United Kingdom through a branch or

agency or if you are a corporation, you are not resident in the UK for UK tax purposes and do not hold the securities for the

purpose of a trade carried on in the United Kingdom through a permanent establishment in the United Kingdom; and

–You are not domiciled in the UK for inheritance tax purposes, or, from 6 April 2025, you are not UK long-term resident for

inheritance tax purposes. On 6 April 2025, the UK introduced a new residence based regime to replace the domicile rules for

inheritance tax purposes. Under the new regime, non-UK assets are in scope if an individual (a "long-term resident") has been

resident in the UK for at least 10 out of the last 20 tax years immediately preceding the tax year in which the chargeable event

(including death) arises.

Beneficial owners of ADSs will be treated as owners of the underlying Prudential ordinary shares for US federal income tax

purposes. Deposits and withdrawals of Prudential ordinary shares in exchange for ADSs generally will not result in the realisation

of gain or loss for US federal income tax purposes.

This summary does not address any tax consideration other than certain UK tax, US federal income tax, Hong Kong tax and

Singapore tax considerations and does not purport to be a comprehensive description of all of the tax considerations that may be

relevant to any particular investor, and does not address the tax treatment of investors that are subject to special rules. Prudential

has assumed that you are familiar with the tax rules applicable to investments in securities generally and with any special rules to

which you may be subject. You should consult your own tax advisers regarding the tax consequences of the ownership of

Prudential ordinary shares or ADSs in the context of your own particular circumstances.

**UK Taxation of Dividends** 

Dividends paid by Prudential plc in respect of the ordinary shares or ADSs are not subject to withholding tax at source in the UK.

**UK Taxation of Capital Gains** 

A holder of Prudential ordinary shares or ADSs who for UK tax purposes is a US corporation that is not resident in the United

Kingdom will not be liable for UK taxation on capital gains realised on the disposal of Prudential ordinary shares or ADSs unless at

the time of disposal:

–The holder carries or has carried on a trade in the United Kingdom through a permanent establishment in the United Kingdom,

and

–The Prudential ordinary shares or ADSs are or have been used, held or acquired for use by or for the purposes of such trade or

permanent establishment.

Subject to the comments in the following paragraph, a holder of Prudential ordinary shares or ADSs who, for UK tax purposes, is

an individual who is not resident in the United Kingdom will not be liable for UK taxation on capital gains realised on the disposal of

Prudential ordinary shares or ADSs unless at the time of the disposal:

–The holder carries or has carried on a trade in the United Kingdom through a branch or agency, and

–The Prudential ordinary shares or ADSs are or have been used, held, or acquired for use by or for the purposes of such trade or

for the purposes of such branch or agency.

A holder of Prudential ordinary shares or ADSs who is an individual who is temporarily a non-UK resident for UK tax purposes will,

in certain circumstances, become liable to UK tax on capital gains in respect of gains realised while he or she was not resident in

the UK.

**UK Inheritance Tax** 

Prudential ordinary shares which are registered on the main Prudential share register are assets situated in the United Kingdom for

the purposes of UK inheritance tax (the equivalent of US estate and gift tax). Prudential ADSs are likely to be treated in the same

manner as the underlying Prudential ordinary shares and as situated in the United Kingdom. Subject to the discussion of the UK-

US estate tax treaty in the next paragraph, UK inheritance tax may apply if an individual who holds Prudential ordinary shares

which are registered on the main Prudential share register or ADSs gifts them or dies even if he or she is, prior to 6 April 2025,

neither domiciled in the United Kingdom, deemed to be domiciled there under UK law, nor from 6 April 2025 a long-term resident

for UK inheritance tax purposes. For inheritance tax purposes, a transfer of Prudential ordinary shares or ADSs at less than full

market value may be treated, to the extent of the undervalue, as a gift for these purposes. Special inheritance tax rules apply (1)

to gifts if the donor retains some benefit, (2) to close companies and (3) to trustees of settlements. Prudential ordinary shares

which are registered on the Hong Kong branch register should not be treated as situated in the United Kingdom for the purpose of

UK inheritance tax.

However, as a result of the UK-US estate tax treaty, Prudential ordinary shares which are registered on the main Prudential share

register or ADSs held by an individual who is domiciled in the United States for the purposes of the UK-US estate tax treaty and

who is not a UK national will, subject to special rules relating to trusts and settlements, not be subject to UK inheritance tax on

that individual's death or on a gift of the Prudential ordinary shares or ADSs unless the Prudential ordinary shares or ADSs:

–Are part of the business property of a permanent establishment of an enterprise in the United Kingdom, or

–Pertain to a fixed base in the UK used for the performance of independent personal services.

The UK-US estate tax treaty provides a credit mechanism if the Prudential ordinary shares or ADSs are subject to both UK

inheritance tax and to US estate and gift tax.

**UK Stamp Duty and Stamp Duty Reserve Tax** 

Relevant legislation provides that, subject to certain exemptions, UK stamp duty and UK stamp duty reserve tax (SDRT) would be

payable upon a transfer of Prudential ordinary shares to the depositary of Prudential ordinary shares that is responsible for issuing

ADSs (the 'ADS Depositary'), or a nominee or agent of the ADS depositary, in exchange for American Depositary Receipts (ADRs)

representing ADSs. For this purpose, the current rate of stamp duty and SDRT is 1.5 per cent (rounded up, in the case of stamp

duty, to the nearest £5). The application of the 1.5 per cent rate of stamp duty and SDRT, and the exemptions therefrom, is

complex, and it is recommended that, before making any such transfer, independent professional tax advice be sought.

Provided that the instrument of transfer is not executed in the United Kingdom no UK stamp duty should be required to be paid on

any transfer of Prudential ADRs representing ADSs. Based on Prudential's understanding of HMRC's application of the exemption

from SDRT for depositary receipts a transfer of Prudential ADRs representing ADSs should not, in practice, give rise to a liability to

SDRT.

Subject to certain special rules relating to clearance services and issuers of depositary receipts, a transfer for value of Prudential

ordinary shares (but excluding Prudential ordinary shares registered on the Hong Kong branch register unless the instruments of

transfer are executed in the UK), as opposed to ADSs, will generally give rise to a charge to UK stamp duty, other than where the

amount or value of the consideration for the transfer is £1,000 or under and the transfer instrument is certified to that effect, at

the rate of 0.5 per cent (rounded up to the nearest £5). The rate is applied to the amount or value of the consideration payable for

the relevant Prudential ordinary shares. Different rules may apply to transfers to a connected company (or its nominee). To the

extent that UK stamp duty is paid on a transfer of Prudential ordinary shares, no SDRT should generally be payable on the

agreement for that transfer.

Subject to certain special rules relating to clearance services and issuers of depositary receipts, a transfer of ordinary shares from

a nominee to their beneficial owner (other than on sale), including a transfer of underlying Prudential ordinary shares from the

ADS Depositary or its nominee to an ADS holder, is not subject to UK stamp duty or SDRT. No UK SDRT should be payable on an

agreement to transfer Prudential ordinary shares registered on the Hong Kong branch register, subject to the special rules relating

to clearance services and issuers of depositary receipts.

UK stamp duty is usually paid by the purchaser. Although SDRT is generally the liability of the purchaser, any such tax payable on

the transfer of Prudential ordinary shares to the ADS Depositary or its nominee would be payable by the ADS Depositary as the

issuer of the ADSs. In accordance with the terms of the Deposit Agreement, the ADS Depositary will recover an amount in respect

of such tax from the initial holders of the ADSs.

**US Federal Income Tax Treatment of Distributions on Prudential Ordinary Shares or ADSs** 

If Prudential pays dividends, you must include those dividends in your income when you receive them. The dividends will be

treated as foreign source income. You should determine the amount of your dividend income by converting pounds sterling into US

dollars at the exchange rate in effect on the date of your (or the depositary's, in the case of ADSs) receipt of the dividend. Subject

to certain exceptions for short-term and hedged positions, the US dollar amount of dividends received by an individual will be

subject to taxation at a lower rate than ordinary income if the dividends are 'qualified dividends.' Dividends received with respect

to the ordinary shares or ADSs will be qualified dividends if Prudential was not, in the year prior to the year in which the dividend

was paid, and is not, in the year in which the dividend is paid, a passive foreign investment company (PFIC) and either (i) at the

time a dividend was paid, Prudential was eligible for the benefits of the 24 July 2001 Treaty between the United States and the

United Kingdom or (ii) such ordinary shares or ADSs were, at the time of payment, readily tradeable on an established securities

market in the United States. As Prudential is a tax resident of Hong Kong, it is not eligible for the benefits of the Treaty, and as a

result, dividends paid with respect to ordinary shares (which are not listed on an established securities market in the United

States) will not be qualified dividends.

Dividends received with respect to ADSs are expected to be qualified dividends, as the ADSs are expected to continue to be listed,

and be viewed as readily tradeable, on the New York Stock Exchange (an established securities market in the United States).

Based on the nature of its business activities and its expectations regarding such activities in the future, Prudential believes that it

was not treated as a PFIC within the meaning of the Code with respect to its 2025 taxable year and does not anticipate becoming

a PFIC for its 2026 taxable year.

**US Federal Income Tax Treatment of Capital Gains** 

If you sell your Prudential ordinary shares or ADSs, you will recognise a US source capital gain or loss equal to the difference

between the US dollar value of the amount realised on the disposition and the US dollar basis in the ordinary shares of the ADSs.

A gain on the sale of Prudential ordinary shares or ADSs held for more than one year will be treated as a long-term capital gain.

The net long-term capital gain generally is subject to taxation at a lower rate than ordinary income. Your ability to offset capital

losses against ordinary income is subject to limitations.

**US Federal Medicare Tax on Net Investment Income** 

A 3.8 per cent surtax will generally apply to the net investment income of individuals whose modified adjusted gross income

exceeds certain threshold amounts. These amounts are $200,000 in the case of single taxpayers, $250,000 in the case of married

taxpayers filing joint returns, and $125,000 in the case of married taxpayers filing separately. Net investment income includes,

among other items, dividends, interest, and net gain from the disposition of property (other than certain property held in a trade

or business).

**US Information Reporting and Backup Withholding** 

Under the US tax code, a US resident holder of Prudential ordinary shares or ADSs may be subject, under certain circumstances,

to information reporting and possibly backup withholding with respect to dividends and proceeds from the sale or other disposition

of Prudential ordinary shares or ADSs, unless the US resident holder provides proof of an applicable exemption or correct taxpayer

identification number and otherwise complies with applicable requirements of the backup withholding rules. Any amount withheld

under the backup withholding rules is not additional tax and may be refunded or credited against the US resident holder's federal

income tax liability, so long as the required information is furnished to the IRS.

**Hong Kong Taxation of Dividends** 

No tax will be payable in Hong Kong in respect of dividends Prudential pays to its US resident holders who are not carrying on a

trade profession or business in Hong Kong. Dividends distributed to Prudential's US resident holders will be free of withholding

taxes in Hong Kong.

**Hong Kong Taxation on gains of sale** 

Hong Kong does not generally impose capital gains tax unless it is deemed taxable under the foreign sourced income exemption

("FSIE") regime. The disposal of Prudential shares listed on the Hong Kong stock exchange will be regarded as Hong Kong sourced

and any capital gains derived therefrom will not be subject to Hong Kong profits tax under the FSIE regime. However, trading

gains from the sale of property by persons carrying on a trade, profession or business in Hong Kong where the trading gains are

derived from or arise in Hong Kong will be chargeable to Hong Kong profits tax. Hong Kong profits tax is currently charged at the

rate of 16.5 per cent on corporations and at a maximum rate of 15 per cent on individuals. Certain categories of taxpayers whose

business consists of buying and selling shares are likely to be regarded as deriving trading gains rather than capital gains (e.g.

financial institutions, insurance companies and securities dealers) unless these taxpayers can prove that the investment securities

are held for long-term investment purposes.

Trading gains from the sale of the Prudential ordinary share by US resident holders effected on the Hong Kong Stock Exchange will

be considered to be derived from Hong Kong. A liability for Hong Kong profits tax would thus arise in respect of trading gains

derived by US resident holders from the sale of Prudential ordinary shares effected on the Hong Kong Stock Exchange where such

trading gains are realised by US resident holders from a business carried on in Hong Kong.

**Hong Kong Stamp duty** 

Hong Kong stamp duty, currently charged at the ad valorem rate of 0.1 per cent on the higher of the consideration for or the value

of the Prudential ordinary shares, will be payable by the purchaser on a purchase and by the seller on a sale of Prudential ordinary

shares where the transfer is required to be registered in Hong Kong (i.e. a total of 0.2 per cent is ordinarily payable on a sale and

purchase transaction involving ordinary shares). In addition, a fixed duty of HK$5 is currently payable on any instrument of

transfer of ordinary shares.

**Hong Kong Estate duty** 

Hong Kong no longer has estate duty.

**Singapore Taxation on gains of sale** 

**Disposal of the Prudential ordinary shares** 

Singapore does not impose tax on capital gains. However, gains of an income nature may be taxable in Singapore. There are no

specific laws or regulations which deal with the characterisation of whether a gain is income or capital in nature. Gains arising from

the disposal of the Prudential ordinary shares by US resident holders may be construed to be of an income nature and subject to

Singapore income tax, especially if they arise from activities which are regarded as the carrying on of a trade or business and the

gains are sourced in Singapore.

Gains on disposal of Prudential ordinary shares by certain non-individual holders may be subject to tax in Singapore if such gains

are received in Singapore.

**Adoption of FRS 109 for Singapore Tax Purposes** 

Any US resident holders who apply, or who are required to apply, the Singapore Financial Reporting Standard 109 Financial

Instruments (FRS 109) for the purposes of Singapore income tax may be required to recognise gains or losses (not being gains or

losses in the nature of capital) in accordance with the provisions of FRS 109 (as modified by the applicable provisions of Singapore

income tax law) even though no sale or disposal is made. Taxpayers who may be subject to such tax treatment should consult

their own accounting and tax advisers regarding the Singapore income tax consequences of their acquisition, holding and disposal

of the Prudential ordinary shares.

**Singapore Taxation of Dividend distributions** 

As Prudential is incorporated in England and Wales and is not tax resident in Singapore for Singapore tax purposes, dividends paid

by Prudential will be considered as sourced outside Singapore (unless the Prudential ordinary shares are held as part of a trade or

business carried out in Singapore in which event the US resident holders of such shares may be taxed on the dividends as they are

derived).

Foreign-sourced dividends received or deemed received in Singapore by a US resident individual not resident in Singapore are

exempt from Singapore income tax. This exemption will also apply in the case of a Singapore tax resident individual who receives

their foreign-sourced income in Singapore (except where such income is received through a partnership in Singapore).

Foreign-sourced dividends received or deemed received by corporate investors in Singapore (including US investors carrying on

trade or business in Singapore) will ordinarily be liable to Singapore tax. However, foreign-sourced income in the form of

dividends, branch profits and service income received or deemed to be received in Singapore by Singapore tax resident companies

can be exempt from tax if certain prescribed conditions are met, including the following:

i.The foreign income has been subject to tax in the foreign jurisdiction from which it is received (known as the 'subject to tax'

condition). The rate at which the foreign income was taxed can be different from the headline tax rate; and

ii.The highest Corporate Income Tax rate (i.e. foreign headline tax rate condition) of the foreign jurisdiction from which the

income is received is at least 15% at the time the foreign income is received in Singapore.

Certain clarifications have been published by the Inland Revenue Authority of Singapore with respect to such conditions.

**Singapore Stamp duty** 

As Prudential is incorporated in England and Wales and the Prudential ordinary shares are not registered on any register kept in

Singapore, no stamp duty is payable in Singapore:

i.On the issuance of the Prudential ordinary shares; and

ii.On any transfer of the Prudential ordinary shares.

Prudential ordinary shares held or traded in Singapore through CDP will be registered on the HK Register. As such, Hong Kong

stamp duty will be payable on a transfer of Prudential ordinary shares held or traded in Singapore through CDP. Please refer to the

description under the Hong Kong stamp duty section above.

All persons, including US resident holders, who hold or transact in Prudential ordinary shares in Singapore through the SGX-ST

and/or CDP should expect that they will have to bear Hong Kong stamp duty in respect of transactions in Prudential ordinary

shares effected in Singapore through the SGX-ST and/or CDP. Such persons should consult their brokers, or custodians for

information regarding what procedures may be instituted for collection of Hong Kong stamp duty from them.

**Singapore Estate duty** 

Singapore no longer has estate duty.

**Singapore Goods and Services Tax** 

There is no Goods and Services Tax (GST) payable in Singapore on the subscription or issuance of the Prudential ordinary shares.

The clearing fees, instruments of transfer deposit fees and share withdrawal fees are subject to GST at the prevailing standard-

rate of 9 per cent if the services are provided by a GST registered person to a holder of the Prudential ordinary shares. However,

such fees could be zero-rated when provided to a US resident holder of the Prudential ordinary shares belonging outside Singapore

provided certain conditions are met. For a holder of the Prudential ordinary shares belonging in Singapore who is registered for

GST, the GST incurred is generally not recoverable as input tax credit from the Inland Revenue Authority of Singapore unless

certain conditions are satisfied. These GST-registered holders of Prudential ordinary shares should seek the advice of their tax

advisors on these conditions.

Documents on display

Prudential is subject to the informational requirements of the Securities Exchange Act of 1934 applicable to foreign private issuers.

In accordance with these requirements, Prudential files its annual report on Form 20-F and other documents with the SEC.

The SEC maintains a website that contains reports, proxy and information statements, and other information regarding

registrants. All SEC filings made electronically by registrants including Prudential can be accessed at www.sec.gov. Prudential's

SEC filings are also available on our corporate website at www.prudentialplc.com

Prudential also files reports and other documents with the London, Hong Kong and Singapore stock exchanges. This information

may be viewed on the Company's website or on the websites of each of those exchanges as well as via the UK Financial Conduct

Authority's National Storage Mechanism. The contents of the Company's website are not incorporated by reference into this Form

20-F.

Controls and procedures

**Disclosure of Controls and Procedures**

Management has evaluated, with the participation of Prudential plc's Chief Executive Officer and Chief Financial Officer, the

effectiveness of Prudential plc's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities

Exchange Act of 1934, as amended (Exchange Act)) as of 31 December 2025. There are inherent limitations to the effectiveness of

any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of

the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance

of achieving their control objectives. Based upon Prudential plc's evaluation, Prudential plc's Chief Executive Officer and Chief

Financial Officer have concluded that as of 31 December 2025 Prudential plc's disclosure controls and procedures were effective to

provide reasonable assurance that information required to be disclosed in the reports Prudential plc files and submits under the

Exchange Act is recorded, processed, summarised and reported within the time periods specified in the applicable rules and forms

and that it is accumulated and communicated to Prudential plc's management, including the Chief Executive Officer and Chief

Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Prudential plc is required to undertake an annual assessment of the effectiveness of internal control over financial reporting under

Section 404 of the Sarbanes-Oxley Act 2002 (Section 404). In accordance with the requirements of Section 404 the following

report is provided by management in respect of Prudential plc's internal control over financial reporting (as defined in

Rules 13a-15(f) and 15d-15(f) under the Exchange Act).

**Management's Annual Report on Internal Control over Financial Reporting** 

Management acknowledges its responsibility for establishing and maintaining adequate internal control over financial reporting for

Prudential plc. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the

reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International

Financial Reporting Standards as issued by the International Accounting Standards Board.

Management has conducted, with the participation of Prudential plc's Chief Executive Officer and Group Chief Financial Officer, an

evaluation of the effectiveness of internal control over financial reporting based on the criteria set forth in '2013 Internal Control—

Integrated Framework' issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the

assessment under these criteria, management has concluded that, as of 31 December 2025, Prudential plc's internal control over

financial reporting was effective.

There have been no changes during 2025 that have materially affected, or are reasonably likely to materially affect, Prudential

plc's internal control over financial reporting.

Ernst & Young LLP (EY), which has audited the consolidated financial statements of Prudential plc for the year ended 31

December 2025, has also audited the effectiveness of Prudential plc's internal control over financial reporting in accordance with

the standards of the Public Company Accounting Oversight Board (US). EY's report on internal control over financial reporting is

included in the Financial Statements section.

Listing information

Prudential ordinary shares are listed in the equity shares (commercial companies) category of the FCA Official List and traded on

the London Stock Exchange under the symbol 'PRU'. Prudential ordinary shares are also listed on the Main Board of the Hong Kong

Stock Exchange and are traded in board lots of 50 shares with the short name 'PRU' and stock code 2378; and via a secondary

listing on the Singapore Stock Exchange, traded in board lots of 100 shares, with the stock code 'K6S'.

Prudential American Depositary Shares (ADSs) are listed for trading on the NYSE under the symbol 'PUK'.

Trading on the Singapore Stock Exchange may be infrequent for certain periods during the year. This does not have any material

impact on the liquidity of the Group.

Description of securities other than equity securities

Citibank, N.A. has provided depositary bank services for holders of ADSs since its appointment on 19 March 2025. Prior to

this date, depositary services were provided by J.P. Morgan Chase Bank, N.A.

The following table summarises the fees and charges payable by holders of ADSs:

---

| | | |
|:---|:---|:---|
| Category | ADR Depositary actions | Associated fee or charge |
| ADS issuance or cancellation | Each person for whom ADRs are issued or <br>are being cancelled<br>| Up to US$5.00 for each 100 ADSs (or <br>fraction thereof) <br>|
| Cash dividends or distributions, stock <br>dividends or distributions, other <br>distributions or rights exercises<br>| Each person to whom the distribution is <br>made<br>| Up to US$5.00 for each 100 ADSs (or <br>fraction thereof) held<br>|
| Depositary services | Each person holding ADSs on the <br>applicable record date(s) established by <br>the ADR Depositary<br>| Up to US$5.00 for each 100 ADSs (or <br>fraction thereof) held on the applicable <br>record date(s) established by the ADR <br>Depositary<br>|
| Registration of ADS transfers or ADS <br>conversions<br>| Each person for whom ADSs are <br>transferred or converted or to whom ADSs <br>are transferred or converted ADS are <br>delivered<br>| Up to US$5.00 for each 100 ADSs (or <br>fraction thereof) transferred or converted<br>|
| Currency charges | Charges incurred by the ADR Depositary in <br>the conversion of foreign currency into US <br>Dollars<br>| Amount paid by the ADR Depositary, and <br>such charges are deductible from the <br>foreign currency<br>|

---

Purchases of equity securities by Prudential plc and affiliated

purchasers

The following table sets forth information with respect to purchases made by or on behalf of Prudential or any 'affiliated

purchasers' (as that term is defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of Prudential's

ordinary shares or American depositary shares for the year ended 31 December 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares** <br>**purchased**<sup>\*</sup><br>| **Average price paid per** <br>**share ($)**<br>| **Total number of shares** <br>**purchased as part of** <br>**publicly announced plans or** <br>**programs†**<br>| **Approximate** <br>**value of shares that may yet** <br>**be purchased under plans or** <br>**programs**<br>**($)**<br>|
| January 2025 | 14156426 | 7.80 | 14027963 | 1101426182 |
| February 2025 | 11133729 | 8.67 | 11016784 | 1005881290 |
| March 2025 | 8753830 | 9.86 | 8650128 | 920609219 |
| April 2025 | 18664827 | 9.85 | 17449798 | 749633415 |
| May 2025 | 9478725 | 11.29 | 8621017 | 652120868 |
| June 2025 | 13049859 | 12.02 | 12643798 | 500018075 |
| July 2025 | 12205953 | 12.47 | 7382557 | 408008855 |
| August 2025 | 6350490 | 13.11 | 6105457 | 328014961 |
| September 2025 | 6418491 | 13.69 | 6282320 | 241947532 |
| October 2025 | 6769725 | 13.74 | 4457259 | 183697410 |
| November 2025 | 5792891 | 14.06 | 5645846 | 104361333 |
| December 2025 | 7164305 | 14.84 | 7030344 | – |

---

\*This column includes shares acquired by employee benefit trusts during the year to satisfy future obligations to deliver shares under the Company's employee

incentive plans, the savings related share option scheme and the share participation plan. Additionally, it includes shares acquired by Prudential to offset

dilution from the scrip dividend and those acquired under the $2 billion share buyback programme announced in June 2024.

†The shares listed in this column were acquired by Prudential under the $2 billion share buyback programme, which was completed on 23 December 2025.

Principal accountant fees and services

Prudential's auditor in 2025 is EY LLP (PCAOB ID: 1438) located in London, UK. Total fees payable to the auditors are set out for

the years shown below.

---

| | | | |
|:---|:---|:---|:---|
| | Note | **2025 $m** | 2024 $m |
| Audit fees: |  |  |  |
| Audit of the Company's annual accounts |  | **5.3** | 5.3 |
| Audit of subsidiaries pursuant to legislation |  | **6.0** | 6.0 |
|  | 1 | **11.3** | 11.3 |
| Audit-related assurance services | 2 | **4.2** | 5.2 |
| Other fees paid to the auditors for other assurance services |  | **0.8** | 1.2 |
| **Total fees payable to the auditor** |  | **16.3** | 17.7 |

---

**Notes**

1. Fees of $11.3 million (2024: $11.3 million) included $1.0 million (2024: $1.0 million) for internal controls over financial reporting audit and $10.3 million

(2024: $10.3 million) in respect of the audit of the group and local statutory financial statements.

2. Audit-related assurance services supplied comprised TEV and interim reporting audit fees, regulatory reporting and other similar work. Of the audit-related

assurance service fees (as defined by SEC guidance) of $4.2 million (2024: $5.2 million), $1.2 million (2024: $1.2 million) relates to services that are required

by law and regulation.

Limitations on enforcement of US Laws against Prudential, its

Directors, management and others

Prudential plc is a public limited company incorporated and registered in England and Wales. All of its directors, GEC members and

executive officers are resident outside the US, and a substantial portion of its assets and the assets of such persons are located

outside the US. As a result, it may be difficult for you to effect service of process within the US upon these persons or to enforce

against them or Prudential plc judgements obtained in US courts predicated upon the civil liability provisions of the federal

securities laws of the US. We believe that there may be doubt as to the enforceability in England and Wales, in original actions or

in actions for enforcement of judgements of US courts, of liabilities predicated solely upon the federal securities laws of the US.

**Index to consolidated financial statements**

---

| | | | |
|:---|:---|:---|:---|
| Section |  |  | Page |
| **[Report of Independent Registered Public Accounting Firm](#if20250981a0d46e4b669404805d1a109_11076)** | **[Report of Independent Registered Public Accounting Firm](#if20250981a0d46e4b669404805d1a109_11076)** | **[Report of Independent Registered Public Accounting Firm](#if20250981a0d46e4b669404805d1a109_11076)** | [166](#if20250981a0d46e4b669404805d1a109_11076) |
| **[Consolidated income statement](#if20250981a0d46e4b669404805d1a109_307)** | **[Consolidated income statement](#if20250981a0d46e4b669404805d1a109_307)** | **[Consolidated income statement](#if20250981a0d46e4b669404805d1a109_307)** | [169](#if20250981a0d46e4b669404805d1a109_307) |
| **[Consolidated statement of comprehensive income](#if20250981a0d46e4b669404805d1a109_310)** | **[Consolidated statement of comprehensive income](#if20250981a0d46e4b669404805d1a109_310)** | **[Consolidated statement of comprehensive income](#if20250981a0d46e4b669404805d1a109_310)** | [170](#if20250981a0d46e4b669404805d1a109_310) |
| **[Consolidated statement of changes in equity](#if20250981a0d46e4b669404805d1a109_313)** | **[Consolidated statement of changes in equity](#if20250981a0d46e4b669404805d1a109_313)** | **[Consolidated statement of changes in equity](#if20250981a0d46e4b669404805d1a109_313)** | [171](#if20250981a0d46e4b669404805d1a109_313) |
| **[Consolidated statement of financial position](#if20250981a0d46e4b669404805d1a109_316)** | **[Consolidated statement of financial position](#if20250981a0d46e4b669404805d1a109_316)** | **[Consolidated statement of financial position](#if20250981a0d46e4b669404805d1a109_316)** | [173](#if20250981a0d46e4b669404805d1a109_316) |
| **[Consolidated statement of cash flows](#if20250981a0d46e4b669404805d1a109_319)** | **[Consolidated statement of cash flows](#if20250981a0d46e4b669404805d1a109_319)** | **[Consolidated statement of cash flows](#if20250981a0d46e4b669404805d1a109_319)** | [174](#if20250981a0d46e4b669404805d1a109_319) |
| Section | Page | Section | Page |
| **Notes to the financial statements** |  |  |  |
|  |  | [C3 Insurance and reinsurance contracts](#if20250981a0d46e4b669404805d1a109_7464) | [210](#if20250981a0d46e4b669404805d1a109_7464) |
| **[A Basis of preparation and accounting](#if20250981a0d46e4b669404805d1a109_322)policies** | [175](#if20250981a0d46e4b669404805d1a109_322) | [C3.1 Group overview](#if20250981a0d46e4b669404805d1a109_7484) | [210](#if20250981a0d46e4b669404805d1a109_7484) |
| [A1 Basis of preparation and exchange rates](#if20250981a0d46e4b669404805d1a109_325) | [175](#if20250981a0d46e4b669404805d1a109_325) | [C3.2 Analysis of movements in insurance and](#if20250981a0d46e4b669404805d1a109_7503) | [211](#if20250981a0d46e4b669404805d1a109_7503) |
| [A2 New accounting pronouncements](#if20250981a0d46e4b669404805d1a109_346)not yet effective | [176](#if20250981a0d46e4b669404805d1a109_346) | [reinsurance contract balances (excluding](#if20250981a0d46e4b669404805d1a109_7503) |  |
| [A3](#if20250981a0d46e4b669404805d1a109_349)[Critical accounting policies, estimates](#if20250981a0d46e4b669404805d1a109_352) | [176](#if20250981a0d46e4b669404805d1a109_349) | [JVs and associates](#if20250981a0d46e4b669404805d1a109_7503)) |  |
| [and judgements](#if20250981a0d46e4b669404805d1a109_349) |  | [C3.3 Analysis of movements in insurance and](#if20250981a0d46e4b669404805d1a109_7576) | [217](#if20250981a0d46e4b669404805d1a109_7576) |
|  |  | [reinsurance contract balances](#if20250981a0d46e4b669404805d1a109_7576) |  |
| **[B Earnings performance](#if20250981a0d46e4b669404805d1a109_358)** | [184](#if20250981a0d46e4b669404805d1a109_358) | [(including JVs and associates)](#if20250981a0d46e4b669404805d1a109_7576) |  |
| [B1 Analysis of performance by segment](#if20250981a0d46e4b669404805d1a109_361) | [184](#if20250981a0d46e4b669404805d1a109_361) | [C3.4 Products and determining contract](#if20250981a0d46e4b669404805d1a109_7722) | [224](#if20250981a0d46e4b669404805d1a109_7722) |
| [B1.1 Segment results](#if20250981a0d46e4b669404805d1a109_364) | [184](#if20250981a0d46e4b669404805d1a109_364) | [liabilities](#if20250981a0d46e4b669404805d1a109_7722) |  |
| [B1.2 Determining operating segments and](#if20250981a0d46e4b669404805d1a109_367) | [185](#if20250981a0d46e4b669404805d1a109_367) | [C4 Intangible assets](#if20250981a0d46e4b669404805d1a109_8014) | [228](#if20250981a0d46e4b669404805d1a109_8014) |
| [performance measure of operating segments](#if20250981a0d46e4b669404805d1a109_367) |  | [C4.1 Goodwill](#if20250981a0d46e4b669404805d1a109_8033) | [228](#if20250981a0d46e4b669404805d1a109_8033) |
| [B1.3 Revenue](#if20250981a0d46e4b669404805d1a109_373) | [186](#if20250981a0d46e4b669404805d1a109_373) | [C4.2 Other intangible assets](#if20250981a0d46e4b669404805d1a109_8053) | [229](#if20250981a0d46e4b669404805d1a109_8053) |
| [B1.4 Net insurance and reinsurance finance](#if20250981a0d46e4b669404805d1a109_5809) | [189](#if20250981a0d46e4b669404805d1a109_5809) | [C5 Borrowings](#if20250981a0d46e4b669404805d1a109_8072) | [230](#if20250981a0d46e4b669404805d1a109_8072) |
| [income](#if20250981a0d46e4b669404805d1a109_5809) (expense) |  | [C5.1 Core structural borrowings of](#if20250981a0d46e4b669404805d1a109_8092) | [230](#if20250981a0d46e4b669404805d1a109_8092) |
| [B1.5 Additional segmental analysis of](#if20250981a0d46e4b669404805d1a109_6830) | [190](#if20250981a0d46e4b669404805d1a109_6830) | [shareholder-financed businesses](#if20250981a0d46e4b669404805d1a109_8092) |  |
| p[rofit after tax](#if20250981a0d46e4b669404805d1a109_6830) |  | [C5.2 Operational borrowings](#if20250981a0d46e4b669404805d1a109_8111) | [230](#if20250981a0d46e4b669404805d1a109_8111) |
| [B2 Insurance service expenses and other](#if20250981a0d46e4b669404805d1a109_382) | [190](#if20250981a0d46e4b669404805d1a109_382) | [C6 Risk and sensitivity analysis](#if20250981a0d46e4b669404805d1a109_8133) | [231](#if20250981a0d46e4b669404805d1a109_8133) |
| [expenditure](#if20250981a0d46e4b669404805d1a109_382) |  | [C6.1 Sensitivity to key market risks](#if20250981a0d46e4b669404805d1a109_8153) | [231](#if20250981a0d46e4b669404805d1a109_8153) |
| [B2.1 Staff and employment costs](#if20250981a0d46e4b669404805d1a109_385) | [191](#if20250981a0d46e4b669404805d1a109_385) | [C6.2 Sensitivity to insurance risks](#if20250981a0d46e4b669404805d1a109_13388) | [234](#if20250981a0d46e4b669404805d1a109_13388) |
| [B2.2 Share-based payments](#if20250981a0d46e4b669404805d1a109_388) | [192](#if20250981a0d46e4b669404805d1a109_388) | [C7 Tax assets and liabilities](#if20250981a0d46e4b669404805d1a109_8192) | [234](#if20250981a0d46e4b669404805d1a109_8192) |
| [B2.3 Key management remuneration](#if20250981a0d46e4b669404805d1a109_391) | [194](#if20250981a0d46e4b669404805d1a109_391) | [C7.1 Current tax](#if20250981a0d46e4b669404805d1a109_8212) | [234](#if20250981a0d46e4b669404805d1a109_8212) |
| [B2.4 Fees payable to the auditor](#if20250981a0d46e4b669404805d1a109_394) | [194](#if20250981a0d46e4b669404805d1a109_394) | [C7.2 Deferred tax](#if20250981a0d46e4b669404805d1a109_8232) | [235](#if20250981a0d46e4b669404805d1a109_8232) |
| [B3 Tax charge](#if20250981a0d46e4b669404805d1a109_397) | [195](#if20250981a0d46e4b669404805d1a109_397) | [C8 Share capital, share premium and own shares](#if20250981a0d46e4b669404805d1a109_8251) | [235](#if20250981a0d46e4b669404805d1a109_8251) |
| [B3.1 Total tax charge by s](#if20250981a0d46e4b669404805d1a109_400)egment | [195](#if20250981a0d46e4b669404805d1a109_400) | [C9 C](#if20250981a0d46e4b669404805d1a109_8271)apital | [237](#if20250981a0d46e4b669404805d1a109_8271) |
| [B3.2 Reconciliation of effective](#if20250981a0d46e4b669404805d1a109_403) | [196](#if20250981a0d46e4b669404805d1a109_403) | [C9.1 Group objectives, policies and processes](#if20250981a0d46e4b669404805d1a109_8290) | [237](#if20250981a0d46e4b669404805d1a109_8290) |
| [tax rate](#if20250981a0d46e4b669404805d1a109_403) |  | [for managing capital](#if20250981a0d46e4b669404805d1a109_8290) |  |
| [B4 Earnings per share](#if20250981a0d46e4b669404805d1a109_406) | [197](#if20250981a0d46e4b669404805d1a109_406) | [C9.2 Local capital regulations](#if20250981a0d46e4b669404805d1a109_8311) | [237](#if20250981a0d46e4b669404805d1a109_8311) |
| [B5 Dividends](#if20250981a0d46e4b669404805d1a109_409) | [198](#if20250981a0d46e4b669404805d1a109_409) | [C9.3 Transferability of capital resources](#if20250981a0d46e4b669404805d1a109_8330) | [238](#if20250981a0d46e4b669404805d1a109_8330) |
|  |  | [C10 Property, plant and equipment](#if20250981a0d46e4b669404805d1a109_8349) | [239](#if20250981a0d46e4b669404805d1a109_8349) |
| **C Financial Position** | [199](#if20250981a0d46e4b669404805d1a109_7293) |  |  |
| [C1 Group assets and liabilities](#if20250981a0d46e4b669404805d1a109_7293) | [199](#if20250981a0d46e4b669404805d1a109_7293) | **[D Other information](#if20250981a0d46e4b669404805d1a109_550)** | [240](#if20250981a0d46e4b669404805d1a109_550) |
| [C1.1 Group investments by business type](#if20250981a0d46e4b669404805d1a109_7314) | [199](#if20250981a0d46e4b669404805d1a109_7314) | [D1 Contingencies and related obligations](#if20250981a0d46e4b669404805d1a109_553) | [240](#if20250981a0d46e4b669404805d1a109_553) |
| [C1.2 Other assets and liabilities](#if20250981a0d46e4b669404805d1a109_7333) | [202](#if20250981a0d46e4b669404805d1a109_7333) | [D2 Ownership interest in Prudential Assurance](#if20250981a0d46e4b669404805d1a109_15806)  | [240](#if20250981a0d46e4b669404805d1a109_15806) |
| [C1.3 Cash and cash equivalents](#if20250981a0d46e4b669404805d1a109_7352) | [202](#if20250981a0d46e4b669404805d1a109_7352) | Malaysia Berhad |  |
| [C1.4 Provisions](#if20250981a0d46e4b669404805d1a109_7371) | [202](#if20250981a0d46e4b669404805d1a109_7371) | [D3 Post balance sheet events](#if20250981a0d46e4b669404805d1a109_556) | [240](#if20250981a0d46e4b669404805d1a109_556) |
| [C2](#if20250981a0d46e4b669404805d1a109_7389)Measurement of financial assets and liabilities | [203](#if20250981a0d46e4b669404805d1a109_7389) | [D4 Related party transactions](#if20250981a0d46e4b669404805d1a109_559) | [240](#if20250981a0d46e4b669404805d1a109_559) |
| [C2.1 Determination of fair value](#if20250981a0d46e4b669404805d1a109_7408) | [203](#if20250981a0d46e4b669404805d1a109_7408) | [D5 Commitments](#if20250981a0d46e4b669404805d1a109_562) | [241](#if20250981a0d46e4b669404805d1a109_562) |
| [C2.2](#if20250981a0d46e4b669404805d1a109_7427)Fair value measurement hierarchy | [204](#if20250981a0d46e4b669404805d1a109_7427) | [D6 Investments in subsidiary undertakings,](#if20250981a0d46e4b669404805d1a109_568) | [241](#if20250981a0d46e4b669404805d1a109_568) |
| [C2.3 Additional information on financial](#if20250981a0d46e4b669404805d1a109_7446) | [206](#if20250981a0d46e4b669404805d1a109_7446) | [joint ventures](#if20250981a0d46e4b669404805d1a109_568)[and associates](#if20250981a0d46e4b669404805d1a109_568) |  |
| [instruments](#if20250981a0d46e4b669404805d1a109_7446) |  | [D6.1 Basis of consolidation](#if20250981a0d46e4b669404805d1a109_571) | [241](#if20250981a0d46e4b669404805d1a109_571) |
|  |  | [D6.2 Dividend restrictions and minimum capital](#if20250981a0d46e4b669404805d1a109_574) | [242](#if20250981a0d46e4b669404805d1a109_574) |
|  |  | [requirements](#if20250981a0d46e4b669404805d1a109_574) |  |
|  |  | [D6.3 Investment in joint ventures](#if20250981a0d46e4b669404805d1a109_577) | [242](#if20250981a0d46e4b669404805d1a109_577) |
|  |  | [and associates](#if20250981a0d46e4b669404805d1a109_577) |  |
|  |  | [D6.4 Related undertakings](#if20250981a0d46e4b669404805d1a109_580) | [245](#if20250981a0d46e4b669404805d1a109_580) |

---

**Report of Independent Registered Public Accounting Firm** 

To the Shareholders and the Board of Directors of Prudential plc

**Opinion on the Financial Statements**

We have audited the accompanying consolidated statement of financial position of Prudential plc (the Company) and subsidiaries

(the Group) as of 31 December 2025 and 2024, the related consolidated statements of income, comprehensive income, changes in

equity and cash flows for each of the three years in the period ended 31 December 2025, the related notes and the disclosures

marked 'audited' within the Risk Review section of the 2025 Form 20-F of the Group (collectively referred to as the "consolidated

financial statements") and the condensed financial information Schedule II (the "parent company financial statements"). In our

opinion, the consolidated financial statements and the parent company financial statements present fairly, in all material respects,

the financial position of the Group and the Company, respectively, at 31 December 2025 and 2024, and the results of their

operations and their cash flows for each of the three years in the period ended 31 December 2025 and, as it pertains to the

consolidated financial statements, in conformity with International Financial Reporting Standards (IFRS) as issued by the

International Accounting Standards Board and, as it pertains to the parent company financial statements, in conformity with

United Kingdom Generally Accepted Accounting Practice, including Financial Reporting Standard 101 Reduced Disclosure

Framework and Part 15 of the Companies Act 2006.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)

(PCAOB), the Group's internal control over financial reporting as of 31 December 2025, based on criteria established in Internal

Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013

framework) and our report dated 26 March 2026 expressed an unqualified opinion thereon.

**Basis for Opinion**

These financial statements are the responsibility of the Group's management. Our responsibility is to express an opinion on the

Group's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to

be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and

regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the

audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to

error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements,

whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a

test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the

accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the

financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matters**

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that

were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that

are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The

communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a

whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters

or on the accounts or disclosures to which they relate.

---

| | |
|:---|:---|
| | **Valuation of best estimate insurance contract liabilities** |
| **Description of** <br>**the Matter**<br>| The Group recorded insurance contract liabilities (net of insurance contract assets) of $172.7 billion as at 31 <br>December 2025 on its Consolidated Statement of Financial Position, of which $146.7 billion, as disclosed in <br>Note C3.1(a) to the consolidated financial statements, relates to best estimate liabilities (BEL) for future cash <br>flows, adjusted to reflect the time value of money and financial risks. As disclosed in note A3(a) to the <br>consolidated financial statements, key assumptions include discount rates (including the illiquidity premium <br>adjustment) and investment return assumptions (together the "economic assumptions") and operating <br>assumptions in respect of mortality, morbidity (including medical claims costs), persistency and expenses <br>(including IFRS 17 Insurance Contracts attribution).<br>Auditing the valuation of BEL was complex and required significant auditor judgment due to the complexity of <br>the fulfilment cashflow models, the selection and use of economic and operating assumptions and the <br>sensitivity of the fulfilment cash flow models to the assumptions set by management.<br>|

---

---

| | |
|:---|:---|
| **How We** <br>**Addressed the** <br>**Matter in Our** <br>**Audit**<br>| We obtained an understanding, evaluated the design, and tested the operating effectiveness of <br>management's controls over the valuation of BEL. The controls we tested related to, among other areas, <br>setting economic and operating assumptions and model changes.<br>To test the valuation of BEL, our procedures included, among others, involving our actuarial professionals, to <br>assess the fulfilment cashflow models and assumptions with respect to compliance with the Group's IFRS 17 <br>valuation policies. We tested the implementation of the economic and operating assumptions in the models. <br>For economic assumptions, we tested discount rates and investment return assumptions for a sample of <br>currencies, including by reference to yield curves and the Group's economic scenario generators. For discount <br>rates, we also compared the information used to determine the illiquidity premium, to the characteristics of <br>the liabilities, asset allocations, and yields-to-maturity and allowance for credit risk on the reference portfolio <br>of assets. For operating assumptions, we compared the key assumptions used in the valuation of BEL, <br>including mortality, morbidity and persistency, with the results of management's experience investigations, <br>market trends and regulatory developments around product features and pricing, as relevant. We also <br>evaluated the Group's expense assumptions, by comparing them to the Group's historical, current and <br>projected expense levels and policy relating to the attribution of expenses to insurance contracts. For a <br>sample of new models and changes to existing models, we compared management's model validation results <br>with the terms and conditions of the related insurance contracts and the Group's IFRS 17 valuation policies. <br>In addition, we performed an independent recalculation of the modelled BEL for a sample of insurance <br>contract groups (ICGs) and compared the results to the output of the fulfilment cashflow models used by <br>management. <br>|

---

---

| | |
|:---|:---|
| | **Revenue recognition in respect of release of contractual service margin** |
| **Description of** <br>**the Matter**<br>| The Group recorded insurance revenue of $11.1 billion for the year ended 31 December 2025 in its <br>Consolidated Income Statement, of which $2.4 billion relates to release of contractual service margin (CSM) <br>as disclosed in Note B1.3 to the consolidated financial statements. There is significant judgment and <br>complexity involved in determining the initial CSM and subsequent movements, including release of CSM, <br>which directly impacts insurance revenue. The release of CSM for the period is measured based on coverage <br>units provided, as described in Note A3(a) to the consolidated financial statements. As disclosed in Note <br>C3.4(a) to the consolidated financial statements, the release of CSM for the period is based on the opening <br>CSM adjusted for movements in the period, including the CSM for new contracts issued in the year, interest <br>accretion for contracts measured using the General Measurement Model ("GMM") and the impact of changes <br>in the operating and economic assumptions (including the change in the fair value of underlying items for <br>contracts measured using the Variable Fee Approach (VFA)). <br>Auditing the release of CSM was complex and required significant auditor judgment, due to the complexity of <br>the calculation of the CSM and its interaction with the valuation of best estimate liabilities described above, <br>and the judgment involved in the determination of the coverage units.<br>|
| **How We** <br>**Addressed the** <br>**Matter in Our** <br>**Audit**<br>| We obtained an understanding, evaluated the design, and tested the operating effectiveness of <br>management's controls over the calculation and release of CSM. The controls we tested related to, among <br>other areas, the determination of coverage units, the change management and governance process over the <br>CSM calculation model, and management review controls over CSM movements during the period, including <br>release of CSM.<br>To test the calculation and release of CSM, with the support of our actuarial professionals, our audit <br>procedures included, testing the determination of coverage units and the release of CSM, through <br>reperformance of the calculation for a sample of ICGs and comparing the release pattern to our expectations, <br>based on the prior year release pattern and changes in the business and economic environment during the <br>period. For a sample of new contracts issued during the year, we recalculated the initial CSM, including, <br>where relevant, the identification of onerous contracts. For movements relating to interest accretion and the <br>impact of assumption changes, we compared the impact of operating and economic assumption changes <br>(including changes in the fair value of underlying items for contracts measuring using VFA) in the CSM <br>movement to related changes in the BEL calculation, including considering whether they related to past or <br>future service, and reperformed the calculation of interest accretion for contracts measured using GMM. <br>|

---

/s/ Ernst & Young LLP

We were engaged in 2021 to serve as the Company's auditor in respect of the financial statements as of and for

the year ending 31 December 2022 that reflected the adoption of IFRS 17, and as the Company's appointed

auditor commencing in 2023.

London, United Kingdom

26 March 2026

**Report of Independent Registered Public Accounting Firm**

To the Shareholders and the Board of Directors of Prudential plc

**Opinion on Internal Control Over Financial Reporting** 

We have audited Prudential plc's and its subsidiaries' (the Group) internal control over financial reporting as of 31 December 2025,

based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of

the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, the Group maintained, in all material respects,

effective internal control over financial reporting as of 31 December 2025, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)

(PCAOB), the 2025 consolidated financial statements of the Group, the disclosures marked 'audited' within the Risk Review section

of the 2025 Form 20-F of the Group and the condensed financial information Schedule II and our report dated 26 March 2026

expressed an unqualified opinion thereon.

**Basis for Opinion**

Prudential plc's management is responsible for maintaining effective internal control over financial reporting and for its assessment

of the effectiveness of internal control over financial reporting included in the accompanying *Management's Annual Report on* 

*Internal Control over Financial Reporting*. Our responsibility is to express an opinion on the Group's internal control over financial

reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with

respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities

and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the

audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all

material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material

weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and

performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a

reasonable basis for our opinion.

**Definition and Limitations of Internal Control Over Financial Reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the

reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally

accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that

(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions

of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation

of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the

company are being made only in accordance with authorizations of management and directors of the company; and (3) provide

reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's

assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,

projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate

because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

London, United Kingdom

26 March 2026

**Consolidated income statement** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Note | **2025 $m** | 2024 $m | 2023 $m |
| Insurance revenue | B1.3 | **11080** | 10358 | 9371 |
| Insurance service expense: |  |  |  |  |
| Claims incurred |  | **(3331)** | (3147) | (2913) |
| Directly attributable expenses incurred |  | **(1455)** | (1328) | (1258) |
| Amortisation of insurance acquisition cash flows |  | **(3435)** | (3157) | (2745) |
| Other insurance service expenses |  | **(23)** | (131) | (197) |
|  |  | **(8244)** | (7763) | (7113) |
| Net expense from reinsurance contracts held |  | **(212)** | (302) | (171) |
| **Insurance service result** |  | **2624** | 2293 | 2087 |
| Investment return: |  |  |  |  |
| Interest revenue calculated using the effective interest method |  | **413** | 477 | 340 |
| Other investment return on financial investments |  | **15851** | 5442 | 9423 |
|  | B1.3 | **16264** | 5919 | 9763 |
| Fair value movements on investment contract liabilities |  | **(72)** | (95) | (24) |
| Net insurance and reinsurance finance income (expense): |  |  |  |  |
| Net finance expense from insurance contracts | B1.4 | **(14612)** | (4154) | (8839) |
| Net finance (expense) income from reinsurance contracts held | B1.4 | **(159)** | (338) | 191 |
|  |  | **(14771)** | (4492) | (8648) |
| **Net investment result** |  | **1421** | 1332 | 1091 |
| Other revenue | B1.3 | **411** | 382 | 369 |
| Non-insurance expenditure | B2 | **(1031)** | (1003) | (990) |
| Finance costs: interest on core structural borrowings of shareholder-financed <br>businesses<br>|  | **(183)** | (171) | (172) |
| Gain (loss) attaching to corporate transactions | B1.1 | **1515** | (71) | (22) |
| Share of profit (loss) from joint ventures and associates, net of related tax | D6.3 | **364** | 477 | (91) |
| Profit before tax *(being tax attributable to shareholders' and policyholders'* <br>*returns)* <sup>note</sup><br>|  | **5121** | 3239 | 2272 |
| Tax charge attributable to policyholders' returns |  | **(180)** | (286) | (175) |
| Profit before tax attributable to shareholders' returns |  | **4941** | 2953 | 2097 |
| Total tax charge attributable to shareholders' and policyholders' returns | B3.1 | **(1002)** | (824) | (560) |
| Remove tax charge attributable to policyholders' returns | B3.2 | **180** | 286 | 175 |
| Tax charge attributable to shareholders' returns | B3.2 | **(822)** | (538) | (385) |
| **Profit for the year** | B1.5 | **4119** | 2415 | 1712 |
| **Attributable to:** |  |  |  |  |
| Equity holders of the Company |  | **3978** | 2285 | 1701 |
| Non-controlling interests |  | **141** | 130 | 11 |
| **Profit for the year** |  | **4119** | 2415 | 1712 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Earnings per share (in cents)** | Note | **2025** | 2024 | 2023 |
| Based on profit attributable to equity holders of the Company: | B4 |  |  |  |
| Basic |  | **154.2¢** | 84.1¢ | 62.1¢ |
| Diluted |  | **153.5¢** | 84.0¢ | 61.9¢ |

---

**Note**

This measure is the formal profit before tax measure under IFRS. It is not the result attributable to shareholders principally because total corporate tax of the

Group includes those taxes on the income of consolidated with-profits and unit-linked funds that, through adjustments to benefits, are borne by policyholders.

These amounts are required to be included in the tax charge under IAS 12. Consequently, the profit before tax measure is not representative of pre-tax profit

attributable to shareholders.

*The accompanying notes are an integral part of these financial statements*

**Consolidated statement of comprehensive income**

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| **Profit for the year** | **4119** | 2415 | 1712 |
| **Other comprehensive income (loss)** |  |  |  |
| Items that may be reclassified subsequently to profit or loss: |  |  |  |
| Exchange translation movements and net investment hedges | **524** | (291) | (135) |
| Cumulative exchange loss of disposed businesses recycled through profit or loss | **34** | – | – |
|  | **558** | (291) | (135) |
| Items that will not be reclassified subsequently to profit or loss: |  |  |  |
| Valuation movements on retained interest in Jackson classified as FVOCI under IFRS 9 <sup>note</sup> | **–** | – | 8 |
| **Total comprehensive income for the year** | **4677** | 2124 | 1585 |
| **Attributable to:** |  |  |  |
| Equity holders of the Company | **4421** | 1976 | 1585 |
| Non-controlling interests | **256** | 148 | – |
| **Total comprehensive income for the year** | **4677** | 2124 | 1585 |

---

**Note**

On the adoption of IFRS 9 at 1 January 2023, the Group elected to measure its retained interest in the equity securities of Jackson at fair value through other

comprehensive income (FVOCI). The Group subsequently disposed of its remaining interest in Jackson in 2023.

*The accompanying notes are an integral part of these financial statements*

**Consolidated statement of changes in equity** 

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** | **Year ended 31 Dec 2025 $m** |
| | <br>Note | **Share**<br>**capital**<br>| **Share**<br>**premium**<br>| **Capital** <br>**redemption** <br>**reserve**<br>| **Retained**<br>**earnings**<br>| **Translation**<br>**reserve**<br>| **Share-**<br>**holders'**<br>**equity**<br>| **Non-**<br>**controlling**<br> **interests**<br>| **Total**<br>**equity**<br>|
| **Reserves** |  |  |  |  |  |  |  |  |  |
| Profit for the year |  | **–** | **–** | **–** | **3978** | **–** | **3978** | **141** | **4119** |
| Other comprehensive income |  | **–** | **–** | **–** | **–** | **443** | **443** | **115** | **558** |
| **Total comprehensive income for** <br>**the year**<br>|  | **–** | **–** | **–** | **3978** | **443** | **4421** | **256** | **4677** |
| **Transactions with owners of the** <br>**Company**<br>|  |  |  |  |  |  |  |  |  |
| Dividends | B5 | **–** | **–** | **–** | **(623)** | **–** | **(623)** | **(91)** | **(714)** |
| Effect of scrip dividends | C8 | **–** | **–** | **–** | **29** | **–** | **29** | **–** | **29** |
| Reserve movements in respect of <br>share-based payments<br>|  | **–** | **–** | **–** | **11** | **–** | **11** | **–** | **11** |
| Effect of transactions relating to non-<br>controlling interests<br>|  | **–** | **–** | **–** | **28** | **–** | **28** | **(104)** | **(76)** |
| New share capital subscribed | C8 | **–** | **2** | **–** | **–** | **–** | **2** | **–** | **2** |
| Share repurchases/buybacks | C8 | **(7)** | **–** | **7** | **(1234)** | **–** | **(1234)** | **–** | **(1234)** |
| Movement in own shares in respect of <br>share-based payment plans<br>|  | **–** | **–** | **–** | **(9)** | **–** | **(9)** | **–** | **(9)** |
| Net (decrease) increase in equity |  | **(7)** | **2** | **7** | **2180** | **443** | **2625** | **61** | **2686** |
| Balance at beginning of year |  | **176** | **5009** | **7** | **11906** | **394** | **17492** | **1182** | **18674** |
| **Balance at end of year** |  | **169** | **5011** | **14** | **14086** | **837** | **20117** | **1243** | **21360** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m | Year ended 31 Dec 2024 $m |
| | <br>Note | Share<br>capital<br>| Share<br>premium<br>| Capital <br>redemption <br>reserve<br>| Retained<br>earnings<br>| Translation<br>reserve<br>| Share-<br>holders'<br>equity<br>| Non-<br>controlling<br> interests<br>| Total<br>equity<br>|
| **Reserves** |  |  |  |  |  |  |  |  |  |
| Profit for the year |  | – | – | – | 2285 | – | 2285 | 130 | 2415 |
| Other comprehensive (loss) income |  | – | – | – | – | (309) | (309) | 18 | (291) |
| **Total comprehensive income** <br>**(loss) for the year**<br>|  | – | – | – | 2285 | (309) | 1976 | 148 | 2124 |
| **Transactions with owners of the** <br>**Company**<br>|  |  |  |  |  |  |  |  |  |
| Dividends | B5 | – | – | – | (575) | – | (575) | (8) | (583) |
| Effect of scrip dividends | C8 | – | – | – | 23 | – | 23 | – | 23 |
| Reserve movements in respect of <br>share-based payments<br>|  | – | – | – | 1 | – | 1 | – | 1 |
| Adjustment to non-controlling <br>interest for Malaysia conventional life <br>business on 1 January 2024<br>| D2 | – | – | – | (857) | – | (857) | 886 | 29 |
| Effect of transactions relating to other <br>non-controlling interests<br>|  | – | – | – | (18) | – | (18) | (4) | (22) |
| Share repurchases/buybacks | C8 | (7) | – | 7 | (878) | – | (878) | – | (878) |
| Movement in own shares in respect of <br>share-based payment plans<br>|  | – | – | – | (3) | – | (3) | – | (3) |
| **Net (decrease) increase in equity** |  | (7) | – | 7 | (22) | (309) | (331) | 1022 | 691 |
| Balance at beginning of year |  | 183 | 5009 | – | 11928 | 703 | 17823 | 160 | 17983 |
| **Balance at end of year** |  | 176 | 5009 | 7 | 11906 | 394 | 17492 | 1182 | 18674 |

---

**Consolidated statement of changes in equity continued**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m | Year ended 31 Dec 2023 $m |
| | <br>Note | Share<br>capital<br>| Share<br>premium<br>| Retained<br>earnings<br>| Translation<br>reserve<br>| Fair <br>value <br>reserve<br>| Share-<br>holders'<br>equity<br>| Non-<br>controlling<br> interests<br>| Total<br>equity<br>|
| **Reserves** |  |  |  |  |  |  |  |  |  |
| Profit for the year |  | – | – | 1701 | – | – | 1701 | 11 | 1712 |
| Other comprehensive (loss) income |  | – | – | – | (124) | 8 | (116) | (11) | (127) |
| **Total comprehensive income (loss)** <br>**for the year**<br>|  | – | – | 1701 | (124) | 8 | 1585 | – | 1585 |
| **Transactions with owners of the** <br>**Company**<br>|  |  |  |  |  |  |  |  |  |
| Dividends | B5 | – | – | (533) | – | – | (533) | (7) | (540) |
| **Transfer of fair value reserve** <br>**following disposal of investment in** <br>**Jackson**<br>|  | – | – | 71 | – | (71) | – | – | – |
| Reserve movements in respect of share-<br>based payments<br>|  | – | – | (5) | – | – | (5) | – | (5) |
| Effect of transactions relating to non-<br>controlling interests<br>|  | – | – | 16 | – | – | 16 | – | 16 |
| New share capital subscribed | C8 | 1 | 3 | – | – | – | 4 | – | 4 |
| Movement in own shares in respect of <br>share-based payment plans<br>|  | – | – | 25 | – | – | 25 | – | 25 |
| **Net increase (decrease) in equity** |  | 1 | 3 | 1275 | (124) | (63) | 1092 | (7) | 1085 |
| Balance at beginning of year |  | 182 | 5006 | 10653 | 827 | 63 | 16731 | 167 | 16898 |
| **Balance at end of year** |  | 183 | 5009 | 11928 | 703 | – | 17823 | 160 | 17983 |

---

*The accompanying notes are an integral part of these financial statements*

**Consolidated statement of financial position**

---

| | | | |
|:---|:---|:---|:---|
| | Note | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| **Assets** |  |  |  |
| Goodwill | C4.1 | **902** | 848 |
| Other intangible assets | C4.2 | **3958** | 3824 |
| Property, plant and equipment | C10 | **530** | 417 |
| Insurance contract assets | C3.1 | **1816** | 1345 |
| Reinsurance contract assets | C3.1 | **3406** | 3390 |
| Deferred tax assets | C7.2 | **119** | 142 |
| Current tax recoverable | C7.1 | **77** | 31 |
| Investments in joint ventures and associates accounted for using the equity method | D6.3 | **2763** | 2412 |
| Investment properties | C1.1 | **3** | 3 |
| Loans | C1.1 | **551** | 517 |
| Equity securities and holdings in collective investment schemes <sup>note</sup> | C1.1 | **89558** | 81002 |
| Debt securities <sup>note</sup> | C1.1 | **92051** | 73804 |
| Derivative assets | C2.2 | **621** | 395 |
| Deposits | C1.1 | **6246** | 5466 |
| Accrued investment income | C1.2 | **1071** | 902 |
| Other debtors | C1.2 | **817** | 1310 |
| Assets held for sale |  | **–** | 296 |
| Cash and cash equivalents | C1.3 | **7706** | 5772 |
| **Total assets** |  | **212195** | 181876 |
| **Equity** |  |  |  |
| Shareholders' equity |  | **20117** | 17492 |
| Non-controlling interests |  | **1243** | 1182 |
| **Total equity** |  | **21360** | 18674 |
| **Liabilities** |  |  |  |
| Insurance contract liabilities | C3.1 | **174498** | 147566 |
| Reinsurance contract liabilities | C3.1 | **640** | 536 |
| Investment contract liabilities without discretionary participation features | C2.2 | **715** | 748 |
| Core structural borrowings of shareholder-financed businesses | C5.1 | **4459** | 3925 |
| Operational borrowings | C5.2 | **831** | 797 |
| Obligations under funding, securities lending and sale and repurchase agreements | C2.3 | **745** | 272 |
| Net asset value attributable to unit holders of consolidated investment funds | C2.3 | **2263** | 2679 |
| Deferred tax liabilities | C7.2 | **1830** | 1514 |
| Current tax liabilities | C7.1 | **273** | 238 |
| Accruals, deferred income and other creditors | C1.2 | **2731** | 2848 |
| Provisions | C1.4 | **268** | 218 |
| Derivative liabilities | C2.2 | **1582** | 1617 |
| Liabilities held for sale |  | **–** | 244 |
| **Total liabilities** |  | **190835** | 163202 |
| **Total equity and liabilities** |  | **212195** | 181876 |

---

**Note**

Included within equity securities and holdings in collective investment schemes and debt securities as at 31 December 2025 are $1,798 million of lent securities

and assets subject to repurchase agreements (31 December 2024: $1,565 million).

*The accompanying notes are an integral part of these financial statements*

**Consolidated statement of cash flows**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Note | **2025 $m** | 2024 $m | 2023 $m |
| **Cash flows from operating activities** |  |  |  |  |
| Profit before tax *(being tax attributable to shareholders' and policyholders'* <br>*returns)*<br>|  | **5121** | 3239 | 2272 |
| Movements in operating assets and liabilities: |  |  |  |  |
| Investments |  | **(23698)** | (6403) | (14539) |
| Other non-investment and non-cash assets |  | **24** | 124 | 23 |
| Insurance and reinsurance contract assets and liabilities |  | **22660** | 7925 | 12787 |
| Other non-insurance liabilities |  | **(330)** | (1440) | 42 |
| Other adjustments to profit before tax for non-cash movements: |  |  |  |  |
| Interest and dividend income and interest payments included in profit <br>before tax<br>|  | **(5482)** | (5180) | (4378) |
| Other non-cash items included in profit before tax |  | **(880)** | 603 | 584 |
| Operating cash items: |  |  |  |  |
| Interest receipts |  | **3416** | 3049 | 2872 |
| Interest payments |  | **(61)** | (75) | (75) |
| Dividend receipts |  | **2198** | 2316 | 1650 |
| Tax paid |  | **(518)** | (549) | (406) |
| Net cash flows from operating activities <sup>note (i)</sup> |  | **2450** | 3609 | 832 |
| **Cash flows from investing activities** |  |  |  |  |
| Purchases of property, plant and equipment | C10 | **(104)** | (101) | (44) |
| Disposal of property, plant and equipment |  | **4** | – | 2 |
| Acquisition of distribution rights and other intangibles |  | **(297)** | (557) | (415) |
| Disposal of businesses, net of associated tax <sup>note (ii)</sup> |  | **1485** | – | – |
| Cash advanced to Mainland China life joint venture <sup>note (i)</sup> |  | **–** | (174) | (176) |
| Disposal of Jackson shares |  | **–** | – | 273 |
| Net cash flows from investing activities |  | **1088** | (832) | (360) |
| **Cash flows from financing activities** |  |  |  |  |
| Structural borrowings of shareholder-financed businesses: <sup>note (iii)</sup> |  |  |  |  |
| Issuance (redemption) of debt, net of costs | C5.1 | **462** | – | (393) |
| Interest paid |  | **(176)** | (164) | (188) |
| Payment of principal portion of lease liabilities |  | **(95)** | (93) | (93) |
| Acquisition of non-controlling interests |  | **–** | (18) | – |
| Equity capital: |  |  |  |  |
| Issues of ordinary share capital | C8 | **2** | – | 4 |
| Share repurchases/buybacks (including costs) |  | **(1252)** | (860) | – |
| External dividends: |  |  |  |  |
| Dividends paid to equity holders of the Company | B5 | **(594)** | (552) | (533) |
| Dividends paid to non-controlling interests |  | **(91)** | (8) | (7) |
| Net cash flows from financing activities |  | **(1744)** | (1695) | (1210) |
| **Net increase (decrease) in cash and cash equivalents** |  | **1794** | 1082 | (738) |
| Cash and cash equivalents at 1 Jan |  | **5772** | 4751 | 5514 |
| Effect of exchange rate changes on cash and cash equivalents |  | **140** | (61) | (25) |
| **Cash and cash equivalents at 31 Dec** | C1.3 | **7706** | 5772 | 4751 |

---

**Notes**

(i)Included in net cash flows from operating activities are dividends from joint ventures and associates of $180 million (2024: $148 million; 2023: $209

million). Cash advanced to the Mainland China life joint venture in 2024 of $174 million has subsequently been converted into a capital injection in 2025.The

$176 million advanced in 2023 was subsequently converted into a capital injection in 2024.

(ii)Cash flows from disposal of businesses in 2025 comprise the net proceeds from the sale of a portion of the Group's interest in ICICI Prudential Asset

Management Company Limited during the company's initial public offering (IPO) in December 2025, as discussed further in note D6.3 and the net proceeds

from the disposal of businesses classified as held for sale at 31 December 2024. Total tax paid of $(750) million in 2025 was included in net cash flows from

operating activities and net cash flows from investing activities.

(iii)Structural borrowings of shareholder-financed businesses exclude borrowings to support short-term fixed income securities programmes, lease liabilities and

other borrowings of shareholder-financed businesses. Cash flows in respect of these borrowings are included within cash flows from operating activities. The

changes in the carrying value of the structural borrowings of shareholder-financed businesses for the Group are analysed below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Balance at 1 Jan <br>$m | Cash movements $m | Cash movements $m | Non-cash movements $m | Non-cash movements $m | Balance at 31 Dec <br>$m |
| | Balance at 1 Jan <br>$m | Issuance<br>of debt<br>| Redemption<br>of debt<br>| Foreign exchange<br>movement<br>| Other<br>movements<br>| Balance at 31 Dec <br>$m |
| **2025** | **3925** | **462** | **–** | **65** | **7** | **4459** |
| 2024 | 3933 | – | – | (15) | 7 | 3925 |
| 2023 | 4261 | – | (393) | 58 | 7 | 3933 |

---

*The accompanying notes are an integral part of these financial statements* 

**Notes to the consolidated financial statements**

**A Basis of preparation and accounting policies**

**A1 Basis of preparation and exchange rates**

Prudential plc (the 'Company') together with its subsidiaries (collectively, the 'Group' or 'Prudential') provides life and health

insurance and asset management in Greater China, ASEAN, India and Africa. The Group is headquartered in Hong Kong.

**Basis of preparation**

These consolidated financial statements have been prepared in accordance with IFRS Standards as issued by the IASB and UK-

adopted international accounting standards. At 31 December 2025, there were no unadopted standards effective for the year

ended 31 December 2025 which impacted the consolidated financial statements of the Group, and there were no differences

between UK-adopted international accounting standards and IFRS Standards as issued by the IASB in terms of their application to

the Group. The accounting policies applied by the Group in determining the IFRS financial results in these consolidated financial

statements are the same as those previously applied in the Group's consolidated financial statements for the year ended

31 December 2024 as disclosed in the 2024 Annual Report. The adoption of the amendments to IAS 21 'Lack of exchangeability'

effective from 1 January 2025 has had no impact on the Group financial statements.

**Going concern basis of accounting**

The Directors have made an assessment of going concern covering a period to 31 March 2027, being at least 12 months from the

date these consolidated financial statements are approved. In making this assessment, the Directors have considered both the

Group's current performance, solvency and liquidity and the Group's business plan taking into account the Group's principal risks,

and the mitigations available to address them, as well as the results of the Group's stress and scenario testing, as described

further in the Risk review section.

Based on the above, the Directors have a reasonable expectation that the Company and the Group have adequate resources to

continue their operations for a period to 31 March 2027, being at least 12 months from the date these consolidated financial

statements are approved. No material uncertainties that may cast significant doubt on the ability of the Company and the Group

to continue as a going concern have been identified. The Directors therefore consider it appropriate to continue to adopt the going

concern basis of accounting in preparing these consolidated financial statements for the year ended 31 December 2025.

**Exchange rates**

The exchange rates applied for balances and transactions in currencies other than the presentation currency of the Group, US

dollars (USD), were:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Closing rate at year end | Closing rate at year end | Average rate for the year to date | Average rate for the year to date | Average rate for the year to date |
| **USD : local currency** | **31 Dec 2025** | 31 Dec 2024 | **2025** | 2024 | 2023 |
| Chinese yuan (CNY) | **6.99** | 7.30 | **7.19** | 7.20 | 7.09 |
| Hong Kong dollar (HKD) | **7.78** | 7.77 | **7.80** | 7.80 | 7.83 |
| Indian rupee (INR) | **89.88** | 85.61 | **87.17** | 83.67 | 82.60 |
| Indonesian rupiah (IDR) | **16675.00** | 16095.00 | **16462.13** | 15844.88 | 15230.82 |
| Malaysian ringgit (MYR) | **4.06** | 4.47 | **4.28** | 4.58 | 4.56 |
| Singapore dollar (SGD) | **1.29** | 1.36 | **1.31** | 1.34 | 1.34 |
| Taiwan dollar (TWD) | **31.42** | 32.78 | **31.16** | 32.12 | 31.17 |
| Thai baht (THB) | **31.49** | 34.24 | **32.87** | 35.29 | 34.80 |
| UK pound sterling (GBP) | **0.74** | 0.80 | **0.76** | 0.78 | 0.80 |
| Vietnamese dong (VND) | **26300.00** | 25485.00 | **26008.80** | 25057.63 | 23835.92 |

---

**Foreign exchange translation**

*In order to present the consolidated financial statements in USD, the results and financial position of entities not using USD as* 

*functional currency (ie the currency of the primary economic environment in which the entity operates) must be translated into* 

*USD.*

*All assets and liabilities of entities not operating in USD are converted at closing exchange rates, while all income and expenses* 

*are converted at average exchange rates where this is a reasonable approximation of the rates prevailing on transaction dates.* 

*The impact of these foreign exchange translations into the Group's USD presentation currency is recorded as a separate* 

*component in the Statement of comprehensive income. Upon the disposal of the entity, the related cumulative foreign exchange* 

*translation differences are recycled from other comprehensive income to the income statement as part of the gain or loss on* 

*disposal.*

*The general principle for converting foreign currency transactions to the functional currency of an entity is to translate at the* 

*functional currency spot rate prevailing at the date of the transactions. Foreign currency monetary assets and liabilities are* 

*translated at the spot exchange rate for the functional currency at the reporting date. Changes resulting from the foreign* 

*exchange translations into the functional currency of the entity are recognised in the income statement.* 

The consolidated financial statements do not represent Prudential's statutory accounts for the purposes of the UK Companies Act.

These financial statements are based on the prescribed formats. The Group's external auditors have reported on the 2025, 2024

and 2023 statutory accounts. Statutory accounts for 2024 and 2023 have been delivered to the UK Registrar of Companies and

those for 2025 will be delivered following the Company's Annual General Meeting. The auditor's reports were (i) unqualified, (ii)

did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report

and (iii) did not contain a statement under Section 498(2) or (3) of the UK Companies Act 2006.

**A2 New accounting pronouncements not yet effective** 

The following standards, interpretations and amendments have been issued by the IASB but are not yet effective for the Group in

2025. The Group prepares consolidated financial statements in accordance with IFRS Standards as issued by the IASB and UK-

adopted international accounting standards. This is not intended to be a complete list as only those standards, interpretations and

amendments that could have an impact on the Group's consolidated financial statements are discussed.

–Amendments to IFRS 9 and IFRS 7 'Classification and Measurement of Financial Instruments' issued in May 2024 and effective

from 1 January 2026;

–Annual Improvements to IFRS Accounting Standards – Volume 11 issued in July 2024 and effective from 1 January 2026;

–IFRS 18 'Presentation and disclosure in financial statements' issued in April 2024 and effective from 1 January 2027; and

–Amendments to IAS 21 'Translation to a Hyperinflationary Presentation Currency' issued in November 2025 and effective from 1

January 2027.

The Group is assessing the impact IFRS 18 will have on the presentation and disclosure in the Group's financial statements. The

Group is not expecting the other accounting amendments listed above to have a significant impact on the Group's financial

statements.

**A3 Critical accounting policies, estimates and judgements** 

This note presents the critical accounting policies, estimates and judgements applied in preparing the Group's consolidated

financial statements. Other accounting policies, where significant, are presented in the relevant individual notes. Unless stated

otherwise, all accounting policies are applied consistently for the years presented and normally are not subject to changes unless

new accounting standards, interpretations or amendments are introduced by the IASB as discussed in note A1 above.

The preparation of these consolidated financial statements requires Prudential to make accounting estimates and judgements

about the amounts of assets, liabilities, revenues and expenses, which are both recognised and unrecognised (eg contingent

liabilities) in the consolidated financial statements. Prudential evaluates its critical accounting estimates, including those related to

insurance business provisioning and the fair value of assets as required. The notes below set out those critical accounting policies,

the application of which requires the Group to make critical estimates and judgements. Also set out are further critical accounting

policies affecting the presentation of the Group's results and other items that require the application of critical estimates and

judgements.

**(a)Critical accounting policies with associated critical estimates and judgements –** 

**Measurement of insurance and reinsurance contracts under IFRS 17**

IFRS 17 establishes principles for the recognition, measurement, presentation and disclosure of insurance contracts, reinsurance

contracts and investment contracts with discretionary participation features (DPF). It introduces a model that measures groups of

contracts based on the Group's estimates of the present value of future cash flows that are expected to arise as the Group fulfils

the contracts, an explicit risk adjustment (RA) for non-financial risk and a contractual service margin (CSM). The process of

determining the present value of future cash flows involves a number of estimates and judgements, which are set out below.

---

| | |
|:---|:---|
| **Determination of fulfilment cash flows used in the measurement of insurance and reinsurance contract assets and** <br>**liabilities (impacts $(144.7) billion of net best estimate insurance and reinsurance contract balances, excluding** <br>**those held by joint ventures and associates)** | **Determination of fulfilment cash flows used in the measurement of insurance and reinsurance contract assets and** <br>**liabilities (impacts $(144.7) billion of net best estimate insurance and reinsurance contract balances, excluding** <br>**those held by joint ventures and associates)** |
| **Estimates of future** <br>**cash flows**<br>| The Group's process for estimating future cash flows incorporates, in an unbiased way, all reasonable <br>and supportable information that is available without undue cost or effort at the reporting date. This <br>information includes both internal and external historical data about claims and other experience, <br>updated to reflect current expectations of future events. As this is a prediction of the future, <br>significant judgement is applied in determining the assumptions that underpin the estimation of <br>future cash flows. These assumptions include, but are not limited to, operating assumptions such as <br>morbidity, mortality, persistency and expenses, and economic assumptions such as risk-free rates <br>and illiquidity premium. Granular assumptions are set at a business unit level. The demographic <br>assumptions are consistent with those used in other metrics such as TEV reporting. The Risk Review <br>included in this Annual Report discusses the insurance and market risks the Group faces and how <br>these risks are mitigated.<br>When estimating future cash flows, the Group takes into account current expectations of future <br>events (other than those from future legislation or regulatory changes that have not been <br>substantively enacted) that might affect those cash flows.<br>Cash flows within the boundary of a contract (the Group's accounting policy on contract boundary is <br>given below) relate directly to the fulfilment of the contract, including those for which the Group has <br>discretion over the amount or timing. These include future premium receipts, payments to (or on <br>behalf of) policyholders, insurance acquisition cash flows and other costs that are incurred in fulfilling <br>contracts.<br>In relation to reinsurance contracts held, the probability weighted estimates of the present value of <br>future cash flows include the potential credit losses and losses from other disputes to reflect the non-<br>performance risk of the reinsurers. <br>The sensitivity of shareholder equity and CSM to insurance risks is set out in note C6.2.<br>|
| **Expense assumptions** <br>**used in future cash** <br>**flow estimation**<br>| Insurance acquisition cash flows (as discussed below) and other costs that are incurred in fulfilling <br>contracts comprise both direct costs and an allocation of fixed and variable overheads incurred by the <br>insurance entities. <br>The Group projects estimates of future expenses relating to the fulfilment of contracts within the <br>scope of IFRS 17 using current expense levels adjusted for inflation. Costs that are incurred in <br>fulfilling the contracts include, but are not limited to, claims handling costs, policy administration <br>expenses, investment management expenses, income tax and other costs specifically chargeable to <br>the policyholders under the terms of the contracts. Expenses included in estimated future cash flows <br>comprise expenses directly attributable to the groups of contracts, including an allocation of fixed and <br>variable overheads incurred by the insurance entities. <br>Investment management expenses in relation to the management of the assets backing policyholder <br>liabilities are included in the fulfilment cash flows for business using the variable fee approach (VFA) <br>model, other participating business using the general model and general model non-participating <br>business where the Group performs investment management activities to enhance benefits from <br>insurance coverage for policyholders. The future expenses of internal asset management and other <br>services excludes the projected future profits or losses generated by any non-insurance entities within <br>the Group in providing those services (ie the IFRS results for the life insurance operations in the <br>consolidated financial statements assume that the cost of internal asset management and other <br>services will be that incurred by the Group as a whole, not the cost that will be borne by the <br>insurance business).<br>Most of the costs incurred by the insurance entities within the Group are considered to be incurred for <br>the purpose of selling and fulfilling insurance contracts and are hence treated as attributable <br>expenses. Cash flows that are not directly attributable to a portfolio of insurance contracts, such as <br>some product development and training costs, are recognised in other operating expenses as <br>incurred.<br>|
| **Policyholder benefits** | The assumptions used to project the cash flows also reflect the actions that management would take <br>over the duration of the projection, the time it would take to implement these actions and any <br>expenses incurred in taking those actions. Management actions encompass, but are not confined to, <br>investment allocation decisions, levels of regular and final bonuses and crediting rates.<br>For participating contracts, estimated future claim payments include bonuses paid to policyholders <br>determined by reference to the relevant profit-sharing arrangement. For example, for the Group's <br>with-profits business in Hong Kong, Singapore and Malaysia, asset shares are used to determine <br>payments to policyholders.<br>Where cash flows from one group of contracts affect, or are affected by, cash flows in other groups of <br>contracts (eg for with-profits business), the fulfilment cash flows for a group include payments arising <br>from the terms of existing contracts to policyholders in other groups and exclude payments to <br>policyholders in the group that have been included in the fulfilment cash flows of another group.<br>|

---

---

| | |
|:---|:---|
| **Determination of fulfilment cash flows used in the measurement of insurance and reinsurance contract assets and** <br>**liabilities (impacts $(144.7) billion of net best estimate insurance and reinsurance contract balances, excluding** <br>**those held by joint ventures and associates)** | **Determination of fulfilment cash flows used in the measurement of insurance and reinsurance contract assets and** <br>**liabilities (impacts $(144.7) billion of net best estimate insurance and reinsurance contract balances, excluding** <br>**those held by joint ventures and associates)** |
| **Insurance acquisition** <br>**cash flows**<br>| Insurance acquisition cash flows arise from the activities of selling, underwriting and starting a group <br>of insurance contracts that are directly attributable to the portfolio of contracts to which the group <br>belongs. Insurance acquisition cash flows that are directly attributable to a group of contracts (eg <br>non-refundable commissions paid on issuance of a contract) are allocated to that group and to the <br>groups that will include renewals of those contracts. Bancassurance payments (eg upfront payments <br>to sell insurance contracts to distribution partners) are capitalised under IAS 38 as intangible assets <br>and amortised on a basis to reflect the pattern in which the future economic benefits are expected to <br>be consumed by reference to new business production levels. The amortisation of the bancassurance <br>intangibles is considered to constitute insurance acquisition cash flows. They generally form part of <br>fulfilment cash flows and are amortised implicitly in line with the coverage unit pattern.<br>|
| **Determining the point** <br>**of recognition and** <br>**the boundary of an** <br>**insurance contract**<br>| The point of initial recognition of a group of contracts is the earliest of the premium due date, the <br>date coverage starts and, for an onerous contract, the date the contract is signed and accepted by <br>both parties. There is limited judgement involved in relation to most contracts issued by the Group as <br>the coverage period generally starts from the premium due date.<br>The contract boundary defines which future cash flows are included in the measurement of a contract. <br>The boundary of the fulfilment cash flows under IFRS 17 is considered to be the point at which the <br>Group both no longer has substantive rights and obligations under the insurance contract to provide <br>services or compel the policyholder to pay premiums. <br>The contract boundary is assessed at inception and then reassessed only when there are changes in <br>features or circumstances that alter the commercial substance of the contract or when there are <br>changes in the products within a portfolio. The reassessment of the contract boundary for any <br>changes is performed at the end of each reporting period.<br>For most contracts issued by the Group, there is little judgement involved in determining the contract <br>boundary as either a single premium is received for a contract that is expected to continue for a long <br>period or a guaranteed premium is received for regular premium contracts.<br>For certain contracts where the premiums are not guaranteed, more judgement is involved in <br>assessing the Group's substantive rights and obligations. When determining the boundary for these <br>contracts various factors are taken into consideration by the Group such as the Group's practical <br>ability to terminate or refuse renewal of a contract, the Group's ability to fully reprice at the individual <br>contract level and whether the Group has the ability to reassess risks at a portfolio level and set a <br>price that fully reflects the risks of that portfolio.<br>The Group has some immaterial business that is general insurance in nature and which is considered <br>to have a boundary of one year.<br>Where riders attach to and are not separated from a base contract, the contract boundary is <br>determined based on the component of the contract that has the longest contract boundary.<br>Future cash flows relating to riders that are not purchased at the inception of the base contract, but <br>are added at a later date, are not included within the contract boundary at initial recognition. As the <br>addition of these riders is the exercise of an option under the contract, it is not considered a contract <br>modification but is instead treated as changes in fulfilment cash flows.<br>Similar considerations to those applying to underlying insurance contracts apply in determining the <br>contract boundary of groups of reinsurance contracts held. Further detail on reinsurance contracts, <br>including on recognition is set out in note C3.4. <br>|

---

---

| | |
|:---|:---|
| **Determination of discount rates** | **Determination of discount rates** |
| **Discount rate and** <br>**risk-free rate** | IFRS 17 enables discount rates to be calculated on a top-down or bottom-up basis. The Group elects <br>to determine discount rates on a bottom-up basis, starting with a liquid risk-free yield curve and <br>adding an illiquidity premium to reflect the characteristics of the insurance contracts. <br>|
| **Discount rate and** <br>**risk-free rate** | Risk-free rates are based on government bond yields for all currencies except HKD where risk-free <br>rates are based on swap rates due to the higher liquidity of the HKD swap market. Government bond <br>yields and swap rates are obtained from publicly available data sources. Yield curves are constructed <br>by using a market-observed curve up to a last liquid point and then extrapolating to an ultimate <br>forward rate.<br>|
| **Discount rate and** <br>**risk-free rate** | Where cash flows vary based on the return on underlying items, the projected earned rate is set <br>equal to the discount rate. Where stochastic modelling techniques are used, the projected average <br>investment returns are calibrated to be equal to the deterministic discount rate (including the <br>illiquidity premium). <br>|
| **Discount rate and** <br>**risk-free rate** | The illiquidity premium is calculated as the yield-to-maturity on a reference portfolio of assets with <br>similar liquidity characteristics to the insurance contracts (in particular, corporate bonds) less the <br>risk-free curve, and an allowance for credit risk. <br>|
| **Discount rate and** <br>**risk-free rate** | The allowance for credit risk includes a credit risk premium, which is derived through a lifetime <br>projection of expected bond cash flows, allowing for the risk of downgrades and defaults. The <br>allowance for credit risk ranges between 6 bps and 32 bps at 31 December 2025 (31 December 2024: <br>between 10 bps and 34 bps).<br>|
| **Discount rate and** <br>**risk-free rate** | A proportion of the reference portfolio's illiquidity premium (either 0%, 50% or 100%) is applied to <br>portfolios of insurance contracts reflecting the liquidity characteristics of the insurance contracts. The <br>liquidity characteristics are assessed from the policyholders' perspective. Consideration is given to the <br>nature of premiums, the level of underwriting, and the surrender and other benefit features of the <br>portfolios. A product's illiquidity premium is restricted to be no greater than reasonably expected to <br>be earned on the assets backing the insurance contract liabilities, over the duration of the insurance <br>contracts.<br>|
| **Discount rate and** <br>**risk-free rate** | The following tables set out the range of yield curves used to discount cash flows of insurance <br>contracts for major currencies. These discount rates include the illiquidity premium applied to the <br>portfolios written in each currency. A range is shown to represent the fact that different products <br>apply different proportions of the reference portfolio's illiquidity premium (either 0%, 50% or 100%). <br>The ranges below reflect only the actual proportions applied for each currency. For the major <br>currencies shown below, except Hong Kong dollar and Malaysian ringgit, all three proportions apply <br>and hence the spread is indicative of the illiquidity premium applying to the term specified.<br>|

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025%** | **31 Dec 2025%** | **31 Dec 2025%** | **31 Dec 2025%** | **31 Dec 2025%** |
| | **1 year** | **5 years** | **10 years** | **15 years** | **20 years** |
| Chinese yuan (CNY) | **1.34 – 1.62**  | **1.64 – 1.92** | **1.86 – 2.14**  | **2.19 – 2.47** | **2.31 – 2.59** |
| Hong Kong dollar (HKD) | **2.99 – 3.34** | **3.08 – 3.43** | **3.46 – 3.81** | **3.69 – 4.04** | **3.81 – 4.16** |
| Indonesian rupiah (IDR) | **4.93 – 5.33** | **5.79 – 6.19** | **6.42 – 6.82** | **6.81 – 7.21** | **7.02 – 7.42** |
| Malaysian ringgit (MYR) | **3.01 – 3.20** | **3.41 – 3.60** | **3.67 – 3.86** | **3.94 – 4.13** | **4.14 – 4.33** |
| Singapore dollar (SGD) | **1.42 – 1.71** | **1.91 – 2.34** | **2.18 – 2.48** | **2.26 – 2.63** | **2.23 – 2.82** |
| United States dollar (USD) | **3.51 – 3.80** | **3.77 – 4.22** | **4.29 – 4.60** | **4.78 – 5.16** | **5.09 – 5.70** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 31 Dec 2024% | 31 Dec 2024% | 31 Dec 2024% | 31 Dec 2024% | 31 Dec 2024% |
| | 1 year | 5 years | 10 years | 15 years | 20 years |
| Chinese yuan (CNY) | 1.08 – 1.51 | 1.42 – 1.85 | 1.70 – 2.13 | 1.92 – 2.35 | 2.03 – 2.46 |
| Hong Kong dollar (HKD) | 4.32 – 4.75 | 4.04 – 4.47 | 4.09 – 4.52 | 4.15 – 4.58 | 4.19 – 4.62 |
| Indonesian rupiah (IDR) | 7.13 – 7.51 | 7.13 – 7.51 | 7.18 – 7.56 | 7.27 – 7.65 | 7.33 – 7.71 |
| Malaysian ringgit (MYR) | 3.43 – 3.68 | 3.65 – 3.90 | 3.87 – 4.12 | 4.06 – 4.31 | 4.21 – 4.46 |
| Singapore dollar (SGD) | 2.76 – 3.37 | 2.79 – 3.40 | 2.89 – 3.50 | 2.93 – 3.54 | 2.84 – 3.45 |
| United States dollar (USD) | 4.20 – 4.84 | 4.44 – 5.08 | 4.66 – 5.30 | 4.89 – 5.53 | 5.02 – 5.66 |

---

The sensitivity of shareholder equity and CSM to changes in interest rates (which includes an associated

change to the risk discount rate) is set out in note C6.1.

---

| | |
|:---|:---|
| **Determination of risk adjustment for non-financial risk** | **Determination of risk adjustment for non-financial risk** |
| **Risk adjustment for** <br>**non-financial risk**<br>| The risk adjustment for non-financial risk reflects the compensation the Group requires for bearing <br>the uncertainty about the amount and timing of the cash flows from non-financial risk as the Group <br>fulfils insurance contracts.<br>For reinsurance contracts held, the risk adjustment for non-financial risk represents the amount of <br>risk being transferred by the Group to the reinsurer.<br>The risk adjustment for non-financial risk is determined by the Group using a confidence level <br>approach. This is implemented through the use of provisions for adverse deviations (PADs) calibrated <br>using non-financial risk distributions and correlation assumptions. The PADs are applied to best <br>estimate assumptions and hence the risk adjustment is calculated on a contract by contract basis.<br>The Group's risk adjustment allows for all insurance, persistency and expense risks and operational <br>risks specific to uncertainty in the amount and timing of insurance contract cash flows. Reinsurance <br>counterparty default risk is excluded from the calculation. Diversification is included on a net of <br>reinsurance basis within each insurance entity of the Group. Diversification is not allowed for between <br>entities.<br>By applying a confidence level technique, the Group estimates the probability distribution of the <br>expected present value of the future cash flows from insurance contracts at each reporting date and <br>calculates the risk adjustment for non-financial risk as the excess of the value at risk at the 75th <br>percentile (the target confidence level) over the expected present value of the future cash flows. The <br>confidence level is calibrated over a one-year period.<br>|

---

---

| | |
|:---|:---|
| **Determination of coverage units** | **Determination of coverage units** |
| **Coverage units** | The proportion of CSM recognised in profit or loss at the end of each period for a group of contracts is <br>determined as the ratio of: <br>–the coverage units in the period; divided by <br>–the sum of the coverage units in the period and the present value of expected coverage units in <br>future periods. <br>The total number of coverage units in a group reflects the quantity of service provided determined by <br>considering the quantity of benefits for each contract and its expected coverage period. The Group <br>defines the quantity of benefits for insurance services as the maximum amount that a policyholder <br>receives when an insured event takes place, for example the sum assured, the annual limit for a <br>medical plan or the present value of a stream of payments. The quantity of benefits is updated each <br>period. Investment-related and investment-return services are assumed to be constant over time.<br>Where there are multiple different services in a group of contracts (for example, both insurance and <br>investment services are provided), the quantities of benefits for the different types of service are <br>combined using weighting factors. These weighting factors are defined as the present value of <br>expected outflows for each type of service, determined at a contract level.<br>The expected coverage period is the expected duration up to the contract boundary. The expected <br>coverage period of the contracts in a group and the calculation of future coverage units allows for <br>expected decrements (eg deaths and lapses) in each future period using current best estimate <br>assumptions consistent with the best estimate liabilities (BEL) calculation. <br>The Group elects to allow for the time value of money by discounting future coverage units in the <br>determination of the proportion of CSM recognised in profit or loss. <br>Determination of coverage units for groups of reinsurance contracts held follows the same principles <br>as for groups of underlying contracts.<br>|

---

---

| | |
|:---|:---|
| **Insurance finance income and expenses**  | **Insurance finance income and expenses**  |
| **Disaggregation** <br>**between profit or** <br>**loss and other** <br>**comprehensive** <br>**income** <br>| IFRS 17 allows an accounting policy choice between:<br>–Including insurance finance income or expenses for the period in profit or loss; or<br>–Disaggregating insurance finance income or expenses for the period to include in profit or loss an <br>amount determined by a systematic allocation of the expected total insurance finance income or <br>expenses over the duration of the group of contracts, with the balance being included in other <br>comprehensive income.<br>The Group has not elected to disaggregate insurance finance income and expenses between profit or <br>loss and other comprehensive income.<br>|

---

---

| | |
|:---|:---|
| **Risk mitigation**  | **Risk mitigation**  |
| **Risk mitigation** <br>**option**<br>| IFRS 17 allows the option in certain circumstances to not recognise a change in the CSM to reflect <br>some or all of the changes in the effect of the time value of money and financial risk on:<br>–the amount of the entity's share of the underlying items if the entity mitigates the effect of financial <br>risk on that amount using derivatives or reinsurance contracts held; and<br>–the fulfilment cash flows if the entity mitigates the effect of financial risk on those fulfilment cash <br>flows using derivatives, non-derivative financial instruments measured at fair value through profit <br>or loss, or reinsurance contracts held.<br>The Group does not utilise the risk mitigation option in its IFRS 17 VFA liability accounting except in <br>connection with a short-term premium prepayment option available on certain participating products <br>in Hong Kong.<br>|

---

---

| | |
|:---|:---|
| **The effect of accounting estimates made in interim financial statements**  | **The effect of accounting estimates made in interim financial statements**  |
| **Effect of estimates** <br>**made in interim** <br>**financial statements** | IFRS 17 allows an accounting policy choice as to whether to change the treatment of accounting <br>estimates made in previous interim financial statements when applying IFRS 17 in the annual <br>reporting period.<br>|
| **Effect of estimates** <br>**made in interim** <br>**financial statements** | The Group has elected to allow updates to accounting estimates made in interim financial statements <br>when applying IFRS 17 in the annual reporting period.<br>|

---

**(b)Further critical accounting policies affecting the presentation of the Group's results**

---

| | |
|:---|:---|
| **Presentation of results before tax attributable to shareholders** | **Presentation of results before tax attributable to shareholders** |
| Profit before tax is a significant IFRS <br>income statement item. The Group <br>has chosen to present a measure of <br>profit before tax attributable to <br>shareholders that distinguishes <br>between tax borne by shareholders <br>and tax attributable to policyholders <br>to support understanding of the <br>performance of the Group.<br>Profit before tax attributable to <br>shareholders is $4,941 million and <br>compares to profit before tax of <br>$5,121 million as shown in the <br>Consolidated income statement. <br>| Total tax charge for the Group reflects tax that relates to shareholders' profit and also tax <br>attributable to policyholders through the interest in with-profits or unit-linked funds. <br>Reported IFRS profit before the tax measure is therefore not representative of pre-tax <br>profit attributable to shareholders. Accordingly, in order to provide a measure of pre-tax <br>profit attributable to shareholders, the Group has chosen to adopt an income statement <br>presentation of the tax charge and pre-tax results that distinguishes between <br>policyholders' and shareholders' returns.<br>|

---

---

| | |
|:---|:---|
| **Segmental analysis of results and earnings attributable to shareholders** | **Segmental analysis of results and earnings attributable to shareholders** |
| The Group uses adjusted operating <br>profit as the segmental measure of <br>its results. | The basis of calculation of adjusted operating profit is provided in note B1.2.<br>The vast majority of the Group's investments are valued at fair value through profit and <br>loss. Short-term fluctuations in the fair value of investments are only partially offset by <br>the effect of economic changes on insurance contract assets and liabilities and so affect <br>the result for the year. The Group therefore provides additional analysis of results before <br>and after the effects of short-term interest rate and other market fluctuations, together <br>with other items that are of a short-term, volatile or one-off nature. |
| The Group uses adjusted operating <br>profit as the segmental measure of <br>its results. | The basis of calculation of adjusted operating profit is provided in note B1.2.<br>The vast majority of the Group's investments are valued at fair value through profit and <br>loss. Short-term fluctuations in the fair value of investments are only partially offset by <br>the effect of economic changes on insurance contract assets and liabilities and so affect <br>the result for the year. The Group therefore provides additional analysis of results before <br>and after the effects of short-term interest rate and other market fluctuations, together <br>with other items that are of a short-term, volatile or one-off nature. |

---

**(c)Other items requiring application of critical estimates or judgements**

---

| | | |
|:---|:---|:---|
| **VFA eligibility assessment** | **VFA eligibility assessment** | **VFA eligibility assessment** |
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | IFRS 17 requires the use of the VFA for insurance contracts with direct participation <br>features, ie substantially investment-related service contracts for which, at inception:<br>–the contractual terms specify that the policyholder participates in a share of a <br>clearly identified pool of underlying items;<br>–the entity expects to pay to the policyholder an amount equal to a substantial <br>share of the fair value returns on the underlying items; and<br>–the entity expects a substantial proportion of any change in the amounts to be <br>paid to the policyholder to vary with the change in fair value of the underlying <br>items.<br>The following key judgements have been made in assessing VFA eligibility: | IFRS 17 requires the use of the VFA for insurance contracts with direct participation <br>features, ie substantially investment-related service contracts for which, at inception:<br>–the contractual terms specify that the policyholder participates in a share of a <br>clearly identified pool of underlying items;<br>–the entity expects to pay to the policyholder an amount equal to a substantial <br>share of the fair value returns on the underlying items; and<br>–the entity expects a substantial proportion of any change in the amounts to be <br>paid to the policyholder to vary with the change in fair value of the underlying <br>items.<br>The following key judgements have been made in assessing VFA eligibility: |
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | Definition of <br>substantial<br>| The term substantial is interpreted to mean greater than 50 <br>per cent.<br>|
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | Contractual terms  | In some circumstances contractual terms are implied by <br>customary business practices. <br>|
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | Granularity of <br>assessment<br>| The assessment has been carried out at a contract level. <br>However, to the extent insurance contracts in a group affect <br>the cash flows to policyholders of contracts in other groups <br>(referred to as 'mutualisation'), eligibility for the VFA has been <br>assessed at the level at which such mutualisation occurs (eg <br>fund level). <br>|
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | Calculation basis | VFA eligibility assessments have been performed on a basis <br>consistent with how the Group measures its realistic <br>expectations, for example when pricing, monitoring or setting <br>returns to policyholders.<br>|
| The Group applies judgements in <br>assessing the VFA eligibility of contracts. <br>Application of the VFA impacts the <br>calculation of the CSM at the balance <br>sheet date, which in turn impacts the <br>future year's amortisation recognised in <br>the income statement. Unlike the <br>general measurement model (GMM) <br>approach, the VFA absorbs economic <br>impacts within the CSM, rather than in <br>the profit and loss account.<br>The total insurance and reinsurance CSM <br>at the balance sheet date is <br>$25,005 million, including joint ventures <br>and associates, and the CSM <br>amortisation (net of reinsurance) <br>recognised in the income statement is <br>$(2554) million as shown in note C3.3. <br>Approximately two thirds of the CSM <br>(including joint ventures and associates <br>and net of reinsurance) at 31 December <br>2025 was calculated under the VFA. | Contracts not qualifying for the VFA are accounted for under the GMM or premium <br>allocation approach (PAA). The PAA is not used significantly within the Group.<br>The measurement model (VFA or GMM) used for key products is set out in note C3.4. | Contracts not qualifying for the VFA are accounted for under the GMM or premium <br>allocation approach (PAA). The PAA is not used significantly within the Group.<br>The measurement model (VFA or GMM) used for key products is set out in note C3.4. |

---

---

| | |
|:---|:---|
| **Carrying value of distribution rights intangible assets** | **Carrying value of distribution rights intangible assets** |
| The Group applies judgement to <br>assess whether factors such as the <br>financial performance of the <br>distribution arrangements, or <br>changes in relevant legislation and <br>regulatory requirements indicate an <br>impairment of intangible assets <br>representing distribution rights.<br>To determine the recoverable <br>amount, the Group estimates the <br>discounted future expected cash <br>flows arising from the cash <br>generating units (CGUs) containing <br>the distribution rights.<br>Impacts $3,699 million of assets as <br>shown in note C4.2. | Distribution rights relate to bancassurance partnership arrangements for the distribution <br>of products for the term of the contractual agreement with the bank partner, for which an <br>asset is recognised based on fees paid and fees payable not subject to performance <br>conditions. Distribution rights impairment testing is conducted when there is an indication <br>of an impairment. <br>|
| The Group applies judgement to <br>assess whether factors such as the <br>financial performance of the <br>distribution arrangements, or <br>changes in relevant legislation and <br>regulatory requirements indicate an <br>impairment of intangible assets <br>representing distribution rights.<br>To determine the recoverable <br>amount, the Group estimates the <br>discounted future expected cash <br>flows arising from the cash <br>generating units (CGUs) containing <br>the distribution rights.<br>Impacts $3,699 million of assets as <br>shown in note C4.2. | To assess indicators of an impairment, the Group monitors a number of internal and <br>external factors, including indications that the financial performance of the arrangement <br>is likely to be worse than expected and changes in relevant legislation and regulatory <br>requirements that could impact the Group's ability to continue to sell new business <br>through the bancassurance channel, and then applies judgement to assess whether these <br>factors indicate that an impairment has occurred.<br>If an impairment has occurred, a charge is recognised in the income statement for the <br>difference between the carrying value and recoverable amount of the asset. The <br>recoverable amount is the greater of fair value less costs to sell and value in use. Value in <br>use is calculated as the present value of future expected cash flows from the asset or the <br>CGUs to which it is allocated. <br>|

---

---

| | |
|:---|:---|
| **Financial investments – Valuation** | **Financial investments – Valuation** |
| Financial investments held at fair <br>value, net of derivative liabilities, <br>excluding those held by joint <br>ventures and associates is <br>$181.0 billion as shown in note <br>C2.2.<br>Financial investments held at <br>amortised cost, comprising loans <br>and deposits, represent $6.5 billion <br>of the Group's total assets.<br>The Group estimates the fair value <br>of financial investments that are not <br>actively traded using quotations <br>from independent third parties or <br>internally developed pricing models. | The Group holds the majority of its financial investments at fair value through profit or <br>loss. Financial investments held at amortised cost, excluding cash and cash equivalents, <br>primarily comprise loans and deposits.<br>|
| Financial investments held at fair <br>value, net of derivative liabilities, <br>excluding those held by joint <br>ventures and associates is <br>$181.0 billion as shown in note <br>C2.2.<br>Financial investments held at <br>amortised cost, comprising loans <br>and deposits, represent $6.5 billion <br>of the Group's total assets.<br>The Group estimates the fair value <br>of financial investments that are not <br>actively traded using quotations <br>from independent third parties or <br>internally developed pricing models. | **Determination of fair value** |
| Financial investments held at fair <br>value, net of derivative liabilities, <br>excluding those held by joint <br>ventures and associates is <br>$181.0 billion as shown in note <br>C2.2.<br>Financial investments held at <br>amortised cost, comprising loans <br>and deposits, represent $6.5 billion <br>of the Group's total assets.<br>The Group estimates the fair value <br>of financial investments that are not <br>actively traded using quotations <br>from independent third parties or <br>internally developed pricing models. | The fair values of the financial instruments for which fair valuation is required under IFRS <br>Standards are determined by the use of quoted market prices for exchange-quoted <br>investments or by using quotations from independent third parties such as brokers and <br>pricing services or by using appropriate valuation techniques. Further details are included <br>in note C2.1.<br>The estimated fair value of derivative financial instruments reflects the estimated amount <br>the Group would receive or pay in an arm's-length transaction. This amount is <br>determined using quoted prices if exchange listed, quotations from independent third <br>parties or valued internally using standard market practices. <br>Quoted market prices are used to value investments having quoted prices. Actively <br>traded investments without quoted prices are valued using prices provided by third <br>parties such as brokers or pricing services. Financial investments measured at fair value <br>are classified into a three-level hierarchy as described in note C2.1. <br>If the market for a financial investment of the Group is not active, the Group establishes <br>fair value by using quotations from independent third parties, such as brokers or pricing <br>services, or by using internally developed pricing models. Priority is given to publicly <br>available prices from independent sources when available, but overall the source of <br>pricing and/or the valuation technique is chosen with the objective of arriving at a fair <br>value measurement, which reflects the price at which an orderly transaction would take <br>place between market participants on the measurement date. Changes in assumptions <br>relating to these variables could positively or negatively impact the reported fair value of <br>these financial investments. Details of the financial investments classified as 'level 3' to <br>which valuation techniques are applied and the sensitivity of profit before tax to a change <br>in the valuation of these items, are presented in note C2.2.<br>|

---

**B Earnings performance**

**B1 Analysis of performance by segment**

**B1.1 Segment results**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | <br>Note | **2025 $m**<br>**note (i)** | 2024 $m<br>note (i) | 2023 $m<br>note (i) |
| Hong Kong |  | **1219** | 1069 | 1013 |
| Indonesia |  | **250** | 268 | 221 |
| Mainland China <sup>note (ii)</sup> |  | **411** | 363 | 368 |
| Malaysia |  | **410** | 338 | 305 |
| Singapore |  | **706** | 693 | 584 |
| Growth markets and other <sup>note (iii)</sup> |  | **614** | 688 | 746 |
| Eastspring |  | **329** | 304 | 280 |
| Other income and expenditure unallocated to a segment: |  |  |  |  |
| Net investment return and other items <sup>note (iv)</sup> |  | **(41)** | 21 | (21) |
| Interest payable on core structural borrowings |  | **(184)** | (171) | (172) |
| Corporate expenditure  |  | **(237)** | (237) | (230) |
| Total other expenditure |  | **(462)** | (387) | (423) |
| Restructuring and IFRS 17 implementation costs <sup>note (v)</sup> |  | **(171)** | (207) | (201) |
| **Adjusted operating profit** | B1.2 | **3306** | 3129 | 2893 |
| Tax charge on adjusted operating profit | B3.2 | **(534)** | (547) | (444) |
| **Adjusted operating profit after tax** |  | **2772** | 2582 | 2449 |
| Short-term interest rate and other market fluctuations |  | **120** | (105) | (774) |
| Gain (loss) attaching to corporate transactions <sup>note (vi)</sup> |  | **1515** | (71) | (22) |
| Tax (charge) credit on non-operating result | B3.2 | **(288)** | 9 | 59 |
| **Profit for the year** | B1.5 | **4119** | 2415 | 1712 |
| **Attributable to:** |  |  |  |  |
| Equity holders of the Company |  | **3978** | 2285 | 1701 |
| Non-controlling interests |  | **141** | 130 | 11 |
| **Profit for the year** |  | **4119** | 2415 | 1712 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Basic earnings per share (in cents)** |  | **2025** | 2024 | 2023 |
|  | Note | **note (i)** | note (i) | note (i) |
| Based on adjusted operating profit, net of tax and non-controlling interest | B4 | **101.4¢** | 89.7¢ | 89.0¢ |
| Based on profit for the year, net of non-controlling interest | B4 | **154.2¢** | 84.1¢ | 62.1¢ |

---

**Notes**

(i)Segment results are attributed to the shareholders of the Group before deducting the amount attributable to the non-controlling interests. This presentation

is applied consistently throughout the document.

(ii)The Mainland China segment reflects the Group's 50 per cent ownership in CITIC-Prudential Life Insurance Company Limited, a life joint venture with CITIC, a

leading Chinese state-owned conglomerate.

(iii)The Growth markets and other segment includes non-insurance entities that support the Group's insurance business and the result for this segment is after

deducting the corporate taxes arising from all the life joint ventures and associates.

(iv)Net investment return and other items include an adjustment to eliminate intercompany profits. Entities within the Prudential Group can provide services to

each other, the most significant example being the provision of asset management services by Eastspring to the life entities. If the associated expenses are

deemed attributable to the entity's insurance contracts then the costs are included within the estimate of future cash flows when measuring the insurance

contract under IFRS 17. In the Group's consolidated accounts, IFRS 17 requires the removal of the intercompany profit from the measurement of the

insurance contract. Put another way, the future cash flows include the cost to the Group (not the insurance entity) of providing the service. In the period that

the service is provided, the entity undertaking the service, for example Eastspring, recognises the profit it earns as part of its results. To avoid any double

counting, an adjustment is included within 'net investment return and other items' unallocated to a segment to remove the benefit already recognised when

valuing the insurance contract.

(v)Restructuring costs largely comprise the costs of Group-wide projects including reorganisation programmes and initial costs of establishing new business

initiatives and operations. The costs include those incurred in insurance and asset management operations of $(49) million (2024: $(59) million; 2023: $(81)

million).

(vi)The gain (loss) attaching to corporate transactions in 2025 and 2024 mainly relates to the disposal or partial disposal of businesses. In 2025, it largely

represents the gain arising from a reduction in the Group's interest in ICICI Prudential Asset Management Company Limited (from 49 per cent to 34.59 per

cent) as discussed further in note D6.3. The $22 million loss in 2023 largely reflected costs incurred on the termination of corporate services.

**B1.2 Determining operating segments and performance measure of operating segments** 

**Operating segments**

The Group's operating and reported segments for financial reporting purposes are defined and presented in accordance with IFRS

8 'Operating Segments'. Under the Group's management and reporting structure, its chief operating decision maker is the Group

Executive Committee (GEC), chaired by the Chief Executive Officer. There have been no changes to the Group's operating

segments from those reported in the Group's consolidated financial statements for the year ended 31 December 2024. Operations

and transactions that do not form part of any business unit are reported as 'Unallocated to a segment' and generally comprise

head office functions.

**Performance measure**

The performance measure of operating segments utilised by the Group is IFRS operating profit based on longer-term investment

returns (adjusted operating profit) as described below. This measurement basis distinguishes adjusted operating profit from other

constituents of total profit or loss for the year, including short-term interest rate and other market fluctuations and gain or loss on

corporate transactions. Note B1.1 shows the reconciliation from adjusted operating profit to total profit for the year.

**Determination of adjusted operating profit**

**(a)Approach adopted for insurance businesses** 

The measurement of adjusted operating profit reflects that, for the insurance business, assets and liabilities are held for the longer

term. The Group believes trends in underlying performance are better understood if the effects of short-term fluctuations in

market conditions, such as changes in interest rates or equity markets, are excluded.

The method of allocating profit between operating and non-operating components involves applying longer-term rates of return to

the Group's assets held by insurance entities (including joint ventures and associates). These longer-term rates of return are not

applied when assets and liabilities move broadly in tandem and hence the effect on profit from short-term market movements is

more muted. In summary, the Group applies the following approach when attributing the 'net investment result' between

operating and non-operating profit:

–Returns on investments that meet the definition of an 'underlying item', namely those investments that determine some of the

amounts payable to a policyholder such as assets within unit-linked funds or with-profits funds, are recorded in adjusted

operating profit on an actual return basis. The exception is for investments backing the shareholders' 10 per cent share of the

estate within the Hong Kong with-profits fund. Changes in the value of these investments, including those driven by market

movements, pass through the income statement with no liability offset. Consequently, adjusted operating profit recognises

investment return on a longer-term basis for these assets.

–For insurance contracts measured under the general measurement model (GMM), the impact of market movements on both the

non-underlying insurance contract balances and the investments they relate to are considered together. Adjusted operating

profit allows for the long-term credit spread (net of the expected defaults) or long-term equity risk premium on the debt and

equity-type instruments, respectively. Deducted from this amount is the unwind of the illiquidity premium included in the

current discount rate for the liabilities and any non-attributable investment management expenses.

–Some GMM best estimate liabilities (BEL) components are calculated by reference to the investment return of assets, even if the

BEL component itself is not considered an underlying item, for example, the BEL component related to future fee income or a

guarantee. In these cases for the purposes of determining operating profit, the BEL component is calculated assuming a longer-

term investment return and any difference between the actual return arising in the period and the longer-term investment

return is taken to non-operating profit. There is no impact on the balance sheet of this allocation.

–A longer-term rate of return is applied to all other investments held by the Group's insurance business for the purposes of

calculating adjusted operating profit. More details on how longer-term rates are determined are set out below.

The difference between the net investment result recorded in the income statement and the longer-term returns determined using

the above principles is recorded as 'short-term interest rate and other market fluctuations' as a component of non-operating profit.

The 'insurance service result' is largely recognised in adjusted operating profit in full with the main exception being the gains or

losses that arise from market and other related movements on onerous contracts measured under the variable fee approach

(VFA). If these gains and losses are capable of being offset across more than one annual cohort of the same product or fund as

applicable, then the adjusted operating profit is determined by amortising the net of the future profits and losses on all contracts

where profits or losses can be shared. Any difference between this and the amount included in the income statement for onerous

contracts is classified as part of 'short-term interest rate and other market fluctuations', a component of non-operating profit.

**(b)Determination of longer-term returns**

The longer-term rates of return are estimates of the long-term trend investment returns having regard to past performance,

current trends and future expectations. These rates are broadly stable from year to year but may be different between regions,

reflecting, for example, differing expectations of inflation in each business unit. The assumptions are for the returns expected to

apply in equilibrium conditions. The assumed rates of return do not reflect any cyclical variability in economic performance and are

not set by reference to prevailing asset valuations.

For collective investment schemes that include different types of assets (eg equities and debt securities), weighted assumptions

are used reflecting the asset mix underlying the relevant fund mandates.

***Debt securities and loans***

For debt securities and loans, the longer-term rates of return are estimates of the long-term government bond yield, plus the

estimated long-term credit spread over the government bond yield, less an allowance for expected credit losses. The credit spread

and credit loss assumptions reflect the mix of assets by credit rating. Longer-term rates of return range from 2.8 per cent to 8.7

per cent for 2025 (2024: 2.8 per cent to 8.8 per cent; 2023: 2.8 per cent to 8.4 per cent).

***Equity-type securities***

For equity-type securities, the longer-term rates of return are estimates of the long-term trend of investment returns for income

and capital. Longer-term rates of return range from 8.6 per cent to 15.7 per cent for all years.

***Derivative value movements***

In the case where derivatives change the nature of other invested assets (eg by lengthening the duration of assets, hedging

overseas bonds to the currency of the local liabilities, or by providing synthetic exposure to equities), the longer-term return on

those invested assets reflects the impacts of the derivatives.

**(c)Non-insurance businesses**

For these businesses, the determination of adjusted operating profit reflects the underlying economic substance of the

arrangements and excludes market-related items only where it is expected these will unwind over time.

**B1.3 Revenue**

*The Group recognises insurance revenue as it satisfies its performance obligations, ie as it provides services under groups of* 

*insurance contracts. The insurance revenue relating to services provided for each period represents the total of the changes in the* 

*liability for remaining coverage that relate to services for which the Group expects to receive consideration and comprises the* 

*following items:*

*–A release of the CSM, measured based on coverage units;*

*–Changes in the risk adjustment for non-financial risk relating to current services;*

*–Claims and other insurance service expenses for the period expected at the beginning of the year; and*

*–Other amounts include the revenue recognised to cover the tax charge attributable to policyholders and other items, for* 

*example experience adjustments for premium receipts for current or past services.*

*In addition, the Group allocates a portion of premiums that relate to recovering insurance acquisition cash flows to each period* 

*using the same amortisation factor used to amortise CSM. The Group recognises the allocated amount, adjusted for interest* 

*accretion, as insurance revenue and an equal amount as insurance service expenses.*

*Non-distinct investment components are excluded from insurance revenue and insurance service expenses.* 

*Policy fees charged on investment contracts without DPF for asset management, policy administration fees and Eastspring's asset* 

*management fee income are recognised when related services are provided.*

**(a)Analysis of total revenue by segment** 

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
|  | **Insurance operations** <sup>note (i)</sup> | **Insurance operations** <sup>note (i)</sup> | **Insurance operations** <sup>note (i)</sup> | **Insurance operations** <sup>note (i)</sup> | **Insurance operations** <sup>note (i)</sup> |  |  |  |  |  |
| | **Hong** <br>**Kong**<br>| **Indonesia** | **Malaysia** | **Singapore** | **Growth** <br>**markets**<br>**and** <br>**other**<br>| **Eastspring** | **Inter-**<br>**segment** <br>**elimination**<br>| **Total** <br>**segment**<br>| **Unallocated** <br>**to a** <br>**segment** <br>**(central** <br>**operations)**<br>| **Total** |
| **Insurance revenue** |  |  |  |  |  |  |  |  |  |  |
| Amounts relating to changes in <br>the liability for remaining <br>coverage:<br>|  |  |  |  |  |  |  |  |  |  |
| Expected claims and other <br>directly attributable expenses<br>| **1326** | **632** | **854** | **1237** | **682** | **–** | **–** | **4731** | **–** | **4731** |
| Change in risk adjustment for <br>non-financial risk<br>| **78** | **33** | **34** | **68** | **59** | **–** | **–** | **272** | **–** | **272** |
| Release of CSM for services <br>provided<br>| **1025** | **148** | **214** | **529** | **522** | **–** | **–** | **2438** | **–** | **2438** |
| Other adjustments <sup>note (ii)</sup> | **46** | **46** | **41** | **2** | **69** | **–** | **–** | **204** | **–** | **204** |
| Recovery of insurance acquisition <br>cash flows<br>| **1549** | **277** | **309** | **557** | **743** | **–** | **–** | **3435** | **–** | **3435** |
|  | **4024** | **1136** | **1452** | **2393** | **2075** | **–** | **–** | **11080** | **–** | **11080** |
| **Other revenue** <sup>note (iii)</sup> | **29** | **3** | **1** | **–** | **20** | **358** | **–** | **411** | **–** | **411** |
| **Total revenue from external** <br>**customers** <sup>note (iv)</sup><br>| **4053** | **1139** | **1453** | **2393** | **2095** | **358** | **–** | **11491** | **–** | **11491** |
| **Intra-group revenue** | **–** | **–** | **–** | **–** | **–** | **224** | **(224)** | **–** | **–** | **–** |
| **Investment return** |  |  |  |  |  |  |  |  |  |  |
| Interest income | **1340** | **105** | **239** | **886** | **822** | **5** | **–** | **3397** | **137** | **3534** |
| Dividend and other investment <br>income<br>| **1253** | **65** | **198** | **549** | **145** | **4** | **–** | **2214** | **–** | **2214** |
| Investment appreciation <br>(depreciation)<br>| **6342** | **212** | **199** | **3453** | **459** | **5** | **–** | **10670** | **(154)** | **10516** |
|  | **8935** | **382** | **636** | **4888** | **1426** | **14** | **–** | **16281** | **(17)** | **16264** |
| **Total revenue** | **12988** | **1521** | **2089** | **7281** | **3521** | **596** | **(224)** | **27772** | **(17)** | **27755** |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
|  | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> |  |  |  |  |  |
| | Hong <br>Kong<br>| Indonesia | Malaysia | Singapore | Growth <br>markets<br>and other<br>| Eastspring | Inter-<br>segment <br>elimination<br>| Total <br>segment<br>| Unallocated <br>to a <br>segment <br>(central <br>operations)<br>| Total |
| **Insurance revenue** |  |  |  |  |  |  |  |  |  |  |
| Amounts relating to changes in the <br>liability for remaining coverage:<br>|  |  |  |  |  |  |  |  |  |  |
| Expected claims and other directly <br>attributable expenses<br>| 1195 | 670 | 740 | 1121 | 715 | – | – | 4441 | – | 4441 |
| Change in risk adjustment for non-<br>financial risk<br>| 68 | 37 | 26 | 64 | 62 | – | – | 257 | – | 257 |
| Release of CSM for services provided | 908 | 146 | 206 | 521 | 505 | – | – | 2286 | – | 2286 |
| Other adjustments <sup>note (ii)</sup> | 88 | 31 | 50 | 32 | 16 | – | – | 217 | – | 217 |
| Recovery of insurance acquisition cash <br>flows<br>| 1445 | 293 | 268 | 513 | 638 | – | – | 3157 | – | 3157 |
|  | 3704 | 1177 | 1290 | 2251 | 1936 | – | – | 10358 | – | 10358 |
| **Other revenue** <sup>note (iii)</sup> | 24 | 2 | – | 2 | 21 | 333 | – | 382 | – | 382 |
| **Total revenue from external** <br>**customers** <sup>note (iv)</sup><br>| 3728 | 1179 | 1290 | 2253 | 1957 | 333 | – | 10740 | – | 10740 |
| **Intra-group revenue** | – | – | – | – | – | 221 | (221) | – | – | – |
| **Investment return** |  |  |  |  |  |  |  |  |  |  |
| Interest income | 1077 | 101 | 216 | 797 | 688 | 7 | – | 2886 | 209 | 3095 |
| Dividend and other investment income | 1279 | 105 | 181 | 651 | 164 | 3 | – | 2383 | – | 2383 |
| Investment appreciation (depreciation) | (3317) | (86) | 736 | 2275 | 604 | 1 | – | 213 | 228 | 441 |
|  | (961) | 120 | 1133 | 3723 | 1456 | 11 | – | 5482 | 437 | 5919 |
| **Total revenue** | 2767 | 1299 | 2423 | 5976 | 3413 | 565 | (221) | 16222 | 437 | 16659 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m | 2023 $m |
|  | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> | Insurance operations <sup>note (i)</sup> |  |  |  |  |  |
| | Hong <br>Kong<br>| Indonesia | Malaysia | Singapore | Growth <br>markets<br>and other<br>| Eastspring | Inter-<br>segment <br>elimination<br>| Total <br>segment<br>| Unallocated <br>to a <br>segment <br>(central <br>operations)<br>| Total |
| **Insurance revenue** |  |  |  |  |  |  |  |  |  |  |
| Amounts relating to changes in the <br>liability for remaining coverage:<br>|  |  |  |  |  |  |  |  |  |  |
| Expected claims and other directly <br>attributable expenses<br>| 1089 | 582 | 642 | 970 | 670 | – | – | 3953 | – | 3953 |
| Change in risk adjustment for non-<br>financial risk<br>| 73 | 35 | 24 | 55 | 41 | – | – | 228 | – | 228 |
| Release of CSM for services provided | 787 | 187 | 203 | 478 | 538 | – | – | 2193 | – | 2193 |
| Other adjustments <sup>note (ii)</sup> | 73 | 32 | 31 | 45 | 71 | – | – | 252 | – | 252 |
| Recovery of insurance acquisition cash <br>flows<br>| 1207 | 306 | 234 | 435 | 563 | – | – | 2745 | – | 2745 |
|  | 3229 | 1142 | 1134 | 1983 | 1883 | – | – | 9371 | – | 9371 |
| **Other revenue** <sup>note (iii)</sup> | 22 | 4 | 4 | – | 39 | 299 | – | 368 | 1 | 369 |
| **Total revenue from external** <br>**customers** <sup>note (iv)</sup><br>| 3251 | 1146 | 1138 | 1983 | 1922 | 299 | – | 9739 | 1 | 9740 |
| **Intra-group revenue** | – | – | – | – | – | 184 | (184) | – | – | – |
| Investment return |  |  |  |  |  |  |  |  |  |  |
| Interest income | 1033 | 92 | 239 | 785 | 627 | 7 | – | 2783 | 164 | 2947 |
| Dividend and other investment income | 775 | 93 | 151 | 528 | 117 | 3 | – | 1667 | 7 | 1674 |
| Investment appreciation <br>(depreciation)<br>| 2155 | 50 | 177 | 1490 | 1309 | 4 | – | 5185 | (43) | 5142 |
|  | 3963 | 235 | 567 | 2803 | 2053 | 14 | – | 9635 | 128 | 9763 |
| **Total revenue** | 7214 | 1381 | 1705 | 4786 | 3975 | 497 | (184) | 19374 | 129 | 19503 |

---

**Notes**

(i)The Group's share of the results from the joint ventures and associates that are equity accounted for, including the Group's life joint venture in Mainland

China, is presented in a single line within the Group's profit before tax on a net of related tax basis, and therefore not shown in the analysis of revenue line

items above. Revenue from external customers of the Mainland China joint venture (Prudential's share) in 2025 is $544 million (2024: $573 million; 2023:

$560 million). Further financial information on the Mainland China joint venture is provided in note D6.3.

(ii)Other adjustments comprise experience adjustment for premium receipts relating to past and current services provided under insurance contracts and

insurance revenue earned from contracts measured under the PAA as well as the revenue recognised to cover the tax charge attributable to policyholders.

(iii)Other revenue comprises revenue from external customers and consists primarily of revenue from the Group's asset management business of $358 million

(2024: $333 million; 2023: $299 million).

(iv)Due to the nature of the business of the Group, there is no reliance on any major customers. Of the Group's markets, other than Hong Kong, Indonesia,

Malaysia and Singapore as shown above, no individual markets have revenue from external customers that exceeds 10 per cent of the Group total for the

years presented.

**(b)Additional analysis of investment return**

*Investment return included in the income statement principally comprises interest income, dividends, investment appreciation and* 

*depreciation (realised and unrealised gains and losses) on investments mandatorily classified or designated as fair value through* 

*profit or loss (FVTPL) and realised gains and losses (including impairment losses) on items classified at amortised cost. Movements* 

*in unrealised appreciation or depreciation of securities designated as FVOCI are recognised in other comprehensive income.* 

*Interest income is recognised as it accrues. Dividends on equity securities are recognised on the ex-dividend date and rental* 

*income is recognised on an accrual basis.*

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Interest income calculated using the effective interest method | **413** | 477 | 340 |
| Net gains on financial instruments at FVTPL <sup>note</sup> | **15784** | 5250 | 9400 |
| Dividend income from Jackson shares designated at FVOCI recognised in the income <br>statement<br>| **–** | – | 7 |
| Other investment returns (including foreign exchange gains and losses) | **331** | 363 | 267 |
| Movement in amounts attributable to external unit holders of consolidated investment <br>funds<br>| **(264)** | (171) | (251) |
| **Investment return recognised in the income statement** | **16264** | 5919 | 9763 |
| Valuation movements in Jackson shares recognised in other comprehensive income | **–** | – | 8 |
| **Total investment return recognised in the income statement and other** <br>**comprehensive income**<br>| **16264** | 5919 | 9771 |

---

**Note**

Net gains on financial instruments at FVTPL comprise interest income, dividend income and investment appreciation (depreciation) on such financial instruments.

Net realised gains and losses on the Group's investments for 2025 recognised in the income statement amounted to a net gain of $2.9 billion (2024: $(0.5) billion

loss; 2023: $(6.0) billion loss).

The overall financial strength of Prudential and the results, both current and future, of the insurance business are in part

dependent upon the quality and performance of the various investment portfolios. Prudential's insurance investments support a

range of businesses operating in many geographic areas. Each of the operations formulates a strategy based on the nature of its

underlying liabilities, its level of capital and its local regulatory requirements. Prudential's insurance business's investments,

excluding assets to cover linked liabilities and those attributable to external unit holders of consolidated investment funds, are

largely held by Prudential's Singapore and Hong Kong operations.

All investments are carried at fair value in the statement of financial position with fair value movements, which are volatile from

year to year, recorded in the income statement, except for loans and receivables, which are generally carried at amortised cost

(unless designated at FVTPL). In 2023, the Group's retained interest in Jackson was classified as FVOCI prior to its disposal.

Subject to the effect of the exceptions, the year-on-year changes in investment returns primarily reflect the cumulative impact

from the changes in interest rates on bond asset values and the performance of the equity markets. In addition, foreign exchange

rates affect the USD value of the translated income. Consistent with the treatment applied for other items of income and

expenditure, investment return for operations not using USD as the functional currency is translated at average exchange rates.

**B1.4 Net insurance and reinsurance finance income (expense)**

Insurance and reinsurance finance income and expenses comprise changes in the carrying amounts of groups of insurance and

reinsurance contracts arising from the effects of the time value of money, financial risk and changes therein. These amounts

exclude any such changes for groups of contracts with direct participation features that are allocated to a loss component and

therefore do not adjust CSM and accordingly are included in insurance service expenses. Insurance finance income and expense

include changes in the measurement of groups of contracts caused by changes in the value of underlying items (excluding

additions and withdrawals). The Group does not disaggregate insurance finance income or expenses between profit or loss and

other comprehensive income.

The following table provides an analysis of net insurance and reinsurance finance income (expense).

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| **Net finance (expense) income from insurance contracts** <sup>notes (i)(ii)</sup> |  |  |  |
| Accretion of interest on GMM contracts | **(337)** | (295) | (233) |
| Changes in fair value of underlying assets and other adjustments relating to VFA <br>contracts<br>| **(13859)** | (3258) | (8162) |
| Effect of changes in interest rates and other financial assumptions | **(208)** | (491) | (276) |
| Effect of measuring changes in estimates at current rates and adjusting the CSM at <br>locked-in rates<br>| **15** | 5 | 43 |
| Net foreign exchange gain | **107** | 21 | 12 |
| Other finance (expense) from insurance contracts <sup>note (iii)</sup> | **(330)** | (136) | (223) |
|  | **(14612)** | (4154) | (8839) |
| **Net finance income (expense) from reinsurance contracts held** <sup>notes (i)(ii)</sup> |  |  |  |
| Accretion of interest on GMM contracts | **151** | 109 | 45 |
| Effect of changes in interest rates and other financial assumptions | **(254)** | (467) | 168 |
| Effect of measuring changes in estimates at current rates and adjusting the CSM at <br>locked-in rates<br>| **15** | (23) | (11) |
| Net foreign exchange (loss) gain | **(71)** | 19 | (8) |
| Other finance income from reinsurance contracts <sup>note (iv)</sup> | **–** | 24 | (3) |
|  | **(159)** | (338) | 191 |

---

**Notes**

(i)The Group has made an accounting policy choice to disaggregate the finance component of the risk adjustment and present it under insurance finance income

(expenses) instead of insurance service result.

(ii)The analysis of the investment return on the assets of the Group is provided in note B1.3. The investment return included in the income statement relates to

all investment assets of the Group, irrespective of whether the return is attributable to shareholders or policyholders or whether the assets are backing

insurance contracts classified as VFA or GMM. The impact of changes in market movements on the assets and insurance contract liabilities will vary depending

on whether the insurance contracts are classified as VFA or GMM, which is discussed further in note C6.1. For example, a significant portion of the Group's

investment portfolio comprises assets that are part of the underlying items relating to VFA contracts. Market movements in these underlying assets, as

included in Investment return, are matched by a movement in insurance liabilities as included in Insurance finance income (expense). Accordingly, the

principal driver for the year-on-year variations in the 'Changes in fair value of underlying assets and other adjustments relating to VFA contracts' in the table

above is the investment return element, as shown directionally in the 'Net gains on financial instruments at FVTPL' in the table in note B1.3.

(iii)Other finance expense from insurance contracts includes the effect of changes in the policyholders' interest in the excess net assets of relevant participating

funds of $(320) million (2024: $(110) million; 2023: $(192) million).

(iv)Other finance income (expense) from reinsurance contracts held includes the effect of changes in non-performance risk of reinsurers of less than $1 million

(2024: $24 million; 2023: $(3) million).

**B1.5 Additional segmental analysis of profit after tax**

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m**<br>**Profit after tax** | 2024 $m<br>Profit after tax | 2023 $m<br>Profit after tax |
| Hong Kong | **1333** | 851 | 976 |
| Indonesia | **224** | 181 | 156 |
| Mainland China <sup>note</sup> | **(24)** | 159 | (577) |
| Malaysia <sup>note</sup> | **325** | 296 | 257 |
| Singapore | **966** | 566 | 512 |
| Growth markets and other <sup>note</sup> | **535** | 503 | 775 |
| Asset management | **1633** | 264 | 254 |
| Total segment profit | **4992** | 2820 | 2353 |
| Unallocated to a segment (central operations) | **(873)** | (405) | (641) |
| **Total profit after tax** | **4119** | 2415 | 1712 |

---

**Note**

The Growth markets and other segment comprises all other Asia and Africa insurance businesses alongside amounts that are not included in the segment profit of

an individual business unit, including tax on life joint ventures and associates that are accounted for on an equity-method basis. Accordingly, on the segmental

analysis of the profit after tax above, the amount shown for Mainland China is before tax (with its tax being included in the Growth markets and other segment).

The Group's share of the Mainland China joint venture's post-tax result was $3 million (2024: $141 million; 2023: $(366) million).

**B2 Insurance service expenses and other expenditure** 

*Insurance service expenses arising from insurance contracts are recognised in profit or loss generally as they are incurred. They* 

*exclude repayments of investment components and comprise:*

*–incurred claims and other insurance service expenses;*

*–amortisation of insurance acquisition cash flows;*

*–losses on onerous contracts and reversals of such losses;*

*–adjustments to the liabilities for incurred claims that do not arise from the effects of the time value of money, financial risk and* 

*changes therein, which are recognised in insurance finance income (expense); and*

*–impairment losses on assets for insurance acquisition cash flows and reversals of such impairment losses.*

An analysis of the expenses incurred by the Group in the year is provided in the table below.

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Expenses attributed to insurance acquisition cash flows <sup>note (i)</sup> | **5379** | 4987 | 4833 |
| Other directly attributable expenses <sup>note (ii)</sup> | **1455** | 1328 | 1258 |
| Other expenditure <sup>note (iii)</sup> | **1031** | 1003 | 990 |
| **Total expenses** | **7865** | 7318 | 7081 |

---

**Notes**

(i)Expenses attributed to insurance acquisition cash flows represent insurance acquisition expenses incurred in the year, which are implicitly deferred within the

CSM and amortised as part of the CSM amortisation. Ceding commissions received from outward reinsurance agreements are not included in the analysis

above.

(ii)Other directly attributable expenses are those incurred in the year when providing insurance services to the policyholders, excluding the cost of claims and

benefit payments. The expected other directly attributable expenses are explicitly included within the BEL and form part of the BEL release to the insurance

revenue. The actual other directly attributable expenses incurred in the year form part of insurance service expenses.

(iii)Other expenditure includes interest expense other than interest on core structural borrowings that is presented separately on the income statement as

Finance costs. Total segment interest expense is $53 million (2024: $62 million; 2023: $58 million), of which $22 million (2024: $23 million; 2023:

$31 million arises in the Hong Kong segment and $23 million (2024: $35 million; 2023: $23 million) arises in central operations with the remainder spread

broadly across the other markets. Included within interest expense is $11 million (2024: $10 million; 2023: $7 million) of interest on lease liabilities. Core

structural borrowings and operational borrowings (other than lease liabilities) represent financial liabilities that are not classified at FVTPL.

Total depreciation and amortisation expenses relate primarily to amortisation of distribution rights intangibles as shown in note

C4.2 and depreciation of property, plant and equipment as shown in note C10. The segmental analysis of total depreciation and

amortisation is shown below.

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Hong Kong | **157** | 51 | 42 |
| Indonesia | **17** | 12 | 11 |
| Malaysia | **51** | 22 | 21 |
| Singapore | **93** | 36 | 36 |
| Growth markets and other | **223** | 372 | 369 |
| Eastspring | **12** | 13 | 12 |
| Total segment | **553** | 506 | 491 |
| Unallocated to a segment (central operations) | **18** | 17 | 33 |
| **Total depreciation and amortisation** | **571** | 523 | 524 |

---

**B2.1 Staff and employment costs** 

Total staff and employment costs are analysed by category below:

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Wages and salaries | **1228** | 1119 | 1079 |
| Social security costs | **38** | 37 | 37 |
| Defined contribution pension schemes | **57** | 54 | 46 |
| **Total Group** | **1323** | 1210 | 1162 |

---

The average number of staff employed by the Group during the years is shown below:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Asia and Africa operations <sup>note</sup> | **14770** | 14851 | 14479 |
| Head office function | **568** | 561 | 551 |
| **Total Group** | **15338** | 15412 | 15030 |

---

**Note**

The Asia and Africa operations staff numbers above exclude 634 (2024: 702; 2023: 621) commission-based sales staff who have an employment contract with the

Group.

**B2.2 Share-based payment**

The Company offers discretionary share awards to certain key employees and all-employee share plans across the Group. The

compensation expense charged to the income statement is primarily based upon the fair value of the awards granted, the vesting

period and the vesting conditions. The Company has established trusts to facilitate the delivery of Prudential plc shares under

some of these plans. The cost to the Company of acquiring these shares held in trusts is shown as a deduction from shareholders'

equity.

**(a)Description of the plans**

The Group operates a number of share award plans that provide Prudential plc shares to participants upon vesting. The plans in

operation include the Prudential Long Term Incentive Plan, the Prudential Annual Incentive Plan, savings-related share option

schemes, share purchase plans and deferred bonus plans. Where Executive Directors participate in these plans, details about those

schemes are provided in the Compensation and employees section. The following information is provided about plans in which the

Executive Directors do not participate:

---

| | |
|:---|:---|
| **Share scheme** | **Description** |
| **Prudential Global Long Term** <br>**Incentive Plan (PG LTIP)**<br>| The PG LTIP provides eligible employees with conditional awards. Awards are discretionary <br>and vest after one, two or three years subject to the employee being in employment. <br>Vesting of awards may also be subject to performance conditions. All awards are made in <br>Prudential shares. In countries where share awards are not feasible for reasons including <br>securities and/or tax considerations, awards will be replaced by the cash value of the shares <br>that would otherwise have vested.<br>|
| **Prudential Agency Long-Term** <br>**Incentive Plan (LTIP)**<br>| Certain agents are eligible to be granted awards in Prudential shares under the Prudential <br>Agency LTIP. These awards are structured in a similar way to the PG LTIP described above, <br>with most awards granted with a three-year vesting period.<br>|
| **Restricted Share Plan (RSP)** | The Company operates the RSP for certain employees. Awards under this plan are <br>discretionary, and the vesting of awards may be subject to performance conditions.<br>|
| **Deferred bonus plans** | The Company operates a number of deferred bonus plans including the Group Deferred <br>Bonus Plan (GDBP) and the Prudential Deferred Bonus Plan. There are no performance <br>conditions attached to deferred share awards made under these arrangements.<br>|
| **Savings-related share option** <br>**schemes**<br>| Eligible agents in certain business units are able to participate in the International Savings-<br>Related Share Option Scheme for Non-Employees (ISSOSNE). The plan is similar to the <br>HMRC-approved Save As You Earn (Sharesave) share option scheme in the UK which is <br>open to eligible employees.<br>|
| **Share purchase plans** | Eligible employees in the UK are invited to participate in the Company's HMRC-approved UK <br>Share Incentive Plan (SIP). The plan allows the purchase of Prudential plc shares each <br>month. Staff based in Asia and Africa are eligible to participate in the Prudential All <br>Employee Share Purchase Plan (PRUshareplus) which is run in a similar way.<br>|

---

**(b)Outstanding options and awards** 

The following table shows the movement in outstanding options and awards under the Group's share-based compensation plans:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Options outstanding under Sharesave and ISSOSNE schemes | Options outstanding under Sharesave and ISSOSNE schemes | Options outstanding under Sharesave and ISSOSNE schemes | Awards outstanding under incentive <br>plans | Awards outstanding under incentive <br>plans | Awards outstanding under incentive <br>plans |
| | **2025** | 2024 | 2023 | **2025** | 2024 | 2023 |
| | **Number**<br>**of options**<br>| Number<br>of options<br>| Number<br>of options<br>| Number of awards | Number of awards | Number of awards |
| | **millions** | £millions | £millions | £millions | millions | millions |
| Balance at beginning of year | **1.7** | 1.7 | 1.9 | **17.5** | 14.3 | 21.0 |
| Granted | **0.3** | 0.6 | 0.4 | **9.0** | 10.9 | 6.3 |
| Exercised | **(0.2)** | (0.1) | (0.3) | **(7.0)** | (6.6) | (10.1) |
| Forfeited | **–** | – | – | **(0.3)** | (0.5) | (1.7) |
| Cancelled | **(0.3)** | (0.5) | (0.3) | **–** | – | (0.1) |
| Lapsed/expired | **–** | – | – | **(0.5)** | (0.6) | (1.1) |
| Balance at end of year | **1.5** | 1.7 | 1.7 | **18.7** | 17.5 | 14.3 |
| Options immediately <br>exercisable at end of year<br>| **0.1** | 0.2 | 0.2 |  |  |  |

---

Certain options granted in 2025 and 2024 were awarded with options prices expressed in Hong Kong dollars. These amounts have

been converted to pound sterling exercise prices, shown in the tables above and below, using the daily spot rate on the grant date.

The weighted average share price of Prudential plc for 2025 was £8.68 (2024: £7.14; 2023: £10.46).

The following table provides a summary of the range of exercise prices for Prudential plc options outstanding at 31 December:

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Outstanding | Outstanding | Outstanding | Outstanding | Outstanding | Outstanding | Outstanding | Outstanding | Outstanding | Exercisable | Exercisable | Exercisable | Exercisable | Exercisable | Exercisable |
|  | Number outstanding<br>millions | Number outstanding<br>millions | Number outstanding<br>millions | Weighted average<br> remaining<br>contractual life<br>years | Weighted average<br> remaining<br>contractual life<br>years | Weighted average<br> remaining<br>contractual life<br>years | Weighted average<br> exercise prices<br>£ | Weighted average<br> exercise prices<br>£ | Weighted average<br> exercise prices<br>£ | Number exercisable<br> millions | Number exercisable<br> millions | Number exercisable<br> millions | Weighted average<br> exercise prices<br>£ | Weighted average<br> exercise prices<br>£ | Weighted average<br> exercise prices<br>£ |
| | **2025** | 2024 | 2023 | **2025** | 2024 | 2023 | **2025** | 2024 | 2023 | **2025** | 2024 | 2023 | **2025** | 2024 | 2023 |
| Between £5 <br>and £6<br>| **0.5** | 0.5 | – | **3.3** | 4.3 | – | **5.24** | 5.24 | – | **–** | – | – | **–** | – | – |
| Between £7 <br>and £8<br>| **0.8** | 0.7 | 0.7 | **2.8** | 2.7 | 3.7 | **7.69** | 7.55 | 7.55 | **0.1** | – | – | **7.37** | – | – |
| Between £9 <br>and £10<br>| **0.1** | 0.1 | 0.3 | **0.4** | 1.4 | 1.4 | **9.64** | 9.64 | 9.64 | **0.1** | – | 0.1 | **9.64** | – | 9.64 |
| Between £11 <br>and £12<br>| **0.1** | 0.4 | 0.6 | **1.4** | 1.3 | 2.0 | **11.89** | 11.70 | 11.59 | **–** | 0.2 | – | **–** | 11.57 | – |
| Between £12 <br>and £13<br>| **–** | – | – | **1.5** | 0.6 | – | **12.02** | 12.02 | – | **–** | – | – | **–** | – | – |
| Between £13 <br>and £14<br>| **–** | – | 0.1 | **–** | – | 0.4 | **–** | – | 13.94 | **–** | – | 0.1 | **–** | – | 13.94 |
| Total | **1.5** | 1.7 | 1.7 | **2.8** | 2.8 | 2.6 | **7.30** | 7.84 | 9.50 | **0.2** | 0.2 | 0.2 | 8.54 | 11.57 | 10.82 |

---

The years shown above for weighted average remaining contractual life include the time period from end of vesting period to

expiration of contract.

**(c)Fair value of options and awards**

The fair value amounts estimated on the date of grant relating to all options and awards were determined by using the following

assumptions:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 |
| | **Sharesave** <br>**and** <br>**ISSOSNE**<br>**options**<br>| **Prudential**<br>**LTIP** <br>**(TSR)**<br>| **Other**<br>**awards**<br>| Sharesave <br>and <br>ISSOSNE<br>options<br>| Prudential<br>LTIP <br>(TSR)<br>| Other<br>awards<br>| Sharesave <br>and <br>ISSOSNE<br>options<br>| Prudential<br>LTIP <br>(TSR)<br>| Other<br>awards<br>|
| Dividend yield (%) | **2.20** | **–** | **–** | 2.08 | – | – | 1.38 | – | – |
| Expected volatility (%) | **22.97** | **29.45** | **–** | 28.17 | 28.45 | – | 30.02 | 31.50 | – |
| Risk-free interest rate (%) | **3.31** | **3.82** | **–** | 3.57 | 4.39 | – | 4.55 | 4.34 | – |
| Expected option life (years) | **3.73** | **–** | **–** | 4.03 | – | – | 3.95 | – | – |
| Weighted average exercise price (£) | **£7.86** | **–** | **–** | £5.24 | – | – | £7.75 | – | – |
| Weighted average share price at grant <br>date (£/HKD)<br>| **£10.39** | **HKD** <br>**82.75**<br>| **–** | £7.16 | HKD <br>75.10<br>| – | £8.89 | HKD <br>112.76<br>| – |
| Weighted average fair value at grant <br>date (£/HKD)<br>| **£3.11** | **HKD** <br>**55.33**<br>| **HKD** <br>**80.82**<br>| £2.50 | HKD <br>29.29<br>| HKD <br>72.58<br>| £2.85 | HKD <br>49.60<br>| HKD <br>111.97<br>|

---

The compensation costs for all awards and options are recognised in net income over the plans' respective vesting periods. The

Group uses the Black-Scholes model to value all options, and financial equivalence to value all awards other than those that have

Total Shareholder Return (TSR) performance conditions attached (some Prudential LTIP and RSP awards) for which the Group uses

a Monte Carlo model in order to allow for the impact of these conditions. These models are used to calculate fair values for share

options and awards at the grant date based on the quoted market price of the stock at the measurement date, the amount, if any,

that the employees are required to pay, the dividend yield, expected volatility, risk-free interest rates and exercise prices.

For all options and awards, the expected volatility is based on the market-implied volatilities as quoted on Bloomberg. The

Prudential specific at-the-money implied volatilities are adjusted to allow for the different terms and discounted exercise price on

Sharesave options by using information on the volatility surface of the FTSE 100.

Risk-free interest rates are taken from swap spot rates with projection terms matching the corresponding vesting periods. For

awards with a TSR condition, volatilities and correlations between Prudential and a basket of 12 competitor companies is required.

For grants in 2025 the average volatility for the basket of competitors was 27 per cent (2024: 27 per cent; 2023: 26 per cent).

Correlations for the basket are calculated for each pairing from the log of daily TSR returns for the three years prior to the

valuation date. Market-implied volatilities are used for both Prudential and the basket of competitors. Changes to the subjective

input assumptions could materially affect the fair value estimate.

Other awards, without market performance conditions or exercise price, are valued based on grant date share price.

**(d)Share-based payment expense charged to the income statement**

The total expense recognised in 2025 in the consolidated financial statements relating to share-based compensation is $95 million

(2024: $85 million; 2023: $81 million), of which $87 million (2024: $76 million; 2023: $71 million) is accounted for as equity-

settled.

The Group had $39 million of liabilities at 31 December 2025 (31 December 2024: $31 million) relating to share-based payment

awards accounted for as cash-settled.

**B2.3 Key management remuneration** 

Key management constitutes the Directors of Prudential plc and other non-Director members of the GEC, as they have authority

and responsibility for planning, directing and controlling the activities of the Group.

Total key management remuneration is analysed in the following table:

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Total Salaries and short term benefits | **25.8** | 24.6 | 24.0 |
| Share based payments and other long term awards | **14.9** | 12.5 | 17.1 |
| Payments made on appointment | **3.1** | 0.8 | 8.1 |
| Post-employment benefits  | **1.5** | 1.3 | 1.0 |
| **Total key management remuneration** | **45.3** | 39.2 | 50.2 |

---

The amount presented for 2025 share based payments and other long-term awards includes the performance related pay that is

deferred into shares or cash as included in the remuneration report plus the IFRS 2 charge for other share award schemes, which

have performance conditions in addition to continued service. Payments on appointment includes both cash and share awards. In

total across all categories total share based payments are $15.6 million (2024: $13.3 million; 2023: $22.2 million). 2024 and

2023 are presented on a consistent basis.

Additional details on the Directors' emoluments, retirement benefits and other payments are given in the Compensation and

Employees section.

**B2.4 Fees payable to the auditor** 

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Audit of the Company's annual accounts | **5.3** | 5.3 | 5.8 |
| Audit of subsidiaries pursuant to legislation | **6.0** | 6.0 | 8.1 |
| Audit fees payable to the auditor  | **11.3** | 11.3 | 13.9 |
| Audit-related assurance services <sup>note (i)</sup> | **4.2** | 5.2 | 4.0 |
| Other assurance services  | **0.8** | 1.2 | 0.9 |
| Non-audit fees payable to the auditor | **5.0** | 6.4 | 4.9 |
| **Total fees payable to the auditor** | **16.3** | 17.7 | 18.8 |

---

**Notes**

(i)Of the audit-related assurance service fees of $4.2 million (2024: $5.2 million; 2023: $4.0 million), $1.2 million (2024: $1.2 million; 2023: $1.1 million)

relates to services that are required by law and regulation as defined by the FRC.

(ii)EY became the Group's statutory auditor in 2023 replacing KPMG. The fees shown above are wholly in respect of fees payable to EY.

In addition to the above, in the period from September 2021 until their appointment as the Group's statutory auditor in May 2023,

EY were paid $12.4 million to provide audit assurance over the implementation of IFRS 17.

**B3 Tax charge** 

*Prudential is subject to tax in numerous jurisdictions and the calculation of the total tax charge inherently involves a degree of* 

*estimation and judgement. Current tax expense is charged or credited based upon amounts estimated to be payable or* 

*recoverable as a result of taxable amounts for the current year and adjustments made in relation to prior years. The positions* 

*taken in tax returns, where applicable tax regulation is subject to interpretation, are recognised in full in the determination of the* 

*tax charge in the consolidated financial statements, if the Group considers that it is probable that the taxation authority will accept* 

*those positions. Otherwise, provisions are established based on the likely amount of the liability, or recovery, by providing for the* 

*single best estimate of the most likely outcome or the weighted average expected value where there are multiple outcomes.*

*The total tax charge includes tax expense attributable to both policyholders and shareholders. The tax expense attributable to* 

*policyholders comprises the tax on the income of the consolidated with-profits and unit-linked funds. In certain jurisdictions, life* 

*insurance companies are taxed on both their shareholders' profits and on their policyholders' insurance and investment returns on* 

*certain insurance and investment products. Although both types of tax are included in the total tax charge in the Group's* 

*Consolidated income statement, they are presented separately in the Consolidated income statement to provide the most relevant* 

*information about tax that the Group pays on its profits.*

*Deferred taxes are provided under the liability method for all relevant temporary differences. IAS 12 'Income Taxes' does not* 

*require all temporary differences to be provided for, in particular, the Group does not provide for deferred tax on undistributed* 

*earnings of subsidiaries where the Group is able to control the timing of the distribution and the temporary difference created is* 

*not expected to reverse in the foreseeable future. Deferred tax assets are only recognised when it is more likely than not that* 

*future taxable profits will be available against which these losses can be utilised.* 

*Deferred tax is measured at the tax rates that are expected to apply to the period when the asset is realised or the liability settled,* 

*based on tax rates (and laws) that have been enacted or are substantively enacted at the end of the reporting period.*

**B3.1 Total tax charge by segment**

The total tax charge in the income statement is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Hong Kong | **(148)** | (229) | (129) |
| Indonesia | **(45)** | (37) | (43) |
| Malaysia | **(123)** | (155) | (98) |
| Singapore | **(249)** | (176) | (174) |
| Growth markets and other | **(110)** | (158) | (103) |
| Eastspring <sup>note (i)</sup> | **(256)** | (29) | (26) |
| Total segment <sup>note (ii)</sup>  | **(931)** | (784) | (573) |
| Unallocated to a segment (central operations) | **(71)** | (40) | 13 |
| **Total tax charge** <sup>note (iii)</sup> | **(1002)** | (824) | (560) |

---

**Notes**

(i)The Eastspring tax charge in 2025 includes tax in relation to the gain attaching to corporate transactions, as discussed further in note D6.3.

(ii)Profit before tax includes Prudential's share of profit after tax from the joint ventures and associates that are equity accounted for. Therefore, the actual tax

charge in the income statement does not include tax arising from the results of joint ventures and associates, including the Group's life joint venture in

Mainland China.

(iii)The total tax charge is analysed between current tax and deferred tax by component as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Current tax arising from: |  |  |  |
| Corporation tax | **(838)** | (520) | (457) |
| Adjustments in respect of prior years <sup>note</sup> | **122** | (1) | 1 |
| Pillar Two income taxes (see below) | **(23)** | – | – |
| Total current tax charge | **(739)** | (521) | (456) |
| Deferred tax arising from: |  |  |  |
| Origination and reversal of temporary differences | **(248)** | (319) | (135) |
| Adjustment in respect of a tax loss, tax credit or temporary difference from a <br>prior year<br>| **(15)** | 16 | 31 |
| Total deferred tax charge | **(263)** | (303) | (104) |
| **Total tax charge** | **(1002)** | (824) | (560) |

---

**Note**

The current tax charge – adjustments in respect of prior years comprises $109 million attributable to policyholders' returns and $13 million attributable to

shareholders' returns.

On 6 June 2025, Hong Kong enacted the OECD Pillar Two global minimum tax and domestic minimum tax rules with retrospective

effect from 1 January 2025 onwards. This brings the whole Group into scope of Hong Kong's Pillar Two rules. The 2025 current tax

charge includes $(23) million (2024: nil; 2023: nil) in respect of Pillar Two income taxes. The amount of tax due in any period is

sensitive to market movements in that period. In periods where the actual investment return is in line with, or below, expected

long-term returns, the Group does not expect the Pillar Two tax rules to have a material impact on the IFRS tax charge. In periods

where the actual investment return exceeds the expected long-term returns, the impact from the Pillar Two tax rules will depend

on how the relevant jurisdiction taxes the actual investment return under local corporate income tax rules.

**B3.2 Reconciliation of effective tax rate** 

In the reconciliation below, the expected tax rate reflects the corporation tax rates that are expected to apply to the taxable profit

or loss for the year. It reflects the corporation tax rates of each jurisdiction weighted by reference to the amount of profit or loss

contributing to the aggregate result. The reconciliation of the expected to actual tax (charge) credit and the percentage impact of

reconciliation items on shareholder effective tax rate (ETR) are provided below.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | 2024 | 2024 | 2023 | 2023 |
|  | **$m** | **ETR %** | $m | ETR % | $m | ETR % |
| Profit before tax (being tax attributable to shareholders' and <br>policyholders' returns)<br>| **5121** |  | 3239 |  | 2272 |  |
| Tax charge attributable to policyholders' returns <sup>note (i)</sup> | **(180)** |  | (286) |  | (175) |  |
| Profit before tax attributable to shareholders' returns | **4941** |  | 2953 |  | 2097 |  |
| Tax charge at the expected rate | **(923)** | **19%** | (585) | 20% | (399) | 19% |
| Effects of recurring tax reconciliation items: |  |  |  |  |  |  |
| Income not taxable or taxable at concessionary rates <sup>note (ii)</sup> | **119** | **(2)%** | 96 | (3)% | 80 | (4)% |
| Deductions and losses not allowable for tax purposes <sup>note (iii)</sup> | **(189)** | **4%** | (164) | 5% | (136) | 6% |
| Items related to taxation of life insurance businesses <sup>note (iv)</sup> | **158** | **(3)%** | 94 | (3)% | 137 | (7)% |
| Deferred tax adjustments including unrecognised tax losses  | **(40)** | **1%** | 4 | 0% | 13 | (1)% |
| Effect of results of joint ventures and associates <sup>note (v)</sup> | **75** | **(2)%** | 100 | (3)% | (38) | 2% |
| Irrecoverable withholding taxes <sup>note (vi)</sup> | **(43)** | **1%** | (61) | 2% | (63) | 3% |
| Pillar Two income taxes | **(23)** | **0%** | – | 0% | – | 0% |
| Other | **(5)** | **0%** | 1 | 0% | (2) | 1% |
| Total credit (charge) on recurring items | **52** | **(1)%** | 70 | (2)% | (9) | 0% |
| Effects of non-recurring tax reconciliation items: |  |  |  |  |  |  |
| Adjustments to tax charge in relation to prior years | **3** | **0%** | 7 | 0% | 42 | (2)% |
| Movements in provisions for open tax matters <sup>note (vii)</sup> | **20** | **0%** | (8) | 0% | (15) | 1% |
| Adjustments in relation to business disposals and corporate <br>transactions<br>| **26** | **(1)%** | (22) | 0% | (4) | 0% |
| Total credit (charge) on non-recurring items | **49** | **(1)%** | (23) | 0% | 23 | (1)% |
| Tax charge attributable to shareholders' returns | **(822)** |  | (538) |  | (385) |  |
| Tax charge attributable to policyholders' returns <sup>note (i)</sup> | **(180)** |  | (286) |  | (175) |  |
| **Tax charge attributable to shareholders' and policyholders'** <br>**returns**<br>| **(1002)** |  | (824) |  | (560) |  |
| Profit before tax attributable to shareholders' returns analysed <br>into:<br>|  |  |  |  |  |  |
| Adjusted operating profit | **3306** |  | 3129 |  | 2893 |  |
| Non-operating result <sup>note (viii)</sup> | **1635** |  | (176) |  | (796) |  |
| Profit before tax attributable to shareholders' returns | **4941** |  | 2953 |  | 2097 |  |
| Tax charge attributable to shareholders' returns analysed into: |  |  |  |  |  |  |
| Tax charge on adjusted operating profit | **(534)** |  | (547) |  | (444) |  |
| Tax (charge) credit on non-operating result <sup>note (viii)</sup> | **(288)** |  | 9 |  | 59 |  |
| Tax charge attributable to shareholders' returns | **(822)** |  | (538) |  | (385) |  |
| Actual tax rate on: |  |  |  |  |  |  |
| Adjusted operating profit: |  |  |  |  |  |  |
| Including non-recurring tax reconciling items <sup>note (ix)</sup> | **16%** |  | 17% |  | 15% |  |
| Excluding non-recurring tax reconciling items | **17%** |  | 17% |  | 16% |  |
| **Profit before tax attributable to shareholders' returns** <sup>note (ix)</sup> | **17%** |  | 18% |  | 18% |  |

---

**Notes** 

(i)The tax charge attributable to policyholders of $(180) million (2024: $(286) million; 2023: $(175) million) is equal to the profit before tax attributable to

policyholders as a result of accounting for policyholder income after the deduction of expenses on a post-tax basis.

(ii)Income not taxable or taxable at concessionary rates primarily relates to non-taxable investment income and gains in growth markets and other as well as in

other (central) operations.

(iii)Deductions and losses not allowable for tax purposes primarily relates to non-deductible head office costs in other (central) operations.

(iv)Items related to taxation of life insurance businesses primarily relates to Hong Kong where the taxable profit is computed as 5 per cent of net insurance

premiums.

(v)Profit before tax includes Prudential's share of profit after tax from the joint ventures and associates. Therefore, the actual tax charge does not include tax

arising from profit or loss of joint ventures and associates and is reflected as a reconciling item.

(vi)The Group incurs withholding tax on remittances received from certain jurisdictions and on certain investment income. Where these withholding taxes cannot

be offset against corporate income tax or otherwise recovered, they represent a cost to the Group. Irrecoverable withholding tax on remittances is included in

other (central) operations and is not allocated to any segment. Irrecoverable withholding tax on investment income is included in the relevant segment where

the investment income is reflected.

(vii)The statement of financial position contains the following provisions in relation to open tax matters.

---

| | |
|:---|:---|
| | **2025 $m** |
| Balance at 1 Jan | **(95)** |
| Movements in the current year included in tax charge attributable to shareholders | **20** |
| Provisions utilised in the year | **5** |
| Other movements (including interest arising on open tax matters and amounts included in the Group's share of <br>profits from joint ventures and associates, net of related tax)<br>| **(7)** |
| **Balance at 31 Dec** | **(77)** |

---

(viii)'Non-operating result' is used to refer to items excluded from adjusted operating profit and includes short-term investment fluctuations in investment returns

and corporate transactions. The tax credit on non-operating result is calculated using the tax rates applicable to investment profit or loss recorded in the non-

operating result for each entity, and then adjusting for any discrete items included in the total tax charge that relate specifically to the amounts (other than

investment related profit or loss) included in the non-operating result. The difference between this tax on non-operating result and the tax charge calculated

on profit before tax is the tax charge on adjusted operating profit.

(ix)The actual shareholder tax rates of the relevant business operations are shown below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025%** | **2025%** | **2025%** | **2025%** | **2025%** | **2025%** | **2025%** | **2025%** |
| | **Hong** <br>**Kong**<br>| **Indonesia** | **Malaysia** | **Singapore** | **Growth**<br>**markets**<br>**and other**<br>| **Eastspring** | **Other** <br>**(central)**<br>**operations**<br>| **Total**<br>**attributable to**<br>**shareholders**<br>|
| Tax rate on adjusted operating profit | **8%** | **21%** | **22%** | **15%** | **20%** | **7%** | **(8)%** | **16%** |
| Tax rate on profit before tax | **6%** | **17%** | **22%** | **15%** | **16%** | **14%** | **(9)%** | **17%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 2024% | 2024% | 2024% | 2024% | 2024% | 2024% | 2024% | 2024% |
| | Hong <br>Kong<br>| Indonesia | Malaysia | Singapore | Growth<br>markets<br>and other<br>| Eastspring | Other <br>(central)<br>operations<br>| Total<br>attributable to<br>shareholders<br>|
| Tax rate on adjusted operating profit | 9% | 19% | 22% | 14% | 23% | 10% | (7)% | 17% |
| Tax rate on profit before tax | 10% | 18% | 22% | 14% | 23% | 10% | (11)% | 18% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 2023% | 2023% | 2023% | 2023% | 2023% | 2023% | 2023% | 2023% |
| | Hong <br>Kong<br>| Indonesia | Malaysia | Singapore | Growth<br>markets<br>and other<br>| Eastspring | Other<br>central <br>operations<br>| Total<br>attributable to<br>shareholders<br>|
| Tax rate on adjusted operating profit | 7% | 22% | 22% | 16% | 20% | 9% | 2% | 15% |
| Tax rate on profit before tax | 7% | 22% | 20% | 16% | 11% | 9% | 2% | 18% |

---

**B4 Earnings per share** 

Basic earnings per share are calculated based on earnings attributable to ordinary shareholders, after related tax and non-

controlling interests, divided by the weighted average number of ordinary shares outstanding during the year, excluding those

held in employee share trusts, which are treated as cancelled. For diluted earnings per share, the weighted average number of

shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares. No adjustment is made if the impact is

anti-dilutive overall.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | **2025** | **2025** | **2025** |
|  | **Before**<br> **tax**<br>| **Tax** | **Non-**<br>**controlling** <br>**interests**<br>| **Net of tax**<br> **and non-**<br>**controlling**<br> **interests**<br>| **Basic** <br>**earnings**<br> **per share**<br>| **Diluted**<br> **earnings**<br> **per share**<br>|
| | **$m** | **$m** | **$m** | **$m** | **cents** | **cents** |
| Based on profit for the year | **4941** | **(822)** | **(141)** | **3978** | **154.2¢** | **153.5¢** |
| Short-term interest rate and other market <br>fluctuations<br>| **(120)** | **48** | **(14)** | **(86)** | **(3.3)¢** | **(3.3)¢** |
| Gain attaching to corporate transactions | **(1515)** | **240** | **–** | **(1275)** | **(49.5)¢** | **(49.2)¢** |
| Based on adjusted operating profit | **3306** | **(534)** | **(155)** | **2617** | **(101.4)¢** | **(101.0)¢** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 |
|  | Before<br> tax<br>| Tax | Non-<br>controlling <br>interests<br>| Net of tax<br> and non-<br>controlling<br> interests<br>| Basic <br>earnings<br> per share<br>| Diluted<br> earnings<br> per share<br>|
| | $m | $m | $m | $m | cents | cents |
| Based on profit for the year | 2953 | (538) | (130) | 2285 | 84.1¢ | 84.0¢ |
| Short-term interest rate and other market <br>fluctuations<br>| 105 | (9) | 10 | 106 | 3.9¢ | 3.9¢ |
| Loss attaching to corporate transactions | 71 | – | (26) | 45 | 1.7¢ | 1.7¢ |
| Based on adjusted operating profit | 3129 | (547) | (146) | 2436 | 89.7¢ | 89.6¢ |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 |
|  | Before<br> tax<br>| Tax | Non-<br>controlling <br>interests<br>| Net of tax<br> and non-<br>controlling<br> interests<br>| Basic <br>earnings<br> per share<br>| Diluted<br> earnings<br> per share<br>|
| | $m | $m | $m | $m | cents | cents |
| Based on profit for the year | 2097 | (385) | (11) | 1701 | 62.1¢ | 61.9¢ |
| Short-term interest rate and other market <br>fluctuations<br>| 774 | (59) | – | 715 | 26.1¢ | 26.0¢ |
| Loss attaching to corporate transactions | 22 | – | – | 22 | 0.8¢ | 0.8¢ |
| Based on adjusted operating profit | 2893 | (444) | (11) | 2438 | 89.0¢ | 88.7¢ |

---

For 2025, the weighted average number of shares for calculating basic earnings per share, which excludes those held in employee

share trusts, is 2,580 million (2024: 2,715 million; 2023: 2,741 million) shares. After including a dilutive effect of the Group's

share options and awards of 12 million (2024: 5 million; 2023: 6 million) shares, the weighted average number of shares for

calculating diluted earnings per share is 2,592 million (2024: 2,720 million; 2023: 2,747 million) shares.

**B5 Dividends**

First and second interim dividends are recorded in the period in which they are paid. Cash and scrip dividends are initially recorded

in the statement of changes in equity as a deduction from retained earnings, at the value of the cash paid, or the cash equivalent

to the scrip dividend. For scrip dividends settled by a new issue of shares the deduction from retained earnings is subsequently

reversed and an amount equal to the nominal value of shares issued is transferred to share capital from share premium or the

capital redemption reserve.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | 2024 | 2024 | 2023 | 2023 |
| | **Cents per** <br>**share**<br>| **$m** | Cents per <br>share<br>| $m | Cents per <br>share<br>| $m |
| Dividends relating to reporting year:\* |  |  |  |  |  |  |
| First interim dividend | **7.71¢** | **197** | 6.84¢ | 185 | 6.26¢ | 172 |
| Second interim dividend | **18.89¢** | **481** | 16.29¢ | 433 | 14.21¢ | 392 |
| Total relating to reporting year | **26.60¢** | **678** | 23.13¢ | 618 | 20.47¢ | 564 |
| Dividends paid in reporting year: |  |  |  |  |  |  |
| Current year first interim dividend | **7.71¢** | **197** | 6.84¢ | 185 | 6.26¢ | 172 |
| Second interim dividend for prior year | **16.29¢** | **426** | 14.21¢ | 390 | 13.04¢ | 361 |
| **Total paid in reporting year** | **24.00¢** | **623** | 21.05¢ | 575 | 19.30¢ | 533 |

---

\*Calculated using the outstanding number of ordinary shares as at 31 December 2025.

**Dividend per share** 

The 2025 first interim dividend of 7.71 cents per ordinary share was paid to eligible shareholders on 16 October 2025.

On 13 May 2026, Prudential will pay a second interim dividend of 18.89 cents per ordinary share for the year ended 31 December

2025. The second interim dividend will be paid to shareholders recorded on the UK register at 5.00pm (Greenwich Mean Time) and

to shareholders recorded on the HK branch register at 4.30pm (Hong Kong Time) on 27 March 2026 (Record Date), and also to

the holders of US American Depositary Receipts (ADRs) as at 27 March 2026. The second interim dividend will be paid on or about

20 May 2026 to shareholders with shares standing to the credit of their securities accounts with the Central Depository (Pte)

Limited (CDP) at 5.00pm (Singapore Time) on the Record Date.

Shareholders holding shares on the UK or HK share registers will continue to receive their dividend payments in either GBP or

HKD, respectively, unless they elect to receive dividend payments in USD or in the form of new fully paid ordinary shares (scrip

dividend alternative). A scrip dividend alternative will again be offered which will involve the issuance of relevant new ordinary

shares on the Hong Kong line only. The scrip dividend alternative is offered in addition to the Dividend Reinvestment Plan (DRIP),

which continues to be available to shareholders on the UK register.

Elections regarding currency, scrip dividend or DRIP must be received by the relevant UK or HK share registrar on or before

21 April 2026. The corresponding amounts per share in GBP and HKD are expected to be announced on or about 28 April 2026.

The USD to GBP and HKD conversion rates will be determined by the actual rates achieved by Prudential buying those currencies

prior to the subsequent announcement.

Shareholders holding an interest in Prudential shares through the CDP in Singapore will continue to receive their dividend

payments in SGD based on the prevailing market exchange rate, unless they elect to participate in the scrip dividend alternative

for which elections must be made through the CDP by 14 April 2026.

Holders of ADRs will continue to receive their dividend payments in USD.

**C Financial position**

**C1 Group assets and liabilities**

**C1.1 Group investments by business type**

The analysis below is structured to show the investments of the Group's subsidiaries by reference to the differing degrees of

policyholder and shareholder economic interest of the different types of business.

Debt securities are analysed below according to the issuing government for sovereign debt and to credit ratings for the rest of the

securities. The Group uses the middle of the Standard & Poor's, Moody's and Fitch ratings, where available. Where ratings are not

available from these rating agencies, local external rating agencies' ratings and, lastly, internal ratings have been used. Securities

with none of the ratings listed above are classified as unrated and included under the 'below BBB- and unrated' category. The total

securities (excluding sovereign debt) that were unrated at 31 December 2025 were $973 million (31 December 2024:

$900 million). Additionally, government debt is shown separately from the rating breakdowns in order to provide a more focused

view of the credit portfolio.

In the table below, AAA is the highest possible rating. Investment grade financial assets are classified within the range of AAA to

BBB- ratings. Financial assets that fall outside this range are classified as below BBB-.

The following table classifies assets into those that primarily back the Group's participating funds that are measured under the

variable fee approach, those backing unit-linked funds, other investments held within the insurance entities, Eastspring's

investments and those that are unallocated to a segment (principally centrally held investments).

In terms of the investments held by the insurance businesses, those within funds with policyholder participation and those within

unit-linked funds represent underlying items. The gains or losses on these investments will be offset by movements in policyholder

liabilities and therefore adjusted operating profit reflects the actual investment return on these assets. The exception is for

investments backing the shareholders' 10 per cent share of the estate within the Hong Kong with-profits fund. Changes in the

value of these investments, including those driven by market movements, pass through the income statement with no liability

offset. Consequently, adjusted operating profit recognises investment return on a longer-term basis for these assets.

In terms of other assets held within the insurance entities, these largely comprise assets backing IFRS shareholders' equity or are

non-underlying items backing GMM liabilities and therefore the returns on these other investments are recognised in adjusted

operating profit at a longer-term rate.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
|  | **Asia and Africa** | **Asia and Africa** | **Asia and Africa** | **Asia and Africa** | **Asia and Africa** | **Unallocated**<br>**to a** <br>**segment** | **Group**<br>**total** |
|  | **Insurance** | **Insurance** | **Insurance** |  |  | **Unallocated**<br>**to a** <br>**segment** | **Group**<br>**total** |
|  | **Funds with** <br>**policyholder** <br>**participation**<br>| **Unit-linked** <br>**funds**<br>| **Other** | **Eastspring** | **Total** | **Unallocated**<br>**to a** <br>**segment** | **Group**<br>**total** |
| | **note (i)** | | | | | | |
| **Debt securities** |  |  |  |  |  |  |  |
| Sovereign debt |  |  |  |  |  |  |  |
| Indonesia | **536** | **475** | **826** | **–** | **1837** | **–** | **1837** |
| Singapore | **2339** | **774** | **1210** | **–** | **4323** | **–** | **4323** |
| Thailand | **–** | **3** | **3725** | **–** | **3728** | **–** | **3728** |
| United States | **16538** | **55** | **281** | **–** | **16874** | **–** | **16874** |
| Vietnam | **2625** | **16** | **137** | **–** | **2778** | **–** | **2778** |
| Other (predominantly Asia) | **4737** | **663** | **2060** | **–** | **7460** | **–** | **7460** |
| Subtotal | **26775** | **1986** | **8239** | **–** | **37000** | **–** | **37000** |
| Other government bonds |  |  |  |  |  |  |  |
| AAA | **1508** | **137** | **112** | **–** | **1757** | **–** | **1757** |
| AA+ to AA- | **133** | **31** | **27** | **–** | **191** | **–** | **191** |
| A+ to A- | **830** | **77** | **367** | **–** | **1274** | **–** | **1274** |
| BBB+ to BBB- | **230** | **40** | **74** | **–** | **344** | **–** | **344** |
| Below BBB- and unrated | **317** | **44** | **40** | **–** | **401** | **–** | **401** |
| Subtotal | **3018** | **329** | **620** | **–** | **3967** | **–** | **3967** |
| Corporate bonds |  |  |  |  |  |  |  |
| AAA | **1538** | **142** | **376** | **–** | **2056** | **–** | **2056** |
| AA+ to AA- | **6263** | **643** | **947** | **–** | **7853** | **–** | **7853** |
| A+ to A- | **20892** | **631** | **1718** | **–** | **23241** | **1** | **23242** |
| BBB+ to BBB- | **13149** | **822** | **1565** | **–** | **15536** | **1** | **15537** |
| Below BBB- and unrated | **1375** | **232** | **247** | **–** | **1854** | **–** | **1854** |
| Subtotal | **43217** | **2470** | **4853** | **–** | **50540** | **2** | **50542** |
| Asset-backed securities |  |  |  |  |  |  |  |
| AAA | **190** | **3** | **85** | **–** | **278** | **–** | **278** |
| AA+ to AA- | **10** | **–** | **3** | **–** | **13** | **–** | **13** |
| A+ to A- | **119** | **–** | **16** | **–** | **135** | **–** | **135** |
| BBB+ to BBB- | **22** | **–** | **2** | **–** | **24** | **–** | **24** |
| Below BBB- and unrated | **21** | **1** | **70** | **–** | **92** | **–** | **92** |
| Subtotal | **362** | **4** | **176** | **–** | **542** | **–** | **542** |
| Total debt securities <sup>notes (ii)</sup><sup>(iii)</sup> | **73372** | **4789** | **13888** | **–** | **92049** | **2** | **92051** |
| **Loans** |  |  |  |  |  |  |  |
| Mortgage loans | **46** | **–** | **161** | **–** | **207** | **–** | **207** |
| Other loans | **344** | **–** | **–** | **–** | **344** | **–** | **344** |
| Total loans | **390** | **–** | **161** | **–** | **551** | **–** | **551** |
| **Equity securities and holdings in** <br>**collective investment schemes**<br>|  |  |  |  |  |  |  |
| Direct equities <sup>note (ii)</sup> | **22874** | **14734** | **285** | **91** | **37984** | **25** | **38009** |
| Collective investment schemes | **39196** | **11053** | **1286** | **14** | **51549** | **–** | **51549** |
| Total equity securities and holdings in <br>collective investment schemes<br>| **62070** | **25787** | **1571** | **105** | **89533** | **25** | **89558** |
| **Derivative assets**  | **326** | **20** | **267** | **–** | **613** | **8** | **621** |
| **Deposits** | **2464** | **201** | **2394** | **79** | **5138** | **1108** | **6246** |
| **Total financial investments**  | **138622** | **30797** | **18281** | **184** | **187884** | **1143** | **189027** |
| Investment properties | **–** | **–** | **3** | **–** | **3** | **–** | **3** |
| Cash and cash equivalents | **1707** | **554** | **1403** | **191** | **3855** | **3851** | **7706** |
| **Total investments** | **140329** | **31351** | **19687** | **375** | **191742** | **4994** | **196736** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
|  | Asia and Africa | Asia and Africa | Asia and Africa | Asia and Africa | Asia and Africa | Unallocated<br>to a segment |  |
|  | Insurance | Insurance | Insurance |  |  | Unallocated<br>to a segment |  |
|  | Funds with <br>policyholder <br>participation<br>| Unit-linked <br>funds<br>| Other | Eastspring | Total | Unallocated<br>to a segment | Group<br>total<br>|
| | note (i) | | | | | | |
| **Debt securities** |  |  |  |  |  |  |  |
| Sovereign debt |  |  |  |  |  |  |  |
| Indonesia | 453 | 573 | 642 | – | 1668 | – | 1668 |
| Singapore | 2265 | 738 | 932 | – | 3935 | – | 3935 |
| Thailand | 3 | 3 | 2580 | – | 2586 | – | 2586 |
| United States | 14851 | 71 | 433 | – | 15355 | – | 15355 |
| Vietnam | 2885 | 17 | 139 | – | 3041 | – | 3041 |
| Other (predominantly Asia) | 4192 | 685 | 1589 | 2 | 6468 | – | 6468 |
| Subtotal | 24649 | 2087 | 6315 | 2 | 33053 | – | 33053 |
| Other government bonds |  |  |  |  |  |  |  |
| AAA | 1617 | 119 | 112 | – | 1848 | – | 1848 |
| AA+ to AA- | 124 | 16 | 23 | – | 163 | – | 163 |
| A+ to A- | 643 | 82 | 268 | – | 993 | – | 993 |
| BBB+ to BBB- | 189 | 45 | 80 | – | 314 | – | 314 |
| Below BBB- and unrated | 354 | 6 | 48 | – | 408 | – | 408 |
| Subtotal | 2927 | 268 | 531 | – | 3726 | – | 3726 |
| Corporate bonds |  |  |  |  |  |  |  |
| AAA | 1400 | 158 | 280 | – | 1838 | – | 1838 |
| AA+ to AA- | 3567 | 486 | 851 | – | 4904 | – | 4904 |
| A+ to A- | 13451 | 491 | 1629 | – | 15571 | 1 | 15572 |
| BBB+ to BBB- | 9753 | 661 | 1784 | – | 12198 | 1 | 12199 |
| Below BBB- and unrated | 1477 | 477 | 342 | – | 2296 | – | 2296 |
| Subtotal | 29648 | 2273 | 4886 | – | 36807 | 2 | 36809 |
| Asset-backed securities |  |  |  |  |  |  |  |
| AAA | 129 | 3 | 34 | – | 166 | – | 166 |
| AA+ to AA- | 4 | – | 1 | – | 5 | – | 5 |
| A+ to A- | 28 | – | 3 | – | 31 | – | 31 |
| BBB+ to BBB- | 2 | – | 1 | – | 3 | – | 3 |
| Below BBB- and unrated | 2 | 1 | 8 | – | 11 | – | 11 |
| Subtotal | 165 | 4 | 47 | – | 216 | – | 216 |
| Total debt securities <sup>notes (ii)</sup><sup>(iii)</sup> | 57389 | 4632 | 11779 | 2 | 73802 | 2 | 73804 |
| **Loans** |  |  |  |  |  |  |  |
| Mortgage loans | 51 | – | 102 | – | 153 | – | 153 |
| Other loans | 364 | – | – | – | 364 | – | 364 |
| Total loans | 415 | – | 102 | – | 517 | – | 517 |
| **Equity securities and holdings in** <br>**collective investment schemes**<br>|  |  |  |  |  |  |  |
| Direct equities <sup>note (ii)</sup> | 19487 | 13465 | 254 | 95 | 33301 | – | 33301 |
| Collective investment schemes | 37652 | 8338 | 1698 | 13 | 47701 | – | 47701 |
| Total equity securities and holdings in <br>collective investment schemes<br>| 57139 | 21803 | 1952 | 108 | 81002 | – | 81002 |
| **Derivative assets**  | 119 | 6 | 129 | – | 254 | 141 | 395 |
| **Deposits** | 2121 | 254 | 1989 | 93 | 4457 | 1009 | 5466 |
| **Total financial investments**  | 117183 | 26695 | 15951 | 203 | 160032 | 1152 | 161184 |
| Investment properties | – | – | 3 | – | 3 | – | 3 |
| Cash and cash equivalents  | 1396 | 564 | 1225 | 142 | 3327 | 2445 | 5772 |
| **Total investments** | 118579 | 27259 | 17179 | 345 | 163362 | 3597 | 166959 |

---

**Notes**

(i)Funds with policyholder participation represent investments held to support insurance products where policyholders participate in the returns of a specified

pool of investments (excluding unit-linked policies) that are measured using the variable fee approach.

(ii)Of the Group's debt securities and direct equities, the following amounts were held by the consolidated investment funds:

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Debt securities held by consolidated investment funds | **12341** | 10409 |
| Direct equities held by consolidated investment funds\* | **6605** | 5851 |

---

\*As of 31 December 2025, the $25 million of direct equities unallocated to a segment is entirely held by a consolidated investment fund.

(iii)The credit ratings, are created using a methodology developed by Prudential using ratings from various credit ratings agencies (Composite Ratings), S&P

Global Ratings (S&P), Moody's and Fitch Solutions and their respective affiliates and suppliers. The ratings displayed are not credit opinions nor are they a

rating issued by a rating agency, including S&P. To the extent that a credit rating is calculated using an S&P rating, such rating was used under a license from

S&P and S&P reserves all rights with respect to such rating.

**C1.2 Other assets and liabilities** 

**(a)Accrued investment income and other debtors** 

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Total accrued investment income, primarily interest receivable | **1071** | 902 |
| Other debtors | **817** | 1310 |
| **Total accrued investment income and other debtors** | **1888** | 2212 |
| Analysed as: |  |  |
| Expected to be settled within one year | **1831** | 2162 |
| Expected to be settled beyond one year | **57** | 50 |
| **Total accrued investment income and other debtors** | **1888** | 2212 |

---

**(b)Accruals, deferred income and other creditors**

Accruals, deferred income and other creditors are analysed as follows (detailed maturity analysis is provided in note C2.3):

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Accruals and deferred income | **329** | 238 |
| Interest payable | **37** | 35 |
| Other creditors | **2365** | 2575 |
| **Total accruals, deferred income and other creditors** | **2731** | 2848 |

---

**C1.3 Cash and cash equivalents**

Cash and cash equivalents consist of cash at bank and in hand, deposits held at call with banks, treasury bills and other short-

term highly liquid investments with less than 90 days maturity from the date of acquisition and are analysed as follows:

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Cash | **2164** | 1923 |
| Cash equivalents | **5542** | 3849 |
| **Total cash and cash equivalents** | **7706** | 5772 |
| Analysed as: |  |  |
| Held by the Group's holding and non-regulated entities and available for general use | **3851** | 2445 |
| Other funds not available for general use by the Group, including funds held for the benefit of <br>policyholders<br>| **3855** | 3327 |
| **Total cash and cash equivalents** | **7706** | 5772 |

---

The Group's cash and cash equivalents are held in the following currencies as at 31 December 2025: USD 62 per cent, MYR 8 per

cent, HKD 7 per cent, SGD 5 per cent, GBP 3 per cent, and other currencies 15 per cent (31 December 2024: USD 54 per cent,

MYR 11 per cent, HKD 6 per cent, GBP 5 per cent, SGD 4 per cent and other currencies 20 per cent).

**C1.4 Provisions**

An analysis of movement in total provisions held is shown below:

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| **Balance at 1 Jan** | **218** | 224 |
| Charge (credit) to income statement: |  |  |
| Additional provisions | **218** | 136 |
| Unused amounts released | **(6)** | (4) |
| Utilisation during the year | **(170)** | (133) |
| Exchange differences | **8** | (5) |
| **Balance at 31 Dec** | **268** | 218 |

---

Of the $268 million of provisions at 31 December 2025 (31 December 2024: $218 million), which excludes any amounts

attributable to insurance contracts, the Group held $225 million (31 December 2024: $199 million) provisions for staff benefits,

which are generally expected to be paid out within the next three years.

**C2 Measurement of financial assets and liabilities**

*The Group uses the trade date method to account for regular purchases and sales of financial assets. The Group holds financial* 

*assets in accordance with IFRS 9, whereby, subject to specific criteria, financial instruments are required to be accounted for* 

*under one of the following categories based on the way in which the assets are managed in order to generate cash flows and their* 

*contractual cash flow characteristics (whether the cash flows represent 'solely payments of principal and interest'):*

*–Financial instruments at FVTPL: this comprises primarily instruments that are managed and the performance evaluated on a fair* 

*value basis, including liabilities related to net assets attributable to unit holders of consolidated investment funds and* 

*policyholder liabilities for investment contracts without DPF. In addition, this includes derivatives. All investments within this* 

*category are measured at fair value with all changes thereon being recognised in investment return in the income statement. An* 

*option is also available at initial recognition to irrevocably designate a financial instrument as at FVTPL if doing so eliminates or* 

*significantly reduces accounting mismatches. The vast majority of the financial investments of the Group are held at FVTPL.*

*–Financial instruments at amortised cost: these instruments comprise non-quoted investments that have fixed or determinable* 

*payments, including loans collateralised by mortgages, deposits and other receivables. These investments are initially* 

*recognised at fair value plus transaction costs. Subsequently, these instruments are carried at amortised cost using the effective* 

*interest method. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the* 

*expected life of the financial instrument or, when appropriate, a shorter period to the net carrying amount of the financial asset.* 

*When assets held at amortised cost are subject to impairment testing based on the expected credit loss approach, estimated* 

*future cash flows are compared to the carrying value of the asset. The estimated future cash flows are discounted using the* 

*financial asset's original or variable effective interest rate and exclude credit losses that have not yet been incurred. If, in* 

*subsequent periods, an impaired loan or receivable recovers in value (in part or in full) and this recovery can be objectively* 

*related to an event occurring after the impairment, then any amount determined to have been recovered is reversed through* 

*the income statement.*

**C2.1 Determination of fair value**

The fair values of the financial instruments for which fair valuation is required under IFRS Standards are determined by the use of

quoted market prices for exchange-quoted investments or by using quotations from independent third parties, such as brokers

and pricing services or by using appropriate valuation techniques. Climate change does not directly impact fair values particularly

where these are built on observable inputs (ie level 1 and level 2), which represent the majority of the Group's financial

instruments as discussed below.

The estimated fair value of derivative financial instruments reflects the estimated amount the Group would receive or pay in an

arm's-length transaction. This amount is determined using quoted prices if exchange listed, quotations from independent third

parties or valued internally using standard market practices.

**Valuation approach for level 2 fair valued assets and liabilities**

A significant proportion of the Group's level 2 assets are private holdings, structured securities and other national and non-national

government debt securities that are valued using observable inputs. These assets, in line with market practice, are generally

valued using a designated independent pricing service or quote from third-party brokers. These valuations are subject to a number

of monitoring controls, such as comparison to multiple pricing sources where available, monthly price variances, stale price

reviews and variance analysis on prices achieved on subsequent trades.

When prices are not available from pricing services, quotes are sourced directly from brokers. Prudential seeks to obtain a number

of quotes from different brokers so as to obtain the most comprehensive information available on their executability. The selected

quote is the one which best represents an executable quote for the security at the measurement date.

Generally, no adjustment is made to the prices obtained from independent third parties. Adjustments are made in only limited

circumstances, where it is determined that the third-party valuations obtained do not reflect fair value (eg either because the

value is stale and/or the values are extremely diverse in range). Securities valued in such manner are classified as level 3 where

these significant inputs are not based on observable market data.

**Valuation approach for level 3 fair valued assets and liabilities**

Investments valued using valuation techniques include financial investments which, by their nature, do not have an externally

quoted price based on regular trades and financial investments for which markets are no longer active as a result of market

conditions, eg market illiquidity. Level 3 assets of the Group consist primarily of property, infrastructure, private credit and private

equity funds held by the participating funds and are externally valued using the net asset value of the invested entities.

The Group's valuation policies, procedures and analyses for instruments categorised as level 3 are overseen by business unit

committees as part of the Group's wider financial reporting governance processes. The procedures undertaken include approval of

valuation methodologies, verification processes and resolution of significant or complex valuation issues. In addition, the Group

has minimum standards for independent price verification to ensure valuation accuracy is regularly independently verified.

Adherence to this policy is monitored across the business units.

**C2.2 Fair value measurement hierarchy**

**(a)Assets and liabilities at fair value** 

All of the Group's financial instruments held at fair value are classified as fair value through profit or loss (FVTPL) at 31 December

2025 and measured on a recurring basis.

The table below shows the assets and liabilities carried at fair value on a recurring basis analysed by level of the IFRS 13 'Fair

Value Measurement' defined fair value hierarchy. This hierarchy is based on the inputs to the fair value measurement and reflects

the lowest level input that is significant to that measurement.

**Financial instruments at fair value**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
|  | **Level 1** | **Level 2** | **Level 3** |  |
|  | **Quoted** <br>**prices** <br>**(unadjusted)** <br>**in active** <br>**markets**<br>| **Valuation** <br>**based on** <br>**significant** <br>**observable** <br>**market** <br>**inputs**<br>| **Valuation** <br>**based on** <br>**significant** <br>**unobservable** <br>**market** <br>**inputs**<br>| **Total** |
| | | | **note (iii)** | |
| Loans <sup>note (iv)</sup> | **–** | **344** | **–** | **344** |
| Equity securities and holdings in collective investment schemes | **78744** | **5537** | **5277** | **89558** |
| Debt securities <sup>note (i)</sup> | **70327** | **21622** | **102** | **92051** |
| Derivative assets | **171** | **450** | **–** | **621** |
| Derivative liabilities | **(440)** | **(1142)** | **–** | **(1582)** |
| Total financial investments, net of derivative liabilities | **148802** | **26811** | **5379** | **180992** |
| Investment contract liabilities without DPF <sup>note (ii)</sup> | **–** | **(715)** | **–** | **(715)** |
| Net asset value attributable to unit holders of consolidated investment funds | **(2263)** | **–** | **–** | **(2263)** |
| **Total financial instruments at fair value** | **146539** | **26096** | **5379** | **178014** |
| Percentage of total (%) | **82%** | **15%** | **3%** | **100%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
|  | Level 1 | Level 2 | Level 3 |  |
|  | Quoted prices <br>(unadjusted) <br>in active <br>markets<br>| Valuation <br>based <br>on significant <br>observable<br>market inputs<br>| Valuation <br>based <br>on significant <br>unobservable <br>market inputs<br>| Total |
| | | | note (iii) | |
| Loans <sup>note (iv)</sup> | – | 364 | – | 364 |
| Equity securities and holdings in collective investment schemes | 72574 | 5311 | 3117 | 81002 |
| Debt securities <sup>note (i)</sup> | 56147 | 17620 | 37 | 73804 |
| Derivative assets | 17 | 378 | – | 395 |
| Derivative liabilities | (493) | (1124) | – | (1617) |
| Total financial investments, net of derivative liabilities | 128245 | 22549 | 3154 | 153948 |
| Investment contract liabilities without DPF <sup>note (ii)</sup>  | – | (748) | – | (748) |
| Net asset value attributable to unit holders of consolidated investment funds | (2679) | – | – | (2679) |
| **Total financial instruments at fair value** | 125566 | 21801 | 3154 | 150521 |
| Percentage of total (%) | 83% | 15% | 2% | 100% |

---

**Notes**

(i)Of the total level 2 debt securities of $21,622 million at 31 December 2025 (31 December 2024: $17,620 million), $7 million (31 December 2024: $12

million) are valued internally. Internal valuations are inherently more subjective than external valuations.

(ii)Investment contract liabilities without DPF are not quoted in an active market and do not have readily available published prices. Their fair values are

determined using valuation techniques with all significant inputs used in the valuation being observable. Therefore, these investment contract liabilities are

classified in level 2.

(iii)At 31 December 2025, the Group held $5,379 million (31 December 2024: $3,154 million) of net financial instruments at fair value within level 3. This

represents 3 per cent (31 December 2024: 2 per cent) of the total fair valued financial assets, net of financial liabilities and comprises the following:

–Equity securities and holdings in collective investment schemes of $5,277 million (31 December 2024: $3,117 million) consisting primarily of property,

infrastructure, private credit and private equity funds, which are externally valued using the net asset value of the invested funds; and

–Debt securities of $102 million (31 December 2024: $37 million).

Of the net financial instruments of $5,379 million (31 December 2024: $3,154 million) referred to above:

–A net asset of $5,266 million (31 December 2024: $3,088 million) is held by the Group's participating and unit-linked funds and therefore shareholders'

profit and equity are not immediately impacted by movements in the valuation of these financial instruments; and

–The remaining level 3 investments comprise a net asset of $113 million (31 December 2024: $66 million), which are primarily externally valued. If the

value of all these level 3 financial instruments decreased by 10 per cent, the change in valuation would be $(11) million (31 December 2024: $(7)

million), which would reduce shareholders' equity by this amount before tax.

(iv)Of the Group's financial assets and financial liabilities at 31 December 2025, only loans contain more than one asset classification. The loans carried at

amortised cost and their fair value are provided in note (c) below.

**Transfers into and transfers out of levels** 

The Group's policy is to recognise transfers into and out of levels as of the end of each reporting period except for material

transfers that are recognised as of the date of the event or change in circumstances that caused the transfer. Transfers are

deemed to have occurred when there is a material change in the observed valuation inputs or a change in the level of trading

activities of the securities.

During 2025, the transfers between levels within the portfolios were primarily transfers from level 1 to level 2 of $1,497 million

(2024: $940 million) and transfers from level 2 to level 1 of $1,416 million (2024: $2,007 million). These transfers primarily

reflect the change in the observed valuation inputs of equity securities and debt securities and, in certain cases, the change in the

level of trading activities of the securities. There were no transfers into level 3 and a small transfer from Level 3 into level 1 as

shown in the table below.

**Reconciliation of movements in level 3 assets and liabilities measured at fair value**

The following table reconciles the value of level 3 fair valued assets and liabilities at the beginning of the year to that presented at

the end of the year.

Total investment return recorded in the income statement represents interest and dividend income, realised gains and losses,

unrealised gains and losses on the assets classified at FVTPL and foreign exchange movements on an individual entity's overseas

investments. Total gains and losses recorded in other comprehensive income comprises the translation of investments into the

Group's presentation currency of USD.

---

| | | | |
|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
| | **Equity** <br>**securities and** <br>**holdings in** <br>**collective** <br>**investment** <br>**schemes**<br>| **Debt**<br>**securities**<br>| **Group total** |
| Balance at 1 Jan | **3117** | **37** | **3154** |
| Total gain in income statement <sup>note</sup> | **118** | **2** | **120** |
| Exchange differences recorded in other comprehensive income | **47** | **4** | **51** |
| Purchases and other additions | **2376** | **60** | **2436** |
| Sales, maturities and capital distribution | **(367)** | **(1)** | **(368)** |
| Transfers out of Level 3 | **(14)** | **–** | **(14)** |
| **Balance at 31 Dec** | **5277** | **102** | **5379** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | Equity securities <br>and holdings in <br>collective <br>investment <br>schemes<br>| Debt<br>securities<br>| Group total |
| Balance at 1 Jan | 2864 | 40 | 2904 |
| Total gain in income statement <sup>note</sup> | 219 | 3 | 222 |
| Exchange differences recorded in other comprehensive income | (31) | (1) | (32) |
| Purchases and other additions | 462 | 2 | 464 |
| Sales, maturities and capital distribution | (397) | (7) | (404) |
| **Balance at 31 Dec** | 3117 | 37 | 3154 |

---

**Note**

Of the total net gain in the income statement of $120 million at 2025 (2024: $222 million), $121 million (2024: $(143) million) relates to unrealised gains (losses)

on financial instruments still held at the end of the year, which can be analysed as follows:

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| Equity securities and holdings in collective investment schemes | **119** | (146) |
| Debt securities | **2** | 3 |
| **Net unrealised gains (losses) on financial instruments still held at the end of the year** | **121** | (143) |

---

**(b)Assets and liabilities carried at amortised cost and their fair value** 

The table below shows the financial assets and liabilities carried at amortised cost on the statement of financial position and their

fair value. Deposits, cash and cash equivalents, accrued investment income, other debtors, accruals, deferred income and other

creditors are excluded from the analysis below, as these are carried at amortised cost which approximates fair value.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | **Carrying**<br>**value**<br>| **Fair**<br>**value**<br>| Carrying<br>value<br>| Fair<br>value<br>|
| **Financial assets** |  |  |  |  |
| Loans <sup>note (i)</sup> | **207** | **260** | 153 | 163 |
| **Financial liabilities** |  |  |  |  |
| Core structural borrowings of shareholder-financed businesses <sup>note (ii)</sup> | **(4459)** | **(4402)** | (3925) | (3694) |
| Operational borrowings (excluding lease liabilities) <sup>note (i)</sup> | **(521)** | **(521)** | (540) | (540) |
| Obligations under funding, securities lending and sale and repurchase <br>agreements <sup>note (i)</sup><br>| **(745)** | **(745)** | (272) | (272) |
| **Net financial liabilities at amortised cost** <sup>note (iii)</sup> | **(5518)** | **(5408)** | (4584) | (4343) |

---

**Notes**

(i)The fair value of loans, operational borrowings (excluding lease liabilities) and obligations under funding, securities lending and sale and repurchase

agreements has been estimated from the discounted cash flows expected to be received or paid.

(ii)The fair value of the subordinated and senior debt issued by the Group is determined using quoted prices from independent third parties.

(iii)All financial assets and liabilities in the table above have been classified within level 2 at 31 December 2025 and 2024, reflecting the observability of the

inputs used to derive their fair value.

**C2.3 Additional information on financial instruments**

**(a)Financial assets and liabilities by IFRS 9 category**

The following table presents measurement categories under IFRS 9 for each class of the Group's financial assets and financial

liabilities as shown on the Consolidated statement of financial position as at 31 December 2025 and 2024.

---

| | |
|:---|:---|
| Financial instruments | Classification under IFRS 9 |
| **Financial assets** |  |
| Loans | Amortised cost (31 Dec 2025: $207 million; 31 Dec 2024: <br>$153 million)<br>|
|  | Mandatorily at FVTPL (31 Dec 2025: $344 million; 31 Dec 2024: <br>$364 million)<br>|
| Equity securities and portfolio holdings in collective <br>investment schemes<br>| Mandatorily at FVTPL |
| Debt securities | Mandatorily at FVTPL |
| Derivative assets | Mandatorily at FVTPL |
| Accrued investment income | Amortised cost |
| Deposits | Amortised cost |
| Cash and cash equivalents | Amortised cost |
| Other debtors | Amortised cost |
| **Financial liabilities** |  |
| Investment contract liabilities without DPF | Mandatorily at FVTPL |
| Derivative liabilities | Mandatorily at FVTPL |
| Core structural borrowings of shareholder-financed <br>businesses<br>| Amortised cost |
| Operational borrowings | Amortised cost |
| Obligations under funding, securities lending and sale and <br>repurchase agreements<br>| Amortised cost |
| Net asset value attributable to unit holders of consolidated <br>investment funds <sup>note</sup><br>| Designated at FVTPL |
| Other liabilities | Amortised cost |

---

**Note**

Net asset value attributable to unit holders of consolidated investment funds represents the interests of investors other than the Group in the investment funds

that the Group is deemed to control and therefore treated as a subsidiary and consolidated in the Group financial statements. The Group has designated Net asset

value attributable to unit holders of consolidated investment funds as financial liabilities measured at FVTPL to eliminate any accounting mismatch with the

underlying investments of those consolidated investment funds, which are measured at FVTPL.

**(b)Financial risk**

**Liquidity analysis**

The vast majority of the Group's financial assets are held to back the Group's policyholder liabilities. Although asset/liability

matching is an important component of managing policyholder liabilities (both those classified as insurance and those classified as

investments), this profile is mainly relevant for managing market risk rather than liquidity risk. Within each business unit, this

asset/liability matching is performed on a portfolio-by-portfolio basis. In terms of liquidity risk, a large proportion of the

policyholder liabilities contain discretionary surrender values or surrender charges, meaning that many of the Group's liabilities are

expected to be held for the long term. Much of the Group's investment portfolios are in marketable securities, which can therefore

be converted quickly to liquid assets. For the reasons provided above, an analysis of the Group's assets by contractual maturity is

not considered meaningful to evaluate the nature and extent of the Group's liquidity risk.

***Contractual maturities of financial liabilities on an undiscounted cash flow basis***

The following table sets out the contractual maturities for applicable classes of financial liabilities, excluding derivative liabilities

that are separately presented. The financial liabilities are included in the column relating to the contractual maturities of the

undiscounted cash flows (including contractual interest payments on debt with a stated maturity) based on the earliest period in

which the Group can be required to pay assuming conditions are consistent with those of year end. For investment contracts

without DPF, the maturity profile is based on undiscounted cash flow projections of expected benefit payments relative to the

carrying value.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
|  | **Total**<br>**carrying**<br>**value** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** | **Contractual maturity profile for financial liabilities** |
| | **Total**<br>**carrying**<br>**value** | **1 year** <br>**or less**<br>| **1-2**<br> **years**<br>| **2-5**<br> **years**<br>| **5-10**<br>**years**<br>| **10-15**<br>**years**<br>| **15-20**<br>**years**<br>| **Over 20** <br>**years**<br>| **No** <br>**stated** <br>**maturity**<br>| **Total**<br>**undiscounted**<br>**cash flows**<br>|
| Investment contracts without <br>DPF <sup>note</sup><br>| **715** | **12** | **19** | **96** | **84** | **18** | **7** | **4** | **480** | **720** |
| Core structural borrowings of <br>shareholder-financed <br>businesses<br>| **4459** | **147** | **148** | **724** | **3610** | **–** | **–** | **–** | **750** | **5379** |
| Lease liabilities under IFRS 16 | **310** | **96** | **73** | **111** | **97** | **5** | **–** | **–** | **–** | **382** |
| Other operational borrowings | **521** | **521** | **–** | **–** | **–** | **–** | **–** | **–** | **–** | **521** |
| Obligations under funding, <br>securities lending and sale and <br>repurchase agreements<br>| **745** | **745** | **–** | **–** | **–** | **–** | **–** | **–** | **–** | **745** |
| Accruals, deferred income and <br>other liabilities<br>| **2731** | **2466** | **–** | **–** | **–** | **–** | **–** | **–** | **288** | **2754** |
| Net asset value attributable to <br>unit holders of consolidated <br>investment funds<br>| **2263** | **2263** | **–** | **–** | **–** | **–** | **–** | **–** | **–** | **2263** |
| **Total non-derivative** <br>**financial liabilities**<br>| **11744** | **6250** | **240** | **931** | **3791** | **23** | **7** | **4** | **1518** | **12764** |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
|  | Total<br>carrying<br>value | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities | Contractual maturity profile for financial liabilities |
| | Total<br>carrying<br>value | 1 year <br>or less<br>| 1-2<br> years<br>| 2-5<br> years<br>| 5-10<br>years<br>| 10-15<br>years<br>| 15-20<br>years<br>| Over 20 <br>years<br>| No stated <br>maturity<br>| Total<br>undiscounted<br>cash flows<br>|
| Investment contracts without <br>DPF <sup>note</sup><br>| 748 | 186 | 9 | 69 | 114 | 19 | 7 | 4 | 360 | 768 |
| Core structural borrowings of <br>shareholder-financed <br>businesses<br>| 3925 | 125 | 125 | 678 | 3111 | – | – | – | 750 | 4789 |
| Lease liabilities under IFRS 16 | 257 | 84 | 71 | 111 | 18 | – | – | – | – | 284 |
| Other operational borrowings | 540 | 540 | – | – | – | – | – | – | – | 540 |
| Obligations under funding, <br>securities lending and sale <br>and repurchase agreements<br>| 272 | 272 | – | – | – | – | – | – | – | 272 |
| Accruals, deferred income and <br>other liabilities<br>| 2848 | 2641 | – | – | – | – | – | – | 265 | 2906 |
| Net asset value attributable to <br>unit holders of consolidated <br>investment funds<br>| 2679 | 2679 | – | – | – | – | – | – | – | 2679 |
| **Total non-derivative** <br>**financial liabilities**<br>| 11269 | 6527 | 205 | 858 | 3243 | 19 | 7 | 4 | 1375 | 12238 |

---

**Note**

The undiscounted cash flows of investment contracts without DPF included under the 'No stated maturity' category in the maturity profile shown above are mostly

repayable on demand due to most of these investment contracts having options to surrender early, though often subject to surrender or other charges, therefore,

these options are unlikely to be exercised in practice.

**Maturity analysis of derivatives**

The following table shows the carrying value of the gross and net derivative positions.

---

| | | | |
|:---|:---|:---|:---|
|  | **Carrying value of net derivatives $m** | **Carrying value of net derivatives $m** | **Carrying value of net derivatives $m** |
| | **Derivative**<br>**assets**<br>| **Derivative**<br>**liabilities**<br>| **Net**<br>**derivative**<br>**position**<br>|
| **31 Dec 2025** | **621** | **(1582)** | **(961)** |
| 31 Dec 2024 | 395 | (1617) | (1222) |

---

All net derivatives are carried at fair value and are considered to be due within one year or less, representing the basis on which

they are managed (ie to manage principally asset or liability value exposures). The Group has no cash flow hedges and, in

general, contractual maturities are not considered essential for an understanding of the timing of the cash flows for these

instruments.

**Credit risk** 

The Group's maximum exposure to credit risk of financial instruments before any allowance for collateral or allocation of losses to

policyholders is represented by the carrying value of financial instruments on the balance sheet that have exposures to credit risk

comprising cash and cash equivalents, deposits, debt securities, loans and derivative assets, accrued investment income and other

debtors. Further details of collateral in place in relation to derivatives, securities lending, repurchase and reverse repurchase

agreements and other transactions are provided in note (c) below. The Group's exposure to credit risk is further discussed in the

Risk review report.

The majority of the Group's financial instruments are carried at FVTPL. The total value of assets held at amortised cost is $16,047

million (31 December 2024: $13,603 million), comprising primarily cash and cash equivalents, deposits and accrued investment

income where the credit risk is considered to be low by nature. There are no material expected credit losses recognised on these

assets. At 31 December 2025, there are immaterial amounts that are past their due date totalling $5 million (31 December 2024:

$4 million).

In addition, the Group did not take possession of any other collateral held as security in both years.

**Foreign exchange risk**

The Group is exposed to exchange gains and losses on financial assets and liabilities held by the Group's business units in a

currency other than the functional currency of the relevant business units or the currency to which the functional currency is

pegged (eg financial assets and liabilities of USD-denominated business in Hong Kong). The exchange risks inherent in these

exposures are mitigated through the use of derivatives, mainly forward currency contracts and currency swaps as described in

note (c) below.

The exchange gains (losses) on financial instruments, recognised in the income statement in 2025, except for those arising on

financial instruments measured at FVTPL, is $(22) million (2024: $(28) million).

**(c)Derivatives and hedging**

Derivative financial instruments are used to reduce or manage investment, interest rate and currency exposures to facilitate

efficient portfolio management and for investment purposes.

The Group does not regularly seek to apply fair value or cash flow hedging treatment under IFRS 9. The Group has no fair value or

cash flow hedges under IFRS 9 at 31 December 2025 and 2024, respectively. All derivatives that are not designated as hedging

instruments are carried at fair value, with movements in fair value being recorded in the income statement. In 2025, the Group

designated the SGD-denominated core structural borrowing as net investment hedge of the currency risk related to the Group's

investment in the Singapore business and the carrying value is shown in note C5.1. During the year ended 31 December 2025, a

loss of $(1) million on the translation of this borrowing was recognised in other comprehensive income to offset an equal

movement on translation of the hedged portion of the net investments in the Singapore business operations. This net investment

hedge was 100 per cent effective. The total accumulated balance in relation to this net investment hedge recognised in the

translation reserve within equity as at 31 December 2025 was a charge of $(1) million.

**Derivatives held and their purpose**

The Group enters into a variety of exchange traded and over-the-counter derivative financial instruments, including futures,

forwards, options, and swaps.

All over-the-counter derivative transactions are conducted under standardised ISDA (International Swaps and Derivatives

Association Inc) master agreements. Collateral agreements are generally in place between the individual entities and relevant

counterparties under these market master agreements. The collateral management for these transactions is conducted under the

usual and customary terms and conditions set out in the Credit Support Annex to the ISDA master agreement where applicable.

Derivatives are used for efficient portfolio management to obtain cost effective management of exposure to various markets in

accordance with the Group's investment strategies and to manage exposure to interest rate, currency, credit and other business

risks. The Group also uses interest rate derivatives to reduce exposure to interest rate volatility.

**(d)Derecognition, collateral and offsetting**

**Derecognition of financial assets and liabilities**

The Group's policy is to derecognise financial assets when it is deemed that substantially all the risks and rewards of ownership

have been transferred.

The Group derecognises financial liabilities only when the obligation specified in the contract is discharged, cancelled or has

expired.

**Reverse repurchase agreements** 

The Group is party to various reverse repurchase agreements under which securities are purchased from third parties with an

obligation to resell the securities. The securities are not recognised as investments in the statement of financial position but the

right to receive the cash paid is recognised as deposits.

At 31 December 2025, the fair value of the collateral held in respect of reverse repurchase agreements, represented by the

purchased securities, was $1,579 million (31 December 2024: $2,871 million).

**Securities lending and repurchase agreements**

The Group is also party to various securities lending agreements (including repurchase agreements) under which securities are

loaned to third parties on a short-term basis. The loaned securities are not derecognised; rather, they continue to be recognised

within the appropriate investment classification. To the extent cash collateral is received it is recognised on the statement of

financial position with the obligation to repay the cash paid recognised as a liability. Other collateral is not recognised.

At 31 December 2025, the Group had $1,798 million (31 December 2024: $1,565 million) of lent securities and assets subject to

repurchase agreements. The cash and securities collateral held or pledged under such agreements were $1,928 million

(31 December 2024: $1,686 million).

**Collateral and pledges under derivative transactions**

At 31 December 2025, the Group had pledged $1,271 million (31 December 2024: $1,527 million) for liabilities and held collateral

of $316 million (31 December 2024: $280 million) for assets in respect of derivative transactions. These transactions are

conducted under terms that are usual and customary to collateralised transactions including, where relevant, standard securities

lending and repurchase agreements.

The Group has entered into collateral arrangements in relation to derivative transactions, which permit sale or re-pledging of

underlying collateral. The Group has not sold any non-cash collateral held or re-pledged any non-cash collateral.

**Offsetting assets and liabilities**

The Group's derivative instruments, repurchase agreements and securities lending agreements are subject to master netting

arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for

amounts due to and due from that same counterparty that is enforceable in the event of a default or bankruptcy. The Group

recognises amounts subject to master netting arrangements on a gross basis within the consolidated balance sheets.

The following tables present the gross and net information about the Group's financial instruments subject to master netting

arrangements:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
| | **Gross** <br>**amount** <br>**included in** <br>**the balance** <br>**sheet** | **Related amounts not offset in the balance** <br>**sheet** | **Related amounts not offset in the balance** <br>**sheet** | **Related amounts not offset in the balance** <br>**sheet** | **Net amount** <br>**included in** <br>**the balance** <br>**sheet** |
| | **Gross** <br>**amount** <br>**included in** <br>**the balance** <br>**sheet** | **Financial** <br>**instruments**<br>| **Cash** <br>**collateral**<br>| **Securities** <br>**collateral**<br>| **Net amount** <br>**included in** <br>**the balance** <br>**sheet** |
| | **note (i)** | **note (ii)** | | **note (iii)** | **note (iv)** |
| Derivative assets | **611** | **(270)** | **(298)** | **–** | **43** |
| Reverse repurchase agreements | **1579** | **–** | **–** | **(1579)** | **–** |
| **Total financial assets** | **2190** | **(270)** | **(298)** | **(1579)** | **43** |
| Derivative liabilities | **(1566)** | **270** | **559** | **681** | **(56)** |
| Securities lending and repurchase agreements | **(745)** | **–** | **40** | **704** | **(1)** |
| **Total financial liabilities** | **(2311)** | **270** | **599** | **1385** | **(57)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | Gross amount <br>included in the <br>balance sheet | Related amounts not offset in the balance <br>sheet | Related amounts not offset in the balance <br>sheet | Related amounts not offset in the balance <br>sheet | Net amount <br>included in the <br>balance sheet |
| | Gross amount <br>included in the <br>balance sheet | Financial <br>instruments<br>| Cash <br>collateral<br>| Securities <br>collateral<br>| Net amount <br>included in the <br>balance sheet |
| | note (i) | note (ii) | | note (iii) | note (iv) |
| Derivative assets | 376 | (106) | (267) | – | 3 |
| Reverse repurchase agreements | 2868 | – | – | (2868) | – |
| **Total financial assets** | 3244 | (106) | (267) | (2868) | 3 |
| Derivative liabilities | (1597) | 106 | 512 | 927 | (52) |
| Securities lending and repurchase agreements | (272) | – | 43 | 228 | (1) |
| **Total financial liabilities** | (1869) | 106 | 555 | 1155 | (53) |

---

**Notes**

(i)The Group has not offset any of the amounts included in the balance sheet.

(ii)Represents the amount that could be offset under master netting or similar arrangements where the Group does not satisfy the full criteria to offset in the

balance sheet.

(iii)Excludes initial margin amounts for exchange-traded derivatives.

(iv)In the tables above, the amounts of assets or liabilities included in the balance sheet would be offset first by financial instruments that have the right of offset

under master netting or similar arrangements with any remaining amount reduced by the amount of cash and securities collateral. The actual amount of

collateral may be greater than amounts presented in the tables.

**C3 Insurance and reinsurance contracts**

Portfolios of insurance contracts that are assets and those that are liabilities, and portfolios of reinsurance contracts that are

assets and those that are liabilities, are presented separately in the statement of financial position. Any assets or liabilities

recognised for cash flows arising before the recognition of the related group of contracts (including any assets for insurance

acquisition cash flows) are included in the carrying amount of the related portfolios of contracts.

The amounts recorded in the balance sheet as insurance and reinsurance contract asset and liabilities are set out in the table

below (on the left-hand side), broken out into their component parts. Additionally, presented on the right-hand side are the same

amounts but including the Group's share of the relevant amounts of its joint venture and associates, which are equity accounted

for on the statement of financial position and hence all assets and liabilities of those businesses are included in a separate line.

Management believes that the movement in the CSM is a key driver for understanding changes in profitability from period to

period and as the Group's share of the results of the joint ventures and associates are included in the Group's adjusted operating

and total profit, it is relevant to understand the movement in insurance assets and liabilities including those entities too.

Therefore, note C3 comprises:

–Note C3.1, which sets out the components of assets and liabilities as described above.

–Note C3.2, which contains the required IFRS 17 disclosures on how certain insurance and reinsurance contract balances have

moved during the year, including an analysis of the movement of CSM by transition type. These exclude balances of joint

ventures and associate.

–Note C3.3 includes the disclosures in C3.2 which management believes would be helpful to show on a basis that includes the

Group's share of joint ventures and associates, together with a further breakdown of the movement in insurance and

reinsurance contract balances by segment. The difference in most cases between the notes in C3.2 and C3.3 is solely the

addition of the amounts of joint ventures and associate and so no explicit reconciliation has been provided to bridge between

the two.

**C3.1 Group overview**

**Analysis of Group insurance and reinsurance contract assets and liabilities**

The table below provides an analysis of the portfolio of insurance and reinsurance (RI) contract assets and liabilities held on the

Group's statement of financial position.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Excluding JVs and associates $m** | **Excluding JVs and associates $m** | **Excluding JVs and associates $m** | **Excluding JVs and associates $m** | **Excluding JVs and associates $m** | **Excluding JVs and associates $m** | **Including JVs and associates $m** <sup>note (i)</sup> | **Including JVs and associates $m** <sup>note (i)</sup> | **Including JVs and associates $m** <sup>note (i)</sup> | **Including JVs and associates $m** <sup>note (i)</sup> | **Including JVs and associates $m** <sup>note (i)</sup> | **Including JVs and associates $m** <sup>note (i)</sup> |
|  | **(Assets)** | **(Assets)** | **Liabilities** | **Liabilities** | **Net liabilities** <br>**(assets)** | **Net liabilities** <br>**(assets)** | **(Assets)** | **(Assets)** | **Liabilities** | **Liabilities** | **Net liabilities** <br>**(assets)** | **Net liabilities** <br>**(assets)** |
|  | Insurance | RI | Insurance | RI | Insurance | RI | Insurance | RI | Insurance | RI | Insurance | RI |
| | | | | | note (ii) | | | | | | note (ii) | |
| **As at 31 Dec 2025** |  |  |  |  |  |  |  |  |  |  |  |  |
| Best estimate liabilities <br>(BEL)<br>| **(5326)** | **(2575)** | **152016** | **562** | **146690** | **(2013)** | **(5610)** | **(2817)** | **174675** | **618** | **169065** | **(2199)** |
| Risk adjustment for non-<br>financial risk (RA)<br>| **894** | **(171)** | **1906** | **(38)** | **2800** | **(209)** | **909** | **(237)** | **2223** | **(42)** | **3132** | **(279)** |
| Contractual service <br>margin (CSM)<br>| **2664** | **(660)** | **20576** | **116** | **23240** | **(544)** | **2834** | **(510)** | **22584** | **97** | **25418** | **(413)** |
| Insurance contract <br>balances <sup>notes C3.2</sup> <sup>C3.3</sup><br>| **(1768)** | **(3406)** | **174498** | **640** | **172730** | **(2766)** | **(1867)** | **(3564)** | **199482** | **673** | **197615** | **(2891)** |
| Assets for insurance <br>acquisition cash flows<br>| **(48)** | **–** | **–** | **–** | **(48)** | **–** | **(48)** | **–** | **–** | **–** | **(48)** | **–** |
| Insurance and reinsurance <br>contract liabilities (assets)<br>| **(1816)** | **(3406)** | **174498** | **640** | **172682** | **(2766)** | **(1915)** | **(3564)** | **199482** | **673** | **197567** | **(2891)** |
| **As at 31 Dec 2024** |  |  |  |  |  |  |  |  |  |  |  |  |
| Best estimate liabilities <br>(BEL)<br>| (4566) | (2624) | 127942 | 423 | 123376 | (2201) | (4799) | (2783) | 148867 | 461 | 144068 | (2322) |
| Risk adjustment for non-<br>financial risk (RA)<br>| 791 | (99) | 1655 | (44) | 2446 | (143) | 803 | (128) | 1940 | (47) | 2743 | (175) |
| Contractual service <br>margin (CSM)<br>| 2462 | (667) | 17968 | 157 | 20430 | (510) | 2599 | (645) | 19862 | 144 | 22461 | (501) |
| Insurance contract <br>balances <sup>notes C3.2</sup> <sup>C3.3</sup><br>| (1313) | (3390) | 147565 | 536 | 146252 | (2854) | (1397) | (3556) | 170669 | 558 | 169272 | (2998) |
| Assets for insurance <br>acquisition cash flows<br>| (32) | – | 1 | – | (31) | – | (32) | – | 1 | – | (31) | – |
| Insurance and reinsurance <br>contract liabilities (assets)<br>| (1345) | (3390) | 147566 | 536 | 146221 | (2854) | (1429) | (3556) | 170670 | 558 | 169241 | (2998) |

---

**Notes**

(i)The Group's investments in joint ventures and associates are accounted for using the equity method. The Group's share of insurance and reinsurance contract

liabilities and assets as shown above relate to the life business of Mainland China, India and Takaful business in Malaysia.

(ii)At 31 December 2025 and 2024, the Group's exposure to credit risk arising from insurance contracts issued is not material to the Group as premiums

receivable from an individual party (policyholders and intermediaries) is not material to the Group.

**C3.2 Analysis of movements in insurance and reinsurance contract balances (excluding** 

**JVs and associates)**

**(a)Analysis of movements in insurance and reinsurance contract balances by measurement** 

**component**

An analysis of movements in insurance and reinsurance contract balances by measurement component and excluding the Group's

share of insurance and reinsurance contract liabilities and assets relate to the life JVs and associates is set out below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
|  | **Insurance** | **Insurance** | **Insurance** | **Insurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** |
|  | **BEL** | **RA** | **CSM** | **Total** | **BEL** | **RA** | **CSM** | **Total** |
| | | | **note (b)** | | | | **note (b)** | |
| Opening assets | **(4566)** | **791** | **2462** | **(1313)** | **(2624)** | **(99)** | **(667)** | **(3390)** |
| Opening liabilities | **127942** | **1655** | **17968** | **147565** | **423** | **(44)** | **157** | **536** |
| **Net liabilities (assets) at 1 Jan** | **123376** | **2446** | **20430** | **146252** | **(2201)** | **(143)** | **(510)** | **(2854)** |
| ***Changes that relate to future service*** |  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the CSM | **(2038)** | **83** | **1955** | **–** | **89** | **(42)** | **(47)** | **–** |
| Changes in estimates that result in losses or <br>reversal of losses on onerous contracts<br>| **7** | **4** | **–** | **11** | **(11)** | **–** | **–** | **(11)** |
| New contracts in the year | **(2770)** | **309** | **2473** | **12** | **85** | **(16)** | **(71)** | **(2)** |
|  | **(4801)** | **396** | **4428** | **23** | **163** | **(58)** | **(118)** | **(13)** |
| ***Changes that relate to current service*** |  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **–** | **–** | **(2438)** | **(2438)** | **–** | **–** | **102** | **102** |
| Release of risk adjustment to profit <br>or loss<br>| **–** | **(272)** | **–** | **(272)** | **–** | **19** | **–** | **19** |
| Experience adjustments | **(145)** | **–** | **–** | **(145)** | **140** | **–** | **–** | **140** |
|  | **(145)** | **(272)** | **(2438)** | **(2855)** | **140** | **19** | **102** | **261** |
| ***Changes that relate to past service*** |  |  |  |  |  |  |  |  |
| Adjustments to assets and liabilities for <br>incurred claims<br>| **(4)** | **–** | **–** | **(4)** | **(35)** | **(1)** | **–** | **(36)** |
| **Insurance service result** | **(4950)** | **124** | **1990** | **(2836)** | **268** | **(40)** | **(16)** | **212** |
| ***Net finance (income) expense*** |  |  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts <sup>note (i)</sup> | **(4)** | **45** | **296** | **337** | **(114)** | **(7)** | **(30)** | **(151)** |
| Other net finance (income) expense | **14215** | **99** | **(39)** | **14275** | **331** | **(17)** | **(4)** | **310** |
|  | **14211** | **144** | **257** | **14612** | **217** | **(24)** | **(34)** | **159** |
| **Total amount recognised in income** <br>**statement**<br>| **9261** | **268** | **2247** | **11776** | **485** | **(64)** | **(50)** | **371** |
| Effect of movements in exchange rates | **3287** | **86** | **563** | **3936** | **(59)** | **(2)** | **16** | **(45)** |
| **Total amount recognised in comprehensive** <br>**income**<br>| **12548** | **354** | **2810** | **15712** | **426** | **(66)** | **(34)** | **326** |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding commissions <br>paid<br>| **28059** | **–** | **–** | **28059** | **(1403)** | **–** | **–** | **(1403)** |
| Insurance acquisition cash flows | **(5004)** | **–** | **–** | **(5004)** | **–** | **–** | **–** | **–** |
| Claims and other insurance service expenses net <br>of recoveries from reinsurance received <sup>note (ii)</sup><br>| **(12167)** | **–** | **–** | **(12167)** | **1165** | **–** | **–** | **1165** |
| **Total cash flows** | **10888** | **–** | **–** | **10888** | **(238)** | **–** | **–** | **(238)** |
| **Other changes** <sup>note (iii)</sup> | **(122)** | **–** | **–** | **(122)** | **–** | **–** | **–** | **–** |
| Closing assets | **(5326)** | **894** | **2664** | **(1768)** | **(2575)** | **(171)** | **(660)** | **(3406)** |
| Closing liabilities | **152016** | **1906** | **20576** | **174498** | **562** | **(38)** | **116** | **640** |
| **Net liabilities (assets) at 31 Dec** | **146690** | **2800** | **23240** | **172730** | **(2013)** | **(209)** | **(544)** | **(2766)** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates |
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
|  | Insurance | Insurance | Insurance | Insurance | Reinsurance | Reinsurance | Reinsurance | Reinsurance |
| | BEL | RA | CSM | Total | BEL | RA | CSM | Total |
|  |  |  | note (b) |  |  |  | note (b) |  |
| Opening assets | (3952) | 631 | 2173 | (1148) | (1175) | 84 | (1335) | (2426) |
| Opening liabilities | 120115 | 1713 | 18011 | 139839 | 1182 | (21) | (10) | 1151 |
| **Net liabilities (assets) at 1 Jan** | 116163 | 2344 | 20184 | 138691 | 7 | 63 | (1345) | (1275) |
| ***Changes that relate to future service*** |  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the CSM | (178) | 25 | 153 | – | (475) | (216) | 691 | – |
| Changes in estimates that result in losses or <br>reversal of losses on onerous contracts<br>| 100 | 24 | – | 124 | 49 | – | – | 49 |
| New contracts in the year | (2709) | 315 | 2401 | 7 | (10) | (5) | 14 | (1) |
|  | (2787) | 364 | 2554 | 131 | (436) | (221) | 705 | 48 |
| ***Changes that relate to current service*** |  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | – | – | (2286) | (2286) | – | – | 159 | 159 |
| Release of risk adjustment to profit or loss | – | (257) | – | (257) | – | 16 | – | 16 |
| Experience adjustments | (153) | – | – | (153) | 112 | – | – | 112 |
|  | (153) | (257) | (2286) | (2696) | 112 | 16 | 159 | 287 |
| ***Changes that relate to past service*** |  |  |  |  |  |  |  |  |
| Adjustments to assets and liabilities for <br>incurred claims<br>| (34) | 4 | – | (30) | (33) | – | – | (33) |
| **Insurance service result** | (2974) | 111 | 268 | (2595) | (357) | (205) | 864 | 302 |
| ***Net finance (income) expense*** |  |  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts <sup>note (i)</sup> | (24) | 49 | 270 | 295 | (73) | (6) | (30) | (109) |
| Other net finance (income) expense | 3849 | 3 | 7 | 3859 | 435 | 5 | 7 | 447 |
|  | 3825 | 52 | 277 | 4154 | 362 | (1) | (23) | 338 |
| **Total amount recognised in income statement** | 851 | 163 | 545 | 1559 | 5 | (206) | 841 | 640 |
| Effect of movements in exchange rates | (1423) | (41) | (299) | (1763) | 15 | – | (6) | 9 |
| **Total amount recognised in comprehensive** <br>**income**<br>| (572) | 122 | 246 | (204) | 20 | (206) | 835 | 649 |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding commissions paid | 24283 | – | – | 24283 | (2837) | – | – | (2837) |
| Insurance acquisition cash flows | (4798) | – | – | (4798) | – | – | – | – |
| Claims and other insurance service expenses net of <br>recoveries from reinsurance received <sup>note (ii)</sup><br>| (11427) | – | – | (11427) | 612 | – | – | 612 |
| **Total cash flows** | 8058 | – | – | 8058 | (2225) | – | – | (2225) |
| **Other changes** <sup>note (iii)</sup> | (273) | (20) | – | (293) | (3) | – | – | (3) |
| Closing assets | (4566) | 791 | 2462 | (1313) | (2624) | (99) | (667) | (3390) |
| Closing liabilities | 127942 | 1655 | 17968 | 147565 | 423 | (44) | 157 | 536 |
| **Net liabilities (assets) at 31 Dec** | 123376 | 2446 | 20430 | 146252 | (2201) | (143) | (510) | (2854) |

---

**Notes**

(i)Accretion of interest includes interest on policy loans.

(ii)Including investment component.

(iii)Other changes include movements in insurance contract liabilities arising from adjustments to remove the incurred non-cash expenses (such as depreciation

and amortisation) from insurance contract asset and liability balances. In 2024, Other changes also included the net insurance and reinsurance liabilities of

businesses classified as held for sale.

**(b)CSM transition approach**

The table below provides an analysis of CSM by transition approach excluding JVs and associates:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** | **Insurance contracts (excluding JVs and associates)** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | **Contracts** <br>**under MRA**<br>| **Contracts** <br>**under FVA**<br>| **Other** <br>**contracts\***<br>| **Total CSM** | Contracts <br>under MRA<br>| Contracts <br>under FVA<br>| Other <br>contracts\*<br>| Total CSM |
| **Balance at 1 Jan** | **747** | **3271** | **16412** | **20430** | 829 | 3674 | 15681 | 20184 |
| ***Changes that relate to future*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the <br>CSM<br>| **19** | **175** | **1761** | **1955** | (11) | 162 | 2 | 153 |
| New contracts in the year | **–** | **–** | **2473** | **2473** | – | – | 2401 | 2401 |
|  | **19** | **175** | **4234** | **4428** | (11) | 162 | 2403 | 2554 |
| ***Changes that relate to current*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **(109)** | **(375)** | **(1954)** | **(2438)** | (114) | (418) | (1754) | (2286) |
|  | **(90)** | **(200)** | **2280** | **1990** | (125) | (256) | 649 | 268 |
| Net finance (income) expenses from <br>insurance contracts<br>| **27** | **3** | **227** | **257** | 35 | (60) | 302 | 277 |
| Effect of movements in exchange <br>rates<br>| **53** | **98** | **412** | **563** | 8 | (87) | (220) | (299) |
| **Balance at 31 Dec** | **737** | **3172** | **19331** | **23240** | 747 | 3271 | 16412 | 20430 |

---

\*Other contracts represent groups of insurance contracts measured under the full retrospective approach at the transition date, 1 January 2022 and groups of

contracts recognised on or after the transition date.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** | **Reinsurance contracts (excluding JVs and associates)** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | **Contracts** <br>**under MRA**<br>| **Contracts** <br>**under FVA**<br>| **Other** <br>**contracts\***<br>| **Total CSM** | Contracts <br>under MRA<br>| Contracts <br>under FVA<br>| Other <br>contracts\*<br>| Total CSM |
| **Balance at 1 Jan** | **–** | **(27)** | **(483)** | **(510)** | – | (45) | (1300) | (1345) |
| ***Changes that relate to future*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the <br>CSM<br>| **–** | **–** | **(47)** | **(47)** | – | 13 | 678 | 691 |
| New contracts in the year | **–** | **–** | **(71)** | **(71)** | – | – | 14 | 14 |
|  | **–** | **–** | **(118)** | **(118)** | – | 13 | 692 | 705 |
| ***Changes that relate to current*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **–** | **2** | **99** | **102** | – | 5 | 154 | 159 |
|  | **–** | **2** | **(19)** | **(16)** | – | 18 | 846 | 864 |
| Net finance (income) expenses from <br>reinsurance contracts<br>| **–** | **(1)** | **(32)** | **(34)** | – | (1) | (22) | (23) |
| Effect of movements in exchange <br>rates<br>| **–** | **–** | **16** | **16** | – | 1 | (7) | (6) |
| **Balance at 31 Dec** | **–** | **(26)** | **(518)** | **(544)** | – | (27) | (483) | (510) |

---

\*Other contracts represent groups of reinsurance contracts measured under the full retrospective approach at the transition date, 1 January 2022 and groups of

contracts recognised on or after the transition date.

**(c)Analysis of movements in insurance and reinsurance contract balances by remaining** 

**coverage and incurred claims (excluding JVs and associates)**

An analysis of movements in insurance and reinsurance contract balances by remaining coverage and incurred claims and

excluding JVs and associates is set out below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
|  | **Insurance** | **Insurance** | **Insurance** | **Insurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** |
|  | **Liabilities for remaining** <br>**coverage** | **Liabilities for remaining** <br>**coverage** | **Liabilities** <br>**for** <br>**incurred** <br>**claims** |  | **Liabilities for remaining** <br>**coverage** | **Liabilities for remaining** <br>**coverage** | **Liabilities** <br>**for** <br>**incurred** <br>**claims** |  |
|  | **Excluding** <br>**loss** <br>**component**<br>| **Loss** <br>**component**<br>| **Liabilities** <br>**for** <br>**incurred** <br>**claims** | **Total** | **Excluding** <br>**loss-**<br>**recovery** <br>**component**<br>| **Loss-**<br>**recovery** <br>**component**<br>| **Liabilities** <br>**for** <br>**incurred** <br>**claims** | **Total** |
| | | **note (i)** | | | | **note (i)** | | |
| Opening assets | **(1480)** | **38** | **129** | **(1313)** | **(2783)** | **(66)** | **(541)** | **(3390)** |
| Opening liabilities | **144561** | **881** | **2123** | **147565** | **542** | **(20)** | **14** | **536** |
| **Net liabilities (assets) at 1 Jan** | **143081** | **919** | **2252** | **146252** | **(2241)** | **(86)** | **(527)** | **(2854)** |
| **Insurance revenue** |  |  |  |  |  |  |  |  |
| Contracts measured under the <br>modified retrospective approach<br>| **(427)** | **–** | **–** | **(427)** |  |  |  |  |
| Contracts measured under the fair <br>value approach<br>| **(1106)** | **–** | **–** | **(1106)** |  |  |  |  |
| Other contracts <sup>note (ii)</sup> | **(9547)** | **–** | **–** | **(9547)** |  |  |  |  |
|  | **(11080)** | **–** | **–** | **(11080)** |  |  |  |  |
| **Insurance service expense**  |  |  |  |  |  |  |  |  |
| Incurred claims and other directly <br>attributable expenses<br>| **–** | **(65)** | **4855** | **4790** |  |  |  |  |
| Amortisation of insurance <br>acquisition cash flows<br>| **3435** | **–** | **–** | **3435** |  |  |  |  |
| Losses or reversal of losses on <br>onerous contracts<br>| **–** | **23** | **–** | **23** |  |  |  |  |
| Adjustments to liability for incurred <br>claims<br>| **–** | **–** | **(4)** | **(4)** |  |  |  |  |
|  | **3435** | **(42)** | **4851** | **8244** |  |  |  |  |
| **Net (income) expense from** <br>**reinsurance contracts held**<br>|  |  |  |  | **1407** | **(14)** | **(1181)** | **212** |
| **Insurance service result** | **(7645)** | **(42)** | **4851** | **(2836)** | **1407** | **(14)** | **(1181)** | **212** |
| Investment components and <br>premium refunds<br>| **(7799)** | **–** | **7799** | **–** | **(99)** | **–** | **99** | **–** |
| Net finance (income) expenses <br>from insurance and reinsurance <br>contracts<br>| **14526** | **25** | **61** | **14612** | **157** | **1** | **1** | **159** |
| **Total amount recognised in** <br>**income statement**<br>| **(918)** | **(17)** | **12711** | **11776** | **1465** | **(13)** | **(1081)** | **371** |
| Effect of movement in exchange <br>rates<br>| **3866** | **12** | **58** | **3936** | **(42)** | **–** | **(3)** | **(45)** |
| **Total amount recognised in** <br>**comprehensive income**<br>| **2948** | **(5)** | **12769** | **15712** | **1423** | **(13)** | **(1084)** | **326** |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding <br>commissions paid<br>| **28059** | **–** | **–** | **28059** | **(1403)** | **–** | **–** | **(1403)** |
| Insurance acquisition cash flows | **(5004)** | **–** | **–** | **(5004)** | **–** | **–** | **–** | **–** |
| Claims and other insurance service <br>expenses net of recoveries from <br>reinsurance received <sup>note (iii)</sup><br>| **–** | **–** | **(12167)** | **(12167)** | **–** | **–** | **1165** | **1165** |
| **Total cash flows** | **23055** | **–** | **(12167)** | **10888** | **(1403)** | **–** | **1165** | **(238)** |
| **Other changes** <sup>note (iv)</sup> | **(73)** | **–** | **(49)** | **(122)** | **–** | **–** | **–** | **–** |
| Closing assets | **(2020)** | **85** | **167** | **(1768)** | **(2842)** | **(78)** | **(486)** | **(3406)** |
| Closing liabilities | **171031** | **829** | **2638** | **174498** | **621** | **(21)** | **40** | **640** |
| **Net liabilities (assets) at 31 Dec** | **169011** | **914** | **2805** | **172730** | **(2221)** | **(99)** | **(446)** | **(2766)** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates | Excluding JVs and associates |
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
|  | Insurance | Insurance | Insurance | Insurance | Reinsurance | Reinsurance | Reinsurance | Reinsurance |
|  | Liabilities for remaining <br>coverage | Liabilities for remaining <br>coverage | Liabilities <br>for incurred <br>claims |  | Liabilities for remaining <br>coverage | Liabilities for remaining <br>coverage | Liabilities <br>for incurred <br>claims |  |
|  | Excluding <br>loss <br>component<br>| Loss <br>component<br>| Liabilities <br>for incurred <br>claims | Total | Excluding <br>loss-<br>recovery <br>component<br>| Loss-<br>recovery <br>component<br>| Liabilities <br>for incurred <br>claims | Total |
| | | note (i) | | | | note (i) | | |
| Opening assets | (1285) | 20 | 117 | (1148) | (2023) | (119) | (284) | (2426) |
| Opening liabilities | 137019 | 805 | 2015 | 139839 | 1200 | (15) | (34) | 1151 |
| **Net liabilities (assets) at 1 Jan** | 135734 | 825 | 2132 | 138691 | (823) | (134) | (318) | (1275) |
| **Insurance revenue** |  |  |  |  |  |  |  |  |
| Contracts measured under the <br>modified retrospective approach<br>| (415) | – | – | (415) |  |  |  |  |
| Contracts measured under the fair <br>value approach<br>| (1176) | – | – | (1176) |  |  |  |  |
| Other contracts <sup>note (ii)</sup> | (8767) | – | – | (8767) |  |  |  |  |
|  | (10358) | – | – | (10358) |  |  |  |  |
| **Insurance service expense** |  |  |  |  |  |  |  |  |
| Incurred claims and other directly <br>attributable expenses<br>| – | (46) | 4551 | 4505 |  |  |  |  |
| Amortisation of insurance acquisition <br>cash flows<br>| 3157 | – | – | 3157 |  |  |  |  |
| Losses or reversal of losses on <br>onerous contracts<br>| – | 131 | – | 131 |  |  |  |  |
| Adjustments to liability for incurred <br>claims<br>| – | – | (30) | (30) |  |  |  |  |
|  | 3157 | 85 | 4521 | 7763 |  |  |  |  |
| **Net (income) expense from** <br>**reinsurance contracts held**<br>| – | – | – | – | 832 | 48 | (578) | 302 |
| **Insurance service result** | (7201) | 85 | 4521 | (2595) | 832 | 48 | (578) | 302 |
| Investment components and premium <br>refunds<br>| (7008) | – | 7008 | – | 240 | – | (240) | – |
| Net finance (income) expenses from <br>insurance and reinsurance contracts<br>| 4007 | 47 | 100 | 4154 | 338 | – | – | 338 |
| **Total amount recognised in** <br>**income statement**<br>| (10202) | 132 | 11629 | 1559 | 1410 | 48 | (818) | 640 |
| Effect of movement in exchange rates | (1695) | (18) | (50) | (1763) | 12 | 1 | (4) | 9 |
| **Total amount recognised in** <br>**comprehensive income**<br>| (11897) | 114 | 11579 | (204) | 1422 | 49 | (822) | 649 |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding <br>commissions paid<br>| 24283 | – | – | 24283 | (2837) | – | – | (2837) |
| Insurance acquisition cash flows | (4798) | – | – | (4798) | – | – | – | – |
| Claims and other insurance service <br>expenses net of recoveries from <br>reinsurance received <sup>note (iii)</sup><br>| – | – | (11427) | (11427) | – | – | 612 | 612 |
| **Total cash flows** | 19485 | – | (11427) | 8058 | (2837) | – | 612 | (2225) |
| **Other changes** <sup>note (iv)</sup> | (241) | (20) | (32) | (293) | (4) | – | 1 | (3) |
| Closing assets | (1480) | 38 | 129 | (1313) | (2783) | (66) | (541) | (3390) |
| Closing liabilities | 144561 | 881 | 2123 | 147565 | 542 | (20) | 14 | 536 |
| **Net liabilities (assets) at 31 Dec** | 143081 | 919 | 2252 | 146252 | (2241) | (86) | (527) | (2854) |

---

**Notes**

(i)The Group establishes a loss component of the liability for remaining coverage for onerous groups of insurance contracts. The loss component determines the

amounts of fulfilment cash flows that are subsequently presented in profit or loss as reversals of losses on onerous contracts and are excluded from insurance

revenue when they occur.

(ii)Other contracts represent groups of insurance and reinsurance contracts measured under the full retrospective approach at the transition date, 1 January

2022 and groups of contracts recognised on or after the transition date.

(iii)Including investment component.

(iv)Other changes include adjustments to remove the incurred non-cash expenses (such as depreciation and amortisation) from insurance contract asset and

liability balances. In 2024, Other changes also included the net insurance and reinsurance liabilities of businesses classified as held for sale.

**(d)Effect of insurance and reinsurance contracts initially recognised in the year**

The following tables summarise the effect on the measurement components arising from the initial recognition of insurance and

reinsurance contracts in the year, excluding the effect from the Group's share of the amounts relating to life JVs and associates.

**(i)Insurance contracts**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m |
| | **Profitable**<br>**contracts**<br> **issued**<br>| **Onerous** <br>**contracts**<br> **issued**<br>| **Total** | Profitable<br>contracts<br> issued<br>| Onerous <br>contracts<br> issued<br>| Total |
| Estimate of present value of expected future <br>cash outflows:<br>|  |  |  |  |  |  |
| Insurance acquisition cash flows | **5030** | **95** | **5125** | 4493 | 95 | 4588 |
| Claims and other directly attributable <br>expenses<br>| **21314** | **781** | **22095** | 19655 | 592 | 20247 |
|  | **26344** | **876** | **27220** | 24148 | 687 | 24835 |
| Estimate of present value of expected future <br>cash inflows<br>| **(29126)** | **(864)** | **(29990)** | (26861) | (683) | (27544) |
| Risk adjustment for non-financial risk | **309** | **–** | **309** | 312 | 3 | 315 |
| CSM | **2473** | **–** | **2473** | 2401 | – | 2401 |
| **Loss recognised on initial recognition** | **–** | **12** | **12** | – | 7 | 7 |

---

**(ii)Reinsurance contracts**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** | **Excluding JVs and associates** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m |
| | **Contracts** <br>**initiated** <br>**without**<br> **loss-recovery**<br> **component**<br>| **Contracts**<br> **initiated with**<br> **loss-recovery** <br>**component**<br>| **Total** | Contracts<br> initiated<br> without<br> loss-recovery<br> component<br>| Contracts <br>initiated with <br>loss-recovery <br>component<br>| Total |
| Estimate of present value of expected future <br>cash outflows<br>| **1610** | **–** | **1610** | 2329 | – | 2329 |
| Estimate of present value of expected future <br>cash inflows<br>| **(1523)** | **(2)** | **(1525)** | (2338) | (1) | (2339) |
| Risk adjustment for non-financial risk | **(16)** | **–** | **(16)** | (5) | – | (5) |
| CSM | **(71)** | **–** | **(71)** | 14 | – | 14 |
| **Profit recognised on initial recognition** | **–** | **(2)** | **(2)** | – | (1) | (1) |

---

**C3.3 Analysis of movements in insurance and reinsurance contract balances (including** 

**JVs and associates)**

**(a)Analysis of movements in insurance and reinsurance contract balances by measurement** 

**component**

An analysis of movements in insurance and reinsurance contract balances by measurement component, excluding assets for

insurance acquisition cash flows, and including the Group's share of insurance and reinsurance contract assets and liabilities

related to the life JVs and associates is set out below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** | **Including JVs and associates** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
|  | **Insurance** | **Insurance** | **Insurance** | **Insurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** | **Reinsurance** |
|  | **BEL** | **RA** | **CSM** | **Total** | **BEL** | **RA** | **CSM** | **Total** |
| | | | **note (b)** | | | | **note (b)** | |
| Opening assets | **(4799)** | **803** | **2599** | **(1397)** | **(2783)** | **(128)** | **(645)** | **(3556)** |
| Opening liabilities | **148867** | **1940** | **19862** | **170669** | **461** | **(47)** | **144** | **558** |
| **Net liabilities (assets) at 1 Jan** | **144068** | **2743** | **22461** | **169272** | **(2322)** | **(175)** | **(501)** | **(2998)** |
| ***Changes that relate to future service*** |  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the CSM | **(1960)** | **91** | **1869** | **–** | **104** | **(46)** | **(58)** | **–** |
| Changes in estimates that result in losses or <br>reversal of losses on onerous contracts<br>| **14** | **6** | **–** | **20** | **(14)** | **–** | **–** | **(14)** |
| New contracts in the year | **(3084)** | **350** | **2777** | **43** | **(6)** | **(55)** | **58** | **(3)** |
|  | **(5030)** | **447** | **4646** | **63** | **84** | **(101)** | **–** | **(17)** |
| ***Changes that relate to current service*** |  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **–** | **–** | **(2656)** | **(2656)** | **–** | **–** | **102** | **102** |
| Release of risk adjustment to profit or loss | **–** | **(307)** | **–** | **(307)** | **–** | **24** | **–** | **24** |
| Experience adjustments | **(159)** | **–** | **–** | **(159)** | **148** | **–** | **–** | **148** |
|  | **(159)** | **(307)** | **(2656)** | **(3122)** | **148** | **24** | **102** | **274** |
| ***Changes that relate to past service*** |  |  |  |  |  |  |  |  |
| Adjustments to assets and liabilities for <br>incurred claims<br>| **(18)** | **(1)** | **–** | **(19)** | **(27)** | **(1)** | **–** | **(28)** |
| **Insurance service result** | **(5207)** | **139** | **1990** | **(3078)** | **205** | **(78)** | **102** | **229** |
| **Net finance (income) expense** |  |  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts <sup>note (i)</sup> | **212** | **54** | **376** | **642** | **(121)** | **(9)** | **(28)** | **(158)** |
| Other net finance (income) expense | **15204** | **100** | **(39)** | **15265** | **332** | **(17)** | **(4)** | **311** |
|  | **15416** | **154** | **337** | **15907** | **211** | **(26)** | **(32)** | **153** |
| **Total amount recognised in income** <br>**statement** <br>| **10209** | **293** | **2327** | **12829** | **416** | **(104)** | **70** | **382** |
| Effect of movements in exchange rates | **3681** | **96** | **630** | **4407** | **(56)** | **–** | **18** | **(38)** |
| **Total amount recognised in comprehensive** <br>**income**<br>| **13890** | **389** | **2957** | **17236** | **360** | **(104)** | **88** | **344** |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding commissions <br>paid<br>| **32098** | **–** | **–** | **32098** | **(1445)** | **–** | **–** | **(1445)** |
| Insurance acquisition cash flows | **(5524)** | **–** | **–** | **(5524)** | **–** | **–** | **–** | **–** |
| Claims and other insurance service expenses net <br>of recoveries from reinsurance received <sup>note (ii)</sup><br>| **(15345)** | **–** | **–** | **(15345)** | **1208** | **–** | **–** | **1208** |
| **Total cash flows** | **11229** | **–** | **–** | **11229** | **(237)** | **–** | **–** | **(237)** |
| **Other changes** <sup>note (iii)</sup> | **(122)** | **–** | **–** | **(122)** | **–** | **–** | **–** | **–** |
| Closing assets | **(5610)** | **909** | **2834** | **(1867)** | **(2817)** | **(237)** | **(510)** | **(3564)** |
| Closing liabilities | **174675** | **2223** | **22584** | **199482** | **618** | **(42)** | **97** | **673** |
| **Net liabilities (assets) at 31 Dec** | **169065** | **3132** | **25418** | **197615** | **(2199)** | **(279)** | **(413)** | **(2891)** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Including JVs and associates | Including JVs and associates | Including JVs and associates | Including JVs and associates | Including JVs and associates | Including JVs and associates | Including JVs and associates | Including JVs and associates |
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
|  | Insurance | Insurance | Insurance | Insurance | Reinsurance | Reinsurance | Reinsurance | Reinsurance |
|  | BEL | RA | CSM | Total | BEL | RA | CSM | Total |
| | | | note (b) | | | | note (b) | |
| Opening assets | (3998) | 630 | 2176 | (1192) | (1315) | 67 | (1321) | (2569) |
| Opening liabilities | 139673 | 1969 | 20176 | 161818 | 1222 | (24) | (19) | 1179 |
| **Net liabilities (assets) at 1 Jan** | 135675 | 2599 | 22352 | 160626 | (93) | 43 | (1340) | (1390) |
| ***Changes that relate to future service*** |  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the CSM | (57) | 31 | 26 | – | (473) | (225) | 698 | – |
| Changes in estimates that result in losses or <br>reversal of losses on onerous contracts<br>| 128 | 29 | – | 157 | 43 | – | – | 43 |
| New contracts in the year | (2894) | 349 | 2585 | 40 | (4) | (8) | 11 | (1) |
|  | (2823) | 409 | 2611 | 197 | (434) | (233) | 709 | 42 |
| ***Changes that relate to current service*** |  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | – | – | (2511) | (2511) | – | – | 159 | 159 |
| Release of risk adjustment to profit or loss | – | (287) | – | (287) | – | 19 | – | 19 |
| Experience adjustments | (114) | – | – | (114) | 116 | – | – | 116 |
|  | (114) | (287) | (2511) | (2912) | 116 | 19 | 159 | 294 |
| ***Changes that relate to past service*** |  |  |  |  |  |  |  |  |
| Adjustments to assets and liabilities for incurred <br>claims<br>| (73) | 2 | – | (71) | (30) | – | – | (30) |
| **Insurance service result** | (3010) | 124 | 100 | (2786) | (348) | (214) | 868 | 306 |
| **Net finance (income) expense** |  |  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts <sup>note (i)</sup> | 243 | 56 | 350 | 649 | (80) | (7) | (29) | (116) |
| Other net finance (income) expense | 5367 | 28 | 7 | 5402 | 432 | 3 | 8 | 443 |
|  | 5610 | 84 | 357 | 6051 | 352 | (4) | (21) | 327 |
| **Total amount recognised in income statement**  | 2600 | 208 | 457 | 3265 | 4 | (218) | 847 | 633 |
| Effect of movements in exchange rates | (2003) | (44) | (348) | (2395) | 18 | – | (8) | 10 |
| **Total amount recognised in comprehensive** <br>**income**<br>| 597 | 164 | 109 | 870 | 22 | (218) | 839 | 643 |
| **Cash flows** |  |  |  |  |  |  |  |  |
| Premiums received net of ceding commissions paid | 27990 | – | – | 27990 | (2931) | – | – | (2931) |
| Insurance acquisition cash flows | (5226) | – | – | (5226) | – | – | – | – |
| Claims and other insurance service expenses net of <br>recoveries from reinsurance received <sup>note (ii)</sup><br>| (14694) | – | – | (14694) | 683 | – | – | 683 |
| **Total cash flows** | 8070 | – | – | 8070 | (2248) | – | – | (2248) |
| **Other changes** <sup>note (iii)</sup> | (274) | (20) | – | (294) | (3) | – | – | (3) |
| Closing assets | (4799) | 803 | 2599 | (1397) | (2783) | (128) | (645) | (3556) |
| Closing liabilities | 148867 | 1940 | 19862 | 170669 | 461 | (47) | 144 | 558 |
| **Net liabilities (assets) at 31 Dec** | 144068 | 2743 | 22461 | 169272 | (2322) | (175) | (501) | (2998) |

---

**Notes**

(i)Accretion of interest includes interest on policy loans.

(ii)Including investment component.

(iii)Other changes include movements in insurance contract liabilities arising from adjustments to remove the incurred non-cash expenses (such as depreciation

and amortisation) from insurance contract asset and liability balances. In 2024, Other changes also included the net insurance and reinsurance liabilities of

businesses classified as held for sale.

**(b)Analysis of CSM by transition approach including JVs and associates**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** | **Insurance contracts (including JVs and associates)** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | **Contracts** <br>**under MRA**<br>| **Contracts**<br> **under FVA**<br>| **Other**<br>**contracts\***<br>| **Total CSM** | Contracts <br>under MRA<br>| Contracts<br> under FVA<br>| Other<br>contracts\*<br>| Total CSM |
| **Balance at 1 Jan** | **1683** | **3690** | **17088** | **22461** | 1922 | 4143 | 16287 | 22352 |
| ***Changes that relate to future*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Changes in estimates that adjust <br>the CSM<br>| **(8)** | **208** | **1669** | **1869** | (81) | 131 | (24) | 26 |
| New contracts in the year | **–** | **–** | **2777** | **2777** | – | – | 2585 | 2585 |
|  | **(8)** | **208** | **4446** | **4646** | (81) | 131 | 2561 | 2611 |
| ***Changes that relate to current*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **(196)** | **(400)** | **(2060)** | **(2656)** | (209) | (442) | (1860) | (2511) |
|  | **(204)** | **(192)** | **2386** | **1990** | (290) | (311) | 701 | 100 |
| Net finance (income) expenses from <br>insurance contracts<br>| **62** | **10** | **265** | **337** | 73 | (53) | 337 | 357 |
| Effect of movements in exchange <br>rates<br>| **93** | **123** | **414** | **630** | (22) | (89) | (237) | (348) |
| **Balance at 31 Dec** | **1634** | **3631** | **20153** | **25418** | 1683 | 3690 | 17088 | 22461 |

---

\*Other contracts represent groups of insurance contracts measured under the full retrospective approach at the transition date, 1 January 2022, and groups of

contracts recognised on or after the transition date.

The majority of the CSM on transition on insurance contracts under MRA arises from the Mainland China joint venture, while the

majority of the CSM on transition under FVA arises from the Hong Kong and Singapore businesses.

The transition approach adopted by the Group's main business segments for the different cohorts of their insurance contracts is

summarised in the table below. The overlap between approaches reflects the fact that the approaches used vary by insurance

contract portfolio and year of issue (cohort).

---

| | | | |
|:---|:---|:---|:---|
| | FRA<br>Cohort  | MRA<br>Cohort | FVA<br>Cohort  |
| Mainland China | n/a | 2016 – 2021 | Pre-2016 |
| Hong Kong | 2010 – 2021  | n/a | Pre-2010 |
| Singapore | 2009 – 2021  | n/a | Pre-2009 |
| Malaysia | 2010 – 2021 <br>(Unit-linked)<br>2010 – 2021 <br>(Non-<br>participating) <br>| 2000 – 2009<br>(Unit-linked)<br>| Pre-1999<br>(Unit-linked)<br>Pre-2009<br>(Non-<br>participating)<br>Pre-2021<br>(Other)<br>|
| Indonesia <sup>note (i)</sup> | 2010 – 2021  | 2007 – 2009 | Pre-2007 |
| Growth markets and other | See note (ii) | See note (ii) | See note (ii)  |

---

**Notes**

(i)The cohorts shown are in respect of Indonesia's unit-linked portfolios.

(ii)CSM on transition for Growth markets primarily arises from Vietnam, Taiwan and the Philippines. Vietnam has applied the FRA for cohorts from 2013 - 2021

(all businesses), MRA for cohorts from 2008 - 2012 (Participating only) and FVA for cohorts prior to 2008 (Participating) and prior to 2013 (Non-

participating). Taiwan and the Philippines have applied the FRA for cohorts from 2010 – 2021 and FVA for all cohorts prior to 2010.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** | **Reinsurance contracts (including JVs and associates)** |
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | **Contracts** <br>**under MRA**<br>| **Contracts**<br> **under FVA**<br>| **Other**<br>**contracts\***<br>| **Total CSM** | Contracts <br>under MRA<br>| Contracts<br> under FVA<br>| Other<br>contracts\*<br>| Total CSM |
| **Balance at 1 Jan**  | **–** | **(49)** | **(452)** | **(501)** | – | (63) | (1277) | (1340) |
| ***Changes that relate to future*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Changes in estimates that adjust the <br>CSM<br>| **–** | **(1)** | **(57)** | **(58)** | – | 8 | 690 | 698 |
| New contracts in the year | **–** | **–** | **58** | **58** | – | – | 11 | 11 |
|  | **–** | **(1)** | **1** | **–** | – | 8 | 701 | 709 |
| ***Changes that relate to current*** <br>***service***<br>|  |  |  |  |  |  |  |  |
| Release of CSM to profit or loss | **–** | **4** | **98** | **102** | – | 7 | 152 | 159 |
|  | **–** | **3** | **99** | **102** | – | 15 | 853 | 868 |
| Net finance (income) expenses from <br>reinsurance contracts<br>| **–** | **(2)** | **(30)** | **(32)** | – | (2) | (19) | (21) |
| Effect of movements in exchange <br>rates<br>| **–** | **(1)** | **19** | **18** | – | 1 | (9) | (8) |
| **Balance at 31 Dec** | **–** | **(49)** | **(364)** | **(413)** | – | (49) | (452) | (501) |

---

\*Other contracts represent groups of reinsurance contracts measured under the full retrospective approach at the transition date, 1 January 2022, and groups of

contracts recognised on or after the transition date.

The CSM on transition on reinsurance contracts held primarily arises from the Hong Kong segment, which has predominantly

applied the FRA to transition reinsurance cohorts from 2010 – 2021 and the FVA for reinsurance cohorts prior to 2010.

**(c)Additional analysis of insurance and reinsurance contract balances by segment**

The table below provides an analysis of portfolio of insurance and reinsurance contract balances, excluding assets for insurance

acquisition cash flows, by segment. The balances presented include the Group's share of insurance contract balances relating to

the life business of Mainland China, India and Takaful business in Malaysia, which are accounted for on an equity method in the

Consolidated statement of financial position.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** |
|  | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) | Liabilities (assets) |
| | **BEL** | **RA** | **CSM** | **Total** | **BEL** | **RA** | **CSM** | **Total** |
| **As at 31 Dec 2025** |  |  |  |  |  |  |  |  |
| Mainland China | **15709** | **184** | **1603** | **17496** | **(85)** | **(39)** | **108** | **(16)** |
| Hong Kong | **73749** | **836** | **10657** | **85242** | **(977)** | **(142)** | **(792)** | **(1911)** |
| Indonesia | **1805** | **157** | **691** | **2653** | **3** | **(9)** | **1** | **(5)** |
| Malaysia | **8328** | **515** | **2330** | **11173** | **10** | **(14)** | **19** | **15** |
| Singapore | **42039** | **952** | **5558** | **48549** | **(1212)** | **(17)** | **284** | **(945)** |
| Growth markets and other | **27435** | **488** | **4579** | **32502** | **62** | **(58)** | **(33)** | **(29)** |
| Total insurance segments | **169065** | **3132** | **25418** | **197615** | **(2199)** | **(279)** | **(413)** | **(2891)** |
| **As at 31 Dec 2024** |  |  |  |  |  |  |  |  |
| Mainland China | 14033 | 168 | 1484 | 15685 | 3 | (3) | (22) | (22) |
| Hong Kong | 63056 | 698 | 8840 | 72594 | (1220) | (84) | (738) | (2042) |
| Indonesia | 1839 | 189 | 622 | 2650 | 11 | (8) | 12 | 15 |
| Malaysia | 7032 | 418 | 2135 | 9585 | 15 | (12) | 14 | 17 |
| Singapore | 34235 | 815 | 5160 | 40210 | (1169) | (15) | 267 | (917) |
| Growth markets and other | 23873 | 455 | 4220 | 28548 | 38 | (53) | (34) | (49) |
| Total insurance segments | 144068 | 2743 | 22461 | 169272 | (2322) | (175) | (501) | (2998) |

---

**Summarised movement analysis of insurance and reinsurance contract balances by segment** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Insurance $m** | **Insurance $m** |
| | **Mainland** <br>**China**<br>| **Hong** <br>**Kong**<br>| **Indonesia** | **Malaysia** | **Singapore** | **Growth** <br>**markets** <br>**and other**<br>| **Total** <br>**insurance** <br>**segments**<br>|
| **Net liabilities (assets) at 1 Jan 2024** | 14833 | 70073 | 3142 | 8394 | 37419 | 26765 | 160626 |
| **Insurance service result** | (104) | (971) | (213) | (290) | (683) | (525) | (2786) |
| **Net finance (income) expenses from insurance** <br>**contracts**<br>|  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts | 286 | 2 | 48 | 94 | 7 | 212 | 649 |
| Other net finance expense | 811 | (1792) | 54 | 857 | 3672 | 1800 | 5402 |
|  | 1097 | (1790) | 102 | 951 | 3679 | 2012 | 6051 |
| **Total amount recognised in income statement** | 993 | (2761) | (111) | 661 | 2996 | 1487 | 3265 |
| Effect of movements in exchange rates | (439) | 376 | (134) | 252 | (1321) | (1129) | (2395) |
| **Total amount recognised in comprehensive income** | 554 | (2385) | (245) | 913 | 1675 | 358 | 870 |
| Total cash flows | 298 | 4907 | (245) | 279 | 1170 | 1661 | 8070 |
| Other changes | – | (1) | (2) | (1) | (54) | (236) | (294) |
| **Net liabilities (assets) at 31 Dec 2024/1 Jan 2025** | **15685** | **72594** | **2650** | **9585** | **40210** | **28548** | **169272** |
| **Insurance service result** | **(117)** | **(1148)** | **(188)** | **(308)** | **(688)** | **(629)** | **(3078)** |
| **Net finance (income) expenses from insurance** <br>**contracts**<br>|  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts | **224** | **(24)** | **42** | **112** | **36** | **252** | **642** |
| Other net finance (income) expense | **508** | **8207** | **247** | **375** | **4277** | **1651** | **15265** |
|  | **732** | **8183** | **289** | **487** | **4313** | **1903** | **15907** |
| **Total amount recognised in income statement** | **615** | **7035** | **101** | **179** | **3625** | **1274** | **12829** |
| Effect of movements in exchange rates | **730** | **(122)** | **(92)** | **1011** | **2536** | **344** | **4407** |
| **Total amount recognised in comprehensive income** | **1345** | **6913** | **9** | **1190** | **6161** | **1618** | **17236** |
| Total cash flows | **466** | **5736** | **(6)** | **397** | **2232** | **2404** | **11229** |
| Other changes | **–** | **(1)** | **–** | **1** | **(54)** | **(68)** | **(122)** |
| **Net liabilities (assets) at 31 Dec 2025** | **17496** | **85242** | **2653** | **11173** | **48549** | **32502** | **197615** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** | **Reinsurance $m** |
| | **Mainland** <br>**China**<br>| **Hong** <br>**Kong**<br>| **Indonesia** | **Malaysia** | **Singapore** | **Growth** <br>**markets** <br>**and other**<br>| **Total** <br>**insurance** <br>**segments**<br>|
| **Net liabilities (assets) at 1 Jan 2024** | (21) | (1389) | 9 | 25 | 6 | (20) | (1390) |
| **Insurance service result** | 5 | 279 | 8 | 12 | (11) | 13 | 306 |
| **Net finance (income) expenses from reinsurance** <br>**contracts**<br>|  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts | (1) | (79) | – | 1 | (32) | (5) | (116) |
| Other net finance (income) expense | 1 | 472 | (1) | – | (23) | (6) | 443 |
|  | – | 393 | (1) | 1 | (55) | (11) | 327 |
| **Total amount recognised in income statement** | 5 | 672 | 7 | 13 | (66) | 2 | 633 |
| Effect of movements in exchange rates | 2 | (11) | (1) | 1 | 18 | 1 | 10 |
| **Total amount recognised in comprehensive income** | 7 | 661 | 6 | 14 | (48) | 3 | 643 |
| Total cash flows | (8) | (1314) | – | (22) | (875) | (29) | (2248) |
| Other changes | – | – | – | – | – | (3) | (3) |
| **Net liabilities (assets) at 31 Dec 2024/1 Jan 2025** | **(22)** | **(2042)** | **15** | **17** | **(917)** | **(49)** | **(2998)** |
| **Insurance service result** | **7** | **182** | **7** | **4** | **(2)** | **31** | **229** |
| **Net finance (income) expenses from reinsurance** <br>**contracts**<br>|  |  |  |  |  |  |  |
| Accretion of interest on GMM contracts | **(1)** | **(99)** | **1** | **2** | **(55)** | **(6)** | **(158)** |
| Other net finance (income) expense | **1** | **259** | **(6)** | **–** | **47** | **10** | **311** |
|  | **–** | **160** | **(5)** | **2** | **(8)** | **4** | **153** |
| **Total amount recognised in income statement** | **7** | **342** | **2** | **6** | **(10)** | **35** | **382** |
| Effect of movements in exchange rates | **(1)** | **5** | **–** | **–** | **(53)** | **11** | **(38)** |
| **Total amount recognised in comprehensive income** | **6** | **347** | **2** | **6** | **(63)** | **46** | **344** |
| Total cash flows | **–** | **(216)** | **(23)** | **(8)** | **35** | **(25)** | **(237)** |
| Other changes | **–** | **–** | **1** | **–** | **–** | **(1)** | **–** |
| **Net liabilities (assets) at 31 Dec 2025** | **(16)** | **(1911)** | **(5)** | **15** | **(945)** | **(29)** | **(2891)** |

---

**(d)Contractual service margin** 

The following tables illustrate when the Group expects to recognise the remaining CSM in profit or loss after the reporting date

based on the assumptions and economics in place at the year ends shown. Future new business is excluded.

**(i)Insurance contracts – expected recognition of the CSM**

---

| | | | |
|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
| | **Total as reported on the** <br>**consolidated statement of** <br>**financial position**<br>| **Group's share relating to**<br>**JVs and associates**<br>| **Total including Group's** <br>**share relating to**<br>**JVs and associates**<br>|
| 1 year or less | **2295** | **213** | **2508** |
| After 1 year to 2 years | **2040** | **185** | **2225** |
| After 2 years to 3 years | **1835** | **160** | **1995** |
| After 3 years to 4 years | **1634** | **140** | **1774** |
| After 4 years to 5 years | **1471** | **124** | **1595** |
| After 5 years to 10 years | **5261** | **444** | **5705** |
| After 10 years to 15 years | **3424** | **303** | **3727** |
| After 15 years to 20 years | **2091** | **211** | **2302** |
| After 20 years | **3189** | **398** | **3587** |
| **Total insurance CSM** | **23240** | **2178** | **25418** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | Total as reported on the <br>consolidated statement of <br>financial position<br>| Group's share relating to<br>JVs and associates<br>| Total including Group's share <br>relating to<br>JVs and associates<br>|
| 1 year or less | 2092 | 214 | 2306 |
| After 1 year to 2 years | 1863 | 181 | 2044 |
| After 2 years to 3 years | 1666 | 156 | 1822 |
| After 3 years to 4 years | 1495 | 136 | 1631 |
| After 4 years to 5 years | 1323 | 119 | 1442 |
| After 5 years to 10 years | 4653 | 436 | 5089 |
| After 10 years to 15 years | 2988 | 278 | 3266 |
| After 15 years to 20 years | 1777 | 187 | 1964 |
| After 20 years | 2573 | 324 | 2897 |
| **Total insurance CSM** | 20430 | 2031 | 22461 |

---

**(ii)Reinsurance contracts – expected recognition of the CSM**

---

| | | | |
|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
| | **Total as reported on the** <br>**consolidated statement** <br>**of financial position**<br>| **Group's share relating to**<br>**JVs and associates**<br>| **Total including Group's** <br>**share relating to**<br>**JVs and associates**<br>|
| 1 year or less | **(65)** | **7** | **(58)** |
| After 1 year to 2 years | **(56)** | **7** | **(49)** |
| After 2 years to 3 years | **(50)** | **6** | **(44)** |
| After 3 years to 4 years | **(47)** | **6** | **(41)** |
| After 4 years to 5 years | **(43)** | **6** | **(37)** |
| After 5 years to 10 years | **(128)** | **23** | **(105)** |
| After 10 years to 15 years | **(58)** | **16** | **(42)** |
| After 15 years to 20 years | **(36)** | **20** | **(16)** |
| After 20 years | **(61)** | **40** | **(21)** |
| **Total reinsurance CSM** | **(544)** | **131** | **(413)** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | Total as reported on the <br>consolidated statement of <br>financial position<br>| Group's share relating to<br>JVs and associates<br>| Total including Group's <br>share relating to<br>JVs and associates<br>|
| 1 year or less | (55) | (4) | (59) |
| After 1 year to 2 years | (48) | 2 | (46) |
| After 2 years to 3 years | (45) | 2 | (43) |
| After 3 years to 4 years | (40) | 2 | (38) |
| After 4 years to 5 years | (37) | 1 | (36) |
| After 5 years to 10 years | (125) | 5 | (120) |
| After 10 years to 15 years | (64) | 2 | (62) |
| After 15 years to 20 years | (36) | 1 | (35) |
| After 20 years | (60) | (2) | (62) |
| **Total reinsurance CSM** | (510) | 9 | (501) |

---

**(e)Maturity analysis of the future cash flows of insurance and reinsurance contract** 

**liabilities** 

The following table shows the maturity profile of the expected future cash flows on a discounted basis (as included in the BEL)

relating to insurance and reinsurance contract liabilities, respectively. The amounts in the table below include the expected

amounts payable on demand at a timing of when they are expected to occur over the outstanding duration of the existing

business. At 31 December 2025, the amounts payable on demand from insurance contracts, excluding JVs and associates, are

$136,648 million (31 December 2024: $123,724 million).

**(i)Insurance contract liabilities – expected cash flows (discounted)**

---

| | | | |
|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
|  | **Total as reported on the** <br>**consolidated statement** <br>**of financial position**<br>| **Group's share relating to**<br>**JVs and associates**<br>| **Total including Group's** <br>**share relating to**<br>**JVs and associates**<br>|
| 1 year or less | **(1134)** | **(92)** | **(1226)** |
| After 1 year to 2 years | **(918)** | **509** | **(409)** |
| After 2 years to 3 years | **2096** | **454** | **2550** |
| After 3 years to 4 years | **4286** | **495** | **4781** |
| After 4 years to 5 years | **6279** | **483** | **6762** |
| After 5 years to 10 years | **29121** | **2746** | **31867** |
| After 10 years to 15 years | **27742** | **2832** | **30574** |
| After 15 years to 20 years | **21275** | **2656** | **23931** |
| After 20 years\* | **63269** | **12576** | **75845** |
| **Total expected future cash flows from insurance** <br>**contract liabilities**<br>| **152016** | **22659** | **174675** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
|  | Total as reported on the <br>consolidated statement of <br>financial position<br>| Group's share relating to<br>JVs and associates<br>| Total including Group's <br>share relating to<br>JVs and associates<br>|
| 1 year or less | (2317) | (178) | (2495) |
| After 1 year to 2 years | (910) | 439 | (471) |
| After 2 years to 3 years | 1140 | 943 | 2083 |
| After 3 years to 4 years | 3351 | 683 | 4034 |
| After 4 years to 5 years | 4707 | 772 | 5479 |
| After 5 years to 10 years | 22466 | 2734 | 25200 |
| After 10 years to 15 years | 21715 | 2686 | 24401 |
| After 15 years to 20 years | 18396 | 2159 | 20555 |
| After 20 years\* | 59394 | 10687 | 70081 |
| **Total expected future cash flows from insurance** <br>**contract liabilities**<br>| 127942 | 20925 | 148867 |

---

\*Including items that have no stated maturity.

**(ii)Reinsurance contract liabilities – expected cash flows (discounted)**

---

| | | | |
|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** |
|  | **Total as reported on the** <br>**consolidated statement** <br>**of financial position**<br>| **Group's share relating to**<br>**JVs and associates**<br>| **Total including Group's** <br>**share relating to**<br>**JVs and associates**<br>|
| 1 year or less | **103** | **18** | **121** |
| After 1 year to 2 years | **104** | **(1)** | **103** |
| After 2 years to 3 years | **60** | **(1)** | **59** |
| After 3 years to 4 years | **51** | **–** | **51** |
| After 4 years to 5 years | **45** | **–** | **45** |
| After 5 years to 10 years | **111** | **(1)** | **110** |
| After 10 years to 15 years | **14** | **1** | **15** |
| After 15 years to 20 years | **(8)** | **4** | **(4)** |
| After 20 years | **82** | **36** | **118** |
| **Total expected future cash flows from reinsurance** <br>**contract liabilities**<br>| **562** | **56** | **618** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
|  | Total as reported on the <br>consolidated statement of <br>financial position<br>| Group's share relating to<br>JVs and associates<br>| Total including Group's <br>share relating to<br>JVs and associates<br>|
| 1 year or less | 136 | 11 | 147 |
| After 1 year to 2 years | 68 | (1) | 67 |
| After 2 years to 3 years | 30 | (1) | 29 |
| After 3 years to 4 years | 4 | (1) | 3 |
| After 4 years to 5 years | 4 | (1) | 3 |
| After 5 years to 10 years | 20 | (1) | 19 |
| After 10 years to 15 years | 8 | 1 | 9 |
| After 15 years to 20 years | (6) | 3 | (3) |
| After 20 years | 159 | 28 | 187 |
| **Total expected future cash flows from reinsurance** <br>**contract liabilities**<br>| 423 | 38 | 461 |

---

**C3.4 Products and determining contract liabilities**

**(a)Approach to transition to IFRS 17**

Transition refers to the determination of the opening balance sheet for the first year of comparative information presented under

IFRS 17 (ie at 1 January 2022). The future cash flows and risk adjustment are measured on a current basis in the same manner

as they would be calculated for subsequent measurement. The key component of transition is therefore the determination of the

CSM.

The standard requires IFRS 17 to be applied retrospectively (the 'Full Retrospective Approach') unless impracticable. If a fully

retrospective approach is impracticable there is an option to choose either a Modified Retrospective Approach or a Fair Value

Approach. Prudential has adopted the Modified Retrospective Approach for cohorts of business for which expected cash flows at

the date of initial recognition are not available but where actual historical cash flows are available. If reasonable and supportable

information necessary to apply the modified retrospective approach is not available, the fair value approach must be applied.

The CSM of the groups of insurance contracts transitioned under retrospective approaches (ie full retrospective approach and

modified retrospective approach) has been calculated as if the Group had only prepared annual financial statements before the

transition date (ie transition CSM has been measured using a year-to-date approach).

**Full retrospective approach (FRA)**

Under the FRA, each group of insurance contracts has been identified, recognised and measured as if IFRS 17 had always applied.

The CSM was calculated at initial recognition of a group of contracts based on the facts and circumstances at that time (ie without

use of hindsight). This CSM was then rolled forward to the transition date in line with the requirements of the standard.

**Modified retrospective approach (MRA)** 

The objective of the MRA is to achieve the closest possible outcome to retrospective application using reasonable and supportable

information without undue cost and effort. A number of specific modifications are permitted under the MRA. The Group has

adopted the following modifications:

–To use information at the transition date to identify insurance contract groups;

–To use information at the transition date to assess eligibility for the variable fee approach; and

–To use information at the transition date to identify discretionary cash flows.

**General measurement model (GMM)**

Under the MRA for GMM business, the cash flows at the date of initial recognition of a group of insurance contracts have been

estimated as the cash flows at the earliest available date (ie the first year when the FRA is practicable, referred to as the 'earlier

date'), adjusted by the cash flows that are known to have occurred between these two dates. A number of further specific

modifications are permitted. The Group has adopted the following modifications:

–To estimate the risk adjustment at the date of initial recognition as the risk adjustment at the earlier date adjusted by the

expected release of risk before that date based on the risk adjustment release pattern for similar contracts;

–To estimate CSM amortisation in line with run-off of the coverage units; and

–If there is a loss component at initial recognition, to estimate the amount allocated to the loss component before the transition

date using a systematic allocation consistent with the modifications adopted above.

Discount rates at the date of initial recognition were determined using observable market data at that date.

**Variable fee approach (VFA)**

Under the MRA for VFA business, the CSM at the transition date for a group of insurance contracts has been determined as:

–The total fair value of the underlying items at that date; minus

–The fulfilment cash flows at that date; plus or minus

–An adjustment for:

–Amounts charged to policyholders before that date;

–Amounts paid before that date not varying with underlying items;

–The change in the risk adjustment caused by the release from risk before that date; and minus

–An estimate of the amounts that would have been recognised in profit or loss for services provided before the transition date by

comparing the remaining coverage units at the transition date with the coverage units provided under the group of contracts

before the transition date.

In implementing this approach, the amounts charged to policyholders, the amounts paid not varying with underlying items and

coverage units have been adjusted for the time value of money.

**Fair value approach (FVA)**

The insurance contracts of the Group under the FVA generally represent groups of contracts that were written many years ago

where suitable historical information required to apply the retrospective transition approaches is no longer practicably available.

Under the FVA, the CSM at the transition date is the difference between the fair value of the insurance contracts, determined in

accordance with IFRS 13 Fair Value Measurement, and the fulfilment cash flows at that date.

IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction

between market participants at the measurement date. The fair value of groups of insurance contracts has therefore been

interpreted as the compensation that a market participant would require for taking on the relevant obligation under the contracts.

The fair value has been determined using a cost of capital approach by reference to a quantum of capital required to be held in

order to fulfil the contracts and a required return on that capital. Expected cash flows and the required locked-in capital are

projected forward over the duration of the groups of contracts and discounted at the required rate of return. These calculations are

based on the following key assumptions:

–The expected cash flows reflect the future cost that a market participant would expect to incur in fulfilling the obligations under

the contracts. The fair value has been based on the same scope of cash flows as are included in the calculation of the best

estimate liability. In particular, the same contract boundaries are assumed in the calculation of the fair value and best estimate

liability. However, the measurement of those cash flows need not be the same.

–The required locked-in capital is the level of capital realistically required for a business to operate in the relevant jurisdiction.

–The required rate of return is compensation the Group would expect a market participant to require to enter into a transaction

to transfer the liability associated with the insurance contracts at the transition date. This return has been determined using the

capital asset pricing model, including allowance for both financial risk and uncertainty in non-financial risk.

A number of specific modifications are permitted under the FVA. The Group has adopted the following modifications:

–To use information at the transition date to identify groups of insurance contracts;

–To use information at the transition date to assess eligibility for the VFA;

–To use information at the transition date to identify discretionary cash flows;

–To use information at the transition date to assess whether a contract meets the definition of an investment contract with DPF;

and

–To group annual cohorts of business.

**(b)Measurement of insurance and reinsurance contracts**

**Level of aggregation and initial recognition** 

Insurance contracts are aggregated into groups for measurement purposes. Groups of insurance contracts are determined by

identifying portfolios of insurance contracts, each comprising contracts subject to similar risks and managed together, and dividing

each portfolio into annual cohorts (ie by year of issue) and each annual cohort into groups based on the profitability of contracts.

Portfolios of reinsurance contracts held are assessed for aggregation separately from portfolios of insurance contracts issued.

When determining 'similar risks' the Group does not divide risks within a contract, eg riders sold under a single contract would not

be split by risk type. The Group have therefore identified three broad categories of risks referred to as 'dominant' risks, namely,

protection, investment and to a less material extent longevity. The requirement 'managed together' is assessed within the

geographical boundary of each local business unit. Each ring-fenced fund is considered to be managed separately.

Under IFRS 17 groups of contracts are measured on initial recognition as the total of:

–Fulfilment cash flows, comprising the best estimate of the present value of future cash flows within the contract boundary that

are expected to arise and an explicit risk adjustment for non-financial risk; and

–A CSM that represents the deferral of any day-one gains arising on initial recognition.

Day-one losses, any subsequent losses on onerous contracts and reversal of those losses arising from groups of insurance

contracts are recognised directly in the income statement. For groups of reinsurance contracts held, any net gains or losses at

initial recognition are recognised as CSM unless the net cost of purchasing reinsurance relates to past events, in which case such

net cost is recognised immediately in the income statement.

**Separating components** 

A contract has an investment component if there is an amount (which could be zero) that the contract requires the entity to repay

to the policyholder in all circumstances that have commercial substance. The surrender value, net of policy loans (where these

exist), is accounted as the investment component of a contract. Participating and non-participating (such as whole-life and

endowment) contracts have explicit surrender values. There are a relatively small number of products that do not have a

surrender value, and the investment components of these contracts are determined on a case-by-case basis. The non-distinct

investment components are excluded from insurance revenue and insurance service expenses.

At initial recognition, the Group is required to separate the following components and account for them as if they were stand-alone

contracts.

–Distinct investment components. An investment component is distinct if and only if (a) the insurance and investment

components are not highly interrelated and (b) a contract with equivalent terms is, or could be, sold separately in the same

market or jurisdiction.

–Embedded derivatives that do not meet the definition of an insurance contract and whose economic characteristics and risks are

not closely related to those of the host contract.

–Distinct services other than insurance contract services. A service component is distinct if it is not highly interrelated with the

insurance component and the entity provides no significant service in integrating the service component with the insurance

component.

There are no material instances within the Group where distinct investment components, distinct services or embedded derivatives

are separated from insurance contracts.

Asset management services for investments held under an insurance contract are not separated.

**Subsequent measurement of CSM**

Under IFRS 17 insurance contracts are measured under the GMM, VFA or PAA. The Group predominantly uses the VFA and GMM,

depending on the specific characteristics of the insurance contracts. The Group makes very limited use of the PAA for some small

portfolios of short duration contracts. Reinsurance contracts held are measured under the GMM.

The CSM calculated under the VFA relates to the Group's with-profits and shareholder-backed participating products and unit-

linked products with a low proportion of protection riders. The CSM calculated under the GMM includes the Group's non-profit

protection products and unit-linked products with a high proportion of protection riders.

The CSM of each group of contracts is calculated at each reporting date as follows.

The carrying amount of the CSM of contracts measured under the GMM at each reporting date is the carrying amount at the start

of the year, adjusted for: (a) the CSM of any new contracts that are added to the group in the year; (b) interest accreted at

locked-in discount rate; (c) changes in fulfilment cash flows arising from operating assumption changes and variances that relate

to future services except for those relating to onerous contracts; (d) the effect of currency exchange differences on the CSM; and

(e) the amount of CSM recognised in profit or loss in the year based on the coverage units.

The carrying amount of the CSM of contracts measured under the VFA at each reporting date is the carrying amount at the start of

the year, adjusted for: (a) the CSM of any new contracts that are added to the group in the year; (b) the change in the amount of

the Group's share of the fair value of the underlying items; (c) changes in fulfilment cash flows arising from both operating and

economic assumption changes and variances that relate to future services except for those relating to onerous contracts; (d) the

effect of currency exchange differences on the CSM; and (e) the amount of CSM recognised in profit or loss in the year based on

the coverage units.

The table below provides a description of the material features of each of the key products written by the Group, together with the

measurement model used to determine their contract liabilities under IFRS 17.

---

| | | |
|:---|:---|:---|
| Contract type | Description and material features | Measurement model |
| **With-profits** <br>**contracts** <br>**(written in** <br>**Hong Kong,** <br>**Singapore and** <br>**Malaysia)**<br>| Provides savings and/or protection where the basic <br>sum assured can be enhanced by a profit share (or <br>bonus) from the underlying fund as determined at <br>the discretion of the local business unit.<br>With-profits products often offer a guaranteed <br>maturity or surrender value. Declared regular <br>bonuses are guaranteed once vested. Future bonus <br>rates and cash dividends are not guaranteed. Market <br>value adjustments and surrender charges are used <br>for certain products where the law permits such <br>adjustments. Guarantees are predominantly <br>supported by the segregated funds and their estates.<br>Additional health and protection benefits can be <br>provided through riders (which are not separated <br>from the base with-profits contracts).<br>| All with-profits contracts of the Group written in Hong <br>Kong, Singapore and Malaysia are measured using the <br>VFA model.<br>The shareholders' share of the excess of the assets of <br>the with-profits funds over policyholder liabilities is <br>recognised within shareholders' equity.<br>|
| **Other** <br>**participating** <br>**contracts**<br>| Similar to the with-profits contracts, other <br>participating contracts include savings and/or <br>protection elements, with policyholders and <br>shareholders sharing in the returns of the underlying <br>funds. <br>| Other participating contracts of the Group are <br>measured under the VFA model except for the contracts <br>without distinct segregated funds written by the <br>Group's life joint venture in Mainland China, where the <br>GMM approach is applied. <br>|
| **Unit-linked** <br>**contracts**<br>| Combines savings with health and protection riders <br>(which, under IFRS 17, are not separated from the <br>base contract). The cash value of the policy primarily <br>depends on the value of the underlying unitised <br>funds.<br>| Unit-linked contracts are measured either under the <br>VFA or the GMM depending on the relative size of the <br>savings and protection benefits of the contract. The <br>larger the protection component the more likely the <br>contract is required to be measured under the GMM. <br>|
| **Health and** <br>**protection –** <br>**Shareholder-** <br>**backed** <br>**participating** <br>**critical illness** <br>**contracts**<br>| Shareholder-backed participating critical illness <br>contracts are written by the Group's Hong Kong <br>business. These products combine critical illness and <br>death benefits with a savings element. These are <br>whole life products and have regular premium <br>payments with a limited payment term.<br>| Shareholder-backed participating critical illness <br>contracts are measured under the VFA.<br>|
| **Health and** <br>**protection –** <br>**Other**<br>| In addition to supplementary heath and protection <br>contract products attached to with-profits and unit-<br>linked contracts described above, the Group also <br>offers stand-alone health and protection products.<br>These are non-participating contracts that provide <br>mortality and/or morbidity benefits including health, <br>disability, critical illness and accident coverage.<br>| Stand-alone non-par health and protection (excluding <br>shareholder-backed participating critical illness) <br>contracts are measured under the GMM. <br>|
| **Non-**<br>**participating** <br>**term, whole** <br>**life and** <br>**endowment** <br>**assurance** <br>**contracts**<br>| Non-participating savings and/or protection where <br>the benefits are guaranteed, determined by a set of <br>defined market-related parameters, or determined at <br>the discretion of the local business unit. These <br>products often offer a guaranteed maturity and/or <br>surrender value. It is common in Asia for regulations <br>or market-driven demand and competition to provide <br>some form of capital value protection and minimum <br>crediting interest rate guarantees. This is reflected <br>within the guaranteed maturity and surrender <br>values. Guarantees are supported by shareholders.<br>| These contracts are measured under the GMM. |

---

The fair value of underlying items of the Group's direct participating contracts at 31 December 2025, excluding the Group's share

of the amounts that relate to life JVs and associates, is $157,825 million (31 December 2024: $133,641 million). The Group's

direct participating contracts are the contracts that are measured under the VFA model and as discussed in the table above

comprise primarily the Group's with-profits, unit-linked and shareholder-backed participating critical illness contracts. Those

underlying items comprise primarily investments in debt securities, equity securities and holdings in collective investment

schemes. The underlying items also include the related reinsurance assets and the policyholders' interest in the excess net assets

of relevant participating funds.

**(c)Reinsurance contracts held** 

The Group cedes certain business to other insurance companies. Although the ceding of insurance does not relieve the Group from

its liability to its policyholders, the Group participates in such agreements largely for the purpose of managing its loss exposure.

The Group evaluates the financial condition of its reinsurers and monitors concentration of credit risk from similar geographic

regions, activities or economic characteristics of the reinsurers to minimise its exposure from reinsurer insolvencies. 98 per cent

(31 December 2024: 99 per cent) of the Group's reinsurance contract BEL that are assets, excluding the Group's share of the

balances held by life joint ventures and associates, are held with reinsurers with a rating of A- and above by Standard & Poor's or

other external rating agencies by reference to the reinsurance BEL.

The reinsurance contracts held primarily relate to business written in Hong Kong and Singapore. The Group cedes insurance and

investment risk to limit exposure to underwriting losses and investment performance volatility under various agreements that

cover individual risks, group risks or defined blocks of business, on a co-insurance, surplus, quota share or catastrophe excess of

loss basis. The amount of each risk retained depends on the evaluation of the specific risk, subject to certain circumstances, to

internally set maximum limits based on characteristics of coverage.

As required by IFRS 17, all reinsurance contracts held by the Group are measured using the GMM.

A group of reinsurance contracts held is recognised on the following date:

–Reinsurance contracts held by the Group that provide proportionate coverage: The later of the start date of the coverage period

and the date on which any underlying insurance contract is initially recognised. This applies to the Group's quota share

reinsurance contracts.

–Other (non-proportionate) reinsurance contracts held by the Group: The earlier of beginning of the coverage period of the group

of reinsurance contracts or the recognition date of an underlying onerous group of insurance contracts issued.

–Reinsurance contracts held acquired via a business acquisition/combination: The date of the business acquisition/combination.

On initial recognition, the CSM of a group of reinsurance contracts held represents a net cost or net gain on purchasing

reinsurance. It is measured as the equal and opposite amount of the total of (a) the fulfilment cash flows, (b) any amount arising

from the derecognition of any assets or liabilities previously recognised for cash flows related to the group, (c) any cash flows

arising at that date, and (d) any income recognised in profit or loss because of onerous underlying contracts recognised at that

date. However, if the net cost of purchasing reinsurance relates to past events, the Group recognises the net cost immediately in

profit or loss.

The carrying amount at the end of each reporting period of a group of reinsurance contracts held is measured in the same way as

the underlying insurance contracts under GMM. Reinsurance contracts held are subject to the same modification requirements as

insurance contracts.

**C4 Intangible assets** 

**C4.1 Goodwill**

**Business combination**

*Business acquisitions are accounted for by applying the purchase method of accounting, which adjusts the net assets of the* 

*acquired company to fair value at the date of purchase. The excess of the acquisition consideration over the fair value of the* 

*assets and liabilities of the acquired business is recorded as goodwill. The Group chooses the full goodwill method or the partial* 

*goodwill method to calculate goodwill on an acquisition-by-acquisition basis. Expenses related to acquiring new subsidiaries are* 

*charged to the income statement in the period in which they are incurred and not included in goodwill. Income and expenses of* 

*acquired businesses are included in the income statement from the date of acquisition.*

Where the Group writes a put option, which if exercised triggers the purchase of non-controlling interests as part of its business

acquisition, the put option is recognised as a financial liability at the acquisition date. Where risks and rewards remain with the

non-controlling interests, a corresponding amount is deducted from equity. Any subsequent changes to the carrying amount of the

put option liability are also recognised within equity.

**Goodwill**

*Goodwill is capitalised and carried on the Consolidated statement of financial position as an intangible asset at initial value less any* 

*accumulated impairment losses. Goodwill impairment testing is conducted annually and when there is an indication that the* 

*goodwill may be impaired.* 

Goodwill shown on the Consolidated statement of financial position represents amounts allocated to businesses in Asia in respect

of both acquired asset management and life businesses.

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| Carrying value at 1 Jan | **848** | 896 |
| Exchange differences | **54** | (7) |
| Reclassification as held for sale  | **–** | (41) |
| **Carrying value at 31 Dec** | **902** | 848 |

---

**Impairment testing** 

Goodwill does not generate cash flows independently of other groups of assets and thus is assigned to CGUs for the purposes of

impairment testing. These CGUs are based upon how management monitors the business and represent the lowest level to which

goodwill can be allocated on a reasonable basis. Of the carrying value at 31 December 2025, $490 million (31 December 2024:

$450 million) relates to asset management business in Thailand and $244 million (31 December 2024: $230 million) relates to the

acquisition of UOB Life in Singapore. Other goodwill amounts are allocated across CGUs, which are not individually material.

Goodwill is tested for impairment by comparing the CGU's carrying amount, including any goodwill, with its recoverable amount.

The Group's methodology of assessing whether goodwill may be impaired for acquired life and asset management operations is

discussed below.

For acquired life businesses, the Group routinely compares the aggregate of net asset value and acquired goodwill on an IFRS

basis of the acquired life business with the value of the current in-force business as determined using its embedded value

methodology. Any excess of IFRS value over TEV carrying value is then compared with a projection of future new business to

determine whether there is any indication that the goodwill in the IFRS statement of financial position may be impaired. The

methodology and assumptions underpinning the Group's TEV basis of reporting are included in the TEV basis supplementary

information in this Annual Report.

The goodwill in respect of asset management businesses comprises mainly the goodwill arising from the acquisition of Thanachart

Fund Management Co., Ltd in 2019 and TMB Asset Management Co., Ltd in Thailand in 2018. The two acquired entities were

merged as Eastspring Asset Management (Thailand) Co., Ltd in 2022. The goodwill impairment testing for these businesses is

prepared as a single CGU reflecting that these businesses are managed together. The recoverable amount has been determined by

calculating the value in use of the combined business calculated using a discounted cash flow valuation.

For the combined Thailand asset management business, the valuation is based on a number of key assumptions for both years as

follows:

–Cash flow projections based on the latest 5-year business plan or forecast;

–A constant growth rate of 3.5 per cent on forecast cash flows beyond the terminal year of the cash flow projection period;

–The risk discount rate applied in accordance with the nature of the businesses. The pre-tax discount rate applied is 9.0 per cent;

and

–The continuation of asset management contracts on similar terms.

The key assumptions used in the impairment testing, including the cash flow projections, are subject to fluctuations in the external

economic conditions and how these impact investor sentiment. No material impairment, in the context of the Group's current

financial position, is expected to occur if a reasonably possible change is made to each of the individual key assumptions, which

the Group has taken to be a 10 per cent fall in cash flow projections, a 1 per cent fall in the growth rate or a 1 per cent increase in

the discount rate. A more significant change in the key assumptions or a combination of effects could have a larger impact on the

recoverable value and so there are circumstances where a more material impairment could occur.

**C4.2 Other intangible assets**

*Intangible assets acquired on the purchase of a subsidiary or portfolio of contracts are measured at fair value on acquisition. Other* 

*intangible assets, such as distribution rights and software, are valued initially at the price paid to acquire or cost to develop them* 

*and are subsequently carried at cost less amortisation and any accumulated impairment losses. For intangibles other than* 

*goodwill, amortisation follows the pattern in which the future economic benefits are expected to be consumed. If the pattern* 

*cannot be determined reliably, a straight-line method is applied. For software, the amortisation generally represents the licence* 

*period of the software acquired. Amortisation of intangible assets is charged to the Consolidated income statement and allocated* 

*between attributable and non-attributable expenses for the Group's insurance entities as shown in note B2. Impairment testing is* 

*conducted when there is an indication that the intangible asset may be impaired.*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m |
|  | **Distribution** <br>**rights**<br>| **Other** <br>**intangibles**<br>| **Total** | Distribution <br>rights<br>| Other<br>intangibles<br>| Total |
| | **note (i)** | **note (ii)** | | note (i) | note (ii) | |
| **Balance at 1 Jan** |  |  |  |  |  |  |
| Cost | **5762** | **570** | **6332** | 5585 | 537 | 6122 |
| Accumulated amortisation and other charges | **(2203)** | **(305)** | **(2508)** | (1876) | (260) | (2136) |
|  | **3559** | **265** | **3824** | 3709 | 277 | 3986 |
| Additions  | **491** | **48** | **539** | 198 | 62 | 260 |
| Amortisation and other charges | **(389)** | **(62)** | **(451)** | (331) | (58) | (389) |
| Disposals and transfers | **–** | **(3)** | **(3)** | (4) | (14) | (18) |
| Exchange differences and other movements | **38** | **11** | **49** | (13) | (2) | (15) |
| **Balance at 31 Dec** | **3699** | **259** | **3958** | 3559 | 265 | 3824 |
| **Comprising:** |  |  |  |  |  |  |
| Cost | **6302** | **624** | **6926** | 5762 | 570 | 6332 |
| Accumulated amortisation and other charges | **(2603)** | **(365)** | **(2968)** | (2203) | (305) | (2508) |
| **Balance at 31 Dec** | **3699** | **259** | **3958** | 3559 | 265 | 3824 |

---

**Notes**

(i)Distribution rights relate to amounts that have been paid or have become unconditionally due for payment as a result of past events in respect of the

bancassurance partnership arrangements for the bank distribution of Prudential's insurance products for a fixed period of time. The distribution rights

amounts are amortised on a basis to reflect the pattern in which the future economic benefits are expected to be consumed by reference to new business

production levels.

(ii)Included within other intangibles are software and licence fees.

**C5 Borrowings**

*Although initially recognised at fair value (net of transaction costs), borrowings are subsequently accounted for on an amortised* 

*cost basis using the effective interest method. Under the effective interest method, the difference between the redemption value* 

*of the borrowing and the initial proceeds (net of related issue costs) is amortised through the income statement to the date of* 

*maturity or, for hybrid debt, over the expected life of the instrument.*

**C5.1 Core structural borrowings of shareholder-financed businesses**

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| **Subordinated debt** |  |  |
| US$750m 4.875% notes  | **750** | 750 |
| £435m 6.125% notes 2031 | **583** | 542 |
| US$1,000m 2.95% notes 2033 | **998** | 997 |
| SGD 600m 3.80% notes 2035 <sup>note (i)</sup> | **464** | – |
| **Senior debt** <sup>note (ii)</sup> |  |  |
| £250m 5.875% notes 2029 | **325** | 299 |
| US$1,000m 3.125% notes 2030 | **992** | 990 |
| US$350m 3.625% notes 2032 | **347** | 347 |
| **Total core structural borrowings of shareholder-financed businesses** | **4459** | 3925 |

---

**Notes**

(i)On 22 May 2025, Prudential Funding (Asia) plc, a wholly owned subsidiary of the Group, issued SGD 600 million 3.80 per cent subordinated debt maturing on

22 May 2035 with proceeds, net of costs, of US$462 million. Under IFRS 9, the Group has designated this SGD-denominated borrowing as a net investment

hedge of the currency risk related to the Group's investment in the Singapore business.

(ii)The senior debt ranks above subordinated debt in the event of liquidation.

**C5.2 Operational borrowings**

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Borrowings in respect of short-term fixed income securities programmes (commercial paper) | **520** | 527 |
| Lease liabilities under IFRS 16 | **310** | 257 |
| Other borrowings | **1** | 13 |
| **Total operational borrowings** | **831** | 797 |

---

**C6 Risk and sensitivity analysis**

The Group's risk framework and the management of risks attaching to the Group's consolidated financial statements including

financial assets, financial liabilities and insurance liabilities, together with the inter-relationship with the management of capital,

have been included in the audited sections of the Risk review report.

The financial and insurance assets and liabilities on the Group's statement of financial position are, to varying degrees, subject to

market and insurance risk and other changes of assumptions that may have an effect on IFRS basis profit or loss and

shareholders' equity as described below. The market and insurance risks and also sustainability-related risks, including how they

affect Group's operations and how these are managed, are discussed in the Risk review report referred to above. The

sustainability-related risks discussed in the Risk review report include in particular the potential long-term impact of environmental

risks associated with climate change (including physical and transition risks) on the Group's investments and liabilities.

During 2025 the Group continued to perform scenario testing of plausible global responses to climate change, which assess the

possible financial consequences of climate change on the Group's business. Though the Group faces potential financial risks and

impacts from plausible global responses to climate change, the results for the Group's scenario testing are not outside observed

market volatility, suggesting no immediate need for explicit climate considerations in the current valuations of the Group's

investment portfolio. The Group remains mindful of the limitations within the results of the scenario testing and that the models

for the testing continue to change and evolve. Additionally, the Group's climate scenario analysis currently does not incorporate

potential management actions the Group could take to mitigate adverse impacts of climate change. Given the current lack of

developed methodologies and tools to isolate climate-related illnesses and deaths, the Group is currently unable to robustly isolate

the effects of climate on morbidity and mortality risks on the Group's life and health book. At this stage, the Group's claims and

lapses assumptions for its life and health insurance business do not include additional assumptions related to the impacts of

climate change over and above those that arise from the annual review of experience. The Group continues to monitor industry

practice, and will over time refine its approach as data quality and methodologies improve.

The Group benefits from diversification achieved through the geographical spread of the Group's operations and, within those

operations, through a broad mix of product types. The simplified sensitivities below are calculated at the individual business unit

level and aggregated to show the Group impact and no group-level adjustments from diversification have been made.

Relevant correlation factors include:

–Correlation across geographic regions for both financial and non-financial risk factors; and

–Correlation across risk factors for mortality and morbidity, expenses, persistency and other risks.

The geographical diversity of the Group's business means that it has some exposure to the risk of foreign exchange rate

fluctuations where a group undertaking has a functional currency that differs from the US dollar, the Group's presentation

currency. Consistent with the Group's accounting policies, the profits of these business units are translated at average exchange

rates and shareholders' equity at the closing rate for the reporting period. For 2025 and 2024, the rates for the most significant

operations are given in note A1. The Group has no exposure to currency fluctuation from business units that operate in USD, or

currencies pegged to the USD (such as HKD), and reduced exposure to currencies partially managed to the USD within a basket of

currencies (such as SGD). The impact of changes of foreign exchange rates on the Group's assets and liabilities from the above

exposure, after reflecting the impact of the designated net investment hedge, is recorded as part of other comprehensive income

and in 2025 represented a gain of $443 million (2024: loss of $(309) million), which corresponds to 3 per cent of opening

shareholders' equity (2024: 2 per cent). Additionally, note B1.1 'Segment results' shows the Group's segment and total profit for

2024 as if it had been prepared using the same exchange rates as 2025 (ie on a CER basis) giving an indication of how foreign

exchange rates impact the Group's profit or loss.

A 5 per cent decrease (weakening of the US dollar) or increase (strengthening of the US dollar) in these rates would have

increased or decreased profit for the year and shareholders' equity of the Group respectively as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m |
| Change in local currency to $ exchange rates | **Decrease of** <br>**5%**<br>| **Increase of** <br>**5%**<br>| Decrease of <br>5%<br>| Increase of <br>5%<br>|
| Profit after tax for the year | **123** | **(111)** | 102 | (92) |
| Shareholders' equity | **747** | **(676)** | 624 | (565) |

---

The Group is also exposed to foreign exchange gains and losses on assets and liabilities held by the Group's undertakings in a

currency other than their functional currency. These will often be managed by derivatives or by having assets and liabilities that

match in terms of currency.

**C6.1 Sensitivity to key market risks**

The table below shows the sensitivity of the Group's profit after tax, shareholders' equity and CSM as at 31 December 2025 and

2024 to the following market risks:

–1 per cent increase and 0.5 per cent decrease in observable risk-free interest rates (as described in note A3) in isolation and

subject to a floor of zero; and

–Instantaneous 10 per cent rise and 20 per cent fall in the market value of equity and property assets. The equity risk sensitivity

analysis assumes that all equity indices fall by the same percentage.

The sensitivity results assume instantaneous market movements and hence reflect the current investment portfolio and all

consequential impacts as at valuation date. If the economic conditions set out in the sensitivities persisted, the financial impacts

may differ to the instantaneous impacts shown below. These sensitivity results allow for limited management actions such as

changes to future policyholder bonuses and re-pricing for medical business, where applicable. In practice, the market movements

would be expected to occur over time and rebalancing of investment portfolios would likely be carried out to mitigate the impact of

the stresses as presented below. Management could also take additional actions to help mitigate the impact of these stresses,

including but not limited to, market risk hedging, increased use of reinsurance, repricing of in-force benefits, changes to new

business pricing and the mix of new business being sold.

The sensitivity of the Group's results to market risks primarily arises from the Group's insurance businesses.

The impact of changes in interest rates and equity values impacts both assets and liabilities. For assets backing insurance contract

liabilities and those related liabilities, these impacts will vary depending on whether insurance contracts are classified as VFA or

GMM. In addition, there will be impacts from other shareholder assets that back IFRS shareholders' equity rather than insurance

contract liabilities. The vast majority of the Group's investments are classified as FVTPL and so movements as a result of interest

rate and equity markets directly impact profit, unless they are offset by corresponding movements in the Group's liabilities.

For VFA contracts (which include the majority of the Group's participating and unit-linked contracts but not all as discussed in note

A3), movements in underlying assets are matched by a movement in insurance liabilities. Changes in BEL and RA as a result of a

change in discount rate or from changes in the variable fee (that is dependent on the value of underlying assets) are taken as a

change to the CSM with no immediate impact on profit or shareholders' equity. There will, however, be an impact on profit and

shareholders' equity from changes to the CSM amortisation as a result of changes both to the CSM and the discounting of the

coverage units. Onerous contracts with no CSM will also have impacts going directly to the income statement.

For GMM contracts, the CSM is calculated on a locked-in basis (ie using discount rates applied at the dates of initial recognition of

each group of contracts), whereas the BEL and RA are calculated using a current discount rate. This accounting mismatch passes

through the income statement. The impact will depend on whether the BEL is an asset or a liability. For BEL assets, which are

largely offset by CSM liabilities (ie for certain protection contracts where future premiums are expected to exceed future claims

and expenses), increases in interest rates will reduce the BEL asset with no impact on the CSM liability and hence reduce profit.

For a BEL liability, where the BEL and CSM liabilities are backed by invested assets (eg certain universal life contracts), there are

likely to be offsetting asset impacts (for example BEL liabilities and bond values will both reduce as interest rates increase) and

the impact on profit will be dependent on any mismatches between assets and liabilities together with the impact of the CSM being

calculated on a locked-in basis.

For other shareholder assets that are not backing insurance contract liabilities, increases in interest rates and falls in equity

markets reduce asset values, which under the Group's accounting policy pass directly through the income statement and hence

reduce profit (vice versa for decreases in interest rates and increases in equity markets).

The income statement volatilities stated above lead to a volatility in the shareholders' equity to the same extent.

For the Group's asset management business, Eastspring, the profit for the period is sensitive to the level of assets under

management as this significantly affects the value of management fees earned by the business in the current and future periods.

Assets under management will rise and fall as market conditions change with a consequential impact on profitability. The effect on

future asset management fees is not reflected in the table below.

In addition, Eastspring holds a small amount of investments directly on its balance sheet, including investments in respect of

seeding capital into retail funds it sells to third parties (see note C1.1). Eastspring's profit will therefore have some direct exposure

to the market movements of these investments.

At 31 December 2025 and 2024, the Group's central operations did not hold significant financial investments other than short-

term deposits and money market funds held by the Group's treasury function for liquidity purposes and so there is immaterial

sensitivity to market movements for these investments. In addition, the central operations hold some derivatives that are used to

reduce or manage investment, interest rate and currency exposures.

---

| | | |
|:---|:---|:---|
| **Base values** | **2025 $m** | 2024 $m |
| Profit after tax for the year for the Group | **4119** | 2415 |
| Group shareholders' equity as at 31 Dec | **20117** | 17492 |
| CSM as at 31 Dec including JVs and associates  | **25005** | 21960 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m |
| **Interest rates and consequential effects** | **-0.5%** | **+1%** | -0.5% | +1% |
| Increase (decrease) to shareholders' equity: |  |  |  |  |
| Financial assets <sup>note</sup> | **8805** | **(15413)** | 7690 | (13462) |
| Net insurance contract liabilities (including CSM) <sup>note</sup> | **(8169)** | **14000** | (7324) | 12474 |
| Net effect on shareholders' equity  | **568** | **(1222)** | 348 | (878) |
| Increase (decrease) to profit after tax: |  |  |  |  |
| Net effect on profit after tax | **609** | **(1299)** | 380 | (940) |
| Increase (decrease) to CSM liability: |  |  |  |  |
| CSM <sup>note</sup> | **390** | **(1069)** | 395 | (975) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m |
| **Equity/property market values** | **-20%** | **+10%** | -20% | +10% |
| Increase (decrease) to shareholders' equity: |  |  |  |  |
| Financial assets <sup>note</sup> | **(16935)** | **8374** | (14133) | 7075 |
| Net insurance contract liabilities (including CSM) <sup>note</sup> | **15802** | **(7855)** | 13132 | (6628) |
| Net effect on shareholders' equity | **(756)** | **341** | (689) | 302 |
| Increase (decrease) to profit after tax: |  |  |  |  |
| Net effect on profit after tax | **(817)** | **370** | (738) | 325 |
| Increase (decrease) to CSM liability: |  |  |  |  |
| CSM <sup>note</sup> | **(1937)** | **917** | (1479) | 651 |

---

**Note**

The sensitivity effects shown above reflect the pre-tax effects on the financial assets, net insurance contract liabilities and CSM as presented on the Consolidated

statement of financial position, together with the Group's share of the relevant amounts of its joint ventures and associates. Changes to the results of the Africa

insurance operations from interest rate or equity price changes would not materially impact the Group's results.

The sensitivity of the Group's businesses presented as a whole at a given point in time will also be affected by a change in the

relative size of the individual businesses.

**C6.2 Sensitivity to insurance risks**

For insurance operations, adverse persistency experience can impact the overall IFRS profitability of certain types of business

written. This risk is managed at a business unit level through regular monitoring of experience and the implementation of

management actions as necessary. These actions could include product enhancements or increased management focus on

premium collection, as well as other customer retention efforts. The potential financial impact of lapses is often mitigated through

the specific features of the products, eg surrender charges, or through the availability of premium holiday or partial withdrawal

policy features. The effects of these management actions have not been factored into the sensitivities below.

In addition, many of the business units are exposed to mortality and morbidity risk and changes in maintenance expense level.

Changes to the assumed levels of persistency, mortality, morbidity and expenses from that when the contract is first recognised

will impact the overall profitability of the insurance contract. These risks are managed on a portfolio basis and reinsurance can be

used to mitigate the risk the Group has. In particular for certain medical contracts, product repricing is a key management action

that is embedded in the process to mitigate morbidity risk. A degree of medical product repricing is assumed to have been

undertaken in the mortality and morbidity sensitivity results shown in the table below.

In terms of the impact on the Group's financial results, changes to shareholders' equity or profit or loss will occur over the life of

the contract, as changes to future cash flows from altered assumptions are recognised as an increase or decrease of CSM (except

for onerous contracts), which is then amortised to profit and loss (and hence shareholders' equity) over time.

The table below shows how the shareholders' equity and CSM would have increased or decreased if changes in the future

assumptions in insurance risk that were reasonably possible at the reporting date had occurred. This analysis presents the

sensitivities both before and after risk mitigation by reinsurance and assumes that the other variables remain constant.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
| | **Net effect on shareholders'** <br>**equity and profit after tax** <br>**attributable to equity** <br>**holders** | **Net effect on shareholders'** <br>**equity and profit after tax** <br>**attributable to equity** <br>**holders** | **Net effect on CSM** | **Net effect on CSM** |
| <br>**Sensitivity to insurance risk:** | **Gross of** <br>**reinsurance**<br>| **Net of** <br>**reinsurance**<br>| **Gross of** <br>**reinsurance**<br>| **Net of** <br>**reinsurance**<br>|
| Maintenance expenses – 10% increase | **(77)** | **(75)** | **(487)** | **(489)** |
| Lapse rates – 10% increase | **(152)** | **(110)** | **(1620)** | **(1775)** |
| Mortality and morbidity – 5% increase | **(115)** | **(105)** | **(813)** | **(341)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
|  | Net effect on shareholders' <br>equity and profit after tax <br>attributable to equity holders | Net effect on shareholders' <br>equity and profit after tax <br>attributable to equity holders | Net effect on CSM | Net effect on CSM |
| **Sensitivity to insurance risk:** | Gross of <br>reinsurance<br>| Net of <br>reinsurance<br>| Gross of <br>reinsurance<br>| Net of <br>reinsurance<br>|
| Maintenance expenses – 10% increase | (73) | (72) | (422) | (424) |
| Lapse rates – 10% increase | (97) | (72) | (1435) | (1593) |
| Mortality and morbidity – 5% increase | (110) | (108) | (689) | (269) |

---

A 10 per cent decrease in the maintenance expense and lapse rate assumptions would have a broadly similar opposite effect on

profit and shareholders' equity to the sensitivities shown above. The effect from a 5 per cent decrease in mortality and morbidity

assumptions is dependent on the degree of product repricing assumed to have been undertaken.

**C7 Tax assets and liabilities**

*Accounting policies on deferred tax are included in note B3. Deferred tax assets and deferred tax liabilities in the statement of* 

*financial position are offset at an entity level (or in some cases at a jurisdiction level where relevant tax grouping rules apply) as* 

*permitted under IAS 12.*

**C7.1 Current tax**

At 31 December 2025, of the $77 million (31 December 2024: $31 million) current tax recoverable, the majority is expected to be

recovered within 12 months of the reporting period.

At 31 December 2025, the current tax liability of $273 million (31 December 2024: $238 million) includes $77 million

(31 December 2024: $95 million) of provisions for uncertain tax matters. Further detail is provided in note B3.2.

**C7.2 Deferred tax**

The statement of financial position contains deferred tax assets of $119 million (31 December 2024: $142 million) and deferred

tax liabilities of $1,830 million (31 December 2024: $1,514 million), which are presented on a net basis in each of the categories

below for the purpose of this movement analysis only:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** |
| | **Net deferred** <br>**tax liabilities** <br>**(assets) at 1** <br>**Jan**<br>| **Movement in**<br>**income**<br>**statement**<br>| **Other**<br>**movements**<br>**including**<br>**foreign**<br>**exchange**<br>**movements**<br>| **Net deferred** <br>**tax liabilities** <br>**(assets) at** <br>**31 Dec**<br>|
| Unrealised losses or gains on investments | **148** | **71** | **6** | **225** |
| Balances relating to insurance and reinsurance contracts | **1408** | **190** | **78** | **1676** |
| Short-term temporary differences | **(60)** | **22** | **–** | **(38)** |
| Unused tax losses | **(124)** | **(20)** | **(8)** | **(152)** |
| **Net deferred tax liabilities**  | **1372** | **263** | **76** | **1711** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | Net deferred <br>tax liabilities <br>(assets) <br>at 1 Jan<br>| Movement in<br>income<br>statement<br>| Other<br>movements<br>including<br>foreign<br>exchange<br>movements<br>| Net deferred <br>tax liabilities <br>(assets) <br>at 31 Dec<br>|
| Unrealised losses or gains on investments | 129 | 32 | (13) | 148 |
| Balances relating to insurance and reinsurance contracts | 1170 | 260 | (22) | 1408 |
| Short-term temporary differences | (94) | 28 | 6 | (60) |
| Unused tax losses | (111) | (17) | 4 | (124) |
| **Net deferred tax liabilities**  | 1094 | 303 | (25) | 1372 |

---

At 31 December 2025, the Group has applied the mandatory exemption from recognising and disclosing information on deferred

tax assets and liabilities in respect of Pillar Two income taxes as required by IAS 12 'Income Taxes'.

At 31 December 2025 the Group has unused tax losses and deductible temporary differences of $1,947 million (31 December

2024: $1,477 million) in respect of which no deferred tax asset has been recognised. Of the unrecognised amounts, $176 million

(31 December 2024: $123 million) relates to unused tax losses that will expire within the next ten years (potential tax benefit:

$39 million) and the remainder of $1,947 million (31 December 2024: $1,354 million) has no expiry date (potential tax benefit:

$373 million).

Some of the Group's businesses are located in jurisdictions in which a withholding tax charge is incurred upon the distribution of

earnings. At 31 December 2025, deferred tax liabilities of $344 million (31 December 2024: $262 million) have not been

recognised in respect of such withholding taxes as the Group is able to control the timing of the distributions and it is probable

that the timing differences will not reverse in the foreseeable future.

**C8 Share capital, share premium and own shares**

Shares are classified as equity when their terms do not create an obligation to transfer assets. Amounts recorded in share capital

represent the nominal value of the shares issued. The difference between the proceeds received on issue of the shares, net of

share issue costs, and the nominal value of the shares issued, is credited to share premium. Where the Group purchases shares

for the purposes of employee incentive plans, the consideration paid, net of issue costs, is deducted from retained earnings. Upon

issue or sale any consideration received is credited to retained earnings net of related costs.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| **Issued shares of 5p each fully paid** | **Number of**<br>**ordinary shares**<br>| **Share**<br> **capital**<br>| **Share**<br>**premium**<br>| Number of<br>ordinary shares<br>| Share<br> capital<br>| Share<br>premium<br>|
|  |  | **$m** | **$m** |  | $m | $m |
| **Balance at 1 Jan** | **2657521888** | **176** | **5009** | 2753520756 | 183 | 5009 |
| Shares issued under share-based <br>schemes<br>| **5162** | **–** | **2** | 758708 | – | – |
| Shares issued under scrip dividends | **2197669** | **–** | **–** | 2813929 | – | – |
| Shares cancelled on repurchases/<br>buybacks<br>| **(111510940)** | **(7)** | **–** | (99571505) | (7) | – |
| **Balance at 31 Dec** | **2548213779** | **169** | **5011** | 2657521888 | 176 | 5009 |

---

Options outstanding under save as you earn schemes to subscribe for shares at each year end shown below are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | <br>**Number of** <br>**shares to** <br>**subscribe for**<br>| **Share price range**<br>**to**<br>**(in pence)**<br>| <br>**Exercisable** <br>**by year**<br>|
| **31 Dec 2025** | **1529193**<br> **520p** | **1,202p** | **2031** |
| 31 Dec 2024 | 1660096<br> 520p | 1,202p | 2030 |

---

**Transactions by Prudential plc and its subsidiaries in Prudential plc shares**

**(a)Purchases by employee share scheme trusts**

The Group buys and sells Prudential plc shares ('own shares') in relation to its employee share schemes through the trusts

established to facilitate the delivery of shares under employee incentive plans.

During the year, a total of 8.4 million shares (2024: 10.0 million shares) were acquired in relation to employee share schemes by

the trusts and for members under employee share purchase plans. The cost of acquiring these shares, was $101.1 million (2024:

$96.8 million). The cost in USD shown has been calculated from the share prices in the purchase currency (pound sterling or Hong

Kong dollar) using the monthly average exchange rate for the month in which those shares were purchased. A portion of these

share purchases were made on the Hong Kong Stock Exchange with the remainder being made on the London Stock Exchange. At

31 December 2025, 16.6 million (31 December 2024: 14.9 million) Prudential plc shares were held in the trusts.

**(b)Share repurchase/buyback programmes by the Company**

The Company made the following purchases during the years shown:

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| Share repurchases to neutralise share scheme issuances | **–** | 48 |
| Share repurchases to neutralise impact of scrip dividend  | **33** | 23 |
| Share buyback programme to return capital to shareholders (excluding costs) | **1211** | 785 |
| Total cash paid on repurchases and buybacks (excluding costs) | **1244** | 856 |
| Costs associated with buyback | **8** | 4 |
| Redemption liability/release associated with buyback | **(18)** | 18 |
| **Total cost recognised in retained earnings on share repurchases and buybacks** | **1234** | 878 |

---

The table below shows the details of the purchases on a monthly basis during 2025. The cost in USD shown has been calculated

from the share prices in pounds sterling using the daily spot rate on which those shares were purchased.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Share price** | **Share price** | |
| | <br>**Number of shares** | **Low £** | **High £** | <br>**Cost $** |
| January | **14027963** | **5.96** | **6.94** | **109413773** |
| February | **11016784** | **6.54** | **7.44** | **95544892** |
| March | **8650128** | **7.13** | **8.46** | **85272071** |
| April | **17449798** | **6.88** | **8.43** | **170975804** |
| May | **8643151** | **7.87** | **8.86** | **97762906** |
| June | **12643798** | **8.38** | **9.39** | **152102793** |
| July | **7382557** | **8.96** | **9.68** | **92009220** |
| August | **6105457** | **9.34** | **10.09** | **79993894** |
| September | **6282320** | **9.56** | **10.59** | **86067429** |
| October | **6632794** | **9.71** | **10.74** | **91145576** |
| November | **5645846** | **10.30** | **11.08** | **79336077** |
| December | **7030344** | **10.69** | **11.51** | **104361333** |
| **Total** | **111510940** |  |  | **1243985768** |

---

On 23 June 2024, the Company announced a $2 billion share buyback programme to reduce the issued share capital of the

Company in order to return capital to shareholders. The first tranche of $700 million was completed on 15 November 2024,

followed by the second tranche of $800 million completed on 26 June 2025. The third and final tranche of $500 million was

completed on 23 December 2025. On 6 January 2026, the Company announced the launch of a new $1.2 billion share buyback

programme as described in note D3.

As at 31 December 2025, 201.4 million ordinary shares in aggregate have been repurchased under the $2 billion share buyback

programme for a total consideration of $1,996 million excluding costs. In 2025, 109.3 million ordinary shares were purchased for

a total consideration of $1,211 million, excluding costs of $8 million.

In December 2025, the Company completed a share buyback programme to offset dilution from the issue of shares under its scrip

dividend alternative. The Company repurchased 2.2 million ordinary shares in aggregate for a total consideration of $33 million.

All of these share purchases were made on the London Stock Exchange, their associates, and/or other regulated exchanges in the

UK and the shares purchased were cancelled after settlement. The nominal value of the shares cancelled in 2025 was $7 million.

On cancellation, the nominal value was transferred from the share capital to the capital redemption reserve account.

Other than as disclosed above, the Company and its subsidiaries did not purchase, sell or redeem any Prudential plc listed

securities during 2025.

**C9 Capital**

**C9.1 Group objectives, policies and processes for managing capital**

**Capital measure**

The Group manages its Group GWS capital resources as its measure of capital. At 31 December 2025, estimated Group

shareholder GWS capital resources is $27.6 billion (31 December 2024: $24.8 billion).

**External capital requirements**

Prudential plc is subject to the Group-wide Supervision (GWS) Framework issued by the Hong Kong Insurance Authority (IA).

Prudential applies the Insurance (Group Capital) Rules set out in the GWS Framework to determine group regulatory capital

requirements (both minimum and prescribed levels). The summation of local statutory capital requirements across the Group is

used to determine group regulatory capital requirements, with no allowance for diversification between business operations. The

GWS eligible group capital resources are determined by the summation of capital resources across local solvency regimes for

regulated entities and IFRS shareholders' equity, with adjustments where applicable, for non-regulated entities.

More details on Group capital are given in section I(i) in the Additional unaudited financial information section.

**Meeting of capital management objectives**

The GWS group capital adequacy requirements have been met since the GWS Framework became effective for Prudential upon

designation. This includes maintaining total eligible group capital resources in excess of the Group Prescribed Capital Requirement

(GPCR) of the supervised group and maintaining Tier 1 group capital resources in excess of the Group Minimum Capital

Requirement (GMCR) of the supervised group.

The Group's capital management framework focuses on achieving sustainable, profitable growth and maintaining a resilient

balance sheet, with a disciplined approach to active capital allocation.

As well as holding sufficient capital to meet GWS requirements at Group level, the Group also closely manages the cash it holds

within its central holding companies so that it can:

–Maintain flexibility and absorb shock events;

–Cover central costs;

–Invest in core capabilities;

–Fund returns to shareholders, for example through dividends and share buybacks; and

–Fund new opportunities where there is a good strategic fit.

The Group monitors regulatory capital, economic capital and rating agency capital metrics and manages the business within its

risk appetite by remaining within its economic and regulatory capital limits. Reserve adequacy testing under a range of scenarios

and dynamic solvency testing is carried out, including under certain scenarios mandated by the local regulators.

The sensitivity of liabilities and other components of total capital vary depending upon the type of business concerned and this

conditions the approach to asset/liability management.

**C9.2 Local capital regulations**

**(a)Insurance operations**

For regulated insurance entities, the capital resources and required capital included in the GWS capital measure for Hong Kong IA

Group regulatory purposes are based on the local solvency regime applicable in each jurisdiction. The local valuation basis for the

assets, liabilities and capital requirements of significant insurance operations are set out below.

**Mainland China** 

A risk-based capital, risk management and governance framework, known as the China Risk Oriented Solvency System (C-ROSS),

applies in Mainland China.

Under C-ROSS, insurers are required to maintain a core solvency ratio (core capital over minimum capital) and a comprehensive

solvency ratio (capital resources over minimum capital) of not lower than 50 per cent and 100 per cent, respectively.

The actual capital is the difference between the admitted assets and admitted liabilities with trading and available-for-sale assets

marked-to-market and other assets at book value. Policyholder liabilities are based on a gross premium valuation method using

best estimate assumptions with a separate risk margin, where the discount rate used to calculate policyholder liabilities is set with

reference to historic average risk-free rates over a 3-year period.

C-ROSS Phase II regulations became effective in 2022. The main updates to the local regulation were to introduce explicit tiering

and admissibility rules on negative reserves in the capital resources and further updates to the risk calibrations used in calculating

capital requirements. A transition period allowed insurers to implement the rules in stages before full implementation of the new

regime was required from 2026 onwards.

**Hong Kong**

Prudential Hong Kong Limited applies the risk-based capital regime (HK RBC). The HK RBC framework requires liabilities to be

based on a gross premium valuation method using best estimate assumptions and capital requirements to be risk-based.

**Indonesia**

Solvency capital is determined using a risk-based capital approach. The capital resources are based on assets that are marked-to-

market, with policyholder liabilities based on a gross premium valuation method using best estimate assumptions with a suitable

margin for prudence. Liabilities are zeroised at policy level (ie negative liabilities are not permitted at a policy level). For unit-

linked policies, an unearned premium reserve is established.

**Malaysia** 

A risk-based capital (RBC) framework applies in Malaysia. The local regulator, Bank Negara Malaysia (BNM), has set a Supervisory

Target Capital Level of 130 per cent, below which supervisory actions of increasing intensity will be taken. Each insurer is also

required to set its own Individual Target Capital Level to reflect its own risk profile and this is expected to be higher than the

Supervisory Target Capital Level.

The capital resources are based on assets that are marked to market, with policyholder liabilities based on a gross premium

valuation method using best estimate assumptions with a suitable margin for prudence. Liabilities are zeroised at a fund level (ie

negative liabilities are not permitted at fund level). The BNM initiated a review of its RBC framework for insurers and Takaful

operators in 2021. A review of the capital adequacy requirements initiated in 2024 is ongoing, with the aim to improve the

consistency of risk-based capital measurements and align to global capital standards. The BNM is expected to release the final

policy document on the updated RBC framework in the second half of 2026, where quantitative impact studies and parallel results

are expected to be produced prior to implementation.

**Singapore**

A risk-based capital framework applies in Singapore. The local regulator, Monetary Authority of Singapore (MAS), has the

authority to direct insurance companies to satisfy additional capital adequacy requirements in addition to those set forth under the

Singapore Insurance Act, if considered appropriate. The capital resources are based on assets that are marked to market, with

policyholder liabilities based on a gross premium valuation method using best estimate assumptions with a suitable margin for

prudence. The updated risk-based capital framework (RBC2) permits the recognition of a prudent allowance for negative reserves

in the capital resources.

**Growth markets**

Details on the more significant changes expected to the local solvency regimes in individual growth markets are summarised

below.

**Taiwan**

A risk-based capital (RBC) framework has applied in Taiwan since 2003. The local regulator, the Financial Supervisory Commission

(FSC) has introduced a new capital framework namely the Taiwan-localised Insurance Capital Standard (T-ICS), effective from 1

January 2026. Subject to a number of localised adjustments, this framework broadly aligns to the global Insurance Capital

Standard (ICS) adopted by the International Association of Insurance Supervisions (IAIS).

The T-ICS framework requires liabilities to be based on a gross premium valuation method using best estimate assumptions and

capital requirements to be risk-based, which results in the release of prudent regulatory margins included in the current liabilities

(which are based on a net premium valuation) and an increase in required capital. The change is expected to be beneficial to the

local solvency position.

**(b)Asset management operations – regulatory and other surplus**

Certain asset management subsidiaries of the Group are subject to local regulatory requirements. The movement in the year of

the estimated surplus regulatory capital position (over the GPCR) of those subsidiaries, combined with the movement in the IFRS

basis shareholders' equity for unregulated asset management operations, is as follows:

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| **Balance at 1 Jan** | **500** | 497 |
| Gains (losses) during the year | **299** | 204 |
| Movement in capital requirement | **(14)** | 8 |
| Net distributions made to the parent company | **(213)** | (191) |
| Exchange and other movements | **(85)** | (18) |
| **Balance at 31 Dec** | **487** | 500 |

---

**C9.3 Transferability of capital resources**

The amounts retained within the insurance companies are at levels that provide an appropriate level of capital strength in excess

of the local regulatory minimum capital requirements. The businesses may, in general, remit dividends to parent entities, provided

the statutory insurance fund meets the local regulatory solvency requirements and there are sufficient unrestricted statutory

accounting profits. For with-profits funds, the excess of assets over liabilities is retained within the funds, with distribution to

shareholders tied to the shareholders' share of declared bonuses.

Capital resources of the non-insurance business units are transferable after taking account of an appropriate level of operating

capital, based on local regulatory solvency and accounting requirements, where relevant.

**C10 Property, plant and equipment**

Property, plant and equipment comprise Group occupied properties and tangible assets. Property, plant and equipment also

include right-of-use assets for operating leases of properties occupied by the Group and leases of equipment and other tangible

assets. Property, plant and equipment, including the right-of-use assets under operating leases, are generally held at cost less

cumulative depreciation calculated using the straight-line method, and impairment charge. Owner occupied properties held by the

Group's Singapore business that are underlying items of direct participating contracts under IFRS 17 are measured at fair value.

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Property, plant and equipment held at cost <sup>note (a)</sup> | **502** | 391 |
| Owner occupied properties held at fair value <sup>note (b)</sup> | **28** | 26 |
| **Total property, plant and equipment** | **530** | 417 |

---

**(a)Property, plant and equipment held at cost**

A reconciliation of the carrying amount of the Group's property, plant and equipment held at cost from the beginning to the end of

the years shown is as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2025 $m** | **2025 $m** | **2025 $m** | **2025 $m** | 2024 $m | 2024 $m | 2024 $m | 2024 $m |
| | **Group** <br>**occupied** <br>**property**<br>| **Tangible**<br>**assets**<br>| **Right-of-**<br>**use assets**<br>| **Total** | Group <br>occupied <br>property<br>| Tangible<br>assets<br>| Right-of-<br>use assets<br>| Total |
| **Balance at 1 Jan** |  |  |  |  |  |  |  |  |
| Cost | **35** | **497** | **782** | **1314** | 24 | 495 | 683 | 1202 |
| Accumulated depreciation | **(7)** | **(371)** | **(545)** | **(923)** | (8) | (380) | (467) | (855) |
| Opening net book amount | **28** | **126** | **237** | **391** | 16 | 115 | 216 | 347 |
| Additions | **–** | **104** | **137** | **241** | 20 | 81 | 51 | 152 |
| Depreciation charge | **(1)** | **(51)** | **(98)** | **(150)** | – | (40) | (94) | (134) |
| Disposals, impairment and lease <br>modifications<br>| **–** | **(8)** | **10** | **2** | (8) | (29) | 67 | 30 |
| Effect of movements in exchange <br>rates<br>| **2** | **4** | **12** | **18** | – | (1) | (3) | (4) |
| **Balance at 31 Dec** | **29** | **175** | **298** | **502** | 28 | 126 | 237 | 391 |
| **Representing:** |  |  |  |  |  |  |  |  |
| Cost | **38** | **578** | **775** | **1391** | 35 | 497 | 782 | 1314 |
| Accumulated depreciation | **(9)** | **(403)** | **(477)** | **(889)** | (7) | (371) | (545) | (923) |
| **Closing net book amount** | **29** | **175** | **298** | **502** | 28 | 126 | 237 | 391 |

---

**Right-of-use assets**

The Group does not have any right-of-use assets that would meet the definition of investment property. As at 31 December 2025,

total right-of-use assets comprised $284 million (31 December 2024: $222 million) of property and $14 million (31 December

2024: $15 million) of non-property assets.

Extension and termination options are included in a number of property and equipment leases across the Group. These are used to

maximise operational flexibility in terms of managing the assets used in the Group's operations. The majority of extension and

termination options held are exercisable only by the Group and not by the respective lessor. The Group assesses at lease

commencement whether it is reasonably certain to exercise the option. This assertion is revisited if there is a material change in

circumstances. As at 31 December 2025, the undiscounted value of lease payments beyond the break period not recognised in the

lease liabilities is $205 million (31 December 2024: $152 million).

The Group has non-cancellable property subleases, which have been classified as operating leases under IFRS 16. The sublease

rental income received in 2025 for the leases is $5 million (2024: $2 million; 2023: $7 million).

**(b)Owner occupied properties held at fair value**

Upon the adoption of IFRS 17, the Group has elected to measure the owner occupied properties held by the participating funds of

its Singapore business at fair value from the transition date. The fair value of these properties is based on market values as

assessed by professionally qualified external valuers or by the Group's qualified surveyors and classified as level 3 under the fair

value measurement hierarchy, similar to investment properties.

**(c)Capital expenditure: property, plant and equipment by segment**

The capital expenditure on property, plant and equipment excluding right-of-use assets in 2025 of $104 million (2024:

$101 million) arose by segment as follows:

---

| | | |
|:---|:---|:---|
| | **2025 $m** | 2024 $m |
| Hong Kong | **39** | 41 |
| Indonesia | **7** | 4 |
| Malaysia | **2** | 2 |
| Singapore | **25** | 24 |
| Growth markets and other | **29** | 21 |
| Eastspring | **1** | 7 |
| Total segment | **103** | 99 |
| Unallocated to a segment (central operations) | **1** | 2 |
| Total capital expenditure on property, plant and equipment | **104** | 101 |

---

**D Other information**

**D1 Contingencies and related obligations**

**Litigation and regulatory proceedings** 

The Group is involved in various litigation and regulatory proceedings from time to time. While the outcome of such litigation and

regulatory issues cannot be predicted with certainty, the Group believes that the ultimate outcome of any current or pending

matters will not have a material adverse effect on the Group's financial condition, results of operations or cash flows.

**Guarantees**

The Group has provided guarantees and commitments to third parties entered into in the normal course of business and the

Company has guaranteed public debt securities issued by one of its wholly-owned subsidiaries, Prudential Funding (Asia) PLC. The

Group considers the likelihood of outflows arising under such guarantees and commitments as remote.

**Intra-group capital support arrangements**

Prudential has provided undertakings to the regulators of its Hong Kong life subsidiary, Prudential Hong Kong Limited, to formalise

the circumstances regarding their solvency levels in which intra-group capital support will be provided by Prudential. Other intra-

group transactions are discussed in note D4 below.

**D2 Ownership interest in Prudential Assurance Malaysia Berhad**

**Settlement reached in Malaysian dividend dispute**

On 31 July 2025, Prudential announced that it has reached a full and final settlement regarding a dividend claim made by Detik

Ria Sdn Bhd ('Detik Ria'), the 49 per cent shareholder in Sri Han Suria Sdn Bhd ('SHS'), the holding company of Prudential

Assurance Malaysia Berhad ('PAMB').

Detik Ria had initiated legal proceedings against Prudential in April 2025 regarding dividends for the equivalent of approximately

$830 million plus interest at a rate of 5 per cent. As a result of the settlement, the equivalent of $83 million was paid to Detik Ria

by way of a dividend from SHS, which was paid out of existing resources. In addition, Prudential has waived the equivalent of

$33 million which was owed by Detik Ria to one of Prudential's subsidiaries as a result of the Federal Court decision disclosed in

the Group's consolidated financial statements for the year ended 31 December 2024.

All proceedings in respect of the dispute have been withdrawn. The settlement also provides for a mutual release of all liability

from all ongoing claims and parties have agreed not to raise new claims for historic matters. It is governed by the laws of England

and Wales and subject to Singapore arbitration.

In aggregate, the effect of the settlement was a small increment to the Group's shareholder equity, which has been reflected in

these consolidated financial statements.

**Increase in ownership interest in January 2026**

On 22 January 2026, the Company announced that Prudential Corporation Holdings Limited, a wholly-owned subsidiary of the

Group, had signed an agreement to acquire a further 19 per cent of Sri Han Suria Sdn. Bhd. (SHS), the holding company that

owns Prudential Assurance Malaysia Berhad (PAMB) from Detik Ria Sdn. Bhd. (Detik Ria) for RM1.52 billion (approximately $375

million using the exchange rate on 21 January 2026 midday (Hong Kong time). The transaction was completed on 30 January

2026. PAMB is the Group's conventional life insurance business in Malaysia. This transaction, which has been approved by Bank

Negara Malaysia, increases the Group's stake in SHS from 51 per cent to 70 per cent.

The Group will continue to consolidate the business of PAMB as a subsidiary controlled by the Group. Further, the Group's

operating performance metrics continue to be presented before the effect of non-controlling interests in line with the Group's

policy. The proportion of profit after tax and equity of the conventional life insurance business in Malaysia attributed to non-

controlling interests in the 2026 consolidated financial statements will reflect a reduction in Detik Ria's non-controlling interest in

SHS from 49 per cent to 30 per cent.

**D3 Post balance sheet events**

**Dividends**

The 2025 second interim dividend approved by the Board of Directors after 31 December 2025 is described in note B5.

**$1.2 billion share buyback programme**

On 6 January 2026, the Company announced the commencement of a new share buyback programme up to a maximum

aggregate amount of $1.2 billion to reduce the issued share capital of the Company in order to return capital to shareholders

comprising $500 million of recurring capital returns and $700 million of net proceeds from the IPO of ICICI Prudential Asset

Management Company Limited. The balance of the net proceeds from the IPO will be returned to shareholders during 2027. It is

intended that the announced buyback programme will be completed by no later than 18 December 2026.

**Increase in ownership interest in Prudential Assurance Malaysia Berhad** 

The Group signed an agreement on 22 January 2026 to acquire a further 19 per cent interest in the conventional life insurance

business in Malaysia, as described in note D2.

**D4 Related party transactions**

Transactions between the Company and its subsidiaries or intra-group transactions are eliminated on consolidation. Intra-group

transactions of the Group mainly related to a limited number of loans, guarantees or services provided by the Company to or from

other business units, or between business units, including investment management services provided by the Group's asset

managers to the insurance operations businesses as shown in note B1.3. All intra-group transactions are subject to the same

internal approval framework as external transactions. Given the nature of the Group's business, there has historically been limited

interconnectedness across the Group. The Group reviews its recovery plan (that also covers intra-group transactions and the level

of the Group's interconnectivity risk) on an annual basis and details the remedial actions that could be used to restore financial

strength and viability if the Group were to come under severe stress.

The Company has transactions and outstanding balances with collective investment schemes and similar entities that are not

consolidated and where a Group company acts as manager, which are regarded as related parties for the purposes of IAS 24. The

balances are included in the Group's statement of financial position at fair value or amortised cost in accordance with IFRS 9

classifications with the corresponding amounts included in the income statement. The transactions include amounts paid on issue

of shares or units, amounts received on cancellation of shares or units, distributions received and amounts paid in respect of the

periodic charge and administration fee.

There are no material transactions between the Group's joint ventures and associates which are accounted for on an equity

method basis, and other Group companies, except for the $174 million cash advanced in 2024 to the Group's life joint venture in

Mainland China that has subsequently been converted into a capital injection in 2025. There were no other transactions with

related parties during the year ended 31 December 2025 that have had a material effect on the results or financial position of the

Group.

Key management personnel of the Company, as described in note B2.3, may from time to time purchase insurance or asset

management products marketed by Group companies in the ordinary course of business on substantially the same terms as those

prevailing at the time for comparable transactions with other persons. In 2025, 2024 and 2023, transactions with key

management personnel were not deemed to be significant both by virtue of their size and in the context of the individuals'

financial positions. All of these transactions were on terms broadly equivalent to those that prevailed in arm's-length transactions.

Key management remuneration is disclosed in note B2.3.

Additional details on the Directors' interests in Prudential plc shares, transactions or arrangements are given in the Compensation

and Employees section.

**D5 Commitments**

The Group has provided, from time to time, certain commitments to third parties.

At 31 December 2025, the Group had $6,691 million unfunded commitments (31 December 2024 $3,293 million) primarily related

to alternative investment funds in Asia.

**D6 Investments in subsidiary undertakings, joint ventures and associates**

**D6.1 Basis of consolidation**

The Group consolidates those investees it is deemed to control. The Group has control over an investee if all three of the following

are met:

–It has power over an investee;

–It is exposed to, or has rights to, variable returns from its involvement with the investee; and

–It has the ability to use its power over the investee to affect its own returns.

**(a)Subsidiaries**

Subsidiaries are those investees that the Group controls. The majority of the Group's subsidiaries are corporate entities.

The Group performs a reassessment of consolidation whenever there is a change in the substance of the relationship between the

Group and an investee. Where the Group is deemed to control an entity, it is treated as a subsidiary and its results, assets and

liabilities are consolidated. Where the Group holds a minority share in an entity with no control over the entity, the investments

are carried at fair value within financial investments in the Consolidated statement of financial position.

**(b) Joint ventures and associates**

Joint ventures are joint arrangements arising from a contractual agreement whereby the Group and other investors have joint

control of the net assets of the arrangement. In a number of these arrangements, the Group's share of the underlying net assets

may be less than 50 per cent but the terms of the relevant agreement make it clear that control is jointly exercised between the

Group and the third party. Associates are entities over which the Group has significant influence but does not control. Generally, it

is presumed that the Group has significant influence if it holds between 20 per cent and 50 per cent voting rights of an entity.

With the exception of those referred to below, the Group accounts for its investments in joint ventures and associates using the

equity method of accounting. The Group's share of profit or loss of its joint ventures and associates is recognised in the income

statement and its share of movements in other comprehensive income is recognised in other comprehensive income. The equity

method of accounting does not apply to investments in joint ventures and associates held by the Group's insurance or investment

funds, including collective investment schemes which, as allowed by IAS 28 'Investments in Associates and Joint Ventures', are

carried at FVTPL.

**(c) Structured entities**

Structured entities are those that have been designed so that voting or similar rights are not the dominant factor in deciding who

controls the entity. Voting rights relate to administrative tasks. Relevant activities are directed by means of contractual

arrangements. The Group invests in both consolidated and unconsolidated structured entities including investment vehicles such

as collective investment schemes, collateralised debt obligations, mortgage-backed securities and similar asset-backed securities.

***Collective investment schemes***

The Group invests in collective investment schemes, that invest mainly in equities, bonds, cash and cash equivalents and

properties. In assessing control under IFRS 10 'Consolidated Financial Statements', the Group determines whether it is acting as

principal or agent and the variable returns from its involvement with these entities. The Group's percentage ownership in these

entities can fluctuate on a daily basis according to the participation of the Group and other investors.

Where the entity is managed by a Group asset manager:

–Where the Group's ownership holding in the entity exceeds 50 per cent, the Group is judged to have control over the entity;

–Where the Group's ownership holding in the entity is between 20 per cent and 50 per cent, the facts and circumstances of the

Group's involvement in the entity are considered, including the rights to any fees earned by the asset manager, in forming a

judgement as to whether the Group has control over the entity; and

–Where the Group's ownership holding in the entity is less than 20 per cent, the Group is judged to not have control over the

entity.

Where the entity is managed by an asset manager outside the Group, an assessment is made of whether the Group has existing

rights that gives it the ability to direct the current activities of the entity and therefore control the entity. In assessing the Group's

ability to direct an entity, the Group considers its ability relative to other investors.

Where the Group is deemed to control an entity, it is treated as a subsidiary and is consolidated, with the interests of investors

other than the Group being classified as liabilities, and presented within 'Net asset value attributable to unit holders of

consolidated investment funds'.

Where the Group does not control these entities (where the Group is deemed to be acting as an agent under IFRS 10) and they do

not meet the definition of associates, they are carried at FVTPL within financial investments in the Consolidated statement of

financial position.

Where the Group's asset manager sets up investment funds as part of its asset management operations, unless the Group also

participates in the ownership holding of the entities, the Group's interest is limited to the fees charged to manage the assets of

such entities. With no participation in ownership holding of these entities, the Group does not retain risks associated with

investment funds. For these investment funds, the Group is not deemed to control the entities but deemed to be acting as an

agent.

The Group generates returns and retains the ownership risks in these investment vehicles commensurate to its participation and

does not have any further exposure to the residual risks of these investment vehicles.

***Other structured entities***

The Group holds investments in mortgage-backed securities, collateralised debt obligations and similar asset-backed securities,

the majority of which are actively traded in a liquid market.

The Group consolidates the vehicles that hold the investments where the Group is deemed to control the vehicles. When assessing

control over the vehicles, the factors considered include the purpose and design of the vehicle, the Group's exposure to the

variability of returns and the scope of the Group's ability to direct the relevant activities of the vehicle including any kick-out or

removal rights that are held by third parties. The outcome of the control assessment is dependent on the terms and conditions of

the respective individual arrangements.

The majority of such vehicles are not consolidated. In these cases, the Group is not the sponsor of the vehicles in which it holds

investments and has no administrative rights over the vehicles' activities. The Group generates returns and retains the ownership

risks commensurate to its holding and its exposure to the investments and does not have any further exposure to the residual

risks or losses of the investments or the vehicles in which it holds investments. Accordingly, the Group does not have power over

the relevant activities of such vehicles and all are carried at FVTPL within financial investments in the Consolidated statement of

financial position.

The table below provides aggregate carrying amounts of the investments in unconsolidated structured entities reported in the

Group's Consolidated statement of financial position:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m |
| **Consolidated statement of financial position line items** | **Investment**<br>**funds**<br>| **Other**<br> **structured**<br> **entities**<br>| Investment<br>funds<br>| Other<br> structured<br> entities<br>|
| Equity securities and holdings in collective investment schemes | **51549** | **–** | 47701 | – |
| Debt securities | **–** | **542** | – | 216 |
| **Total investments in unconsolidated structured entities** | **51549** | **542** | 47701 | 216 |

---

The Group's maximum exposure to loss related to the interest in unconsolidated structured entities is limited to the carrying value

in the Consolidated statement of financial position and the unfunded investment commitments provided by the Group (see note

D5).

During the year, the Group receives dividend and interest income from its investments in these unconsolidated structured entities.

Where the Group's asset manager manages these entities, such as the collective investment schemes, the Group also receives

asset management fees from these entities.

As at 31 December 2025 and 2024, the Group did not have an agreement, contractual or otherwise, or intention to provide

financial support to structured entities (both consolidated and unconsolidated) that could expose the Group to a loss.

**D6.2 Dividend restrictions and minimum capital requirements** 

Certain Group entities are subject to restrictions on the amounts of funds they may transfer in the form of cash dividends or

otherwise to the parent company.

Under UK company law, UK companies can only declare dividends if they have sufficient distributable reserves.

The Group's subsidiaries, joint ventures and associates may remit dividends to the Group, in general, provided the statutory

insurance fund meets the capital adequacy standard required under local statutory regulations and has sufficient distributable

reserves. Further details on local capital regulations in certain Asia operations are provided in note C9.2.

**D6.3 Investments in joint ventures and associates**

Joint ventures represent arrangements where the controlling parties through contractual or other agreement have the rights to the

net assets of the arrangements. The Group has insurance joint ventures in Mainland China with CITIC Group, and the Takaful

insurance joint venture in Malaysia. In addition, there is an asset management joint venture in Hong Kong with Bank of China

International Holdings Limited (BOCI) and until December 2025 an asset management joint venture in India with ICICI Bank (see

below). For the Group's joint ventures that are accounted for using the equity method, the net-of-tax results of these operations

are included in the Group's profit before tax.

The Group's associates, which are also accounted for using the equity method, include the insurance entity in India and from

December 2025 following the IPO (see below), the asset management company in India. ICICI Bank is the majority shareholder of

both of these associates in India.

On 19 December 2025, the asset management entity in India, ICICI Prudential Asset Management Company Limited (IPAMC),

completed its IPO and was listed on BSE Limited and the National Stock Exchange of India Limited. The IPO was priced at

INR2,165 per equity share indicating a market capitalisation for IPAMC of INR1,070 billion (approximately $11.8 billion based on

the exchange rate at the time of listing).

In connection with this IPO, the Group sold 48,972,994 IPAMC shares at a price per share of INR2,165. The Group retains a 34.59

per cent stake in IPAMC post-listing, reduced from a pre-listing stake of 49 per cent. The Group has announced its intention to

return the net proceeds in connection with this IPO including the pre-IPO private placement of approximately $1.4 billion (net of

applicable fees and other costs, including any tax chargeable) to Prudential shareholders, subject to regulatory and shareholder

approvals where required.

Following its listing and consequent amendments to the shareholder agreement, the Group ceased to exercise joint control over

the asset management business in India but retained significant influence. Therefore the retained investment has been re-

classified as an associate from December 2025, and continues to be accounted for using the equity method.

In addition, the Group has investments in collective investment schemes, funds holding collateralised debt obligations and

property funds where the Group has significant influence. As allowed under IAS 28, these investments are accounted for on an

FVTPL basis. The aggregate fair value of associates accounted for at FVTPL, for which published price quotations were available, is

approximately $0.7 billion at 31 December 2025 (31 December 2024: $0.6 billion).

For joint ventures and associates accounted for using the equity method, the 12-month financial information of these investments

for the years ended 31 December 2025 and 2024 (covering the same period as that of the Group) has been used in these

consolidated financial statements.

The Group's share of the profit for shareholder-backed business (including short-term interest rate and other market fluctuations),

net of related tax, in joint ventures and associates that are equity accounted for as shown in the Consolidated income statement, is

allocated across segments as follows with the related tax of the life joint ventures and associates included in the Growth markets and

other segment:

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Mainland China | **(24)** | 159 | (577) |
| Malaysia | **35** | 21 | 18 |
| Growth markets and other <sup>note</sup> | **129** | 104 | 310 |
| Insurance operations | **140** | 284 | (249) |
| Eastspring | **224** | 193 | 158 |
| **Total segment and Group total** | **364** | 477 | (91) |

---

**Note**

For growth markets and other, as well as the segment results for associates and joint ventures within the segment, the amount shown includes taxes for all life

joint ventures and associates, which is less than $1 million in 2025 (2024: charge of $(44) million; 2023: credit of $191 million).

There is no other comprehensive income in the joint ventures and associates other than the foreign exchange differences that

arise from translating the associates and joint ventures into the Group's presentation currency. There has been no unrecognised

share of losses of a joint venture or associate that the Group has stopped recognising in total comprehensive income.

The Group's interest in joint ventures and associates gives rise to no contingent liabilities or capital commitments that are material

to the Group.

**CITIC-Prudential Life Insurance Company (Mainland China)**

CITIC-Prudential Life Insurance Company, the Group's Mainland China segment, is a joint venture with the CITIC Group in which

the Group owns a 50 per cent interest. The joint venture is incorporated in China and is principally engaged in underwriting

insurance and investment contracts. The summarised financial information for this entity, which is considered to be a material

joint venture to the Group, is set out below. The financial information represents the entity's financial statements prepared in

accordance with Group's IFRS accounting policies, on a 100 per cent basis, for the years shown:

---

| | | |
|:---|:---|:---|
| **Statement of financial position** | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Total assets | **40647** | 36344 |
| Total liabilities (including non-controlling interest) <sup>note</sup> | **38259** | 34452 |
| Shareholders' equity | **2388** | 1892 |
| The above amounts of assets and liabilities include the following: |  |  |
| Cash and cash equivalents | **1934** | 1374 |
| Financial liabilities (excluding trade and other payables and provisions) | **2166** | 1835 |

---

**Note** 

The Group's 50 per cent share of the Mainland China joint venture's insurance and reinsurance contract balances are shown in the analysis of insurance and

reinsurance contract balances by segment in note C3.3(c).

---

| | | | |
|:---|:---|:---|:---|
| **Income statement** | **2025 $m** | 2024 $m | 2023 $m |
| Revenue | **2358** | 3491 | 1676 |
| Profit (loss) for the year after tax | **6** | 282 | (733) |
| The above profit (loss) for the year includes the following: |  |  |  |
| Depreciation and amortisation | **(43)** | (38) | (39) |
| Interest income | **615** | 582 | 543 |
| Interest expense | **(34)** | (2) | (2) |
| Income tax credit (charge) | **54** | (36) | 422 |

---

The summarised financial information above is reconciled to the carrying amount of the Group's interest in the joint venture

recognised in the consolidated financial statements as follows:

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Net assets of the Mainland China joint venture as shown above (100%) | **2388** | 1892 |
| Proportion owned by the joint venture partner (50%) | **1194** | 946 |
| Carrying amount of the Group's interest in the joint venture (50%) | **1194** | 946 |

---

The Group has received no dividends from the Mainland China joint venture in 2025 (2024: nil; 2023:$88 million) and made

capital injections into the Mainland China joint venture as discussed in note D4.

At 31 December 2025, the Group's investments in joint ventures and associates accounted for using the equity method are $2,763

million (31 December 2024: $2,412 million), of which $1,194 million (31 December 2024: $946 million) relates to the Group's

interest in Mainland China, as discussed above. The aggregate carrying amount of the Group's investments in the other joint

ventures and associates accounted for using the equity method is $1,569 million (31 December 2024: $1,466 million).

**D6.4 Related undertakings**

In accordance with Section 409 of the Companies Act 2006, a list of Prudential Group's subsidiaries, joint ventures, associates and

significant holdings (being holdings of more than 20 per cent) is disclosed below, along with the classes of shares held, the

registered office address and the effective percentage of equity owned at 31 December 2025. The Group also operates through

branches, none of which are significant.

The definitions of a subsidiary undertaking, joint venture and associate in accordance with the Companies Act 2006 are different

from the definition under IFRS Standards. As a result, the related undertakings included within the list below may not be the same

as the undertakings consolidated in the Group consolidated financial statements. The Group's consolidation policy is described in

note D6.1.

**Simplified corporate structure as at 31 December 2025**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | **Prudential plc** | **Prudential plc** | **Prudential plc** | **Prudential plc** |  |  |  |  |
|  |  |  | **Prudential Corporation Asia** <br>**Limited** | **Prudential Corporation Asia** <br>**Limited** | **Prudential Corporation Asia** <br>**Limited** | **Prudential Corporation Asia** <br>**Limited** |  | Prudential Group Holdings <br>Limited and subsidiaries | Prudential Group Holdings <br>Limited and subsidiaries | Prudential Group Holdings <br>Limited and subsidiaries |
| CITIC-<br>Prudential <br>Life <br>Insurance <br>Company <br>Limited <br>(Mainland <br>China life <br>joint <br>venture) | Prudential <br>Hong Kong <br>Limited<br>Prudential <br>General <br>Insurance <br>Hong Kong <br>Limited | PT <br>Prudential <br>Life <br>Assurance <br>PT <br>Prudential <br>Sharia Life <br>Assurance<br>(Indonesia) |  | Prudential <br>Assurance <br>Malaysia<br>Berhad<br>Prudential <br>BSN <br>Takaful <br>Berhad | Prudential <br>Assurance <br>Company <br>Singapore <br>(Pte) <br>Limited | Eastspring <br>Investment<br>s Group <br>Pte. Ltd <br>and <br>subsidiaries | Growth <br>markets <br>and other <br>entities<br>(including <br>Africa, <br>Cambodia, <br>India, <br>Laos, <br>Myanmar, <br>the <br>Philippines, <br>Taiwan, <br>Thailand, <br>Vietnam) | Growth <br>markets <br>and other <br>entities<br>(including <br>Africa, <br>Cambodia, <br>India, <br>Laos, <br>Myanmar, <br>the <br>Philippines, <br>Taiwan, <br>Thailand, <br>Vietnam) | Prudential <br>Internation<br>al Treasury <br>Limited | Prudential <br>Funding <br>(Asia) plc |

---

Other than Prudential Hong Kong businesses, Prudential International Treasury Limited and Prudential Funding (Asia) plc, other

entities shown above are indirectly held by Prudential Corporation Asia Limited.

**Direct subsidiary undertakings of the parent company, Prudential plc (shares held** 

**directly or via nominees)** 

Key to share classes:

---

| | |
|:---|:---|
| **Abbreviation** | **Class of share held** |
| LBG | Limited by Guarantee |
| MI | Membership Interest |
| MI – WFOE | Membership Interest of a Wholly Foreign Owned Enterprise in Mainland China |
| MI – JV | Membership Interest of a Sino-Foreign Equity Joint Venture in Mainland China |
| OS | Ordinary Shares |
| PI | Partnership Interest |
| PS | Preference Shares |
| U | Units |

---

---

| | | | |
|:---|:---|:---|:---|
| **Name of entity** | **Classes of shares** <br>**held**<br>| **Proportion** <br>**held**<br>| **Registered office address** |
| Prudential Corporation Asia <br>Limited<br>| OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential Group Holdings <br>Limited<br>| OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |

---

**Other subsidiaries, joint ventures, associates and significant holdings of the Group – no** 

**shares held directly by the parent company (Prudential plc) or its nominees** 

---

| | | | |
|:---|:---|:---|:---|
| Name of entity | Classes of <br>shares held<br>| Proportion <br>held<br>| Registered office address |
| Aberdeen Cash Creation Fund | U | 47.05% | 28th Floor Bangkok City Tower, 179 South Sathorn Road, <br>Thungmahamek, Sathorn, Bangkok 10120, Thailand<br>|
| Aberdeen Standard Global Opportunities <br>Fund<br>| U | 28.84% | 7 Straits View, #23-04, Marina One East Tower, Singapore <br>018936 |
| Aberdeen Standard Singapore Equity <br>Fund<br>| U | 62.05% | 7 Straits View, #23-04, Marina One East Tower, Singapore <br>018936 |
| ABRDN India Opportunities Fund | U | 30.79% |  |
| Alternatives North America, Ltd. | U | 100.00% | PO Box 1093, Queensgate House, Grand Cayman, KY1-1102, <br>Cayman Islands<br>|
| ARDIAN Prudential Infrastructure Sub-<br>Fund<br>| U | 99.99% | 1 Temasek Avenue, #36-01 Millenia Tower, Singapore 039192 |
| ARDIAN Prudential PE Sub-Fund | U | 99.99% | 1 Temasek Avenue, #36-01 Millenia Tower, Singapore 039192 |
| ARDIAN Prudential RE Sub-Fund | U | 99.99% | 1 Temasek Avenue, #36-01 Millenia Tower, Singapore 039192 |
| ATRAM - PRUINVEST PHP Liquid Fund | U | 90.51% | 8th Floor 8 Rockwell Building, Metro Manila Manila, Philippines |
| ATRAM Global Technology Feeder Fund | U | 21.18% | 8th Floor 8 Rockwell Building, Metro Manila Manila, Philippines |
| ATRAM Philippine Equity Index Tracker <br>Fund - Class V<br>| U | 96.88% | 8th Floor 8 Rockwell Building, Metro Manila Manila, Philippines |
| Barings International Umbrella Fund-<br>Barings Global Balanced Fund<br>| U | 40.28% | 21st Floor, No. 333, Sec. 1, Keelong Rd, Taipei |
| Blackrock Global Funds Systematic <br>Global Equity High Income Fund<br>| U | 35.10% | Twenty Anson, #18-01, 20 Anson Road, Singapore 079912 |
| BOCHK Aggressive Growth Fund | U | 43.66% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCHK Balanced Growth Fund | U | 37.26% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCHK China Equity Fund | U | 53.67% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCHK Conservative Growth Fund | U | 43.51% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCHK US Dollar Money Market Fund | U | 25.81% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCI-Prudential Asset Management <br>Limited<br>| OS | 36.00% | 27th Floor, Bank of China Tower, 1 Garden Road, Hong Kong |
| BOCI-Prudential Trustee Limited | OS | 36.00% | Suites 1501-1507 & 1513-1516, 15th Floor, 1111 King's Road, <br>Taikoo Shing, Hong Kong<br>|
| BSP Debt Fund V Unlevered (Non US) LP | U | 52.79% | c/o Benefit Street Partners LLC, New York, New York 10019 |
| Capital East Millennium Equity Fund | U | 21.23% | 105, Taipei City, Songshan District, Dongxing Rd, No.8 8F |
| Cathay High Yield EX China Cash Pay <br>1-5 Year 2% Issuer Capped ETF<br>| U | 77.09% | 6th Floor, No.39, Sec.2, Dunhua South. Rd., Taipei, Taiwan |
| CITIC-Prudential Fund Management <br>Company Limited<br>| MI - JV | 49.00% | 19th Floor, No. 16, Yincheng Road, China (Shanghai) Pudong <br>New Area, Shanghai, China<br>|
| CITIC-Prudential Life Insurance <br>Company Limited<br>| MI - JV | 50.00% | Room 1101-A, 1201, 1301, 1401, 1501, 1601, 1701, 1801, <br>Unit 01, Building 1, No. B2, North Road of East Third Ring <br>Road, Chaoyang District, Beijing, PRC,100027, China<br>|
| Eastspring Al-Wara' Investments Berhad | OS | 100.00% | Level 25, Menara Hong Leong, No. 6 Jalan Damanlela, Bukit <br>Damansara, 50490 Kuala Lumpur, Wilayah Persekutuan, <br>Malaysia<br>|
| Eastspring Asia Pacific High Yield Equity <br>Fund<br>| U | 55.61% | 4th Floor, No.1, Songzhi Rd., Xinyi Dist., Taipei, Taiwan |
| Eastspring Asset Management <br>(Thailand) Co., Ltd.<br>| OS | 59.50% | 944 Mitrtown Office Tower, 9th Floor, Rama 4 Road, Wangmai, <br>Pathumwan, Bangkok 10330, Thailand<br>|
| Eastspring Global Private Credit Fund | U | 99.99% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936 |
| Eastspring Global Real Assets & Private <br>Equity Fund<br>| U | 99.99% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936 |
| Eastspring Global Real Estate Fund | U | 99.99% |  |
| Eastspring Global Technology Fund | U | 23.69% | 944 Mitrtown Office Tower, 9th floor, Rama 4 road, Wangmai <br>Pathumwan, Bangkok 10330, Thailand<br>|
| Eastspring Investment Management <br>(Shanghai) Company Limited<br>| MI - <br>WFOE<br>| 100.00% | Unit 2901, 29th Floor Azia Center, 1233 Lujiazui Ring Road, <br>China (Shanghai) Pilot Free Trade Zone, Shanghai, 200120, <br>China<br>|

---

---

| | | | |
|:---|:---|:---|:---|
| Eastspring Investments - Asia Select <br>Bond Fund<br>| U | 97.15% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asia <br>Opportunities Equity Fund<br>| U | 99.99% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asia Pacific <br>Equity Fund<br>| U | 99.98% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Bond <br>Fund<br>| U | 97.03% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Dynamic <br>Fund<br>| U | 97.55% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Equity <br>Fund<br>| U | 99.21% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Equity <br>Income Fund<br>| U | 92.16% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian High <br>Yield Bond Fund<br>| U | 68.12% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Local <br>Bond Fund<br>| U | 91.61% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Low <br>Volatility Equity Fund<br>| U | 78.18% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Asian Multi <br>Factor Equity Fund<br>| U | 97.94% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - China A <br>Shares Growth Fund<br>| U | 97.54% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - China Bond <br>Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - China Equity <br>Fund<br>| U | 21.15% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Dragon <br>Peacock Fund<br>| U | 97.70% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - European <br>Investment Grade Bond Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global <br>Emerging Markets Bond Fund<br>| U | 92.33% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global <br>Emerging Markets Dynamic Fund<br>| U | 40.76% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global <br>Emerging Markets ex-China Dynamic <br>Fund<br>| U | 92.41% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Equity <br>Navigator Fund<br>| U | 85.88% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Growth <br>Equity Fund<br>| U | 39.72% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Low <br>Volatility Equity Fund<br>| U | 96.33% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Market <br>Navigator Fund<br>| U | 99.60% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Multi <br>Asset Balanced Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Multi <br>Asset Conservative Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Multi <br>Asset Dynamic Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global Multi <br>Asset Income Plus Growth Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Global <br>Technology Fund<br>| U | 75.78% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Greater China <br>Equity Fund<br>| U | 89.73% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - India Equity <br>Fund<br>| U | 28.38% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - Pan European <br>Fund<br>| U | 50.02% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - US Corporate <br>Bond Fund<br>| U | 88.69% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - US High <br>Investment Grade Bond Fund<br>| U | 89.08% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - US High Yield <br>Bond Fund<br>| U | 25.87% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments - US Investment <br>Grade Bond Fund <br>| U | 28.99% | 26, Boulevard Royal, L-2449, Luxembourg |

---

---

| | | | |
|:---|:---|:---|:---|
| Eastspring Investments - World Value <br>Equity Fund<br>| U | 86.43% |  |
| Eastspring Investments (Hong Kong) <br>Limited<br>| OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Eastspring Investments (Luxembourg) <br>S.A.<br>| OS | 100.00% | 26, Boulevard Royal, L-2449 Luxembourg |
| Eastspring Investments (Singapore) <br>Limited<br>| OS | 100.00% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| Eastspring Investments Asia Pacific ex-<br>Japan Target Return Fund<br>| U | 86.27% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia |
| Eastspring Investments Asian High Yield <br>Bond MY Fund<br>| U | 83.58% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia |
| Eastspring Investments Berhad | OS | 100.00% | Level 25, Menara Hong Leong, No. 6 Jalan Damanlela, Bukit <br>Damansara, 50490 Kuala Lumpur, Wilayah Persekutuan, <br>Malaysia<br>|
| Eastspring Investments Dana Dinamik | U | 27.11% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia |
| Eastspring Investments Dinasti Equity <br>Fund<br>| U | 46.90% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia |
| Eastspring Investments Fund <br>Management Limited Liability Company<br>| MI | 100.00% | 23rd Floor Saigon Trade Center, 37 Ton Duc Thang Street, Sai <br>Gon Ward, Ho Chi Minh City, Vietnam<br>|
| Eastspring Investments Global Equity <br>Fund<br>| U | 95.27% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia<br>|
| Eastspring Investments Group Pte. Ltd. | OS | 100.00% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| Eastspring Investments Growth Fund | U | 26.45% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia<br>|
| Eastspring Investments Incorporated | OS | 100.00% | 874 Walker Road, Suite C, Dover, Kent, Delaware 19904, <br>United States of America<br>|
| Eastspring Investments India Consumer <br>Equity Open Limited<br>| OS | 100.00% | 3rd Floor, 355 NEX, Rue du Savoir, Cybercity Ebene 72201, <br>Mauritius |
| Eastspring Investments India Equity <br>Open Limited<br>| OS | 100.00% | 3rd Floor, 355 NEX, Rue du Savoir, Cybercity Ebene 72201, <br>Mauritius |
| Eastspring Investments India <br>Government Bond Fund (Semi-Annual <br>Distribution)<br>| U | 29.44% | Eastspring Investments Limited, Marunouchi Park Bldg., 2-6-1 <br>Marunochi, Chiyoda-ku, Tokyo, Japan 100-6905<br>|
| Eastspring Investments India <br>Infrastructure Equity Open Limited<br>| OS | 100.00% | 3rd Floor, 355 NEX, Rue du Savoir, Cybercity Ebene 72201, <br>Mauritius<br>|
| Eastspring Investments India Innovation <br>High Growth Equity Fund QII<br>| U | 100.00% | Eastspring Investments Limited, Marunouchi Park Bldg., 2-6-1 <br>Marunochi, Chiyoda-ku, Tokyo, Japan 100-6905<br>|
| Eastspring Investments Islamic Equity <br>Income Fund<br>| U | 54.69% | Level 22, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia<br>|
| Eastspring Investments Limited | OS | 100.00% | Marunouchi Park Building, 6-1 Marunouchi 2-chome, Chiyoda-<br>Ku, Tokyo, Japan<br>|
| Eastspring Investments Services Pte. <br>Ltd.<br>| OS | 100.00% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| Eastspring Investments SICAV-FIS - <br>Alternative Investment Fund<br>| U | 100.00% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments Unit Trusts - <br>Asian Balanced Fund<br>| U | 96.11% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| Eastspring Investments Unit Trusts - <br>Dragon Peacock Fund ID<br>| U | 97.79% |  |
| Eastspring Investments Unit Trusts - <br>Global Technology Fund<br>| U | 90.44% |  |
| Eastspring Investments Unit Trusts - <br>Pan European Fund<br>| U | 51.87% |  |
| Eastspring Investments Unit Trusts - <br>Singapore ASEAN Equity Fund<br>| U | 99.23% |  |
| Eastspring Investments Unit Trusts - <br>Singapore Select Bond Fund<br>| U | 59.12% |  |
| Eastspring Investments Vietnam ESG <br>Equity Fund<br>| U | 98.55% | 26, Boulevard Royal, L-2449, Luxembourg |
| Eastspring Investments Vietnam <br>Navigator Fund<br>| U | 74.68% | 23rd Floor, Saigon Trade Center Building, 37 Ton Duc Thang <br>Street, Ben Nghe Ward, District 1, Ho Chi Minh City, Vietnam<br>|
| Eastspring Overseas Investment Fund <br>Management (Shanghai) Company <br>Limited<br>| MI - <br>WFOE<br>| 100.00% | Unit 2901, 29th Floor Azia Center, 1233 Lujiazui Ring Road, <br>China (Shanghai) Pilot Free Trade Zone, Shanghai, 200120, <br>China<br>|
| Eastspring Private Equity Fund 2 | U | 99.99% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| Eastspring Securities Investment Trust <br>Co., Ltd.<br>| OS | 99.54% | 4th Floor, No.1 Songzhi Road, Taipei 110, Taiwan |

---

---

| | | | |
|:---|:---|:---|:---|
| Eastspring SGD Cash Fund | U | 87.91% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936<br>|
| First Sentier Global Property Securities <br>Fund<br>| U | 66.69% | 38 Beach Road, #06-11 South Beach Tower, Singapore 189767 |
| FSITC Global Trends Fund | U | 33.32% | 1st Floor, No.6, Sec. 3, Minquan West Rd, Taipei, Taiwan |
| FSSA China Focus Fund  | U | 64.88% | 70 Sir John Rogerson's Quay, Dublin 2, D02 R296, Ireland |
| Fubon 1-5 Years US High Yield Bond Ex <br>China ETF<br>| U | 31.75% | 8th Floor, No.108, Sec.1, Dunhua South. Rd., Taipei, Taiwan |
| Fuh Hwa 1-5 Yr High Yield ETF | U | 66.33% | 8th & 9th Floor, No.308, Sec. 2, Bade Rd., Da-an District |
| Furnival Insurance Company PCC <br>Limited<br>| OS | 100.00% | PO Box 155, Mill Court, La Charroterie, St Peter Port, GY1 4ET, <br>Guernsey<br>|
| GS Twenty Two Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| HSBC Senior Global Infrastructure Debt <br>Fund<br>| U | 100.00% | 8 Canada Square, London, E14 5HQ, United Kingdom |
| ICICI Prudential Asset Management <br>Company Limited<br>| OS | 34.59% | 12th Floor, Narain Manzil, 23, Barakhamba Road, New Delhi <br>110001, India<br>|
| ICICI Prudential Life Insurance Company <br>Limited<br>| OS | 21.93% | ICICI PruLife Towers, 1089 Appasaheb Marathe Marg, <br>Prabhadevi, Mumbai 400025, India<br>|
| ICICI Prudential Pension Funds <br>Management Company Limited<br>| OS | 21.93% | Unit No. A, 2nd Floor, Cnergy Building, Appasaheb Marathe <br>Marg, Prabhadevi, Mumbai, Maharashtra - 400025, India<br>|
| ICICI Prudential Trust Limited | OS | 49.00% | 12th Floor, Narain Manzil, 23, Barakhamba Road, New Delhi <br>110001, India<br>|
| iShares Core MSCI Asia | U | 44.86% | 16th Floor, Champion Tower, 3 Garden Road, Central, Hong <br>Kong<br>|
| iShares MSCI Asia ex Japan Climate <br>Action ETF<br>| U | 48.85% | 20 Anson Road, #18-01 Twenty Anson, Singapore 079912 |
| iShares MSCI Europe ESG Enhanced <br>UCITS ETF<br>| U | 47.56% | 12 Throgmorton Avenue, London, EC2N 2DL, United Kingdom |
| iShares MSCI USA ESG Enhanced UCITS <br>ETF<br>| U | 41.49% | 78 Sir John Rogerson's Quay, Dublin, D02 HD32, Ireland |
| KKP Active Equity Fund | U | 29.91% | 209 KKP Tower A, 17 Fl., Sukhumvit 21 (Asoke), Khlong Toey <br>Nua, Wattana, Bangkok 10110, Thailand<br>|
| Krungsri Greater China Equity Hedged <br>Dividend Fund<br>| U | 22.00% | 12th, 18th Zone B Floor, Ploenchit Tower 898 Ploenchit Road, <br>Lumpini Pathumwan, Bangkok 10330, Thailand<br>|
| Lasalle Property Securities SICAV-FIS | U | 99.95% | 11-13 Bouldevard de la Foire, L-1528 Luxembourg |
| M&G Asia Property TS Trust | U | 100.00% | 8 Marina Boulevard, #05-02 Marina Bay, Financial Centre, <br>Singapore, 018981<br>|
| M&G Real Estate Asia Holding Company <br>Pte. Ltd.<br>| OS | 33.00% | 138 Market Street, #35-01 CapitaGreen, Singapore 048946 |
| Manulife Asia Pacific Bond Fund | U | 60.89% | 9th Floor, No 89 Son Ren Road, Taipei, Taiwan |
| Manulife China Offshore Bond Fund | U | 68.24% |  |
| Manulife Global Equity Fund | U | 25.71% |  |
| Manulife Superior Selection China Fund | U | 27.98% |  |
| Manulife Taiwan Dynamic Fund | U | 20.48% |  |
| MEAG FlexConcept  | U | 74.98% | R.C.S. Luxembourg NR. 28878, 1c, rue Gabriel Lippmann, <br>L-5365 Munsbach<br>|
| Nomura Global Shariah Sustainable <br>Equity Fund<br>| U | 28.39% | Suite No 12.2, Level 12, Menara IMC,No.8 Jalan Sultan <br>Ismail,Kuala Lumpur,50250,WP Kuala Lumpur, Malaysia<br>|
| North Sathorn Holdings Company <br>Limited<br>| OS | 100.00% | No. 63, Athenee Tower, 34th Floor, Wireless Road, Lumpini <br>Subdistrict Pathumwan District, Bangkok Metropolis, Thailand |
|  | PS | 99.99% | No. 63, Athenee Tower, 34th Floor, Wireless Road, Lumpini <br>Subdistrict Pathumwan District, Bangkok Metropolis, Thailand |
| PCA IP Services Limited | OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| PCA Life Assurance Co., Ltd. | OS | 99.79% | 8th Floor, No.1 Songzhi Road, Taipei City, 11047, Taiwan |
| PCA Reinsurance Co. Ltd. | OS | 100.00% | Unit Level 13(A), Main Office Tower, Financial Park Labuan, <br>Jalan Merdeka, 87000 Federal Territory of Labuan, Malaysia<br>|
| Pinebridge ESG Emerging Market <br>Corporate Strategy Bond Fund<br>| U | 24.59% | 10th Floor, No. 144, Sec. 2, Minquan East Rd, Taipei, Taiwan |
| Pinebridge US Dual Core Income Fund | U | 23.54% |  |
| Principal Core Fixed Income Fund | U | 24.43% | 44, 16th Floor, CIMB Thai Bank, Lungsuan Road, Lumpini, <br>Bangkok 10330, Thailand <br>|
| Principal Global Silver Age Fund | U | 35.07% |  |
| Principal Islamic Malaysia Government <br>Sukuk Fund<br>| U | 50.87% | Level 32, Exchange 106, Lingkaran TRX, 55188 Tun Razak <br>Exchange, Kuala Lumpur, Malaysia<br>|
| Principal Malaysia Titans Fund | U | 63.07% | Level 31, Exchange 106, Lingkaran TRX, 55188 Tun Razak <br>Exchange, Kuala Lumpur, Malaysia<br>|

---

---

| | | | |
|:---|:---|:---|:---|
| Pru Life Insurance Corporation of U.K. | OS | 100.00% | 9th Floor, Uptown Place Tower 1, 1 East 11th Drive, Uptown <br>Bonifacio, 1634 Taguig City, Metro Manila, Philippines<br>|
| Prudence Foundation | LBG | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential (Cambodia) Life Assurance <br>Plc<br>| OS | 100.00% | Chip Mong Tower Building, Units L19, L20, and L21, 19th, <br>20th, 21st Floor, Russian Federation Blvd (110), Phum 10, <br>Sangkat Phsar Depou 3, Khan Tuol Kork, Phnom Penh, <br>Cambodia<br>|
| Prudential (US Holdco 1) Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential Africa Holdings Limited | OS | 100.00% |  |
| Prudential Africa Services Limited | OS | 100.00% | 3rd Floor, One Africa Place, LR No. 1870/X/45, P.O. Box <br>1393-00606, Westlands, Nairobi, Kenya<br>|
| Prudential Assurance Company <br>Singapore (Pte) Limited<br>| OS | 100.00% | 30 Cecil Street, #30-01 Prudential Tower, Singapore 049712 |
| Prudential Assurance Malaysia Berhad | OS | 51.00% | Level 26, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia<br>|
| Prudential Assurance Uganda Limited | OS | 100.00% | 9th Floor Zebra Plaza, Plot 23 Kampala Road, P.O. Box 2660, <br>Kampala, Uganda<br>|
| Prudential Bermuda ISAC Ltd. | OS | 100.00% | Clarendon House, 2 Church Street, Hamilton HM11, Bermuda |
| Prudential Bermuda Re ISA, Ltd. | OS | 100.00% |  |
| Prudential BSN Takaful Berhad | OS | 49.00% | Level 13, Menara Prudential, Persiaran TRX Barat, 55188 Tun <br>Razak Exchange, Kuala Lumpur, Malaysia<br>|
| Prudential Corporation Asia Limited | OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential Corporation Holdings Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential Enterprise Management <br>(Beijing) Co., Ltd.<br>| MI-WFOE  | 100.00% | Unit 1817, Level 18, Building 1, No.1 Jianguomenwai Avenue, <br>Chaoyang District, Beijing, China<br>|
| Prudential Financial Advisers Singapore <br>Pte. Ltd.<br>| OS | 100.00% | 30 Cecil Street, #30-01 Prudential Tower, Singapore 049712 |
| Prudential Financial Partners HK Limited | OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential Funding (Asia) PLC | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential General Insurance Hong Kong <br>Limited<br>| OS | 100.00% | 59th Floor, One Island East, 18 Westlands Road, Quarry Bay, <br>Hong Kong<br>|
| Prudential Group Holdings Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential Group Secretarial Services HK <br>Limited<br>| OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential Group Secretarial Services <br>Limited<br>| OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential HCL Health Insurance Limited | OS | 70.00% | Suite 6, 48th Floor, Commerz III, International Business Park, <br>Oberoi Garden City, Off Western Express Highway, Goregaon <br>(East), Mumbai, 400063, India<br>|
| Prudential Holdings Limited | OS | 100.00% | 4th Floor, Saltire Court, 20 Castle Terrace, Edinburgh, EH1 <br>2EN, United Kingdom<br>|
| Prudential Hong Kong Limited | OS | 100.00% | 59th Floor, One Island East, 18 Westlands Road, Quarry Bay, <br>Hong Kong<br>|
| Prudential International Treasury <br>Limited<br>| OS | 100.00% | 13th Floor, One International Finance Centre, 1 Harbour View <br>Street, Central, Hong Kong<br>|
| Prudential Investment Fund - Post <br>Retirement Care Investment Fund<br>| U | 38.98% | F377/9/H/3, Kabulonga Road, Kabulonga, Lusaka, Zambia |
| Prudential Investment Fund - Pru <br>Offshore Fund<br>| U | 28.64% |  |
| Prudential Investment Management <br>Private Limited<br>| OS | 100.00% | 1 Pasir Panjang Road, #12-02, Singapore 118479 |
| Prudential IP Services Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential Life Assurance (Lao) <br>Company Limited<br>| OS | 100.00% | 5th Floor, Lao International Business and Tourist Center Project <br>(Vientiane Center), Khouvieng Road, Nongchan Village, <br>Sisattanak District, Vientiane Capital, Lao PDR<br>|
| Prudential Life Assurance (Thailand) <br>Public Company Limited<br>| OS | 99.93% | 944 Mitrtown Office Tower, 10th, 29th-31st Floor, Rama 4 <br>Road, Wangmai, Pathumwan, Bangkok, 10330, Thailand<br>|
| Prudential Life Assurance Kenya Limited | OS | 100.00% | Vienna Court, Ground Floor, State House Crescent, Off State <br>House Avenue, P.O. Box 25093-00603, Nairobi, Kenya<br>|
| Prudential Life Assurance Zambia <br>Limited<br>| OS | 100.00% | Prudential House, Plot No. 32256, Thabo Mbeki Road, P.O. Box <br>31357, Lusaka, Zambia<br>|
| Prudential Life Insurance Ghana Limited | OS | 100.00% | 12th Floor, 335 Place, N1, North Dzorwulu, Accra, Accra <br>Metropolitan, Greater Accra, P.O. Box AN 10476, Ghana<br>|
| Prudential Life Vault Limited | OS | 100.00% | 48 Awolowo Road, South-West Ikoyi, Lagos, Nigeria |
| Prudential Life Vault Limited | PS | 100.00% |  |

---

---

| | | | |
|:---|:---|:---|:---|
| Prudential Mauritius Holdings Limited | OS | 100.00% | 3rd Floor, 355 NEX, Rue du Savoir, Cybercity Ebene 72201, <br>Mauritius<br>|
| Prudential Myanmar Life Insurance <br>Limited<br>| OS | 100.00% | #15-01, 15th Floor, Sule Square, 221 Sule Pagoda Road, <br>Kyauktada Township, Yangon, Myanmar<br>|
| Prudential Pensions Management <br>Zambia Limited<br>| OS | 49.00% | Prudential Pensions Management Zambia Limited Support <br>Office, Plot F/377/9/H/3, Kabulonga Road, Kabulonga, Lusaka, <br>Zambia<br>|
| Prudential Services Asia Sdn. Bhd. | OS | 100.00% | Suite 1005, 10th Floor, Wisma Hamzah-Kwong Hing, No. 1 <br>Leboh Ampang, 50100 Kuala Lumpur, Malaysia<br>|
|  | PS | 51.00% |  |
| Prudential Services Limited | OS | 100.00% | 5th Floor, 10 Old Bailey, London, EC4M 7NG, United Kingdom |
| Prudential Services Philippines <br>Corporation<br>| OS | 100.00% | 19th Floor Uptown Place Tower I East, 11th Drive Uptown <br>Bonifacio Fort Bonifacio Bonifacio Global City, Taguig City, <br>Fourth District, National Capital Region (NCR), 1630, <br>Philippines<br>|
| Prudential Services Singapore Pte. Ltd. | OS | 100.00% | 1 Pasir Panjang Road, #12-02, Singapore 118479 |
| Prudential Singapore Holdings Pte. <br>Limited<br>| OS | 100.00% | 30 Cecil Street, #30-01 Prudential Tower, Singapore 049712 |
|  | PS | 100.00% |  |
| Prudential Technology and Services <br>India Private Limited<br>| OS | 100.00% | Unit 401, 4th Floor, CIGNUS, Tower-1, Whitefield Bangalore, <br>Hoodi Village, K.R. Puram Hobli, Whitefield, Bangalore, <br>Bangalore South, Karnataka, India, 560066<br>|
| Prudential Vietnam Assurance Private <br>Limited<br>| OS | 100.00% | 25th Floor Saigon Trade Center, 37 Ton Duc Thang Street, Sai <br>Gon Ward, Ho Chi Minh City, Vietnam<br>|
| Prudential Zenith Life Insurance Limited | OS | 100.00% | 6th Floor, Civic Towers, Plots Ga & G1 Ozumba Mbadiwe <br>Avenue, Victoria Island, Lagos, Nigeria<br>|
| PT Prudential Sharia Life Assurance | OS | 94.62% | Prudential Tower, 2nd Floor, Jl. Jend. Sudirman Kav. 79, <br>Jakarta 12910, Indonesia<br>|
| PT. Eastspring Investments Indonesia | OS | 99.95% | 23rd Floor, Prudential Tower, JL. Jend. Sudirman Kav.79, <br>Jakarta 12910, Indonesia<br>|
| PT. Prudential Life Assurance | OS | 94.62% | Prudential Tower, Jl. Jend. Sudirman Kav. 79, Jakarta 12910, <br>Indonesia<br>|
| Pulse Ecosystems Pte. Ltd. | OS | 100.00% | 1 Pasir Panjang Road, #12-02, Singapore 118479 |
| Reksa Dana Eastspring IDR Fixed <br>Income Fund (NDEIFF)<br>| U | 95.42% | Prudential Tower, 23rd Floor, Jl. Jend. Sudirman Kav.79, <br>Jakarta 12910, Indonesia<br>|
| Reksa Dana Syariah Eastspring Syariah <br>Fixed Income Amanah<br>| U | 76.89% |  |
| Reksa Dana Syariah Eastspring Syariah <br>Mixed Asset Fund<br>| U | 34.11% | Prudential Tower Lantai 23, JL, Jend. Sudirman Kav. 79, <br>Kakarta 12910 - Indonesia<br>|
| Reksa Dana Syariah Eastspring Syariah <br>Money Market Khazanah<br>| U | 67.70% | Prudential Tower, 23rd Floor, Jl. Jend. Sudirman Kav.79, <br>Jakarta 12910, Indonesia<br>|
| Rhodium Investment Funds - Singapore <br>Bond Fund<br>| U | 99.99% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936 |
| Rhodium Passive Long Dated Bond Fund | U | 99.93% | 7 Straits View, #09-01 Marina One East Tower, Singapore <br>018936 |
| Robeco QI European Active Index <br>Equities<br>| U | 43.61% | 6, route de Trèves, L-2633 Senningerberg, Grand Duchy of <br>Luxembourg<br>|
| Schroder Asian Investment Grade Credit | U | 26.05% | 138 Market Street, #23-01 CapitaGreen, Singapore 048946 |
| Schroder Emerging Markets Fund | U | 72.14% |  |
| Schroder Multi-Asset Revolution | U | 49.69% |  |
| Schroder US Dollar Money Fund | U | 29.48% | 9th Floor, No. 108, Section 5, Xinyi Road, Taipei, Taiwan |
| Scotts Spazio Pte. Ltd. | OS | 45.00% | 316 Tanglin Road, #01-01,Singapore, 247978 |
| Shanghai CPE Asset Management Co., <br>Ltd.<br>| MI - JV | 26.95% | Room 101-2, No.128 North Zhangjiabang Road, Pudong <br>District, Shanghai, China<br>|
| Shenzhen Prudential Technology Limited | MI - <br>WFOE<br>| 100.00% | Unit 5, 8th Floor, China Resources Tower, No.2666 Keyuan <br>South Road, Yuehai Street, Nanshan District, Shenzhen, <br>518054, China<br>|
| Sri Han Suria Sdn. Bhd. | OS | 51.00% | Suite 1005, 10th Floor, Wisma Hamzah-Kwong Hing, No. 1 <br>Leboh Ampang, 50100 Kuala Lumpur, Malaysia<br>|
| Staple Limited | OS | 100.00% | No. 63, Athenee Tower, 34th Floor, Wireless Road, Lumpini <br>Subdistrict Pathumwan District, Bangkok Metropolis, Thailand<br>|
| StepStone Prudential Private Credit <br>Fund<br>| U | 100.00% | 103 South Church Street, Harbour Place, 5th Floor, KY1-1202 <br>Cayman Islands<br>|
| Tisco US Equity Fund | U | 20.46% | 48/16-17, Tisco Tower Building, 9 Floor. North Sathorn, Silom, <br>Bangrak, Bangkok 10500<br>|
| United Global Innovation Fund | U | 20.43% | 23A, 25th Floor, Asia Centre Building, 173/27-30, 32-33 South <br>Sathorn Road, Thungmahamek, Sathorn, Bangkok 10120, <br>Thailand<br>|
| United Global Quality Equity Fund | U | 59.66% | Jln Raja Laut, City Centre, 50100 Kuala Lumpur, Wilayah <br>Persekutuan, Kuala Lumpur, Malaysia<br>|

---

---

| | | | |
|:---|:---|:---|:---|
| United Global Quality Growth Fund | U | 27.94% | 23A, 25th Floor, Asia Centre Building, 173/27-30, 32-33 South <br>Sathorn Road, Thungmahamek, Sathorn, Bangkok 10120, <br>Thailand<br>|
| United-I Malaysia Discovery Fund  | U | 32.95% | Level 20, UOB Plaza 1, 7, Jalan Raja Laut, 50350, Kuala <br>Lumpur, Malaysia<br>|
| United-I Malaysia Equity Fund  | U | 67.05% | Level 20, UOB Plaza 1, 7, Jalan Raja Laut, 50350, Kuala <br>Lumpur, Malaysia<br>|
| UOB Smart Global Healthcare Fund | U | 33.50% | 23A, 25th Floor, Asia Centre Building, 173/27-30, 32-33 South <br>Sathorn Road, Thungmahamek, Sathorn, Bangkok 10120, <br>Thailand<br>|
| UOB Smart Japan Small and Mid Cap <br>Fund<br>| U | 42.24% |  |
| UOB Smart Millennium Growth Fund | U | 31.06% |  |
| USD Investment Grade Infrastructure <br>Debt Fund SCSp<br>| U | 21.23% | 35a, Avenue John F. Kennedy, L-1855 Luxembourg, Grand <br>Duchy of Luxembourg<br>|

---

\*Prudential Assurance Malaysia Berhad is consolidated in the Group's consolidated financial statements reflecting the controlling interest of the Group. In

January 2026, the Group acquired an additional 19 per cent stake in Sri Han Suria Sdn. Bhd., the holding company that owns Prudential Assurance Malaysia

Berhad, increasing the Group's aggregate stake to 70 per cent going forward (see note D2 for further details).

†Prudential BSN Takaful Berhad is a joint venture that is accounted for using the equity method, for which the Group has an economic interest of 70 per cent for

all business sold up to 31 December 2016 and of 49 per cent for new business sold subsequent to this date.

‡The holding of 94.62 per cent for PT. Prudential Life Assurance represents the proportion held in the Indonesia subsidiary attaching to the aggregate of the

shares across the types of capital in issue.

The below table lists the issued share capital of the subsidiaries of the Group which, in the opinion of the Directors, principally

affect the results or assets of the Group:

---

| | |
|:---|:---|
| **Name of entity** | **Issued and fully paid up share / registered capital** |
| Prudential Assurance Company Singapore (Pte) Limited | 526,557,000 ordinary shares of SGD 1 each |
| PT. Prudential Life Assurance | 105,500 ordinary shares and 6,000 preference shares of RP <br>1,000,000 each <br>|
| Prudential Hong Kong Limited | 3,691,854,873 ordinary shares of HKD 1 each |
| Prudential Assurance Malaysia Berhad | 100,000,000 ordinary shares of RM 1 each |

---

**Index to the Condensed financial information of registrant Prudential plc**

---

| | |
|:---|:---|
| | Page |
| [Profit and Loss Accounts for the years ended 31 December 2025, 2024 and 202](#if20250981a0d46e4b669404805d1a109_583)3 | [254](#if20250981a0d46e4b669404805d1a109_583) |
| [Statements of Financial Position at 31 December 2025 and 202](#if20250981a0d46e4b669404805d1a109_589)4 | [255](#if20250981a0d46e4b669404805d1a109_589) |
| [Statements of Changes in Equity for the years ended 31 December 2025, 2024 and 202](#if20250981a0d46e4b669404805d1a109_595)3 | [256](#if20250981a0d46e4b669404805d1a109_595) |
| [Statements of Cash Flows for the years ended 31 December 2025, 2024 and 202](#if20250981a0d46e4b669404805d1a109_9655)3 | [257](#if20250981a0d46e4b669404805d1a109_9655) |
| [Notes to the Condensed Financial I](#if20250981a0d46e4b669404805d1a109_601)nformation | [258](#if20250981a0d46e4b669404805d1a109_601) |

---

**Schedule II** 

**Condensed Financial Information of Registrant Prudential plc** 

**Profit and Loss Accounts (FRS 101 Basis)** 

---

| | | | |
|:---|:---|:---|:---|
| Years ended 31 Dec | **2025 $m** | 2024 $m | 2023 $m |
| Investment income, including dividends received from subsidiary undertakings | **2191** | 825 | 1430 |
| Investment expenses and charges | **(224)** | (209) | (203) |
| Gain on transfer of debt to Prudential Funding (Asia) PLC  | **–** | – | 370 |
| Write-down of investment in Prudential Group Holdings Limited | **(482)** | – | – |
| Gains on financial instruments held at fair value through profit and loss | **(161)** | 210 | – |
| Other corporate income (expenditure) | **1** | (39) | (47) |
| Foreign currency exchange losses | **(7)** | (1) | (27) |
| **Profit on ordinary activities before tax** | **1318** | 786 | 1523 |
| Tax credit on profit on ordinary activities | **–** | – | 2 |
| **Profit for the year** | **1318** | 786 | 1525 |
| **Other comprehensive income:** |  |  |  |
| Valuation movements on retained interest in Jackson measured at fair value through <br>other comprehensive income<br>| **–** | – | 8 |
| **Total comprehensive income for the year** | **1318** | 786 | 1533 |

---

*The accompanying notes are an integral part of this condensed financial information*

**Schedule II** 

**Condensed Financial Information of Registrant Prudential plc** 

**Statements of Financial Position (FRS 101 Basis)**

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| **Fixed assets** |  |  |
| Investments in subsidiary undertakings | **13308** | 13789 |
| **Current assets** |  |  |
| Amounts owed by subsidiary undertakings | **8067** | 6577 |
| Cash at bank and in hand | **42** | 107 |
| Prepayments and other debtors | **2** | 3 |
|  | **8111** | 6687 |
| **Liabilities: amounts falling due within one year** |  |  |
| Amounts owed to subsidiary undertakings | **(1754)** | (852) |
| Tax payable | **(9)** | (8) |
| Other liabilities | **(1)** | (19) |
|  | **(1764)** | (879) |
| **Net current assets** | **6347** | 5808 |
| **Total assets less current liabilities** | **19655** | 19597 |
| **Liabilities: amounts falling due after more than one year** |  |  |
| Amounts owed to subsidiary undertakings | **(4210)** | (3637) |
| **Total net assets** | **15445** | 15960 |
| **Capital and reserves** |  |  |
| Share capital | **169** | 176 |
| Capital redemption reserve | **14** | 7 |
| Share premium | **5011** | 5009 |
| Profit and loss account | **10251** | 10768 |
| **Shareholders' funds** | **15445** | 15960 |

---

*The accompanying notes are an integral part of this condensed financial information* 

**Condensed Financial Information of Registrant Prudential plc** 

**Statements of Changes in Equity (FRS 101 basis)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Share capital**<br>**$m**<br>| **Share** <br>**premium**<br>**$m**<br>| **Capital** <br>**redemption** <br>**reserve**<br>**$m**<br>| **Profit and** <br>**loss account**<br>**$m**<br>| **Shareholders'** <br>**funds**<br>**$m**<br>|
| **Balance at 1 Jan 2023** | 182 | 5006 | – | 10354 | 15542 |
| Profit for the year | – | – | – | 1525 | 1525 |
| Valuation movements on Jackson equity securities measured <br>at fair value through other comprehensive income<br>| – | – | – | 8 | 8 |
| **Total comprehensive income for the year** | – | – | – | 1533 | 1533 |
| **Transactions with owners, recorded directly in equity** |  |  |  |  |  |
| New share capital subscribed | 1 | 3 | – | – | 4 |
| Share-based payment transactions | – | – | – | 38 | 38 |
| Dividends | – | – | – | (533) | (533) |
| Total transactions with owners | 1 | 3 | – | (495) | (491) |
| **Balance at 31 Dec 2023 / 1 Jan 2024** | 183 | 5009 | – | 11392 | 16584 |
| **Profit and total comprehensive income for the year** | – | – | – | 786 | 786 |
| **Transactions with owners, recorded directly in equity** |  |  |  |  |  |
| **Share repurchase/buyback programmes** | (7) | – | 7 | (878) | (878) |
| Share-based payment transactions | – | – | – | 20 | 20 |
| Dividends | – | – | – | (575) | (575) |
| Effect of scrip dividends | – | – | – | 23 | 23 |
| Total transactions with owners | (7) | – | 7 | (1410) | (1410) |
| **Balance at 31 Dec 2024 / 1 Jan 2025** | **176** | **5009** | **7** | **10768** | **15960** |
| Profit and total comprehensive income for the year | **–** | **–** | **–** | **1318** | **1318** |
| **Transactions with owners, recorded directly in equity** |  |  |  |  |  |
| New share capital subscribed | **–** | **2** | **–** | **–** | **2** |
| Share repurchase/buyback programmes | **(7)** | **–** | **7** | **(1234)** | **(1234)** |
| Share-based payment transactions | **–** | **–** | **–** | **(7)** | **(7)** |
| Dividends | **–** | **–** | **–** | **(623)** | **(623)** |
| Effect of scrip dividends | **–** | **–** | **–** | **29** | **29** |
| Total transactions with owners | **(7)** | **2** | **7** | **(1835)** | **(1833)** |
| **Balance at 31 Dec 2025** | **169** | **5011** | **14** | **10251** | **15445** |

---

*The accompanying notes are an integral part of this condensed financial information* 

**Schedule II** 

**Condensed Financial Information of Registrant Prudential plc** 

**Statements of Cash Flows (FRS 101 Basis)** 

---

| | | | |
|:---|:---|:---|:---|
| **Years ended 31 Dec** | **2025 $m** | 2024 $m | 2023 $m |
| **Operating activities** |  |  |  |
| Net cash inflow from operating activities before interest and tax | **2001** | 983 | 1527 |
| Interest paid | **(176)** | (165) | (35) |
| Dividends paid | **(623)** | (575) | (533) |
| **Net cash flows from operating activities** | **1202** | 243 | 959 |
| **Financing activities** |  |  |  |
| Issuance of ordinary share capital | **2** | – | 4 |
| Redemption of core structural borrowings | **–** | – | (393) |
| Movement in commercial paper and other borrowings to support a short-term fixed <br>income securities program<br>| **–** | – | (501) |
| Movement in net amount owed to subsidiary undertakings | **1474** | 13 | – |
| Movement in share-based payment receivable | **–** | – | (4) |
| Non-cash transfer of debt to Prudential Funding (Asia) plc | **–** | – | (3552) |
| Movement in net amount owed by subsidiary undertakings | **(1491)** | 690 | 3610 |
| Share repurchase/buyback programmes (including costs) | **(1252)** | (860) | – |
| **Net cash flows from financing activities** | **(1267)** | (157) | (836) |
| **Investing activities** |  |  |  |
| Disposal of Jackson shares | **–** | – | 273 |
| Investment in subsidiaries | **–** | – | (609) |
| Capitalisation of intercompany loans | **–** | – | 189 |
| **Net cash flows from investing activities** | **–** | – | (147) |
| **Net cash (outflow) inflow for the year** | **(65)** | 86 | (24) |
| **Reconciliation of profit on ordinary activities before tax to net cash inflow from** <br>**operating activities before interest and tax**<br>|  |  |  |
| Profit on ordinary activities before tax | **1318** | 786 | 1523 |
| Add back: interest charged to profit or loss | **224** | 209 | 203 |
| Adjustments for non-cash items: |  |  |  |
| Gain on transfer of subordinated liabilities and debenture loans | **–** | – | (370) |
| Impairment of investment in Prudential Group Holdings Limited | **482** | – | – |
| Foreign currency exchange and other movements | **(7)** | (22) | 27 |
| Decrease (increase) in debtors | **1** | (3) | – |
| Increase (decrease) in creditors | **(17)** | 13 | 144 |
| **Net cash inflow from operating activities before interest and tax** | **2001** | 983 | 1527 |

---

*The accompanying notes are an integral part of this condensed financial information* 

**Condensed Financial Information of Registrant Prudential plc** 

**Notes to the Condensed Financial Information** 

**31 December 2025**

**1 Basis of preparation**

The financial statements of the Parent Company, which comprise the profit and loss accounts, statement of financial position,

statement of changes in equity, statement of cash flows and related notes, are prepared in accordance with UK Generally Accepted

Accounting Practice, including Financial Reporting Standard 101 Reduced Disclosure Framework ('FRS 101') and Part 15 of the

Companies Act 2006.

In preparing these financial statements, the Company applies the recognition, measurement and disclosure requirements in

accordance with international accounting standards adopted for use in the UK but makes amendments where necessary, in order

to comply with the Companies Act 2006.

The accounting policies set out in note 2 below have been applied consistently to both years presented in these financial

statements.

The Company and the Group manage cash resources, remittances and financing primarily in USD. Accordingly, the functional and

presentational currency of the Company is USD.

On the basis of the assessment of going concern for the Company and the Group as set out in note A1 to the Group IFRS

consolidated financial statements, the Directors consider it appropriate to continue to adopt the going concern basis of accounting

in preparing these financial statements for the year ended 31 December 2025.

**2 Significant accounting policies**

**Investments in subsidiary undertakings**

Investments in subsidiary undertakings are shown at cost less impairment. Investments are assessed for indicators of impairment,

and if any are identified, any impairment is assessed by comparing the net assets and value in use of the subsidiary undertakings

with the carrying value of the investments.

**Amounts owed by subsidiary undertakings**

Amounts owed by subsidiary undertakings are shown at cost less expected credit losses, which are determined using the expected

credit loss approach under IFRS 9.

**Financial instruments**

Under IFRS 9, except for derivative instruments (where applicable) that are mandatorily classified as FVTPL, all financial assets

and liabilities of the Company are held at amortised cost. The Company assesses impairment on its loans and receivables using

the expected credit loss approach. The expected credit loss on the Company's loans and receivables, the majority of which

represent loans to its subsidiaries, have been assessed by taking into account the probability of defaults on those loans. In all

cases, the subsidiaries are expected to have sufficient resources to repay the loans either now or over time based on projected

earnings. For loans recallable on demand, the expected credit loss has been limited to the impact of discounting the value of the

loan between the balance sheet date and the anticipated recovery date. For loans with a fixed maturity date, when held, the

expected credit loss has been determined with reference to the historical experience of loans with equivalent credit characteristics.

**Dividends**

Interim dividends are recorded in the year in which they are paid.

Cash and scrip dividends are initially recorded in the statement of changes in equity as a deduction from retained earnings, at the

value of the cash paid, or the cash equivalent to the scrip dividend. For scrip dividends settled by a new issue of shares the

deduction from retained earnings is subsequently reversed and an amount equal to the nominal value of shares issued is

transferred to share capital from share premium or the capital redemption reserve.

**Foreign currency translation**

Transactions not denominated in the Company's functional currency, USD, are initially recorded at the rate of currency prevailing

on the date of the transaction. Monetary assets and liabilities not denominated in the Company's functional currency are translated

to the Company's functional currency at year end spot rates. The impact of these currency translations is recorded within the

profit and loss account for the year.

**Tax**

Current tax recoverable (payable) recognised in the balance sheet is measured at the amount expected to be recovered from (paid

to) relevant tax authorities in accordance with the provisions of IAS 12 'Income Taxes'.

Deferred tax assets and liabilities are recognised in accordance with the provisions of IAS 12.

The Company has applied the IAS 12 paragraph 4A mandatory exemption from recognising and disclosing information on the

associated deferred tax assets and liabilities related to Pillar Two income taxes at 31 December 2025. For further details of the

impact of Pillar Two income taxes, refer to note B3 to the Group IFRS consolidated financial statements.

**Share-based payments**

The Group offers share awards and option plans for certain key employees and a Save As You Earn (SAYE) plan for all UK and

certain overseas employees. The share-based payment plans operated by the Group are mainly equity-settled.

Under IFRS 2 'Share-based payment', where the Company, as the parent company, has the obligation to settle the options or

awards of its equity instruments to employees of its subsidiary undertakings, and such share-based payments are accounted for

as equity-settled in the Group financial statements, the Company records an increase in the investment in subsidiary undertakings

for the value of the share options and awards granted with a corresponding credit entry recognised directly in equity. The value of

the share options and awards granted is based upon the fair value of the options and awards at the grant date, the vesting period

and the vesting conditions. Cash receipts from business units in respect of newly issued share schemes are treated as returns of

capital within investments in subsidiaries.

**3 Dividends received from subsidiary undertakings** 

The parent company received dividends totalling $2,087 million from its consolidated subsidiary undertakings in 2025 (2024: $710

million; 2023: $1,277 million).

**4 Reconciliation from the FRS 101 parent company results to the Group IFRS** 

**results**

The parent company financial statements are prepared in accordance with FRS 101 and the Group financial statements are

prepared in accordance with IFRS as issued by the IASB and international financial reporting standards adopted for use in the UK.

The tables below provide a reconciliation between the FRS 101 parent company results and the Group IFRS results.

---

| | | | |
|:---|:---|:---|:---|
| **Profit after tax** | **2025 $m** | 2024 $m | 2023 $m |
| Profit for the year of the Company in accordance with FRS 101  | **1318** | 786 | 1525 |
| Accounting policy difference <sup>note (i)</sup> | **(1)** | 11 | (65) |
| Share in the IFRS result of the Group, net of distributions to the Company <sup>note (ii)</sup> | **2661** | 1488 | 241 |
| **Profit after tax of the Group attributable to equity holders in accordance with IFRS** | **3978** | 2285 | 1701 |

---

---

| | | |
|:---|:---|:---|
| **Shareholders' equity** | **31 Dec 2025 $m** | 31 Dec 2024 $m |
| Shareholders' funds of the Company in accordance with FRS 101 | **15445** | 15960 |
| Accounting policy difference <sup>note (i)</sup> | **(1)** | 11 |
| Share in the IFRS net equity of the Group <sup>note(ii)</sup> | **4673** | 1521 |
| **Shareholders' equity of the Group in accordance with IFRS** | **20117** | 17492 |

---

**Notes**

(i)Accounting policy difference represents the difference in accounting for expected credit losses on loan assets.

(ii)The share in the IFRS result of the Group represents the Company's interest in the earnings of its subsidiaries, JVs and associates. The share in the IFRS net

equity of the Group represents the Company's interest in the net assets of its subsidiaries, JVs and associates. The movement compared with the prior year

reflects movements in the results of the Group relative to the result of the Company.

**5 Guarantees provided by the parent company**

In certain instances, the parent company has guaranteed that its subsidiaries will meet their obligations when they fall due for

payment.

**6 Share repurchase/buyback programmes**

On 23 December 2025 the Company completed its $2 billion share buyback programme to reduce the issued share capital of the

Company in order to return capital to shareholders, announced in 2024. As at 31 December 2025, 201.4 million (2024:

92.1 million) ordinary shares in aggregate have been repurchased for a total consideration excluding costs of approximately

$1,996 million (2024: $785 million).

Further details of the share repurchase/buyback programmes by the Company are provided in note C8 to the Group IFRS

consolidated financial statements.

**7 Post balance sheet events**

**Dividends**

The second interim dividend for the year ended 31 December 2025, which was approved by the Board of Directors after

31 December 2025, is described in note B5 to the IFRS consolidated Group financial statements.

**Share Buyback**

On 6 January 2026 the Company announced that it will commence a buyback programme of its ordinary shares up to a maximum

aggregate amount of $1.2 billion. It is intended that this buyback will be completed by no later than 18 December 2026.

**Index to the additional unaudited financial information**

---

| | | |
|:---|:---|:---|
| Section | Section | Page |
| I | **[Additional financial information](#if20250981a0d46e4b669404805d1a109_13487)** | [261](#if20250981a0d46e4b669404805d1a109_13487) |
| (i) | [Group capital position](#if20250981a0d46e4b669404805d1a109_772) | [261](#if20250981a0d46e4b669404805d1a109_772) |
| (ii) | [Eastspring adjusted operating profit and funds under management or advice](#if20250981a0d46e4b669404805d1a109_775) | [264](#if20250981a0d46e4b669404805d1a109_775) |
| (iii) | [Group funds under management](#if20250981a0d46e4b669404805d1a109_778) | [265](#if20250981a0d46e4b669404805d1a109_778) |
| II | **[Calculation of alternative performance measures](#if20250981a0d46e4b669404805d1a109_7138)** | [266](#if20250981a0d46e4b669404805d1a109_7138) |
| (i) | A[djusted operating profit](#if20250981a0d46e4b669404805d1a109_799) | [266](#if20250981a0d46e4b669404805d1a109_799) |
| (ii) | [Return on IFRS shareholders' equity](#if20250981a0d46e4b669404805d1a109_805) | [266](#if20250981a0d46e4b669404805d1a109_805) |
| (iii) | [IFRS shareholders' equity per share](#if20250981a0d46e4b669404805d1a109_808) | [266](#if20250981a0d46e4b669404805d1a109_808) |
| (iv) | [Eastspring cost/income ratio](#if20250981a0d46e4b669404805d1a109_811) | [266](#if20250981a0d46e4b669404805d1a109_811) |
| (v) | [Insurance premiums](#if20250981a0d46e4b669404805d1a109_10633) | [266](#if20250981a0d46e4b669404805d1a109_10633) |

---

**I Additional unaudited financial information**

**I(i) Group capital position** 

Prudential applies the Insurance (Group Capital) Rules set out in the Group-wide Supervision (GWS) Framework issued by the

Hong Kong IA to determine group regulatory capital requirements (both minimum and prescribed levels). For regulated insurance

entities, the capital resources and required capital included in the GWS capital measure for Hong Kong IA Group regulatory

purposes are based on the local solvency regime applicable in each jurisdiction. The Group holds material participating business in

Hong Kong, Singapore and Malaysia. Alongside the total regulatory GWS capital basis, a shareholder GWS capital basis is also

presented which excludes the contribution to the Group GWS eligible group capital resources, the Group Minimum Capital

Requirements (GMCR) and the Group Prescribed Capital Requirements (GPCR) from these participating funds.

The Group monitors regulatory capital, economic capital and rating agency capital metrics and manages the business within its

risk appetite by remaining within its economic and regulatory capital limits. While the GWS shareholder capital position is a key

metric for assessing regulatory solvency, and for risk management, there are some elements of the shareholder GWS capital

surplus that will only become available as cash flow for distribution over time. The Group's free surplus metric is a better measure

of the shareholder capital available for distribution and is used as the primary metric for assessing the Group's sources and uses of

capital in the Group's capital management framework, and underpinning the Group's dividend policy. Further details are included

in the Capital management section of the Financial review.

Separate from the capital management framework applied for shareholder-owned capital, the capital held in ring-fenced with-

profits funds supports policyholder investment freedom, which increases expected returns for our with-profits funds' customers.

GWS policyholder capital surplus is not available for distribution out of the ring-fenced funds other than as a defined proportion

distributable to shareholders when policyholder bonuses are declared.

**Estimated GWS capital position** 

As at 31 December 2025, the estimated shareholder GWS capital surplus over the GPCR is $17.1 billion (31 December 2024:

$15.9 billion), representing a coverage ratio of 262 per cent (31 December 2024: 280 per cent) and the estimated total GWS

capital surplus over the GPCR is $23.1 billion (31 December 2024: $20.9 billion), representing a coverage ratio of 197 per cent

(31 December 2024: 203 per cent). The estimated Group Tier 1 capital resources are $21.4 billion with headroom over the GMCR

of $14.6 billion (31 December 2024: $18.9 billion with headroom of $13.1 billion), representing a coverage ratio of 316 per cent

(31 December 2024: 325 per cent).

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | 31 Dec 2024  | 31 Dec 2024  | 31 Dec 2024  | |
|  | **Shareholder** | **Add**<br>**policyholder**<br>| **Total** | Shareholder | Add<br>policyholder<br>| Total | |
| | | **note (1)** | **note (2)** | | note (1) | note (2) | <br>Change<br>in total<br>note (3) |
| Group capital resources ($bn) | **27.6** | **19.3** | **46.9** | 24.8 | 16.3 | 41.1 | 5.8 |
| of which: Tier 1 capital resources ($bn) <sup>note (4)</sup> | **19.9** | **1.5** | **21.4** | 17.6 | 1.3 | 18.9 | 2.5 |
| Group Minimum Capital Requirement ($bn) | **6.0** | **0.8** | **6.8** | 5.1 | 0.7 | 5.8 | 1.0 |
| Group Prescribed Capital Requirement ($bn) | **10.5** | **13.3** | **23.8** | 8.9 | 11.3 | 20.2 | 3.6 |
| **GWS capital surplus over GPCR ($bn)** | **17.1** | **6.0** | **23.1** | 15.9 | 5.0 | 20.9 | 2.2 |
| **GWS coverage ratio over GPCR (%)** | **262%** |  | **197%** | 280% |  | 203% | (6)% |
| **GWS Tier 1 surplus over GMCR ($bn)** |  |  | **14.6** |  |  | 13.1 | 1.5 |
| **GWS Tier 1 coverage ratio over GMCR (%)** |  |  | **316%** |  |  | 325% | (9)% |

---

**Notes**

(1)This allows for any associated diversification impacts between the shareholder and policyholder positions reflected in the total company results where relevant.

(2)The total company GWS coverage ratio over GPCR presented above represents the eligible group capital resources coverage ratio as set out in the GWS

framework while the total company GWS tier 1 coverage ratio over GMCR represents the tier 1 group capital coverage ratio.

(3)Refer to section on Material changes in GMCR, GPCR, tier 1 group capital and eligible group capital resources below.

(4)The classification of tiering of capital under the GWS framework reflects the different local regulatory regimes along with guidance issued by the Hong Kong IA.

At 31 December 2025, total Tier 1 capital resources of $21.4 billion comprises: $27.6 billion of total shareholder capital resources; less $(4.1) billion of

Prudential plc issued subordinated and senior Tier 2 debt capital; less $(3.6) billion of local regulatory tiering classifications, which are classified as GWS Tier 2

capital resources primarily in Singapore and Mainland China; plus $1.5 billion of Tier 1 capital resources in policyholder funds.

**GWS sensitivity analysis**

The estimated sensitivity of the GWS capital position (based on the GPCR) to changes in market conditions as at 31 December

2025 and 31 December 2024 are shown below, for both the shareholder and the total capital position.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Shareholder | Shareholder | Shareholder | Shareholder |
|  | **31 Dec 2025** | **31 Dec 2025** | 31 Dec 2024 | 31 Dec 2024 |
| **Impact of market sensitivities** | **Surplus $bn** | **Coverage** <br>**ratio %**<br>| Surplus $bn | Coverage ratio %<br>|
| Base position | **17.1** | **262%** | 15.9 | 280% |
| Impact of: |  |  |  |  |
| 10% increase in equity markets | **0.4** | **0%** | 0.2 | (3)% |
| 20% fall in equity markets | **(0.7)** | **9%** | (0.8) | 5% |
| 50 basis points reduction in interest rates | **1.3** | **9%** | 1.1 | 10% |
| 100 basis points increase in interest rates | **(3.3)** | **(27)%** | (2.6) | (25)% |
| 100 basis points increase in credit spreads | **(0.6)** | **(4)%** | (0.5) | (4)% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Total | Total | Total | Total |
|  | **31 Dec 2025** | **31 Dec 2025** | 31 Dec 2024 | 31 Dec 2024 |
| Impact of market sensitivities | **Surplus $bn** | **Coverage** <br>**ratio %**<br>| Surplus $bn | Coverage ratio %<br>|
| Base position | **23.1** | **197%** | 20.9 | 203% |
| Impact of: |  |  |  |  |
| 10% increase in equity markets | **1.4** | **1%** | 1.1 | 1% |
| 20% fall in equity markets | **(2.9)** | **(2)%** | (2.8) | (4)% |
| 50 basis points reduction in interest rates | **1.1** | **4%** | 0.8 | 4% |
| 100 basis points increase in interest rates | **(3.2)** | **(13)%** | (2.6) | (13)% |
| 100 basis points increase in credit spreads | **(1.3)** | **(5)%** | (1.3) | (7)% |

---

The sensitivity results assume instantaneous market movements and, hence, reflect the current investment portfolio and all

consequential impacts as at the valuation date. If the economic conditions set out in the sensitivities persisted, the financial

impacts may differ to the instantaneous impacts shown above. These sensitivity results allow for limited management actions such

as changes to future policyholder bonuses where applicable. In practice, the market movements would be expected to occur over

time and rebalancing of investment portfolios would likely be carried out to mitigate the impact of the stresses as presented

above. Management could also take additional actions to help mitigate the impact of these stresses including, but not limited to,

market risk hedging, increased use of reinsurance, repricing of in-force benefits, changes to new business pricing and the mix of

new business being sold.

**Material changes in GMCR, GPCR, tier 1 group capital and eligible group capital** 

**resources** 

Detail on the material changes in GPCR, GMCR, eligible group capital resources and tier 1 group capital are provided below.

–Total eligible capital resources increased by $5.8 billion to $46.9 billion at 31 December 2025 (31 December 2024:

$41.1 billion). This includes a $2.5 billion increase in tier 1 group capital to $21.4 billion (31 December 2024: $18.9 billion) and

a $3.3 billion increase in tier 2 group capital to $25.5 billion (31 December 2024: $22.2 billion). The increase in total eligible

capital resources is primarily driven by positive operating capital generation, issuance of subordinated debt, proceeds from the

IPO of ICICI Prudential Asset Management Company Limited (IPAMC) as detailed in note D6.3, and positive market (including

foreign exchange) movements over the year, partially offset by payments of external dividends and share repurchases/buybacks

over the year.

–Total regulatory GPCR increased by $3.6 billion to $23.8 billion at 31 December 2025 (31 December 2024: $20.2 billion), while

the total regulatory GMCR increased by $1.0 billion to $6.8 billion at 31 December 2025 (31 December 2024: $5.8 billion).

Movements in the GPCR and GMCR are primarily driven by increases from new business sold and market (including foreign

exchange) movements over the year, offset by the release of capital as the policies matured or were surrendered over the year.

**Reconciliation of Group IFRS shareholders' equity to Group total GWS capital resource** 

---

| | |
|:---|:---|
| | **31 Dec 2025** <br>**$bn**<br>|
| **Group IFRS shareholders' equity** | **20.1** |
| Remove goodwill and intangibles recognised on the IFRS consolidated statement of financial position | **(4.7)** |
| Add debt treated as capital under GWS <sup>note (1)</sup> | **4.1** |
| Asset valuation differences <sup>note (2)</sup> | **(0.5)** |
| Remove IFRS 17 CSM (including joint ventures and associates) <sup>note (3)</sup> | **23.9** |
| Liability valuation (including insurance contracts) differences excluding IFRS 17 CSM <sup>note(4)</sup> | **2.9** |
| Differences in associated net deferred tax liabilities <sup>note (5)</sup> | **1.1** |
| **Group total GWS capital resources** | **46.9** |

---

**Notes**

(1)As per the GWS Framework, debt in issuance at the date of designation that satisfies the criteria for transitional arrangements, and qualifying debt issued since

the date of designation, are included as Group capital resources but are treated as liabilities under IFRS.

(2)Asset valuation differences reflect differences in the basis of valuing assets between IFRS and local statutory valuation rules, including deductions for

inadmissible assets. Differences include for some markets where government and corporate bonds are valued at book value under local regulations but are

valued at market value under IFRS.

(3)The IFRS 17 CSM represents a discounted stock of unearned profit that is released over time as services are provided. On a GWS basis the level of future

profits will be recognised within the capital resources to the extent permitted by the local solvency reserving basis. Any restrictions applied by the local

solvency bases (such as zeroisation of future profits) is captured in the liability valuation differences line.

(4)Liability valuation differences (excluding the CSM) reflect differences in the basis of valuing liabilities between IFRS and local statutory valuation rules. This

includes the negative impact of moving from the IFRS 17 best estimate reserving basis to a more prudent local solvency reserving basis (including any

restrictions in the recognition of future profits) offset by the fact that certain local solvency regimes capture some reserves within the required capital instead of

the capital resources.

(5)Differences in associated net deferred tax liabilities mainly results from the tax impact of changes in the valuation of assets and liabilities.

**Basis of preparation for the Group GWS capital position** 

Prudential applies the Insurance (Group Capital) Rules set out in the GWS Framework to determine group regulatory capital

requirements (both minimum and prescribed levels). The summation of local statutory capital requirements across the Group is

used to determine group regulatory capital requirements, with no allowance for diversification between business operations. The

GWS eligible group capital resources are determined by the summation of capital resources across local solvency regimes for

regulated entities and IFRS shareholders' equity (with adjustments described below) for non-regulated entities.

In determining the GWS eligible group capital resources and required capital, the following principles have been applied:

–For regulated insurance entities, capital resources and required capital are based on the local solvency regime applicable in each

jurisdiction, with minimum required capital set at the solo legal entity statutory minimum capital requirements and prescribed

capital requirement set at the level at which the local regulator of a given entity can impose penalties, sanctions or intervention

measures;

–The classification of tiering of eligible capital resources under the GWS framework reflects the different local regulatory regimes

along with guidance issued by the Hong Kong IA. In general, if a local regulatory regime applies a tiering approach, then this

should be used to determine tiering of capital on a GWS capital basis, where a local regulatory regime does not apply a tiering

approach then all capital resources should be included as Group Tier 1 capital. For non-regulated entities tiering of capital is

determined in line with the Insurance (Group Capital) Rules.

–For asset management operations and other regulated entities, the capital position is derived based on the sectoral basis

applicable in each jurisdiction, with minimum required capital based on the solo legal entity statutory minimum capital

requirement;

–For non-regulated entities, the capital resources are based on IFRS shareholder equity after deducting intangible assets. No

required capital is held in respect of unregulated entities;

–For entities where the Group's interest is less than 100 per cent, the contribution of the entity to the GWS eligible group capital

resources and required capital represents the Group's share of these amounts and excludes any amounts attributable to non-

controlling interests. This does not apply to investment holdings that are not part of the Group;

–Investments in subsidiaries, joint ventures and associates (including, if any, loans that are recognised as capital on the receiving

entity's balance sheet) are eliminated from the relevant holding company to prevent the double counting of capital resources;

–At 31 December 2025, all debt instruments with the exception of the senior debt maturing in 2032 are included as Group capital

resources. The eligible amount permitted to be included as Group capital resources for transitional debt is based on the net

proceeds amount translated using 31 December 2020 exchange rates for debt not denominated in US dollars. The eligible

amount permitted to be included as Group capital resources for qualifying debt is based on the IFRS carrying value. Under the

GWS Framework, debt instruments in issuance at the date of designation that satisfy the criteria for transitional arrangements

and qualifying debt issued since the date of designation are included in eligible group capital resources as tier 2 group capital;

–The total company GWS capital basis is the capital measure for Hong Kong IA Group regulatory purposes as set out in the GWS

framework. This framework defines the eligible group capital resources coverage ratio (or total company GWS coverage ratio

over GPCR as presented above) as the ratio of total company eligible group capital resources to the total company GPCR and

defines the tier 1 group capital coverage ratio (or total company GWS tier 1 coverage ratio over GMCR as presented above) as

the ratio of total company tier 1 group capital to the total company GMCR; and

–Prudential also presents a shareholder GWS capital basis, which excludes the contribution to the Group GWS eligible group

capital resources, the GMCR and GPCR from participating business in Hong Kong, Singapore and Malaysia. In Hong Kong, the

present value of future shareholder transfers from the participating business are included in the shareholder GWS eligible capital

resources along with an associated required capital, this is in line with the local solvency presentation. The shareholder GWS

coverage ratio over GPCR presented above reflects the ratio of shareholder eligible group capital resources to the shareholder

GPCR.

**I(ii) Eastspring adjusted operating profit and funds under management or advice**

**(a)Eastspring adjusted operating profit**

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 AER $m | 2023 AER $m |
| Operating income before performance-related fees <sup>note (1)</sup> | **809** | 747 | 700 |
| Performance-related fees | **5** | – | (2) |
| Operating income (net of commission)<sup>note (2)</sup> | **814** | 747 | 698 |
| Operating expense <sup>note (2)</sup> | **(418)** | (385) | (372) |
| Group's share of tax on joint ventures' operating profit | **(67)** | (58) | (46) |
| Adjusted operating profit | **329** | 304 | 280 |
| Average funds managed or advised by Eastspring | **$271.7bn** | $249.3bn | $225.9bn |
| Margin based on operating income <sup>note (3)</sup> | **30bps** | 30bps | 31bps |
| Cost/income ratio <sup>note II(v)</sup> | **52%** | 52% | 53% |

---

**Notes**

(1)Operating income before performance-related fees for Eastspring can be further analysed as follows (institutional below includes internal funds under

management or under advice). Amounts are classified between retail or institutional depending on whether the owner of the holding, where known, is a retail

or institutional investor.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Retail<br>$m | Margin<br>bps | Institutional<br>$m | Margin<br>bps | Total<br>$m | Margin<br>bps |
| **2025** | **470** | **59** | **339** | **18** | **809** | **30** |
| 2024 | 414 | 62 | 333 | 18 | 747 | 30 |
| 2023 | 353 | 67 | 347 | 20 | 700 | 31 |

---

(2)Operating income and expense include the Group's share of contribution from joint ventures. In the consolidated income statement of the Group IFRS financial

results, the net income after tax of the joint ventures and associates is shown as a single line item. A reconciliation is provided in note II(v) of this additional

information.

(3)Margin represents operating income before performance-related fees as a proportion of the related funds under management or advice. Monthly closing internal

and external funds managed or advised by Eastspring have been used to derive the average. Any funds held by the Group's insurance operations that are not

managed or advised by Eastspring are excluded from these amounts.

**(b) Eastspring total funds under management or advice**

Eastspring manages funds from external parties and funds for the Group's insurance operations. In addition, Eastspring advises on

certain funds for the Group's insurance operations where the investment management is delegated to third-party investment

managers. The table below analyses the total funds managed or advised on by Eastspring. All amounts are presented on an AER

basis unless otherwise stated.

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $bn** | 31 Dec 2024 $bn |
| External funds under management <sup>note (1)</sup> |  |  |
| Retail | **63.7** | 64.5 |
| Institutional | **23.9** | 31.0 |
| Money market funds (MMF) | **15.6** | 13.9 |
|  | **103.2** | 109.4 |
| Internal funds under management or advice: |  |  |
| Internal funds under management | **127.5** | 115.4 |
| Internal funds under advice | **47.0** | 33.2 |
|  | **174.5** | 148.6 |
| **Total funds under management or advice** <sup>note (2)</sup> | **277.7** | 258.0 |

---

**Notes**

(1)Movements in external funds under management, are analysed below:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | **31 Dec 2025 $m** | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m | 31 Dec 2024 $m |
| | **Retail** | **Institu-**<br>**tional**<br>| **Total**<br>**excl.**<br>**MMF**<br>| **MMF** | **Total** | Retail | Institu-<br>tional<br>| Total<br>excl.<br>MMF<br>| MMF | Total |
| At beginning of year | **64481** | **31059** | **95540** | **13914** | **109454** | 50779 | 33493 | 84272 | 11775 | 96047 |
| Market gross inflows | **29942** | **9340** | **39282** | **82636** | **121918** | 27994 | 12144 | 40138 | 70640 | 110778 |
| Redemptions | **(24595)** | **(9114)** | **(33709)** | **(79514)** | **(113223)** | (19153) | (15161) | (34314) | (68822) | (103136) |
| Market and other movements\* | **(6113)** | **(7404)** | **(13517)** | **(1464)** | **(14981)** | 4861 | 583 | 5444 | 321 | 5765 |
| **At end of year** | **63715** | **23881** | **87596** | **15572** | **103168** | 64481 | 31059 | 95540 | 13914 | 109454 |

---

\*Other movements include the effect of divestments in the year.

(2)Total funds under management or advice are analysed by asset class below (multi-asset funds include a mix of debt, equity and other investments):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | **31 Dec 2025** | 31 Dec 2024 | 31 Dec 2024 |
|  | **Funds under management** | **Funds under management** | **Funds under advice** | **Funds under advice** | **Total** | **Total** | Total | Total |
| | **$bn** | **% of total** | **$bn** | **% of total** | **$bn** | **% of total** | $bn | % of total |
| Equity | **57.9** | **25%** | **2.1** | **5%** | **60.0** | **21** | 61.8 | 24% |
| Fixed income | **40.9** | **18%** | **3.0** | **6%** | **43.9** | **16** | 45.2 | 17% |
| Multi-asset | **113.0** | **49%** | **41.9** | **89%** | **154.9** | **56** | 134.0 | 52% |
| Alternatives | **2.2** | **1%** | **–** | **0%** | **2.2** | **1** | 2.0 | 1% |
| MMF | **16.7** | **7%** | **–** | **0%** | **16.7** | **6** | 15.0 | 6% |
| **Total funds** | **230.7** | **100%** | **47.0** | **100%** | **277.7** | **100** | 258.0 | 100% |

---

**I(iii) Group funds under management**

For Prudential's asset management businesses, funds managed on behalf of third parties are not recorded on the balance sheet.

They are, however, a driver of profitability. Prudential therefore analyses the movement in the funds under management each

year, focusing on those that are external to the Group and those primarily held by the Group's insurance businesses. The table

below analyses the funds of the Group held in the balance sheet and the external funds that are managed by Prudential's asset

management businesses. The 2024 comparatives excluded the assets classified as held for sale. All amounts are presented on an

AER basis unless otherwise stated.

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $bn** | 31 Dec 2024 $bn |
| Internal funds | **223.9** | 191.3 |
| Eastspring external funds <sup>note I(ii)</sup> | **103.2** | 109.4 |
| **Total Group funds under management** <sup>note</sup> | **327.1** | 300.7 |

---

**Note**

Total Group funds under management comprise:

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025 $bn** | 31 Dec 2024 $bn |
| Total investments held on the balance sheet (including Investment in joint ventures and <br>associates accounted for using the equity method)<br>| **199.5** | 169.4 |
| External funds of Eastspring | **103.2** | 109.4 |
| Internally managed funds held in joint ventures and associates, excluding assets attributable <br>to external unit holders of the consolidated collective investment schemes and other <br>adjustments<br>| **24.4** | 21.9 |
| **Total Group funds under management** | **327.1** | 300.7 |

---

**II Calculation of alternative performance measures**

Prudential uses alternative performance measures (APMs) to provide more relevant explanations of the Group's financial position

and performance. This section sets out explanations for each APM and reconciliations to relevant IFRS balances. All amounts are

presented on an AER basis unless otherwise stated.

**II(i) Adjusted operating profit**

The measurement of adjusted operating profit reflects that, for the insurance business, assets and liabilities are held for the longer

term. Management believes trends in underlying performance are better understood if the effects of short-term fluctuations in

market conditions, such as changes in interest rates or equity markets, are excluded. This measurement basis distinguishes

adjusted operating profit from other constituents of total profit or loss for the year, including short-term interest rate and other

market fluctuations and loss on corporate transactions.

More details on how adjusted operating profit is determined are included in note B1.2 to the IFRS consolidated financial

statements. A full reconciliation to profit after tax is given in note B1.1 to the IFRS consolidated financial statements.

**II(ii) Return on IFRS shareholders' equity**

This measure is calculated as adjusted operating profit, after tax and non-controlling interests, divided by average IFRS

shareholders' equity.

Detailed reconciliation of adjusted operating profit to IFRS profit before tax for the Group is shown in note B1.1 to the Group IFRS

financial results.

---

| | | |
|:---|:---|:---|
|  | **2025 $m** | 2024\* $m |
| Adjusted operating profit | **3306** | 3129 |
| Tax on adjusted operating profit | **(534)** | (547) |
| Non-controlling interests' share of adjusted operating profit  | **(155)** | (146) |
| Adjusted operating profit, net of tax and non-controlling interests | **2617** | 2436 |
| IFRS shareholders' equity at beginning of year | **17492** | 16966 |
| IFRS shareholders' equity at end of year | **20117** | 17492 |
| Average IFRS shareholders' equity | **18805** | 17229 |
| **Operating return on IFRS shareholders' equity (%)** | **14%** | 14% |

---

\*Operating profit and IFRS shareholders' equity are net of the non-controlling interest arising in Malaysia at 1 January 2024 of 49 per cent.

**II(iii) IFRS shareholders' equity per share**

IFRS shareholders' equity per share is calculated as closing IFRS shareholders' equity divided by the number of issued shares at

the end of the year.

---

| | | |
|:---|:---|:---|
| | **31 Dec 2025** | 31 Dec 2024 |
| Number of issued shares at the end of the year (million shares) | **2548** | 2658 |
| Closing IFRS shareholders' equity ($ million) | **20117** | 17492 |
| **Group IFRS shareholders' equity per share (cents)** | **790¢** | 658¢ |

---

**II(iv) Eastspring cost/income ratio**

The cost/income ratio is calculated as operating expenses, adjusted for commissions and share of contribution from joint ventures

and associates, divided by operating income, adjusted for commission, share of contribution from joint ventures and associates

and performance-related fees. It is based on profit recorded during the year, using the ownership for that period.

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| **IFRS revenue** | **596** | 565 | 497 |
| Share of revenue from joint ventures and associates | **437** | 385 | 330 |
| Commissions and other | **(219)** | (203) | (129) |
| Performance-related fees | **(5)** | – | 2 |
| **Operating income before performance-related fees** <sup>note</sup> | **809** | 747 | 700 |
| **IFRS charges** | **491** | 454 | 376 |
| Share of expenses from joint ventures and associates | **146** | 134 | 125 |
| Commissions and other | **(219)** | (203) | (129) |
| **Operating expense** | **418** | 385 | 372 |
| Cost/income ratio (operating expense/operating income before performance-related <br>fees)<br>| **52%** | 52% | 53% |

---

**Note**

IFRS revenue and charges for Eastspring are included within the IFRS Income statement in 'other revenue' and 'non-insurance expenditure', respectively.

Operating income and expense include the Group's share of contribution from joint ventures and associates. In the IFRS condensed consolidated income

statement, the net income after tax from the joint ventures and associates is shown as a single line item.

**II(v) Insurance premiums**

New business sales are provided as an indicative volume measure of transactions undertaken in the reporting period that have the

potential to generate profits for shareholders. The Group reports annual premium equivalent (APE) new business sales as a

measure of the new policies sold in the year, which is calculated as the aggregate of annualised regular premiums and one-tenth

of single premiums on new business written during the year for all insurance products, including premiums for contracts

designated as investment contracts and excluded from the scope of IFRS 17. The use of one-tenth of single premiums is to

normalise policy premiums into the equivalent of regular annual payments. This measure is commonly used in the insurance

industry to allow comparisons of the amount of new business written in a period by life insurance companies, particularly when the

sales contain both single premium and regular premium business.

Gross premiums earned is the measure of premiums as defined under the previous IFRS 4 basis and reflects the aggregate of

single and regular premiums of new business sold in the year and renewal premiums on business sold in previous years but

excludes premiums for policies classified as investment contracts without discretionary participation features under IFRS, which

are recorded as deposits. Gross premiums earned is no longer a metric presented under IFRS 17 and is not directly reconcilable to

primary statements.

---

| | | | |
|:---|:---|:---|:---|
| | **2025 $m** | 2024 $m | 2023 $m |
| Gross premiums earned | **28317** | 24262 | 22248 |
| Gross premiums earned from joint ventures and associates | **4316** | 4003 | 3973 |
| Total Group, including joint ventures and associates | **32633** | 28265 | 26221 |

---

**EXHIBITS**

**Documents filed as Exhibits to the Form 20-F**

---

| | |
|:---|:---|
| **Exhibit** <br>**Number**<br>| **Description** |
| **1** | <u>[Memorandum and Articles of Association of Prudential](https://www.sec.gov/Archives/edgar/data/1116578/000110465924038849/puk-20231231xex1.htm)</u><sup>(5)</sup> |
| **2.1** | <u>[Second Amended and Restated Deposit Agreement, by and among Prudential, Citibank, N.A, as depositary, and](https://www.sec.gov/Archives/edgar/data/1116578/000119380525000266/e664245_ex99-a.htm)</u><br><u>[holders and beneficial owners of ADSs issued thereunder](https://www.sec.gov/Archives/edgar/data/1116578/000119380525000266/e664245_ex99-a.htm)</u><sup>(6)</sup>.<br>|
| **2.2** | The total amount of long-term debt securities of Prudential Funding (Asia) plc, a wholly-owned indirect subsidiary of <br>Prudential plc authorised under any instrument does not exceed 10 per cent of the total assets of the Company on a <br>consolidated basis. Prudential plc hereby agrees to furnish to the Securities and Exchange Commission, upon its <br>request, a copy of any instrument defining the rights of holders of long-term debt of Prudential plc or of its <br>subsidiaries for which consolidated or unconsolidated financial statements are required to be filed <br>|
| **2.3** | <u>[Description of rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934](exhibit23descriptionofri.htm)</u> |
| **4.1** | <u>[Prudential Long-Term Incentive plan](https://www.sec.gov/Archives/edgar/data/1116578/000110465924038849/puk-20231231xex4d1.htm)</u><sup>(5)</sup>, <u>[Prudential Deferred Annual Incentive Plan](https://www.sec.gov/Archives/edgar/data/1116578/000110465924038849/puk-20231231xex4d1.htm)</u><sup>(5)</sup> |
| **4.2** | <u>[Executive Director's Service Contract - Anil Wadhwani](https://www.sec.gov/Archives/edgar/data/1116578/000110465923036042/puk-20181231xex4d2.htm)</u><sup>(4)</sup> |
| **4.3** | Form of <u>[Letter of Appointment for Non-executive Directors](https://www.sec.gov/Archives/edgar/data/1116578/000104746920001629/a2240980zex-4_6.htm)</u><sup>(2)</sup>, <u>[form of Letter of Appointment for the Chair, Shriti](https://www.sec.gov/Archives/edgar/data/1116578/000104746921000601/a2243032zex-4_3.htm)</u><br><u>[Vadera](https://www.sec.gov/Archives/edgar/data/1116578/000104746921000601/a2243032zex-4_3.htm)</u><sup>(3)</sup> and <u>[form of Letter of Appointment for the Chair-Designate, Sir Douglas Flint.](exhibit43formoftheletter.htm)</u>Each Letter of appointment <br>substantially follows the form exhibited.<br>|
| **4.4** | <u>[Other benefits between the Prudential Group and the Directors](https://www.sec.gov/Archives/edgar/data/1116578/000104746919001527/a2238062zex-4_3.htm)</u>. Each of the Directors has the benefit of a deed of <br>indemnity granted by the Company which substantially follows the form exhibited<sup>(1)</sup><br>|
| **8.0** | <u>[Subsidiaries of Prudential (set forth in Note D6.4 to the consolidated financial statements included in this Form 20-](#if20250981a0d46e4b669404805d1a109_580)</u><br><u>[F)](#if20250981a0d46e4b669404805d1a109_580)</u><br>|
| **11.1** | <u>[Prudential's Code of Conduct](https://www.sec.gov/Archives/edgar/data/1116578/000110465924038849/puk-20231231xex11d1.htm)</u><sup>(5)</sup> |
| **11.2** | <u>[Insider Trading Policies](https://www.sec.gov/Archives/edgar/data/1116578/000110465925027998/puk-20241231xex11d2.htm)</u><sup>(7)(8)</sup> |
| **12.1** | <u>[Certification of Prudential plc's Chief Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002](exhibit121s302certificat.htm)</u> |
| **12.2** | <u>[Certification of Prudential plc's Chief Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002](exhibit122s302certificat.htm)</u> |
| **13.1** | <u>[Annual certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit131s906certificat.htm)</u> |
| **14.1** | <u>[Consent of EY LLP](exhibit141consentlettero.htm)</u> |
| **97** | <u>[Prudential Directors' compensation recovery policy](https://www.sec.gov/Archives/edgar/data/1116578/000110465924038849/puk-20231231xex97.htm)</u><sup>(5)</sup> |
| **101.INS**  | XBRL Instance Document  |
| **101.SCH**  | XBRL Taxonomy Extension Schema Linkbase Document  |
| **101.CAL**  | XBRL Taxonomy Extension Calculation Linkbase Document  |
| **101.DEF**  | XBRL Taxonomy Extension Definition Linkbase Document  |
| **101.LAB**  | XBRL Taxonomy Extension Label Linkbase Document  |
| **101.PRE**  | XBRL Taxonomy Extension Presentation Linkbase Document  |
| **104** | Cover page interactive data file (formatted as inline XBRL and contained in Exhibit 101)  |

---

(1)As previously filed with the Securities and Exchange Commission on 22 March 2019 as an exhibit to Prudential's Form 20-F.

(2)As previously filed with the Securities and Exchange Commission on 20 March 2020 as an exhibit to Prudential's Form 20-F.

(3)As previously filed with the Securities and Exchange Commission on 15 March 2021 as an exhibit to Prudential's Form 20-F.

(4)As previously filed with the Securities and Exchange Commission on 22 March 2023 as an exhibit to Prudential's Form 20-F.

(5)As previously filed with the Securities and Exchange Commission on 26 March 2024 as an exhibit to Prudential's Form 20-F.

(6)As previously filed with the Securities and Exchange Commission on 5 March 2025 as an exhibit to Prudential's Form F-6.

(7)As previously filed with the Securities and Exchange Commission on 26 March 2025 as an exhibit to Prudential's Form 20-F.

(8)Certain confidential information contained in this document, has been redacted in accordance with Instructions as to Exhibits to Form 20-F, because (i) the

Company customarily and actually treats that information as private or confidential and (ii) the omitted information is not material. "[\*\*\*]" indicates where the

information has been omitted from this exhibit.

**SIGNATURES**

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and

authorised the undersigned to sign this registration statement annual report on its behalf.

---

| | | |
|:---|:---|:---|
|  | Prudential plc | Prudential plc |
| 26 March 2026 |  |  |
|  | By:  | /s/ Anil Wadhwani |
|  | Name: | Anil Wadhwani |
|  | Title | Chief Executive Officer |

---

## Exhibit 2.3

![](exhibit23descriptionofri001.jpg)

1 DESCRIPTION OF SECURITIES As at 31 December 2025, Prudential plc ("Prudential", the "Company", "we", "us", "our") and its subsidiaries had four classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"): (i) our Ordinary Shares, 5 pence par value each (the "Ordinary Shares"), (ii) American Depositary Shares, each representing two Ordinary Shares, (iii) 3.125% senior notes due 2030 issued by Prudential Funding (Asia) plc and guaranteed by us (the "2030 Notes"); and (iv) 3.625% senior notes due 2032 issued by Prudential Funding (Asia) plc and guaranteed by us (the "2032 Notes"). Each of the foregoing securities are listed on the New York Stock Exchange. The following is a summary of the terms of Prudential's share capital, including brief descriptions of provisions contained in our articles of association, as last amended on 25 May 2023 (the "Articles"), a summary of the terms of the American Depositary Receipts representing ownership interests in the Ordinary Shares and a summary of the terms of the senior debt securities issued by us and our subsidiaries (collectively, the "Group"). These summaries and descriptions are being provided for information and references purposes only and are not intended to be, and must not be taken as, the basis for any investment decision. Capitalised terms used but not defined herein have the meanings given to them in our annual report on Form 20-F for the fiscal year ended 31 December 2025 of which this Exhibit 2.3 is a part. DESCRIPTION OF ORDINARY SHARES General The issued share capital as at 31 December 2025 consisted of 2,548,213,779 Ordinary Shares, all fully paid up and listed on the London Stock Exchange and the Hong Kong Stock Exchange. Prudential also maintains a secondary listing of the Ordinary Shares on the Singapore Stock Exchange. Rights and obligations The issued share capital of Prudential is not currently divided into different classes of shares. The Companies Act 2006 abolished the requirement for a company to have an authorised share capital. The rights and obligations attaching to the Company's shares are set out in full in the Articles. There are currently no voting restrictions on the Ordinary Shares, all of which are fully paid, and each share carries one vote on a poll. If votes are cast on a show of hands, each shareholder present in person or by proxy, or in the case of a corporation, by its duly authorised corporate representatives, has one vote. The same individual may be appointed as proxy or as a corporate representative by more than one member. Holders of Ordinary Shares have the right to participate in a distribution of profits, by way of dividend and have the right to participate in the surplus assets of the Company available for distribution in the event of a winding up or liquidation, voluntary or otherwise in proportion to the amounts paid up or credited as paid up on such Ordinary Shares. Where, under an employee share scheme, participants are the beneficial owners of the shares but not the registered owners, the voting rights are normally exercisable by the trustee on behalf of the registered owner in accordance with the relevant plan rules. The trustees would not usually vote any unallocated shares held in trust but they may do so at their discretion provided it would be considered to be in the best interests of the beneficiaries of the trust and permitted under the relevant trust deed. Transfer of shares In accordance with English company law, shares may be transferred by an instrument of transfer or through an electronic system (currently CREST) and no transfer is restricted except that the Directors may, in certain circumstances, refuse to register transfers of shares. If the Directors make use of that power, they must send the transferee notice of the refusal within two months. Certain restrictions may be imposed from time to time by applicable laws and regulations (for example, insider trading laws) and pursuant to the listing rules of both the Financial Conduct Authority and the Hong Kong Stock Exchange, as well as under the rules of some of the Group's employee share plans. Changes in share capital and authority to issue shares Under English law, directors require authority from shareholders, other than under certain types of employee share schemes, whenever shares are issued. Newly issued shares must first be offered to existing shareholders pro rata to their holdings (pre-emption rights) subject to certain exemptions, for example, where shares are issued for non- cash consideration or in respect of certain types of employee share schemes.

------

![](exhibit23descriptionofri002.jpg)

2 Prudential seeks authority from its shareholders on an annual basis to issue shares up to a maximum amount of which a defined number may be issued without pre-emption rights applying. Dis-application of statutory pre-emption procedures is also available for rights issues. The existing authorities to issue shares and dis-apply pre-emption rights are due to expire at the end of the 2026 annual general meeting of the Company when shareholder approval will be sought to renew those authorities. Shares may not be consolidated or sub-divided without approval by an ordinary resolution of the shareholders. Reductions in Prudential's issued share capital and share premium account must be approved by a special resolution of the shareholders and must be confirmed by an order of the court. Subject to the Articles, if the share capital is divided into different classes of shares, the rights of any class of shares may be changed or deemed varied, only if such measure is approved by a special resolution passed at a separate meeting of the members of that class, or with the written consent of members holding at least three quarters of the shares of that class. At least two persons holding or representing by proxy at least one-third in nominal amount of the issued shares of the class must be present at such a meeting in person or by proxy to constitute a quorum. The Board may not authorise, create or increase the amount of, any shares of any class or any security convertible into shares of any class or any security which is convertible into shares of any class ranking, as regards rights to participate in the profits or assets in the company, in priority to a series or class of preference shares without the consent in writing of at least three-quarters in nominal value of, or the sanction of a special resolution of, the holders of such series or class of preference shares. Dividends Under English law, Prudential may pay dividends only if distributable profits are available for that purpose. Distributable profits are accumulated, realised profits not previously distributed or capitalised, less accumulated, realised losses not previously written off in a reduction or reorganisation of capital. Even if distributable profits are available, Prudential may only pay dividends if the amount of its net assets is not less than the aggregate of its called-up share capital and undistributable reserves (including, for example, the share premium account) and the payment of the dividend does not reduce the amount of the net assets to less than that aggregate. Subject to these restrictions, Prudential's Directors may recommend to ordinary shareholders that a final dividend be declared and recommend the amount of any such dividend or determine whether to pay a distribution by way of an interim dividend, and the amount of any such interim dividend, but must take into account Prudential's financial position. Final dividends become a legal liability of a company upon the later of the date they are declared and the date the shareholder approval expresses them to be payable. Interim dividends only become a legal liability of a company at the point they are paid. The Company or its Directors determine the date on which Prudential pays dividends. Prudential pays dividends to the shareholders on its share registers on the record date in proportion to the number of Ordinary Shares held by each shareholder. There are no fixed dates on which entitlements to dividends arise. Interest is not payable on dividends or on other amounts payable in respect of Ordinary Shares. If a shareholder does not claim a dividend within six years of such dividend becoming due for payment, such shareholder forfeits their right to receive it. Such unclaimed amounts may be invested or otherwise used for Prudential's benefit. The Company periodically undertakes share forfeiture programmes. If a shareholder is recorded as untraced for more than six years, the shares are deemed as forfeited and sold by the Company. The proceeds from the sale of the forfeited shares are held for a period of two years by the Company, as required under the Articles. A number of dividend waivers are in place and these relate to Ordinary Shares issued but not allocated under the Group's employee share plans. These shares are primarily held by the Trustees and will, in due course, be used to satisfy requirements under the Group's employee share plans.

------

![](exhibit23descriptionofri003.jpg)

3 DESCRIPTION OF THE AMERICAN DEPOSITARY SHARES American Depositary Shares, which are frequently referred to as "ADSs", represent ownership interests in securities that are on deposit with a depositary bank. ADSs may be represented by certificates that are commonly known as "American Depositary Receipts" or "ADRs." We have one class of American Depositary Shares registered under Section 12 of the Exchange Act, with each such American Depositary Share representing two Ordinary Shares. Effective from 19 March 2025, our ADSs are deposited pursuant to a Second Amended and Restated Deposit Agreement, by and among Prudential, Citibank, N.A, as depositary (the "Depositary"), and all holders and beneficial owners of ADSs issued thereunder (the "Deposit Agreement"). Prior to 19 March 2025, J.P. Morgan Chase Bank, N.A. acted as our ADS depositary. The following is a summary of the general terms of the Deposit Agreement. This summary does not purport to be complete. For complete information, please read the Deposit Agreement, the form of which has been filed with the SEC as Exhibit 99.(a) to the Registration Statement on Form F-6 (File Number 333-285564), which became effective on 17 March 2025. Dividends and Distributions An owner of an ADS generally has the right to receive the distributions, if any, that we make on the Ordinary Shares deposited with the relevant custodian bank. Receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders will receive such distributions under the terms of the Deposit Agreement in proportion to the number of ADSs held as of a specified record date. Distributions of Cash Whenever the Depositary receives any cash dividend or any other cash distribution on any Ordinary Shares, the Depositary will arrange for the funds to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders in proportion to the number of ADSs held as of a specified record date, subject to the laws and regulations of England and Wales and/or Hong Kong. The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The Depositary will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the Depositary in respect of the Ordinary Shares. The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the Deposit Agreement. Distributions of Shares If any distribution in respect of an Ordinary Share consists of a dividend in, or free distribution of, Ordinary Shares, the Depositary will distribute additional ADRs for an aggregate number of ADSs representing the number of Ordinary Shares received as such dividend or distribution. Holders will receive such ADRs in proportion to the number of ADSs held as of a specified record date. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution. The distribution of additional ADRs will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the Deposit Agreement. In order to pay such taxes or governmental charges, the Depositary may sell all or a portion of the new Ordinary Shares so distributed. Distribution of Rights Whenever the Depositary receives any rights to subscribe for additional Ordinary Shares or any rights of any nature, the Depositary has the discretion to determine the appropriate procedure to make such rights available to the holders of ADSs or in disposing of such rights and distributing the net proceeds thereof, subject to the terms of the Deposit Agreement. Other Distributions Whenever the Depositary receives any distribution other than cash or Ordinary Shares, the Depositary will cause such securities or property to be distributed to the holders of ADSs in proportion to the number of ADSs held as of a specified record date in any manner the Depositary deems equitable and practicable. Any such distribution will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the Deposit Agreement. Changes Affecting Ordinary Shares The Ordinary Shares held on deposit for a holder's ADSs may change from time to time. For example, there may be a change in nominal or par value, a split-up, cancellation, consolidation or reclassification of such Ordinary Shares or a recapitalization, reorganization, merger, consolidation or sale of assets.

------

![](exhibit23descriptionofri004.jpg)

4 If any such change were to occur, the securities received by the Depositary will become deposited securities, each ADS will automatically represent its proportionate share of the new deposited securities, and the Depositary may issue new ADSs or ask a holder to surrender such holder's outstanding ADRs in exchange for new ADRs identifying the new deposited securities. Deposit, Withdrawal and Cancellation The Depositary will issue ADSs if Ordinary Shares have been deposited or evidence of rights to receive Ordinary Shares with the custodian has been received. Upon payment of its fees and expenses and of any taxes or charges, the Depositary will register the appropriate number of ADSs in the names requested and will deliver the ADSs at the Depositary office facilities in the Borough of Manhattan, the City of New York, to the persons requested. Upon written instruction, holders may request that the Ordinary Shares represented by the ADSs be withdrawn. Upon payment of its fees and expenses and of any taxes or charges, the Depositary will deliver the underlying Ordinary Shares and any other deposited securities underlying the ADSs at the office of the relevant custodian or at the holder's request, any other place specified in such order. Voting Rights A holder generally has the right under the Deposit Agreement to instruct the Depositary to exercise the voting rights for the Ordinary Shares represented by its ADSs. As soon as practicable after receipt of notice of any meeting or solicitation of consents or proxies of holders of Ordinary Shares, the Depositary will distribute to holders of ADSs notice of the same, together with information explaining how to instruct the Depositary to exercise the voting rights of the Ordinary Shares. If the Depositary receives voting instructions from a holder of ADSs, it will endeavor to vote the Ordinary Shares represented by the holder's ADSs in accordance with such voting instructions. The Depositary will not vote any Ordinary Shares except in accordance with such instructions. Fees and Charges ADS holders will be required to pay the following service fees to the Depositary, among others : Service Fees • Delivery of Receipts against deposit of Ordinary Shares Up to U.S. 5¢ per ADS issued • Withdrawal of Deposited Securities against surrender of Receipts Up to U.S. 5¢ per ADS cancelled • Cash dividends or distributions, stock dividends or distributions, other distributions or rights exercises Up to U.S. 5¢ per ADS held • Depositary services Up to U.S. 5¢ per ADS held on the applicable record date(s) established by the ADR Depositary • Registration of ADS transfers or ADS conversions Up to U.S. 5¢ per ADS transferred or converted ADS holders will also be responsible to pay certain fees and expenses incurred by the Depositary and certain taxes and governmental charges such as: • fees for the transfer and registration of Ordinary Shares charged by the registrar and transfer agent for the Ordinary Shares in England or Hong Kong (i.e., upon deposit and withdrawal of Ordinary Shares); • expenses incurred for converting foreign currency into U.S. dollars; • expenses for the cable, telex and fax transmissions for delivery of securities; • taxes and duties upon the transfer of securities (i.e., when Ordinary Shares are deposited or withdrawn from deposit); and • fees and expenses incurred in connection with the delivery or servicing of Ordinary Shares on deposit. We have agreed to pay certain other charges and expenses of the Depositary. Note that the fees and charges an ADS holder may be required to pay may vary over time and may be changed by us and by the Depositary. The holders will receive prior notice of such changes. Amendments and Termination We may agree with the Depositary to amend the Deposit Agreement and the ADSs for any reason without the consent of the holders party thereto. If the amendment adds or increases fees or charges (except for taxes and other governmental charges, transfer or registration fees or certain expenses of the Depositary), or prejudices an important right of ADS holders, it will not become effective until 30 days after the Depositary notifies the holders of ADSs of such amendment. No amendment will impair a holder's right request that the Ordinary Shares represented by the ADSs be withdrawn. If a governmental body adopts new laws or rules that require the Deposit Agreement or ADSs to be amended, we and the Depositary may make the necessary amendments, which could take effect before a holder receives notice thereof.

------

![](exhibit23descriptionofri005.jpg)

5 A holder of ADSs will be bound by the modifications to the Deposit Agreement if such holder continues to hold ADSs after the modifications to the Deposit Agreement become effective. We have the right to direct the Depositary to terminate the Deposit Agreement. Similarly, the Depositary may in certain circumstances on its own initiative terminate the Deposit Agreement. In either case, the Depositary must give notice to the holders at least 30 days before termination. As soon as practicable after the expiration of six months from the date of termination of the Deposit Agreement, the Depositary will sell the Ordinary Shares and any other the securities held on deposit. The Depositary will hold the proceeds from such sale and any other funds then held for the holders of ADSs for the pro rata benefit of the holders of ADSs. At that point, the Depositary will have no further obligations to holders of ADSs other than to account for the funds then held for the holders of ADSs still outstanding. Limitations on Obligations and Liabilities The Deposit Agreement expressly limits our and the Depositary's obligations and liabilities. Under the Deposit Agreement, we and the Depositary: • are only obligated to take the actions specifically set forth in the Deposit Agreement without negligence or bad faith; • are not liable if either of them is prevented, forbidden, subject to civil or criminal penalty on account of, or delayed by law or circumstances beyond its control from performing its respective obligations under the Deposit Agreement; • are not liable if either of them exercises discretion permitted under the Deposit Agreement; • have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the Deposit Agreement on a holder's behalf or on behalf of another party unless satisfactory indemnification is furnished; • may rely upon any documents they believe to be genuine and to have been signed or presented by the proper party; and • will not be liable for any action or inaction while relying on advice or information from legal counsel or certain other advisers, any holder or anyone else competent to give advice or information. In addition, a holder may request the Depositary to cause its nominee to take certain actions as a shareholder on the holder's behalf. For actions other than voting, a holder must indemnify the Depositary for any resulting losses, pay the expenses associated with such request and comply with certain other conditions. The Depositary will not, if acting in good faith, be responsible for failing to carry out instructions to vote the ADSs or for the manner in which the ADSs are voted or the effect of the vote. Taxes Holders of ADSs will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the Depositary and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. Holders of ADSs will be liable for any deficiency if the sale proceeds do not cover the taxes that are due. The Depositary may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The Depositary and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on a holder's behalf. However, a holder may be required to provide to the Depositary and to the custodian proof of taxpayer status and residence and such other information as the Depositary and the custodian may require to fulfill legal obligations. Holders are required to indemnify us, the Depositary and the custodian for any claims with respect to taxes based on any tax benefit obtained for such holder.

------

![](exhibit23descriptionofri006.jpg)

6 DESCRIPTION OF THE SENIOR DEBT SECURITIES The outstanding senior debt securities of the Group were issued under and governed by a document called a senior indenture, which we entered into on 14 April 2020 with Citibank, N.A., as senior trustee. The senior trustee has two main roles: • first, the senior trustee can enforce the rights of holders of the senior debt securities against the issuer if it defaults, subject to certain limitations on the extent to which the senior trustee acts on behalf of holders of the senior debt securities; and • second, the senior trustee performs administrative duties for the issuer, such as sending interest payments and notices to the holders of the senior debt securities. The senior indenture and its associated documents, including any supplemental indenture relating to a particular series of senior debt securities and the senior debt securities themselves, contain the full text of the matters summarized herein. The following description of the 2030 Notes and the 2032 Notes is a summary and does not purport to be complete. This description is qualified in its entirety by reference, as applicable, to the senior indenture as so supplemented. General The senior indenture does not limit the aggregate principal amount of senior debt securities that we may issue thereunder. We may issue such securities under the senior indenture from time to time in one or more series. All senior debt securities of any one series need not be issued at the same time. As of 31 December 2025 we have two series of senior debt securities outstanding that are registered under Section 12 of the Exchange Act – the 2030 Notes and the 2032 Notes (collectively the "Notes"). The 2030 Notes were issued pursuant to the senior indenture, as supplemented by the first supplemental indenture dated as of 14 April 2020. We issued $1,000,000,000 aggregate principal amount of the 2030 Notes on 14 April 2020. The 2030 Notes mature on 14 April 2030 and bear interest at a rate of 3.125% per annum. Interest on the 2030 Notes is payable semi- annually in arrears on 14 April and 14 October of each year, with the first such interest payment having been made on 14 October 2020. The 2032 Notes were issued pursuant to the senior indenture, as supplemented by the second supplemental indenture dated as of 24 March 2022. We issued $350,000,000 aggregate principal amount of the 2032 Notes on 24 March 2022. The 2032 Notes mature on 24 March 2032 and bear interest at a rate of 3.625% per annum. Interest on the 2032 Notes is payable semi-annually in arrears on 24 March and 24 September of each year, with the first such interest payment having been made on 24 September 2022. With effect from 2 March 2023, pursuant to the third supplemental indenture dated 2 March 2023, Prudential Funding (Asia) plc, an indirect wholly-owned subsidiary of Prudential incorporated in England and Wales, was substituted in place of Prudential as principal debtor in respect of each of the two series of the Notes and Prudential issued an irrevocable guarantee in respect of such Notes (the "Guarantees"). As of 26 March 2026, $1,000,000,000 aggregate principal amount of the 2030 Notes was outstanding and $350,000,000 aggregate principal amount of the 2032 Notes was outstanding. The Senior Trustee Citibank, N.A. is senior trustee under the senior indenture. We and certain of our subsidiaries maintain deposit accounts and conduct other banking transactions with Citibank, N.A. in the ordinary course of our business. Status of the Notes and the Guarantees The Notes constitute the direct unsubordinated and unsecured obligations of Prudential Funding (Asia) plc, without any preference among themselves and will rank at least equally with all other unsecured and unsubordinated obligations of Prudential Funding (Asia) plc. The Guarantees constitute our direct unsubordinated and unsecured obligations, without any preference among themselves and will rank at least equally with all of our other unsecured and unsubordinated obligations. These rankings are subject to such exceptions as are from time to time applicable under the laws of the United Kingdom and to laws or legal procedures of general applicability relating to or affecting creditors' rights. So long as the Notes remain outstanding, we and Prudential Funding (Asia) plc will not create or permit to exist any mortgage or charge upon the whole or any part of our undertaking or assets (other than assets representing the fund or funds we maintain in respect of long-term business (as defined in the Financial Services and Markets Act 2000 of the United Kingdom)), present or future, to secure payment of any of our or our subsidiaries' present or future relevant indebtedness, or to secure any guarantee or indemnity in respect thereof, without at the same

------

![](exhibit23descriptionofri007.jpg)

7 time securing the Notes and all amounts payable under the senior indenture in respect thereof equally and ratably with the same security as is created or subsisting to secure any such relevant indebtedness, guarantee or indemnity, or such other security as shall be approved by the holders of at least 75% in principal amount of the outstanding Notes of the relevant series. Defaults, Remedies and Waivers of Default Defaults and Remedies An "event of default" with respect to the Notes shall result if: 1. Prudential Funding (Asia) plc does not pay any principal (or premium, if any) on the Notes on the due date for payment, or default is made on the payment of interest, and, in each case, such default continues for a period of 14 days from the due date for payment; 2. any covenant or warranty in the senior indenture (other than as stated above with respect to payments when due) has been breached in any material respect and that breach has not been remedied within 30 days of receipt by Prudential Funding (Asia) plc of a written notice from the senior trustee, or receipt by Prudential Funding (Asia) plc and the senior trustee of written notice of such breach from holders of at least 25% in aggregate principal amount of the outstanding Notes of the relevant series, requiring that the breach be remedied; 3. either a court of competent jurisdiction issues an order that is not successfully appealed within 30 days, or an effective shareholders' resolution is validly adopted, for the winding up of us or Prudential Funding (Asia) plc; 4. we or Prudential Funding (Asia) plc stops or threatens to stop payments to creditors generally or we or Prudential Funding (Asia) plc ceases or threatens to cease to carry on our business or substantially the whole of our business (except for the purposes of, or in connection with, a reconstruction or amalgamation the terms of which have previously been approved in writing by the holders of at least 75% in aggregate principal amount of the outstanding Notes of the relevant series); 5. an encumbrancer takes possession or an administrative or other receiver or an administrator is appointed of the whole or any substantial part of the undertaking, property and assets of us or Prudential Funding (Asia) plc, or if a distress or execution is levied or enforced upon or sued out against the whole or any substantial part of our or Prudential Funding (Asia) plc's chattels and, in the case of any of the foregoing events, is not discharged within 60 days; 6. we or Prudential Funding (Asia) plc is unable to pay debts within the meaning of Section 123(2) of the Insolvency Act 1986 of the United Kingdom; or 7. the indebtedness for moneys borrowed (as defined below) of us or Prudential Funding (Asia) plc, which indebtedness in respect of any single company has an outstanding aggregate principal amount of at least £30,000,000 (or its equivalent in any other currency or currencies) is not paid on its due date as extended by any applicable grace period and following a demand therefor, or is declared to be or automatically becomes, due and payable prior to its stated maturity by reason of default or if any guarantee or indemnity in respect of indebtedness for moneys borrowed of any third party that we or Prudential Funding (Asia) plc have given (having in respect of any single company an outstanding aggregate principal amount as aforesaid) is not honored when due and called upon and, in any such case, our liability to make payment is not being contested in good faith. "Indebtedness for moneys borrowed" means the principal amount of (i) all moneys borrowed and (ii) all debentures (together in each case with any fixed or minimum premium payable on final redemption or repayment) that neither we nor Prudential Funding (Asia) plc nor any of our subsidiaries beneficially owns for the time being. If an event of default occurs and is continuing in relation to a series of Notes, the senior trustee or the holders of at least 25% of the aggregate principal amount of the outstanding Notes of the relevant series may declare by a notice in writing to Prudential Funding (Asia) plc (and to the senior trustee if given by the holders of the Notes): • the entire principal amount of (including premium, if any, on) of all such Notes; and • any accrued but unpaid interest payments thereon, to be due and payable immediately. This is called an acceleration of the maturity. If the maturity of the relevant series of Notes has been accelerated, but a judgment for payment has not yet been obtained, the holders of a majority in aggregate principal amount of the relevant series of Notes may, under certain circumstances, cancel the acceleration. If an event of default occurs, the senior trustee will have certain additional duties. In that situation, the senior trustee will be obligated to use its rights and powers under the senior indenture, and to use the same degree of care and skill in its exercise of the rights and powers vested in it by the senior indenture, as a prudent person would exercise under the circumstances in the conduct of such person's own affairs. The senior trustee will be under no obligation to exercise any of its rights or powers under the senior indenture at the request of any holder of Notes, unless such holder shall have offered to the senior trustee indemnity and/or security satisfactory to the senior trustee against any loss, liability or expense, and then only to the extent required by the terms of the senior indenture. Subject to these senior indenture provisions for the indemnification of the senior trustee, the holder(s) of a majority in aggregate principal amount of the Notes of the relevant series will,

------

![](exhibit23descriptionofri008.jpg)

8 subject to certain limitations, have the right to direct the time, method and place of conducting any proceeding seeking any remedy available to the senior trustee. Before holders are allowed to bypass the senior trustee and bring their own lawsuit or other formal legal action or take other steps to enforce their rights or protect their interests relating to a series of the Notes, all of the following must generally occur: • such holders must give the senior trustee written notice that an event of default has occurred, and the event of default must not have been cured or waived; • holders of at least 25% of the aggregate principal amount of the Notes of the relevant series must make a written request that the senior trustee take action because of the event of default, and they or other holders must offer to the senior trustee indemnity and/or security satisfactory to the senior trustee against the cost and other liabilities of taking that action; • the senior trustee must not have taken action for 60 days after the above steps have been taken; and • during those 60 days, the holders of a majority of the aggregate principal amount of the outstanding Notes of the relevant series must not have given the senior trustee directions that are inconsistent with the written request of the holders of at least 25% of the aggregate principal amount of the Notes of the relevant series. Notwithstanding these limitations, nothing will impair the right of a holder of the Notes to institute suit for the enforcement of payment of the principal of (and premium, if any, on) and interest, if any, on the Notes on or after its stated maturity. The senior trustee will, within 90 days of a default with respect to a series of the Notes, give to each holder of such series notice of any default it knows about, unless the default has been cured or waived. However, except in the case of a default in the payment of the principal of (or premium, if any), or interest, if any, on a series of the Notes, the senior trustee will be entitled to withhold such notice if it determines in good faith that withholding of the notice is in the interest of the holder(s) of the Notes of such series. We Will Give the Senior Trustee Information about Defaults Annually Prudential Funding (Asia) plc will furnish the senior trustee with an annual certificate of certain of its officers certifying, to the best of their knowledge, whether of Prudential Funding (Asia) plc is, or has been, in default and specifying the nature and status of any such default. In addition, of Prudential Funding (Asia) plc is required to provide the senior trustee with written notice within five days of its becoming aware of any event of default, or event that could mature into an event of default, under the senior indenture. Waivers of Certain Defaults The holders of not less than a majority in aggregate principal amount of a series of the Notes may generally also waive any events of default. If this happens, the relevant event of default will be treated as if it had not occurred. No one, however, can waive defaults by Prudential Funding (Asia) plc in the payment of the principal of (and premium, if any, on) and interest, if any, on the Notes or in respect of a covenant or a provision that under the senior indenture (together with any related amendments or supplements thereto) cannot be modified or amended without the consent of each holder of the Notes of the relevant series. Consolidation, Merger and Sale or Lease of Assets We and Prudential Funding (Asia) plc may, without the consent of the holders of the Notes, consolidate with or merge into or transfer or lease our properties and assets substantially as an entirety, provided that any successor corporation formed by any such consolidation or merger or any such transferee or lessee of our assets is a corporation or other person organized and validly existing under the laws of a member country of the Organisation for Economic Co-operation and Development that assumes our obligations on or in respect of the Notes and the senior indenture, and a number of other conditions are met. Note that any such conditions will apply only if we or Prudential Funding (Asia) plc wish to merge or consolidate with another entity or sell our assets substantially as an entirety to another entity. We will not need to satisfy these conditions if we enter into other types of transactions, including any transaction in which we acquire the securities or assets or another entity, any transaction that involves a change of control of us or Prudential Funding (Asia) plc but in which we do not merge or consolidate, and any transaction in which we sell less than substantially all our assets. Modifications Under certain circumstances, we can make changes to the senior indenture and the Notes. The following three types of changes are possible. Changes Requiring Approval by each Holder The first type of change comprises changes that cannot be made without the specific approval of each holder of the Notes of the relevant series. These include changes that:

------

![](exhibit23descriptionofri009.jpg)

9 • change the stated maturity of the principal, any installment of principal or any interest on the Notes of such series; • reduce the rate or amount of any interest; • reduce the principal or any premium payable on redemption; • change the place of payment; • change the right of holders to waive an existing default by majority vote; • impair the right to sue for payment; • reduce the percentage of holders who must consent to a waiver or amendment of the senior indenture or the waiver of defaults; and • make any change to the list of changes that requires the approval of each holder, including the foregoing. Changes Requiring Majority Approval The second type of change comprises changes that require approval by the holders of more than 50% of the aggregate principal amount of the outstanding Notes of the relevant series. Most changes fall into this category, except for those described under "Changes Requiring Approval by each Holder" above and "Changes Not Requiring Approval" below. Changes Not Requiring Approval The third type of change does not require any approval by holders of the Notes of the relevant series . This type is limited to clarifications and other changes that would not adversely affect holders of the Notes of such series in any material respect. Waivers of Certain Covenants The obligations of us and/or of Prudential Funding (Asia) plc to comply with certain restrictive covenants in the senior indenture pertaining to corporate existence and maintenance of certain agencies or as pertain to the negative pledge covenant described above may be waived in respect of a series of Notes by holders of not less than a majority in aggregate principal amount of the outstanding Notes of the relevant series. Notices Notices to holders of the Notes in registered form will be given by mail to the addresses of such holders as they appear in the security register, or, in the case of the Notes held by a depositary, in accordance with the applicable procedures of the depositary. Consent to Service; Jurisdiction We have appointed Cogency Global Inc, located at 18th Floor, 122 East 42nd Street, New York, NY 10168, as our authorized agent for service of process in any suit or proceeding to which we are party arising out of or relating to the Notes or the senior indenture that may be instituted in any federal or state court in the Borough of Manhattan in New York City and have submitted to the jurisdiction of those courts. Notwithstanding the foregoing, actions relating to the Notes or the senior indenture may (subject to certain limitations) be instituted by a holder of the Notes in any competent court in England and Wales. Legal Ownership and Form The Notes are represented by one or more permanent global securities in fully registered form (the "Global Notes"). The Global Notes have been deposited with DTC as depositary, and registered in the name of a nominee of DTC in the form of a global certificate. The Global Notes DTC has advised us that pursuant to procedures established by it (i) DTC or its custodian has credited, on its internal system, the principal amount at maturity of the individual beneficial interests represented by such Global Notes to the respective accounts of persons who have accounts with such depositary and (ii) ownership of beneficial interests in the Global Notes are shown on, and the transfer of such ownership will be effected only through, records maintained by DTC or its nominee (with respect to interests of participants) and the records of participants (with respect to interests of persons other than participants). Ownership of beneficial interests in the Global Notes will be limited to persons who have accounts with DTC ("participants") or persons who hold interests through participants. Holders may hold their interests in the Global Notes directly through DTC if they are participants in such system, or indirectly through organizations that are participants in such system. So long as DTC, or its nominee, is the registered owner or holder of the Notes, DTC or such nominee, as the case may be, will be considered the sole owner or holder of the Notes represented by such Global Notes for all purposes under the senior indenture governing. No beneficial owner of an interest in the Global Notes will be able to transfer that interest except in accordance with DTC's procedures, in addition to those provided for under the senior indenture. Payments of the principal of, premium, if any, and interest on, the Global Notes will be made to DTC or its nominee, as the case may be, as the registered owner of the Global Notes. None of we, the trustee or any paying agent under the senior indenture will have any responsibility or liability for any aspect of the records relating to or

------

![](exhibit23descriptionofri010.jpg)

10 payments made on account of beneficial ownership interests in the Global Notes or for maintaining, supervising or reviewing any records relating to such beneficial ownership interest. DTC's present practice is, upon receipt of any payment of principal, premium, if any, and interest on the Global Notes, to credit immediately participants' accounts with payments in amounts proportionate to their respective beneficial interests in the principal amount of the Global Notes as shown on the records of DTC. Payments by participants to owners of beneficial interests in the Global Notes held through such participants will be governed by standing instructions and customary practice, as is now the case with securities held for the accounts of customers registered in the names of nominees for such customers. Such payments will be the responsibility of such participants. Transfers between participants in DTC will be effected in the ordinary way through DTC's same-day funds system in accordance with DTC rules and will be settled in same-day funds. If a holder requires physical delivery of a certificated security for any reason, including to sell notes to persons in states which require physical delivery of the notes, or to pledge such securities, such holder must transfer its interest in a Global Note in accordance with the normal procedures of DTC and with the procedures set forth in the indenture governing the Notes. DTC will take any action permitted to be taken by a holder of notes, including the presentation of notes for exchange as described below, only at the direction of one or more participants to whose account the DTC interests in the Global Notes are credited and only in respect of such portion of the aggregate principal amount of notes as to which such participant or participants has or have given such direction. However, if there is an event of default under the indenture governing the notes, DTC will exchange the Global Notes for certificated securities, which it will distribute to its participants. Certificated Securities A Global Note is exchangeable for certificated securities if: DTC (i) notifies Prudential Funding (Asia) plc that it is unwilling or unable to continue as depositary for the Global Notes or (ii) has ceased to be a Clearing Agency registered under the Exchange Act and, in either case, a successor depositary is not appointed by us within 120 days. In addition, beneficial interests in a Global Note may be exchanged for certificated securities upon prior written notice given to the trustee by or on behalf of DTC in accordance with the senior indenture. In all cases, certificated securities delivered in exchange for any Global Note or beneficial interests in Global Notes will be registered in the names, and issued in any approved denominations, requested by or on behalf of the depositary (in accordance with its customary procedures). Governing Law The senior indenture and the Notes are governed by and construed in accordance with the laws of the State of New York.

------

## Exhibit 4.3

![](exhibit43formoftheletter001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prudential plc, 5th Floor, 10 Old Bailey London, EC4M 7NG Incorporated and registered in England and Wales. Registered Office as above. Registered number 1397169. Prudential plc is a holding company, some of whose subsidiaries are authorised and regulated, as applicable, by the Hong Kong Insurance Authority and other regulatory authorities. The Group is subject to a group-wide supervisory framework which is regulated by the Hong Kong Insurance Authority. STRICTLY PRIVATE [FULL NAME] [ADDRESS] [ADDRESS] [ADDRESS] [ADDRESS] Dear PRUDENTIAL PLC - LETTER OF APPOINTMENT AS NON-EXECUTIVE DIRECTOR I am delighted to confirm that the Board of Prudential plc (the 'Company') has agreed to appoint you as a Non-executive Director and Chair-Designate with effect from 4 March 2026 and as Chair of the Board, and Chair of the Nomination & Governance Committee with effect from the conclusion of the Company's Annual General Meeting on 28 May 2026. I am now writing to set out the main terms of your appointment. It is agreed that this is a contract for services, subject to the Company's Articles of Association as amended from time to time, and does not constitute a contract of employment. Initial appointment and continuation Your appointment is subject to election by shareholders at the Annual General Meeting ('AGM') in 2026 and subsequent AGMs, and remains subject to any relevant regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any provisions relating to the removal of Directors, including any provisions set out in this letter and any additional provisions, both statutory and those contained in the Articles of Association. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination & Governance Committee, a second term of three years. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum tenure of nine years from initial appointment, subject to annual review by the Nomination & Governance Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director, including as Chair. Your maximum tenure and relevant milestones are as follows: Date of appointment End of first three- year term End of second three-year term End of additional one- year terms (maximum of three terms) Notice period March 2026 March 2029 March 2032 March 2033 March 2034 March 2035 12 months PRUDENTIAL PLC 5th Floor, 10 Old Bailey London, EC4M 7NG www.prudentialplc.com

------

![](exhibit43formoftheletter002.jpg)

Page 2 of 9 If you are not confirmed by the Nomination & Governance Committee to be a suitable candidate for re-election by shareholders, or you are not re-elected by shareholders, or you are removed from office under the Company's Articles of Association or any other statutory provisions or the terms of this letter, your appointment shall terminate automatically with immediate effect. Participation in Committees You will be asked to serve as a member of the Nomination & Governance and Remuneration Committees. Once your appointment as Chair becomes effective, you will also chair the Nomination & Governance. In your capacity as Chair, you will be invited to attend meetings of all other Board Committees. Role Your duties as Chair will be assigned to you by the Board and will be consistent with the Terms of Reference for the role of Chair as approved by the Board. These Terms of Reference are regularly reviewed and refreshed. Non-executive Directors have the same general legal responsibilities to the Company as any other Director. You are expected to perform your duties (whether statutory, fiduciary or common law) faithfully, diligently and to a standard commensurate with the functions of your role and your knowledge, skills and experience. The Board as a whole is collectively responsible for the success of the Company. Directors of any company must take decisions objectively in the interests of that company. As a Director, you owe a fiduciary duty to the Company, which includes an obligation not to do anything that might bring it into disrepute. All Directors must act with integrity, lead by example and promote the culture desired by the Board. In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: • Strategy. Non-executive Directors should constructively challenge, offer specialist advice and help develop proposals on strategy. • Performance. Non-executive Directors should scrutinise and hold to account the performance of Management against agreed objectives and monitor the reporting of performance. This is achieved both at the Board and on a more individual level through the Remuneration Committee. • Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Risk Committee also has an important role in this context. • People. Non-executive Directors have a prime role in appointing, and where necessary removing, the Chief Executive Officer, the Chief Financial Officer, the Risk and Compliance Officer and in succession planning. In addition, they are responsible for determining appropriate levels of remuneration for the Chief Executive Officer and other senior executives. This business is mainly conducted via the Nomination & Governance Committee and the Remuneration Committee. Non-executive Directors also have a prime role in

------

![](exhibit43formoftheletter003.jpg)

Page 3 of 9 upholding high standards of integrity and probity and in supporting the other Directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. As a director of a company which is the holding company of a number of regulated subsidiaries, you must comply with relevant guidance and regulations applicable from time to time. A summary of the duties and responsibilities of Directors under applicable legislation will be provided to you as part of your induction. Time commitment, fees and expenses Once you commence your role as Chair, we would anticipate a time commitment of approximately three to four days per week. We currently schedule five Board meetings per year in person, which usually take place at our head office in Hong Kong or at one of our businesses, and two shorter virtual meetings. In addition, the Board holds a two-day Board Strategy Day and visits to a major business in Asia are scheduled around at least one of the Board meetings. You may be required to devote additional time to the Company in respect of preparation time and ad hoc matters which may arise and particularly when the Company is undergoing a period of increased activity, which could include additional meetings of the Board and Board Committees or shareholder meetings. You must discuss any additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company and Chair with me prior to accepting. You will be entitled to a fee for your services as, first, Chair-Designate, and then Chair, of $1,005,000. No additional fees will be paid for any other duties you may perform as a Director of Prudential or any other company within the Prudential group. This fee will be reviewed with effect from 1 July 2026 and annually thereafter. All fees are payable monthly in arrears, net of any tax and National Insurance contributions, where the Company is required to deduct these. As a Non-executive Director you are not entitled to participate in any of the Group's executive remuneration programmes or pension arrangements. Benefits and Facilities Please note that the arrangements and benefits described in this section are subject to periodic review by the Remuneration Committee. You will be responsible for any tax or National Insurance contributions due on the benefits provided to you. 1. Car and Office Facilities The Company will reimburse you for commuting to the Company's head office in London. You will be provided with an office and administrative support at the Company's head office in London as your principal place of work: these facilities will be provided to cover all your commitments including those outside Prudential.

------

![](exhibit43formoftheletter004.jpg)

Page 4 of 9 2. Life Assurance The Company will provide life assurance cover of four times your annual fee plus an additional sum of four times your annual fee which would be used to purchase an annuity for any financial dependants. These benefits are subject to medical underwriting and any other terms and conditions of the insurance policy. 3. Medical Cover The Company will arrange appropriate cover under the terms of its medical insurance scheme (subject to the rules of that scheme from time to time) to provide private health care for you, your spouse or cohabiting partner and any dependent children under 21 years of age. The Company reserves the right to request you to undergo a medical examination as a condition of providing cover. 4. Expenses Directors are entitled to claim for business related expenses (including any banking fees and any other reasonable fees for professional services such as legal, tax, property and financial advice) properly incurred by them in connection with their attendance at meetings of the Board or Committees of the Board, general meetings or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to the Chair of the Remuneration Committee for approval. Any taxes due on these benefits, other than for business related travel and expenses, would be for your own account. Shareholding, dealing and compliance I would also like to make you aware of the Board's shareholding guidelines. You are required to hold 2,500 qualification shares in Prudential plc, which must be purchased within your first year of appointment and must be retained during the tenure of your office. As Chair, you will be required to hold shares with a value equivalent to one times your annual fee and you will be expected to attain this level of share ownership within five years of the date of your appointment as Chair. During your term in office you are a person discharging managerial responsibility (PDMR) under the UK Market Abuse Regulation, and are subject to Prudential's PDMR Dealing Rules, which can be found in the Board Reading Room on your iPad and are available from Group Secretariat on request. The rules incorporate all relevant obligations arising from the Company's primary listings in Hong Kong and the UK, as well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to securities dealings. If you have any questions on this please consult with the Company Secretary. Conflicts of interests, independence and disclosure obligations It is accepted and acknowledged that you have business interests other than those of the

------

![](exhibit43formoftheletter005.jpg)

Page 5 of 9 Company and we have discussed these and agreed that no conflicts of interest currently exist (other than any conflict authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as apparent and also prior to accepting appointments. In certain circumstances, you may have to seek agreement from the Nomination & Governance Committee or the Board before accepting further commitments which might give rise to a conflict of interest or a conflict with any of your duties to the Company, or which might impact on the time you are able to devote to your role at the Company. In particular we would not wish our Directors to serve on the Boards of financial services competitors or for the Chair to take up an executive role or to become Chair of another public company. The Board of the Company has determined that you are independent on appointment according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence in relation to the Hong Kong Listing Rules, and you will be identified as such in the annual report and other documentation. Any changes in your external appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly as the Company is required to announce this to various stock exchanges. Wrongdoing You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. Termination of appointment a. Other than as set out in paragraph (b) below, your appointment may be terminated by, and at the discretion of, either party upon twelve months' written notice. b. Notwithstanding the above paragraph (a), your appointment may be terminated with immediate effect if you: (i) commit a material breach of your obligations under this letter; or (ii) commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or (iii) are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests of the Company; or (iv) are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or (v) are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or

------

![](exhibit43formoftheletter006.jpg)

Page 6 of 9 (vi) are disqualified from acting as a Director; or (vii) cease to hold applicable regulatory status; or (viii) do not comply with relevant Group policies including the Group Code of Conduct, the Group Anti-Money Laundering and Sanctions Policy, the Group Anti-Bribery and Corruption Policy, the Inside Information Policy and the PDMR Dealing Rules; or (ix) you are not confirmed by the Nomination & Governance Committee to be a suitable candidate for re-election by shareholders; or (x) you are not re-elected as a Director by shareholders; or (xi) you are removed from office under the Company's Articles of Association. On termination of your appointment you shall resign from your office as Director of the Company and from any other offices you hold in any of the Company's Group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be returned to the Company forthwith on termination. If matters arise which cause you concern about your role, you should discuss these matters with the Chief Executive or myself. If you have any concerns which cannot be resolved, and you choose to resign for that, or any other reason, you should provide an appropriate written statement to the Chief Executive or myself for circulation to the Board. Confidentiality During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries, undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by any competent regulatory body. This does not apply, however, to any information already in the public domain. You acknowledge the need to hold and retain Company information (in whatever format you may receive it) under appropriately secure conditions and in accordance with Company policy. Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior agreement of the Chief Executive Officer or the Company Secretary. Data Protection

------

![](exhibit43formoftheletter007.jpg)

Page 7 of 9 By signing this letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 2018, incorporating the General Data Protection Regulation) including, as appropriate: (a) information about you that may be relevant to ensuring equality of opportunity and treatment in line with the Company's equal opportunities policy and in compliance with equal opportunities legislation; and (b) information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. You consent to the transfer of such personal information to other offices the Company may have or to a company in the Group or to other third parties, whether or not outside the UK, for administration purposes and other purposes in connection with your appointment, where it is necessary or desirable for the Company to do so You will comply at all times with the Company's data protection policy, a copy of which will be provided to you. You will allow Group Security to carry out a security audit of your primary residence to ensure that the Company's data and property is safeguarded. The cost of any home security equipment recommended by the audit (for instance, a shredder, safe or alarm) would be for your own account. Induction and professional development Following your appointment, the Company will provide an induction programme which will include meetings with senior management and the Company's advisers and will focus on areas of specific interest to you. As part of your induction you will receive a briefing on your duties as a director generally and as a director of a company listed in Hong Kong and the UK. You will also receive a briefing on your obligations under applicable financial services regulation. You should expect to spend up to ten days in the first year following your appointment on activities related to the induction programme. As a Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each Director annually to ascertain their specific professional development needs. Board evaluation The performance of individual Directors and the whole Board and its Committees is evaluated annually. As Chair you will lead this exercise. The evaluation of your performance as Chair will be led by me. Directors' and officers' protection The Company has Directors' and Officers' liability insurance and it is intended to maintain such cover for the full term of your appointment.

------

![](exhibit43formoftheletter008.jpg)

Page 8 of 9 The Company also provides you with indemnity cover for Directors' and Officers' liability within the limitations imposed by law. In addition, the Company provides you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company's constitutional documents or otherwise. In addition, the Board has resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. Independent professional advice Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice from independent advisers at the Company's expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure under which Directors may obtain such independent advice will be provided to you. Governing law and jurisdiction This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction to settle any dispute arising in respect of it. Yours sincerely Senior Independent Director Prudential plc

------

![](exhibit43formoftheletter009.jpg)

Page 9 of 9 Acknowledgement: 1. By signing this letter, I agree to its terms. 2. I acknowledge that this appointment letter does not constitute a contract of employment. 3. I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 4. I confirm that I am not subject to any restrictions which prevent me from holding office as a Director. Signed: ____________________ Dated: _____________________

------

## Exhibit 12.1

![](exhibit121s302certificat001.jpg)

Section 302 Certification for Chief Executive Officer I, Anil Wadhwani, certify that: 1. I have reviewed this annual report on Form 20-F of Prudential plc (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and 5. The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarise and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting. Date: 26 March 2026 /s/ Anil Wadhwani _______________________ Anil Wadhwani Chief Executive Officer

------

## Exhibit 12.2

![](exhibit122s302certificat001.jpg)

Section 302 Certification for Chief Financial Officer I, Ben Bulmer, certify that: 1. I have reviewed this annual report on Form 20-F of Prudential plc (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and 5. The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarise and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting. Date: 26 March 2026 /s/ Ben Bulmer _______________________ Ben Bulmer Chief Financial Officer

------

## Exhibit 13.1

![](exhibit131s906certificat001.jpg)

Annual Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Prudential plc (the Company), does hereby certify, to such officer's knowledge, that: The Annual Report on Form 20-F for the year ended 31 December 2025 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company. 26 March 2026 /s/ Anil Wadhwani ________________________ Anil Wadhwani Chief Executive Officer 26 March 2026 /s/ Ben Bulmer ________________________ Ben Bulmer Chief Financial Officer

------

## Exhibit 14.1

![](exhibit141consentlettero001.jpg)

Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: 1) Registration Statements (Form S-8 No. 333-213731 and Form S-8 No. 333-228081) pertaining to Prudential plc; and 2) Registration Statement (Form F-3 No. 333-279008) of Prudential plc and Prudential Funding (Asia) plc of our reports dated 26 March 2026, with respect to the consolidated financial statements of Prudential plc, and the effectiveness of internal control over financial reporting of Prudential plc included in this Annual Report (Form 20-F) of Prudential plc for the year ended 31 December 2025. /s/ Ernst & Young LLP London, United Kingdom 26 March 2026

------